Clustering O 0 2.206152238670711e-08
of O 0 1.761384704757063e-09
missense O 0 5.2722953114425763e-08
mutations O 0 1.2258505321938173e-10
in O 0 7.20600098688684e-12
the O 0 2.3036333729464786e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.6230784183335345e-07
in O 0 3.415785709837138e-10
a O 0 2.7687198020376336e-11
sporadic B-Disease 0 8.517786227457691e-06
T I-Disease 1 0.9999996423721313
- I-Disease 0 0.0003206395194865763
cell I-Disease 0 5.923468779656105e-05
leukaemia I-Disease 1 0.9995009899139404
. O 0 1.004289007511261e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.1851283327787314e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.230375290722877e-14
is O 0 8.213703371117776e-16
a O 0 3.247145484287328e-15
recessive B-Disease 0 1.7498457127729239e-09
multi I-Disease 0 1.358804729534313e-05
- I-Disease 1 0.9999998807907104
system I-Disease 1 0.9446225166320801
disorder I-Disease 0 5.8094596170121804e-05
caused O 0 5.516150869411263e-10
by O 0 2.4553031049284746e-12
mutations O 0 5.852272659534474e-12
in O 0 1.6682571123138867e-12
the O 0 1.8959771252990976e-11
ATM O 0 1.761384704757063e-09
gene O 0 2.7783675967535393e-12
at O 0 2.0329384009531992e-11
11q22 O 0 8.003854645721731e-08
- O 0 1.420633566340257e-07
q23 O 0 9.91322963272978e-07
( O 0 2.31869714401034e-11
ref O 0 4.31887627883043e-08
. O 0 1.0297603048048387e-10
3 O 0 1.8865702056114486e-10
) O 0 9.12580774836691e-13
. O 0 3.292135730692536e-10

The O 0 5.752820442239681e-09
risk O 0 3.891357902574555e-09
of O 0 4.076620707671452e-10
cancer B-Disease 0 3.28151301687285e-08
, O 0 4.7901617568346655e-12
especially O 0 1.4117158553261788e-09
lymphoid B-Disease 0 7.358891025432968e-07
neoplasias I-Disease 0 4.623053428076673e-06
, O 0 4.65331592702789e-12
is O 0 5.820773144081873e-14
substantially O 0 9.843093007333437e-11
elevated O 0 4.87842015672868e-08
in O 0 6.05399841369092e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 1.0
and O 0 4.642184206482547e-11
has O 0 1.5595093575890284e-13
long O 0 8.582124946679773e-14
been O 0 3.502936262995797e-14
associated O 0 3.0604584838611615e-11
with O 0 2.4396065723131244e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 4.385073282264784e-07

By O 0 3.4474384458249574e-10
analysing O 0 2.922504194202702e-08
tumour B-Disease 1 0.9999984502792358
DNA O 0 2.7888058085068224e-08
from O 0 1.0943859707346348e-10
patients O 0 5.078373832567706e-10
with O 0 2.342271071108931e-13
sporadic B-Disease 0 8.519815963836663e-08
T I-Disease 0 7.584550621686503e-05
- I-Disease 0 9.062730441655731e-07
cell I-Disease 0 3.759407718462171e-06
prolymphocytic I-Disease 1 0.6092926263809204
leukaemia I-Disease 1 0.9999995231628418
( O 0 4.14595831624287e-12
T B-Disease 0 1.3193679038181472e-08
- I-Disease 0 8.219809277676404e-10
PLL I-Disease 0 2.233712059762638e-08
) O 0 1.1520043816451442e-13
, O 0 3.5002247411250464e-14
a O 0 6.503954005140228e-14
rare O 0 2.63765103508673e-11
clonal B-Disease 0 8.781646521072162e-09
malignancy I-Disease 0 2.2419158085540403e-08
with O 0 5.737741011480058e-13
similarities O 0 1.76049296668479e-11
to O 0 4.4940392553149966e-12
a O 0 2.647752329887343e-11
mature B-Disease 0 5.2631218494525456e-08
T I-Disease 0 1.1147852063686514e-07
- I-Disease 0 1.0434426656047435e-09
cell I-Disease 0 1.8003094570673284e-09
leukaemia I-Disease 0 5.387870487538748e-07
seen O 0 6.4713425590445794e-12
in O 0 2.357897948071508e-12
A B-Disease 1 1.0
- I-Disease 1 0.6512017846107483
T I-Disease 1 1.0
, O 0 7.882953838300732e-12
we O 0 1.789497640781318e-13
demonstrate O 0 5.291210720438644e-13
a O 0 1.8008645518829275e-14
high O 0 1.8534906682382557e-12
frequency O 0 6.458789232610673e-12
of O 0 1.860501162853634e-11
ATM O 0 8.215726410298885e-08
mutations O 0 2.7737863117494044e-09
in O 0 3.304475981735777e-08
T B-Disease 0 0.0021480137947946787
- I-Disease 0 4.512585292104632e-06
PLL I-Disease 0 5.011356188333593e-05
. O 0 3.050445229746401e-08

In O 0 4.31559454838748e-10
marked O 0 8.810498441924608e-10
contrast O 0 1.0687069007531136e-09
to O 0 8.92703792831906e-12
the O 0 5.524139826129648e-11
ATM O 0 4.079998561223874e-09
mutation O 0 1.7977409491609642e-11
pattern O 0 2.1632975966134893e-10
in O 0 3.557562230915856e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.509852833037062e-11
the O 0 2.6150177943190522e-12
most O 0 1.3507193952731755e-13
frequent O 0 2.231303825787987e-14
nucleotide O 0 1.7392184697637147e-12
changes O 0 7.332237247914541e-12
in O 0 1.2196601367753246e-11
this O 0 6.483308334637172e-10
leukaemia B-Disease 0 0.0015891895163804293
were O 0 6.485290526825338e-09
missense O 0 1.5473912071684026e-06
mutations O 0 7.670438506579558e-09
. O 0 1.7468186896962834e-08

These O 0 1.874812749491639e-09
clustered O 0 1.2942728000453485e-09
in O 0 1.837422575201586e-12
the O 0 5.303166326214859e-12
region O 0 3.5740008175189075e-11
corresponding O 0 1.9186201238863276e-10
to O 0 2.698668510880964e-10
the O 0 3.5946163823297184e-09
kinase O 0 4.0264605538631315e-10
domain O 0 6.293445209415438e-10
, O 0 1.1280653060968815e-12
which O 0 2.533052977440886e-13
is O 0 1.0755633851004115e-13
highly O 0 2.771467083606538e-11
conserved O 0 2.4101163773049272e-11
in O 0 4.232506706225436e-12
ATM O 0 2.419839262302048e-08
- O 0 1.6857913953671755e-09
related O 0 1.1616140938031094e-08
proteins O 0 1.3601421378073297e-10
in O 0 8.66202942706451e-11
mouse O 0 3.55169427201929e-09
, O 0 3.134976219593133e-12
yeast O 0 2.5300753492274453e-08
and O 0 4.904023853669059e-10
Drosophila O 0 1.2688429862350858e-08
. O 0 3.2569498209511494e-09

The O 0 1.7919741246430476e-09
resulting O 0 3.4661915560008083e-09
amino O 0 2.3639807888997666e-09
- O 0 1.7735952706487979e-09
acid O 0 6.440076472102874e-09
substitutions O 0 1.1305833602648363e-08
are O 0 8.982346116903628e-11
predicted O 0 1.4782703061655411e-08
to O 0 1.2534615012604888e-10
interfere O 0 5.6292757122378134e-09
with O 0 4.234420539900308e-12
ATP O 0 5.821967974384279e-08
binding O 0 6.32069641071098e-09
or O 0 3.5280611765386993e-10
substrate O 0 2.50352911734808e-08
recognition O 0 3.528426439913801e-09
. O 0 1.060388665763412e-08

Two O 0 3.7208871539462507e-09
of O 0 3.653661595492963e-09
seventeen O 0 1.4277038218324378e-08
mutated O 0 3.178657559388398e-09
T B-Disease 0 2.2558484147339186e-07
- I-Disease 0 2.9605864426685002e-09
PLL I-Disease 0 5.898578336882565e-08
samples O 0 3.037164408858928e-10
had O 0 3.2297936027048113e-12
a O 0 7.876331694061517e-14
previously O 0 1.546746411507094e-11
reported O 0 1.8565070314391363e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 7.783062301314203e-07
. O 0 1.197080390369365e-08

In O 0 2.4847088830881603e-09
contrast O 0 3.90416721174347e-09
, O 0 1.6201106428637146e-11
no O 0 1.9694934919045615e-11
mutations O 0 1.9756713626195577e-11
were O 0 2.1953820705800098e-11
detected O 0 8.971700604654131e-10
in O 0 1.193008192235112e-10
the O 0 8.295473197250658e-10
p53 O 0 1.565203522346792e-10
gene O 0 6.976962757532235e-11
, O 0 6.782503378377491e-12
suggesting O 0 8.574317644782781e-11
that O 0 1.043130642627843e-12
this O 0 2.6861585178394876e-10
tumour B-Disease 1 1.0
suppressor O 0 1.4450408343691379e-05
is O 0 4.306701262973833e-12
not O 0 9.381825828366774e-13
frequently O 0 2.7459777073718383e-12
altered O 0 3.8206127150886005e-10
in O 0 4.2408240114033546e-11
this O 0 1.1932500543210267e-09
leukaemia B-Disease 0 0.017056185752153397
. O 0 4.2299408420376494e-08

Occasional O 0 1.0605664328977582e-06
missense O 0 2.7554328880796675e-06
mutations O 0 4.4996726344948e-09
in O 0 6.715021871883664e-10
ATM O 0 1.973152848222526e-06
were O 0 4.604350234416188e-09
also O 0 2.7631171656272713e-11
found O 0 3.2401655143676766e-12
in O 0 1.8636229712210017e-11
tumour B-Disease 1 1.0
DNA O 0 1.021973794479436e-08
from O 0 4.516917395669395e-11
patients O 0 1.7974742527737675e-10
with O 0 1.8466617937498014e-13
B B-Disease 0 2.1507028691303276e-07
- I-Disease 0 4.71510996913338e-10
cell I-Disease 0 5.1765265851599906e-08
non I-Disease 0 0.00023917070939205587
- I-Disease 0 0.0011812037555500865
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.8337880373001099
( O 0 1.5280634830389106e-12
B B-Disease 0 3.7600047519958935e-09
- I-Disease 0 5.52052414198867e-12
NHL I-Disease 0 6.035969057904822e-09
) O 0 3.544443926729868e-14
and O 0 6.93857623267069e-13
a O 0 8.245820692920347e-12
B B-Disease 0 3.229393996662111e-07
- I-Disease 0 1.7241073013707364e-09
NHL I-Disease 0 8.264839834737359e-07
cell O 0 1.7723219514209632e-07
line O 0 4.1253719018641277e-07
. O 0 1.0608619760432703e-08

The O 0 5.557008186940493e-10
evidence O 0 1.2336165422510703e-10
of O 0 2.042258029355537e-11
a O 0 2.6330543648200866e-13
significant O 0 2.8204320823288498e-11
proportion O 0 9.91388637849866e-10
of O 0 1.45308695631563e-10
loss O 0 9.944561146779662e-11
- O 0 3.5612504611926e-10
of O 0 9.783152066233924e-09
- O 0 1.3748193694596011e-09
function O 0 5.240785236337864e-11
mutations O 0 2.1456788169144092e-12
and O 0 1.3318445196523754e-13
a O 0 3.84147398678307e-14
complete O 0 7.720378503162095e-11
absence O 0 8.812182983319872e-09
of O 0 2.18750823011149e-10
the O 0 1.2696738625750381e-11
normal O 0 9.920823190734396e-11
copy O 0 1.165163382443879e-10
of O 0 4.5104090601322255e-11
ATM O 0 3.2155749174478387e-09
in O 0 5.981475297706096e-12
the O 0 2.274374265309742e-11
majority O 0 1.7493433784876444e-11
of O 0 2.551648337068002e-10
mutated O 0 8.811226734906086e-07
tumours B-Disease 1 1.0
establishes O 0 3.8718197536979915e-09
somatic O 0 1.380171976705924e-08
inactivation O 0 4.0162026948564744e-07
of O 0 8.887253433176312e-11
this O 0 1.3969603468791392e-12
gene O 0 1.1185502394109315e-12
in O 0 2.290048142436496e-12
the O 0 4.19116095995431e-11
pathogenesis O 0 2.0533154554414068e-07
of O 0 1.3714382962604077e-09
sporadic B-Disease 0 3.4316650499022217e-07
T I-Disease 0 4.7696379624539986e-05
- I-Disease 0 5.951035291218432e-07
PLL I-Disease 0 6.549719273607479e-06
and O 0 1.606984857682736e-11
suggests O 0 1.5313729451182923e-11
that O 0 4.966817820066137e-15
ATM O 0 1.254265691308376e-09
acts O 0 2.7389070178518438e-11
as O 0 4.783115917228464e-11
a O 0 2.309852309423377e-10
tumour B-Disease 1 1.0
suppressor O 0 5.8578920288709924e-05
. O 0 4.100792239114526e-08

As O 0 1.4963976724402528e-08
constitutional O 0 1.0117896920291969e-07
DNA O 0 4.839317835347856e-09
was O 0 1.7925749773439748e-10
not O 0 5.405686748921612e-13
available O 0 7.34610896419019e-12
, O 0 1.5560686419946457e-13
a O 0 3.838475544359898e-12
putative O 0 1.562051920700469e-06
hereditary O 1 0.999977707862854
predisposition O 1 0.9999828338623047
to O 0 0.00038929592119529843
T B-Disease 1 1.0
- I-Disease 0 5.412466998677701e-05
PLL I-Disease 0 1.8618355170474388e-05
will O 0 1.2506166241488259e-11
require O 0 1.384644395668877e-11
further O 0 1.034889101497738e-11
investigation O 0 4.490802521517345e-11
. O 0 4.045850807155027e-11
. O 0 5.467694075278473e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 4.717715273727663e-05
kinase O 0 3.12965937609988e-08
is O 0 7.165702493178161e-13
involved O 0 2.264014713551643e-13
in O 0 3.823418971292576e-14
the O 0 1.225591487021352e-13
modulation O 0 3.59512506570292e-12
of O 0 8.263119463843005e-13
the O 0 9.637031624099013e-12
Ca2 O 0 2.136981425149287e-10
+ O 0 3.2830014262685836e-09
homeostasis O 0 2.2516351450008187e-08
in O 0 7.40171313129423e-10
skeletal O 0 6.452792717936973e-07
muscle O 0 1.9000040083483327e-06
cells O 0 0.0005126843461766839
. O 0 2.3059463671870617e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.1393654847656762e-08
DM B-Disease 1 1.0
) O 0 2.2127610507793882e-11
, O 0 5.480183364395264e-13
the O 0 2.7966572200416318e-12
most O 0 2.11804618982514e-11
prevalent O 0 5.494501237990335e-06
muscular B-Disease 0 2.4451952640447416e-07
disorder I-Disease 0 1.0020312402048148e-06
in O 0 1.1216412243442164e-09
adults O 0 5.988399220946405e-10
, O 0 1.2897918071574054e-14
is O 0 1.8105517712391434e-15
caused O 0 4.928114665479766e-13
by O 0 5.476623061301256e-12
( O 0 1.6001450381733506e-12
CTG O 0 4.042414847305054e-09
) O 0 1.1472499687715468e-14
n O 0 3.503178649943983e-13
- O 0 8.49140365227069e-13
repeat O 0 2.8414458286274424e-12
expansion O 0 3.9049454642059445e-11
in O 0 5.985192810115114e-13
a O 0 2.2040142876999375e-13
gene O 0 2.396892905508208e-13
encoding O 0 7.111098515588665e-11
a O 0 6.792449935844047e-11
protein O 0 3.817016480667235e-09
kinase O 0 1.6782848888396984e-08
( O 0 1.2201167853831407e-10
DM B-Disease 1 0.9999996423721313
protein O 0 1.560194640148893e-08
kinase O 0 6.743193781133527e-10
; O 0 1.458801482390193e-11
DMPK O 0 9.523097105557099e-06
) O 0 5.480946100623607e-13
and O 0 1.5404412229309827e-13
involves O 0 1.279101932878668e-12
changes O 0 6.138328040306007e-11
in O 0 7.143851066260254e-10
cytoarchitecture O 0 5.094290099805221e-05
and O 0 2.2011965583601523e-08
ion O 0 1.0431783721287502e-06
homeostasis O 0 6.810465492890216e-06
. O 0 1.253026084668818e-06

To O 0 1.4474164922173571e-10
obtain O 0 1.2354042233653217e-09
clues O 0 6.878119740427735e-10
to O 0 4.1949717354342053e-13
the O 0 4.732828712272763e-12
normal O 0 4.629182370763374e-09
biological O 0 5.982052075914623e-10
role O 0 3.3973845958712445e-10
of O 0 6.514203221286152e-08
DMPK O 1 1.0
in O 0 3.5109453619952546e-06
cellular O 0 4.902448580423879e-08
ion O 0 1.76449947986157e-08
homeostasis O 0 1.4010511861783925e-08
, O 0 8.96803534211621e-11
we O 0 6.294943039053535e-11
have O 0 8.940600863815984e-12
compared O 0 4.158912381146962e-10
the O 0 5.798874574969304e-11
resting O 0 2.55506837909536e-09
[ O 0 6.869525347868999e-12
Ca2 O 0 3.892173855348652e-13
+ O 0 3.681033776403719e-12
] O 0 1.832435939097543e-11
i O 0 3.3932947597625773e-12
, O 0 1.850708713883875e-14
the O 0 1.0599329844807742e-13
amplitude O 0 9.691353622387489e-12
and O 0 1.2370883397533339e-12
shape O 0 4.168855816111261e-10
of O 0 3.1777769304852654e-10
depolarization O 0 1.5680100551307419e-09
- O 0 9.113418908412996e-10
induced O 0 2.199542104008856e-09
Ca2 O 0 1.1802787913683943e-11
+ O 0 1.4359847512468438e-11
transients O 0 4.451966295615506e-10
, O 0 1.0528525344307219e-13
and O 0 2.5671032614633764e-14
the O 0 5.473915049535039e-13
content O 0 1.0288056864760087e-11
of O 0 7.946477677267527e-12
ATP O 0 1.4502476552991084e-08
- O 0 2.3802053661370337e-09
driven O 0 2.7617816922287375e-09
ion O 0 9.018625291012938e-10
pumps O 0 1.0242955372774531e-09
in O 0 3.3235473401171944e-11
cultured O 0 2.780780050670728e-08
skeletal O 0 1.4607413945100234e-08
muscle O 0 2.963584933013408e-10
cells O 0 9.020607372178802e-09
of O 0 4.3531020454956604e-10
wild O 0 2.2078507078138188e-10
- O 0 3.0872795639402817e-12
type O 0 9.569023524946818e-12
and O 0 4.4459686041227464e-13
DMPK O 0 4.276311756257201e-06
[ O 0 8.74243877291292e-09
- O 0 2.4549339627810696e-07
/ O 0 3.939048269785417e-07
- O 0 3.148254791085492e-06
] O 0 1.7101160665333737e-07
knockout O 0 4.2560608903841057e-07
mice O 0 1.832333929030483e-08
. O 0 6.020581255761215e-10

In O 0 2.9672756696186298e-08
vitro O 0 3.488555648800684e-07
- O 0 3.3432436907787633e-07
differentiated O 0 7.162780661928991e-07
DMPK O 0 0.0018962936010211706
[ O 0 1.999111809425358e-08
- O 0 2.0989748605870773e-08
/ O 0 9.341240669868967e-09
- O 0 1.1069410277286806e-08
] O 0 1.349398592864759e-09
myotubes O 0 6.5117040648488e-09
exhibit O 0 4.183111149136387e-11
a O 0 4.74560820327985e-13
higher O 0 3.7991756962618695e-10
resting O 0 1.0969862795917606e-09
[ O 0 1.3900558655521866e-11
Ca2 O 0 1.1248380699102611e-12
+ O 0 6.331558107669499e-12
] O 0 6.203404456783801e-11
i O 0 1.379285661379237e-11
than O 0 2.0299385002781056e-12
do O 0 1.0676151802890832e-12
wild O 0 2.0000468295422458e-11
- O 0 6.942366386625265e-12
type O 0 1.7678798702736032e-10
myotubes O 0 1.5551385956769082e-07
because O 0 2.262835335775648e-10
of O 0 6.31706215115102e-11
an O 0 1.594680638895233e-14
altered O 0 1.5705264866383573e-10
open O 0 3.490389921534387e-11
probability O 0 8.629011567784506e-12
of O 0 1.3891812179755991e-11
voltage O 0 3.4658032888046364e-08
- O 0 8.831904096950893e-09
dependent O 0 7.528422329983187e-09
l O 0 4.318474397524419e-11
- O 0 7.997479761767678e-11
type O 0 5.21757637095277e-11
Ca2 O 0 1.697582872883796e-11
+ O 0 5.360985266822382e-11
and O 0 5.138142515626054e-12
Na O 0 7.799597079305443e-10
+ O 0 1.8566523318774841e-10
channels O 0 7.341027785656706e-11
. O 0 1.3493052508639636e-10

The O 0 1.6567378224863205e-07
mutant O 0 3.421776000323007e-07
myotubes O 0 2.3591094304720173e-06
exhibit O 0 1.584155917555563e-09
smaller O 0 1.6245735312558907e-10
and O 0 1.0983118711380135e-12
slower O 0 3.0959763641646987e-09
Ca2 O 0 7.232707766036128e-10
+ O 0 3.724144603811652e-10
responses O 0 9.001395982755067e-12
upon O 0 4.414775142680405e-11
triggering O 0 2.9837694814904836e-11
by O 0 1.5746221600915211e-12
acetylcholine O 0 6.543486308352442e-10
or O 0 3.516378577206325e-10
high O 0 3.1172719960892437e-09
external O 0 1.6835741689646966e-09
K O 0 3.610353260796728e-08
+ O 0 6.247781181301093e-10
. O 0 2.3801133286482923e-10

In O 0 8.63874127787767e-09
addition O 0 1.2784721059588833e-09
, O 0 9.841046727521174e-11
we O 0 1.078652184932638e-11
observed O 0 1.4767574316176812e-11
that O 0 6.345055367619826e-14
these O 0 4.0311439082618694e-12
Ca2 O 0 5.75516301282164e-11
+ O 0 6.553566023193014e-10
transients O 0 1.137518079730171e-08
partially O 0 4.0808037504724837e-11
result O 0 5.2382542747864136e-12
from O 0 2.2443243010566993e-12
an O 0 4.700670665973121e-14
influx O 0 3.5338246218152847e-11
of O 0 1.4543506156317054e-11
extracellular O 0 1.5455756466331572e-11
Ca2 O 0 1.5225831012655178e-11
+ O 0 1.9189046185363878e-11
through O 0 1.2209443525645902e-12
the O 0 2.6590014912120097e-12
l O 0 3.6052192047691944e-12
- O 0 4.743485812475079e-11
type O 0 6.586846346134934e-11
Ca2 O 0 1.5234320749346608e-10
+ O 0 9.432491454575143e-10
channel O 0 8.59257179297579e-11
. O 0 1.890907846968659e-10

Neither O 0 3.7260138014971744e-06
the O 0 2.2223401785481656e-08
content O 0 8.284282593251646e-09
nor O 0 3.3517013608985735e-09
the O 0 2.0009360487960315e-11
activity O 0 3.2954969308995885e-10
of O 0 1.1672475486168565e-10
Na O 0 1.7809614893948833e-09
+ O 0 2.3896201684081575e-10
/ O 0 5.76859560119658e-10
K O 0 5.54953027975813e-10
+ O 0 1.7021316647825024e-11
ATPase O 0 3.363122280664044e-11
and O 0 7.913138460463598e-13
sarcoplasmic O 0 2.5083590760033303e-10
reticulum O 0 4.967455891069505e-10
Ca2 O 0 8.006637713942055e-11
+ O 0 7.389042849803573e-11
- O 0 9.167652054165032e-11
ATPase O 0 4.110449480787537e-11
are O 0 4.134787605076899e-14
affected O 0 2.2519828883627024e-12
by O 0 7.45668544271938e-12
DMPK O 1 0.5182119011878967
absence O 0 1.3302696970640682e-05
. O 0 2.8566572041199834e-07

In O 0 2.1997770272008665e-09
conclusion O 0 1.793089765556033e-08
, O 0 3.285760552529382e-11
our O 0 1.8562405085242872e-11
data O 0 8.921999423983085e-12
suggest O 0 2.1189393989429206e-11
that O 0 5.497687808470042e-13
DMPK O 0 0.030146576464176178
is O 0 3.1316236496353733e-12
involved O 0 5.28708478907125e-13
in O 0 4.026800052257806e-13
modulating O 0 1.1599082111457548e-10
the O 0 6.807491202687199e-12
initial O 0 5.2245371223724746e-11
events O 0 1.250856243670967e-13
of O 0 1.7117408293750025e-13
excitation O 0 5.305872963212721e-10
- O 0 8.247889038415224e-10
contraction O 0 1.1148310052888633e-09
coupling O 0 2.6929569685307797e-09
in O 0 2.8281799124840745e-10
skeletal O 0 3.1811033807116473e-08
muscle O 0 1.595680210186856e-08
. O 0 9.78680958496625e-09
. O 0 2.8475879432221518e-08

Constitutional O 0 0.00012236171460244805
RB1 O 0 0.0026311681140214205
- O 0 9.552169649396092e-05
gene O 0 3.581811069963692e-09
mutations O 0 4.060868530331163e-09
in O 0 1.7473034130688347e-10
patients O 0 1.0799799810001787e-07
with O 0 6.350029529977874e-11
isolated O 0 5.2317727750050835e-06
unilateral B-Disease 0 0.00048183754552155733
retinoblastoma I-Disease 1 1.0
. O 1 0.9037414789199829

In O 0 2.371260299227629e-09
most O 0 2.0597769323504878e-10
patients O 0 4.343489734548456e-10
with O 0 1.0791908816240592e-12
isolated O 0 4.15358911709518e-08
unilateral B-Disease 0 9.688026693766005e-06
retinoblastoma I-Disease 1 1.0
, O 0 1.2723039617412724e-05
tumor B-Disease 1 1.0
development O 0 8.579202699365851e-07
is O 0 2.326523956125426e-12
initiated O 0 2.935790846536612e-11
by O 0 6.846849205221356e-14
somatic O 0 1.0601333144677483e-09
inactivation O 0 3.730126962864233e-08
of O 0 8.357071284992301e-11
both O 0 1.264301857650807e-11
alleles O 0 1.0564906588461653e-11
of O 0 4.734384412286019e-11
the O 0 1.1903766861109943e-09
RB1 O 0 1.0795946764119435e-05
gene O 0 4.261130559513049e-09
. O 0 1.6034480410098695e-08

However O 0 2.278710326208966e-06
, O 0 1.6148143933136794e-10
some O 0 1.7377892744599444e-12
of O 0 2.2481643283112085e-11
these O 0 1.9905641024386966e-10
patients O 0 5.390147772565967e-10
can O 0 1.02985805647271e-11
transmit O 0 5.977606853946327e-09
retinoblastoma B-Disease 0 3.247298809583299e-05
predisposition O 0 5.6356144341407344e-05
to O 0 1.747715856481591e-07
their O 0 2.0484289962041657e-06
offspring O 0 2.13193579838844e-05
. O 0 2.6283190734943673e-08

To O 0 1.576306446482434e-10
determine O 0 5.907700023621842e-11
the O 0 1.1115388991178587e-11
frequency O 0 9.855773835942827e-11
and O 0 1.5541592535486815e-12
nature O 0 5.423827359463118e-11
of O 0 9.537760164990416e-11
constitutional O 0 1.026633299261448e-06
RB1 O 0 6.862255395390093e-05
- O 0 1.3640348015542259e-06
gene O 0 2.079006966582142e-10
mutations O 0 1.5781595474884114e-10
in O 0 3.919653143724666e-11
patients O 0 3.975524354160598e-09
with O 0 2.771444749041785e-12
isolated O 0 7.830325188251663e-08
unilateral B-Disease 0 4.14279566030018e-06
retinoblastoma I-Disease 1 0.9998956918716431
, O 0 5.497919453034683e-09
we O 0 7.628046805319144e-11
analyzed O 0 9.09773090196353e-11
DNA O 0 1.9121099148478038e-10
from O 0 1.184389825797938e-11
peripheral O 0 1.698447071873943e-08
blood O 0 1.4918750679271398e-08
and O 0 1.0030436897734418e-10
from O 0 2.396992604403181e-10
tumor B-Disease 0 3.272662922881864e-07
tissue O 0 1.380098808567709e-07
. O 0 2.2846689873290416e-08

The O 0 2.4106889817687716e-09
analysis O 0 4.663147090688824e-10
of O 0 1.618951728232787e-08
tumors B-Disease 1 1.0
from O 0 3.696640149541963e-08
54 O 0 8.022868058787935e-08
( O 0 1.970360723538289e-12
71 O 0 6.817086894983504e-10
% O 0 9.725735841681349e-13
) O 0 2.7532632308746845e-15
of O 0 1.6614140618820272e-12
76 O 0 2.089829864715398e-09
informative O 0 9.46386635725105e-10
patients O 0 1.0849858789185873e-09
showed O 0 2.213883937285388e-11
loss O 0 5.82193737663772e-11
of O 0 5.926065194117314e-10
constitutional O 0 0.00019061114289797843
heterozygosity O 1 0.9223296046257019
( O 0 3.6005725068122274e-09
LOH O 0 0.04129008203744888
) O 0 1.611552037650288e-11
at O 0 2.7323443507754064e-10
intragenic O 0 1.2259285995241953e-06
loci O 0 1.4902516909387487e-07
. O 0 5.883959275365669e-08

Three O 0 2.620504035988347e-09
of O 0 7.411517510824694e-10
13 O 0 1.522010606436197e-08
uninformative O 0 0.0014151938958093524
patients O 0 5.600736039923504e-05
had O 0 5.4646838165695044e-09
constitutional O 0 1.680187415331602e-05
deletions O 0 3.1338488042820245e-05
. O 0 4.172167336946586e-06

For O 0 4.7626581789472766e-08
39 O 0 1.4494740980808274e-06
randomly O 0 4.2330562166625896e-08
selected O 0 7.241959792736452e-06
tumors B-Disease 1 1.0
, O 0 2.727198022967059e-08
SSCP O 1 0.9999961853027344
, O 0 6.735896285192666e-09
hetero O 0 1.7401278640249984e-08
- O 0 1.5848049261801833e-10
duplex O 0 2.9855984351456755e-10
analysis O 0 2.8552125941327944e-12
, O 0 7.886237913786245e-14
sequencing O 0 1.267417143457905e-10
, O 0 2.5934009714040362e-12
and O 0 6.524461526602465e-12
Southern O 0 1.4602051512380143e-10
blot O 0 9.625381380828912e-09
analysis O 0 2.7750150267957796e-12
were O 0 6.30154348840728e-13
used O 0 1.100582949428719e-12
to O 0 5.33892444143369e-11
identify O 0 1.271706828731567e-08
mutations O 0 5.331310859446603e-08
. O 0 1.8232111642646487e-07

Mutations O 0 2.4301304080154296e-08
were O 0 1.797553078608516e-10
detected O 0 4.5342438137474517e-10
in O 0 1.3612211184621525e-11
21 O 0 9.260095468199836e-10
( O 0 6.252909431556097e-13
91 O 0 1.6944241565397533e-09
% O 0 5.111009272057432e-12
) O 0 1.8372007745421498e-13
of O 0 2.8977567567700646e-10
23 O 0 0.0002417368086753413
tumors B-Disease 1 1.0
with O 0 7.469007687177509e-05
LOH O 1 1.0
. O 0 0.0017442667158320546

In O 0 2.9673026258336677e-09
6 O 0 5.405233149957667e-09
( O 0 1.347901933297646e-12
38 O 0 3.0740268663898007e-10
% O 0 2.0400263509717798e-12
) O 0 6.835653462537727e-14
of O 0 3.8790173850777876e-10
16 O 0 2.0056997982464964e-06
tumors B-Disease 1 1.0
without O 1 0.9999990463256836
LOH O 1 1.0
, O 0 1.2864765253084443e-08
one O 0 1.1834441759894787e-10
mutation O 0 7.2489145762355545e-12
was O 0 1.0061933057581296e-11
detected O 0 7.847628102908288e-11
, O 0 2.6212785739741784e-13
and O 0 6.010257395938634e-13
in O 0 1.2299390672598776e-11
9 O 0 1.2316681008428532e-09
( O 0 5.53006913265458e-13
56 O 0 3.1099955943858504e-10
% O 0 1.091737052323627e-12
) O 0 3.0707509153732673e-14
of O 0 5.3746847250568663e-11
the O 0 1.2946335345986881e-06
tumors B-Disease 1 1.0
without O 1 1.0
LOH O 1 1.0
, O 0 1.2879894484285614e-07
both O 0 3.8357148568479715e-09
mutations O 0 6.121202988929042e-10
were O 0 1.697418594570621e-10
found O 0 1.1702748492492532e-10
. O 0 2.428808487664469e-09

Thus O 0 1.3677164290015753e-08
, O 0 1.2451779191069434e-11
a O 0 5.566801902258389e-13
total O 0 5.950637552154525e-12
of O 0 5.609912187565236e-11
45 O 0 9.232442588213985e-10
mutations O 0 3.0818170237978393e-10
were O 0 3.418894889417601e-10
identified O 0 4.045176194011901e-09
in O 0 4.856241275774664e-08
tumors B-Disease 1 1.0
of O 0 5.096790573588805e-06
36 O 0 3.0522485303663416e-06
patients O 0 6.56091287964955e-07
. O 0 3.356193545300812e-08

Thirty O 0 1.6222519434450078e-06
- O 0 3.775572565700713e-08
nine O 0 8.112030491780331e-10
of O 0 1.430433410609666e-10
the O 0 3.626360878250523e-10
mutations O 0 1.158294293812645e-10
- O 0 5.279809922598133e-09
including O 0 3.651910718271978e-10
34 O 0 4.459407065837695e-08
small O 0 3.5718625279734795e-10
mutations O 0 7.808822338750687e-11
, O 0 7.73865607012203e-12
2 O 0 5.627039945110823e-10
large O 0 2.3725335931978897e-11
structural O 0 1.9816552843110458e-09
alterations O 0 9.850116475718096e-05
, O 0 1.2725754672260337e-08
and O 0 1.0077582324186096e-08
hypermethylation O 1 0.9044128060340881
in O 0 1.2889887557321345e-06
3 O 0 5.45756347491988e-06
tumors O 1 1.0
- O 0 1.6336102470759784e-09
were O 0 3.8102042354548615e-11
not O 0 7.150969811957342e-13
detected O 0 1.8976749338595056e-10
in O 0 1.2083413696711842e-12
the O 0 8.798280680399895e-12
corresponding O 0 3.8074890462702626e-10
peripheral O 0 2.8180929234622454e-07
blood O 0 2.021334566393307e-08
DNA O 0 5.370163336237965e-08
. O 0 1.4046688256996731e-08

In O 0 8.059659606374225e-09
6 O 0 7.171049087872916e-09
( O 0 7.004316289298262e-13
17 O 0 5.543106251781893e-11
% O 0 1.793899230551066e-13
) O 0 6.595365927862854e-16
of O 0 5.493956526693433e-13
the O 0 1.5072382231196002e-10
36 O 0 1.810371941246558e-08
patients O 0 1.9748688373510959e-07
, O 0 1.3166432354105861e-11
a O 0 1.9317573582422476e-11
mutation O 0 2.410043831169162e-10
was O 0 3.226656442034681e-10
detected O 0 6.083123782474331e-09
in O 0 2.8579230648695386e-10
constitutional O 0 6.533589669288631e-08
DNA O 0 6.991277334833512e-09
, O 0 9.377608065075371e-12
and O 0 5.2966463680304e-12
1 O 0 5.757274101902965e-10
of O 0 1.194757071054653e-10
these O 0 3.3345404215623375e-10
mutations O 0 3.7425066518048666e-11
is O 0 8.900968612342297e-13
known O 0 4.438870278289375e-12
to O 0 2.505090969731616e-12
be O 0 7.385798569958801e-12
associated O 0 7.195089524181242e-10
with O 0 1.8987277028426064e-11
reduced O 0 4.6583429025304213e-07
expressivity O 0 1.8839433323591948e-05
. O 0 9.96337021774707e-08

The O 0 4.283033927521274e-09
presence O 0 4.3944298200315757e-10
of O 0 1.8724719552665192e-09
a O 0 1.162709598739875e-11
constitutional O 0 4.628319416610793e-08
mutation O 0 1.1685953593687515e-10
was O 0 8.413123496475716e-12
not O 0 1.258394294800444e-13
associated O 0 2.9505026893916764e-12
with O 0 1.9771422726019144e-14
an O 0 3.7561078887764134e-15
early O 0 9.006574375192145e-10
age O 0 1.0385561299841584e-09
at O 0 3.073128557185001e-11
treatment O 0 7.182742223221794e-08
. O 0 3.761060796136917e-08

In O 0 1.7889553172167894e-09
1 O 0 3.236645440551911e-08
patient O 0 2.970316614891999e-08
, O 0 1.8747319668888096e-11
somatic O 0 4.243939656589646e-06
mosaicism O 0 0.012758851982653141
was O 0 1.4987476815164769e-09
demonstrated O 0 7.458111905833675e-11
by O 0 7.033138719851617e-13
molecular O 0 1.2363648299595908e-11
analysis O 0 3.1242077067755725e-12
of O 0 3.4064522036469924e-12
DNA O 0 2.314023972438406e-10
and O 0 2.4984308025222113e-11
RNA O 0 6.218973669369632e-10
from O 0 6.292938392604697e-11
peripheral O 0 5.289398359309416e-07
blood O 0 1.654663037697901e-07
. O 0 3.0843782639067285e-08

In O 0 8.051132205366685e-09
2 O 0 2.0591583549389725e-08
patients O 0 1.202507982078771e-09
without O 0 1.3226060004145612e-11
a O 0 8.866221125336526e-12
detectable O 0 1.2604986920905503e-07
mutation O 0 2.688655964533382e-09
in O 0 2.7075050534897116e-10
peripheral O 0 3.076833309023641e-06
blood O 0 7.046703558444278e-07
, O 0 1.7040166500059684e-10
mosaicism O 0 7.045184247544967e-06
was O 0 4.966262401318033e-10
suggested O 0 3.4313007990505184e-10
because O 0 1.7664732523958726e-11
1 O 0 2.4117086105945873e-10
of O 0 8.701152645618215e-12
the O 0 3.7270436736847046e-10
patients O 0 1.4013055249506579e-07
showed O 0 7.942477253664038e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 1.5374723716377048e-07
the O 0 6.695690757396733e-08
other O 0 4.2911263431477664e-10
later O 0 1.2014676364913157e-08
developed O 0 1.604237098717931e-08
bilateral B-Disease 0 0.0002769082202576101
retinoblastoma I-Disease 0 0.003123415634036064
. O 0 5.603867521131178e-07

In O 0 2.203321081140075e-09
conclusion O 0 1.5153830190683948e-08
, O 0 6.07926695095351e-11
our O 0 4.3357234469354466e-11
results O 0 4.28415705688856e-11
emphasize O 0 1.274087224611975e-10
that O 0 4.938009975420134e-14
the O 0 6.0235388725515815e-12
manifestation O 0 8.035958565244528e-09
and O 0 1.5291963528785146e-10
transmissibility O 0 3.618384596393298e-07
of O 0 1.288494422269082e-09
retinoblastoma B-Disease 0 1.3961001243956161e-08
depend O 0 1.8017212166654417e-09
on O 0 1.4417488036766457e-10
the O 0 8.878608785678477e-12
nature O 0 1.0757306503905717e-11
of O 0 1.638917300483822e-11
the O 0 1.0315841930674807e-11
first O 0 1.1847128313091648e-11
mutation O 0 7.524215083452857e-13
, O 0 3.227857976566273e-13
its O 0 5.144111590686673e-13
time O 0 3.818474182681886e-12
in O 0 3.167784437541066e-11
development O 0 5.815816717102962e-09
, O 0 2.166298390671173e-11
and O 0 2.299731585719833e-11
the O 0 1.8758096465010254e-10
number O 0 7.909795735061564e-11
and O 0 4.388352528583717e-12
types O 0 2.5429031103030297e-10
of O 0 3.2160621388221955e-11
cells O 0 1.0709447217926993e-10
that O 0 5.056493418420516e-13
are O 0 3.520367808027003e-12
affected O 0 9.858673877261026e-10
. O 0 8.425207198570206e-10
. O 0 1.0600731847887346e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.01674003154039383
the I-Disease 0 1.1356935374351451e-06
fifth I-Disease 0 6.656661071247072e-07
component I-Disease 0 1.8221334130430478e-07
of I-Disease 0 4.324531133192977e-08
complement I-Disease 0 4.0039802229330235e-07
in O 0 5.159011493560683e-07
man O 0 5.38824565410323e-07
. O 0 1.784737833077088e-07

I O 0 0.009234394878149033
. O 0 1.0387745987827657e-06

Clinical O 0 5.015945703235047e-07
, O 0 1.8113509303585573e-10
immunochemical O 0 7.252868817886338e-05
, O 0 8.314450239410576e-10
and O 0 9.862416439077037e-10
family O 0 2.854040781485878e-09
studies O 0 6.485583736726142e-10
. O 0 2.9931661593707304e-09

The O 0 6.52357223795974e-10
first O 0 4.799043801240188e-11
recognized O 0 2.403071630574516e-10
human O 0 3.125182335139698e-10
kindred O 0 8.371236617676914e-06
with O 0 1.7883301783871985e-10
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.813435971736908
the I-Disease 0 8.181867769962992e-07
fifth I-Disease 0 5.235628464106412e-07
component I-Disease 0 6.328871791083657e-07
of I-Disease 0 6.9485126914514694e-06
complement I-Disease 0 0.00011808685667347163
( O 0 1.9312446752906e-08
C5 O 1 0.9993423819541931
) O 0 1.547002977109191e-11
is O 0 7.251417782211389e-12
described O 0 6.419163534054917e-10
. O 0 1.6914285083657887e-08

The O 0 2.938871013213884e-08
proband O 0 1.8595552319311537e-05
, O 0 1.2882332700581145e-10
a O 0 4.5398901651894086e-12
20 O 0 2.570433796367233e-11
- O 0 3.6152936113559297e-12
year O 0 2.5561773184246128e-11
- O 0 6.099374338930375e-10
old O 0 3.834352280129849e-10
black O 0 3.351996414810432e-12
female O 0 5.5616095225290846e-14
with O 0 1.5180493309879112e-13
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 9.103977208724245e-05
age O 0 0.0008441788959316909
11 O 0 1.3850551816574352e-09
, O 0 1.5008793903883988e-12
lacked O 0 4.407509912596197e-09
serum O 0 8.58969606554183e-09
hemolytic O 0 0.00018714390171226114
complement O 0 8.460881772975881e-09
activity O 0 1.1942776545481593e-08
, O 0 1.3742746090422697e-12
even O 0 2.2048354895304323e-12
during O 0 1.845245622966729e-10
remission O 0 8.288979813642072e-08
. O 0 2.023046175025911e-09

C5 O 1 0.9683991074562073
was O 0 1.24841690762878e-07
undetectable O 0 1.418516291096239e-07
in O 0 2.333619131267284e-10
her O 0 8.054161504400525e-12
serum O 0 6.580781058973528e-11
by O 0 3.993423647319361e-12
both O 0 9.644484516568852e-11
immunodiffusion O 0 5.332651562639512e-05
and O 0 3.5175222734551426e-08
hemolytic O 1 0.9993926286697388
assays O 0 5.807122215628624e-05
. O 0 9.68499421105662e-07

Other O 0 1.8001881929574637e-10
complement O 0 3.965039754860733e-11
components O 0 9.552762053610664e-11
were O 0 6.4183862218125665e-12
normal O 0 4.7859632923419326e-11
during O 0 3.2133642968723564e-11
remission O 0 2.515456998253285e-08
of O 0 1.4068103348918726e-09
lupus O 0 1.563703449392051e-06
, O 0 1.0241177905712107e-09
but O 0 1.6606316322054226e-08
C1 O 0 1.42111093737185e-05
, O 0 2.6760946236770167e-10
C4 O 0 6.187200938256865e-07
, O 0 5.7207870385322934e-11
C2 O 0 2.393399611833047e-08
, O 0 2.13405595278493e-11
and O 0 9.587247662423692e-10
C3 O 1 0.8690063953399658
levels O 0 2.0403809685376473e-05
fell O 0 4.0412478483631276e-06
during O 0 5.277252412838607e-09
exacerbations O 0 8.53976234793663e-05
. O 0 1.3989767921884777e-07

A O 0 2.5006095256685512e-06
younger O 0 2.1157254650461255e-06
half O 0 9.728278627108011e-09
- O 0 2.4680397814336175e-07
sister O 0 2.3701680618160026e-07
, O 0 1.661959979359917e-11
who O 0 7.233252191651829e-12
had O 0 1.7288119547043124e-10
no O 0 1.581928543714639e-08
underlying O 1 0.9997679591178894
disease O 0 7.493663724744692e-05
, O 0 3.789655221575483e-12
was O 0 7.355860365265698e-10
also O 0 2.497787567057319e-11
found O 0 2.6059572902359385e-11
to O 0 1.856769182850826e-10
lack O 0 2.7355827114661224e-05
immunochemically O 1 0.704734206199646
detectable O 1 0.5207464694976807
C5 O 0 0.003537776879966259
. O 0 1.0181626919347764e-07

By O 0 1.9509334592271443e-08
hemolytic O 0 0.014762967824935913
assay O 0 9.691935701994225e-06
, O 0 1.1137810673744752e-09
she O 0 9.166458390941212e-12
exhibited O 0 3.46460846123442e-11
1 O 0 2.9636570975100085e-11
- O 0 2.1914076456241993e-11
2 O 0 7.159683956814433e-11
% O 0 5.045192779176699e-13
of O 0 1.4761476275267776e-13
the O 0 7.733418072586318e-12
normal O 0 3.601996212410086e-08
serum O 0 1.5258045493737882e-07
C5 O 0 5.291176421451382e-06
level O 0 1.025605378401906e-09
and O 0 2.1427751066560585e-12
normal O 0 5.395030949761903e-11
concentrations O 0 1.1231585106408204e-10
of O 0 1.5742566972232197e-11
other O 0 1.7738099183928213e-11
complement O 0 1.6328283169997349e-09
components O 0 7.765077469912285e-08
. O 0 7.53111137896667e-08

C5 O 0 7.520021608797833e-05
levels O 0 3.0185194788145964e-08
of O 0 2.1109018977227834e-09
other O 0 8.742497004110561e-11
family O 0 2.328864705247735e-11
members O 0 2.200469217646453e-13
were O 0 2.808620740493706e-12
either O 0 5.4252526950071545e-12
normal O 0 1.3158136802360332e-09
or O 0 1.5129942654637518e-12
approximately O 0 8.596672906955455e-14
half O 0 1.955332814065902e-12
- O 0 3.230078357563393e-11
normal O 0 3.8171914518159156e-09
, O 0 1.1478048329502388e-12
consistent O 0 1.176687497439488e-10
with O 0 6.030006680611544e-13
autosomal O 0 1.2678584404568483e-08
codominant O 0 5.550562036660267e-07
inheritance O 0 1.1466584126651469e-08
of O 0 1.7660723578005744e-11
the O 0 2.94448875004516e-11
gene O 0 5.881159448328788e-10
determining O 0 5.5414526286767796e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.7858716293849284e-06

Normal O 0 2.661390863067936e-05
hemolytic O 0 0.05484843626618385
titers O 0 4.6442939492408186e-05
were O 0 4.907738659909455e-10
restored O 0 3.5997758107697564e-09
to O 0 6.7910213043254064e-12
both O 0 1.0487214568977166e-10
homozygous O 0 5.637984941131435e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 5.668332025976497e-09
C5D B-Disease 1 1.0
) O 0 7.328102014092508e-11
sera O 0 2.9926680578107323e-10
by O 0 1.6113537370729403e-13
addition O 0 3.6350013277175464e-11
of O 0 1.792264892053197e-09
highly O 0 1.4903491319273598e-05
purified O 0 0.0015211086720228195
human O 0 3.3773030736483634e-06
C5 O 0 0.026213018223643303
. O 0 2.437035675484367e-07

In O 0 1.608434629929434e-08
specific O 0 2.7355749665503026e-08
C5 O 0 1.4727852430951316e-05
titrations O 0 2.9893971031924593e-07
, O 0 1.571008080569758e-11
however O 0 5.072640224534908e-11
, O 0 2.3412673709477527e-12
it O 0 7.050747247334954e-13
was O 0 5.132515523698089e-10
noted O 0 3.383810176504909e-10
that O 0 2.86235960064371e-13
when O 0 6.566785309969347e-12
limited O 0 1.7127257945226404e-11
amounts O 0 2.5461352470834697e-10
of O 0 4.356873473110312e-10
C5 O 0 1.8381679183221422e-06
were O 0 6.028003651792346e-10
assayed O 0 4.545572362957273e-09
in O 0 7.17849607881349e-12
the O 0 1.8000250812458263e-12
presence O 0 3.328627304344245e-12
of O 0 3.6097142636082324e-11
low O 0 1.5484310722513328e-08
dilutions O 0 8.134268796311517e-07
of O 0 2.2963499990424907e-09
either O 0 2.0294548264132573e-08
C5D B-Disease 1 1.0
serum O 0 2.3655475445139018e-07
, O 0 2.326103545891023e-11
curving O 0 6.03582739344688e-10
rather O 0 6.50935945770148e-12
than O 0 8.067317972502985e-13
linear O 0 2.3593477865846424e-11
dose O 0 6.792893469942385e-10
- O 0 4.204315715017337e-11
response O 0 1.4388888691652113e-10
plots O 0 3.8751815090165564e-09
were O 0 1.5654125218311776e-10
consistently O 0 3.7272906983076837e-11
obtained O 0 1.1489861145852487e-11
, O 0 4.54177602644823e-13
suggesting O 0 2.91677515473765e-11
some O 0 9.165461792304264e-12
inhibitory O 0 8.28077517667225e-09
effect O 0 7.107203003897666e-08
. O 0 1.4248885804590827e-07

Further O 0 8.136362694699528e-09
studies O 0 1.3042292246190357e-10
suggested O 0 2.8549090175244984e-11
that O 0 3.3255351055382076e-13
low O 0 6.28864871288215e-09
dilutions O 0 5.925860932620708e-06
of O 0 2.0176752713041424e-08
C5D B-Disease 1 1.0
serum O 0 1.7532039819911915e-08
contain O 0 8.851166327650262e-12
a O 0 1.8384064073579537e-13
factor O 0 1.502934061925476e-11
( O 0 2.4706716097370844e-14
or O 0 5.621517791196129e-13
factors O 0 1.3764053265197251e-11
) O 0 6.517527538713389e-14
interfering O 0 5.23937594698598e-11
at O 0 8.152727798416137e-11
some O 0 2.680822577816322e-12
step O 0 2.0244625975607278e-09
in O 0 6.438792554686046e-11
the O 0 1.0395252436623537e-09
hemolytic O 0 0.0001359258749289438
assay O 0 5.15855208504945e-06
of O 0 2.2527819965034723e-05
C5 O 0 0.0007672338979318738
, O 0 4.491331351968997e-12
rather O 0 1.2501366044789797e-12
than O 0 9.521786706540372e-14
a O 0 1.757992189321822e-12
true O 0 4.451951252093522e-09
C5 O 0 1.2310130841797218e-05
inhibitor O 0 4.608235926184534e-08
or O 0 1.0060426935964983e-09
inactivator O 0 1.767420030773792e-06
. O 0 7.629469678249734e-08

Of O 0 1.2626281886696233e-07
clinical O 0 1.369485858049302e-06
interest O 0 2.2744825400877744e-07
are O 0 3.788955954542317e-11
( O 0 3.286578366228088e-13
a O 0 2.980478819476773e-13
) O 0 7.762148942266206e-15
the O 0 1.1804103430389928e-13
documentation O 0 2.993701397890902e-10
of O 0 1.5980482215294245e-10
membranous O 0 0.4562765955924988
glomerulonephritis B-Disease 1 1.0
, O 0 1.9887824720399294e-08
vasculitis B-Disease 1 1.0
, O 0 1.224724655024545e-09
and O 0 1.0837806208030543e-08
arthritis B-Disease 1 1.0
in O 0 2.102994614006093e-07
an O 0 1.6162987614976032e-11
individual O 0 5.2875495093474e-09
lacking O 0 0.0004557444481179118
C5 O 0 0.00024703703820705414
( O 0 7.930151218853154e-13
and O 0 4.912170388331194e-13
its O 0 3.8267186728419e-13
biologic O 0 1.130604943000435e-08
functions O 0 2.3374522803432107e-12
) O 0 2.7761807660538337e-15
, O 0 1.4160215697483353e-14
and O 0 4.641335669204778e-14
( O 0 6.221500365669735e-14
b O 0 2.363234608004916e-11
) O 0 2.5099750396325154e-15
a O 0 7.212525525825478e-14
remarkable O 0 2.839171953095132e-11
propensity O 0 1.7273361629932538e-09
to O 0 2.2042770386754285e-11
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.364104745300466e-11
the O 0 3.492772260652033e-12
proband O 0 2.225087447627061e-09
, O 0 4.32273872729913e-13
even O 0 9.275991433299602e-13
during O 0 3.0477812114348968e-12
periods O 0 9.610956475114563e-10
of O 0 3.010442589657103e-11
low O 0 5.408272718554485e-10
- O 0 1.6795313403927814e-11
dose O 0 5.895467447558644e-10
or O 0 6.911713822804755e-12
alternate O 0 1.4510825874225475e-09
- O 0 4.93627805298047e-10
day O 0 6.088715642782461e-10
corticosteroid O 0 3.3183209779963363e-07
therapy O 0 3.7686653797663894e-08
. O 0 6.121016471460905e-10

Other O 0 5.00312546947157e-09
observations O 0 4.710723477963086e-10
indicate O 0 2.7986968645365984e-11
that O 0 1.0252512543367648e-13
the O 0 1.5903857397692178e-10
C5D B-Disease 1 1.0
state O 0 1.3379841234950618e-08
is O 0 4.4651773598025635e-12
compatible O 0 1.4258136338263228e-10
with O 0 2.450810008495369e-13
normal O 0 9.599433470341978e-10
coagulation O 0 2.3709889607204104e-09
function O 0 5.402280012223315e-11
and O 0 1.0914081053844948e-12
the O 0 1.6111118515682588e-12
capacity O 0 3.9386809785879606e-11
to O 0 1.556512557732148e-11
mount O 0 1.510454161746111e-08
a O 0 4.808832221314674e-10
neutrophilic O 0 0.003498413134366274
leukocytosis O 0 0.00016400519234593958
during O 0 3.6365744904287567e-07
pyogenic B-Disease 0 4.916644684271887e-05
infection I-Disease 0 3.820978236035444e-07
. O 0 6.943141062087932e-10
. O 0 2.985514502285014e-09

Susceptibility O 0 1.507486649643397e-05
to O 0 1.929455173410588e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 3.757250669877976e-05
twins O 0 1.9767596313613467e-05
: O 0 2.372024560277908e-13
the O 0 3.917690553478098e-13
role O 0 1.6414348179283333e-12
of O 0 8.084346386771912e-11
genes O 0 5.0885323732430265e-11
, O 0 1.3636481700773917e-11
HLA O 0 8.181728480849415e-05
, O 0 9.418199553579143e-10
and O 0 1.3995220260465402e-10
the O 0 2.2975943370084906e-09
environment O 0 3.412878584185819e-07
. O 0 4.442258827452861e-08

OBJECTIVE O 0 1.0476848046891973e-06
To O 0 3.303903678419928e-11
determine O 0 5.0100052578772036e-11
the O 0 7.2488313095087076e-12
relative O 0 3.274914783801819e-09
effects O 0 5.399391156402089e-09
of O 0 2.519383590637858e-09
genetic O 0 1.3843059143425762e-08
and O 0 1.888552031772961e-12
environmental O 0 2.0173693271452464e-10
factors O 0 4.826758090437089e-11
in O 0 2.5662492963984818e-12
susceptibility O 0 9.575354731339303e-09
to O 0 7.227581200197619e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 2.0343943560874322e-06
AS B-Disease 1 1.0
) O 0 1.2637840773876974e-10
. O 0 1.7173823474436745e-09

METHODS O 0 0.0007059099152684212
Twins O 0 0.004654325544834137
with O 0 1.2289564331469105e-11
AS B-Disease 1 1.0
were O 0 3.712298871083597e-11
identified O 0 2.1287281019941734e-13
from O 0 1.6578669250681514e-14
the O 0 7.336090014544577e-14
Royal O 0 2.437485768780334e-10
National O 0 7.886412009550092e-12
Hospital O 0 2.687790967570436e-08
for O 0 2.388809150488669e-10
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9998900890350342
database O 0 7.061948537057106e-08
. O 0 7.170409332957206e-08

Clinical O 0 7.538022828157409e-07
and O 0 1.1749851092091035e-10
radiographic O 0 3.0981578902355977e-07
examinations O 0 4.990490509726442e-08
were O 0 7.406790458741597e-12
performed O 0 1.3963849607862011e-12
to O 0 3.150846689678813e-14
establish O 0 1.891209758242418e-11
diagnoses O 0 4.138587974011898e-05
, O 0 5.598688526675666e-11
and O 0 4.1474892964465937e-10
disease O 0 5.333176886779256e-07
severity O 0 1.4931587429600768e-05
was O 0 1.7050546530228416e-09
assessed O 0 2.1488357759835708e-09
using O 0 1.2315305893129125e-11
a O 0 1.4636556940408885e-12
combination O 0 1.92823187972202e-10
of O 0 1.419751261000357e-10
validated O 0 1.4596099617847358e-07
scoring O 0 5.6993407326899614e-08
systems O 0 2.5684195747999183e-07
. O 0 1.6721500628591457e-08

HLA O 0 5.9273006627336144e-05
typing O 0 3.5248231000650776e-08
for O 0 7.209895180881887e-11
HLA O 0 1.7742229374562157e-07
- O 0 9.828098512798533e-08
B27 O 0 4.574336998075523e-08
, O 0 2.943650531661568e-12
HLA O 0 1.356647572059444e-09
- O 0 1.1041043634918424e-09
B60 O 0 8.058860245796495e-09
, O 0 7.676730887258565e-13
and O 0 9.881512925621894e-13
HLA O 0 1.6298862703933992e-07
- O 0 2.4165474314941093e-06
DR1 O 0 0.0012020423309877515
was O 0 1.4887750754422058e-10
performed O 0 6.960437868436253e-12
by O 0 1.5312137137662302e-13
polymerase O 0 2.4921198785166077e-11
chain O 0 1.6181465889442137e-11
reaction O 0 3.940394191492835e-11
with O 0 2.810065819359303e-13
sequence O 0 6.87712527983747e-13
- O 0 1.7468084270721995e-12
specific O 0 4.597884139395658e-12
primers O 0 3.0997501787588533e-10
, O 0 9.455642649078277e-13
and O 0 1.2538954249907697e-12
zygosity O 0 3.3561679657623245e-08
was O 0 3.5677977239245706e-10
assessed O 0 7.061191631407837e-09
using O 0 4.023167077260581e-10
microsatellite O 0 2.4527108166694234e-07
markers O 0 1.4055429176096368e-07
. O 0 2.6657151153131053e-08

Genetic O 0 5.893157890568546e-07
and O 0 5.768108560233465e-11
environmental O 0 4.3536169114233303e-10
variance O 0 5.492790666750125e-10
components O 0 3.118627800446916e-09
were O 0 3.7964159593784075e-10
assessed O 0 4.317646684626197e-09
with O 0 5.82422174724706e-12
the O 0 1.140402439148147e-09
program O 0 1.2961522133370096e-10
Mx O 0 2.81374396005063e-10
, O 0 2.0304901016858848e-14
using O 0 7.75208788491872e-15
data O 0 1.7275567640914063e-13
from O 0 8.749355677895726e-14
this O 0 2.1371453055602646e-13
and O 0 1.6178857841116223e-13
previous O 0 7.063204882085117e-11
studies O 0 4.1195519218106824e-12
of O 0 5.883812534412947e-12
twins O 0 6.935298557664282e-08
with O 0 8.31453655925074e-12
AS B-Disease 1 1.0
. O 0 1.453389870675892e-07

RESULTS O 0 3.7600175346597098e-06
Six O 0 1.2852299224874741e-09
of O 0 4.5734771525474116e-10
8 O 0 3.93196160075604e-08
monozygotic O 0 3.684020157379564e-06
( O 0 7.796959605732567e-11
MZ O 0 9.085827514354605e-06
) O 0 1.508172059461188e-11
twin O 0 2.3580095653841227e-09
pairs O 0 1.4124524466696542e-11
were O 0 9.072254232578292e-12
disease O 0 1.225065049403895e-10
concordant O 0 2.392448550381232e-07
, O 0 1.4154890801143516e-11
compared O 0 2.5137567027933017e-10
with O 0 4.008661349912124e-13
4 O 0 2.663669007585412e-10
of O 0 1.507280411594536e-11
15 O 0 5.88714910154664e-11
B27 O 0 6.64948895945372e-09
- O 0 7.526307910232788e-10
positive O 0 2.310575064612408e-10
dizygotic O 0 4.503220907281502e-07
( O 0 8.472879516052689e-13
DZ O 0 2.306834367971078e-08
) O 0 5.392360820019593e-13
twin O 0 2.023481243673686e-10
pairs O 0 3.023388397277449e-12
( O 0 9.43747575747611e-14
27 O 0 1.269655824920335e-09
% O 0 3.792938185753769e-12
) O 0 1.6924948177980334e-14
and O 0 1.135055808024199e-12
4 O 0 2.2224991291786012e-10
of O 0 3.598442099850274e-10
32 O 0 1.4579356388821907e-08
DZ O 0 1.6773665265645832e-05
twin O 0 2.67289870237164e-08
pairs O 0 4.5852491942222073e-11
overall O 0 2.664534370921956e-09
( O 0 3.9414652097669034e-13
12 O 0 2.0038233225494473e-11
. O 0 2.0966858891441342e-12
5 O 0 9.390409977383385e-11
% O 0 1.899088742166044e-12
) O 0 1.1478612385682624e-13
. O 0 3.378592960956439e-10

Nonsignificant O 0 2.286411836394109e-05
increases O 0 4.8182020151443794e-08
in O 0 2.1113588308252496e-11
similarity O 0 1.0726450977438517e-11
with O 0 2.8189866348345138e-14
regard O 0 1.8188496542226318e-10
to O 0 8.474253200205228e-13
age O 0 1.6295553795231399e-09
at O 0 8.962181691218873e-12
disease O 0 1.4050612062721513e-10
onset O 0 2.400723886353262e-08
and O 0 4.775704484649701e-11
all O 0 3.514906464843759e-12
of O 0 1.0683409018552581e-11
the O 0 6.684987285954236e-11
disease O 0 3.913857848925062e-10
severity O 0 1.1501493091259363e-09
scores O 0 3.858911887949512e-12
assessed O 0 3.9433942222721896e-11
were O 0 1.7622390092314477e-12
noted O 0 4.88110029825406e-12
in O 0 5.123433795273247e-12
disease O 0 7.66957519715561e-09
- O 0 1.2733858056890313e-07
concordant O 0 0.0006348199094645679
MZ O 0 0.006400942336767912
twins O 0 1.256735004062648e-06
compared O 0 2.4442559087844984e-09
with O 0 1.567757382248125e-11
concordant O 0 0.00027692512958310544
DZ O 1 0.5378286838531494
twins O 0 0.00013289156777318567
. O 0 3.1803150335463215e-08

HLA O 0 4.5075019443174824e-05
- O 0 3.344332526467042e-06
B27 O 0 4.915003728456213e-07
and O 0 9.957121065162777e-12
B60 O 0 2.673035126576906e-09
were O 0 5.677412533156012e-12
associated O 0 3.484707314371782e-12
with O 0 7.491933234817644e-14
the O 0 4.170118070301321e-11
disease O 0 4.972539269232357e-09
in O 0 2.2916484682111715e-11
probands O 0 3.3263418117712718e-06
, O 0 3.6510226265884516e-12
and O 0 1.5981861016881038e-13
the O 0 2.9333881244181237e-12
rate O 0 5.098969579897528e-10
of O 0 1.730387100967734e-12
disease O 0 4.596406866230751e-10
concordance O 0 1.4198874298543274e-09
was O 0 1.1736877095214204e-11
significantly O 0 3.9193784329150105e-10
increased O 0 1.2248414504867355e-09
among O 0 3.453848873569143e-10
DZ O 0 6.100287919252878e-07
twin O 0 1.2046406094867734e-09
pairs O 0 9.660160041682908e-13
in O 0 2.364124792198635e-13
which O 0 9.315844536755824e-14
the O 0 1.2278107350272016e-11
co O 0 6.170645244774065e-11
- O 0 1.0772244207757353e-09
twin O 0 1.5106034201295415e-09
was O 0 6.711856070928945e-11
positive O 0 1.3606240266417213e-11
for O 0 3.5678957618218154e-12
both O 0 2.21537926892168e-11
B27 O 0 4.1037742448679637e-07
and O 0 4.4435952695209835e-09
DR1 O 0 0.0006530943792313337
. O 0 4.204843406796499e-08

Additive O 0 4.621157586370828e-06
genetic O 0 3.6930668301238256e-08
effects O 0 1.097555490936486e-09
were O 0 2.7318427034406234e-11
estimated O 0 1.2565529129357489e-12
to O 0 6.443859660275331e-13
contribute O 0 2.1768229579999243e-11
97 O 0 4.54202764288425e-09
% O 0 5.573602018284218e-13
of O 0 2.8033781893088694e-14
the O 0 2.725583972927603e-13
population O 0 6.029843237134042e-14
variance O 0 2.1410286044076798e-10
. O 0 4.926695940099535e-09

CONCLUSION O 0 1.324970980931539e-06
Susceptibility O 0 2.3136163918024977e-07
to O 0 4.4849154945403313e-10
AS B-Disease 1 1.0
is O 0 1.0928001559218359e-11
largely O 0 1.0072114670078847e-10
genetically O 0 1.8462304601785107e-11
determined O 0 2.464774218058352e-10
, O 0 1.9004550537438103e-12
and O 0 1.2394525510106558e-12
the O 0 1.7255563297680077e-11
environmental O 0 7.338781582433285e-09
trigger O 0 2.04354894117742e-10
for O 0 2.8814615624095374e-12
the O 0 6.540741281924056e-10
disease O 0 2.4321382241510037e-08
is O 0 1.1891273556108306e-11
probably O 0 2.7851261297229257e-09
ubiquitous O 0 6.84591583421934e-08
. O 0 2.4910022489166295e-08

HLA O 0 8.682635780132841e-06
- O 0 6.117089128565567e-07
B27 O 0 1.5056484414799343e-07
accounts O 0 6.163019747318366e-12
for O 0 2.1749686809056402e-14
a O 0 1.0494922530850104e-13
minority O 0 4.0912425899354565e-13
of O 0 4.597039979584161e-13
the O 0 8.203042412002759e-12
overall O 0 2.6998758784202437e-08
genetic O 0 9.11088626764922e-09
susceptibility O 0 1.017812678583141e-06
to O 0 1.235364965879171e-08
AS B-Disease 1 1.0
. O 0 4.300826276448788e-06

Cell O 0 2.5884159526867734e-07
cycle O 0 3.143778926073537e-08
- O 0 1.0676418860100512e-08
dependent O 0 2.6202242597861414e-09
colocalization O 0 2.2028899593351525e-07
of O 0 1.3857614611367808e-08
BARD1 O 1 0.9999997615814209
and O 0 9.477314222294808e-08
BRCA1 O 0 2.79391021429376e-09
proteins O 0 2.624347787694159e-11
in O 0 1.282461463414375e-11
discrete O 0 5.588683960056073e-10
nuclear O 0 1.486622824842243e-08
domains O 0 3.468905163117597e-08
. O 0 1.691170403717024e-08

Germ O 0 6.820580892963335e-05
- O 0 1.0214670282948646e-06
line O 0 1.400116644845184e-07
mutations O 0 6.321512202589474e-10
of O 0 8.124165229439484e-11
the O 0 7.247940025933985e-10
BRCA1 O 0 2.9238728105340783e-10
gene O 0 2.606572293076259e-12
predispose O 0 1.0002702000022623e-09
women O 0 4.3986662185899195e-13
to O 0 5.0669754850241056e-14
early O 0 1.2595410225912929e-07
- O 0 0.0002173739776480943
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 4.7090838173335925e-12
compromising O 0 4.361955685538987e-09
the O 0 2.9981983562521464e-10
genes O 0 1.1360901802648371e-10
presumptive O 0 2.3648574654089316e-07
function O 0 1.5006204612255658e-10
as O 0 8.372367903131117e-12
a O 0 1.2184882443311285e-11
tumor B-Disease 0 1.7394152962424414e-07
suppressor O 0 2.386813321209047e-06
. O 0 4.579444023988799e-08

Although O 0 6.132403740366499e-08
the O 0 6.628974702493906e-09
biochemical O 0 2.685326990103931e-06
properties O 0 1.054591302818153e-05
of O 0 4.1192544131263276e-07
BRCA1 O 0 2.099067053507042e-08
polypeptides O 0 1.2756513623202181e-09
are O 0 4.192299990230658e-13
not O 0 1.7688113343808376e-13
understood O 0 2.3438643387274638e-11
, O 0 8.103832546419582e-14
their O 0 9.943598272251289e-14
expression O 0 7.789950867524709e-13
pattern O 0 8.494404832304348e-12
and O 0 1.6019031533111988e-13
subcellular O 0 3.355283162420619e-09
localization O 0 7.038507554568696e-09
suggest O 0 9.671433792712847e-11
a O 0 5.425704915733298e-13
role O 0 8.851453424385536e-12
in O 0 6.55002579952324e-11
cell O 0 3.8162468740665645e-08
- O 0 4.33982361158769e-09
cycle O 0 2.6840513811521305e-08
regulation O 0 1.1655494347451167e-07
. O 0 2.9480655694413826e-09

When O 0 1.9775896475948684e-08
resting O 0 1.0247028825460802e-07
cells O 0 3.928786462825684e-10
are O 0 9.71463035882858e-13
induced O 0 1.1994676085702594e-10
to O 0 1.953163542359193e-12
proliferate O 0 1.7333420809784172e-10
, O 0 4.302101752097498e-13
the O 0 3.578323184635912e-12
steady O 0 2.056612796730306e-10
- O 0 4.725565099818196e-13
state O 0 4.487937799169117e-13
levels O 0 2.478951488527059e-10
of O 0 1.8355842887340934e-11
BRCA1 O 0 4.590540621240979e-12
increase O 0 1.7694297633000233e-12
in O 0 5.914721837307901e-12
late O 0 3.340189991263287e-08
G1 O 0 7.267961343870866e-09
and O 0 1.3823955001546206e-12
reach O 0 3.164809722882439e-13
a O 0 5.448098976080715e-15
maximum O 0 7.957848789652555e-13
during O 0 1.814442346370626e-10
S O 0 6.824768661317648e-07
phase O 0 6.41517374333489e-07
. O 0 3.4725260888990306e-08

Moreover O 0 8.07877654551703e-07
, O 0 2.079038746716222e-10
in O 0 6.065533075805263e-10
S O 0 3.135610086246743e-06
phase O 0 2.593758154034731e-06
cells O 0 1.275978718240367e-07
, O 0 1.558179696381501e-10
BRCA1 O 0 1.2744014732390951e-09
polypeptides O 0 1.7905017468677897e-09
are O 0 3.0812615913616836e-12
hyperphosphorylated O 0 1.70650000796968e-08
and O 0 4.0507458498595383e-11
accumulate O 0 6.231072324780484e-10
into O 0 3.8388139889100614e-11
discrete O 0 5.182401618952781e-09
subnuclear O 0 4.12275812777807e-06
foci O 0 1.801648522814503e-06
termed O 0 1.7557691762704053e-06
" O 0 6.943795369807049e-07
BRCA1 O 0 2.692653424674063e-07
nuclear O 0 5.472164161801629e-07
dots O 0 2.614353206809028e-06
. O 0 3.007789928233251e-08

" O 0 2.7182504709344357e-06
BRCA1 O 0 8.523844599039876e-07
associates O 0 1.88082260876854e-09
in O 0 2.6639877803713574e-11
vivo O 0 1.2163386964303413e-10
with O 0 3.429801744263966e-14
a O 0 8.329600030554385e-12
structurally O 0 3.112556896667229e-07
related O 0 5.046552359999623e-06
protein O 0 3.627795376814902e-05
termed O 0 3.908541475539096e-05
BARD1 O 1 0.9999997615814209
. O 0 6.79182539897738e-06

Here O 0 4.532810571333812e-09
we O 0 1.5540414441406192e-11
show O 0 9.269217338125912e-13
that O 0 1.099279020133452e-14
the O 0 5.1081144522568955e-12
steady O 0 8.197436063284158e-10
- O 0 5.2838918136732804e-12
state O 0 6.687674719563219e-12
levels O 0 8.590937405905663e-10
of O 0 5.021494678403293e-11
BARD1 O 0 0.0002959269331768155
, O 0 4.8720684604763864e-12
unlike O 0 4.078485119074493e-11
those O 0 8.245773855386496e-12
of O 0 1.7905076032942446e-10
BRCA1 O 0 2.1444575282192346e-10
, O 0 6.787896525244086e-13
remain O 0 1.310552447814084e-11
relatively O 0 1.5820217314985174e-12
constant O 0 4.805973327637325e-13
during O 0 3.997157205920532e-12
cell O 0 4.629085559315627e-09
cycle O 0 5.420113069476429e-08
progression O 0 1.7880427094496554e-07
. O 0 5.1711750437277715e-09

However O 0 3.1533670608041575e-07
, O 0 1.0253999871423503e-09
immunostaining O 0 3.3229935070266947e-06
revealed O 0 2.6938112185348473e-08
that O 0 1.871967442168554e-10
BARD1 O 1 0.9993379712104797
resides O 0 1.2337358157310518e-07
within O 0 3.791808200759306e-09
BRCA1 O 0 9.82050107900534e-10
nuclear O 0 1.4111505297620397e-09
dots O 0 1.2284023798159183e-09
during O 0 2.0085118290769088e-10
S O 0 4.450915636056152e-09
phase O 0 1.9918944271779537e-09
of O 0 3.226851771898076e-11
the O 0 2.9296697446473674e-12
cell O 0 9.451716319330838e-12
cycle O 0 4.275925533786529e-12
, O 0 1.70026990262747e-14
but O 0 8.806078425054736e-14
not O 0 1.8225593018290909e-13
during O 0 6.630586357747603e-11
the O 0 1.9244768278969815e-10
G1 O 0 7.854063710510673e-08
phase O 0 1.0807053740791162e-07
. O 0 5.785589785034517e-09

Nevertheless O 0 2.8092428692616522e-05
, O 0 6.326365209474716e-09
BARD1 O 0 0.00015058665303513408
polypeptides O 0 5.784787049378792e-08
are O 0 1.1789669934758606e-11
found O 0 5.849523881766572e-13
exclusively O 0 1.8784715536540597e-12
in O 0 6.313333102830887e-13
the O 0 2.4002611963974685e-12
nuclear O 0 4.368725381453942e-09
fractions O 0 1.1808101163524043e-07
of O 0 1.9029569031658866e-09
both O 0 3.885501989597806e-11
G1 O 0 7.890124997800285e-09
- O 0 1.3843632906684888e-09
and O 0 1.6612754574762967e-11
S O 0 3.3298849899665584e-08
- O 0 5.142275494307569e-10
phase O 0 9.911016896069214e-09
cells O 0 2.8446063282672185e-09
. O 0 2.9832419867759086e-10

Therefore O 0 4.630533290139738e-09
, O 0 1.553988014657559e-11
progression O 0 1.3003649268483741e-09
to O 0 7.0821144088073495e-12
S O 0 2.0496599972830154e-08
phase O 0 1.564581175728108e-08
is O 0 2.1576447226112627e-13
accompanied O 0 5.0103658201516854e-12
by O 0 1.7211105045496222e-13
the O 0 9.564388343819008e-12
aggregation O 0 1.3366010520599048e-09
of O 0 6.535474939006747e-11
nuclear O 0 5.045398552283586e-07
BARD1 O 1 0.9949361085891724
polypeptides O 0 3.518600806273753e-06
into O 0 9.710559112363626e-08
BRCA1 O 0 5.6252321911642866e-08
nuclear O 0 6.405691266309077e-08
dots O 0 6.561231771229359e-07
. O 0 8.625224090508254e-09

This O 0 2.834039114496534e-10
cell O 0 2.074745486524421e-09
cycle O 0 9.133169776021077e-10
- O 0 4.723175184295769e-10
dependent O 0 8.732035650105274e-10
colocalization O 0 4.7907015243708884e-08
of O 0 8.963353947955e-10
BARD1 O 1 0.9967041611671448
and O 0 2.044637570364216e-09
BRCA1 O 0 1.7670369334421565e-10
indicates O 0 3.8447474370872925e-12
a O 0 1.384217091941536e-14
role O 0 3.069159509871966e-13
for O 0 3.2792663983566284e-12
BARD1 O 0 0.4207722544670105
in O 0 5.308145887283899e-07
BRCA1 O 0 1.4510744676954346e-06
- O 0 6.89329453962273e-07
mediated O 0 1.3188215461923392e-06
tumor B-Disease 0 0.00013102505181450397
suppression O 0 4.260958303348161e-05
. O 0 1.169624894714616e-07

Ethnic O 0 5.961998539305569e-08
differences O 0 1.1151676027054691e-08
in O 0 6.727774587433899e-11
the O 0 5.753947873721188e-10
HFE O 0 9.778932144399732e-05
codon O 0 4.399844044655765e-07
282 O 0 1.6909775979456754e-07
( O 0 2.152271971755937e-10
Cys O 0 1.2253711247467436e-05
/ O 0 1.403395941679264e-07
Tyr O 0 7.115883136066259e-07
) O 0 2.669903707841481e-11
polymorphism O 0 3.376180401915008e-08
. O 0 6.169474264794417e-09

Recent O 0 4.737380976393979e-08
studies O 0 1.591392989608309e-10
have O 0 3.0737584244371063e-13
shown O 0 3.173358711222596e-12
that O 0 2.6732923166794542e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.3265409881668688e-09
HH B-Disease 0 7.047429244266823e-05
) O 0 3.6216410187646375e-13
is O 0 3.8167883973814695e-14
likely O 0 6.064763708596432e-12
to O 0 1.97564309204791e-13
be O 0 1.1300292299121217e-12
caused O 0 7.591643980120466e-11
by O 0 7.659622068556526e-12
homozygosity O 0 3.883708075136383e-07
for O 0 2.2341392624802836e-11
a O 0 3.7667122892992566e-11
Cys282Tyr O 0 2.433247914268577e-07
mutation O 0 8.401233597687963e-10
in O 0 2.691757754191837e-11
the O 0 1.6745206332657858e-09
HFE O 0 0.00028881372418254614
gene O 0 3.491986788617396e-08
located O 0 5.606708874950073e-09
4 O 0 4.5940975468283796e-08
. O 0 1.965882390209117e-08

5 O 0 4.917057481179654e-07
Mb O 0 2.0715680193461594e-07
telomeric O 0 3.426439661780023e-06
to O 0 1.1745987293920734e-08
HLA O 0 0.002158676739782095
- O 0 0.00013367278734222054
A O 0 1.9133067326038145e-06
. O 0 2.3169324236960165e-08

Population O 0 1.2010037409027063e-10
studies O 0 9.477947073011084e-12
of O 0 4.4360072256124927e-13
this O 0 2.523581658312596e-13
polymorphism O 0 2.783133168371421e-10
are O 0 4.74570503608638e-14
facilitated O 0 9.23989834297756e-13
by O 0 1.4092271457839117e-13
the O 0 6.804505743585043e-12
fact O 0 2.149877715088011e-12
that O 0 4.310723802111553e-14
the O 0 3.872672668658872e-11
Cys282Tyr O 0 6.22346306045074e-06
mutation O 0 4.516097007467579e-08
creates O 0 3.9123673190033514e-09
a O 0 4.3662549270573336e-11
Rsal O 0 4.152926067035878e-06
restriction O 0 1.4024649317434523e-06
site O 0 3.174503433456266e-07
. O 0 3.568325013247886e-08

We O 0 2.478451444076768e-09
have O 0 2.8550271955612994e-12
studied O 0 4.033430187067033e-11
the O 0 1.455346780587785e-11
codon O 0 6.039216238207246e-09
282 O 0 2.695728440471612e-08
( O 0 9.530977396199347e-11
Cys O 0 3.0888345463608857e-06
/ O 0 3.509547497060339e-08
Tyr O 0 7.350131170369423e-08
) O 0 6.694690917082025e-13
polymorphism O 0 3.3536884380680476e-10
in O 0 5.495342028649652e-12
different O 0 2.7778496516916995e-11
ethnic O 0 7.397644302686857e-11
groups O 0 2.5531271541368028e-11
. O 0 1.8956961000959893e-10

In O 0 5.206017839043398e-10
agreement O 0 1.1775664887636594e-08
with O 0 2.6858805110552275e-11
previous O 0 5.515367718089692e-08
observations O 0 1.2962697581997418e-08
the O 0 6.819857456541456e-10
Tyr O 0 7.478305974473187e-07
allele O 0 6.512321237828189e-10
appeared O 0 6.436990940272835e-10
to O 0 3.889442750076161e-13
be O 0 4.4414596783379223e-13
rare O 0 5.524413565494157e-11
or O 0 1.553715489599483e-11
absent O 0 5.85151127552308e-09
in O 0 5.329848021262684e-11
Asiatic O 0 1.2870410515120057e-08
( O 0 4.5859417473334205e-14
Indian O 0 1.2087470781241283e-12
, O 0 1.1655238406349522e-13
Chinese O 0 6.378737121837119e-11
) O 0 1.4792487981057922e-12
populations O 0 1.2890142078725297e-11
. O 0 4.334328451705005e-10

The O 0 1.959031603604444e-09
highest O 0 2.864369630373176e-09
allele O 0 5.3052805204512055e-12
frequency O 0 1.164545109649806e-11
( O 0 1.9142883621574985e-14
7 O 0 6.030159878378516e-12
. O 0 3.007587126395428e-13
5 O 0 2.5410158352445755e-11
% O 0 7.44664746532564e-13
) O 0 1.6809035107280372e-14
was O 0 1.5444675052767032e-11
found O 0 2.417159875034436e-11
in O 0 3.347521149166255e-10
Swedes O 0 4.187282684142701e-06
. O 0 3.7196016933194187e-07

Saamis O 0 0.0011466983705759048
( O 0 2.734403814486086e-10
2 O 0 2.5248241275477312e-09
% O 0 1.45798356027127e-11
) O 0 6.161251250944716e-14
and O 0 2.683508363438003e-12
Mordvinians O 0 2.3152131234382978e-06
( O 0 7.342098391933949e-13
1 O 0 1.3638075391231297e-10
. O 0 2.8782978604702247e-12
8 O 0 9.528849931328409e-11
% O 0 4.725718514425603e-13
) O 0 4.8249622477741436e-15
had O 0 5.698663112577163e-13
significantly O 0 6.040318800693001e-10
lower O 0 2.796940279381488e-08
frequencies O 0 1.157252516037488e-09
of O 0 1.0325531402122223e-10
the O 0 4.378151174933009e-09
Tyr O 0 1.1907032785529736e-05
allele O 0 1.3633204787311115e-07
. O 0 2.056265913097377e-08

Comparisons O 0 1.9731970724023995e-07
with O 0 3.6461878655247304e-11
allele O 0 3.857502928195089e-10
frequencies O 0 6.268224828076541e-11
based O 0 8.318085803482589e-13
on O 0 2.335268697167825e-12
prevalence O 0 5.1296359521169066e-11
estimates O 0 5.130826753046991e-12
of O 0 4.148798492253913e-12
HH B-Disease 1 0.9999982118606567
showed O 0 1.2433901019903715e-06
some O 0 1.1042533554217471e-10
disagreements O 0 1.394758619710501e-08
with O 0 5.312832422263436e-13
the O 0 2.5490059715749247e-11
RFLP O 0 1.6286737292148246e-08
data O 0 5.696476623739954e-10
, O 0 2.8556699106091488e-12
particularly O 0 4.189564806189594e-10
in O 0 4.792933064323712e-11
Finns O 0 2.1320863652363187e-07
. O 0 9.495258801450746e-09

The O 0 1.171026724477997e-07
newly O 0 9.18989655929181e-07
described O 0 4.641323414489307e-08
HFE O 0 0.0011299283942207694
marker O 0 2.5518804136481776e-07
provides O 0 1.3693092666688944e-11
a O 0 1.5116118805887785e-13
new O 0 6.638377781503779e-12
approach O 0 1.1770645569342264e-10
to O 0 5.375499307833098e-13
the O 0 1.388820156968118e-12
screening O 0 1.0519072279890906e-09
of O 0 3.298452622146897e-10
HH B-Disease 1 0.7710029482841492
as O 0 2.271916960117082e-10
well O 0 9.542736609594038e-13
as O 0 1.884563265532914e-14
studies O 0 3.288144631791515e-14
of O 0 3.5776371150536904e-14
the O 0 7.734844123703788e-13
relationship O 0 9.391068651887213e-12
between O 0 4.323955429819115e-11
the O 0 2.5200082021115122e-09
HFE O 0 6.743837002431974e-05
Tyr O 0 5.1036386139458045e-06
allele O 0 1.835159935126285e-08
and O 0 2.6814578335532246e-11
different O 0 8.473393653396499e-10
disorders O 0 1.4530252883560024e-05
including O 0 1.3417767341650233e-08
cancer B-Disease 1 0.9999616146087646

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.6063173413276672
associated O 0 2.5086821509034962e-08
with O 0 1.0056522455059724e-11
a O 0 5.118562518280356e-11
missense O 0 2.164624746114896e-08
mutation O 0 2.137658244860674e-10
encoding O 0 1.1755932893819931e-09
Gly23 O 0 4.588336651067948e-06
- O 0 5.74442367451411e-07
- O 0 4.147802599163697e-07
> O 0 1.158976559167968e-07
Val O 0 8.450060207110255e-09
in O 0 9.033821607440373e-11
neurophysin O 0 1.2824231816921383e-05
II O 1 1.0
. O 0 5.843099188496126e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 7.431278370439998e-10
ADNDI B-Disease 1 1.0
) O 0 7.886397264400546e-12
is O 0 4.0628283615000427e-13
an O 0 7.024464560370647e-13
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.2867927807747037e-06
by O 0 5.961844906643421e-10
progressive O 1 0.9999988079071045
degeneration O 1 1.0
of O 0 1.0704847142051221e-07
the O 0 1.872511257161591e-09
magnocellular O 0 6.574642696932642e-08
neurons O 0 3.0022156982667525e-10
of O 0 1.8884557112519573e-11
the O 0 4.0930502043234895e-11
hypothalamus O 0 1.5165475542033846e-09
leading O 0 1.0220591040166482e-09
to O 0 5.756941798273907e-11
decreased O 0 1.9846186205541017e-07
ability O 0 3.5662189867835536e-10
to O 0 2.881084086581165e-11
produce O 0 7.258592615855264e-10
the O 0 2.638811169575206e-09
hormone O 0 1.1289371215639221e-08
arginine O 0 3.4982264196514734e-08
vasopressin O 0 7.462092810328613e-08
( O 0 1.2545856020729218e-10
AVP O 0 6.693851446470944e-07
) O 0 3.402856468825988e-11
. O 0 1.6759617027517493e-09

Affected O 0 1.5378066109406063e-07
individuals O 0 1.7589254705518975e-11
are O 0 1.2404405844504418e-13
not O 0 1.088509504428882e-13
symptomatic O 0 1.5028899236213533e-09
at O 0 1.5189508721993872e-12
birth O 0 3.560206351949091e-09
, O 0 5.665467010460001e-13
but O 0 1.0727903808349648e-11
usually O 0 2.8641634841619634e-08
develop O 0 2.6698626243160106e-06
diabetes B-Disease 1 0.9503225088119507
insipidus I-Disease 0 1.2500419870775659e-05
at O 0 2.726145975628924e-09
1 O 0 1.3114527064317372e-07
- O 0 1.542918823815853e-07
6 O 0 1.772218922724278e-07
yr O 0 1.0739598792497418e-06
of O 0 4.741860237800211e-10
age O 0 2.0470658057547553e-08
. O 0 3.847306029314268e-09

The O 0 2.906635487853748e-10
genetic O 0 2.5245677770513453e-10
locus O 0 1.2027963347538417e-10
of O 0 7.690558606610054e-11
the O 0 7.000974244775193e-10
disease O 0 2.1429842433917656e-07
is O 0 5.466218189892347e-12
the O 0 5.290492488541076e-10
AVP O 0 1.0285039934387896e-05
- O 0 3.3195840387634235e-07
neurophysin O 0 2.3954005882842466e-05
II O 1 1.0
( O 0 2.3754373468243273e-10
NPII O 0 0.0006190233398228884
) O 0 1.941150018502924e-11
gene O 0 1.6015870921148867e-11
, O 0 1.1316107773051698e-11
and O 0 9.661680483441515e-11
mutations O 0 4.642396883580702e-11
that O 0 6.092694057602266e-12
cause O 0 9.443570547773561e-08
ADNDI B-Disease 1 0.9999959468841553
have O 0 5.96908189542944e-10
been O 0 2.2398524007760656e-11
found O 0 1.5058860191805024e-12
in O 0 5.288708381824547e-13
both O 0 5.0100453841996073e-14
the O 0 7.099733669892194e-13
signal O 0 6.470975144612368e-11
peptide O 0 2.2448178732537016e-11
of O 0 1.3178072522102013e-10
the O 0 4.502299422171063e-09
prepro O 0 0.0008796657202765346
- O 0 0.0003950122045353055
AVP O 0 0.000347215827787295
- O 0 2.23599840865063e-06
NPII O 0 0.000925014610402286
precursor O 0 4.4446318270274787e-07
and O 0 2.3684385008770903e-10
within O 0 4.1736152311955266e-09
NPII O 1 0.9994533658027649
itself O 0 9.93454207787181e-09
. O 0 5.464495966833738e-09

An O 0 2.2020636702979601e-10
affected O 0 1.6037576244798402e-07
girl O 0 3.384304818609962e-07
who O 0 2.527336846747108e-11
presented O 0 5.278357195770411e-10
at O 0 3.257760033958945e-11
9 O 0 5.0160289116751855e-11
months O 0 7.830757743632066e-12
of O 0 2.5141678669515777e-11
age O 0 6.723676282405222e-09
and O 0 2.372236296288577e-10
her O 0 1.030320273542884e-10
similarly O 0 1.4036288797925067e-09
affected O 0 3.642655244107118e-08
younger O 0 2.011546257563168e-06
brother O 0 3.4199555898339895e-07
and O 0 9.023735092483776e-10
father O 0 7.3760393348720754e-09
were O 0 5.80103465264159e-10
all O 0 5.150741378551205e-12
found O 0 9.542299676118526e-13
to O 0 4.65871319386274e-13
have O 0 5.49781357592205e-13
a O 0 1.8765343012122626e-12
novel O 0 1.1301861668755464e-09
missense O 0 1.697375040521365e-08
mutation O 0 2.1685318818409627e-10
( O 0 1.948080368893712e-13
G1758 O 0 8.236192838850798e-10
- O 0 2.372372021053337e-10
- O 0 3.7185793333449624e-10
> O 0 5.965872240665249e-10
T O 0 1.0113272025380482e-10
) O 0 6.684728433193775e-16
encoding O 0 1.5980427159507926e-13
the O 0 7.92819965494268e-13
amino O 0 3.2369413139471392e-12
acid O 0 2.0017910939973405e-11
substitution O 0 7.233439403009356e-10
Gly23 O 0 2.7695142534867045e-07
- O 0 6.106096606117717e-08
- O 0 7.920118605397874e-08
> O 0 6.626613213711607e-08
Val O 0 6.101576577322021e-09
within O 0 2.229352702443066e-09
NPII O 0 0.12224165350198746
. O 0 2.0489845553584018e-07

The O 0 1.842025199039199e-07
mutation O 0 2.6449701095998535e-08
was O 0 2.6865684676913304e-10
confirmed O 0 5.6740702414348476e-11
by O 0 1.198823592479803e-12
restriction O 0 1.0869064759333469e-08
endonuclease O 0 1.950152750396228e-07
analysis O 0 9.436108561189371e-10
. O 0 6.509480954264291e-09

A O 0 4.053017619298771e-07
T1 O 0 5.263585626380518e-05
- O 0 2.2797589593892553e-08
weighted O 0 9.277318469003148e-09
magnetic O 0 2.8603608370758593e-10
resonance O 0 9.9463492997387e-10
imaging O 0 3.787408076050269e-08
of O 0 1.0978088438307054e-09
the O 0 4.4682832367470837e-07
fathers O 0 0.000146687583765015
pituitary O 0 7.30475876480341e-05
gland O 0 1.397716800966009e-06
demonstrates O 0 5.923785462158548e-09
an O 0 3.9394377517043555e-12
attenuated O 0 3.7725671973021235e-06
posterior O 0 1.8570261772765662e-06
pituitary O 0 0.0016188116278499365
bright O 1 0.9992129802703857
spot O 0 1.453729419154115e-05
. O 0 8.096734660512084e-08

This O 0 5.0334026724385694e-08
mutation O 0 2.8493918335925628e-08
may O 0 1.1410573597103735e-09
be O 0 3.615708774051818e-11
valuable O 0 1.1553382694984293e-09
for O 0 7.475706794053683e-13
developing O 0 5.6006112941764385e-11
models O 0 3.63438584782827e-10
of O 0 4.00261868094276e-09
dominantly B-Disease 0 0.00011612047092057765
inherited I-Disease 0 0.3674257695674896
neurodegeneration I-Disease 1 1.0
, O 0 2.7771980895541226e-11
as O 0 1.872593063684952e-13
the O 0 3.742522581445286e-14
early O 0 1.507717561910482e-11
age O 0 7.530694817736716e-12
of O 0 5.649367150299678e-13
onset O 0 2.0175065174043993e-07
of O 0 1.682252381840499e-08
symptoms O 0 0.003453667741268873
suggests O 0 1.488012157935259e-09
that O 0 1.03352743030527e-12
this O 0 3.8516342892869204e-11
mutation O 0 3.809915716246337e-10
may O 0 1.7590470746675635e-10
be O 0 4.5130423703687583e-11
particularly O 0 4.20168255743647e-09
deleterious O 0 3.207967935736633e-08
to O 0 2.1504172054154225e-10
the O 0 8.100129456067862e-09
magnocellular O 0 3.1464864150621e-05
neuron O 0 7.815044682502048e-07
. O 0 4.172246548250769e-09
. O 0 1.2874092902848133e-08

Frequent O 0 3.000139248143796e-09
inactivation O 0 6.620279236813076e-06
of O 0 4.893643108516699e-07
PTEN O 1 0.9999960660934448
/ O 0 0.002913419157266617
MMAC1 O 1 0.9999998807907104
in O 0 1.5509813238168135e-06
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.9704789337993134e-06

Sporadic B-Disease 1 0.9999997615814209
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 6.834719457060601e-09
the O 0 1.9896388980811253e-09
most O 0 2.47755704840813e-10
common O 0 5.647016743104416e-10
male B-Disease 0 5.211409775940368e-11
cancer I-Disease 0 3.452426122763086e-10
in O 0 1.5435773319250057e-12
the O 0 2.700139417610714e-11
Western O 0 1.329071075417687e-09
world O 0 4.693998553566281e-13
, O 0 2.242123994062803e-13
yet O 0 3.950574242739258e-12
many O 0 8.581830856840486e-14
of O 0 1.631841227900041e-13
the O 0 9.057035178262896e-13
major O 0 1.602424269664393e-11
genetic O 0 1.6987481300106966e-12
events O 0 2.0266955973700929e-13
involved O 0 2.782667217308965e-13
in O 0 4.1112293148841406e-13
the O 0 4.734074677409383e-12
progression O 0 1.1691622114895495e-09
of O 0 5.634573970597634e-12
this O 0 6.522449247370332e-11
often O 0 1.8551142844103197e-08
fatal O 0 1.6690391930751503e-06
cancer B-Disease 1 0.9996402263641357
remain O 0 1.3256661759442068e-06
to O 0 3.534015025064008e-10
be O 0 7.245690714086095e-09
elucidated O 0 0.00014791756984777749
. O 0 4.003598235158279e-07

Numerous O 0 6.161489540801313e-09
cytogenetic O 0 8.051217264437582e-06
and O 0 7.801590484746157e-10
allelotype O 0 1.7940457837539725e-05
studies O 0 1.906746316393537e-09
have O 0 3.5480190833936387e-12
reported O 0 7.898228945868446e-12
frequent O 0 1.5456315047290836e-11
loss O 0 3.0216676383254537e-10
of O 0 6.830079612996087e-09
heterozygosity O 0 4.5172138925408944e-05
on O 0 4.6729428504477255e-06
chromosomal O 0 4.637032816390274e-06
arm O 0 3.3134301702375524e-06
10q O 0 1.9246192096034065e-05
in O 0 3.630579783475696e-07
sporadic B-Disease 1 0.9999996423721313
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.976241143594962e-06

Deletion O 0 4.282570387204032e-07
mapping O 0 3.828954930895634e-08
studies O 0 9.153922619908883e-10
have O 0 1.3820718007540034e-11
unambiguously O 0 1.0948583151204616e-09
identified O 0 4.221890198552458e-11
a O 0 1.1751902619441812e-12
region O 0 1.5175218026630688e-10
of O 0 4.2162590085936813e-10
chromosome O 0 6.734017232723488e-10
10q23 O 0 3.945228144175417e-08
to O 0 5.8637027525176855e-12
be O 0 1.07504901248473e-12
the O 0 6.3429201127562784e-12
minimal O 0 2.5484700572064867e-08
area O 0 2.6709863210072626e-09
of O 0 6.781462613680844e-10
loss O 0 9.119182209360588e-08
. O 0 2.495263800028624e-07

A O 0 1.391143342743817e-07
new O 0 4.108433060423522e-08
tumor B-Disease 0 1.884995072032325e-06
suppressor O 0 1.0603743021420087e-06
gene O 0 1.2013960937196089e-09
, O 0 2.3277822724931951e-10
PTEN O 0 7.164814451243728e-05
/ O 0 3.645536708063446e-07
MMAC1 O 1 0.9999732971191406
, O 0 2.5087656951860993e-10
was O 0 7.638595533876469e-09
isolated O 0 3.1361711005928328e-09
recently O 0 1.4943453419125063e-10
at O 0 1.655127077060392e-11
this O 0 3.7617920931043436e-12
region O 0 4.699676203756553e-10
of O 0 6.665472618294643e-10
chromosome O 0 3.3476746374994093e-10
10q23 O 0 1.6097544630611083e-08
and O 0 6.674791361988008e-12
found O 0 2.86381758151516e-13
to O 0 1.9233353516605323e-14
be O 0 4.478580998895296e-14
inactivated O 0 1.200360227882058e-10
by O 0 3.9176778141025714e-12
mutation O 0 3.115375957207789e-09
in O 0 1.2455931397425957e-08
three O 0 1.9724031119494612e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 2.639029116835445e-05
lines O 0 2.529255205274694e-08
. O 0 4.6132906383888894e-09

We O 0 4.081404767930508e-06
screened O 0 6.96410788805224e-05
80 O 0 8.166040970536415e-06
prostate B-Disease 1 0.9944972395896912
tumors I-Disease 1 1.0
by O 0 2.0218338114830203e-10
microsatellite O 0 6.058760604332747e-09
analysis O 0 3.2961237905748675e-11
and O 0 4.53627196569939e-12
found O 0 1.789822847222955e-12
chromosome O 0 2.8011962541207858e-11
10q23 O 0 2.185150371758482e-08
to O 0 7.70431496377455e-11
be O 0 2.3458918141372465e-10
deleted O 0 8.451961797106833e-09
in O 0 9.447251314576022e-11
23 O 0 1.214816025552068e-09
cases O 0 2.283290084781342e-10
. O 0 3.600970854833463e-09

We O 0 4.049900859115496e-09
then O 0 3.874202000875293e-11
proceeded O 0 1.8026070913723657e-10
with O 0 1.4680317644020016e-15
sequence O 0 8.01728797147341e-15
analysis O 0 1.1610567752183814e-14
of O 0 2.2152375420136927e-13
the O 0 1.9429095485246073e-11
entire O 0 7.754096031931113e-08
PTEN O 0 0.000491534941829741
/ O 0 3.7681913909182185e-06
MMAC1 O 0 0.0325157567858696
coding O 0 1.2815397099075199e-07
region O 0 1.7281610809050107e-08
and O 0 1.0208700551572747e-10
tested O 0 1.2726621978487174e-09
for O 0 1.3850043334429074e-10
homozygous O 0 1.957992878942605e-09
deletion O 0 3.1164085201318414e-10
with O 0 5.722712885167236e-13
new O 0 7.203782015352544e-10
intragenic O 0 1.3761995205641142e-06
markers O 0 2.178645708283966e-08
in O 0 6.249792350310202e-11
these O 0 9.581698282024043e-12
23 O 0 1.3733058093490236e-11
cases O 0 1.4841322615311014e-12
with O 0 2.6876816202302256e-13
10q23 O 0 4.275449612123339e-07
loss O 0 5.949945958150238e-08
of O 0 3.195330577909772e-07
heterozygosity O 0 0.0015066232299432158
. O 0 3.059204800592852e-06

The O 0 1.610366839877031e-10
identification O 0 2.644780783267464e-10
of O 0 4.3054632775652024e-11
the O 0 2.005077354150231e-11
second O 0 1.9046043908677035e-10
mutational O 0 1.5240324557908025e-08
event O 0 4.173778336835632e-11
in O 0 8.235776643994441e-12
10 O 0 1.1256349151389511e-11
( O 0 3.515065300462028e-13
43 O 0 1.7938276419826593e-09
% O 0 7.632562359916051e-10
) O 0 1.4659852221043934e-09
tumors B-Disease 1 1.0
establishes O 0 9.597621829016134e-05
PTEN O 1 0.9999977350234985
/ O 0 0.00011885414278367534
MMAC1 O 1 0.9999725818634033
as O 0 2.8416748121262714e-11
a O 0 1.5187298033764174e-13
main O 0 9.831436879881306e-12
inactivation O 0 2.2987294290288673e-09
target O 0 4.6477544035639085e-12
of O 0 2.0220988078412105e-11
10q O 0 7.325407409553009e-07
loss O 0 1.516586394245678e-07
in O 0 1.016918602658734e-07
sporadic B-Disease 1 0.9999995231628418
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.701669689832215e-09
. O 0 4.918518037300146e-09

Risk O 0 9.909921345752082e-07
reversals O 0 5.342293718513247e-08
in O 0 1.6426006388403636e-11
predictive O 0 5.147034465302625e-10
testing O 0 1.1197324178979784e-09
for O 0 1.9819736962745083e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.744018380937632e-07

The O 0 4.851607449118944e-10
first O 0 3.3366939853479716e-12
predictive O 0 4.224516222950392e-11
testing O 0 2.304474805425727e-10
for O 0 8.119866556910438e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 7.454281983343414e-12
HD B-Disease 0 2.248219210798652e-08
) O 0 8.768568418018527e-14
was O 0 8.718313397604316e-12
based O 0 1.3169616222205582e-12
on O 0 2.5062488542837436e-11
analysis O 0 2.516690198253735e-12
of O 0 3.490228288674513e-12
linked O 0 1.6520181056467464e-10
polymorphic O 0 4.539386200264062e-09
DNA O 0 2.3481983024709052e-09
markers O 0 3.5902700257217646e-10
to O 0 1.7236705769294036e-12
estimate O 0 8.587574401586195e-11
the O 0 1.8949061070250295e-12
likelihood O 0 1.3894732586727798e-10
of O 0 1.954011258353816e-10
inheriting O 0 5.982422379702257e-08
the O 0 1.2996267173548404e-08
mutation O 0 1.9851660315595154e-09
for O 0 5.137275604916169e-10
HD B-Disease 0 1.1365613318048418e-05
. O 0 1.548106922655279e-07

Limits O 0 2.856733374301257e-07
to O 0 4.3168377206193043e-10
accuracy O 0 1.4003992632183326e-08
included O 0 6.834846022485408e-10
recombination O 0 1.8255157108182374e-10
between O 0 1.4754735627731108e-11
the O 0 1.6738324268295024e-11
DNA O 0 1.5923889984392758e-10
markers O 0 1.063261922951142e-09
and O 0 2.082160832639346e-11
the O 0 2.6263921593105977e-10
mutation O 0 1.19568951961746e-10
, O 0 1.1721283665888649e-11
pedigree O 0 1.3829230205431031e-08
structure O 0 1.5896109317736773e-08
, O 0 7.917554112335523e-11
and O 0 5.147935203120291e-11
whether O 0 3.21805047887036e-11
DNA O 0 8.536785167656546e-11
samples O 0 3.308955193181973e-11
were O 0 5.396188595789553e-13
available O 0 2.841706037148839e-12
from O 0 4.861544500300852e-11
family O 0 4.871506531500813e-10
members O 0 3.561826181219807e-11
. O 0 5.148441228897127e-09

With O 0 8.548289159859834e-11
direct O 0 1.5989598534105198e-10
tests O 0 1.4194588560112464e-10
for O 0 1.1285500312041563e-11
the O 0 6.587490553044972e-10
HD B-Disease 0 8.929504815569089e-07
mutation O 0 4.925190255633538e-10
, O 0 6.386781294803745e-12
we O 0 1.7219518996455796e-12
have O 0 3.4745909491609717e-13
assessed O 0 6.222815318590591e-11
the O 0 2.133582590116423e-12
accuracy O 0 2.341877247680202e-10
of O 0 9.008266355081673e-12
results O 0 3.356455738345865e-12
obtained O 0 1.8721513055097727e-12
by O 0 2.0476307281691586e-13
linkage O 0 2.7306133049131986e-11
approaches O 0 2.6607341330198153e-10
when O 0 2.5163638533998167e-12
requested O 0 1.4484666799319257e-09
to O 0 1.4257871550071854e-09
do O 0 5.171132966275138e-10
so O 0 2.6090603635897658e-11
by O 0 2.240765515845733e-12
the O 0 5.3087454571221215e-11
test O 0 5.177172579529099e-10
individuals O 0 1.247146691474299e-10
. O 0 1.251637460342181e-08

For O 0 1.0738886446759466e-09
six O 0 2.7446125233643315e-11
such O 0 2.242929149701145e-12
individuals O 0 3.76866994642594e-13
, O 0 2.676356044336442e-13
there O 0 1.4412433648868656e-13
was O 0 1.0118746118781274e-11
significant O 0 3.595684028301349e-10
disparity O 0 1.8962838410629956e-08
between O 0 1.2816551986372104e-10
the O 0 7.968447013340096e-10
tests O 0 1.5538296205264146e-09
. O 0 6.209992076122717e-09

Three O 0 1.0715996978660769e-08
went O 0 7.370245302951162e-09
from O 0 1.6333000923962615e-11
a O 0 1.91535676208332e-12
decreased O 0 7.17135222316756e-08
risk O 0 4.349301196970856e-10
to O 0 1.6060094877243247e-12
an O 0 1.1448891185409597e-14
increased O 0 4.6599619996090524e-11
risk O 0 2.4265289777503085e-10
, O 0 3.687075330379569e-13
while O 0 1.1970711965084146e-12
in O 0 2.5044077055225156e-12
another O 0 3.2375031475129212e-12
three O 0 1.4441003731366364e-12
the O 0 1.1697705304403172e-10
risk O 0 2.4144481969301523e-09
was O 0 2.2205299821109747e-09
decreased O 0 7.819338634362794e-07
. O 0 8.704191856168109e-08

Knowledge O 0 2.3541106486391072e-07
of O 0 6.9516916667566875e-09
the O 0 4.2390954635429523e-10
potential O 0 9.9084171423236e-11
reasons O 0 3.867920428390903e-10
for O 0 1.0843946183711206e-12
these O 0 9.747259423209531e-13
changes O 0 2.91063943780312e-11
in O 0 1.4488823335545575e-11
results O 0 1.9151467911537878e-10
and O 0 1.5754942489509816e-11
impact O 0 1.0972331931924373e-09
of O 0 2.704501345096588e-10
these O 0 1.5656873020297724e-10
risk O 0 9.012893903426189e-11
reversals O 0 4.336304926244594e-10
on O 0 3.894214395394613e-10
both O 0 2.2400916191434028e-11
patients O 0 2.1574435571380945e-09
and O 0 2.7462303264780275e-11
the O 0 3.4058726949837137e-09
counseling O 0 1.2206061716923955e-09
team O 0 1.1179679144240895e-12
can O 0 1.855682897925967e-13
assist O 0 1.5685268361931293e-10
in O 0 1.4337439568912203e-10
the O 0 1.6284741333194575e-09
development O 0 9.432191028224679e-09
of O 0 6.578099176479668e-10
strategies O 0 4.774622919256899e-10
for O 0 3.7119268704761954e-13
the O 0 2.3299743211191437e-12
prevention O 0 5.871809288793273e-11
and O 0 6.420118072152786e-14
, O 0 5.1638461539269594e-15
where O 0 5.190837112901102e-14
necessary O 0 1.1116454978754575e-10
, O 0 2.7519128469044585e-12
management O 0 5.4534324972488335e-11
of O 0 1.7888955941569584e-11
a O 0 9.607025244773304e-12
risk O 0 5.970789973552826e-10
reversal O 0 5.278359971327973e-09
in O 0 4.031799546999615e-11
any O 0 8.59003215780696e-11
predictive O 0 6.686125542110233e-10
testing O 0 1.2626595324860546e-09
program O 0 4.0853070926161195e-10
. O 0 1.6278698874994113e-11
. O 0 6.756686876663309e-10

A O 0 1.5232476613391555e-08
novel O 0 2.047220837297914e-09
common O 0 2.300611257055607e-09
missense O 0 2.4688091571078985e-08
mutation O 0 1.410148942060374e-10
G301C O 0 2.6529720642542998e-09
in O 0 3.1264192623670084e-12
the O 0 1.2595097707845948e-11
N O 0 2.3507973345715527e-09
- O 0 1.3039985757856698e-09
acetylgalactosamine O 0 2.335688407129055e-07
- O 0 2.5557913119200748e-08
6 O 0 2.0967731995114036e-09
- O 0 4.897536820536175e-10
sulfate O 0 2.3530404291705054e-09
sulfatase O 0 1.3455779424020875e-07
gene O 0 4.063888392469295e-10
in O 0 1.379094949349735e-09
mucopolysaccharidosis B-Disease 0 0.3754710555076599
IVA I-Disease 1 0.9999990463256836
. O 0 2.3651514311495703e-06

Mucopolysaccharidosis B-Disease 1 0.9999994039535522
IVA I-Disease 1 1.0
( O 0 3.7581712604151107e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 9.830142776168227e-12
is O 0 3.445960422392147e-13
an O 0 7.78742576066499e-13
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 5.268987379736245e-08
by O 0 3.528813352637883e-11
a O 0 1.1506282149298386e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.8981111793436867e-08
N O 0 6.993760592877152e-08
- O 0 3.6382581392047086e-09
acetylgalactosamine O 0 2.138504981985534e-07
- O 0 2.5421297067396154e-08
6 O 0 6.326726698091534e-09
- O 0 5.633883581879218e-09
sulfate O 0 4.4619763883702035e-08
sulfatase O 0 6.672234121651854e-06
( O 0 1.873539101637789e-10
GALNS O 1 0.9847714304924011
) O 0 2.9847729843268667e-10
. O 0 8.460187217451676e-09

In O 0 2.4053850466998483e-08
previous O 0 1.197434755795257e-07
studies O 0 1.7474443003706597e-09
, O 0 1.8079950730998107e-11
we O 0 1.8261000350738854e-11
have O 0 1.1678526201652772e-11
found O 0 1.2984551801820121e-11
two O 0 6.729358823648335e-13
common O 0 1.629138074443759e-10
mutations O 0 1.205828492611971e-10
in O 0 6.0125453227311e-11
Caucasians O 0 6.617062009439678e-09
and O 0 9.009571734497346e-12
Japanese O 0 1.331215582212053e-08
, O 0 2.043501132198422e-11
respectively O 0 4.4130619158977424e-09
. O 0 1.974193963860671e-08

To O 0 1.2369469892803409e-08
characterize O 0 4.265390316504636e-07
the O 0 2.4427565747942026e-08
mutational O 0 5.973819042992545e-06
spectrum O 0 8.787595788817271e-07
in O 0 4.0344613067011537e-11
various O 0 3.850738131139231e-11
ethnic O 0 6.5690274400620474e-12
groups O 0 3.9630473382124e-13
, O 0 1.4506755172116748e-13
mutations O 0 3.6272682990903804e-13
in O 0 7.260759701810393e-12
the O 0 2.3687560801732843e-09
GALNS O 1 0.9993491768836975
gene O 0 7.005853674968421e-09
in O 0 1.845022268298635e-08
Colombian O 0 1.5535658803855767e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.017212260514497757
were O 0 5.23051213452419e-10
investigated O 0 1.3612068139323696e-09
, O 0 1.8790422343095692e-11
and O 0 4.348585380675729e-11
genetic O 0 2.938208121250341e-09
backgrounds O 0 3.497499179161423e-08
were O 0 9.595566008435696e-11
extensively O 0 5.092795282712892e-11
analyzed O 0 1.7468301805045883e-10
to O 0 1.3646317582882705e-11
identify O 0 2.347229910437676e-10
racial O 0 6.771145449890881e-11
origin O 0 2.9127292244801595e-10
, O 0 4.2053941709183085e-13
based O 0 2.2293821790812102e-13
on O 0 1.710501532081743e-12
mitochondrial O 0 1.3066837542541343e-11
DNA O 0 1.9883934776476764e-10
( O 0 6.299188059187555e-13
mtDNA O 0 9.31011604615728e-12
) O 0 1.4812421037999068e-12
lineages O 0 5.871184649564043e-10
. O 0 5.385626389298181e-10

Three O 0 8.44316829784475e-08
novel O 0 9.396870268574276e-07
missense O 0 1.7325248336419463e-05
mutations O 0 1.3198113890666718e-07
never O 0 5.97548890368671e-08
identified O 0 2.5183841678710905e-09
previously O 0 1.6920278511634024e-09
in O 0 7.662197959446004e-11
other O 0 5.252984505710323e-11
populations O 0 1.8926674463792814e-11
and O 0 3.1537121004954205e-12
found O 0 2.6077458335077575e-12
in O 0 6.313123634971163e-11
16 O 0 1.6929446733371378e-09
out O 0 2.5572160708420277e-11
of O 0 1.564054580294183e-10
19 O 0 2.993999936862224e-09
Colombian O 0 3.6611627507454614e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 4.17862793256063e-07
alleles O 0 1.5862595958981984e-10
account O 0 2.707591616191163e-11
for O 0 8.461272481274928e-12
84 O 0 1.9232166081906144e-08
. O 0 1.2574616903293645e-08

2 O 0 2.2789198084183226e-08
% O 0 5.296224570017216e-11
of O 0 2.3804604121213657e-12
the O 0 2.0493131497323347e-11
alleles O 0 1.1899033841578088e-11
in O 0 1.0764982655286914e-11
this O 0 1.00342581466073e-11
study O 0 4.2697179125639195e-11
. O 0 3.6359321109458165e-10

The O 0 3.4217489286447744e-08
G301C O 0 2.0849035990977427e-06
and O 0 1.6293408844347823e-09
S162F O 0 3.6225384292265517e-07
mutations O 0 3.9688627384570907e-10
account O 0 2.921931099852948e-11
for O 0 2.8049174094491036e-11
68 O 0 4.505170991819796e-08
. O 0 9.225880504004635e-09

4 O 0 1.2052844340360025e-06
% O 0 5.202942521265186e-09
and O 0 5.540009423432579e-11
10 O 0 8.085614955355425e-10
. O 0 4.311795365197213e-09

5 O 0 7.443384930638786e-08
% O 0 4.086702087846561e-10
of O 0 5.81780769393081e-11
mutations O 0 2.029862042340902e-11
, O 0 1.2558467286927222e-11
respectively O 0 2.3189292708281073e-09
, O 0 4.663349914557635e-11
whereas O 0 6.777625571885437e-09
the O 0 2.1745563572039828e-08
remaining O 0 4.846981755690649e-05
F69V O 1 0.9999979734420776
is O 0 1.8545347549303592e-11
limited O 0 9.35531253160038e-12
to O 0 7.088232995347554e-13
a O 0 3.179144230855413e-12
single O 0 6.905105376375786e-10
allele O 0 3.891285516033349e-08
. O 0 1.766196255914565e-08

The O 0 2.2477047778579617e-08
skewed O 0 9.35338491103721e-08
prevalence O 0 1.1524204701629515e-08
of O 0 5.215864545826676e-11
G301C O 0 2.8712742405900826e-08
in O 0 2.0367032713131117e-11
only O 0 2.4512510077290273e-12
Colombian O 0 1.37800840183111e-10
patients O 0 8.416132790678432e-10
and O 0 1.7438190648422225e-12
haplotype O 0 1.4255899412340955e-11
analysis O 0 2.4558358276659253e-13
by O 0 1.2642541026108671e-14
restriction O 0 8.954754299184131e-11
fragment O 0 5.952990878022035e-11
length O 0 9.33937857605649e-11
polymorphisms O 0 8.168997700508385e-10
in O 0 1.799528234758263e-11
the O 0 4.69264460623009e-10
GALNS O 0 0.00019594223704189062
gene O 0 3.2082583811821053e-10
suggest O 0 2.427371637025999e-10
that O 0 1.8899781099954854e-13
G301C O 0 4.862569458197186e-09
originated O 0 5.625052160174171e-11
from O 0 8.920071170419319e-13
a O 0 2.699482889827187e-13
common O 0 3.730811493074526e-11
ancestor O 0 1.0485025292439332e-08
. O 0 1.0100481340202805e-08

Investigation O 0 2.202902464887302e-07
of O 0 1.7339322866405382e-08
the O 0 3.097145651054234e-09
genetic O 0 1.28358368378656e-09
background O 0 2.967714129997745e-10
by O 0 4.4379961944979174e-13
means O 0 2.374753171885402e-10
of O 0 4.99317975855007e-10
mtDNA O 0 1.4449118290738028e-10
lineages O 0 1.569735140483086e-11
indicate O 0 1.4945347476952309e-12
that O 0 1.1349962819367978e-14
all O 0 9.586392010069167e-13
our O 0 2.571654868221973e-11
patients O 0 5.3844526060053965e-11
are O 0 2.313030816143355e-14
probably O 0 1.2926037844251947e-11
of O 0 1.4980230597649857e-11
native O 0 2.3553606287585183e-10
American O 0 5.641310751869355e-10
descent O 0 5.569736458710395e-07

Low O 0 1.5111278628410219e-07
frequency O 0 2.109887375922881e-09
of O 0 6.729433121854811e-10
BRCA1 O 0 1.5482036985758896e-08
germline O 0 4.2689098478376764e-08
mutations O 0 7.189736306312255e-11
in O 0 9.046883251220827e-13
45 O 0 4.2628275909173396e-10
German O 0 0.2007773071527481
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.174023260361537e-08
. O 0 4.5506212131840584e-09

In O 0 3.443061946661885e-10
this O 0 5.332754203501988e-12
study O 0 1.475616395567314e-12
we O 0 2.1950855439963404e-14
investigated O 0 7.992717598881427e-12
45 O 0 1.5102222250540365e-10
German O 0 3.522600309224799e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.63668759101121e-10
for O 0 9.48087615360027e-12
germline O 0 1.1406705802130546e-08
mutations O 0 1.408772404287717e-10
in O 0 8.746700586037548e-11
the O 0 6.28764151855421e-09
BRCA1 O 0 1.745439703881857e-08
gene O 0 7.549311176191509e-10
. O 0 8.46399661469377e-09

We O 0 1.3095125872553126e-08
identified O 0 4.874688208644784e-09
four O 0 6.973982502600506e-11
germline O 0 1.7221196912942105e-08
mutations O 0 3.015415139806521e-10
in O 0 4.786839674641996e-11
three O 0 2.809995014452227e-10
breast B-Disease 0 7.086272671585903e-05
cancer I-Disease 0 2.6343843273934908e-05
families O 0 8.032369214205914e-10
and O 0 1.5985726631306818e-10
in O 0 1.4480426102636557e-07
one O 1 0.9999996423721313
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.992711145566318e-08
. O 0 5.120620073795212e-12
among O 0 1.3584107254847877e-13
these O 0 1.3158203672968775e-14
were O 0 2.9682587767906887e-13
one O 0 2.1696828903829124e-13
frameshift O 0 2.2981541669686578e-10
mutation O 0 3.3638326499274562e-12
, O 0 5.418589838976362e-13
one O 0 2.566298302336678e-12
nonsense O 0 7.001792479144342e-09
mutation O 0 9.409294454698625e-10
, O 0 4.8127543617049184e-12
one O 0 3.5714703763845e-12
novel O 0 4.3909945124376293e-10
splice O 0 2.2551423839445306e-08
site O 0 1.019201789631552e-08
mutation O 0 8.15749134908117e-10
, O 0 6.7111351198523295e-12
and O 0 3.286612995645477e-11
one O 0 3.136259307812139e-10
missense O 0 1.720258865134383e-06
mutation O 0 2.682307069790113e-07
. O 0 1.359378956067303e-07

The O 0 2.9262420753184415e-07
missense O 0 4.4889266064274125e-06
mutation O 0 1.9284142283026995e-08
was O 0 3.6459064656213513e-09
also O 0 6.29289051423676e-11
found O 0 2.1729194832342813e-11
in O 0 1.1023804091792044e-10
2 O 0 4.6208043613660266e-08
. O 0 1.006907091039011e-08

8 O 0 1.58632165181416e-08
% O 0 4.6324017538568185e-11
of O 0 5.778997072547476e-12
the O 0 6.570430831354113e-12
general O 0 6.771991856169279e-09
population O 0 2.9926151834391845e-11
, O 0 7.597401982702146e-13
suggesting O 0 1.9077812246637293e-11
that O 0 1.19622831063447e-13
it O 0 9.478015160907516e-13
is O 0 1.3446382679180302e-12
not O 0 4.1438658060499733e-11
disease O 0 1.504729141288408e-08
associated O 0 1.1176040004556853e-07
. O 0 5.04940317114233e-07

The O 0 6.122300999500396e-10
average O 0 1.8236027132800814e-09
age O 0 3.3392075771132568e-09
of O 0 1.7884657296796114e-11
disease O 0 3.3690581435763534e-09
onset O 0 2.851735985132109e-07
in O 0 1.2736961485515508e-10
those O 0 1.3113307661960505e-10
families O 0 4.411324083797297e-11
harbouring O 0 1.0335452493848152e-08
causative O 0 8.893739966708836e-09
mutations O 0 2.1042168008023054e-09
was O 0 9.930123390233803e-10
between O 0 5.811477965522727e-10
32 O 0 4.028531108701827e-08
. O 0 1.1513812125940603e-08

3 O 0 2.0878881059616106e-06
and O 0 2.899211981599592e-09
37 O 0 1.1157297308272973e-07
. O 0 1.421139828039486e-08

4 O 0 3.769211787130189e-08
years O 0 2.2803654797787232e-10
, O 0 4.121839154713758e-12
whereas O 0 2.5305796347296905e-10
the O 0 3.546094529127686e-10
family O 0 6.972629695845001e-10
harbouring O 0 1.6126554314155328e-08
the O 0 1.0838421271586185e-09
missense O 0 5.986726137052756e-08
mutation O 0 7.879789598597142e-10
had O 0 8.774081287910018e-12
an O 0 3.4488369462810226e-15
average O 0 4.1155074140264425e-12
age O 0 3.507527948642952e-11
of O 0 1.075291591878802e-11
onset O 0 1.3133667380316183e-06
of O 0 4.583249335610162e-07
51 O 0 7.829143555682094e-07
. O 0 1.5170175515777373e-07

2 O 0 1.6695421436452307e-06
years O 0 8.695574926775862e-09
. O 0 3.1838897740499306e-08

These O 0 6.622971504555153e-09
findings O 0 1.529078375028803e-08
show O 0 5.550218618033398e-10
that O 0 2.404354146334775e-11
BRCA1 O 0 3.562712791449485e-09
is O 0 1.7838654815457988e-12
implicated O 0 1.2818110288470574e-11
in O 0 5.122180891242722e-13
a O 0 5.244527143295763e-14
small O 0 4.7889508114282164e-14
fraction O 0 4.55499284124361e-11
of O 0 2.3468120957659266e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.9212233326747494e-11
suggesting O 0 2.604776745858406e-13
the O 0 5.3219371455321546e-14
involvement O 0 5.133692407809087e-13
of O 0 1.5062135566568102e-12
another O 0 2.5411936010327763e-12
susceptibility O 0 1.2698688767187605e-09
gene O 0 1.3475615068259117e-10
( O 0 3.7545112852033213e-11
s O 0 1.622994858507809e-07
) O 0 1.444471764422417e-09

Paternal O 0 0.0002151944354409352
transmission O 0 2.3795246306690387e-05
of O 0 3.1519737149210414e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00811520405113697

We O 0 1.1539227351420323e-08
report O 0 2.15886961085765e-11
a O 0 7.732642380142013e-14
rare O 0 1.552038228838648e-12
case O 0 5.4885965564133166e-12
of O 0 4.5843048107618856e-11
paternally O 1 0.9999945163726807
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3422758904368948e-08
DM B-Disease 1 1.0
) O 0 4.020674071458785e-10
. O 0 3.530230552328817e-09

The O 0 7.1334116391597036e-09
proband O 0 8.025973556868848e-07
is O 0 1.4176743546451265e-12
a O 0 1.5275674063348899e-13
23 O 0 2.3600498291753702e-11
year O 0 1.4269719086912325e-11
old O 0 2.6028713406844872e-08
, O 0 6.90818846571517e-10
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.0846613273024559
who O 0 3.171833995452289e-08
suffers O 0 1.3411133295448963e-05
severe O 1 0.9977497458457947
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999446868896484

He O 0 1.6263809743399804e-10
presented O 0 1.1680721945239725e-09
with O 0 1.814226720242562e-11
respiratory O 1 1.0
and O 0 1.059913827816672e-07
feeding O 0 3.7574293401121395e-06
difficulties O 0 6.3201923694578e-08
at O 0 3.706571716222129e-09
birth O 0 4.9392965593142435e-05
. O 0 4.2518942677816085e-07

His O 0 7.266190493737668e-08
two O 0 1.7801837781661334e-09
sibs O 1 0.9999977350234985
suffer O 0 7.547950531261449e-08
from O 0 6.39290620441102e-10
childhood O 0 9.101472642214503e-07
onset O 1 0.9999991655349731
DM B-Disease 1 1.0
. O 0 9.385494195157662e-05

Their O 0 1.2951797856430858e-08
late O 0 1.0737994671217166e-05
father O 0 8.105665472157852e-08
had O 0 1.058163071054885e-10
the O 0 1.6500955333023648e-12
adult O 0 4.0123096902225375e-13
type O 0 2.1514283410351e-12
of O 0 5.155461821337859e-11
DM B-Disease 1 1.0
, O 0 1.0615369694377819e-10
with O 0 9.48058146744979e-13
onset O 0 1.5256326832968625e-06
around O 0 4.702617184548785e-10
30 O 0 9.358820385330091e-10
years O 0 1.0269574080012944e-10
. O 0 1.3400829335097342e-09

Only O 0 6.428148235926301e-09
six O 0 5.9856980483274924e-12
other O 0 1.7126740225136515e-14
cases O 0 1.462962780432453e-13
of O 0 1.0675602112389382e-12
paternal O 0 9.577057369369868e-08
transmission O 0 4.257745445102046e-07
of O 0 1.2670176147366874e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.00010506846592761576
been O 0 1.467073240668526e-09
reported O 0 1.0983276788056884e-10
recently O 0 6.943459140984487e-10
. O 0 2.3912216651211793e-09

We O 0 2.0660066990529913e-09
review O 0 3.6744715603553857e-10
the O 0 1.6326398566413047e-11
sex O 0 8.705502464734227e-12
related O 0 1.1317446112213414e-11
effects O 0 7.106145533120056e-12
on O 0 2.47932837454945e-11
transmission O 0 5.670235392329914e-09
of O 0 3.5700526979098868e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.007738668005913496

Decreased O 0 7.209644081740407e-07
fertility O 0 2.8575229293892335e-08
of O 0 1.9100167628072207e-11
males O 0 1.1256322480016068e-12
with O 0 7.406298542663413e-15
adult O 0 1.777782955569851e-11
onset O 0 4.9161851478629615e-08
DM B-Disease 1 1.0
and O 0 7.114995259627221e-10
contraction O 0 4.098999362156519e-09
of O 0 6.024383214509044e-10
the O 0 2.508874531736982e-11
repeat O 0 7.68130437728276e-12
upon O 0 5.618326116840766e-12
male O 0 1.0888464609115633e-12
transmission O 0 1.7822456835001055e-13
contribute O 0 2.839693032856503e-14
to O 0 1.1185432598594461e-13
the O 0 6.422880456657953e-12
almost O 0 2.6430283742856497e-12
absent O 0 2.344284662225693e-11
occurrence O 0 4.276168178232731e-13
of O 0 8.150231791542728e-13
paternal O 0 1.3905141038605962e-08
transmission O 0 1.7434233612334538e-08
of O 0 1.2710763996892638e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00010690560156945139

Also O 0 2.288497169544712e-09
the O 0 2.9488742003813684e-10
fathers O 0 3.6038356743262057e-09
of O 0 1.486340044098977e-11
the O 0 2.5004187956256807e-11
reported O 0 1.7347509539966666e-10
congenitally O 0 0.0004111380549147725
affected O 0 1.0409369366470855e-07
children O 0 9.930079675202208e-11
showed O 0 1.3203981311105117e-11
, O 0 2.2537390519366401e-13
on O 0 1.0510163572785558e-10
average O 0 1.2966449025597626e-09
, O 0 3.1856708243571674e-11
shorter O 0 6.794065257054172e-07
CTG O 0 2.427642721158918e-05
repeat O 0 1.4394887948299129e-08
lengths O 0 1.3846444346654607e-07
and O 0 6.351382093872093e-12
hence O 0 7.347713548710999e-10
less O 0 1.0751875778591824e-10
severe O 0 9.283439017515605e-10
clinical O 0 1.327206677892434e-09
symptoms O 0 6.337137481438049e-09
than O 0 3.0381172837906645e-12
the O 0 3.53354116799931e-11
mothers O 0 2.2082129180756027e-10
of O 0 9.498646444047742e-13
children O 0 9.585020494320973e-13
with O 0 6.068836405637157e-12
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00011095502850366756

We O 0 5.998985197486206e-10
conclude O 0 5.663379765152854e-10
that O 0 2.3000362465303015e-13
paternal O 0 9.663057909392592e-08
transmission O 0 1.0356177426729118e-07
of O 0 8.472981249951772e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 9.93164306350991e-09
rare O 0 1.7046830613764996e-10
and O 0 4.717190180136832e-13
preferentially O 0 1.575448322146955e-12
occurs O 0 1.7734664919336757e-13
with O 0 1.5685340235387373e-16
onset O 0 1.2584105979485116e-10
of O 0 6.825440213020784e-10
DM B-Disease 1 1.0
past O 0 1.2901673507315081e-08
30 O 0 1.2979332886242645e-10
years O 0 2.3214529257242766e-12
in O 0 4.372934577379778e-13
the O 0 9.20567094775393e-12
father O 0 2.3298876716815187e-10
. O 0 4.287361091148689e-11
. O 0 1.2889910250279968e-09

The O 0 3.802725530022144e-07
RB1 O 0 8.293650898849592e-05
gene O 0 1.2652101588628284e-09
mutation O 0 2.6867235103367193e-09
in O 0 3.685257654595375e-11
a O 0 1.8038212590276714e-10
child O 0 1.4412147208986426e-07
with O 0 4.853636603741052e-09
ectopic B-Disease 1 0.9998750686645508
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.001920892158523202

The O 0 4.165486586771294e-07
RB1 O 0 0.00010364585614297539
gene O 0 1.2688060602172868e-09
mutation O 0 1.309117259040704e-09
was O 0 8.152416242079852e-11
investigated O 0 5.179484063866369e-10
in O 0 1.5178547307925783e-10
a O 0 1.392251536280753e-09
child O 0 7.976443612278672e-07
with O 0 6.9806436187036525e-09
ectopic B-Disease 0 0.0006007476476952434
intracranial I-Disease 1 0.9905945062637329
retinoblastoma I-Disease 0 6.572450729436241e-06
using O 0 9.093810426907822e-11
DNA O 0 2.7875640684627e-10
obtained O 0 4.112982524007158e-11
from O 0 7.46981036053862e-12
both O 0 4.5059355552323765e-12
the O 0 2.6428745303341827e-10
pineal B-Disease 0 3.4931959817186e-05
and I-Disease 0 1.5508805351061028e-09
retinal I-Disease 1 0.9648804664611816
tumours I-Disease 1 1.0
of O 0 5.7731142533157254e-08
the O 0 1.5370845929396637e-08
patient O 0 1.7273491721425671e-06
. O 0 6.443615419016169e-09

A O 0 1.4697857864121033e-07
nonsense O 0 2.057824133316899e-07
mutation O 0 2.1729549271043425e-09
in O 0 1.982311953474536e-10
exon O 0 1.484594047695964e-08
17 O 0 2.4349635641129908e-09
( O 0 2.3214837170659752e-12
codon O 0 1.393385962167315e-09
556 O 0 6.590686218999053e-09
) O 0 9.894149301942212e-13
of O 0 1.4162000738782154e-10
the O 0 7.1945174262566525e-09
RB1 O 0 2.482245872670319e-05
gene O 0 1.4611306609069175e-09
was O 0 3.0643867443558293e-09
found O 0 1.539758251456469e-11
to O 0 5.401574370081375e-13
be O 0 2.5702758064266584e-12
present O 0 6.172154454198164e-10
homozygously O 0 2.8340415155980736e-05
in O 0 2.7859496931625927e-09
both O 0 1.3858685032897e-10
the O 0 1.1213310280311362e-09
retinal B-Disease 0 3.857782940031029e-05
and I-Disease 0 3.21984181539392e-08
the I-Disease 0 7.686927347094752e-06
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 4.279804215912009e-06

The O 0 3.0727385080808745e-09
same O 0 2.442987201423108e-10
mutation O 0 1.1170952357586472e-10
was O 0 7.879785018927166e-11
present O 0 3.250704427859574e-10
heterozygously O 0 1.0819825320140808e-06
in O 0 4.868366820787173e-10
the O 0 9.190587180185616e-11
DNA O 0 3.8944519831218827e-10
from O 0 1.0668341210440246e-11
the O 0 4.9488798475882945e-11
constitutional O 0 7.114130617935643e-09
cells O 0 1.1924514708994138e-09
of O 0 1.5682335985367502e-10
the O 0 3.31505933814924e-10
patient O 0 2.710738158384629e-07
, O 0 4.586891196728393e-12
proving O 0 5.411925352305502e-10
it O 0 2.5811267728194365e-13
to O 0 1.1515657134461565e-12
be O 0 1.0834193785169699e-11
of O 0 1.483927869472268e-09
germline O 0 2.1001966388212168e-07
origin O 0 8.278122187732606e-09
. O 0 7.808799828978863e-09

The O 0 1.980443364857365e-08
initial O 0 9.631647657215581e-08
mutation O 0 2.3436568241663736e-09
was O 0 3.0387639626816565e-10
shown O 0 1.0366493254088116e-11
to O 0 3.227933545457695e-12
have O 0 2.1900276730990598e-12
occurred O 0 1.3669619880474215e-09
in O 0 1.1144025806320013e-11
the O 0 9.771449621664985e-11
paternally O 0 2.4935224018918234e-07
derived O 0 1.0224616175946721e-07
RB1 O 0 0.0001056173350661993
allele O 0 1.9496953029829456e-07
. O 0 1.5646975271010888e-08

The O 0 3.1225146912561286e-09
mutation O 0 7.098210907940938e-11
is O 0 4.661859548567293e-13
in O 0 1.744357154380427e-13
an O 0 1.3717426471449089e-15
area O 0 1.3277597771255145e-11
of O 0 6.455774803626468e-11
the O 0 6.047696232691635e-10
gene O 0 4.861310139159247e-12
that O 0 3.0364257115611526e-12
encodes O 0 8.680296065266546e-13
the O 0 1.075689537444191e-11
protein O 0 2.8512288016702136e-12
- O 0 1.41890041382986e-11
binding O 0 1.3750048322158648e-10
region O 0 4.682258136767814e-09
known O 0 9.664703759515447e-11
as O 0 3.2092602880728904e-11
the O 0 3.301228457264216e-10
pocket O 0 1.1774314998547197e-06
region O 0 7.264971202403103e-08
and O 0 2.3813040428422028e-09
has O 0 6.547403591516954e-11
been O 0 3.015608943113257e-11
detected O 0 1.8245629451740797e-09
in O 0 2.1815655185108973e-11
other O 0 1.0350944060211198e-11
cases O 0 2.1982073106219246e-10
of O 0 1.0611407308402931e-09
retinoblastoma B-Disease 0 1.6928443073993549e-06
. O 0 4.5113793589734996e-08
. O 0 1.6594434271155478e-07

Low O 0 9.684255246611428e-07
levels O 0 5.2932200844679755e-09
of O 0 5.3647700865022685e-11
beta O 0 1.7022787346387958e-10
hexosaminidase O 0 4.502507877646167e-08
A O 0 2.5102686596056856e-10
in O 0 2.035507006004078e-11
healthy O 0 5.951301673690068e-10
individuals O 0 8.782427909914681e-14
with O 0 2.4275807058993237e-13
apparent O 0 1.640815935388673e-05
deficiency O 1 0.9999990463256836
of O 0 1.2300627076911042e-06
this O 0 5.8459811214106594e-08
enzyme O 0 7.129938239813782e-07
. O 0 1.2166130147761578e-07

Appreciable O 0 5.677380272572918e-07
beta O 0 2.3823956141200142e-08
hexosaminidase O 0 2.4157041025318904e-06
A O 0 5.667750997417897e-07
( O 0 1.847548919409192e-10
hex O 0 1.8772688292756357e-07
A O 0 1.6017576598414962e-08
) O 0 1.0896281273098385e-11
activity O 0 1.3292138056897329e-08
has O 0 5.836766400063587e-12
been O 0 2.872628176997516e-11
detected O 0 3.603445719591036e-08
in O 0 4.3398067361977155e-09
cultured O 0 3.3046431781258434e-05
skin O 0 3.985879175161244e-06
fibroblasts O 0 1.207415749604479e-07
and O 0 6.360941773309037e-10
melanoma B-Disease 0 5.258165103327883e-08
tissue O 0 2.428742484905655e-10
from O 0 2.5946540055388212e-11
healthy O 0 5.364496624693516e-10
individuals O 0 8.35404675666486e-14
previously O 0 4.2816956577484966e-12
reported O 0 3.3475752551914706e-12
as O 0 8.767812864629576e-11
having O 0 1.7136767382908147e-07
deficiency B-Disease 1 0.9999978542327881
of I-Disease 0 0.0012712337775155902
hex I-Disease 0 7.082923730195034e-06
A I-Disease 0 3.804043302579885e-09
activity O 0 4.73338424011871e-10
indistinguishable O 0 8.073617295545343e-12
from O 0 1.0067171866574571e-15
that O 0 5.123555059792228e-18
of O 0 2.6470906155516734e-15
patients O 0 3.713586296111293e-12
with O 0 2.5105559298133073e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.088274329130172e-10
TSD B-Disease 0 0.002013345481827855
) O 0 8.894002895276643e-11
. O 0 5.500216282428028e-09

Identification O 0 8.028501952139777e-08
and O 0 2.0530933897422443e-10
quantitation O 0 0.00012792754569090903
of O 0 1.1097103197243996e-05
hex O 0 0.0002469379105605185
A O 0 1.732739605131428e-07
, O 0 1.1027835762622562e-11
amounting O 0 6.011929287730311e-10
to O 0 1.3019325895147205e-10
3 O 0 2.1912731185125267e-08
. O 0 5.755959264774901e-09

5 O 0 5.312060693540843e-07
% O 0 1.5676070219683425e-08
- O 0 4.825900035143604e-08
6 O 0 2.902632800783067e-08
. O 0 6.315321154914955e-09

9 O 0 4.552038390670532e-08
% O 0 1.155143689035576e-10
of O 0 1.1825455545344532e-11
total O 0 2.514820122978545e-11
beta O 0 5.365980437765927e-10
hexosaminidase O 0 1.3363488733375561e-06
activity O 0 7.169669515860733e-07
, O 0 4.481835041980631e-11
has O 0 2.1373939944335785e-13
been O 0 9.687610685437525e-14
obtained O 0 2.0491908950953652e-12
by O 0 4.776312591964205e-12
cellulose O 0 5.75595109353344e-08
acetate O 0 1.8541168600449964e-08
gel O 0 2.8386022421500456e-08
electrophoresis O 0 1.0348861767539574e-09
, O 0 4.414059395774217e-11
DEAE O 0 7.6173364504938945e-06
- O 0 3.751322363854115e-09
cellulose O 0 1.4866427200388443e-08
ion O 0 8.58456949970332e-09
- O 0 1.3728940650992172e-08
exchange O 0 1.5197276326262e-08
chromatography O 0 2.0484836937839646e-08
, O 0 8.564179747316825e-12
radial O 0 1.374122038377834e-09
immunodiffusion O 0 3.780844053835608e-06
, O 0 2.718661962219926e-10
and O 0 4.6087145211259894e-10
radioimmunoassay O 0 6.925966590642929e-05
. O 0 5.064614470029483e-07

Previous O 0 0.004088444635272026
family O 0 4.447311994226766e-07
studies O 0 7.583370598140959e-10
suggested O 0 2.182627967250994e-10
that O 0 2.1955012677668528e-13
these O 0 3.320593149405693e-12
individuals O 0 1.0297626873391127e-13
may O 0 5.628150723246961e-12
be O 0 9.384169873463688e-13
compound O 0 2.7486685150179824e-10
heterozygotes O 0 2.8080358038806708e-09
for O 0 7.610512697472926e-13
the O 0 3.523352443135508e-11
common O 0 8.81375861183642e-10
mutant O 0 1.0071990352855664e-08
TSD B-Disease 0 3.286601213403628e-06
gene O 0 5.282564316533289e-11
and O 0 2.3215017148220385e-12
a O 0 8.801549441529721e-13
rare O 0 5.868385222207451e-10
( O 0 2.3038496457794544e-11
allelic O 0 3.03012583913187e-08
) O 0 5.0286930869392066e-11
mutant O 0 8.103993032193557e-09
gene O 0 2.0225907615412098e-09
. O 0 9.108436671567688e-09

Thus O 0 3.8210540509453494e-08
, O 0 5.419814944063184e-11
the O 0 2.2176549485664054e-10
postulated O 0 6.759553627944115e-08
rate O 0 1.6387415868734934e-08
mutant O 0 6.17244866329969e-10
gene O 0 2.300644050268197e-11
appears O 0 1.650396069807769e-10
to O 0 1.8013498678803863e-13
code O 0 8.922164764814389e-13
for O 0 3.8336003750812087e-13
the O 0 1.721623603227751e-12
expression O 0 1.317251255988916e-11
of O 0 8.354182796932452e-12
low O 0 3.299704676162918e-10
amounts O 0 1.2857981346314773e-10
of O 0 4.103244688469232e-10
hex O 0 2.2862504920340143e-06
A O 0 4.2936201793963846e-07
. O 0 7.785529021475668e-08

Heterozygotes O 0 5.662998228217475e-05
for O 0 9.074483386939391e-09
the O 0 1.1590247872561577e-08
rare O 0 1.8427643411200734e-08
mutant O 0 4.08495859360869e-09
may O 0 8.75664887822758e-11
be O 0 3.959128164199299e-12
indistinguishable O 0 2.423263811834886e-10
from O 0 8.632777110349765e-13
heterozygotes O 0 3.951226290599408e-10
for O 0 1.8356394963087164e-12
the O 0 1.9455619060249063e-10
common O 0 5.603173391932614e-08
TSD B-Disease 0 0.00046206830302253366
mutant O 0 1.1475410701677902e-06
. O 0 5.219674292789023e-08

However O 0 6.734829582910606e-09
, O 0 3.300387524038384e-12
direct O 0 3.0257419833534804e-12
visualization O 0 1.0847561737747924e-09
and O 0 1.5408247594494995e-11
quantitation O 0 0.00045083052827976644
of O 0 0.0003055690904147923
hex O 0 8.129732123052236e-06
A O 0 2.1667674321435015e-09
by O 0 7.530762580372496e-13
the O 0 3.952579149396618e-12
methods O 0 2.2412297018270522e-10
described O 0 3.123077491062887e-11
may O 0 9.995748152802353e-12
prevent O 0 4.689061205292999e-12
false O 0 9.138688417120733e-11
- O 0 1.8304554053050204e-11
positive O 0 4.501425707875706e-12
prenatal O 0 3.667863568423968e-09
diagnosis O 0 4.9363371168453796e-09
of O 0 8.594358558156046e-11
TSD B-Disease 0 5.1838240324286744e-05
in O 0 2.7982300920825764e-09
fetuses O 0 8.745474566751454e-09
having O 0 9.710893547620891e-12
the O 0 2.926037467876341e-10
incomplete O 0 0.489606112241745
hex B-Disease 0 0.00016373081598430872
A I-Disease 0 9.72540306065639e-07
deficiency I-Disease 0 7.422076305374503e-05
of O 0 2.9050090333271328e-08
the O 0 1.4904151246497577e-09
type O 0 1.808577287931712e-08
described O 0 1.0459213495295216e-09
in O 0 1.1896043872194895e-10
the O 0 2.1404256145274303e-09
four O 0 5.266510560986148e-10
healthy O 0 8.184975541780659e-08
individuals O 0 7.768433119004214e-10

The O 0 2.3402591864396527e-07
tumor B-Disease 0 5.660870101564797e-06
suppressor O 0 5.2953614613215905e-06
gene O 0 4.1999519417856845e-09
Smad4 O 0 1.1434212865424342e-05
/ O 0 5.110648970685361e-08
Dpc4 O 0 3.05686967294605e-07
is O 0 7.125699769822136e-13
required O 0 4.371585992507532e-12
for O 0 1.1558433246974809e-12
gastrulation O 0 3.7567880895039707e-07
and O 0 1.7149255973625266e-11
later O 0 7.234612353634873e-10
for O 0 2.2878445665730496e-11
anterior O 0 3.1440712255914605e-09
development O 0 1.0491467250517417e-08
of O 0 1.468887678157671e-09
the O 0 3.6797269675759026e-09
mouse O 0 2.5135770798101476e-08
embryo O 0 1.5491761473640508e-07
. O 0 6.269319285934216e-09

Mutations O 0 1.208550486353488e-07
in O 0 2.5760696353849255e-10
the O 0 2.73417044560631e-09
SMAD4 O 1 0.9983264803886414
/ O 0 4.40842177340528e-06
DPC4 O 0 0.0002822393144015223
tumor B-Disease 0 2.5148488020931836e-06
suppressor O 0 5.674035463698601e-08
gene O 0 1.8048012737081898e-11
, O 0 4.2306642130535144e-13
a O 0 7.234104266139185e-13
key O 0 1.4619454979936108e-08
signal O 0 1.561010947170871e-07
transducer O 0 2.252651682965734e-07
in O 0 1.502053947888271e-08
most O 0 7.959519265909876e-09
TGFbeta O 0 0.00027851303457282484
- O 0 2.019319822466059e-07
related O 0 4.1856233679027355e-07
pathways O 0 3.292495609485968e-09
, O 0 4.201727941272049e-14
are O 0 2.91424279541243e-16
involved O 0 2.2640125536176276e-15
in O 0 4.582411923872987e-13
50 O 0 2.353636174845519e-10
% O 0 4.907018125166474e-10
of O 0 9.903174280623261e-09
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0005953508662059903

Homozygous O 0 0.0001528575230622664
Smad4 O 0 0.005546220578253269
mutant O 0 7.533520147262607e-06
mice O 0 2.1012145623444667e-07
die O 0 1.7473276159307716e-09
before O 0 7.14522330191869e-11
day O 0 3.2603371113992807e-09
7 O 0 2.080052041719682e-08
. O 0 2.7089219756248895e-09

5 O 0 8.150746566570888e-07
of O 0 1.0645510251094947e-08
embryogenesis O 0 1.3767674317932688e-05
. O 0 3.530919912009267e-07

Mutant O 0 2.328221171410405e-06
embryos O 0 8.173586962811896e-08
have O 0 1.6358348703393588e-11
reduced O 0 1.382858272336307e-10
size O 0 6.378765293746369e-10
, O 0 3.457129374440093e-11
fail O 0 5.057052998580502e-09
to O 0 7.258492418227291e-11
gastrulate O 0 2.555655782998656e-06
or O 0 6.168717758825437e-10
express O 0 2.7279688924464196e-11
a O 0 4.094146625454459e-13
mesodermal O 0 7.040833338578523e-08
marker O 0 5.566898053643854e-09
, O 0 3.5103103149941584e-12
and O 0 3.843281162069223e-12
show O 0 1.0784985404743708e-10
abnormal O 0 1.498505497465885e-08
visceral O 0 1.820915485950536e-06
endoderm O 0 0.0017750730039551854
development O 0 1.2543376897156122e-06
. O 0 1.4436714934618067e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 2.2606207039643778e-07
the O 0 1.8334317175572323e-08
Smad4 O 0 0.0013016843004152179
- O 0 3.704801929416135e-05
deficient O 0 7.323884574361728e-07
embryos O 0 8.263325135260402e-09
results O 0 2.2878761385403124e-10
from O 0 1.2458526398029246e-11
reduced O 0 2.765914608460207e-09
cell O 0 7.471503415956704e-09
proliferation O 0 9.700467096251941e-09
rather O 0 8.306931531532058e-11
than O 0 2.184912407249273e-12
increased O 0 1.080444733680963e-09
apoptosis O 0 4.301103473380863e-08
. O 0 9.899379094235883e-09

Aggregation O 0 4.761051002333261e-07
of O 0 1.1675225231044806e-08
mutant O 0 2.5896108013512276e-07
Smad4 O 0 4.587694274960086e-05
ES O 0 2.746104428297258e-07
cells O 0 9.821713581326108e-11
with O 0 4.3043480157109806e-14
wild O 0 1.0658380428241188e-10
- O 0 3.4361062606347303e-11
type O 0 9.263928513192354e-10
tetraploid O 0 3.0501360015477985e-06
morulae O 0 3.087854929617606e-05
rescues O 0 2.7906528998755675e-07
the O 0 1.1602893090767452e-09
gastrulation B-Disease 0 4.2027648305520415e-05
defect I-Disease 0 2.518093651815434e-06
. O 0 1.4798733616316895e-07

These O 0 3.2355942369832746e-09
results O 0 6.255377327235578e-10
indicate O 0 1.3271028720396316e-09
that O 0 1.927935675688497e-12
Smad4 O 0 4.38695565208036e-07
is O 0 5.203835409459123e-13
initially O 0 2.1045548116715995e-12
required O 0 1.9903341128002516e-12
for O 0 2.2168141074977582e-13
the O 0 7.0844380709034205e-12
differentiation O 0 1.836264612586902e-10
of O 0 5.983772505269158e-11
the O 0 3.48163997632156e-11
visceral O 0 3.2950147055288426e-09
endoderm O 0 1.0022112206797829e-07
and O 0 4.666203621411791e-12
that O 0 6.979667359482619e-14
the O 0 1.2446792728437739e-11
gastrulation B-Disease 0 9.117964339111495e-08
defect I-Disease 0 3.377441437635298e-09
in O 0 2.7356490336916117e-11
the O 0 9.555149033113608e-11
epiblast O 0 5.751297749156947e-07
is O 0 1.0543547805663689e-11
secondary O 0 2.825959910524034e-09
and O 0 4.3346632706831034e-12
non O 0 6.701542076825717e-08
- O 0 1.7149666575733136e-07
cell O 0 6.5358603933418635e-06
autonomous O 0 1.2064535326317127e-07
. O 0 2.7647610423287006e-08

Rescued O 0 5.073928605270339e-06
embryos O 0 7.704780387030041e-07
show O 0 2.005932531190524e-09
severe O 0 3.88344076895919e-08
anterior O 0 6.721742238369188e-07
truncations O 1 0.9860547184944153
, O 0 3.5272760268156844e-09
indicating O 0 2.528965836745556e-08
a O 0 1.5149935125857716e-11
second O 0 5.377414624696542e-10
important O 0 8.494576153594835e-10
role O 0 1.543761368738572e-10
for O 0 4.6484330273877106e-10
Smad4 O 0 6.727926665917039e-05
in O 0 5.4404651450568053e-08
anterior O 0 3.923953215689835e-07
patterning O 0 3.193037264281884e-05
during O 0 3.5858131468557985e-06
embryogenesis O 0 4.641796840587631e-05
. O 0 2.515436392513948e-07

Prevalence O 0 1.4933602869859897e-06
of O 0 2.377396723929337e-09
p16 O 0 3.720008834307009e-08
and O 0 1.4950846116690286e-09
CDK4 O 0 0.07271306216716766
germline O 0 4.10899956477806e-05
mutations O 0 2.2808071875601854e-08
in O 0 3.012425864312718e-10
48 O 0 2.537789001166857e-08
melanoma B-Disease 1 0.9990021586418152
- O 0 5.031160617363639e-05
prone O 0 8.979787708085496e-06
families O 0 3.4239604485009068e-09
in O 0 7.713891192473454e-10
France O 0 2.6676071129827506e-08
. O 0 1.6075306064067263e-07

The O 0 9.032076775383757e-08
French O 0 3.7888714814471314e-06
Familial B-Disease 1 0.9677914381027222
Melanoma I-Disease 1 1.0
Study O 0 1.9960185682066367e-07
Group O 0 4.6600712177991e-10
. O 0 7.382848221659799e-10

Germline O 0 7.007816020632163e-05
mutations O 0 3.426856665100786e-08
in O 0 4.0702263781611236e-10
the O 0 1.3345757832183835e-09
p16 O 0 3.486057309487478e-08
and O 0 9.683585044939491e-10
CDK4 O 0 0.06491627544164658
genes O 0 1.9487169211629407e-08
have O 0 3.9397856504974627e-11
been O 0 1.2098317139774828e-11
reported O 0 6.497488311274502e-12
in O 0 3.7797508178893935e-12
a O 0 6.4770970704952635e-12
subset O 0 5.149295656536879e-09
of O 0 8.591969358207052e-10
melanoma B-Disease 0 5.09508481627563e-06
pedigrees O 0 1.464780581272862e-07
, O 0 6.8605819809886e-12
but O 0 3.4608485782045006e-12
their O 0 1.853498778070506e-11
prevalence O 0 3.7165232003033566e-10
is O 0 3.0786032496074936e-14
not O 0 1.2919820378473612e-12
well O 0 4.3997111509597175e-11
known O 0 4.423880428650051e-10
. O 0 1.8350339914263714e-08

We O 0 2.4892341521365324e-09
searched O 0 9.203156459136608e-09
for O 0 2.3349315536602688e-11
such O 0 3.14142156732089e-09
germline O 0 8.886315299605485e-06
mutations O 0 3.20019424293605e-08
in O 0 2.749986016681305e-09
48 O 0 4.032174771850805e-08
French O 0 1.3295299083893042e-07
melanoma B-Disease 1 0.9998747110366821
- O 0 0.00015446321049239486
prone O 0 6.128179666120559e-05
families O 0 9.745713125397515e-10
selected O 0 8.12154718476954e-11
according O 0 1.976269625378335e-12
to O 0 1.2209723249806403e-12
two O 0 1.735450026957644e-13
major O 0 4.758147695294035e-11
criteria O 0 7.735657447938138e-09
families O 0 9.447192160505491e-12
with O 0 3.1052177024365815e-14
at O 0 7.983286774704279e-12
least O 0 2.2646376961199532e-12
three O 0 1.0696044744351596e-12
affected O 0 7.692428916072913e-09
members O 0 1.8891556374800444e-10
( O 0 6.116805196035302e-13
n O 0 1.3351243721704265e-11
= O 0 6.569337088202509e-13
20 O 0 3.89421784749433e-12
) O 0 5.740855161991956e-15
or O 0 1.0753033663143952e-12
families O 0 3.439881409231238e-12
with O 0 1.6744086314950807e-13
two O 0 2.5400016291643457e-12
affected O 0 1.2047215669497291e-08
members O 0 1.0336723837989226e-10
, O 0 3.548332114244879e-11
one O 0 1.2957338327290735e-11
of O 0 8.902064502214202e-11
them O 0 3.356295710105206e-12
affected O 0 9.335032746804472e-11
before O 0 9.120491167857736e-11
the O 0 4.402002373726788e-11
age O 0 7.90823129204199e-10
of O 0 1.3918366459364506e-10
50 O 0 1.0492577640075496e-10
( O 0 6.75904441465626e-14
n O 0 9.9576718398664e-12
= O 0 9.304133852250374e-12
28 O 0 6.667786878189474e-10
) O 0 1.645041389350052e-13
, O 0 8.035728658005448e-13
and O 0 4.362904080981028e-13
one O 0 2.9917331090777155e-13
additional O 0 1.0805363548360702e-11
minor O 0 2.9412825952590538e-08
criterion O 0 0.00012250401778146625
. O 0 1.777323291207722e-06

Sixteen O 0 1.0041827408713289e-05
different O 0 3.418474392447024e-08
p16 O 0 1.0466561661814922e-06
germline O 0 1.2560016102725058e-06
mutations O 0 1.1958177781323798e-09
were O 0 3.689189231881329e-11
found O 0 3.660434043546712e-13
in O 0 4.0833376718958647e-13
21 O 0 1.5105794393122096e-10
families O 0 9.132428320512975e-12
, O 0 1.180669819723923e-12
while O 0 7.649810472576402e-12
one O 0 2.7451306852666058e-11
germline O 0 4.61477078772532e-08
mutation O 0 1.6593580953738751e-09
, O 0 2.69792573698302e-11
Arg24His O 0 9.16364024305949e-06
, O 0 3.074107288170147e-11
was O 0 1.0531474303743238e-10
detected O 0 2.7508675337628574e-09
in O 0 2.0593685090553038e-10
the O 0 6.0482885366752726e-09
CDK4 O 1 0.9863176345825195
gene O 0 9.13329927243467e-08
. O 0 1.2711107899576746e-07

The O 0 6.581114320169945e-09
frequency O 0 1.7103835014964375e-09
of O 0 5.009166970104673e-10
p16 O 0 8.492194170095502e-10
gene O 0 1.1447183478896505e-11
mutation O 0 1.922810174970202e-11
in O 0 3.3100772556943214e-12
our O 0 5.8647535612632584e-12
sample O 0 4.758245013281037e-12
( O 0 4.1365307988823485e-14
44 O 0 4.3824246315216087e-11
% O 0 3.8633728377882037e-13
) O 0 1.7267446373719084e-15
is O 0 1.1342648689868437e-14
among O 0 8.601856070966293e-14
the O 0 2.222868699004732e-13
highest O 0 2.577347502086269e-10
rates O 0 1.7089968329386807e-10
yet O 0 6.866643538494532e-12
reported O 0 3.897316497303294e-12
and O 0 1.6076583423882407e-12
the O 0 9.361778713357083e-11
CDK4 O 0 0.00011506606824696064
mutation O 0 4.039807099953663e-10
is O 0 2.1666556623920613e-13
the O 0 1.4159475458450088e-12
second O 0 2.3241608290702764e-11
mutation O 0 1.7716999742289907e-11
detected O 0 6.840845667710482e-10
in O 0 4.014557089537796e-11
this O 0 3.241510115881141e-10
gene O 0 1.4974447237747768e-09
worldwide O 0 9.71331126642383e-10
. O 0 6.129515384145634e-08

In O 0 7.747480990083488e-10
summary O 0 1.0451276510892171e-09
, O 0 1.0583179298195855e-11
our O 0 2.7322961601572437e-11
results O 0 2.0193902106058204e-10
show O 0 1.3286947063428922e-11
frequent O 0 4.855599429476332e-13
involvement O 0 9.024822447516179e-13
of O 0 1.1803214655659033e-11
the O 0 2.3753332634157687e-10
p16 O 0 9.544917078940784e-10
gene O 0 1.449162179145702e-10
in O 0 4.939923470281826e-10
familial B-Disease 0 1.244192731064686e-07
melanoma I-Disease 0 1.4930363249732181e-05
and O 0 1.512954692084456e-11
confirm O 0 8.78877595700267e-11
the O 0 2.8357679052182228e-11
role O 0 2.70236524130274e-11
of O 0 4.892812266454882e-10
the O 0 4.061952996181617e-09
CDK4 O 1 0.940802276134491
gene O 0 2.874626314763873e-09
as O 0 5.342400410945913e-10
a O 0 2.878487448398914e-10
melanoma B-Disease 0 5.832201350131072e-05
- O 0 9.732501666803728e-07
predisposing O 0 1.2355744729575235e-06
gene O 0 7.222014541952149e-09
. O 0 4.460093627756123e-09
. O 0 3.169929030377716e-08

Progression O 0 6.514552751468727e-06
of O 0 2.7615355335797176e-08
somatic O 0 2.1952275346848182e-05
CTG O 0 1.0832517546077725e-05
repeat O 0 2.5730806374468784e-09
length O 0 4.5012327198890034e-10
heterogeneity O 0 1.0696979968471965e-09
in O 0 1.073721190084087e-12
the O 0 1.2312715950979491e-12
blood O 0 1.8748823674141768e-11
cells O 0 7.11779135631474e-10
of O 0 6.20561990682944e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9949888586997986
. O 0 9.221890451271975e-08

The O 0 3.754026256519438e-10
genetic O 0 2.8400073959211625e-10
basis O 0 3.1741242967342487e-10
of O 0 2.075378979782272e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.979436892174391e-10
DM B-Disease 1 1.0
) O 0 2.340886544934667e-13
is O 0 7.026387325160914e-15
the O 0 2.2938577171624855e-14
expansion O 0 1.6374933353713317e-10
of O 0 4.958214741557221e-11
an O 0 9.543355689034527e-13
unstable O 0 1.449338498105135e-07
CTG O 0 5.875178317182872e-07
repeat O 0 4.589643665120491e-10
in O 0 1.6042195349896815e-11
the O 0 3.621091967942469e-11
34 O 0 6.343325309465797e-10
UTR O 0 5.813051757286303e-06
of O 0 1.536039767602304e-10
the O 0 3.86794463125284e-09
DM B-Disease 1 1.0
protein O 0 5.360707859836111e-07
kinase O 0 2.285414346658854e-08
gene O 0 4.2004943967555164e-10
on O 0 4.05560518501602e-09
chromosome O 0 1.3486864069989224e-08
19 O 0 3.080556609802443e-08
. O 0 2.8438590149448828e-08

One O 0 5.902184851969139e-10
of O 0 1.2012189853916055e-10
the O 0 3.8401615221062e-11
principal O 0 3.804338788437889e-10
features O 0 5.351540608225513e-13
of O 0 3.312388557885626e-12
the O 0 1.2251498704429764e-09
DM B-Disease 1 1.0
mutation O 0 3.875587850643569e-09
is O 0 7.922546624815341e-13
an O 0 8.000301572749172e-15
extraordinarily O 0 1.3260977038687116e-10
high O 0 3.830448735975267e-10
level O 0 1.0136431694007797e-09
of O 0 3.872054343823095e-10
somatic O 0 1.0028113592852606e-06
mosaicism O 0 8.252732186520007e-06
, O 0 6.08343930785793e-12
due O 0 2.2201700478063913e-09
to O 0 1.9575766355139912e-11
an O 0 1.887366538012511e-13
extremely O 0 2.1750229395323117e-10
high O 0 7.922388439718375e-11
degree O 0 3.233679990444216e-10
of O 0 1.7396084572851578e-10
somatic O 0 3.8012565255485242e-06
instability O 0 3.440918661112846e-08
both O 0 1.678206462685239e-10
within O 0 1.766686380522131e-10
and O 0 6.2635604168581605e-12
between O 0 1.55703522991546e-11
different O 0 4.2452691362271366e-10
tissues O 0 2.863120869278646e-07
. O 0 2.9196293382938165e-08

This O 0 1.571384977694379e-08
instability O 0 1.0363502944699121e-08
appears O 0 5.31032773309903e-10
to O 0 3.994335786607073e-13
be O 0 9.13218068873678e-13
biased O 0 3.301144774203735e-11
towards O 0 8.377355059652203e-11
further O 0 3.034737044993463e-11
expansion O 0 1.6055373697199116e-09
and O 0 9.831192283871193e-12
continuous O 0 8.05436481399191e-11
throughout O 0 8.391684569453162e-11
the O 0 1.772147151246628e-10
life O 0 8.693000763670966e-10
of O 0 9.712570747666405e-10
an O 0 9.56743148247674e-13
individual O 0 1.0360543152565516e-11
, O 0 1.0084022375803081e-12
features O 0 1.4418132486537782e-12
that O 0 1.1364519080566543e-14
could O 0 1.7697470008556926e-12
be O 0 1.0610297362934062e-12
associated O 0 1.5039214318335326e-10
with O 0 6.70445361554417e-13
the O 0 4.235848560796285e-09
progressive O 0 0.1440260112285614
nature O 0 1.5157125332621035e-08
of O 0 3.3075875371935126e-10
the O 0 1.6055281548688072e-09
disease O 0 1.4557078031884885e-07
. O 0 4.5817678540061024e-08

Although O 0 3.8137417668338e-09
increasing O 0 1.1369529623328489e-10
measured O 0 1.3105355689546627e-10
allele O 0 5.6604824993922165e-11
size O 0 5.300711952704873e-11
between O 0 5.6541160642353816e-11
patients O 0 4.9629814924401217e-08
clearly O 0 2.705718982198846e-10
correlates O 0 6.707133459737946e-11
with O 0 1.3981097240017512e-15
an O 0 7.036143874163863e-17
increased O 0 6.211412677606387e-13
severity O 0 1.3051905112249074e-09
of O 0 3.99255933869469e-10
symptoms O 0 2.4933700615292764e-07
and O 0 7.717563567377628e-12
an O 0 4.474002192892323e-15
earlier O 0 1.0126855083669728e-11
age O 0 1.3494698414273643e-10
of O 0 6.468775168300134e-12
onset O 0 2.072657379059706e-09
, O 0 8.919476485527711e-13
this O 0 4.852192324149296e-13
correlation O 0 6.255093014731483e-13
is O 0 9.996763311625242e-15
not O 0 6.021602622996794e-14
precise O 0 3.853017349619847e-10
and O 0 1.693036509597956e-11
measured O 0 4.33698327251264e-10
allele O 0 3.820168348322994e-10
length O 0 1.3396017628508616e-10
cannot O 0 3.849115123855107e-11
be O 0 2.7292827286390375e-13
used O 0 5.952643976694927e-13
as O 0 1.1354904917802028e-13
an O 0 5.362771523952277e-16
accurate O 0 6.065033197888425e-11
predictor O 0 2.812421762143913e-08
of O 0 7.651799333041609e-11
age O 0 7.311383498631585e-09
of O 0 2.388417241760976e-10
onset O 0 7.5287871368345805e-06
. O 0 3.486217678982939e-07

In O 0 7.588115691348207e-10
order O 0 4.654368557233113e-10
to O 0 4.183316453659769e-12
further O 0 3.099542150719614e-11
characterize O 0 8.994561540021095e-09
the O 0 5.085857290865192e-10
dynamics O 0 1.9755727720394134e-08
of O 0 5.191417429273315e-08
DM B-Disease 1 1.0
CTG O 0 0.0002103211882058531
repeat O 0 1.4533656056414657e-08
somatic O 0 4.2696106561379565e-07
instability O 0 2.910263419142467e-10
, O 0 4.4341377900165846e-13
we O 0 2.2826597383118763e-13
have O 0 5.4710423881164025e-14
studied O 0 1.646523954505763e-12
repeat O 0 7.353436978253802e-13
length O 0 1.7149869848895327e-12
changes O 0 1.3980912781652588e-11
over O 0 3.5448735960508237e-12
time O 0 5.47287432386967e-12
in O 0 3.783539453960927e-11
111 O 0 1.274487715363648e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 8.60606732544511e-08
with O 0 2.889295790467483e-14
varying O 0 5.040120057420161e-11
clinical O 0 6.040419553432486e-11
severity O 0 1.0718225418315797e-08
and O 0 6.061982582572512e-10
CTG O 0 1.195869003822736e-07
repeat O 0 1.041533317924781e-10
size O 0 2.2330358048772148e-11
over O 0 6.378439443288642e-13
time O 0 7.419582526493884e-13
intervals O 0 4.848337009644155e-12
of O 0 1.858882839322895e-12
1 O 0 1.9811288720639197e-10
- O 0 2.2878761385403124e-10
7 O 0 3.5607544690563486e-10
years O 0 1.992625682512017e-11
. O 0 6.165600807683802e-10

We O 0 1.1232195618049445e-08
have O 0 8.102341714222305e-12
found O 0 3.7400695062674016e-13
a O 0 1.4209105592165924e-14
direct O 0 1.323493723469349e-12
progression O 0 8.548390884044466e-10
of O 0 3.346294075168288e-11
the O 0 4.5811666959938435e-11
size O 0 3.231102885248305e-10
heterogeneity O 0 1.8112862321117973e-09
over O 0 3.6917795209756576e-11
time O 0 1.6856063420056522e-11
related O 0 2.1117636528344974e-09
to O 0 1.9186346955635258e-10
initial O 0 3.985449481547221e-08
CTG O 0 2.895937143421179e-07
repeat O 0 2.1194901389520737e-10
size O 0 1.333262389380252e-10
and O 0 3.7543232411785254e-12
the O 0 5.568758995599943e-12
time O 0 6.748398281158918e-12
interval O 0 1.2539301541547587e-10
and O 0 5.1484333289664175e-12
always O 0 1.913590293167733e-11
biased O 0 3.915692770029011e-11
towards O 0 1.5094100969115232e-10
further O 0 5.660927837602969e-10
expansion O 0 6.798148319830943e-07
. O 0 9.548858770358493e-08

Attempts O 0 9.352011431928986e-08
to O 0 8.321680150524813e-11
mathematically O 0 1.927328296957853e-09
model O 0 1.8280522928737497e-10
the O 0 1.7073229496844533e-09
dynamics O 0 3.397171894903295e-07
have O 0 8.52328962963611e-09
proved O 0 1.8860943384879647e-07
only O 0 1.8564859372016684e-10
partially O 0 2.2791100118269014e-09
successful O 0 8.426713493658866e-11
suggesting O 0 3.173898990849189e-11
that O 0 2.2660309907792872e-14
individual O 0 1.296780879293108e-13
specific O 0 4.0261262206076065e-12
genetic O 0 3.600445289131393e-11
and O 0 6.752376435770202e-12
/ O 0 7.830441184353276e-09
or O 0 3.8600914131770026e-11
environmental O 0 3.069284204570977e-08
factors O 0 9.580470639036776e-09
also O 0 2.3262452727990102e-11
play O 0 2.320909436859253e-11
a O 0 3.2874829161005925e-12
role O 0 1.586090009331187e-10
in O 0 2.1113366610592266e-09
somatic O 0 3.488887523417361e-05
mosaicism O 0 0.00015944219194352627
. O 0 5.751887854898996e-09
. O 0 1.0250504445252773e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 3.667697257014879e-08
Palestinian O 0 4.280871621631377e-07
Arabs O 0 2.0825775948196679e-07
. O 0 1.270465599390036e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.3671780824661255
AGU B-Disease 1 1.0
) O 0 2.2455844475577358e-11
is O 0 8.228891201257638e-14
a O 0 4.0759357559016704e-14
rare O 0 1.4191183783651695e-09
disorder B-Disease 0 0.0009411765495315194
of I-Disease 0 9.058885552803986e-07
glycoprotein I-Disease 0 3.544683204381727e-05
metabolism I-Disease 1 0.9347813129425049
caused O 0 2.1822750273514657e-09
by O 0 1.970796789652063e-12
the O 0 1.2444414387857705e-08
deficiency B-Disease 0 0.007362618576735258
of I-Disease 0 2.2210424610591417e-09
the I-Disease 0 1.6701888760906058e-09
lysosomal I-Disease 0 3.0477633572445484e-06
enzyme I-Disease 0 7.56252021005821e-08
aspartylglucosaminidase I-Disease 0 2.6076870199176483e-05
( O 0 1.2376726032936602e-10
AGA O 0 7.588383596157655e-05
) O 0 9.051967508888481e-11
. O 0 1.586196729519429e-09

AGU B-Disease 1 1.0
is O 0 1.1215395545605134e-07
inherited O 0 0.00010035430750576779
as O 0 2.545107236073818e-09
an O 0 6.994604201393528e-11
autosomal O 0 1.1462731890787836e-05
recessive O 0 1.7650668269197922e-06
trait O 0 5.7590920476968677e-08
and O 0 3.222908745437181e-11
occurs O 0 2.291402527790365e-12
with O 0 2.0896080462614935e-15
a O 0 2.4628848358529756e-14
high O 0 6.738523627980442e-11
frequency O 0 5.6125239872306665e-11
in O 0 6.79930287419972e-12
Finland O 0 1.0799213745471548e-09
because O 0 1.4727245811752e-10
of O 0 4.828712429905124e-10
a O 0 8.340462348543909e-11
founder O 0 7.952644764941397e-09
effect O 0 2.2615690653537968e-08
. O 0 2.3581277375228638e-08

While O 0 1.4179549623349885e-07
very O 0 2.2940735977527993e-09
few O 0 1.7103900518122828e-09
patients O 0 1.8137347623792266e-08
with O 0 9.035665965440032e-11
AGU B-Disease 1 1.0
have O 0 5.4828603879286675e-09
been O 0 4.7665222463466606e-11
reported O 0 3.272118903954735e-12
from O 0 8.781046202666065e-12
non O 0 4.6267525921628305e-10
- O 0 6.352012665855611e-12
Finnish O 0 9.376217163792333e-11
origin O 0 8.090497022328336e-12
, O 0 1.333548397576545e-12
we O 0 7.583279143519306e-11
diagnosed O 0 0.00022694532526656985
the O 0 3.078477561757609e-08
disorder O 0 3.24180000461638e-05
in O 0 7.919677358358967e-09
8 O 0 4.1963268415656785e-08
patients O 0 4.2314716175440026e-09
originating O 0 1.1072629618746888e-10
from O 0 1.5046866530532554e-11
3 O 0 1.3052246783384902e-10
unrelated O 0 7.874305096855494e-10
families O 0 5.961691210143449e-12
, O 0 5.3269539522721523e-14
all O 0 9.729812577375166e-14
Palestinian O 0 2.3049673281150262e-10
Arabs O 0 4.4142359906240713e-11
from O 0 1.4346973045351041e-12
the O 0 2.8322962464938373e-12
region O 0 2.0768182312780326e-11
of O 0 1.383701833668205e-11
Jerusalem O 0 1.0345343071094248e-06
. O 0 1.0247928372564274e-07

The O 0 1.848099451251528e-09
clinical O 0 8.559864816959362e-09
diagnosis O 0 0.0314224436879158
of O 0 0.3406115174293518
AGU B-Disease 1 1.0
is O 0 5.5371418561378505e-09
often O 0 3.1387531462812035e-11
difficult O 0 1.8121205924703787e-11
, O 0 1.1817868732222347e-13
in O 0 3.709364900742612e-13
particular O 0 8.078408601785991e-12
early O 0 1.4280190363535894e-09
in O 0 1.6198195128963588e-12
the O 0 7.284632966286786e-12
course O 0 1.193709298075163e-10
of O 0 3.205612641651867e-12
the O 0 1.1128244159497314e-11
disease O 0 4.4984946323545216e-10
, O 0 1.3107619373578516e-12
and O 0 1.936013415554383e-12
most O 0 3.465419357723265e-12
of O 0 7.930034233438743e-12
the O 0 1.3087221584218156e-10
patients O 0 2.287184841520684e-08
are O 0 7.895232211063696e-12
diagnosed O 0 5.130078584159037e-10
after O 0 3.6755706117608256e-11
the O 0 1.209795458256835e-10
age O 0 3.27898375118707e-09
of O 0 2.647430608071488e-10
5 O 0 9.055735605834059e-10
years O 0 1.0477218398419197e-10
. O 0 3.1875277972659433e-09

However O 0 1.3331954562545434e-07
, O 0 8.690277664147317e-11
since O 0 2.016457556486273e-10
these O 0 2.9270197376973783e-10
patients O 0 6.259363583005495e-10
excrete O 0 2.6813944398185185e-09
early O 0 2.6079027826142465e-10
large O 0 6.008389315595442e-13
amounts O 0 1.1647538836201399e-11
of O 0 4.706338790905207e-11
aspartylglucosamine O 0 1.2875525499111973e-06
in O 0 2.188828229776618e-09
urine O 0 2.8223507975155826e-09
, O 0 4.2495886909237057e-13
biochemical O 0 5.044466927506264e-11
screening O 0 1.6522969659149567e-08
is O 0 4.902057579303509e-11
easy O 0 4.609207182593167e-10
by O 0 2.3061358378484442e-11
urine O 0 4.045577206568396e-09
chromatography O 0 1.0233352831789944e-08
. O 0 7.221556130865281e-10
. O 0 3.3305442848075018e-09

Detection O 0 1.7173773869672004e-07
of O 0 3.6241065703990216e-10
heterozygous O 0 6.748797267558393e-12
carriers O 0 1.5015523546768605e-12
of O 0 2.6635139406538944e-12
the O 0 5.0775458504404014e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.2614101985164439e-09
ATM O 0 2.1896777013807878e-07
) O 0 2.6270459332206064e-12
gene O 0 1.0023235496800509e-12
by O 0 1.8129667688979167e-12
G2 O 0 1.0983769698214019e-06
phase O 0 2.7205175001654425e-07
chromosomal O 0 1.5975872713624995e-07
radiosensitivity O 0 4.998858457838651e-06
of O 0 2.6096417471421773e-08
peripheral O 0 1.8095617633662187e-05
blood O 0 9.608996151655447e-06
lymphocytes O 0 1.5519192402280169e-06
. O 0 8.112916560776284e-09

In O 0 2.7908603783544095e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.7377969641074742e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.002084246281569e-11
patients O 0 4.441479006800364e-08
, O 0 1.1414844763857346e-12
mutations O 0 1.5697583207255339e-12
in O 0 1.1446217237920386e-12
a O 0 5.07881172014113e-13
single O 0 8.914072605059609e-12
gene O 0 8.199660026485256e-13
, O 0 2.0955813310758603e-13
ATM O 0 8.691736219645918e-11
, O 0 6.660902455178695e-16
result O 0 3.0664137678701464e-14
in O 0 1.6199213194803552e-12
an O 0 2.440817992166444e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.7453855027937948e-09
embraces O 0 1.467834631618814e-09
a O 0 2.9107640776848687e-13
variety O 0 3.4113874919361464e-12
of O 0 1.747934913129412e-12
clinical O 0 3.912169199704607e-11
features O 0 1.986224379413315e-11
and O 0 3.8780372142721564e-12
manifests O 0 5.984448492313277e-10
extreme O 0 3.536201553799856e-09
radiosensitivity O 0 3.5398784348217305e-07
and O 0 1.388159448501014e-10
a O 0 1.0502342051577074e-11
strong O 0 4.07222977560906e-10
pre O 0 1.249955403181957e-06
- O 0 1.651866057272855e-07
disposition O 0 0.0009871398797258735
to O 0 2.6820963228146866e-08
malignancy B-Disease 0 0.00037846685154363513
. O 0 1.6025795801510867e-08

Heterozygotes O 0 1.7176638493765495e-06
for O 0 8.513326155146217e-10
the O 0 2.9531759260237322e-09
ATM O 0 4.063318925773274e-08
gene O 0 1.854290852809637e-11
have O 0 8.85084052489743e-13
no O 0 6.216544748589847e-13
clinical O 0 3.226253248930777e-12
expression O 0 8.27264417992829e-13
of O 0 1.6735268726364438e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 4.8935282909168265e-11
may O 0 3.2922095605236734e-11
be O 0 2.3915749589042967e-11
cancer B-Disease 0 3.111025037583204e-08
prone O 0 2.5580124130009096e-10
with O 0 3.402916240891757e-14
a O 0 1.4662262289716343e-12
moderate O 0 2.6511308703902614e-09
increase O 0 1.953321948633402e-10
in O 0 3.490631395042243e-10
in O 0 2.6192796820367903e-09
vitro O 0 1.0275226713929442e-06
radiosensitivity O 0 7.5574248512566555e-06
. O 0 5.438836225835075e-08

We O 0 8.174518839609846e-09
performed O 0 1.8661645562190188e-09
a O 0 2.221158847126592e-11
blind O 0 4.211171966694849e-10
chromosomal O 0 6.101596450314162e-10
analysis O 0 2.382825048385939e-10
on O 0 7.928923073663441e-10
G2 O 0 7.362984177916587e-08
- O 0 1.3870213311228952e-10
phase O 0 1.4876836651467329e-08
lymphocytes O 0 2.8736926727113143e-10
from O 0 7.459384130346913e-13
7 O 0 2.930895456887406e-11
unrelated O 0 1.7454188094845335e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0006721417303197086
, O 0 1.9616010205059098e-12
13 O 0 1.7970003957090697e-11
obligate O 0 7.582498517955116e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 5.077390952124006e-08
( O 0 5.782784055210696e-14
parents O 0 1.182070934191426e-13
of O 0 8.916643837945503e-15
the O 0 5.6830730307258145e-14
patients O 0 9.869591038533243e-13
) O 0 1.950308819404314e-15
, O 0 9.264033903064531e-14
and O 0 2.476633047948651e-12
14 O 0 7.108630351027045e-11
normal O 0 1.173523167530277e-09
controls O 0 1.4959167238259852e-10
following O 0 1.9530649320032012e-10
X O 0 2.119569728620263e-07
- O 0 5.197447805471711e-09
irradiation O 0 7.553523460046563e-07
with O 0 1.5935298870381476e-12
1 O 0 2.707370994059488e-10
Gy O 0 1.833767448999879e-08
in O 0 1.1173513828587056e-13
order O 0 2.1879650868861233e-12
to O 0 1.1349692886908347e-12
evaluate O 0 1.2375310498580205e-10
this O 0 4.717354545186181e-12
cytogenetic O 0 2.6708787004281476e-07
method O 0 1.848523645264777e-08
as O 0 6.049539341690391e-11
a O 0 1.122829693805949e-12
tool O 0 1.0849894593878417e-10
for O 0 4.220710152907925e-13
detection O 0 1.2880625455125028e-08
of O 0 3.0106639403726376e-09
ATM O 0 1.289649480895605e-05
carriers O 0 1.25386975469155e-07
. O 0 5.160240945656369e-08

Both O 0 7.556204906222774e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.085374492504343e-06
and O 0 4.697243028567444e-12
heterozygotes O 0 1.1716981829223982e-09
showed O 0 6.148155769214458e-12
significantly O 0 2.2732380214329773e-11
increased O 0 8.027567326152063e-12
levels O 0 1.022776238701617e-10
of O 0 2.375117897496226e-12
radiation O 0 6.147429871816712e-07
- O 0 7.594896267448803e-09
induced O 0 2.816690312101855e-07
chromatid O 0 1.993374354469779e-07
damage O 0 3.7764489313474314e-09
relative O 0 1.5720618140591114e-09
to O 0 1.6574386177761746e-12
that O 0 1.4865112450430235e-13
of O 0 5.2079320023157294e-11
normal O 0 1.2946296124027867e-07
controls O 0 8.423801745038872e-08
. O 0 4.536800446430789e-08

These O 0 5.294489846541239e-10
results O 0 8.618296631901501e-10
show O 0 6.401126850796857e-11
that O 0 1.724718729379654e-13
the O 0 2.965375861530006e-11
G2 O 0 5.992838509882858e-07
- O 0 6.600221702512954e-09
phase O 0 4.3097014668092015e-07
chromosomal O 0 2.185967318268922e-08
radiosensitivity O 0 1.8638503718193533e-07
assay O 0 2.877369009723907e-09
can O 0 1.1732171224104748e-12
be O 0 3.8995059080653566e-14
used O 0 1.8170638875925765e-14
for O 0 5.349351028056861e-15
the O 0 3.7201893719448e-14
detection O 0 4.943486175967848e-10
of O 0 5.051384643905976e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.579979602363892e-05
. O 0 6.869591118174867e-08

In O 0 2.83137668866118e-09
combination O 0 2.6146076415045627e-09
with O 0 7.736029698779401e-12
molecular O 0 1.2997952048010575e-08
genetic O 0 2.1979831288376772e-08
analyses O 0 2.669519494347128e-09
, O 0 2.3502740552350243e-12
this O 0 2.5760376904521154e-12
test O 0 7.37648206405872e-11
may O 0 4.128599892516682e-11
be O 0 6.068081150403803e-13
of O 0 1.464292337556572e-12
value O 0 3.991093480010255e-12
in O 0 2.820407752832099e-13
studies O 0 1.0251558716506404e-12
of O 0 8.690417634647785e-13
familial B-Disease 0 1.3163508061353468e-09
and I-Disease 0 1.8434382909049418e-09
sporadic I-Disease 0 7.216549988697807e-07
cancers I-Disease 0 4.1352151924911595e-07
aimed O 0 3.88612875212857e-09
at O 0 2.706751212055991e-10
determination O 0 4.237715067745285e-09
of O 0 1.1870076033204668e-09
the O 0 6.212817760253841e-11
potential O 0 6.268249114205204e-11
involvement O 0 8.604100765197131e-11
of O 0 2.1821824902623632e-10
ATM O 0 3.3077429861805285e-07
mutations O 0 2.183953240475489e-09
in O 0 5.403602010289887e-10
tumor B-Disease 0 0.0020741247572004795
risk O 0 2.3851333708080347e-07
or O 0 2.1885350476313903e-10
development O 0 1.1331432459016355e-09
. O 0 6.101200655805883e-10
. O 0 7.482626962485028e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 5.22617449316698e-10
identification O 0 7.363862297715684e-10
and O 0 4.637205875367145e-13
detection O 0 1.6635569588530075e-09
of O 0 1.291232565314715e-09
founder O 0 8.822105712624762e-09
- O 0 2.0728716521034585e-08
effect O 0 4.694207120792271e-07
mutations O 0 8.288655872767947e-10
in O 0 5.267974945155629e-11
the O 0 1.7098999993692132e-10
ATM O 0 5.432273653127595e-08
gene O 0 3.3453625286616884e-11
in O 0 3.760825678655877e-11
ethnic O 0 2.653203490243783e-10
populations O 0 1.3874078275133428e-10
. O 0 4.877298565020283e-10

To O 0 4.070715431403471e-10
facilitate O 0 2.573659507731918e-09
the O 0 1.6159266980064757e-10
evaluation O 0 2.4852029767430395e-08
of O 0 4.740922321389007e-09
ATM O 0 6.610523541894509e-07
heterozygotes O 0 7.556032244337985e-08
for O 0 2.352141814654374e-10
susceptibility O 0 1.2010558236852376e-07
to O 0 5.171811243154245e-11
other O 0 9.054349631165692e-11
diseases O 0 3.394966086034401e-07
, O 0 5.8577895138689495e-12
such O 0 2.285098082976944e-10
as O 0 2.728129970819282e-07
breast B-Disease 0 0.0016695552039891481
cancer I-Disease 0 8.26441464596428e-07
, O 0 1.696233258019486e-11
we O 0 1.006208658060892e-11
have O 0 1.122780948076274e-11
attempted O 0 1.7273979469045742e-10
to O 0 1.647379281599637e-11
define O 0 2.7872024133124285e-10
the O 0 7.796409351445988e-11
most O 0 8.861048179931164e-12
common O 0 5.84509957796131e-12
mutations O 0 7.953686808562926e-14
and O 0 8.789361043994547e-15
their O 0 3.967916015830582e-14
frequencies O 0 8.105139823189056e-12
in O 0 2.669421350631751e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.5877388648277702e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.422906063808238e-11
homozygotes O 0 2.1677069028669393e-08
from O 0 2.0686031013128492e-11
10 O 0 1.8456071740335922e-11
ethnic O 0 1.052279444135884e-11
populations O 0 4.212784635027056e-11
. O 0 5.824961069045287e-10

Both O 0 1.843605161866435e-07
genomic O 0 7.261631367327936e-07
mutations O 0 2.2860072945718457e-08
and O 0 1.1981550473993963e-10
their O 0 2.4640444198920086e-11
effects O 0 1.4824928784573643e-10
on O 0 6.020994813837888e-10
cDNA O 0 2.6539539454972783e-09
were O 0 9.999033545593505e-11
characterized O 0 1.8846650906567675e-09
. O 0 3.9378211802443275e-09

Protein O 0 7.278077873706934e-08
- O 0 5.12216180581504e-09
truncation O 0 1.8526780110050822e-08
testing O 0 2.608679938731484e-09
of O 0 1.2216729849967578e-09
the O 0 6.557954734809357e-10
entire O 0 4.356667471228093e-09
ATM O 0 1.6031847849262704e-08
cDNA O 0 3.041117913049618e-10
detected O 0 1.1758533036143604e-09
92 O 0 2.6554729526395704e-09
( O 0 2.754453024174375e-13
66 O 0 9.806271072942963e-11
% O 0 2.4566850290175246e-12
) O 0 2.3852222822730307e-13
truncating O 0 7.183712291691791e-09
mutations O 0 7.508786370458154e-10
in O 0 2.781053165534786e-10
140 O 0 6.539946362238425e-09
mutant O 0 1.8348938368717427e-08
alleles O 0 1.869249643959847e-09
screened O 0 6.922347495219583e-08
. O 0 1.3909463802974642e-08

The O 0 5.806021619036983e-08
haplotyping O 0 0.00019002630142495036
of O 0 7.900140417405055e-07
patients O 0 1.4216070667316671e-05
with O 0 2.827521827786228e-10
identical O 0 2.5958713649743004e-06
mutations O 0 1.5546813614264465e-08
indicates O 0 1.7764577364687284e-07
that O 0 1.3014404658118206e-11
almost O 0 4.224354893667126e-11
all O 0 1.4982623431844533e-12
of O 0 1.3750664018888359e-12
these O 0 7.120808933822054e-13
represent O 0 3.3503137330387345e-13
common O 0 5.151458686708521e-12
ancestry O 0 6.897095741753567e-12
and O 0 2.6880919907525114e-13
that O 0 9.011418862633555e-14
very O 0 1.6437330663254812e-10
few O 0 1.7571635257951357e-09
spontaneously O 0 1.0004579564792948e-07
recurring O 0 3.716456120628209e-08
ATM O 0 5.195694029680453e-06
mutations O 0 5.9016279863044474e-08
exist O 0 2.0046099891146696e-08
. O 0 4.2559186397284066e-08

Assays O 0 2.0647674148221995e-07
requiring O 0 1.743822508615267e-08
minimal O 0 3.243969501909305e-07
amounts O 0 8.085033975646638e-09
of O 0 4.859099234089115e-10
genomic O 0 6.060236756866288e-10
DNA O 0 6.21660167787752e-10
were O 0 1.6172795741509205e-11
designed O 0 3.233431578042456e-11
to O 0 7.039598071134634e-12
allow O 0 9.825306367117204e-12
rapid O 0 1.7879857316938086e-10
screening O 0 1.5698115030104987e-09
for O 0 2.8487623718320698e-11
common O 0 3.2553053586070746e-08
ethnic O 0 9.235599840451414e-09
mutations O 0 6.117518047688009e-09
. O 0 1.3683087551896733e-08

These O 0 2.0909233455768117e-08
rapid O 0 1.9587485411420857e-08
assays O 0 6.563854526575597e-08
detected O 0 9.304736892090659e-08
mutations O 0 4.114585339110022e-10
in O 0 4.844826970162863e-11
76 O 0 1.564539431342382e-08
% O 0 2.3132152443539056e-11
of O 0 1.1071610642177099e-11
Costa O 0 2.073317517670148e-09
Rican O 0 2.378344134967847e-07
patients O 0 7.461337077074859e-07
( O 0 4.750915372914166e-13
3 O 0 4.760453142793608e-11
) O 0 1.508129457092073e-14
, O 0 1.6057482763159187e-13
50 O 0 5.205566012966845e-12
% O 0 1.7012698758436806e-13
of O 0 5.385864822703146e-13
Norwegian O 0 8.975353438245293e-08
patients O 0 1.4375605417171755e-07
( O 0 1.8926005240001847e-13
1 O 0 5.500001148961431e-11
) O 0 1.1852309261264297e-14
, O 0 7.638591229810685e-14
25 O 0 4.853786643443936e-12
% O 0 1.623459125379284e-13
of O 0 2.6788226042788466e-13
Polish O 0 2.0578595183451398e-07
patients O 0 2.065684566332493e-05
( O 0 6.813593200934165e-13
4 O 0 8.87343254429851e-11
) O 0 1.9336308677278188e-14
, O 0 8.908896027576968e-14
and O 0 1.1862679892213346e-12
14 O 0 3.116793281798813e-11
% O 0 9.011543681408662e-13
of O 0 1.4627792250046512e-12
Italian O 0 7.003983171216532e-09
patients O 0 4.3692858753274777e-07
( O 0 2.9102702235953015e-13
1 O 0 4.0493269848340674e-10
) O 0 1.7272800214868794e-13
, O 0 3.098092095366045e-12
as O 0 3.1533105987469057e-11
well O 0 5.602983008112794e-11
as O 0 6.76291965137632e-12
in O 0 1.577232094929215e-11
patients O 0 7.725081130338651e-10
of O 0 1.7757810499841042e-10
Amish O 0 1.0223933344377656e-07
/ O 0 2.551543865081385e-08
Mennonite O 0 4.83326942912754e-08
and O 0 7.773005329669846e-12
Irish O 0 2.6298760391618714e-10
English O 0 9.497826969351308e-10
backgrounds O 0 2.1731507260369654e-08
. O 0 1.1232554886220214e-09

Additional O 0 5.862115415311564e-08
mutations O 0 3.982096430377169e-09
were O 0 1.5407021491942174e-10
observed O 0 5.05754015056592e-11
in O 0 4.750772258227398e-12
Japanese O 0 7.885942565621917e-09
, O 0 8.073725715762592e-12
Utah O 0 5.818467929685767e-09
Mormon O 0 7.444674210432822e-09
, O 0 2.805856404424628e-13
and O 0 4.497381200091466e-13
African O 0 1.840786204021505e-12
American O 0 1.5324512492309594e-11
patients O 0 1.980389408018368e-09
. O 0 3.599439413193295e-09

These O 0 2.6363360383641066e-09
assays O 0 3.0771771242221746e-10
should O 0 1.9432346357040053e-12
facilitate O 0 2.333816950458867e-12
screening O 0 9.717086163485433e-11
for O 0 2.863394417407239e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
heterozygotes O 0 1.0817880280455938e-07
in O 0 2.361238635173457e-11
the O 0 5.801869835259099e-12
populations O 0 1.8406949141985818e-12
studied O 0 7.476908849002317e-12
. O 0 7.078144494132577e-12
. O 0 5.227500099458382e-10

The O 0 2.2333549054565083e-07
von B-Disease 1 0.9999990463256836
Hippel I-Disease 1 0.999996542930603
- I-Disease 1 0.9999996423721313
Lindau I-Disease 1 0.9997865557670593
tumor I-Disease 1 0.520300030708313
suppressor O 0 1.6030128335842164e-06
gene O 0 4.5077344634769645e-11
is O 0 5.710367481604958e-14
required O 0 1.1516447517845307e-12
for O 0 3.1439984621815797e-13
cell O 0 1.0987614984525607e-10
cycle O 0 3.957954242128636e-10
exit O 0 1.5987922097338014e-10
upon O 0 2.902612004918037e-11
serum O 0 6.689940268422845e-10
withdrawal O 0 1.1516206654960115e-08
. O 0 1.5925484930789935e-08

The O 0 1.6568714455988953e-10
inactivation O 0 1.989205429708818e-06
of O 0 1.1145078193663949e-09
the O 0 2.4560902645021088e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 1.2054273135220228e-08
VHL I-Disease 1 0.9940943121910095
) I-Disease 0 1.7630620297026667e-09
tumor I-Disease 0 3.6578478557203198e-06
suppressor O 0 3.432117409829516e-06
gene O 0 9.196167716218895e-10
predisposes O 0 1.467566601576209e-08
affected O 0 8.540487206332159e-10
individuals O 0 1.152721472962026e-12
to O 0 3.3290384338080514e-13
the O 0 5.768009334050639e-11
human O 0 6.623582157772034e-05
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.222870321312188e-12
is O 0 1.0381395890775736e-14
associated O 0 2.479089253760308e-13
with O 0 2.26636512833632e-13
sporadic B-Disease 0 1.6416843209299259e-06
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.9940153972441976e-09
RCC B-Disease 1 0.9939079284667969
) O 0 5.813517445218963e-10
and O 0 2.757088424232279e-08
brain B-Disease 0 1.77641304617282e-05
hemangioblastomas I-Disease 0 0.00047217923565767705
. O 0 1.1696577075781533e-06

VHL O 0 0.06983695924282074
- O 0 7.989212463144213e-05
negative O 0 5.623933816423232e-07
786 O 0 1.6942898355409852e-06
- O 0 2.4624583261356747e-07
0 O 0 1.4371734025075966e-08
RCC B-Disease 0 4.049501569625136e-07
cells O 0 3.848744434264972e-09
are O 0 1.476926567156589e-11
tumorigenic O 0 2.842324420271325e-06
in O 0 4.3377070824135444e-08
nude O 0 4.143339253914746e-07
mice O 0 3.81803610949305e-09
which O 0 2.283195334185084e-13
is O 0 6.677954901296995e-14
suppressed O 0 2.596678948252329e-11
by O 0 1.1222365267973822e-12
the O 0 1.0096022629024759e-10
reintroduction O 0 2.6656343266040494e-07
of O 0 2.3939095150637968e-09
VHL B-Disease 0 0.003354941960424185
. O 0 8.751816835683712e-07

Remarkably O 0 1.1633943586275564e-06
, O 0 7.00148435322373e-13
this O 0 2.0658791382221695e-14
occurs O 0 8.366759433713067e-13
without O 0 1.3643082974121312e-12
affecting O 0 3.179934093822112e-11
the O 0 1.4249809665578539e-11
growth O 0 1.0346058454402396e-09
rate O 0 1.2660791304242025e-09
and O 0 3.611494241682889e-13
cell O 0 2.4386935179587788e-11
cycle O 0 3.5271646714463145e-11
profile O 0 1.9618940153010023e-11
of O 0 2.4058541617244522e-11
these O 0 4.740266512648361e-11
cells O 0 5.612772469021365e-10
in O 0 1.6144502401616023e-11
culture O 0 5.934129299056679e-10
. O 0 8.389255956586794e-10

The O 0 7.848417027389587e-08
786 O 0 2.637701186358754e-07
- O 0 5.404769076733373e-09
0 O 0 3.451056940217967e-10
cell O 0 7.532881957095228e-11
line O 0 5.538472347410561e-09
, O 0 8.822697780686006e-12
like O 0 5.3222905249672436e-11
many O 0 1.7831121301714603e-10
cancer B-Disease 0 1.7732096901923455e-09
cells O 0 1.476555405721669e-10
, O 0 1.324256242857258e-12
fails O 0 8.211891583398412e-11
to O 0 5.821678642631278e-12
exit O 0 1.1251037879134174e-09
the O 0 6.3519636599174145e-12
cell O 0 5.426289972909615e-11
cycle O 0 9.545252609155508e-12
upon O 0 1.813804662020857e-11
serum O 0 1.0040873688055285e-09
withdrawal O 0 1.5844831224853806e-08
. O 0 1.7985803069109352e-08

Here O 0 2.710970115060718e-08
, O 0 9.936460508563894e-12
it O 0 5.771147855394496e-14
is O 0 1.7728567298556062e-14
shown O 0 2.6433936555500873e-14
that O 0 2.068567324335223e-15
reintroduction O 0 1.118711900893743e-09
of O 0 1.2788611315761589e-11
the O 0 7.369366228360263e-11
wild O 0 3.2504769986729798e-09
- O 0 3.7451722278980526e-10
type O 0 3.6080864962428905e-09
VHL B-Disease 0 3.749572715605609e-05
gene O 0 2.7934732305112675e-09
restores O 0 1.8245469846078777e-07
the O 0 7.117180733651196e-10
ability O 0 5.244917833380214e-10
of O 0 3.906826417932052e-09
VHL O 1 1.0
- O 1 0.9999998807907104
negative O 0 0.0034742034040391445
RCC B-Disease 1 0.9984967708587646
cancer I-Disease 0 4.991460968994943e-07
cells O 0 2.7528803889231845e-11
to O 0 1.4227532997221348e-12
exit O 0 1.5622209081911365e-10
the O 0 2.542066383781627e-12
cell O 0 2.481362684769728e-11
cycle O 0 4.436629535975456e-11
and O 0 5.890446008564865e-13
enter O 0 3.9212872948724e-09
G0 O 0 8.624809561297297e-05
/ O 0 2.6349598059027812e-08
quiescence O 0 9.029562164641902e-08
in O 0 3.087293268255742e-11
low O 0 1.8250884137316348e-09
serum O 0 2.207603211346054e-09
. O 0 1.6100759614445792e-09

Both O 0 2.2636540109033376e-07
VHL O 0 0.2203012853860855
- O 0 1.964915281860158e-05
positive O 0 2.2757097539738425e-08
and O 0 1.5782537499120508e-09
VHL O 1 0.9993597865104675
- O 0 4.676390381064266e-05
negative O 0 2.32395663601892e-07
RCC B-Disease 0 3.692126119858585e-05
cells O 0 7.442874050411774e-08
exit O 0 3.2653669990168055e-08
the O 0 7.817193073411666e-12
cell O 0 9.011828089322549e-11
cycle O 0 2.682348093641096e-11
by O 0 4.2361467523892304e-13
contact O 0 9.599556566319833e-11
inhibition O 0 3.9081552216657656e-08
. O 0 5.9147222231104024e-08

The O 0 3.405992003990832e-07
cyclin O 0 3.499259037198499e-06
- O 0 1.243967346908903e-07
dependent O 0 1.723605080883317e-08
kinase O 0 2.796406839422616e-08
inhibitor O 0 3.3230453055921316e-08
, O 0 8.959981367961944e-11
p27 O 0 5.257984625473e-08
, O 0 9.736413064675986e-12
accumulates O 0 4.905453127035386e-11
upon O 0 4.115617135286298e-12
serum O 0 2.6317500696065865e-12
withdrawal O 0 7.907925009265071e-11
, O 0 7.748133731833029e-13
only O 0 1.539465983076832e-13
in O 0 4.097764066002957e-13
the O 0 1.7972805318663965e-12
presence O 0 1.4306045931222755e-11
of O 0 3.1112605825001083e-09
VHL B-Disease 1 0.9995076656341553
, O 0 5.76551584252627e-10
as O 0 4.8001676418441e-12
a O 0 2.985637995514545e-14
result O 0 6.133125691337726e-13
of O 0 1.3976665961742962e-12
the O 0 1.3587353898253385e-12
stabilization O 0 8.024915842952396e-09
of O 0 8.92587170842063e-10
the O 0 8.563784348325498e-09
protein O 0 6.24974134666445e-08
. O 0 3.2283587358961086e-08

We O 0 2.4797175424140505e-10
propose O 0 7.991521888683906e-10
that O 0 2.519551407786924e-13
the O 0 3.466313694411305e-11
loss O 0 5.200251340653494e-10
of O 0 5.237060785034942e-10
wild O 0 2.85619727868891e-09
- O 0 1.7869389301594651e-10
type O 0 1.7975301247474818e-09
VHL B-Disease 0 2.785781134662102e-06
gene O 0 1.5503409320216655e-11
results O 0 5.8126833207827744e-11
in O 0 1.9541957028273993e-12
a O 0 1.3801000544200887e-13
specific O 0 1.0915966047742032e-10
cellular O 0 1.5655565732686227e-09
defect O 0 1.93813320947811e-09
in O 0 2.443274749186486e-11
serum O 0 2.336600024577251e-09
- O 0 3.059675179883925e-08
dependent O 0 1.1561367863066607e-08
growth O 0 1.485442185922281e-10
control O 0 9.674035184037422e-11
, O 0 5.919662004506832e-13
which O 0 1.5854775175030977e-12
may O 0 2.191100412218816e-09
initiate O 0 4.897355054822583e-08
tumor B-Disease 0 2.8155886866443325e-06
formation O 0 1.7658636863870925e-07
. O 0 7.196276641252553e-08

This O 0 8.040370591544388e-10
is O 0 1.6043938746990172e-11
corrected O 0 1.0354764823361506e-09
by O 0 7.797799949152417e-13
the O 0 8.86584902715093e-12
reintroduction O 0 8.371709547816408e-09
of O 0 1.2964012675864556e-11
wild O 0 1.427177598323226e-09
- O 0 5.088117704943329e-10
type O 0 1.5244975060113575e-08
VHL B-Disease 1 0.922800600528717
, O 0 1.2952754424588875e-09
implicating O 0 6.252078037505271e-07
VHL B-Disease 1 0.9999998807907104
as O 0 3.1274691281169e-08
the O 0 1.9128441053339884e-09
first O 0 2.114729225066725e-10
tumor B-Disease 0 5.84004888892764e-09
suppressor O 0 5.54422197041049e-09
involved O 0 8.789944466736088e-12
in O 0 1.1989934219081011e-11
the O 0 1.8645971919251103e-11
regulation O 0 1.7116725814503297e-09
of O 0 5.251121412697124e-11
cell O 0 1.1399755445173909e-10
cycle O 0 6.503789867773335e-11
exit O 0 2.0382665000262534e-10
, O 0 2.7179046028212063e-14
which O 0 1.6835184708428007e-14
is O 0 4.0315014239282465e-14
consistent O 0 2.99258083591436e-11
with O 0 6.379117611747531e-14
its O 0 5.976526131629134e-12
gatekeeper O 0 2.560692491382355e-10
function O 0 5.684682759243831e-12
in O 0 1.027131244640822e-11
the O 0 3.649515134540593e-10
kidney O 0 1.7266739860133384e-06
. O 0 2.1591435306334006e-09
. O 0 9.216752694385377e-09

Piebaldism B-Disease 1 1.0
with O 0 4.672476279665716e-05
deafness B-Disease 1 1.0
: O 0 7.707930821387876e-11
molecular O 0 4.547846040731107e-12
evidence O 0 1.1379367500369275e-12
for O 0 2.600165362968282e-13
an O 0 5.719504730938851e-13
expanded O 0 0.0232445877045393
syndrome O 1 1.0
. O 0 6.076967474655248e-05

In O 0 5.440760619812579e-10
a O 0 1.3711413081318735e-11
South O 0 9.991445865109583e-11
African O 0 5.245533174491612e-12
girl O 0 1.1498899749051716e-10
of O 0 4.3651701177316315e-12
Xhosa O 0 1.6120926815688108e-08
stock O 0 1.5292138388911525e-10
with O 0 1.1603875980142268e-15
severe O 0 8.567974801865219e-11
piebaldism B-Disease 0 5.2916361710231286e-06
and O 0 1.2978382812889322e-08
profound O 1 0.9999834299087524
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 2.0770707820361167e-08
identified O 0 4.18495446630196e-11
a O 0 4.447077133081477e-14
novel O 0 6.326427662989298e-12
missense O 0 1.3053740033353023e-10
substitution O 0 4.338797321423726e-09
at O 0 2.6320037815885655e-10
a O 0 1.0990962480417199e-11
highly O 0 3.3078983996404077e-09
conserved O 0 2.905550466891782e-09
residue O 0 1.956523121293685e-08
in O 0 7.480920743985209e-11
the O 0 1.1887425765966242e-10
intracellular O 0 6.885414460811035e-11
kinase O 0 7.883923514029334e-10
domain O 0 6.99515501079162e-10
of O 0 5.500517819001516e-10
the O 0 3.261444225799437e-09
KIT O 0 0.0021114875562489033
proto O 0 2.5535532586218324e-06
- O 0 1.8531924297349178e-06
oncogene O 0 6.085215318307746e-07
, O 0 5.5785848163125706e-11
R796G O 0 6.322313765849685e-07
. O 0 1.6438319150324787e-08

Though O 0 6.565933290403336e-07
auditory B-Disease 0 0.0001394579012412578
anomalies I-Disease 0 9.95110076473793e-06
have O 0 1.4225513822463398e-10
been O 0 2.3742674493121285e-11
observed O 0 2.686409705798809e-10
in O 0 1.3670238552254688e-10
mice O 0 3.1186619953160744e-10
with O 0 2.1235426611587727e-12
dominant O 0 1.6470305297389132e-07
white O 0 3.17915123559942e-07
spotting O 0 9.818521675697411e-07
( O 0 1.5603589600954315e-11
W O 0 2.2623542150768117e-08
) O 0 3.2307714988542846e-13
due O 0 7.422190861916533e-08
to O 0 1.234594648735765e-08
KIT O 1 1.0
mutations O 0 0.00018197577446699142
, O 0 5.935074796070694e-07
deafness B-Disease 1 1.0
is O 0 2.9154179070900454e-11
not O 0 1.6245565006081653e-12
typical O 0 5.096597033293904e-10
in O 0 6.524785052530735e-12
human O 0 2.102109875057323e-10
piebaldism B-Disease 0 8.625229384051636e-06
. O 0 1.480519813412684e-07

Thus O 0 3.956218408429635e-10
, O 0 5.406652637532025e-14
the O 0 3.4310384123669574e-14
occurrence O 0 4.216530249956385e-11
of O 0 1.7974008059695734e-08
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 3.907249265466817e-06
this O 0 5.7466351677248895e-09
patient O 0 1.5378712703295605e-07
extends O 0 1.8247010846739187e-10
considerably O 0 1.7547119313121584e-09
the O 0 2.308463836753205e-11
phenotypic O 0 1.38132935645352e-10
range O 0 2.206824500916582e-09
of O 0 1.9942807127915074e-10
piebaldism B-Disease 0 2.6660868002181815e-07
due O 0 3.6377261380948767e-07
to O 0 3.725041386459793e-09
KIT O 0 0.0001099912406061776
gene O 0 3.9644389993043205e-09
mutation O 0 6.773955618655236e-09
in O 0 4.036539158480679e-11
humans O 0 1.5184309365423587e-10
and O 0 1.0263479302552447e-11
tightens O 0 1.3401033616133873e-09
the O 0 1.1385414833142704e-10
clinical O 0 9.870754213991972e-10
similarity O 0 6.153335618819256e-10
between O 0 2.285106964761141e-10
piebaldism B-Disease 0 1.034347678796621e-05
and O 0 1.3836808435141457e-11
the O 0 9.967718924558389e-13
various O 0 2.9750832873653987e-13
forms O 0 1.8566523318774841e-10
of O 0 1.3579038338207283e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9998823404312134
. O 0 7.183245998021448e-09
. O 0 9.118935828666963e-09

Cycloheximide O 0 6.883138667035382e-06
facilitates O 0 7.458073048027813e-10
the O 0 2.4765965320194816e-11
identification O 0 1.155133433350386e-09
of O 0 1.359885981599973e-09
aberrant O 0 7.394692858042617e-08
transcripts O 0 1.1373791686253298e-08
resulting O 0 6.282139253244168e-09
from O 0 4.4823675326988166e-10
a O 0 3.603426931841902e-11
novel O 0 3.1468787575761326e-09
splice O 0 5.6341121990044485e-08
- O 0 3.6694167704354186e-09
site O 0 3.569445017337358e-10
mutation O 0 5.729676108567894e-11
in O 0 1.8390948486324277e-12
COL17A1 O 0 0.07531657814979553
in O 0 3.6334900366252754e-11
a O 0 7.002422947044451e-12
patient O 0 1.1385122178353413e-08
with O 0 1.6269138813918005e-11
generalized O 1 0.9884053468704224
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999791383743286
bullosa I-Disease 0 0.01068158634006977
. O 0 6.409351840375166e-07

Patients O 0 1.7717029550112784e-06
with O 0 1.541387018022533e-10
generalized O 0 0.00307651050388813
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999984502792358
bullosa I-Disease 0 0.0140824094414711
often O 0 1.3980073765296197e-09
show O 0 2.8933699186550754e-11
decreased O 0 3.1975552761132064e-10
expression O 0 2.036043035558155e-11
of O 0 1.3586790546804561e-11
type O 0 2.7888590992120044e-08
XVII O 1 0.9998878240585327
collagen O 0 1.1085191999882227e-06
, O 0 2.896927697726426e-10
a O 0 3.3652011732776543e-11
transmembrane O 0 3.615366062081904e-10
hemidesmosomal O 0 3.3328969806234454e-08
protein O 0 3.787483937589542e-10
encoded O 0 2.6749397835645894e-11
by O 0 1.7046333095072086e-11
COL17A1 O 0 0.0004165339341852814
. O 0 1.0839029584985838e-07

This O 0 2.2041364289293597e-09
report O 0 1.6017527582068425e-10
documents O 0 4.667136010994e-09
a O 0 3.538748460929497e-11
novel O 0 1.477406974537132e-09
splice O 0 4.006691867175505e-08
- O 0 2.303597090858034e-09
site O 0 5.90076654205518e-10
mutation O 0 4.4267652044016614e-11
in O 0 2.711492055190723e-12
COL17A1 O 1 0.9982245564460754
in O 0 3.819313962316606e-11
a O 0 1.0591176373420108e-11
patient O 0 8.631646153389738e-08
with O 0 3.066336420887161e-11
generalized O 1 0.9999966621398926
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9997798800468445
bullosa I-Disease 0 0.0001513527677161619
, O 0 1.609641413213847e-11
and O 0 4.631955084245798e-13
applies O 0 1.5466577671374715e-11
a O 0 4.545621284978221e-14
new O 0 3.353755207574638e-12
methodology O 0 2.8041111099774696e-10
to O 0 6.694463993567323e-12
define O 0 5.771489952621778e-10
and O 0 2.7462043056258878e-11
characterize O 0 8.459961620133072e-09
the O 0 5.906318212289818e-10
resulting O 0 2.0586870874694796e-08
mRNA O 0 3.081414590155873e-08
splice O 0 1.4710367679526826e-07
variants O 0 2.234547480384208e-08
. O 0 1.5584072698970886e-08

Mutational O 0 2.348756197534385e-06
analysis O 0 7.010689251352176e-10
of O 0 3.0230122849417285e-09
COL17A1 O 1 0.9999934434890747
identified O 0 7.354057629527233e-08
a O 0 4.3614628575383563e-10
maternally O 0 2.378598367158702e-07
inherited O 0 1.387212819281558e-06
G O 0 1.1305650104986853e-06
- O 0 3.533506287567434e-08
to O 0 3.288817440605385e-09
- O 0 4.620576419256395e-06
T O 0 8.334506674145814e-06
transversion O 0 3.146916682794654e-08
at O 0 1.1397141043423265e-11
the O 0 2.175954295219329e-12
- O 0 9.192423731929633e-12
1 O 0 9.265761768961767e-11
position O 0 2.3770270474177124e-11
of O 0 1.1377599556938733e-10
exon O 0 8.135478068993507e-09
32 O 0 7.0060943713201596e-09
. O 0 7.122833878270285e-09

This O 0 9.627212360641124e-10
acceptor O 0 2.3440767105142868e-09
splice O 0 1.2088463563486584e-08
- O 0 1.06494846274785e-09
site O 0 5.485430998319885e-10
mutation O 0 7.575660931902206e-11
led O 0 9.264909152373324e-12
to O 0 6.789696842951498e-13
the O 0 1.5793935603802822e-11
formation O 0 5.043442552477018e-09
of O 0 2.109887375922881e-09
aberrant O 0 6.983839728746943e-09
transcripts O 0 1.3815460997435025e-09
present O 0 5.838573374772338e-11
at O 0 1.8421335290508267e-10
extremely O 0 1.909844726810661e-08
low O 0 6.353963755145742e-08
levels O 0 1.8857017280993205e-08
. O 0 7.69806529632433e-09

Based O 0 1.2353130962594605e-08
on O 0 6.246926531616737e-09
our O 0 2.0268532685552287e-10
recent O 0 2.4574219395501196e-11
finding O 0 3.183745281298833e-11
that O 0 4.533813374642953e-13
cycloheximide O 0 1.1276575833107927e-06
stabilized O 0 3.115776053164154e-05
mutant O 0 2.2980211156209407e-07
COL17A1 O 0 1.5918634744593874e-05
transcripts O 0 1.8439096916011977e-09
in O 0 5.517334419197217e-12
keratinocytes O 0 5.969790439763756e-09
homozygous O 0 3.007171595070801e-11
for O 0 5.128084914172992e-13
a O 0 2.502645660151792e-12
frameshift O 0 1.0763643309985582e-08
mutation O 0 3.4829567008287654e-10
, O 0 2.8929547559591873e-12
the O 0 2.880473984334664e-11
effects O 0 4.9816744507324984e-08
of O 0 3.1572997727380425e-07
the O 0 8.241843119094483e-08
splice O 0 7.86481137993178e-08
- O 0 3.8661891466063025e-09
site O 0 6.531042373580931e-10
mutation O 0 5.721842704503599e-12
on O 0 1.2234503774660732e-12
splicing O 0 7.140632529711866e-11
of O 0 1.3173422075407615e-10
COL17A1 O 0 0.01343656424432993
transcripts O 0 1.6579509320990837e-08
were O 0 6.5483733886761986e-12
determined O 0 8.159926727369093e-12
using O 0 8.269394826017351e-13
reverse O 0 1.221830830955284e-10
transcriptase O 0 1.0227288634034881e-11
polymerase O 0 6.9030575526596305e-12
chain O 0 3.5382198473182802e-12
reaction O 0 3.4134653437156715e-11
of O 0 9.228001002226094e-11
total O 0 8.274952771614164e-12
RNA O 0 4.5787098071348176e-12
from O 0 6.133324642436377e-13
keratinocytes O 0 1.8201415930008125e-09
incubated O 0 7.254499223563471e-09
for O 0 4.424213599640847e-12
2 O 0 7.287988545989776e-10
. O 0 3.991737218544955e-10

5 O 0 5.837200944824872e-08
h O 0 1.1668674915199517e-09
in O 0 1.2965571324907721e-11
the O 0 1.976527101710257e-11
presence O 0 2.3647730995612903e-10
or O 0 2.0041810433468754e-09
absence O 0 1.0013817473009112e-06
of O 0 1.1428069157659593e-08
10 O 0 4.4502940221846643e-10
microg O 0 1.0299424957338488e-07
cycloheximide O 0 1.3085217176467268e-07
per O 0 1.8462650075434794e-08
ml O 0 2.550843873905251e-07
. O 0 2.744119242947818e-08

Using O 0 5.793442982293673e-12
this O 0 2.2392018794725743e-12
approach O 0 3.5092180272755513e-09
, O 0 4.290928029559993e-11
an O 0 1.857511323574701e-12
abnormally O 0 7.480900343637131e-09
spliced O 0 1.0336690392520609e-09
transcript O 0 1.9555828956185906e-08
was O 0 2.674355847887e-09
identified O 0 5.901945598907332e-11
that O 0 6.374045578459372e-14
contains O 0 4.626260312334818e-13
an O 0 5.1069187636078924e-15
extra O 0 1.0487230008016102e-11
264 O 0 7.617084740729752e-11
bases O 0 3.1447577181209496e-11
upstream O 0 6.976207944653368e-10
from O 0 6.338850555565045e-10
exon O 0 5.816260362223602e-09
32 O 0 1.8440705906730415e-10
, O 0 3.249266158325721e-14
resulting O 0 8.681277051392211e-12
in O 0 2.959198858176748e-12
a O 0 8.040608109882719e-12
premature O 0 2.2003703747941472e-07
termination O 0 2.342238076380454e-06
codon O 0 6.610309242205403e-07
27 O 0 1.8264356640429469e-06
bp O 0 3.6025221561430953e-07
downstream O 0 6.078440151213726e-08
from O 0 2.292926265523576e-10
the O 0 2.405365684410299e-09
cryptic O 0 6.576812552339106e-07
splice O 0 2.7994494189442776e-07
site O 0 8.984380173160389e-08
. O 0 2.0189339977605414e-08

Three O 0 9.097081310471822e-09
other O 0 1.0015123452777885e-10
splice O 0 3.387260250065083e-09
variants O 0 3.5007124976615955e-10
, O 0 4.709263794894225e-12
including O 0 6.206379811121709e-13
one O 0 1.7135178367357062e-13
derived O 0 9.430701011781117e-12
from O 0 5.677357889366519e-12
the O 0 1.4366839662383057e-10
skipping O 0 3.0506427606269426e-08
of O 0 9.892922925303083e-09
exon O 0 1.3997877523763691e-08
32 O 0 3.6736818032068186e-09
, O 0 1.9056535863204438e-11
were O 0 5.458440921479735e-10
also O 0 1.3004486376644309e-10
identified O 0 3.2355509382853143e-09
. O 0 2.5491992516890605e-08

These O 0 6.702571275774005e-10
results O 0 1.9373522230914375e-10
indicate O 0 1.221644452265025e-10
the O 0 8.627201383837324e-12
usefulness O 0 1.2550123162924365e-09
of O 0 1.457861088793866e-11
cycloheximide O 0 1.2174331764924773e-08
treatment O 0 1.6763269883313114e-08
in O 0 7.531498862067831e-12
evaluating O 0 6.216076958720507e-11
the O 0 7.964898705858925e-12
abnormal O 0 1.7308773858637494e-10
processing O 0 1.9126517258882814e-08
of O 0 3.776636336993988e-09
mRNA O 0 5.451888718255304e-09
due O 0 6.417590725504851e-07
to O 0 4.1769498970722907e-10
splice O 0 1.7994382872643655e-08
- O 0 1.7392509654712285e-09
site O 0 5.989244655779657e-10
mutations O 0 1.2829557728688545e-11
, O 0 1.5851258023183434e-13
because O 0 6.7359629159213785e-12
( O 0 1.8204166472857164e-12
i O 0 7.48433190422837e-11
) O 0 6.496468944391931e-13
aberrant O 0 3.005865834015964e-10
splicing O 0 2.007879695842263e-10
often O 0 4.555242901632672e-12
generates O 0 4.854803082980641e-13
a O 0 6.191373097801794e-14
premature O 0 1.7967691778864037e-09
termination O 0 2.7143125080897335e-08
codon O 0 3.45140738211569e-09
, O 0 3.4413794730570046e-11
( O 0 3.583689876969498e-13
ii O 0 3.484448640733717e-08
) O 0 2.453397944870983e-12
transcripts O 0 2.8275867758331685e-10
with O 0 6.208167118403052e-13
premature O 0 3.3667085119759577e-08
termination O 0 2.428494561002026e-08
codons O 0 4.1737244216299985e-10
can O 0 3.0324093930333973e-12
occur O 0 2.352221369072982e-11
at O 0 1.0403851391505015e-11
low O 0 7.21966930683493e-10
or O 0 9.206086414026426e-13
undetectable O 0 7.102449878226835e-11
levels O 0 5.668812641523857e-11
due O 0 4.2047268444811436e-10
to O 0 1.871063373681814e-11
nonsense O 0 1.1461112059407697e-09
- O 0 2.7389018136814158e-11
mediated O 0 9.114144161603832e-11
mRNA O 0 2.0866412764330988e-11
decay O 0 2.16613527115328e-09
, O 0 2.8171497253037803e-13
and O 0 6.73914320615393e-14
( O 0 1.8484896569686583e-14
iii O 0 1.8151873337757252e-09
) O 0 4.814395952214279e-13
the O 0 4.121636365539416e-11
levels O 0 4.051321944587016e-09
of O 0 1.4856547936314968e-10
these O 0 4.1155721192120964e-11
transcripts O 0 1.296911328330097e-10
can O 0 4.2781099843236525e-13
be O 0 5.065345387057774e-13
increased O 0 7.619787439905323e-11
by O 0 9.876492679250504e-11
cycloheximide O 0 3.356800152687356e-05
. O 0 4.3907141389354365e-07

A O 0 1.9675184148582048e-07
deletion O 0 5.51097230072628e-08
mutation O 0 3.5113740803893734e-09
in O 0 1.0318640386586253e-10
COL17A1 O 1 0.999908447265625
in O 0 1.6225948362702525e-10
five O 0 1.1378195477820818e-12
Austrian O 0 6.947089015163499e-10
families O 0 3.9903188392420574e-11
with O 0 4.272395805193785e-12
generalized O 0 0.0005182187887839973
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9987092018127441
bullosa I-Disease 0 0.00011462996917543933
represents O 0 2.144111110879976e-09
propagation O 0 9.51055678655166e-09
of O 0 4.32909645631252e-11
an O 0 9.965988537891102e-13
ancestral O 0 3.039920954961417e-07
allele O 0 1.048470963382897e-07
. O 0 1.503268975966421e-08

Patients O 0 2.1594141799141653e-06
with O 0 2.1635204738856828e-10
generalized O 0 0.44764915108680725
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9765690565109253
, O 0 1.1364694602056247e-10
a O 0 1.5949589739217007e-12
usually O 0 1.0097422897814567e-11
nonlethal O 0 1.695375395627252e-08
form O 0 8.252247774009902e-10
of O 0 1.325469867197171e-07
junctional B-Disease 1 0.9999940395355225
epidermolysis I-Disease 1 0.9548474550247192
bullosa I-Disease 0 0.0007592265610583127
, O 0 8.847744065176855e-11
have O 0 1.800996851653025e-12
generalized O 0 2.1871506827864096e-09
blistering B-Disease 0 7.625788356335761e-08
, O 0 1.330643095709405e-10
nail B-Disease 0 0.00962172169238329
dystrophy I-Disease 1 0.9999992847442627
, O 0 2.2354731754603563e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.9999958276748657
, O 0 2.160857492938817e-09
and O 0 2.489065025201853e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9999887943267822

Skin B-Disease 1 0.9999804496765137
fragility I-Disease 0 0.00011806141264969483
in O 0 1.5397745301015675e-09
most O 0 2.8602285470635813e-11
cases O 0 3.637428552805133e-11
is O 0 1.564010422908102e-13
due O 0 9.541549772507096e-10
to O 0 5.962001725645649e-11
mutations O 0 1.0200876948696092e-10
in O 0 6.030496241260508e-11
the O 0 1.3257335507166346e-10
gene O 0 2.645903461606647e-12
encoding O 0 1.6404638758515944e-09
type O 0 2.1351722807594342e-06
XVII O 1 0.9999914169311523
collagen O 0 1.3959683201392181e-05
( O 0 1.5309773448990427e-09
COL17A1 O 0 0.022152628749608994
) O 0 1.86974075111479e-10
. O 0 2.114948216558332e-09

Recently O 0 1.0067545872516348e-06
, O 0 1.4740819676006822e-10
we O 0 1.5489989499406498e-11
reported O 0 2.780106223357337e-12
five O 0 5.0770561935359684e-14
Austrian O 0 4.138857659374828e-11
families O 0 4.228835163988531e-12
with O 0 7.232379300482761e-13
generalized O 0 0.0009264222462661564
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999903440475464
who O 0 2.1681453077349033e-08
share O 0 3.564056827443096e-10
the O 0 7.398011370174373e-11
same O 0 1.948686323416382e-09
COL17A1 O 1 0.9994326233863831
mutation O 0 5.640283120555978e-07
. O 0 2.5342240306258645e-08

Affected O 0 3.033242364836042e-06
individuals O 0 1.2966473450504168e-09
in O 0 4.4626954909254835e-10
three O 0 6.461943393570868e-12
families O 0 6.869708794876583e-12
are O 0 2.6306799620623433e-13
homozygous O 0 1.6507093001522088e-12
for O 0 1.5128327193400515e-12
4003delTC O 0 2.319833036779073e-08
, O 0 1.4080706219055106e-11
whereas O 0 3.778069856963384e-09
those O 0 1.0130614125358761e-09
in O 0 1.9205240175956817e-10
two O 0 1.1084352186108148e-11
others O 0 2.801735926594162e-11
are O 0 6.250977925385814e-13
compound O 0 1.6096183275138287e-09
heterozygotes O 0 2.438911792523868e-07
. O 0 7.040645044753546e-08

To O 0 2.0107626674814583e-09
determine O 0 4.433958478156086e-10
if O 0 1.667971490093567e-11
the O 0 7.451012896952935e-12
occurrence O 0 5.317845816477096e-11
of O 0 6.241322736411092e-11
4003delTC O 0 1.8907726939687564e-08
in O 0 1.8624291345248345e-11
these O 0 4.6775916473507095e-12
unrelated O 0 4.124934005478309e-10
families O 0 7.070935091786634e-13
signifies O 0 6.5244368067929326e-12
propagation O 0 5.883100673287345e-10
of O 0 2.434337670678688e-12
an O 0 9.934802004500642e-14
ancestral O 0 2.948235966471202e-08
allele O 0 6.536504226772877e-09
or O 0 2.375478147520482e-10
a O 0 9.72409514021777e-11
mutational O 0 7.16306612957851e-06
hot O 0 2.9961098334752023e-05
spot O 0 3.388806391058097e-08
, O 0 1.5422597227088275e-11
haplotypes O 0 3.0032121234313536e-10
were O 0 2.4598323378199893e-11
determined O 0 2.1957013984774676e-10
for O 0 1.3148095112658353e-10
polymorphisms O 0 1.848957822403463e-07
both O 0 1.3724665848258155e-09
within O 0 7.443623495362317e-09
and O 0 2.68281152848715e-09
flanking O 0 2.505646534700645e-06
COL17A1 O 1 0.9998283386230469
. O 0 2.8916917926835595e-06

Five O 0 2.6225404070601144e-08
intragenic O 0 2.9827695016138023e-06
polymorphisms O 0 1.3659727926551568e-07
were O 0 8.717623845022615e-10
chosen O 0 3.236450552002168e-10
based O 0 4.386965790637021e-11
on O 0 5.145522896654597e-10
their O 0 3.2796826365810716e-10
informativeness O 0 6.72757323627593e-06
. O 0 1.2234556834300747e-07

One O 0 7.372927268711749e-10
of O 0 6.482835102072926e-11
these O 0 4.986626563063812e-12
, O 0 2.0137601167754399e-13
not O 0 2.66698962176834e-13
previously O 0 1.7806776886342135e-11
reported O 0 5.3979511832613625e-12
, O 0 6.805748456115146e-13
was O 0 1.563496832002187e-10
2988 O 0 2.1374489733716473e-07
A O 0 3.119944835816568e-07
or O 0 4.202085435167646e-08
C O 0 0.00011166671174578369
that O 0 2.8221958190549623e-12
introduces O 0 1.4311048179838082e-10
a O 0 7.641028651819703e-13
new O 0 1.9026754130568868e-11
restriction O 0 6.174607047881864e-09
site O 0 3.4195535292269597e-10
for O 0 1.6327706547913934e-11
Eco0109 O 0 1.5367056676041102e-06
I O 0 9.905415936373174e-06
. O 0 3.9601026458058186e-08

All O 0 2.412666733064839e-09
the O 0 4.659342356383434e-10
4003delTC O 0 9.086350871712057e-08
alleles O 0 2.9136904000637287e-10
showed O 0 1.7712144251280648e-10
the O 0 3.6170174928101817e-12
same O 0 1.4253588760670954e-11
haplotype O 0 1.369088620251091e-09
for O 0 1.3562141860934407e-11
these O 0 9.57655135747082e-11
five O 0 7.953694994289329e-12
polymorphic O 0 1.088736478749297e-08
markers O 0 2.0150984880729084e-08
. O 0 1.7582571842922334e-08

Fourteen O 0 1.1782650517488946e-06
microsatellite O 0 5.594068852587952e-07
polymorphisms O 0 3.4680257954278204e-07
were O 0 9.958954771960293e-10
selected O 0 3.7150632570259745e-10
based O 0 3.514197613463388e-11
on O 0 4.5202119824949705e-10
their O 0 5.226919591594381e-11
high O 0 7.499072474104196e-09
heterozygosity O 0 2.0586348625784012e-07
and O 0 4.19340812074509e-11
their O 0 2.40788344124665e-11
location O 0 6.997596946334284e-10
within O 0 1.019574646932142e-09
10q23 O 0 6.380998343047395e-07
- O 0 5.53226726651701e-08
q25 O 0 9.767313713382464e-07
near O 0 6.631063342865673e-08
COL17A1 O 0 0.006846179254353046
. O 0 2.0849105908382626e-07

Three O 0 8.154072972388349e-09
families O 0 7.898718901167001e-10
shared O 0 3.3679770083949734e-10
microsatellite O 0 4.3484430278795116e-08
polymorphisms O 0 5.162190319651927e-08
covering O 0 2.702187584802118e-09
at O 0 5.17899001462041e-10
most O 0 3.1610020156946916e-10
19 O 0 7.099230092677544e-10
cM O 0 4.750523308061361e-10
, O 0 1.9947502850892196e-12
whereas O 0 9.290023611496778e-11
the O 0 6.29249763406392e-10
others O 0 5.733297170351648e-10
shared O 0 1.3770966311721367e-10
smaller O 0 2.8818053499080065e-10
regions O 0 6.689672149562398e-10
consistent O 0 4.440941225869466e-10
with O 0 1.1984869748103005e-13
cross O 0 2.6036022296449524e-11
- O 0 7.885152947251228e-11
over O 0 6.404884868999039e-12
events O 0 2.333669011072431e-13
during O 0 1.2853308912000316e-12
passage O 0 3.463220682453638e-11
of O 0 2.7225045134970927e-12
this O 0 1.0391059540593162e-11
mutation O 0 3.4975338597531547e-11
through O 0 2.975426849349816e-11
several O 0 5.52303341949667e-11
generations O 0 5.3126201216002755e-09
. O 0 1.2415418915168175e-08

These O 0 3.2735096855418533e-09
results O 0 1.3839092094514172e-09
indicate O 0 7.43862416108243e-10
that O 0 1.2779314282132526e-12
4003delTC O 0 9.538352330196176e-09
occurs O 0 3.3092265039336155e-11
on O 0 2.5295778926376355e-12
a O 0 1.0780752104835173e-13
single O 0 8.759250269552155e-12
ancestral O 0 1.1813750866451755e-08
allele O 0 2.2420429957037413e-09
. O 0 3.6041916673390517e-10
. O 0 1.7558769993542e-09

The O 0 9.218320684567516e-08
haptoglobin O 0 1.2821103155147284e-05
- O 0 5.028441592003219e-07
gene O 0 7.877474783590799e-10
deletion O 0 1.2440658503365398e-09
responsible O 0 9.309481657782115e-11
for O 0 8.994964495467883e-11
anhaptoglobinemia B-Disease 0 0.01756332628428936
. O 0 3.611690090110642e-06

We O 0 2.363517559444972e-08
have O 0 4.287574115191539e-11
found O 0 1.6751984998827907e-12
an O 0 1.472106501098063e-14
allelic O 0 3.749925370222229e-10
deletion O 0 2.0900202402085455e-10
of O 0 2.780617958109133e-10
the O 0 9.145027846102494e-09
haptoglobin O 0 1.158939085144084e-05
( O 0 1.4830209976723907e-11
Hp O 0 3.4068128873521175e-10
) O 0 1.1375939253099876e-12
gene O 0 2.35538975476568e-12
from O 0 1.7388411890917332e-11
an O 0 1.559896011188791e-13
individual O 0 9.274598450348392e-12
with O 0 5.431589206184029e-12
anhaptoglobinemia B-Disease 0 0.0001325273624388501
. O 0 2.643510924826842e-06

The O 0 7.19380679470305e-08
Hp O 0 2.224986772603188e-08
gene O 0 9.735898198748316e-11
cluster O 0 1.0408862660682416e-09
consists O 0 2.6583384798994913e-11
of O 0 2.908203539098153e-11
coding O 0 8.182677646573211e-09
regions O 0 4.0554632505518384e-06
of O 1 0.9768968224525452
the O 1 0.7922787666320801
alpha O 0 1.443814880985883e-06
chain O 0 1.374758362704398e-10
and O 0 1.856271646810681e-12
beta O 0 7.150128145810841e-12
chain O 0 1.7004304865217423e-12
of O 0 2.4285499826415258e-12
the O 0 4.3693375306741444e-11
haptoglobin O 0 8.097565284970187e-09
gene O 0 8.63787080057632e-12
( O 0 6.457748019054327e-14
Hp O 0 5.471225035524885e-12
) O 0 3.097746194215441e-14
and O 0 5.352347254641843e-13
of O 0 4.8427015869600964e-11
the O 0 3.622496469457559e-10
alpha O 0 1.4798013925343412e-09
chain O 0 7.894964543231353e-11
and O 0 7.0026098634989875e-12
beta O 0 5.3764274282608326e-11
chain O 0 9.194141975532588e-12
of O 0 1.06179561670805e-11
the O 0 4.570248693380741e-11
haptoglobin O 0 5.200376307357146e-08
- O 0 1.7395629381411482e-09
related O 0 2.9065331474953382e-08
gene O 0 1.5407256026556126e-10
( O 0 2.500923079740147e-12
Hpr O 0 2.2900744411913365e-08
) O 0 5.634903893318721e-13
, O 0 1.1156908730214354e-12
in O 0 1.5038402814693264e-11
tandem O 0 1.1573827451982766e-09
from O 0 1.1345700073883691e-10
the O 0 1.0076544931791886e-08
5 O 0 2.51600411615982e-08
side O 0 2.47697364841315e-08
. O 0 3.814951554659274e-08

Southern O 0 2.3360989871434867e-06
blot O 0 2.0723161924252054e-06
and O 0 2.7476673714055266e-10
PCR O 0 1.4428670702670843e-08
analyses O 0 7.371113164289511e-10
have O 0 1.6131627283977323e-12
indicated O 0 5.492157076347759e-12
that O 0 5.36983694340268e-15
the O 0 8.065455855271741e-13
individual O 0 8.737049305611658e-14
with O 0 3.731225194807987e-14
anhaptoglobinemia B-Disease 0 1.2572818341993752e-08
was O 0 6.418833242705091e-10
homozygous O 0 4.089140484553333e-11
for O 0 1.2835725538007381e-11
the O 0 2.2909678321081373e-10
gene O 0 3.6000312973738513e-12
deletion O 0 3.361172798421741e-11
and O 0 7.976513546892328e-12
that O 0 5.599558360394608e-13
the O 0 1.3172593571475488e-10
gene O 0 1.4572821031497152e-12
deletion O 0 1.4016103382086254e-11
was O 0 4.475044293461572e-11
included O 0 6.007349132031159e-12
at O 0 6.845380165487747e-12
least O 0 5.491902505677659e-13
from O 0 1.9831191810232296e-12
the O 0 3.3922805536823475e-11
promoter O 0 7.096336851475371e-09
region O 0 4.226180294608639e-09
of O 0 1.0553080187492014e-08
Hp O 0 1.52729739966162e-08
to O 0 5.1069267925640816e-08
Hpr O 0 9.089623745239805e-06
alpha O 0 3.2418581152882098e-09
but O 0 8.518742135310564e-12
not O 0 3.122980389916319e-12
to O 0 1.640503843880481e-10
Hpr O 0 5.300373686623061e-06
beta O 0 5.9648186834238e-08
( O 0 3.752535435164184e-11
Hpdel O 0 1.1246622761973413e-06
) O 0 9.591138300235613e-11
. O 0 5.130864177971262e-09

In O 0 2.8115405559248074e-09
addition O 0 3.9255054762321606e-10
, O 0 3.8603273355697354e-11
we O 0 1.6621978099484735e-11
found O 0 1.888405404271154e-11
seven O 0 2.538519524794558e-12
individuals O 0 9.082234882782161e-14
with O 0 4.051468633237826e-13
hypohaptoglobinemia B-Disease 0 1.1788686151703587e-06
in O 0 9.193734662460429e-09
three O 0 8.530225831249183e-11
families O 0 9.860304933662078e-11
, O 0 1.0455728080213667e-12
and O 0 4.349603576619954e-12
the O 0 2.5847662898925705e-10
genotypes O 0 4.53173250036798e-08
of O 0 4.9622144615568686e-08
six O 0 4.567601297189583e-10
of O 0 1.7971495402946402e-09
the O 0 7.962127068772418e-10
seven O 0 1.0831920430054431e-11
individuals O 0 1.0192750641993889e-13
were O 0 9.284846329282725e-12
found O 0 6.802373876853285e-13
to O 0 1.8651512626033373e-12
be O 0 4.1763123515003997e-10
Hp2 O 0 0.0010426947847008705
/ O 0 6.560614565387368e-06
Hpdel O 0 0.00012892250379081815
. O 0 3.257998741901247e-07

The O 0 1.9135536888370552e-07
phenotypes O 0 3.729579134414962e-07
and O 0 3.195191444760326e-09
genotypes O 0 2.861356840355711e-08
in O 0 2.8776571403543727e-11
one O 0 6.918251778745277e-13
of O 0 4.631330475374229e-12
these O 0 1.8986361961792486e-12
three O 0 2.128236822884766e-13
families O 0 2.2284734821353958e-12
showed O 0 1.3131397011423296e-11
the O 0 5.851785028765377e-11
father O 0 1.9155421693284325e-09
to O 0 7.523060646663637e-11
be O 0 1.0105453362996286e-08
hypohaptoglobinemic B-Disease 0 0.02088276669383049
( O 0 4.591340155291057e-11
Hp2 O 0 2.3092077583442006e-07
) O 0 6.685911047889237e-13
and O 0 4.595595605449976e-12
Hp2 O 0 1.1725845183718775e-07
/ O 0 1.424414475259539e-09
Hpdel O 0 5.076215074950596e-07
, O 0 1.5055191468493767e-11
the O 0 3.562955486202668e-10
mother O 0 3.033142625952223e-09
to O 0 4.7669677233352914e-11
be O 0 7.156780168493526e-10
Hp2 O 0 4.51427222287748e-05
- O 0 5.273320979881646e-08
1 O 0 8.147233110378238e-09
and O 0 2.974229543206697e-11
Hp1 O 0 2.789758752896887e-07
/ O 0 1.5830141641970386e-09
Hp2 O 0 4.2542305322967877e-07
, O 0 4.965660261452287e-12
one O 0 9.66849213537846e-13
of O 0 1.470859892216403e-11
the O 0 9.340055812101511e-11
two O 0 2.4946342734588622e-12
children O 0 2.2520858875690886e-12
to O 0 3.5644746702867547e-12
be O 0 7.927077882996514e-10
hypohaptoglobinemic B-Disease 0 0.0007054522866383195
( O 0 1.8671819645987853e-10
Hp2 O 0 3.518989842632436e-06
) O 0 1.0323754004448737e-11
and O 0 9.565433861657979e-11
Hp2 O 0 4.073184754815884e-06
/ O 0 2.6079998605155197e-08
Hpdel O 0 1.7505411960883066e-05
, O 0 1.47334269784416e-10
and O 0 5.124706908832266e-11
the O 0 6.30508756316317e-10
other O 0 1.2709999719362486e-10
child O 0 5.108548584153993e-10
to O 0 8.07146276898818e-12
be O 0 2.4972315881832685e-10
Hp1 O 0 1.0206695151282474e-05
and O 0 4.362153416259673e-10
Hp1 O 0 2.1265408577164635e-05
/ O 0 8.371968363007909e-08
Hpdel O 0 1.1364184047124581e-06
, O 0 4.1139374892806835e-12
showing O 0 1.5692261726152346e-11
an O 0 7.222519159350363e-14
anomalous O 0 7.724896136096504e-07
inheritance O 0 5.6573786423541605e-05
of O 0 6.168959316710243e-07
Hp O 0 1.5517548490606714e-07
phenotypes O 0 1.1099600669695064e-06
in O 0 2.3218138522906884e-10
the O 0 3.3555505596361e-10
child O 0 6.858639767237662e-10
with O 0 2.9605254879550014e-12
Hp1 O 0 5.2826238970737904e-05
. O 0 3.686480170017603e-07

The O 0 3.142100268860304e-08
Hp2 O 0 2.8894130082335323e-05
/ O 0 3.100061292116152e-07
Hpdel O 0 5.8639884628064465e-06
individuals O 0 3.3122702497445644e-11
had O 0 6.599207985624744e-11
an O 0 4.892195657369043e-14
extremely O 0 3.123221958833966e-10
low O 0 9.518070775982324e-09
level O 0 1.1489346141146939e-09
of O 0 5.044142326049439e-10
Hp O 0 6.006693809013086e-09
( O 0 2.0071550324574083e-11
mean O 0 9.595320094035742e-09
+ O 0 1.4481786603237623e-10
/ O 0 8.789479560844526e-11
- O 0 2.620407779652112e-10
SD O 0 2.6169129085928944e-09
= O 0 3.237159151847635e-11
0 O 0 2.6590282059535397e-11
. O 0 1.0930329991803989e-12
049 O 0 1.4673140480425673e-09
+ O 0 1.028754685605815e-11
/ O 0 3.760789943352272e-11
- O 0 1.547499350884607e-10
0 O 0 3.366908835067406e-11
. O 0 1.0702003519491576e-12
043 O 0 1.3188489189630559e-09
mg O 0 8.783211657981127e-11
/ O 0 1.4372780743343583e-11
ml O 0 2.5789493804384556e-11
; O 0 1.2330906695029453e-12
n O 0 1.2927042249144538e-12
= O 0 3.2375819148007523e-13
6 O 0 2.1786246851701607e-12
) O 0 1.2209284308862807e-15
, O 0 1.1999387215192586e-14
compared O 0 2.619225799790903e-12
with O 0 5.04520978759828e-14
the O 0 3.5941344345147286e-10
level O 0 1.88027122760559e-08
( O 0 1.7663569717128735e-13
1 O 0 4.781164006373295e-11
. O 0 1.5618916750226308e-12
64 O 0 4.307327758357182e-11
+ O 0 4.661489076684955e-12
/ O 0 2.7049642040144484e-11
- O 0 5.936708069587127e-11
1 O 0 2.4722829686241177e-11
. O 0 5.029963533360882e-13
07 O 0 7.761512960113848e-11
mg O 0 1.6554689563630376e-10
/ O 0 2.29836340931433e-11
ml O 0 1.5694745850169944e-11
) O 0 7.405902978277045e-15
obtained O 0 1.9024495520603146e-12
from O 0 3.592460356971472e-11
52 O 0 1.4599196518361168e-08
healthy O 0 3.4257585213026687e-08
volunteers O 0 7.993244399706612e-10
having O 0 1.602687982327211e-10
phenotype O 0 2.562694305652258e-07
Hp2 O 0 1.3158016372472048e-05
, O 0 1.0860081584018744e-10
whereas O 0 1.3608277837917626e-09
the O 0 6.060996843304522e-11
serum O 0 7.855373573839586e-10
Hp O 0 1.9446196042327557e-10
level O 0 1.840654850759904e-10
of O 0 8.748898307209263e-12
an O 0 1.4060529236953941e-14
individual O 0 3.0395648563212585e-13
with O 0 2.3081577339538473e-13
Hp1 O 0 5.571108431468019e-06
/ O 0 1.4638993661719724e-07
Hpdel O 0 1.9402073121455032e-06
was O 0 1.4745615395383993e-08
0 O 0 1.9679044171994065e-08
. O 0 1.2268241977864136e-09

50 O 0 2.8206033064748226e-08
mg O 0 3.984406138357599e-09
/ O 0 6.732386315100314e-10
ml O 0 1.136355121111876e-09
, O 0 6.773063013221226e-13
which O 0 1.7407467272647324e-14
was O 0 1.1611510364328836e-12
approximately O 0 9.534616883999023e-14
half O 0 8.036464289179479e-13
the O 0 5.2040767528627185e-12
level O 0 2.861377357277206e-09
of O 0 4.6250409058146147e-10
Hp O 0 5.83192050207515e-10
in O 0 2.4055893388386096e-10
control O 0 3.542939053247096e-09
sera O 0 4.991703717038831e-10
from O 0 3.837874896356341e-12
the O 0 1.5779098860857488e-10
Hp1 O 0 3.0491762572637526e-06
phenotype O 0 3.1151220269975965e-08
( O 0 5.592119107188098e-13
1 O 0 2.7863451129706007e-11
. O 0 1.1325061981953821e-12
26 O 0 1.3208797944308515e-10
+ O 0 1.4327536553004894e-11
/ O 0 4.175012419116442e-11
- O 0 2.367056550767188e-10
0 O 0 3.5159743172474833e-11
. O 0 4.918264146641649e-13
33 O 0 1.0767159733249265e-11
mg O 0 5.1007930518265354e-12
/ O 0 2.0447049001864892e-12
ml O 0 5.4411804922827045e-12
; O 0 2.2264415517388864e-13
n O 0 1.1914334536317073e-12
= O 0 6.413585483013018e-13
9 O 0 9.778212961553123e-12
) O 0 3.76129317036962e-14
, O 0 3.9343823880245987e-13
showing O 0 2.8206529126273416e-11
a O 0 5.900400827651975e-12
gene O 0 7.194043277758411e-11
- O 0 7.399429957644088e-09
dosage O 0 2.756047706498066e-06
effect O 0 3.9851493056630716e-06
. O 0 3.130770380721515e-07

The O 0 5.558275262274037e-08
other O 0 1.304764851717266e-09
allele O 0 6.505977423465481e-10
( O 0 1.044653838259968e-12
Hp2 O 0 4.188618163425417e-08
) O 0 3.307891612534808e-13
of O 0 1.634646411285967e-11
individuals O 0 6.206214470290405e-13
with O 0 1.4259046417566812e-12
Hp2 O 0 0.0009347719606012106
/ O 0 4.886988449470664e-07
Hpdel O 0 1.6583562683081254e-05
was O 0 3.2886293688250134e-09
found O 0 5.991546668526748e-12
to O 0 1.2791873680098598e-12
have O 0 1.5705968426857342e-12
, O 0 1.9490243024101322e-13
in O 0 5.749246564934474e-12
all O 0 9.059981237458103e-11
exons O 0 3.2494648638525803e-10
, O 0 1.6882921926794636e-12
no O 0 2.4958066863201012e-11
mutation O 0 2.039214283544588e-11
, O 0 1.6437399401672548e-13
by O 0 8.028282357484817e-13
DNA O 0 1.3559802169993418e-09
sequencing O 0 2.005903496637984e-07
. O 0 8.674457774304756e-08

On O 0 4.793788477286398e-09
the O 0 1.1891885913495326e-11
basis O 0 3.1034817077335575e-11
of O 0 3.339431812673932e-12
the O 0 3.2098035167293926e-12
present O 0 3.140903162557329e-11
study O 0 1.147109490728937e-11
, O 0 3.451819857508073e-14
the O 0 4.161556082377116e-13
mechanism O 0 3.6156971860989984e-10
of O 0 1.2744987287760523e-09
anhaptoglobinemia B-Disease 0 5.042366319685243e-05
and O 0 1.7409561292591746e-10
the O 0 3.2113790793264485e-11
mechanism O 0 3.705862838820906e-10
of O 0 7.613221164604056e-11
anomalous O 0 8.749213407099887e-07
inheritance O 0 1.2479150655053672e-06
of O 0 8.39803337981948e-09
Hp O 0 1.4268136006023724e-08
phenotypes O 0 3.438449311943259e-07
were O 0 4.374194784162455e-09
well O 0 3.1953725776467934e-10
explained O 0 7.434556970054018e-09
. O 0 1.1666232424545342e-08

However O 0 1.17367640939392e-07
, O 0 1.7199177845816926e-11
the O 0 1.180566928937754e-11
mechanism O 0 3.83719989116571e-09
of O 0 2.8735078760888655e-09
hypohaptoglobinemia B-Disease 0 0.03476959094405174
remains O 0 2.9690772862522863e-05
unknown O 0 5.102806426293682e-06

ATM O 0 2.20012752834009e-05
mutations O 0 2.872227256034421e-08
and O 0 1.4697389139062267e-10
phenotypes O 0 6.227811013559403e-07
in O 0 3.485519357582234e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.1133278096385766e-06
in O 0 3.76853027950208e-11
the O 0 8.202103926602256e-12
British O 0 4.8941815877778794e-11
Isles O 0 1.7940886110068277e-08
: O 0 2.654861139955722e-12
expression O 0 3.497173731159542e-11
of O 0 7.648381060432197e-12
mutant O 0 2.8635583487757188e-11
ATM O 0 4.180137902487502e-10
and O 0 5.974172166082342e-14
the O 0 1.214869134111285e-13
risk O 0 9.118360363644107e-13
of O 0 2.872752816879265e-12
leukemia B-Disease 0 0.0016188371228054166
, O 0 1.267710914021336e-08
lymphoma B-Disease 1 1.0
, O 0 8.093428505162592e-07
and O 0 0.00016397784929722548
breast B-Disease 1 0.9999998807907104
cancer I-Disease 0 0.08812772482633591
. O 0 2.460796849845792e-06

We O 0 7.150039449399515e-10
report O 0 1.7488328493686645e-11
the O 0 4.8656235290822636e-12
spectrum O 0 1.5572950706754796e-09
of O 0 2.347909193456399e-11
59 O 0 1.3770572182547625e-10
ATM O 0 2.5763841060566506e-10
mutations O 0 6.727151388025154e-13
observed O 0 5.508480824256701e-12
in O 0 3.074309917749929e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.088175617449451e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.335597399295903e-12
patients O 0 9.70849622916603e-10
in O 0 3.187940905181874e-13
the O 0 3.490840862901967e-12
British O 0 2.8842633836845266e-10
Isles O 0 4.462001967908691e-08
. O 0 1.574403185600204e-08

Of O 0 2.552675323386211e-05
51 O 0 3.946051947423257e-06
ATM O 0 9.328428859589621e-06
mutations O 0 6.1760441205649386e-09
identified O 0 9.834258962726494e-10
in O 0 5.204776609701867e-10
families O 0 7.78990372207744e-10
native O 0 5.110046413792091e-11
to O 0 2.5557813244231342e-12
the O 0 3.163214135071257e-11
British O 0 6.809004471364233e-10
Isles O 0 8.401289619541785e-08
, O 0 4.3004485389408487e-11
11 O 0 1.5906768957574258e-10
were O 0 4.987696922142959e-10
founder O 0 9.898283970244393e-09
mutations O 0 7.847373445502015e-11
, O 0 2.515942836012197e-11
and O 0 1.871663067587459e-11
2 O 0 4.0665093514746786e-10
of O 0 2.7185153433917364e-11
these O 0 4.0592845057529914e-11
11 O 0 7.121695160677843e-12
conferred O 0 1.8737891793740857e-10
a O 0 1.0854210325678126e-12
milder O 0 9.493249990555341e-07
clinical O 0 3.924362168561402e-09
phenotype O 0 4.184136592755294e-09
with O 0 1.269159202645781e-13
respect O 0 7.110121519326995e-11
to O 0 9.036889986324681e-11
both O 0 4.1230425296134854e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 2.7264859454589896e-06
cellular O 0 4.768693884216191e-08
features O 0 9.611104134776838e-10
. O 0 2.7315121275961474e-09

We O 0 1.9179249854950342e-10
report O 0 5.925968483283528e-12
, O 0 1.281071738490694e-13
in O 0 1.265806171902098e-13
two O 0 5.029682657235572e-14
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
families O 0 3.899895517633922e-09
, O 0 4.058018840662897e-13
an O 0 3.257705655798984e-14
ATM O 0 4.551723442602906e-09
mutation O 0 4.950862289576641e-11
( O 0 1.1812436879338195e-13
7271T O 0 9.775146248003352e-10
- O 0 5.347038922742797e-10
- O 0 1.7601958779422944e-09
> O 0 1.2851882891240507e-09
G O 0 2.927968978383433e-10
) O 0 8.305833027208258e-16
that O 0 2.6957996157604463e-16
may O 0 3.4292669615423876e-13
be O 0 5.242206950646644e-14
associated O 0 6.707219415286181e-12
with O 0 1.1328794618983146e-13
an O 0 1.4116045470382883e-14
increased O 0 9.20891030098403e-10
risk O 0 6.758855253252705e-09
of O 0 6.743856317825703e-08
breast B-Disease 0 0.007393496576696634
cancer I-Disease 0 4.180639280093601e-06
in O 0 5.5884199490208175e-09
both O 0 5.262537072781015e-09
homozygotes O 0 3.563014274732268e-07
and O 0 1.2730645704284171e-10
heterozygotes O 0 5.513376866161934e-09
( O 0 5.01393848315046e-13
relative O 0 1.0082249479737015e-09
risk O 0 6.631370452758745e-11
12 O 0 2.0768803343784725e-12
. O 0 3.0726736801635346e-13
7 O 0 1.8751182898069096e-11
; O 0 1.5616622578429329e-12
P O 0 1.650003467190686e-09
= O 0 9.915024530571248e-13
. O 0 5.918611954702779e-13
0025 O 0 1.2459291931499195e-10
) O 0 9.622079346198486e-16
, O 0 1.3715542881932632e-15
although O 0 5.5265972462477386e-14
there O 0 6.026922667531909e-14
is O 0 2.292422038668537e-15
a O 0 8.230366393838576e-14
less O 0 7.145690705812058e-10
severe O 0 0.00019978855561930686
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.5884496324124484e-08
in O 0 1.3171267462114278e-13
terms O 0 2.463534476242202e-13
of O 0 1.0651449476118194e-14
the O 0 3.0550299838722275e-14
degree O 0 7.343338437326707e-11
of O 0 4.777683804135791e-10
cerebellar B-Disease 1 0.9999995231628418
degeneration I-Disease 1 1.0
. O 0 3.0003870051587e-05

This O 0 4.781540163811826e-10
mutation O 0 1.1639017527542705e-10
( O 0 9.942402939356124e-14
7271T O 0 2.3051739683754846e-10
- O 0 8.297589004779837e-11
- O 0 2.264035486865268e-10
> O 0 4.477232196098413e-10
G O 0 5.212018594491497e-10
) O 0 7.140985800726737e-15
also O 0 6.497131493563273e-15
allows O 0 5.284105350679283e-15
expression O 0 1.695536072654491e-13
of O 0 8.897488865469705e-13
full O 0 1.9659909551023036e-12
- O 0 4.313829241736622e-12
length O 0 2.0242944473447544e-11
ATM O 0 1.5187040514064165e-09
protein O 0 1.0058517387057098e-11
at O 0 1.7992766564861595e-12
a O 0 1.662370463723431e-13
level O 0 5.609492037539354e-12
comparable O 0 1.4293152772459905e-10
with O 0 5.5255330340528083e-14
that O 0 1.9623110645086705e-13
in O 0 8.964682468581842e-11
unaffected O 0 6.803414862588397e-07
individuals O 0 1.527170612192208e-10
. O 0 7.715204475289283e-09

In O 0 1.802060445310616e-10
addition O 0 4.658220337239172e-11
, O 0 3.2513028727643167e-12
we O 0 4.29657476047271e-13
have O 0 9.084106486782415e-14
studied O 0 6.943694230709951e-11
18 O 0 6.263053409227837e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.440979344304651e-05
, O 0 3.61712443580197e-14
in O 0 1.8587248642901004e-14
15 O 0 8.19928435043249e-13
families O 0 3.49763729264041e-13
, O 0 9.799449527661194e-14
who O 0 4.897846993430488e-13
developed O 0 4.414173027100787e-09
leukemia B-Disease 1 1.0
, O 0 3.7548147702182177e-06
lymphoma B-Disease 1 1.0
, O 0 5.6641631829279504e-08
preleukemic O 0 0.014535163529217243
T O 0 0.0009061719756573439
- O 0 3.2895030699364725e-08
cell O 0 2.272785071255612e-09
proliferation O 0 2.2345250094701896e-09
, O 0 5.374914922862128e-13
or O 0 3.3536389221211493e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.3601389287364327e-08
mostly O 0 2.7434990390595715e-10
in O 0 3.2809199801420164e-11
childhood O 0 1.8754679587118517e-08
. O 0 8.588074251747457e-09

A O 0 3.3643577808106784e-06
wide O 0 1.011114463267404e-07
variety O 0 6.615459735570539e-09
of O 0 1.9765742376165463e-09
ATM O 0 5.108368554829212e-07
mutation O 0 1.8759753750430264e-09
types O 0 3.3342180127959864e-09
, O 0 1.9352904695457696e-11
including O 0 2.4604482340429e-10
missense O 0 5.225611516834761e-07
mutations O 0 5.4969024887441265e-09
and O 0 2.1283334816768473e-10
in O 0 2.3001976712233585e-10
- O 0 1.971371066389338e-09
frame O 0 6.302433686045106e-09
deletions O 0 5.652084134055713e-09
, O 0 1.5435958067300248e-11
were O 0 5.4228760371088924e-11
seen O 0 3.1015778834131424e-10
in O 0 2.2996306248135312e-11
these O 0 4.564179312271932e-10
patients O 0 2.2497291141121423e-08
. O 0 4.3382843983863495e-09

We O 0 5.396755042852419e-09
also O 0 5.407163432280537e-12
show O 0 3.981572016531487e-13
that O 0 1.0196220512462316e-15
25 O 0 6.520664000073118e-13
% O 0 6.052658916601283e-14
of O 0 2.597865228059354e-13
all O 0 1.6411226544388313e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.04718437045812607
carried O 0 1.3113276089993242e-11
in O 0 2.6175927744787053e-12
- O 0 5.28697918777965e-11
frame O 0 5.269015446174308e-09
deletions O 0 6.293102927656946e-08
or O 0 1.59763914098221e-07
missense O 0 7.988052175278426e-07
mutations O 0 5.437638117555821e-10
, O 0 5.028584753458132e-12
many O 0 9.767619655806636e-13
of O 0 9.483873105245455e-13
which O 0 2.113270496095776e-13
were O 0 1.764850071639401e-11
also O 0 1.7619556529936686e-13
associated O 0 9.347500204426318e-12
with O 0 8.761083763846045e-13
expression O 0 1.0046831144805424e-09
of O 0 1.149002559763801e-09
mutant O 0 8.195172540581552e-09
ATM O 0 7.120573854990653e-07
protein O 0 4.3089862344913854e-08
. O 0 9.604511852501219e-09

The O 0 2.0290601199235425e-08
DMPK O 0 0.04385264590382576
gene O 0 5.737996389143518e-08
of O 0 4.725036362174251e-08
severely O 1 0.9999959468841553
affected O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999147653579712
is O 0 1.7828051535051515e-11
hypermethylated O 0 2.386015474087344e-08
proximal O 0 1.4883868288961821e-06
to O 0 4.471556458440773e-10
the O 0 9.793364341703636e-09
largely O 0 7.989502393002113e-08
expanded O 0 7.704150561949064e-08
CTG O 0 6.392252544173971e-05
repeat O 0 2.208708593798292e-07
. O 0 4.055731039898092e-08

Using O 0 3.13925929695813e-09
methylation O 0 1.922571470913681e-07
- O 0 1.5639494677088805e-07
sensitive O 0 5.562761202781985e-07
restriction O 0 3.7958191256848295e-08
enzymes O 0 2.649573671575922e-09
, O 0 1.1336349393931133e-11
we O 0 2.2004115109858224e-12
characterized O 0 1.2934818147125604e-11
the O 0 5.817116753570328e-12
methylation O 0 5.571386060831962e-11
pattern O 0 5.189115248604992e-10
on O 0 8.287751041002878e-11
the O 0 1.2750396224947558e-11
5 O 0 2.7035920377449507e-11
side O 0 3.051918787133623e-11
of O 0 6.478755726346819e-11
the O 0 1.5866958857913005e-09
CTG O 0 2.165031219192315e-06
repeat O 0 1.8692283276777744e-09
in O 0 1.5582866941254991e-10
the O 0 2.9371588494697676e-10
DMPK O 0 1.0226864105788991e-05
gene O 0 5.014843054707008e-11
of O 0 5.032204514199279e-11
normal O 0 3.3264808685373737e-09
individuals O 0 7.186068146786129e-13
and O 0 5.553196249195869e-13
of O 0 2.8233547444411755e-11
patients O 0 1.5008138731786858e-08
affected O 0 2.1631625379825437e-09
with O 0 2.1965194108020114e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.788321406046236e-10
showing O 0 5.424262081166198e-11
expansions O 0 4.026514677235582e-10
of O 0 8.710505927655987e-11
the O 0 3.2202746025333795e-10
repetitive O 0 6.075566005847577e-08
sequence O 0 4.334931857918889e-10
. O 0 1.7762967763346182e-09

The O 0 1.0614776613238064e-07
gene O 0 4.620693827561695e-10
segment O 0 1.6734990060385257e-09
analyzed O 0 1.1545533973311706e-10
corresponds O 0 1.225605034127497e-10
to O 0 8.794371481046781e-12
the O 0 3.4992239661413294e-10
genomic O 0 2.1065911681716898e-08
SacI O 0 2.3514501208410366e-06
- O 0 1.525779613764655e-09
HindIII O 0 1.5601409941723432e-08
fragment O 0 3.1750205242708773e-10
carrying O 0 7.293436687927368e-11
exons O 0 1.952577877162298e-09
11 O 0 2.3493440526323184e-10
- O 0 1.8708332660821725e-09
15 O 0 1.2840439822525695e-09
. O 0 2.0304371517454456e-09

There O 0 2.0914088239010198e-09
is O 0 1.5380178033930214e-11
constitutive O 0 4.395280939206714e-08
methylation O 0 4.005477194368723e-07
in O 0 7.499546939016e-08
intron O 0 8.53627398100798e-07
12 O 0 1.914344238684862e-09
at O 0 2.0187037805263763e-11
restriction O 0 9.889862262468796e-10
sites O 0 2.2751217576555405e-10
of O 0 1.588778830718951e-10
SacII O 0 3.555597686499823e-06
and O 0 1.250119452400611e-09
HhaI O 0 8.378432539757341e-06
, O 0 2.5605495154734648e-11
localized O 0 1.0042424669620686e-09
1 O 0 6.066574465002361e-10
, O 0 3.8451560728861023e-13
159 O 0 1.0996818733399749e-10
- O 0 4.7218937093695956e-11
1 O 0 4.392812502640453e-10
, O 0 2.8289109336304685e-12
232 O 0 3.684528793179709e-10
bp O 0 3.2029283669743336e-09
upstream O 0 1.883392997115152e-09
of O 0 8.093978265399926e-10
the O 0 8.15833534062449e-09
CTG O 0 8.202296157833189e-06
repeat O 0 1.451537201546671e-08
, O 0 4.0852272953362245e-11
whereas O 0 1.8836254778165085e-10
most O 0 5.0934850087669403e-11
, O 0 5.040672198218521e-13
if O 0 6.784324079085746e-13
not O 0 1.4292981728725174e-11
all O 0 2.0853999083136898e-11
, O 0 3.266961571060656e-12
of O 0 4.767158889862344e-11
the O 0 3.2425909179956136e-11
other O 0 4.81188266315824e-12
sites O 0 1.3557235889471997e-10
of O 0 8.769619058712763e-11
SacII O 0 4.408647669151833e-07
, O 0 9.003443129929067e-11
HhaI O 0 2.1269615899655037e-06
, O 0 2.2854118597592787e-10
and O 0 1.272918853656435e-10
HpaII O 0 4.307927611080231e-06
in O 0 4.73213856988508e-10
this O 0 1.2040403396529342e-10
region O 0 1.0937108996245115e-08
are O 0 7.464259765832537e-11
unmethylated O 0 5.1795090882933437e-08
, O 0 1.0255881430568103e-12
in O 0 4.4383286108840014e-12
normal O 0 9.59923696086662e-09
individuals O 0 6.9677571004622685e-12
and O 0 1.174321317271021e-11
most O 0 7.3029264927027e-12
of O 0 4.593968261357162e-11
the O 0 2.85865531246543e-09
patients O 0 1.3550298660902627e-07
. O 0 7.187727746327255e-09

In O 0 4.3680148387181816e-10
a O 0 2.8153033290040375e-12
number O 0 4.064442359064113e-12
of O 0 3.99350170987578e-11
young O 0 2.876237303883755e-10
and O 0 4.229942437983247e-11
severely O 0 8.309526577932047e-08
affected O 0 6.200378379617177e-07
patients O 0 0.00015921221347525716
, O 0 1.3151098265939964e-11
however O 0 1.229185087048279e-09
, O 0 6.972276922478926e-12
complete O 0 2.817616140404766e-10
methylation O 0 6.545100017518735e-09
of O 0 3.928736003189215e-09
these O 0 3.577519530617579e-11
restriction O 0 1.1011033196339781e-09
sites O 0 1.0244298465078572e-10
was O 0 2.254188502526233e-11
found O 0 1.4262772820433645e-12
in O 0 1.9250438916540435e-12
the O 0 6.753023834571437e-11
mutated O 0 1.36830093921958e-08
allele O 0 5.0934147566294996e-08
. O 0 1.7131236873524358e-08

In O 0 5.7516791329703665e-09
most O 0 2.055678544055084e-11
of O 0 1.7643409519832454e-12
these O 0 7.868303448024805e-13
patients O 0 1.9778808799109093e-11
, O 0 1.0074393881241098e-15
the O 0 1.8328002350932564e-14
onset O 0 7.120171563457234e-09
of O 0 5.609530062677948e-10
the O 0 5.724059093381584e-08
disease O 0 0.3991064429283142
was O 0 3.659801905087079e-06
congenital O 1 1.0
. O 0 8.14416489447467e-06

Preliminary O 0 3.9825778230806463e-07
in O 0 6.698050558640034e-09
vivo O 0 1.883724962681299e-07
footprinting O 0 2.1106483472976834e-05
data O 0 1.0463004906924311e-09
gave O 0 2.422307077143415e-10
evidence O 0 1.0208078132789566e-10
for O 0 3.391192058069259e-12
protein O 0 1.4447990026589252e-10
- O 0 5.496207378108409e-10
DNA O 0 1.1180677494948554e-09
contact O 0 1.0051119658793795e-10
in O 0 2.944074706245914e-10
normal O 0 2.3638507627765648e-05
genes O 0 1.3312480007243721e-09
at O 0 2.5748058199437374e-11
an O 0 2.36610508746668e-13
Sp1 O 0 3.0459956779083086e-09
consensus O 0 2.8749498337532486e-09
binding O 0 1.7780178718229678e-10
site O 0 1.092419821269175e-09
upstream O 0 3.364470924083207e-10
of O 0 1.7224850018537907e-11
the O 0 9.692134594896373e-11
CTG O 0 2.2229130536288721e-07
repeat O 0 2.2644025543527846e-10
and O 0 1.3378717621595482e-12
for O 0 4.9155232835496054e-14
a O 0 6.67680581640075e-15
significant O 0 3.9796741206285513e-13
reduction O 0 8.356070835269236e-10
of O 0 1.542790062369903e-10
this O 0 1.2230566386051134e-11
interaction O 0 9.662749766992107e-11
in O 0 1.7941611737959384e-11
cells O 0 1.5856928617385968e-11
with O 0 7.732613242208627e-14
a O 0 7.116494459696865e-12
hypermethylated O 0 4.6101354200800415e-06
DMPK O 0 0.1116904765367508
gene O 0 9.868274197799565e-09
. O 0 5.012208870169843e-09
. O 0 2.047448610653646e-08

The O 0 6.610769105463987e-07
hemochromatosis B-Disease 1 1.0
gene O 0 1.929440607284505e-08
product O 0 2.352987849008059e-08
complexes O 0 2.6782813744574696e-09
with O 0 1.83930518385389e-12
the O 0 1.1381722647696435e-10
transferrin O 0 1.1583091463762685e-07
receptor O 0 5.7245044260412214e-09
and O 0 1.083911849164565e-10
lowers O 0 3.875114895635079e-09
its O 0 1.5145622386456004e-12
affinity O 0 1.1871801285090466e-12
for O 0 1.5010990497485444e-13
ligand O 0 3.1701552494212137e-10
binding O 0 9.254644162126624e-09
. O 0 2.160442313936528e-08

We O 0 3.710641038878748e-08
recently O 0 6.663031792975005e-10
reported O 0 1.4336612626231204e-11
the O 0 4.7193251910548906e-12
positional O 0 7.952913883002566e-10
cloning O 0 1.8227889198030311e-09
of O 0 7.681831733219457e-12
a O 0 2.379538840274753e-12
candidate O 0 4.02823729928059e-09
gene O 0 3.1826480340058083e-10
for O 0 5.8304991945590245e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999940395355225
HFE O 1 0.999987006187439
. O 0 1.028579617923242e-06

The O 0 4.275394260844223e-09
gene O 0 1.9839366694612837e-12
product O 0 4.28651905637345e-11
, O 0 1.363470642813669e-12
a O 0 3.4668323984146654e-13
member O 0 1.0918494840889137e-12
of O 0 4.434945813369673e-11
the O 0 3.082646082841478e-10
major O 0 1.5538423880911978e-08
histocompatibility O 0 7.032296593934007e-07
complex O 0 3.9707603605165787e-07
class O 0 3.3023553336342104e-10
I O 0 1.2985803543585916e-09
- O 0 6.588944667651475e-11
like O 0 1.5344538790637574e-12
family O 0 1.7912470551967319e-12
, O 0 2.8058547442400515e-14
was O 0 6.2595115722652306e-12
found O 0 9.64734477200413e-13
to O 0 3.581170299540859e-12
have O 0 2.1827808657781667e-11
a O 0 3.715387372760226e-11
mutation O 0 2.5512639223457256e-10
, O 0 2.3521495515210766e-11
Cys O 0 7.590656281308839e-08
- O 0 5.0491117953299636e-09
282 O 0 3.0772899783926277e-09
- O 0 3.9413605712468325e-09
- O 0 7.152430647749952e-09
> O 0 1.7771924376575043e-08
Tyr O 0 9.957157942608319e-08
( O 0 1.494759313070207e-13
C282Y O 0 3.167205941956297e-10
) O 0 1.1494841028732248e-14
, O 0 1.0717803496107254e-14
in O 0 1.252718631952754e-13
85 O 0 7.285150260827322e-11
% O 0 2.2782895361950217e-12
of O 0 5.2891957307010795e-12
patient O 0 2.4220740968416976e-08
chromosomes O 0 3.307231466465055e-08
. O 0 1.3997441783430986e-07

This O 0 2.6666033825506474e-09
mutation O 0 2.3476161015167918e-09
eliminates O 0 2.2042498937224764e-09
the O 0 8.739696466530944e-11
ability O 0 3.370301260297026e-11
of O 0 8.689502450920372e-10
HFE O 0 0.0006237312336452305
to O 0 5.875127606635999e-10
associate O 0 2.5057803054728822e-11
with O 0 2.2579846860001397e-14
beta2 O 0 4.3903122559640906e-07
- O 0 2.1012385786889354e-07
microglobulin O 0 4.169185194768943e-05
( O 0 1.7822136127998434e-11
beta2m O 0 9.886775842460338e-07
) O 0 2.3842319177985738e-12
and O 0 2.8049106006594604e-12
prevents O 0 7.879965430168667e-11
cell O 0 4.6186983126972336e-08
- O 0 4.568248890279847e-09
surface O 0 2.1152170575078344e-06
expression O 0 3.43668887126114e-07
. O 0 3.656409930385962e-08

A O 0 4.3724872966777184e-07
second O 0 1.2051950548652712e-08
mutation O 0 4.232042771779021e-10
that O 0 6.452186332960019e-13
has O 0 2.622288779348392e-13
no O 0 9.21999970945539e-14
effect O 0 3.505287726746076e-11
on O 0 2.020682066117274e-09
beta2m O 0 8.030283424886875e-06
association O 0 6.513004580099846e-10
, O 0 2.687602397577482e-11
H63D O 0 0.0014966874150559306
, O 0 1.5865187635855094e-11
was O 0 1.4539824899628684e-10
found O 0 6.459639680794771e-12
in O 0 1.3276610713597314e-11
eight O 0 1.8348947361523926e-11
out O 0 1.310480023108962e-11
of O 0 3.346480870192181e-10
nine O 0 4.81007955688284e-10
patients O 0 1.6844157180173625e-09
heterozygous O 0 1.1316819877038586e-11
for O 0 3.889534094109193e-12
the O 0 4.638904815834621e-09
C282Y O 0 9.229294846591074e-06
mutant O 0 1.3543908607971389e-06
. O 0 1.391751140999986e-07

In O 0 1.664727383721143e-10
this O 0 1.653031335945021e-12
report O 0 7.693298255395664e-12
, O 0 6.275850607424804e-13
we O 0 1.9332114847749743e-13
demonstrate O 0 9.204318730804406e-12
in O 0 2.0625829169618193e-11
cultured O 0 1.7255267437121802e-07
293 O 0 9.288490865344556e-09
cells O 0 4.162906019899992e-09
overexpressing O 0 6.428199839092485e-08
wild O 0 2.1206638667337074e-09
- O 0 1.9673132567454843e-10
type O 0 1.3486909367088629e-09
or O 0 3.9295208753564737e-10
mutant O 0 1.2530803061849838e-08
HFE O 0 2.1478058442880865e-06
proteins O 0 2.2625838702605705e-11
that O 0 1.4008345265020816e-12
both O 0 1.7137672574454865e-12
the O 0 1.9499186987292916e-11
wild O 0 2.081690153588056e-09
- O 0 1.8382059763233372e-10
type O 0 8.565021469841838e-10
and O 0 1.2656632686347535e-10
H63D O 0 0.0002398482756689191
HFE O 0 2.7356454666005448e-05
proteins O 0 5.326131757854569e-10
form O 0 1.8091826647914644e-10
stable O 0 7.800429746573911e-10
complexes O 0 5.182226175959315e-12
with O 0 3.744462879817561e-15
the O 0 8.614502340631436e-13
transferrin O 0 7.71393882104121e-09
receptor O 0 1.818368566830486e-09
( O 0 1.5033585487600476e-11
TfR O 0 2.8394345008564414e-07
) O 0 6.395156106064892e-12
. O 0 3.356651345765016e-10

The O 0 2.4742018212009498e-08
C282Y O 0 3.2384971291321563e-06
mutation O 0 3.1741699046961e-08
nearly O 0 7.068798324461056e-11
completely O 0 2.2309072991721912e-11
prevents O 0 6.8512196783887536e-12
the O 0 4.903085923380068e-11
association O 0 1.3435834389508017e-10
of O 0 1.2030693108400214e-10
the O 0 7.336104501654006e-10
mutant O 0 1.7379852224053138e-08
HFE O 0 8.356560101674404e-06
protein O 0 1.9626145153495145e-09
with O 0 4.387061731687264e-13
the O 0 1.3674567034271945e-10
TfR O 0 3.6150088362774113e-06
. O 0 2.766320728042615e-09

Studies O 0 1.5889652260625553e-08
on O 0 1.2753881284410795e-10
cell O 0 9.491193248001295e-11
- O 0 1.1363453580881533e-11
associated O 0 1.5585652560212715e-11
transferrin O 0 6.391790208226666e-08
at O 0 1.3665970577392272e-09
37 O 0 3.6644143275310626e-10
degrees O 0 4.274969711559606e-09
C O 0 2.6000563924100106e-09
suggest O 0 2.4006092252948363e-12
that O 0 2.927963183322821e-14
the O 0 1.8630945397557497e-10
overexpressed O 0 1.9710415699591977e-07
wild O 0 6.397276042235944e-09
- O 0 1.7762959159117742e-10
type O 0 9.320235694332268e-10
HFE O 0 7.491282758564921e-07
protein O 0 1.5646871298624632e-10
decreases O 0 2.6525101559649045e-10
the O 0 1.3052707786148643e-12
affinity O 0 7.050240165978883e-12
of O 0 6.396582916123883e-12
the O 0 8.669830825480673e-11
TfR O 0 2.2862651860577898e-07
for O 0 1.046666746329361e-11
transferrin O 0 2.1135060990218335e-07
. O 0 4.481653803622976e-08

The O 0 3.5743472835747525e-05
overexpressed O 0 0.0015864227898418903
H63D O 0 0.462439626455307
protein O 0 4.800479302957683e-08
does O 0 9.334463063614962e-11
not O 0 3.966421809054044e-12
have O 0 1.3305395468125175e-13
this O 0 4.886069237468142e-14
effect O 0 4.176103560182831e-11
, O 0 6.195239091698335e-13
providing O 0 8.853744560416432e-13
the O 0 2.93307343473756e-13
first O 0 1.1024292373082445e-13
direct O 0 1.9420405496413384e-13
evidence O 0 2.7645813156090826e-12
for O 0 4.742555767588488e-14
a O 0 7.837552221806598e-13
functional O 0 5.488897780736579e-09
consequence O 0 1.736672849972365e-08
of O 0 2.965689915868097e-09
the O 0 2.2335033378340086e-08
H63D O 1 0.6121507883071899
mutation O 0 5.315278599482554e-07
. O 0 3.79672400185882e-08

Addition O 0 1.900571078294888e-08
of O 0 1.100293545164277e-08
soluble O 0 0.015417001210153103
wild O 0 1.2661712389672175e-06
- O 0 2.2870626281701334e-08
type O 0 1.583834006169127e-07
HFE O 1 0.9999651908874512
/ O 0 0.00012023410818073899
beta2m O 0 8.927974704420194e-05
heterodimers O 0 2.2912774966243887e-06
to O 0 3.5737093839749434e-10
cultured O 0 3.242700685746058e-08
cells O 0 1.5557304333668753e-09
also O 0 2.728200152769811e-13
decreased O 0 2.462296685989962e-11
the O 0 9.983587307554886e-13
apparent O 0 7.386281170029818e-11
affinity O 0 1.3819083898025664e-11
of O 0 1.6904004238038617e-11
the O 0 1.735186994089588e-11
TfR O 0 5.576100914339577e-09
for O 0 8.692269723008933e-14
its O 0 4.591656848035135e-14
ligand O 0 1.6172355338586741e-12
under O 0 3.316151520049715e-11
steady O 0 2.380821650938003e-10
- O 0 6.184424175027792e-13
state O 0 3.6955871305852095e-13
conditions O 0 2.8274870444988665e-08
, O 0 4.415850931444032e-12
both O 0 1.683902366503287e-12
in O 0 3.1585116466725793e-11
293 O 0 6.955003795106052e-10
cells O 0 6.297227739260336e-10
and O 0 2.145876358550236e-11
in O 0 2.826810174827443e-10
HeLa O 0 1.0416137001811876e-06
cells O 0 5.2690580787384533e-08
. O 0 9.103937159693487e-09

Furthermore O 0 2.4965386202779882e-08
, O 0 9.217126194227543e-12
at O 0 4.2327890324711515e-12
4 O 0 4.982284376731094e-11
degrees O 0 3.0615549206913784e-08
C O 0 1.6165917315902334e-07
, O 0 3.520487124476085e-13
the O 0 1.0693215410362278e-11
added O 0 2.4260479736248897e-10
soluble O 0 2.1779440828595398e-07
complex O 0 5.201765418405557e-08
of O 0 2.5391966307353186e-09
HFE O 0 6.694262992823496e-05
/ O 0 5.706856853748832e-08
beta2m O 0 5.29434380780458e-08
inhibited O 0 4.2048470261235593e-10
binding O 0 1.7509431404771902e-10
of O 0 7.990496458942786e-11
transferrin O 0 3.0070214762645264e-08
to O 0 8.634009063257508e-10
HeLa O 0 5.467302912620653e-07
cell O 0 8.67185701025619e-09
TfR O 0 1.3410020471837925e-07
in O 0 6.452654166197447e-13
a O 0 1.450169194797124e-13
concentration O 0 8.786634753121803e-10
- O 0 3.2875129285514504e-09
dependent O 0 1.1526051224564071e-08
manner O 0 5.445386008773312e-08
. O 0 6.425000265153358e-08

Scatchard O 0 0.00017120531992986798
plots O 0 4.612201678355632e-07
of O 0 3.384812652384994e-09
these O 0 8.973784215715597e-11
data O 0 4.5897816797202395e-11
indicate O 0 1.5154970334219087e-10
that O 0 2.596458475740554e-13
the O 0 1.2528734993910717e-10
added O 0 4.764252325983875e-10
heterodimer O 0 4.171960110710415e-09
substantially O 0 4.681829146591099e-09
reduced O 0 1.982676023359886e-09
the O 0 5.529368282686242e-11
affinity O 0 3.7613367975808387e-10
of O 0 1.5515425055845355e-10
TfR O 0 1.878411381994738e-07
for O 0 1.378788489631022e-11
transferrin O 0 1.6172856476259767e-07
. O 0 3.938604464792661e-08

These O 0 4.856060553670716e-10
results O 0 2.873166704553398e-10
establish O 0 6.103316463335062e-11
a O 0 7.34920262666916e-13
molecular O 0 8.81146371145558e-12
link O 0 4.217559981811725e-11
between O 0 3.8272207625311694e-10
HFE O 1 0.9999831914901733
and O 0 2.560553546970823e-08
a O 0 1.0844459774617121e-09
key O 0 6.01159058533085e-07
protein O 0 1.1478853423341207e-09
involved O 0 7.416293273942998e-11
in O 0 2.99499626488231e-11
iron O 0 5.6660432790067716e-08
transport O 0 3.493405742460709e-08
, O 0 4.331712506050467e-12
the O 0 4.7032874123109636e-11
TfR O 0 9.399078493288471e-08
, O 0 7.679894047096791e-13
and O 0 3.625940422479629e-13
raise O 0 1.1127734150795376e-11
the O 0 8.223262565679179e-13
possibility O 0 1.2343478669740726e-11
that O 0 1.3933113289423676e-13
alterations O 0 2.5780533263741745e-08
in O 0 4.596115502075726e-11
this O 0 3.193419704020095e-12
regulatory O 0 1.5426296684495355e-08
mechanism O 0 5.422177817848706e-09
may O 0 3.6277738590939634e-09
play O 0 3.989071226118135e-11
a O 0 5.743971379264246e-13
role O 0 2.3918566779967954e-12
in O 0 3.4242361550418376e-12
the O 0 1.3190797065742998e-10
pathogenesis O 0 3.44225627486594e-05
of O 0 1.7416673472325783e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0002308995753992349
. O 0 4.53962236690586e-08

Genomic O 0 3.137226087801537e-07
organization O 0 1.1982127512411012e-09
of O 0 3.3029098900350107e-10
the O 0 7.610731600493637e-09
UBE3A O 0 0.009640282019972801
/ O 0 2.2635620098299114e-06
E6 O 0 1.5283416360034607e-05
- O 0 3.3474486826889915e-07
AP O 0 2.783688614726998e-06
gene O 0 1.0378764514484828e-10
and O 0 4.348600039089101e-12
related O 0 1.2937577231753039e-08
pseudogenes O 0 1.114200222218642e-05
. O 0 1.5615991344475333e-07

The O 0 1.5895751914740686e-07
UBE3A O 0 2.5393143005203456e-05
gene O 0 2.1483631540419879e-10
encodes O 0 5.965842837102331e-12
the O 0 7.418316655405377e-11
E6 O 0 3.7221957427391317e-07
- O 0 7.663550682934783e-09
AP O 0 1.2666093596180872e-07
ubiquitin O 0 3.39834560492136e-09
- O 0 1.4464354158860715e-08
protein O 0 2.4340943149958605e-10
ligase O 0 6.56511345287214e-10
and O 0 3.92761767553651e-10
has O 0 2.355281985069735e-12
recently O 0 2.4434460531297386e-12
been O 0 1.6055645040476824e-13
shown O 0 7.142841819320761e-14
to O 0 7.839100191458365e-15
be O 0 3.258440609346658e-13
mutated O 0 4.153082144853215e-08
in O 0 2.00362435975876e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999892711639404
who O 0 1.0548682760624928e-10
lack O 0 1.5821780552371933e-09
15q11 O 0 8.602374634847365e-08
- O 0 1.5242127560100016e-08
q13 O 0 2.2738925053999992e-07
deletions O 0 2.476123306394129e-08
or O 0 8.36618219146601e-10
chromosome O 0 5.835750993554711e-09
15 O 0 4.392085362070475e-09
paternal O 0 2.0608282284229062e-05
uniparental B-Disease 0 0.20307277143001556
disomy I-Disease 0 0.010049493983387947
. O 0 7.672651918255724e-06

Previous O 0 1.1741997241188074e-06
UBE3A O 0 1.847861312853638e-05
cDNA O 0 1.1037091240950758e-08
analysis O 0 1.8970199022749767e-10
has O 0 4.6276638120471e-13
shown O 0 1.3473204214624335e-13
a O 0 1.419768030355359e-13
coding O 0 5.132584357525616e-10
region O 0 1.1078465922409464e-09
of O 0 1.0297942498738166e-09
approximately O 0 2.2211600614330251e-10
2 O 0 7.069614227361853e-09
. O 0 2.488512507170526e-09

6 O 0 5.378904916142346e-06
kb O 0 3.107147108494246e-07
and O 0 2.578901259209232e-10
a O 0 7.05639158216087e-11
3 O 0 1.3897079931268763e-08
- O 0 6.085539894229441e-08
untranslated O 0 0.0023388501722365618
region O 0 7.2690431451860604e-09
( O 0 3.1591665047847606e-12
UTR O 0 1.4206202649802435e-06
) O 0 1.6262048673811036e-13
of O 0 3.0103336490228116e-11
< O 0 2.4086757033359163e-09
50 O 0 4.912767970211007e-10
bp O 0 3.6434852357380976e-10
, O 0 6.701103972932276e-13
whereas O 0 3.579970000999744e-11
Northern O 0 1.5780572681922678e-10
analysis O 0 9.229070632721381e-12
has O 0 4.4711318523439625e-13
indicated O 0 2.952917858151105e-12
mRNA O 0 6.643786649301875e-12
sizes O 0 2.4713600610404285e-10
of O 0 1.1371003444393679e-10
5 O 0 6.079713177342683e-09
- O 0 3.258336889189195e-08
8 O 0 1.8335784446321668e-08
kb O 0 5.955896043019493e-08
. O 0 2.2771601493332128e-08

We O 0 2.0377171949803596e-07
have O 0 3.290585304238647e-10
analyzed O 0 5.71530434090306e-10
additional O 0 6.380599520960928e-11
cDNA O 0 7.74201946995845e-09
clones O 0 1.3343296245693637e-08
and O 0 8.523927223780259e-12
provide O 0 2.9346289938045333e-13
evidence O 0 8.962280245196352e-13
for O 0 7.017805526152512e-14
an O 0 2.207522020541107e-14
additional O 0 1.3162246292885982e-10
0 O 0 9.148795498958862e-09
. O 0 1.5348718962471253e-09

5 O 0 6.985393952163577e-07
kb O 0 1.6303620498092641e-07
of O 0 1.3662223352639558e-08
5 O 0 6.812712882720007e-08
- O 0 9.025532676787407e-08
UTR O 0 0.0831112414598465
and O 0 1.8847863547666321e-10
> O 0 1.069890398497364e-08
2 O 0 8.455102173954288e-10
kb O 0 7.404170054847725e-10
of O 0 2.380299291004917e-10
3 O 0 1.1028236457377716e-07
- O 0 1.283967094423133e-06
UTR O 0 0.07512254267930984
. O 0 1.2438451335583522e-07

We O 0 2.909643415094365e-09
have O 0 1.238485984773885e-12
established O 0 2.326199996516287e-12
the O 0 1.145379581110606e-12
genomic O 0 3.0376787890640244e-11
organization O 0 6.867861314374668e-12
of O 0 3.377560384154599e-11
UBE3A O 0 4.2906790440611076e-06
and O 0 9.789372437674082e-12
the O 0 3.410250554169991e-11
sequence O 0 2.518372142767955e-11
of O 0 2.362284812207349e-10
intron O 0 2.554845757174462e-08
- O 0 2.590843450889224e-07
exon O 0 2.2299327895325405e-07
borders O 0 2.1413821826854473e-08
. O 0 1.0086854729252082e-07

We O 0 4.581505663736607e-07
have O 0 8.63623228486432e-10
also O 0 7.311264094145287e-11
mapped O 0 4.671999231931068e-09
two O 0 1.45208324531243e-11
highly O 0 3.7591725288166344e-09
homologous O 0 5.964563287719216e-10
processed O 0 1.2717680419882527e-07
pseudogenes O 0 5.831959128954622e-07
, O 0 1.264871818396074e-10
UBE3AP1 O 0 0.003910374827682972
and O 0 4.803563768973618e-09
UBE3AP2 O 1 0.9997811913490295
, O 0 4.217272642215164e-10
to O 0 8.274136237274021e-11
chromosomes O 0 2.532317688874741e-10
2 O 0 1.3053441660915155e-10
and O 0 2.141982338027537e-12
21 O 0 1.653947673263545e-10
, O 0 1.8732905851526205e-12
respectively O 0 8.765103920449491e-11
, O 0 3.0053006524338732e-12
and O 0 1.6542267772604036e-12
determined O 0 3.0849753307471417e-10
their O 0 5.728891805389935e-10
genomic O 0 9.57791268518804e-09
organization O 0 3.973811057988996e-09
. O 0 1.2972591001414457e-08

These O 0 4.246882845393429e-09
results O 0 4.930152952553613e-10
will O 0 5.612413745553768e-12
form O 0 4.2173807848766565e-12
the O 0 2.1024605667552265e-12
basis O 0 3.405932437125503e-12
for O 0 2.264415190729105e-14
studies O 0 2.0633679227027857e-13
of O 0 4.0683881502405483e-13
mutation O 0 5.473229074820507e-12
and O 0 1.801025301118031e-11
imprinting O 0 3.16601358463231e-07
of O 0 1.588402369634423e-07
UBE3A O 1 0.9631090760231018
. O 0 3.0282883471954847e-06

Mutation O 0 6.55223459489207e-07
spectrum O 0 6.387866164914158e-07
and O 0 2.0816456891559199e-10
genotype O 0 3.1305017955673975e-07
- O 0 7.686053038469254e-08
phenotype O 0 1.586739273307103e-08
analyses O 0 1.4862321442987714e-11
in O 0 7.782777785951545e-13
Cowden B-Disease 0 8.4790495748166e-05
disease I-Disease 0 2.3259916659412738e-08
and O 0 1.4093474998144728e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.103388433016278e-10
two O 0 1.6814552528110482e-10
hamartoma B-Disease 1 0.99992835521698
syndromes I-Disease 1 0.9988798499107361
with O 0 9.617035345854674e-08
germline O 1 0.9997279047966003
PTEN O 1 0.9979008436203003
mutation O 0 8.219977644330356e-06
. O 0 6.432247090515375e-08

The O 0 1.5005759451014455e-05
tumour B-Disease 1 1.0
suppressor O 0 0.10785126686096191
gene O 0 1.6290065332213999e-06
PTEN O 0 0.002456287620589137
, O 0 6.294582910459923e-11
which O 0 3.957103199801748e-13
maps O 0 1.052645332011437e-10
to O 0 5.7918111279198214e-11
10q23 O 0 6.039223080733791e-06
. O 0 1.1745297001652943e-07

3 O 0 5.2985363652169326e-08
and O 0 1.813036699938042e-11
encodes O 0 1.874695494327727e-12
a O 0 1.2197409965733486e-12
403 O 0 6.383350792393827e-11
amino O 0 2.1140627443072546e-11
acid O 0 1.311248193358594e-10
dual O 0 6.009108766136251e-10
specificity O 0 6.314141209884383e-09
phosphatase O 0 4.4580056055565365e-06
( O 0 2.2986364200949794e-10
protein O 0 9.93599647003407e-10
tyrosine O 0 1.764875356968787e-09
phosphatase O 0 5.23139265240502e-09
; O 0 3.0538110235012184e-11
PTPase O 0 5.3657199572398895e-08
) O 0 2.8209243751672886e-13
, O 0 2.9737895631230804e-13
was O 0 2.5218665697379627e-11
shown O 0 8.224223385644436e-12
recently O 0 1.3228994288905227e-10
to O 0 1.0538748346222704e-10
play O 0 1.3937553333676078e-09
a O 0 8.304888721166748e-11
broad O 0 8.774183157811422e-08
role O 0 2.0415931445416646e-10
in O 0 2.6134150399315104e-10
human O 0 7.952356995133414e-09
malignancy B-Disease 0 5.476619480759837e-05
. O 0 3.116709024197917e-08

Somatic O 0 0.0071252561174333096
PTEN O 0 0.002346387365832925
deletions O 0 6.31846887699794e-07
and O 0 3.5986205682014827e-10
mutations O 0 4.961412183868141e-11
were O 0 1.289372580058623e-12
observed O 0 4.431629108819779e-12
in O 0 1.4285569255312325e-11
sporadic B-Disease 0 7.134248789952835e-06
breast I-Disease 1 0.9999974966049194
, I-Disease 0 7.702106472606829e-07
brain I-Disease 1 1.0
, I-Disease 0 6.251686136238277e-05
prostate I-Disease 1 1.0
and I-Disease 1 1.0
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.527262151692412e-06
lines O 0 1.5575148948343553e-09
and O 0 2.907004064550689e-12
in O 0 2.122963480358231e-12
several O 0 8.632139274211692e-12
primary O 0 1.48007941902506e-07
tumours B-Disease 1 1.0
such O 0 5.6624697986062955e-11
as O 0 2.130057552562903e-08
endometrial B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 1.0
, O 0 3.3198257369804196e-06
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.893940806388855
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0012685413239523768

In O 0 1.0364210600855017e-09
addition O 0 1.7532866269931446e-09
, O 0 7.892890785399231e-10
PTEN O 1 0.8105846047401428
was O 0 5.017778192950573e-08
identified O 0 6.342261160696694e-10
as O 0 6.958672353618578e-12
the O 0 1.3613171354065479e-11
susceptibility O 0 1.4612248910861325e-10
gene O 0 1.8408213321718936e-12
for O 0 7.625508297720573e-13
two O 0 1.1429887591951626e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9637089967727661
( O 0 4.8933114504823294e-12
CD B-Disease 0 5.03885871694365e-07
; O 0 4.0360026432040286e-10
MIM O 0 6.906072940182639e-07
158350 O 0 1.4433764405907823e-08
) O 0 1.6404668693337926e-13
and O 0 2.3978542675745507e-12
Bannayan B-Disease 0 4.118235210626153e-06
- I-Disease 0 4.119515324418899e-06
Zonana I-Disease 0 0.0005620484589599073
( I-Disease 0 4.1792191235456855e-11
BZS I-Disease 0 6.869990556879202e-06
) I-Disease 0 9.725680547370552e-13
or I-Disease 0 7.657956734019589e-12
Ruvalcaba I-Disease 0 3.749686925402784e-07
- I-Disease 0 3.1588356819156616e-07
Riley I-Disease 0 3.324163844808936e-05
- I-Disease 1 1.0
Smith I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8258520029235115e-08
MIM O 0 0.0893884226679802
153480 O 0 5.733500529458979e-06
) O 0 1.1007374178806373e-10
. O 0 4.588560642559969e-09

Constitutive O 0 3.2617931537970435e-06
DNA O 0 1.8686664304823353e-07
from O 0 9.843191817182628e-10
37 O 0 9.829201452760117e-09
CD B-Disease 0 1.0712832931858429e-07
families O 0 7.544845304074954e-11
and O 0 5.886203850724581e-12
seven O 0 1.2402192987870375e-11
BZS B-Disease 0 0.22518876194953918
families O 0 1.9116212779390906e-10
was O 0 2.781450902933358e-10
screened O 0 7.925540224107408e-09
for O 0 3.1663378585733426e-09
germline O 0 0.00012389023322612047
PTEN O 0 0.0022098086774349213
mutations O 0 1.5529556094406871e-06
. O 0 1.143910850487373e-07

PTEN O 0 0.011247646994888783
mutations O 0 3.9026656395435566e-07
were O 0 1.3079791694181608e-09
identified O 0 4.6532742936644667e-11
in O 0 6.698627763590537e-12
30 O 0 2.6237134687079333e-10
of O 0 4.226807237550645e-10
37 O 0 2.2330389981561893e-08
( O 0 6.810971925341747e-12
81 O 0 2.7068987051848126e-08
% O 0 5.741958991611895e-12
) O 0 1.9433068638974836e-14
CD B-Disease 0 2.3800339477020316e-08
families O 0 2.0151724039463303e-11
, O 0 3.2195326591343e-13
including O 0 8.31301433940057e-12
missense O 0 1.657977009017486e-07
and O 0 8.300256482129953e-09
nonsense O 0 2.004183670578641e-06
point O 0 2.625808903644611e-08
mutations O 0 5.1952823987289065e-11
, O 0 5.302164957088351e-12
deletions O 0 2.6815002995839166e-10
, O 0 2.89388877444674e-11
insertions O 0 8.181893496050918e-10
, O 0 1.560649829854266e-12
a O 0 6.269082475363064e-12
deletion O 0 2.70123412526857e-09
/ O 0 3.8990567219343575e-08
insertion O 0 1.2806491156425182e-07
and O 0 1.8691007852567054e-08
splice O 0 1.5762496332172304e-05
site O 0 1.70108171460015e-06
mutations O 0 4.5859295028094493e-08
. O 0 3.4549923810800465e-08

These O 0 3.4398425441395375e-08
mutations O 0 1.4102786716208016e-09
were O 0 3.1126362598499213e-10
scattered O 0 9.222440866540893e-11
over O 0 3.0620683939830418e-12
the O 0 2.3543668750680702e-11
entire O 0 4.135222164691754e-10
length O 0 1.2953613182098422e-10
of O 0 2.4212367666365253e-09
PTEN O 0 2.978849579449161e-06
, O 0 4.388042880443255e-12
with O 0 1.1717846169019466e-14
the O 0 6.381578750679073e-13
exception O 0 3.303977534271918e-12
of O 0 4.996696958102509e-13
the O 0 5.177570069729576e-13
first O 0 5.570150677508545e-12
, O 0 3.1204082286823143e-12
fourth O 0 8.757672365078406e-10
and O 0 4.259168365217114e-11
last O 0 4.552348720210375e-09
exons O 0 2.607572113788592e-08
. O 0 4.13465031101623e-08

A O 0 2.232261294921045e-06
hot O 0 6.593044236069545e-05
spot O 0 1.4200105624695425e-07
for O 0 8.118376526589088e-10
PTEN O 0 1.9335177057655528e-05
mutation O 0 6.78034117740367e-09
in O 0 2.9866750739238057e-10
CD B-Disease 0 2.7601407737165573e-07
was O 0 5.371307842949591e-09
identified O 0 1.0355041268894638e-09
in O 0 9.393944511160157e-10
exon O 0 1.0252186655179685e-08
5 O 0 6.351546510963146e-10
that O 0 1.4271937310347121e-13
contains O 0 4.839384535465507e-12
the O 0 1.1260607030161296e-10
PTPase O 0 6.291126919677481e-05
core O 0 2.9229806386865675e-05
motif O 0 1.0226928193191043e-09
, O 0 3.0420821027152267e-13
with O 0 5.771552483033399e-15
13 O 0 6.760830610630375e-12
of O 0 7.96075271675134e-12
30 O 0 2.875864268947481e-10
( O 0 6.497571578001349e-13
43 O 0 5.890263832242226e-10
% O 0 2.6473218148886923e-12
) O 0 5.4630751962145285e-14
CD B-Disease 0 4.046042079153267e-08
mutations O 0 1.974425484219111e-10
identified O 0 4.194186109529596e-10
in O 0 1.3712832258594432e-10
this O 0 3.1123648103204005e-09
exon O 0 5.039887014390843e-07
. O 0 4.8902421667662566e-08

Seven O 0 1.2588703413030089e-08
of O 0 2.3999993103984707e-09
30 O 0 3.3971143675870508e-09
( O 0 1.3064861692502205e-12
23 O 0 4.6419296184652126e-10
% O 0 9.493828249593217e-13
) O 0 5.706248783898934e-15
were O 0 1.0631290119078596e-11
within O 0 6.303461225209972e-11
the O 0 3.959660932473241e-10
core O 0 5.159208171789942e-08
motif O 0 3.797087644308306e-11
, O 0 1.344524670635408e-13
the O 0 9.137935200187464e-12
majority O 0 9.431943073789917e-12
( O 0 4.5140532479483186e-13
five O 0 1.216254527647287e-11
of O 0 1.7046310196722203e-10
seven O 0 1.235257035547832e-11
) O 0 5.568901798578586e-14
of O 0 5.889887102344948e-12
which O 0 2.815050926738283e-12
were O 0 4.553998955714178e-09
missense O 0 3.728690103343979e-07
mutations O 0 2.861235470774659e-09
, O 0 4.859532568013414e-11
possibly O 0 7.43303996131317e-09
pointing O 0 1.4406149162482507e-08
to O 0 1.4748518378793207e-11
the O 0 1.5964184141292748e-10
functional O 0 2.81433187865332e-08
significance O 0 2.6017545451395563e-08
of O 0 2.0528201361003084e-09
this O 0 3.11974474032084e-10
region O 0 1.2703879725961542e-08
. O 0 1.5561795407847967e-08

Germline O 0 0.02347605489194393
PTEN O 0 0.002515701809898019
mutations O 0 6.027330812230502e-08
were O 0 4.978439882563634e-10
identified O 0 3.2239971109460086e-11
in O 0 4.6907516933203386e-12
four O 0 3.9500447726083243e-13
of O 0 5.88901358233862e-11
seven O 0 1.040306243926814e-10
( O 0 2.46006101774221e-12
57 O 0 7.420036585159551e-09
% O 0 4.99506304374453e-11
) O 0 3.2354414286617228e-12
BZS B-Disease 0 0.0017291286494582891
families O 0 2.2304329494460262e-09
studied O 0 1.9332309975084172e-08
. O 0 4.7297611160956876e-08

Interestingly O 0 9.534733180771582e-07
, O 0 4.823944022014359e-10
none O 0 4.065193071056683e-09
of O 0 1.322066900399932e-10
these O 0 1.0001265093873002e-10
mutations O 0 4.0661966849153686e-11
was O 0 6.752264025688959e-11
observed O 0 2.6572802291902065e-10
in O 0 5.4565334889344896e-11
the O 0 5.727987861803285e-09
PTPase O 0 0.001009698840789497
core O 0 0.0001088464559870772
motif O 0 1.692103666073308e-07
. O 0 6.561486465272992e-09

It O 0 3.7554512277715446e-10
is O 0 2.9307316122550997e-12
also O 0 2.0706299088540936e-13
worthy O 0 1.6279513848083127e-10
of O 0 5.800851552578701e-12
note O 0 6.008403410223684e-12
that O 0 7.574558249503691e-16
a O 0 2.6923801119886452e-14
single O 0 2.618576362689584e-12
nonsense O 0 1.1585467030172936e-09
point O 0 5.2080117995956243e-11
mutation O 0 2.9431394387574583e-12
, O 0 5.116146764051754e-13
R233X O 0 1.0798189009619819e-08
, O 0 8.480628525819878e-12
was O 0 2.9352884012290303e-10
observed O 0 4.972309231021654e-10
in O 0 1.931916987496507e-10
the O 0 4.273184472936009e-09
germline O 0 6.126465024181016e-08
DNA O 0 1.2463322818234701e-08
from O 0 1.9190153632830942e-10
two O 0 4.3071096819322086e-13
unrelated O 0 1.2457279652267061e-09
CD B-Disease 0 5.384747510106536e-07
families O 0 1.6435135197223616e-10
and O 0 2.5897641670047378e-11
one O 0 4.847445222999625e-10
BZS B-Disease 1 0.9999918937683105
family O 0 9.243569110140015e-08
. O 0 1.4443904206018487e-07

Genotype O 0 1.8613880456541665e-05
- O 0 7.619462962793477e-07
phenotype O 0 6.458765255956678e-08
studies O 0 1.9801682862863323e-11
were O 0 5.350744803830909e-13
not O 0 6.860195733964652e-14
performed O 0 9.395780160847966e-12
on O 0 6.627333664493973e-12
this O 0 2.60810904123554e-12
small O 0 1.7005676380965618e-11
group O 0 9.74396995381821e-13
of O 0 5.6794190878006745e-11
BZS B-Disease 1 0.9999995231628418
families O 0 1.2480050770591333e-07
. O 0 1.1003443489698839e-07

However O 0 5.9921752892933e-08
, O 0 5.08560471512709e-10
genotype O 0 9.208286400053112e-08
- O 0 2.2930160881173833e-08
phenotype O 0 3.1583414994429404e-08
analysis O 0 4.232427949779627e-11
inthe O 0 5.470755581882258e-07
group O 0 3.46845490696579e-12
of O 0 7.77235307364288e-12
CD B-Disease 0 6.036756531102583e-05
families O 0 5.208828368630236e-10
revealed O 0 7.927875717017585e-11
two O 0 3.2667340105771783e-14
possible O 0 1.4442684244733717e-12
associations O 0 9.957570792223924e-13
worthy O 0 4.503757367047001e-10
of O 0 5.7234581657406025e-12
follow O 0 4.145438506353294e-11
- O 0 5.296294999790341e-11
up O 0 5.463966952501398e-12
in O 0 1.0487924547927796e-12
independent O 0 2.132715878899738e-12
analyses O 0 4.600123407194623e-11
. O 0 3.6824560067927337e-10

The O 0 4.566027556052177e-09
first O 0 4.0848396887227523e-10
was O 0 8.504842163858939e-09
an O 0 1.499494538953483e-12
association O 0 4.161234898325539e-11
noted O 0 3.4858074760002467e-10
in O 0 1.0588671432720798e-11
the O 0 4.2175679615397144e-11
group O 0 6.753245965912535e-14
of O 0 4.4104105675728256e-13
CD B-Disease 0 1.8813883798429742e-05
families O 0 2.2446018377308974e-09
with O 0 2.6253768048434267e-09
breast B-Disease 1 0.9999998807907104
disease I-Disease 1 0.790391743183136
. O 0 2.720799602684565e-05

A O 0 1.305853558619674e-08
correlation O 0 8.167762993727123e-11
was O 0 2.0067876180251965e-11
observed O 0 4.819662464267127e-12
between O 0 1.2182017547490709e-12
the O 0 9.870630354735788e-12
presence O 0 3.7860681256773887e-10
/ O 0 2.802484004860162e-07
absence O 0 3.770945227188349e-07
of O 0 6.151613884952667e-09
a O 0 5.703260086420414e-10
PTEN O 0 3.568404508769163e-06
mutation O 0 3.4811900584408306e-10
and O 0 4.65350034981743e-13
the O 0 6.059337601983794e-13
type O 0 3.073628018768204e-10
of O 0 2.4000359477582833e-09
breast O 0 2.1157859464437934e-06
involvement O 0 2.5129635261578187e-08
( O 0 2.5646271217816263e-10
unaffected O 0 3.571273555280641e-05
versus O 0 0.000288663140963763
benign O 1 0.9913160800933838
versus O 0 0.0005508871981874108
malignant O 0 0.0002779146016109735
) O 0 3.4656147396283643e-10
. O 0 4.537923370406816e-09

Specifically O 0 1.9973422915597894e-09
and O 0 2.7872064031764232e-11
more O 0 3.6856338835912494e-13
directly O 0 2.1774654562073392e-12
, O 0 6.717202206789341e-13
an O 0 4.449079518968786e-14
association O 0 2.9955791319702385e-11
was O 0 2.176854252411431e-09
also O 0 3.707655276546928e-12
observed O 0 1.1219502757398025e-11
between O 0 1.1511857005847004e-12
the O 0 1.6440605387496587e-12
presence O 0 2.8658026472727638e-12
of O 0 5.161867461245251e-11
a O 0 1.6835806082582394e-09
PTEN O 1 0.9999985694885254
mutation O 1 0.9716514348983765
and O 0 6.085712811909616e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 0 0.4357122480869293
. O 0 1.608162278898817e-06

Secondly O 0 1.4574997294403147e-05
, O 0 7.447141792127354e-10
there O 0 3.360044534272966e-11
appeared O 0 1.4815373927667963e-10
to O 0 5.050873456459437e-13
be O 0 2.675326323323124e-12
an O 0 1.456234655430877e-12
interdependent O 0 1.9804204498541367e-08
association O 0 3.928309233458549e-09
between O 0 3.6519685053804096e-09
mutations O 0 3.324717612329664e-09
upstream O 0 1.1845091130169294e-08
and O 0 2.1340070335829076e-11
within O 0 1.3082779304340875e-10
the O 0 2.8070181734562993e-09
PTPase O 0 0.00013589269656222314
core O 0 4.590478056343272e-05
motif O 0 1.3862425873867323e-08
, O 0 3.772389952499955e-12
the O 0 2.9889014874218134e-11
core O 0 1.1120154574939534e-08
motif O 0 8.701340342698316e-11
containing O 0 1.010263921130683e-12
the O 0 1.686355742547274e-11
majority O 0 3.9814467694965217e-11
of O 0 1.1005410804898474e-08
missense O 0 4.823700692213606e-07
mutations O 0 2.8826094844447425e-09
, O 0 1.6301909475102683e-11
and O 0 1.6669369877486684e-12
the O 0 3.676346987252499e-12
involvement O 0 2.955769309864742e-12
of O 0 4.564688037278497e-12
all O 0 1.6725349946157542e-13
major O 0 9.791015220805832e-12
organ O 0 2.791525410827944e-08
systems O 0 5.833313844050281e-05
( O 0 9.614564006055204e-11
central O 0 6.030770123288676e-07
nervous O 0 1.0767811318146414e-06
system O 0 3.489571327008889e-06
, O 0 3.5456482194717864e-10
thyroid O 1 0.9999852180480957
, O 0 5.522445644601248e-05
breast O 1 1.0
, O 0 0.0030637485906481743
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 0.9999998807907104
) O 0 7.23764825849571e-10
. O 0 8.120985484083576e-08

However O 0 3.632945890785777e-06
, O 0 6.070788316492326e-10
these O 0 2.66500935902636e-11
observations O 0 7.724075545834097e-11
would O 0 2.833675308289152e-11
need O 0 1.9638153603285247e-10
to O 0 8.65938223904017e-12
be O 0 1.0464491252692998e-11
confirmed O 0 2.506063689899918e-10
by O 0 3.1178499452361175e-12
studying O 0 8.815637803083476e-11
a O 0 1.872071697965258e-13
larger O 0 6.652231716863799e-12
number O 0 1.5062307954713527e-12
of O 0 9.725407111582651e-12
CD B-Disease 0 7.484080470021581e-06
families O 0 3.404846626864355e-09
. O 0 1.0798642868792285e-08

Molecular O 0 3.6144723708275706e-05
defects O 0 0.25381430983543396
leading O 0 6.107281791400965e-09
to O 0 3.2264009172666697e-12
human O 0 1.7701697746508316e-11
complement B-Disease 0 7.033490874164272e-07
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.1746460455183154e-11
an O 0 1.2761982836066894e-14
African O 0 3.5867329614171217e-13
- O 0 1.2986732349229424e-11
American O 0 3.9951605391996825e-12
family O 0 3.396948694556201e-11
. O 0 5.239298994652586e-10

Complement B-Disease 0 4.587224111674004e-07
component I-Disease 1 0.9788353443145752
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.4113860254127975e-11
C6D B-Disease 0 2.0713441699626856e-06
) O 0 5.003372390878502e-13
was O 0 2.843476287761604e-10
diagnosed O 0 2.6538597808212216e-07
in O 0 3.401540715763929e-10
a O 0 1.1722200467245703e-11
16 O 0 7.466523233023992e-11
- O 0 4.9615988401141564e-12
year O 0 5.53979778716851e-11
- O 0 3.7871081270957063e-10
old O 0 1.2300411800225675e-09
African O 0 2.699901066605115e-12
- O 0 2.86601558457944e-12
American O 0 7.019385073192552e-14
male O 0 4.447800634743704e-13
with O 0 1.791994558384552e-13
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 6.552059517161979e-08

The O 0 2.6692916321735538e-08
patients O 0 8.822191261970147e-07
father O 0 3.577661544795774e-08
and O 0 6.6374385987444384e-09
two O 0 2.4611817028841187e-09
brothers O 0 4.708446965651092e-07
also O 0 8.196732181886546e-10
had O 0 1.5744271664175358e-08
C6D B-Disease 1 1.0
, O 0 6.112403638791619e-11
but O 0 1.2238780301709884e-11
gave O 0 8.971656750844659e-12
no O 0 5.422477245865809e-13
history O 0 5.4182201260355445e-12
of O 0 9.100469509915055e-12
meningitis B-Disease 1 1.0
or O 0 1.0565275043727951e-10
other O 0 2.310618016365673e-11
neisserial B-Disease 0 3.536045596774784e-06
infection I-Disease 0 4.350718427303946e-06
. O 0 9.703542502847995e-08

By O 0 7.824804693079557e-11
using O 0 2.070718943536498e-11
exon O 0 8.834426523662842e-10
- O 0 3.040658350106362e-11
specific O 0 1.8966678921872315e-11
polymerase O 0 8.362839067077577e-12
chain O 0 7.246923981046871e-12
reaction O 0 5.4681710548454276e-11
( O 0 6.897246987956629e-14
PCR O 0 6.84097223313529e-11
) O 0 2.3520697176493584e-14
/ O 0 7.577199501521137e-13
single O 0 1.8198359214970788e-13
- O 0 1.900922561720586e-12
strand O 0 5.406637811067316e-12
conformation O 0 2.2330431774519877e-12
polymorphism O 0 7.155407776709977e-12
as O 0 1.9272571142063197e-14
a O 0 1.4103335741009332e-15
screening O 0 3.976822777335132e-12
step O 0 2.3139080929102107e-11
and O 0 5.272291934629858e-13
nucleotide O 0 1.8919024333263756e-11
sequencing O 0 1.1215871981162806e-10
of O 0 2.488206342354804e-11
target O 0 1.4197294728734988e-10
exons O 0 5.569795180626613e-10
, O 0 1.3618800098064154e-12
we O 0 4.2437570384884493e-13
determined O 0 1.4403545196828293e-11
that O 0 7.271922864218738e-14
the O 0 1.6386484183450456e-11
proband O 0 1.9946638474266365e-07
was O 0 2.2943437427702662e-10
a O 0 2.6082283034745135e-12
compound O 0 2.039632684969206e-09
heterozygote O 0 1.2754190947816824e-07
for O 0 3.2640123937e-10
two O 0 1.4010076432313667e-09
C6 O 0 0.00041385251097381115
gene O 0 3.006453752618654e-08
mutations O 0 8.980543242387284e-08
. O 0 1.0007881456886025e-07

The O 0 6.6279755017717434e-09
first O 0 3.7175867939609475e-10
, O 0 8.661760544925734e-12
1195delC O 0 1.1284505774256104e-08
located O 0 9.680237167408734e-11
in O 0 4.597895328362078e-11
exon O 0 3.172176965549056e-09
7 O 0 1.0072586320575283e-08
, O 0 4.07884099759559e-12
is O 0 2.639158152000637e-13
a O 0 1.7333129289504035e-13
novel O 0 1.2318171656311439e-11
mutation O 0 2.1235992565121764e-12
, O 0 2.878384108753046e-13
while O 0 1.1305681868120643e-12
the O 0 9.672295950280407e-12
second O 0 1.3312421998090684e-10
, O 0 4.227302969478375e-12
1936delG O 0 4.621833138429565e-09
in O 0 3.370200230001785e-10
exon O 0 8.68294158795635e-10
12 O 0 4.945749920715059e-10
, O 0 5.2435725032828895e-12
has O 0 5.322021035675251e-13
been O 0 1.6195228751819668e-12
described O 0 6.871989522566624e-12
before O 0 2.690455358500543e-10
to O 0 1.0628457142169978e-10
cause O 0 7.32565183625411e-07
C6D B-Disease 1 0.9999998807907104
in O 0 3.33328942225819e-09
an O 0 1.0712358734440985e-12
unrelated O 0 3.727351316484828e-09
African O 0 3.960157549109944e-11
- O 0 1.0873408423650588e-10
American O 0 1.2787586094187287e-11
individual O 0 2.5551585153271716e-11
. O 0 1.2880324584685354e-09

Both O 0 1.1180000925037348e-08
mutations O 0 1.2275849226028868e-09
result O 0 8.335739043463519e-11
in O 0 2.554078060157394e-10
premature O 0 4.092427388968645e-06
termination O 0 7.841406841180287e-06
codons O 0 2.2630518969890545e-07
and O 0 1.2096352364210361e-08
C6 O 0 0.00010982272942783311
null O 0 2.7869612040376524e-06
alleles O 0 7.590291062342658e-09
. O 0 1.080544098641667e-08

Allele O 0 5.958881388323789e-09
- O 0 5.393716584478625e-10
specific O 0 2.917576250038856e-11
PCR O 0 9.796685684904105e-10
indicated O 0 1.0772197717168197e-10
that O 0 7.80126153563862e-14
the O 0 2.4438293402817557e-11
probands O 0 2.508264333300758e-05
two O 0 7.780073807417409e-10
brothers O 0 1.8011791169669777e-08
also O 0 2.0486798021912556e-11
inherited O 0 1.7806872421033404e-08
the O 0 6.0539901980405375e-09
1195delC O 0 1.5971882305620966e-07
mutation O 0 6.167917843136195e-10
from O 0 7.975543836469257e-11
their O 0 2.7640251198945975e-10
heterozygous O 0 7.308531557725928e-11
mother O 0 1.123880710718339e-10
and O 0 1.2759245699919819e-12
the O 0 2.4472672152664465e-11
1936delG O 0 2.3653260683431654e-08
mutation O 0 3.259278402722998e-10
from O 0 9.523835192704055e-11
their O 0 1.4492460564952125e-09
homozygous O 0 2.0163393177341504e-09
father O 0 3.1541498302090076e-09
. O 0 4.353069016360678e-10
. O 0 4.175717549514957e-09

PAX6 O 0 0.08222511410713196
mutations O 0 1.1099568837380502e-05
reviewed O 0 8.535055712854955e-06
. O 0 5.244853582553333e-07

Mutations O 0 2.6181555767834652e-06
in O 0 1.214267619786824e-08
PAX6 O 0 0.05823420360684395
are O 0 3.2846159125909935e-10
responsible O 0 1.9339040091548299e-10
for O 0 1.3592214853641593e-10
human O 0 1.3351370853342814e-07
aniridia B-Disease 1 1.0
and O 0 0.044169023633003235
have O 0 1.792026438351968e-08
also O 0 6.701285793636602e-12
been O 0 7.247044761168886e-13
found O 0 6.737741874845993e-14
in O 0 1.0795031725073165e-13
patients O 0 3.8055543959136795e-12
with O 0 6.061588676744417e-14
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 6.118074935557161e-10
with O 0 7.872657192820043e-09
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 3.9389880157614243e-07
with O 0 6.380292205676596e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999988079071045
keratitis I-Disease 1 0.9999998807907104
, O 0 8.123270944793148e-10
and O 0 4.882722698384967e-11
with O 0 4.1712097664792225e-10
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9999765157699585

No O 0 8.005026863600051e-09
locus O 0 3.706555617988272e-10
other O 0 7.239795134922344e-12
than O 0 7.498674424455398e-12
chromosome O 0 6.235661431652773e-10
11p13 O 0 1.673944325375487e-07
has O 0 2.7849266295842945e-11
been O 0 3.460889907991316e-11
implicated O 0 2.3278888539035592e-10
in O 0 8.530571804499232e-10
aniridia B-Disease 1 1.0
, O 0 2.3547555016989463e-09
and O 0 8.684565289129864e-10
PAX6 O 0 0.00021221814677119255
is O 0 2.6005251771432647e-11
clearly O 0 5.063717847808569e-11
the O 0 3.598625911149789e-11
major O 0 1.650000358566217e-09
, O 0 2.7214762561567074e-12
if O 0 4.757292216411857e-12
not O 0 9.960122136776217e-12
only O 0 1.684786685163253e-11
, O 0 8.349435726140442e-12
gene O 0 4.0259899580785685e-11
responsible O 0 6.8159984323301614e-09
. O 0 8.199341436920804e-07

Twenty O 0 1.8732734474724566e-07
- O 0 3.929959646598036e-08
eight O 0 4.798707542441605e-10
percent O 0 1.7120961592897999e-10
of O 0 1.3106724039424478e-11
identified O 0 6.390748485962661e-10
PAX6 O 0 0.0033499919809401035
mutations O 0 3.452127117498094e-08
are O 0 5.891050425255173e-10
C O 0 6.251511877053417e-07
- O 0 1.521128467629751e-08
T O 0 7.787132716430278e-08
changes O 0 6.471916336181494e-10
at O 0 7.866229334574371e-10
CpG O 0 5.901549116060778e-08
dinucleotides O 0 8.92678286845694e-08
, O 0 9.155694431772776e-12
20 O 0 4.9131591156603704e-11
% O 0 1.311357055930329e-12
are O 0 1.118619492824699e-14
splicing O 0 6.986110995255146e-11
errors O 0 1.751135236816026e-08
, O 0 2.9186004307790725e-11
and O 0 1.2398740020791443e-11
more O 0 1.337588568552095e-12
than O 0 3.324541380037016e-12
30 O 0 2.0360130248420205e-10
% O 0 9.564753503110701e-12
are O 0 8.903544812229394e-14
deletion O 0 6.212162294988444e-12
or O 0 7.0608709851205376e-12
insertion O 0 8.380188210033168e-10
events O 0 5.01021779619748e-10
. O 0 3.159498263016758e-08

There O 0 1.4673952053456674e-09
is O 0 7.320694397905392e-12
a O 0 5.0357162016678725e-12
noticeably O 0 2.9534487566706957e-07
elevated O 0 1.8926217535408796e-06
level O 0 1.2466151666501446e-08
of O 0 4.02399613630422e-10
mutation O 0 3.486663735507989e-11
in O 0 2.930040238213749e-11
the O 0 8.28857329993049e-11
paired O 0 9.702858308480167e-12
domain O 0 1.0562327922014614e-11
compared O 0 3.461167463747472e-11
with O 0 7.590011518593398e-14
the O 0 1.9221978175831822e-11
rest O 0 4.536034325930416e-10
of O 0 3.689716934762721e-11
the O 0 7.736671303604226e-10
gene O 0 3.634004763775067e-10
. O 0 2.996560866108666e-08

Increased O 0 2.168972557115012e-08
mutation O 0 7.535386203905148e-10
in O 0 9.70870779604116e-12
the O 0 6.447960915201278e-11
homeodomain O 0 1.1601111538084297e-07
is O 0 1.298642833894026e-12
accounted O 0 1.3338619271607843e-11
for O 0 3.8398480223375206e-14
by O 0 3.8574674596052183e-13
the O 0 1.565502172340416e-10
hypermutable O 0 1.3668071687789052e-06
CpG O 0 3.070772152113932e-07
dinucleotide O 0 5.845345540933522e-08
in O 0 1.7465913160208402e-09
codon O 0 1.935334026370583e-08
240 O 0 6.313382261424749e-09
. O 0 3.463026088112997e-09

Very O 0 1.3200731530105259e-07
nearly O 0 6.058364365735258e-10
all O 0 2.6540524986073954e-11
mutations O 0 1.9313963622868968e-11
appear O 0 2.0258339450407448e-09
to O 0 3.570627821192218e-11
cause O 0 5.850476014757078e-08
loss O 0 6.487285020284617e-08
of O 0 3.6698526884038074e-08
function O 0 9.208524498482973e-10
of O 0 1.173782848695737e-09
the O 0 3.534662007531608e-10
mutant O 0 4.238771833531274e-10
allele O 0 3.758623967620167e-11
, O 0 5.87062679285183e-13
and O 0 1.243852162111439e-13
more O 0 2.824427805081086e-14
than O 0 7.884539104507232e-14
80 O 0 8.803065047746639e-12
% O 0 6.112746485202603e-13
of O 0 1.3320891698725967e-12
exonic O 0 1.9975756160306446e-08
substitutions O 0 9.177839044305358e-10
result O 0 2.7104207767081334e-09
in O 0 2.6373017103509255e-09
nonsense O 0 3.354012108047755e-07
codons O 0 7.261937184921408e-08
. O 0 3.808117909898101e-08

In O 0 1.0053642363061499e-08
a O 0 6.856229473051201e-11
gene O 0 1.5545276871309355e-11
with O 0 8.600170814214436e-13
such O 0 1.437841623541658e-09
extraordinarily O 0 1.1259527354923193e-07
high O 0 1.6589007145739743e-07
sequence O 0 7.232928700418029e-10
conservation O 0 8.295714337691606e-09
throughout O 0 7.97095098259426e-11
evolution O 0 3.7091582583137495e-10
, O 0 1.971285331150985e-12
there O 0 6.919231680668769e-12
are O 0 3.4734149584325635e-11
presumed O 0 2.929604079326964e-07
undiscovered O 0 1.5776573491166346e-05
missense O 0 2.547912345107761e-06
mutations O 0 1.2291669904129776e-08
, O 0 4.774365625070942e-11
these O 0 2.6897817306803518e-11
are O 0 3.188690630984148e-12
hypothesized O 0 5.307634332041289e-10
to O 0 9.830616182204821e-11
exist O 0 2.0207899797952678e-09
in O 0 3.5582289892310826e-10
as O 0 1.259294779565323e-09
- O 0 1.1880728401081342e-08
yet O 0 1.7344738978408714e-09
unidentified O 0 3.9223174708169495e-10
phenotypes O 0 1.3377162488836802e-08
. O 0 1.0046519866024894e-10
. O 0 1.42135325731374e-09

Genetic O 0 4.441242253960809e-07
heterogeneity O 0 1.0158311170016532e-07
and O 0 9.128044153872139e-11
penetrance O 0 7.997766005019002e-08
analysis O 0 2.0191003383129846e-11
of O 0 3.452623742461469e-10
the O 0 1.6677171288392856e-07
BRCA1 O 0 2.618967073431122e-06
and O 0 6.080991852286388e-07
BRCA2 O 0 1.1476690815470647e-06
genes O 0 8.250112593088943e-09
in O 0 2.1879362321897133e-08
breast B-Disease 1 0.9997877478599548
cancer I-Disease 0 0.020175116136670113
families O 0 9.409876611243817e-08
. O 0 4.848582761951548e-07

The O 0 0.0009923031320795417
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.5727385693462566e-05
Consortium O 0 3.4232833456826484e-08
. O 0 2.1171073782966232e-09

The O 0 3.1296623625998166e-10
contribution O 0 4.093538397142993e-09
of O 0 3.798887870942735e-09
BRCA1 O 0 4.9209507579917044e-08
and O 0 9.657711075305997e-09
BRCA2 O 0 2.0905977180518676e-06
to O 0 1.381101014885644e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 4.6440862888630363e-07
assessed O 0 2.8546194741352338e-08
by O 0 4.7285089038728856e-11
linkage O 0 2.6583566459237318e-09
and O 0 7.162056971793396e-12
mutation O 0 1.739214241375242e-13
analysis O 0 3.022681795616586e-14
in O 0 4.19829102038527e-14
237 O 0 1.572087252044163e-11
families O 0 1.448508522329528e-12
, O 0 2.3292787715441764e-14
each O 0 1.8547751496570536e-15
with O 0 4.2311201539483624e-15
at O 0 5.900782900497559e-12
least O 0 1.005459929724617e-12
four O 0 1.8531388514095477e-14
cases O 0 3.5035967183016936e-11
of O 0 3.370595536011933e-08
breast B-Disease 0 0.0008768823463469744
cancer I-Disease 0 2.8150566322437953e-08
, O 0 3.0162845962231066e-13
collected O 0 3.909362417120477e-12
by O 0 2.556590356084243e-12
the O 0 8.188768561012694e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 9.337912132423298e-08
Consortium O 0 1.0300673647378744e-09
. O 0 1.6802627345047227e-10

Families O 0 9.438418047125197e-09
were O 0 4.172099124510886e-11
included O 0 1.9890742698758235e-12
without O 0 7.522511259738796e-12
regard O 0 3.084922317597716e-10
to O 0 2.302507414331939e-13
the O 0 3.778835751255816e-12
occurrence O 0 1.0082850110393338e-08
of O 0 2.439676427457016e-05
ovarian B-Disease 1 1.0
or I-Disease 0 9.376609523314983e-05
other I-Disease 0 4.26308633905137e-06
cancers I-Disease 0 0.02216564677655697
. O 0 3.2549087336519733e-07

Overall O 0 0.0007212929194793105
, O 0 2.724431880096745e-08
disease O 0 0.00021185462537687272
was O 0 2.8887482130812714e-06
linked O 0 1.7137668692157604e-05
to O 0 6.730678023814107e-07
BRCA1 O 0 7.816877882760309e-07
in O 0 4.881477444484972e-10
an O 0 7.945831763823269e-14
estimated O 0 4.2182819737224264e-12
52 O 0 6.531387930497345e-11
% O 0 1.1051076503551527e-12
of O 0 7.180632390774155e-12
families O 0 4.367354394796408e-11
, O 0 4.2147455664443e-11
to O 0 3.065889098152752e-09
BRCA2 O 0 3.867135234258967e-08
in O 0 7.956221237392924e-10
32 O 0 5.310388795365384e-10
% O 0 7.459925147230984e-13
of O 0 6.946084332715152e-13
families O 0 1.7812883329818008e-12
, O 0 2.7609175796278196e-13
and O 0 1.9395466135940787e-12
to O 0 2.0163757816216155e-11
neither O 0 1.5619892046458972e-09
gene O 0 9.868389959366564e-12
in O 0 1.2857588604919812e-10
16 O 0 3.5970010303643107e-10
% O 0 3.0259670637244884e-12
( O 0 7.844514426057214e-15
95 O 0 1.325025644760558e-10
% O 0 8.556521810532125e-12
confidence O 0 3.2422584061997384e-10
interval O 0 5.315647921833033e-10
[ O 0 2.959739786589921e-09
CI O 0 2.888142262236215e-06
] O 0 3.78417686075494e-10
6 O 0 9.247470844631067e-11
% O 0 1.4283300020165313e-12
- O 0 1.2053495354602539e-11
28 O 0 1.991806025669618e-10
% O 0 4.450102612796325e-12
) O 0 4.446322596132063e-14
, O 0 2.8857501783129125e-13
suggesting O 0 2.4530164011160593e-10
other O 0 3.1086508922584244e-09
predisposition O 0 0.001040829112753272
genes O 0 6.0713714447047096e-06
. O 0 8.880300015334797e-07

The O 0 8.068180790132828e-09
majority O 0 2.952791344768002e-10
( O 0 1.2195921356150663e-12
81 O 0 1.3128504949833086e-09
% O 0 5.120363768401637e-13
) O 0 2.5050584368901778e-15
of O 0 3.184928015764754e-12
the O 0 2.734424742811825e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.7467077784161233e-09
were O 0 7.429627225941093e-12
due O 0 1.1924059517554042e-09
to O 0 3.42258776875326e-10
BRCA1 O 0 2.905294338440001e-10
, O 0 4.668774047922319e-13
with O 0 2.1225764743927622e-14
most O 0 4.665046560853314e-12
others O 0 2.975629508419897e-12
( O 0 5.1383823953567165e-14
14 O 0 2.2459398923979634e-11
% O 0 9.527386475235988e-13
) O 0 2.6147258254502655e-14
due O 0 6.919374406777479e-09
to O 0 9.170305759198527e-08
BRCA2 O 0 1.1671032552840188e-05
. O 0 7.746940013930725e-07

Conversely O 0 3.7181263223828864e-07
, O 0 1.6766185662042687e-11
the O 0 6.888195309279199e-12
majority O 0 2.2012931841924877e-12
of O 0 2.5488843674592587e-11
families O 0 2.8040883850999343e-11
with O 0 4.89078992148978e-13
male B-Disease 0 4.356325022936147e-10
and I-Disease 0 7.206719943031459e-11
female I-Disease 0 7.27543303380429e-10
breast I-Disease 0 1.4009476672072196e-06
cancer I-Disease 0 2.179069369390163e-08
were O 0 2.249409269960978e-10
due O 0 1.9077178876614198e-05
to O 0 6.3754993107068e-07
BRCA2 O 0 5.048103162152984e-07
( O 0 9.199228184764152e-12
76 O 0 1.1390117293785806e-08
% O 0 1.2627811123155919e-11
) O 0 1.6328189072090799e-13
. O 0 1.5531888275521766e-10

The O 0 1.5192407332165203e-08
largest O 0 2.0828976321496384e-09
proportion O 0 8.646038884840834e-10
( O 0 3.881253771067378e-13
67 O 0 1.2329955112466706e-10
% O 0 1.6940200869668132e-13
) O 0 3.2883809539837987e-15
of O 0 2.2595821047577402e-11
families O 0 5.613851397634484e-11
due O 0 1.3243393368611578e-05
to O 0 9.013370316779401e-08
other O 0 4.792592989133482e-08
genes O 0 1.0756291413116514e-09
was O 0 1.507230229513823e-09
found O 0 1.996068241250093e-11
in O 0 2.4698321512972576e-11
families O 0 6.837437560580639e-11
with O 0 6.479268076925448e-13
four O 0 1.3563998015053702e-12
or O 0 8.325386820912106e-13
five O 0 6.776083329423227e-14
cases O 0 4.322782149596138e-12
of O 0 4.709717615902775e-10
female O 0 1.2501682533638814e-07
breast B-Disease 0 0.006655453238636255
cancer I-Disease 0 1.71296892403916e-06
only O 0 1.9461754430238898e-09
. O 0 1.7474725666488666e-07

These O 0 2.011453226202775e-09
estimates O 0 8.795722483689872e-10
were O 0 9.601878320220081e-12
not O 0 2.0971139321618315e-12
substantially O 0 1.4192598207785068e-08
affected O 0 1.9161707776049752e-09
either O 0 1.4105463325142509e-11
by O 0 1.1509310214943835e-12
changing O 0 5.738045039116457e-10
the O 0 5.628346746999746e-11
assumed O 0 5.478979492323788e-10
penetrance O 0 1.1559141199768419e-08
model O 0 1.580463954153899e-10
for O 0 9.352445207166937e-11
BRCA1 O 0 8.197670320342354e-10
or O 0 1.6222063839790857e-12
by O 0 1.701935169401772e-13
including O 0 2.022919592253869e-12
or O 0 1.401290972147251e-09
excluding O 0 2.5203496534231817e-06
BRCA1 O 0 1.2076115751824545e-07
mutation O 0 3.06154146478832e-09
data O 0 1.1467583549418237e-09
. O 0 4.4246930563929254e-09

Among O 0 3.444600826796318e-09
those O 0 7.716492028686517e-11
families O 0 3.1913874320999014e-11
with O 0 2.3637054770084265e-13
disease O 0 2.274885169128993e-08
due O 1 0.9778826832771301
to O 0 4.889985802947194e-07
BRCA1 O 0 4.29509441346454e-08
that O 0 6.013826589490456e-12
were O 0 4.881344634055651e-11
tested O 0 9.747469324750124e-12
by O 0 4.089955641956716e-13
one O 0 2.6136352197086987e-13
of O 0 2.451053411883092e-13
the O 0 1.322286870926101e-13
standard O 0 1.7871756591986143e-12
screening O 0 2.1727081939149073e-11
methods O 0 2.425233625036327e-10
, O 0 4.849881347218643e-12
mutations O 0 1.1610231873127042e-11
were O 0 3.2958094586810205e-11
detected O 0 2.270012400273913e-09
in O 0 9.991960731037253e-11
the O 0 6.754444226153566e-10
coding O 0 5.357944754535993e-09
sequence O 0 3.4185360098248907e-10
or O 0 6.019498788312205e-11
splice O 0 2.6425586163725256e-09
sites O 0 2.5788227109302397e-10
in O 0 1.4911123551175631e-12
an O 0 4.526325959143063e-15
estimated O 0 7.400022435100073e-13
63 O 0 2.2465238003199772e-10
% O 0 5.190297844293035e-12
( O 0 1.1681032931285668e-13
95 O 0 1.6178303141600736e-09
% O 0 9.02214761233644e-11
CI O 0 5.229799171502236e-07
51 O 0 6.500667781850211e-10
% O 0 1.3782705012010954e-11
- O 0 4.836067657443266e-10
77 O 0 1.0656677762455047e-09
% O 0 1.262376574800994e-11
) O 0 3.7560831723550125e-13
. O 0 4.707866874120725e-10

The O 0 5.207331010836924e-09
estimated O 0 1.7445393740711523e-10
sensitivity O 0 9.877835216443032e-10
was O 0 2.8602134549693403e-10
identical O 0 4.777854847870522e-11
for O 0 3.740376335482215e-13
direct O 0 4.70627356530251e-12
sequencing O 0 5.365806687862573e-10
and O 0 1.277710229286022e-11
other O 0 5.26208720694199e-12
techniques O 0 1.9824377694988016e-09
. O 0 3.99397048767014e-09

The O 0 6.029296883980351e-08
penetrance O 0 0.0009440121939405799
of O 0 3.85102703148732e-06
BRCA2 O 0 9.004114644994843e-07
was O 0 1.3003667587163648e-10
estimated O 0 8.626637815548066e-13
by O 0 1.1299380891669972e-13
maximizing O 0 3.4721980846086353e-10
the O 0 4.5276671301053284e-10
LOD O 0 0.0010183375561609864
score O 0 3.104741708170877e-08
in O 0 2.203169868764121e-09
BRCA2 O 0 1.0478907519484437e-08
- O 0 1.076302780234073e-08
mutation O 0 3.326453834606724e-10
families O 0 1.7734039930994427e-11
, O 0 7.48809041574254e-14
over O 0 2.7218955171368076e-13
all O 0 1.3352383435027981e-12
possible O 0 1.0083422985474044e-09
penetrance O 0 6.908892828505486e-06
functions O 0 1.0114844073427776e-08
. O 0 1.0862081012419367e-08

The O 0 3.4360944645150937e-10
estimated O 0 1.718147152329763e-11
cumulative O 0 5.24053855865958e-10
risk O 0 5.026001281827064e-10
of O 0 7.563450421521623e-10
breast B-Disease 0 2.5452989120822167e-06
cancer I-Disease 0 1.2919826986035332e-07
reached O 0 8.384064642541489e-08
28 O 0 2.517063251161744e-07
% O 0 8.970121867513114e-11
( O 0 4.3642335838950386e-14
95 O 0 3.957561778289431e-10
% O 0 1.0646691861460056e-11
CI O 0 2.627632511575939e-08
9 O 0 6.172340416554789e-11
% O 0 9.489827543576745e-13
- O 0 1.1053442883213194e-11
44 O 0 1.8524667910746473e-11
% O 0 6.619898585465828e-14
) O 0 1.7250912555286476e-16
by O 0 3.118994862730262e-14
age O 0 1.7809367869325854e-10
50 O 0 1.0638511772909087e-11
years O 0 1.3838489815870547e-12
and O 0 2.285631970147528e-12
84 O 0 1.070685873294508e-09
% O 0 2.592065668008403e-12
( O 0 2.3790826147768347e-14
95 O 0 2.040040081308092e-10
% O 0 1.0837706600208552e-11
CI O 0 5.4842438146351924e-08
43 O 0 1.8025554660017207e-10
% O 0 7.716278245702146e-13
- O 0 5.345728200378819e-12
95 O 0 5.16787689031073e-11
% O 0 7.656181732432904e-14
) O 0 1.4568179216830815e-16
by O 0 4.629029635733889e-14
age O 0 1.5747956272349484e-09
70 O 0 3.888172839250359e-10
years O 0 3.573136786449993e-10
. O 0 1.0355797108729803e-08

The O 0 4.910529582957679e-07
corresponding O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 5.746193210143247e-07
were O 0 8.178554500304358e-10
0 O 0 6.304898381159774e-09
. O 0 5.296489358208589e-10

4 O 0 3.0088634161984373e-07
% O 0 1.3182955838075827e-09
( O 0 2.6946537449307195e-12
95 O 0 5.021270510496834e-09
% O 0 1.4874325382496778e-10
CI O 0 2.970413675029704e-07
0 O 0 1.1455730114517948e-10
% O 0 8.395982476969155e-13
- O 0 5.014161395117123e-12
1 O 0 1.9542823956331112e-11
% O 0 1.0189718264042719e-13
) O 0 2.060399438564409e-16
by O 0 3.2150392509930695e-14
age O 0 1.8943117907621598e-10
50 O 0 1.0421965374041164e-11
years O 0 9.93338549436229e-13
and O 0 1.4563095738009957e-12
27 O 0 1.5162727740047899e-09
% O 0 5.495300395286229e-12
( O 0 2.023014019486829e-14
95 O 0 1.5365642092035614e-10
% O 0 2.7535194176836475e-12
CI O 0 4.380573681572741e-09
0 O 0 5.122447171296285e-12
% O 0 1.517299469660366e-13
- O 0 4.88302757603587e-12
47 O 0 3.817347479784239e-11
% O 0 1.156625657880092e-13
) O 0 4.54209824201653e-16
by O 0 1.562245206246024e-13
age O 0 3.3383669162390106e-09
70 O 0 5.779884904022481e-10
years O 0 2.007293914418895e-10
. O 0 1.4089835964625763e-08

The O 0 1.6028935956313717e-09
lifetime O 0 5.3775128350253e-08
risk O 0 7.734184492846907e-08
of O 0 3.432640198752779e-07
breast B-Disease 1 0.9999159574508667
cancer I-Disease 0 0.002847388619557023
appears O 0 2.7368379562631162e-08
similar O 0 5.609722131261208e-10
to O 0 4.915186035958641e-10
the O 0 6.461722534822911e-08
risk O 0 3.468005260742757e-08
in O 0 1.1953822376398193e-09
BRCA1 O 0 3.9006870650171166e-11
carriers O 0 4.80083594406322e-12
, O 0 1.3758108151004644e-13
but O 0 5.252137700445525e-13
there O 0 9.64355440120912e-13
was O 0 1.2836876527033692e-11
some O 0 9.178823066197106e-13
suggestion O 0 1.385956460708826e-09
of O 0 9.521092941833231e-11
a O 0 8.78579223262399e-11
lower O 0 1.7553172710904619e-06
risk O 0 4.388275520739171e-09
in O 0 4.093887728817691e-10
BRCA2 O 0 1.1007652567229798e-09
carriers O 0 1.984316877479131e-10
< O 0 3.345799637344271e-09
50 O 0 4.9534883139745745e-11
years O 0 3.3292368428056163e-12
of O 0 9.97986068784762e-12
age O 0 1.2357395995366005e-08
. O 0 2.5588690277800197e-08

Eye B-Disease 1 0.9247452020645142
movement I-Disease 0 7.871074672038958e-07
abnormalities I-Disease 0 2.2300645241557504e-07
correlate O 0 2.69753219761526e-09
with O 0 1.2820916203692967e-12
genotype O 0 1.4623533672875055e-07
in O 0 4.1615466628286413e-10
autosomal O 1 0.999652624130249
dominant O 1 0.9999946355819702
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 3.8851926547067706e-06

We O 0 3.654121227825158e-09
compared O 0 1.3776812579635589e-08
horizontal O 0 9.61652162345672e-08
eye O 0 1.655395135458093e-05
movements O 0 2.894032036238059e-07
( O 0 3.9580276556261396e-11
visually O 0 3.648673030376415e-10
guided O 0 1.3146840560640527e-10
saccades O 0 7.234684407109171e-09
, O 0 2.064238753887726e-12
antisaccades O 0 1.3007128707442916e-08
, O 0 8.224035168147292e-12
and O 0 4.095601895820478e-12
smooth O 0 1.1530085913813437e-10
pursuit O 0 2.557373479650238e-10
) O 0 7.739666654967003e-14
in O 0 5.229250192584356e-12
control O 0 1.1612059092058757e-09
subjects O 0 2.3256633951973527e-08
( O 0 4.4298435362619126e-13
n O 0 3.043106738820356e-11
= O 0 1.3527162029403073e-11
14 O 0 3.127291828275425e-11
) O 0 1.3170740268807907e-13
and O 0 5.1764074797400195e-12
patients O 0 1.411777084125987e-10
with O 0 2.334509369400061e-14
three O 0 9.269742227502667e-14
forms O 0 2.2323949355751438e-09
of O 0 2.81924883438478e-07
autosomal O 1 0.9980781078338623
dominant O 1 0.8698056936264038
cerebellar B-Disease 1 0.9999978542327881
ataxias I-Disease 0 9.86903251032345e-05
type I-Disease 0 0.00017532646597828716
I I-Disease 0 0.0012749964371323586
spinocerebellar B-Disease 0 0.08498016744852066
ataxias I-Disease 0 3.0350185625138693e-05
1 I-Disease 0 1.5516158669015567e-07
and I-Disease 0 1.3470011217542321e-10
2 I-Disease 0 1.4245259416512113e-09
( O 0 9.160301640484536e-13
SCA1 B-Disease 0 1.4695277059217915e-05
, O 0 2.1980217992934037e-11
n O 0 2.094944009933819e-11
= O 0 4.743511139437828e-12
11 O 0 2.3273182426369887e-12
; O 0 5.250565607295421e-13
SCA2 B-Disease 0 9.963064258045051e-07
, O 0 8.371153596697933e-12
n O 0 2.174731401904939e-11
= O 0 7.644647068150157e-12
10 O 0 1.5451797827359393e-12
) O 0 6.304714237660713e-14
and O 0 3.3665494003631835e-11
SCA3 B-Disease 1 1.0
/ O 0 0.00027819484239444137
Machado B-Disease 0 1.8824356118329888e-07
- I-Disease 0 5.911113021284109e-07
Joseph I-Disease 0 4.314317266107537e-06
disease I-Disease 0 1.3404974197328556e-06
( O 0 3.5719493335362174e-11
MJD B-Disease 1 1.0
) O 0 5.876962805295705e-11
( O 0 1.185148442058026e-12
n O 0 1.9801504880234688e-10
= O 0 2.0071101725083196e-10
16 O 0 2.560760770098369e-10
) O 0 2.9847582738717904e-12
. O 0 9.381678767184098e-10

In O 0 1.393663051629801e-08
SCA1 B-Disease 0 2.7416941520641558e-05
, O 0 2.4442442861372093e-11
saccade O 0 1.2384429037837208e-09
amplitude O 0 7.292966786032196e-10
was O 0 1.1068210584164184e-11
significantly O 0 2.709830138059033e-10
increased O 0 2.1564056096323725e-10
, O 0 2.2501451656803395e-12
resulting O 0 5.042795625520569e-10
in O 0 5.896142463157616e-10
hypermetria B-Disease 0 2.1359835955081508e-05
. O 0 2.65786667341672e-07

The O 0 5.795839363997857e-09
smooth O 0 3.800512970997261e-08
pursuit O 0 3.331689413244021e-08
gain O 0 2.1512027714720716e-08
was O 0 3.5528460173850362e-09
decreased O 0 1.2067429224771331e-06
. O 0 6.617860037749779e-08

In O 0 3.675618032161765e-08
SCA2 B-Disease 0 0.00021757801005151123
, O 0 8.307914772798242e-11
saccade O 0 4.495160244033514e-09
velocity O 0 2.0124240052155073e-09
was O 0 2.379129560026172e-09
markedly O 0 1.8719192667049356e-05
decreased O 0 5.477184458868578e-06
. O 0 7.405561319728804e-08

The O 0 3.577912410790418e-09
percentage O 0 7.07695662072183e-08
of O 0 6.301517085915975e-10
errors O 0 8.000357638593414e-07
in O 0 8.151572927772577e-08
antisaccades O 1 0.999936580657959
was O 0 2.3057879161569872e-07
greatly O 0 3.157191770242207e-07
increased O 0 1.5566604005812223e-08
and O 0 9.980259674247094e-12
was O 0 1.6298178084905857e-11
significantly O 0 1.6994400331427073e-10
correlated O 0 4.708441969647481e-10
with O 0 8.79437920598726e-14
age O 0 6.465426527491047e-10
at O 0 4.384799121015526e-11
disease O 0 2.1759161139556227e-09
onset O 0 3.238198758026556e-07
. O 0 1.3588864078428742e-07

In O 0 1.2536104376792423e-09
addition O 0 1.738049704158584e-10
, O 0 1.9424416502350494e-12
a O 0 2.4351955998577757e-13
correlation O 0 6.807591057707285e-13
between O 0 3.230699128359271e-12
smooth O 0 9.265784250978015e-10
pursuit O 0 1.6547435643943231e-09
gain O 0 2.193620979307198e-10
and O 0 3.934427382414757e-13
the O 0 5.460611997298859e-12
number O 0 3.0994592309374625e-11
of O 0 3.342340848533354e-10
trinucleotide O 0 7.049015948723536e-07
repeats O 0 1.134289329129956e-09
was O 0 3.8768208088235667e-10
found O 0 1.828896201150343e-10
. O 0 4.605096748377946e-09

In O 0 2.0979547343813465e-07
SCA3 B-Disease 1 1.0
, O 0 5.027338545460225e-08
gaze B-Disease 0 1.0439473953738343e-05
- I-Disease 0 1.451378921046853e-06
evoked I-Disease 0 7.302271569642471e-07
nystagmus I-Disease 0 3.18229979257012e-07
was O 0 3.3353803052804665e-10
often O 0 2.2091501804960556e-12
present O 0 2.504001780229137e-12
as O 0 6.520664000073118e-13
was O 0 1.3336354590109956e-11
saccade O 0 1.6459612561803283e-09
hypometria O 0 1.0165191355326897e-07
and O 0 6.650610617775499e-11
smooth O 0 5.528656643605245e-09
pursuit O 0 4.2917509546214205e-09
gain O 0 6.028582077988176e-09
was O 0 3.0879792056737188e-09
markedly O 0 3.1520092306891456e-05
decreased O 0 3.5251298413641052e-06
. O 0 2.9185546424059794e-08

Three O 0 8.49258274815412e-10
major O 0 5.862702545655907e-10
criteria O 0 4.933974118159767e-09
, O 0 1.9682469196147245e-11
saccade O 0 1.219131018359576e-09
amplitude O 0 2.3071357324599973e-10
, O 0 4.410141414383506e-13
saccade O 0 5.893283777647085e-11
velocity O 0 5.8144575959540035e-11
, O 0 5.998384081107311e-12
and O 0 2.017163346079709e-12
presence O 0 1.5423427812688573e-10
of O 0 6.126032303654938e-08
gaze B-Disease 0 1.996746323129628e-05
- I-Disease 0 4.610354835676844e-07
evoked I-Disease 0 3.5240438478467695e-07
nystagmus I-Disease 0 1.972940388839106e-08
, O 0 2.9034505919303677e-13
permitted O 0 4.3383933598373225e-12
the O 0 2.460765098633022e-12
correct O 0 1.780220276748068e-10
assignment O 0 6.647110639690368e-11
of O 0 6.387515516514952e-11
90 O 0 4.522022756248134e-10
% O 0 4.0307210694146e-12
of O 0 3.752476194357479e-12
the O 0 1.7916829131436884e-10
SCA1 B-Disease 1 0.9984099864959717
, O 0 6.610006986207395e-10
90 O 0 2.920502062409014e-09
% O 0 8.785652760856522e-12
of O 0 8.766837950036077e-12
the O 0 1.16336454358823e-10
SCA2 B-Disease 0 0.15027156472206116
, O 0 1.7679033237349984e-10
and O 0 2.2775170638311693e-11
93 O 0 4.754602822565346e-10
% O 0 4.2531161426918873e-13
of O 0 2.799158474453556e-13
the O 0 8.491926779818915e-12
patients O 0 6.081890546738578e-10
with O 0 1.2754847525386914e-11
SCA3 B-Disease 1 1.0
to O 0 3.479856241028756e-05
their O 0 1.6552863826291286e-06
genetically O 0 1.0043628208222799e-05
confirmed O 0 1.081112350220792e-05
patient O 1 0.9999997615814209
group O 0 1.1066016158967074e-11
and O 0 5.177333171554888e-13
, O 0 1.7185124850938038e-13
therefore O 0 5.974774147654571e-11
, O 0 1.3878113068466202e-12
may O 0 4.3885498013374047e-10
help O 0 1.0472168687769567e-09
orient O 0 8.961940238805255e-07
diagnoses O 0 6.734429007337894e-06
of O 0 1.3811173538158528e-08
SCA1 B-Disease 1 0.9868724346160889
, O 0 2.732125636839555e-10
SCA2 B-Disease 0 0.004953386262059212
, O 0 2.9506896925823867e-11
and O 0 4.867593828006278e-11
SCA3 B-Disease 1 1.0
at O 0 2.138756505232209e-09
early O 0 7.007658009428042e-09
clinical O 0 4.1251227433924953e-10
stages O 0 9.137839374062651e-10
of O 0 4.5270259763086074e-11
the O 0 9.297206893243981e-10
diseases O 0 1.2854002306994516e-07
. O 0 1.160975537928266e-09
. O 0 9.109478504853996e-09

Genetic O 0 4.5202511955722e-08
basis O 0 1.0274590206416079e-10
and O 0 2.377605219910234e-13
molecular O 0 7.059039984491644e-12
mechanism O 0 2.4197996384422993e-10
for O 0 1.7823097164804125e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 1.3498696716851555e-05

Ventricular B-Disease 1 0.9867924451828003
fibrillation I-Disease 0 0.16591788828372955
causes O 0 1.5611493608957971e-06
more O 0 1.577623275073048e-11
than O 0 9.966919867557267e-13
300 O 0 1.8797225061206735e-12
, O 0 4.9428065535938454e-14
000 O 0 1.1025985680035433e-11
sudden O 0 1.4151753770577646e-12
deaths O 0 1.1856367667165135e-12
each O 0 2.2050517336537345e-14
year O 0 2.5780641510486646e-11
in O 0 9.455634192301332e-11
the O 0 7.075954489010883e-09
USA O 0 2.7532573554367445e-08
alone O 0 1.192708598551917e-09
. O 0 1.5289842725252356e-09

In O 0 2.1990690157736026e-08
approximately O 0 1.2129978965713661e-10
5 O 0 5.260015201180579e-10
- O 0 1.1246982234425218e-09
12 O 0 2.9627938991083624e-10
% O 0 7.42856384045032e-12
of O 0 7.089111741208354e-13
these O 0 1.5080150398815578e-13
cases O 0 1.4662878116550315e-12
, O 0 3.563451346066254e-14
there O 0 5.087923287436062e-14
are O 0 1.237179117968357e-14
no O 0 8.979288124676132e-13
demonstrable O 0 1.2255501502522748e-08
cardiac O 0 1.503383032286365e-06
or O 0 1.5514635132163335e-09
non O 0 5.899506049900083e-06
- O 0 5.594262802333105e-06
cardiac O 0 0.024065475910902023
causes O 0 6.04009198212907e-09
to O 0 3.152785758159249e-12
account O 0 4.553105722310269e-12
for O 0 4.2729578556000014e-12
the O 0 1.0369157976697352e-08
episode O 0 1.4243691559556737e-08
, O 0 4.0915082194677155e-13
which O 0 2.3011672726841112e-14
is O 0 1.1641790233652555e-14
therefore O 0 1.3941069436015918e-12
classified O 0 2.18076667835021e-11
as O 0 9.660832550606457e-11
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999998807907104
fibrillation I-Disease 1 1.0
( O 0 2.271603172232517e-08
IVF B-Disease 1 1.0
) O 0 3.2656191639723886e-10
. O 0 4.607267012346483e-09

A O 0 5.378132641453703e-07
distinct O 0 1.356705325861185e-08
group O 0 1.5146524659503946e-11
of O 0 1.7626282655669456e-09
IVF B-Disease 1 1.0
patients O 1 1.0
has O 0 7.293544240782879e-12
been O 0 8.133553509523384e-13
found O 0 1.2154695110642988e-13
to O 0 8.168716625431977e-14
present O 0 1.0805054767581979e-11
with O 0 3.334452668406901e-13
a O 0 9.1372898830544e-12
characteristic O 0 7.53685558407824e-09
electrocardiographic O 0 8.053590931922372e-07
pattern O 0 4.152940391577431e-07
. O 0 2.8335229274034646e-08

Because O 0 3.399669523673765e-08
of O 0 1.368783753008529e-08
the O 0 9.211018614507793e-10
small O 0 6.905836579668145e-12
size O 0 4.679298615251071e-11
of O 0 5.573588812701757e-10
most O 0 3.111104707187451e-10
pedigrees O 0 3.962518757560929e-09
and O 0 8.616705439445926e-13
the O 0 8.851279626777286e-13
high O 0 2.5290004465605698e-11
incidence O 0 1.7599253651634506e-11
of O 0 3.3302659675077395e-12
sudden B-Disease 0 1.3433118506434027e-10
death I-Disease 0 5.30416555122315e-09
, O 0 1.3908222663838732e-11
however O 0 2.702387202901946e-10
, O 0 4.051284915179698e-12
molecular O 0 3.587762725798527e-11
genetic O 0 1.750808699407802e-11
studies O 0 8.244023953080104e-13
of O 0 1.0428287573749362e-11
IVF B-Disease 1 1.0
have O 0 3.750705024341272e-10
not O 0 6.257020596089902e-11
yet O 0 1.3816936483834752e-09
been O 0 7.075380559218303e-11
done O 0 1.0862178934090139e-09
. O 0 5.2694071328573955e-09

Because O 0 2.265134746437525e-08
IVF B-Disease 1 1.0
causes O 0 1.8945937654279987e-06
cardiac O 1 0.9997476935386658
rhythm O 0 0.00018468360940460116
disturbance O 0 1.1056295988964848e-05
, O 0 1.1080547070163593e-11
we O 0 4.6200725536960086e-12
investigated O 0 2.1653494275408747e-10
whether O 0 8.856224642528332e-10
malfunction O 0 8.797794180281926e-06
of O 0 3.462332864856421e-09
ion O 0 3.431062012282382e-08
channels O 0 1.9665602479790323e-09
could O 0 6.153966225497243e-11
cause O 0 1.469474053550357e-08
the O 0 9.603774442368262e-10
disorder O 0 1.4626427180530754e-08
by O 0 9.704190576109717e-12
studying O 0 8.297023623704547e-10
mutations O 0 3.045952032265653e-11
in O 0 6.026434559713856e-12
the O 0 3.5599803660524287e-10
cardiac O 0 4.148641323808988e-07
sodium O 0 1.7016463971231133e-06
channel O 0 9.087026597853765e-08
gene O 0 2.6003887931835834e-09
SCN5A O 0 0.004461533855646849
. O 0 1.1095070249211858e-06

We O 0 2.3939337623346546e-08
have O 0 1.6604209673865e-10
now O 0 9.771575042172298e-12
identified O 0 1.1836287158728531e-11
a O 0 3.61404526097453e-12
missense O 0 3.954849248088976e-08
mutation O 0 7.257001111149464e-10
, O 0 1.4489147728835583e-12
a O 0 5.437203963974679e-13
splice O 0 2.0871688821699763e-09
- O 0 2.2895974005621156e-09
donor O 0 1.599222976267356e-09
mutation O 0 1.0034570396832976e-10
, O 0 1.7770081738553711e-13
and O 0 5.5548562982472155e-14
a O 0 5.12847631115726e-13
frameshift O 0 2.579286340065323e-09
mutation O 0 4.064653821855835e-11
in O 0 1.0131531030799223e-11
the O 0 8.924216227113035e-11
coding O 0 1.315597852880046e-09
region O 0 3.8797204338081315e-10
of O 0 8.021437958305455e-10
SCN5A O 0 0.0055993772111833096
in O 0 3.667253167805029e-10
three O 0 1.5894334459698456e-10
IVF B-Disease 1 1.0
families O 0 2.058733405974067e-09
. O 0 8.650756777583979e-10

We O 0 8.918711102978705e-09
show O 0 3.768300255169166e-11
that O 0 7.25754024477436e-14
sodium O 0 3.815811902563304e-11
channels O 0 1.6523976197752033e-12
with O 0 1.2098252900796108e-14
the O 0 3.0149188701145135e-11
missense O 0 1.8311601124310073e-08
mutation O 0 1.8121527889380928e-10
recover O 0 1.1278840084116837e-09
from O 0 1.0431630385887569e-11
inactivation O 0 3.894110250257654e-06
more O 0 3.800070935006117e-12
rapidly O 0 1.5950578358125966e-10
than O 0 5.841663958117138e-13
normal O 0 2.1592289067839943e-10
and O 0 5.498600164598189e-13
that O 0 5.767637750861074e-14
the O 0 1.0038417319613302e-10
frameshift O 0 6.371050176312565e-08
mutation O 0 5.2562922764343156e-11
causes O 0 6.716773665038644e-11
the O 0 1.4010704055267276e-11
sodium O 0 4.65989358211516e-10
channel O 0 5.1404189932435784e-11
to O 0 6.981681942644369e-13
be O 0 2.8522257472518575e-11
non O 0 3.2412728501185484e-07
- O 0 1.0423932650382994e-07
functional O 0 4.1178560650223517e-07
. O 0 1.1001508148922312e-08

Our O 0 1.2775319468971702e-08
results O 0 5.287253967978245e-10
indicate O 0 1.1588517923044606e-09
that O 0 5.291234030785352e-12
mutations O 0 8.497957892927843e-11
in O 0 5.306011879868677e-11
cardiac O 0 1.2975758245659108e-08
ion O 0 2.0386572430197702e-08
- O 0 3.2431514682684792e-06
channel O 0 4.492657357246799e-09
genes O 0 1.4114236689122261e-11
contribute O 0 2.7023843232609757e-12
to O 0 8.024470302646358e-13
the O 0 1.1207504542476432e-11
risk O 0 1.6024984117457564e-10
of O 0 4.9583188249657795e-11
developing O 0 6.353296555516863e-08
IVF B-Disease 1 1.0
. O 0 4.793038410610961e-09
. O 0 1.825015472078917e-09

Molecular O 0 7.221397169132615e-08
heterogeneity O 0 3.636227745573706e-07
in O 0 4.991496549422436e-09
mucopolysaccharidosis B-Disease 0 0.0004274205130059272
IVA I-Disease 1 0.9999637603759766
in O 0 4.764493866105113e-08
Australia O 0 2.0049981119818483e-10
and O 0 1.120162816670156e-11
Northern O 0 1.1541444466800499e-09
Ireland O 0 8.123596795250876e-10
: O 0 8.115828321886287e-12
nine O 0 1.3513391794450769e-11
novel O 0 5.105798769888814e-11
mutations O 0 3.10589011107143e-12
including O 0 3.1842884991133136e-13
T312S O 0 2.0849656223731472e-08
, O 0 9.59312382135813e-13
a O 0 3.1528322704324485e-13
common O 0 6.229773641397429e-11
allele O 0 4.679343024172056e-11
that O 0 9.807022679836006e-14
confers O 0 4.253284668909174e-10
a O 0 2.5695221991806072e-11
mild O 0 1.0996577657351736e-06
phenotype O 0 1.4854124856356066e-05
. O 0 1.031519261118774e-07

Mucopolysaccharidosis B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
( O 0 1.2045745279465336e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.1245148041905129e-11
is O 0 2.4073161541439403e-13
an O 0 4.564625045132276e-13
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.537328557787987e-07
by O 0 5.110787487661028e-11
a O 0 1.2942561689044396e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.2086204037586867e-08
N O 0 8.120412786638553e-08
- O 0 7.128242884846259e-09
acetylgalactosamine O 0 6.857389962533489e-07
- O 0 4.116936835885099e-08
6 O 0 1.147546679902689e-08
- O 0 7.944655600056194e-09
sulfate O 0 2.4396182851660342e-08
sulfatase O 0 5.00299802297377e-06
( O 0 1.238801561331826e-10
GALNS O 1 0.9620917439460754
) O 0 2.9944210999666154e-10
. O 0 8.178277610682017e-09

Previous O 0 4.074385984154105e-08
studies O 0 1.473356853187724e-10
of O 0 4.33479745154397e-11
patients O 0 2.429140777415739e-10
from O 0 5.913681003222315e-13
a O 0 3.723582585931501e-14
British O 0 8.892641831237391e-12
- O 0 3.4952216121375557e-10
Irish O 0 5.585902296267875e-10
population O 0 2.905079063593441e-13
showed O 0 1.8934201808425838e-13
that O 0 4.024446232400681e-15
the O 0 7.643276636604135e-12
I113F O 0 2.5276781556726746e-08
mutation O 0 1.2084394596101333e-10
is O 0 9.014289965511568e-14
the O 0 1.0816445395606111e-13
most O 0 1.778906408571486e-14
common O 0 5.965612660981112e-13
single O 0 4.393478202774359e-12
mutation O 0 1.357949169777939e-10
among O 0 1.6584238149430774e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0005603646277450025
and O 0 1.3640955552618461e-11
produces O 0 2.2626787596347064e-11
a O 0 1.374421301596207e-12
severe O 0 7.71832873169842e-08
clinical O 0 5.14989778821473e-07
phenotype O 0 5.87645590712782e-05
. O 0 1.308302159941377e-07

We O 0 1.2383585712427703e-08
studied O 0 1.0659102933630038e-08
mutations O 0 1.9862253508584615e-10
in O 0 3.1939451083928816e-11
the O 0 7.901958531952857e-10
GALNS O 0 0.08894407749176025
gene O 0 3.997100428421163e-10
from O 0 2.0178579640539596e-10
23 O 0 2.4230570883077007e-09
additional O 0 1.0245910786466084e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.07728457450866699
( O 0 1.4239416666183419e-13
15 O 0 4.156988555464869e-12
from O 0 1.0623298031184336e-12
Australia O 0 5.985969098870614e-13
, O 0 1.0366640407427977e-13
8 O 0 3.807311237113975e-12
from O 0 1.3201102537496734e-12
Northern O 0 6.233910609942939e-11
Ireland O 0 6.606068556763711e-12
) O 0 5.681848221084085e-14
, O 0 3.197664911178989e-14
with O 0 7.247411255384504e-15
various O 0 5.695245663961401e-11
clinical O 0 1.4010089444127516e-07
phenotypes O 0 0.00012677727499976754
( O 0 1.1997558502230277e-10
severe O 0 5.403070417742128e-07
, O 0 6.490481069265641e-11
16 O 0 2.915990712781813e-11
cases O 0 6.6540588143648716e-12
; O 0 4.047282257599316e-13
intermediate O 0 1.1975371805306168e-08
, O 0 5.393924781653403e-13
4 O 0 1.8213482805284897e-11
cases O 0 4.015935500811807e-11
; O 0 7.50566137019959e-11
mild O 0 1.4912653796272934e-06
, O 0 3.513663249243848e-10
3 O 0 2.362024797974982e-09
cases O 0 3.440895346429329e-10
) O 0 4.814003362607622e-12
. O 0 3.960644701095362e-09

We O 0 6.498399898191565e-07
found O 0 4.776429030073359e-09
two O 0 2.1076411449438837e-11
common O 0 7.058979512031271e-10
mutations O 0 9.729957117787791e-11
that O 0 1.0591917967706088e-12
together O 0 1.895774683069451e-11
accounted O 0 2.0730130945167957e-09
for O 0 6.083833957448714e-12
32 O 0 4.391128571867853e-10
% O 0 3.1962473032859373e-12
of O 0 1.6949193784587813e-12
the O 0 4.7596544761052684e-11
44 O 0 3.457526487338214e-10
unrelated O 0 2.6434205935288446e-09
alleles O 0 4.1926163929506544e-11
in O 0 1.6025068425018496e-11
these O 0 2.0567149372485716e-10
patients O 0 6.438025668131786e-09
. O 0 1.50303314239153e-09

One O 0 7.589201489466291e-10
is O 0 1.5393347404038527e-12
the O 0 4.172871076457696e-11
T312S O 0 6.809373189753387e-07
mutation O 0 7.167821891584936e-09
, O 0 6.812323274929533e-12
a O 0 2.6666860993701524e-12
novel O 0 2.175675417603884e-09
mutation O 0 8.540600449080671e-10
found O 0 4.0876880873230714e-12
exclusively O 0 7.687548514434539e-12
in O 0 9.298563655169012e-12
milder O 1 0.9998328685760498
patients O 1 0.9705286622047424
. O 0 4.844972636419698e-07

The O 0 2.7166276339585238e-08
other O 0 6.137860358856884e-11
is O 0 3.7821286900940887e-13
the O 0 8.446916668729265e-13
previously O 0 2.945183810373897e-12
described O 0 1.1504926351879607e-11
I113F O 0 1.0119996396440456e-08
that O 0 1.0345825758595328e-12
produces O 0 4.3204186755962937e-11
a O 0 5.606539971864111e-12
severe O 0 9.613089559934451e-07
phenotype O 0 0.0023848528508096933
. O 0 8.30377416605188e-07

The O 0 6.757246495681102e-08
I113F O 0 3.871286935464013e-06
and O 0 2.150500222342089e-09
T312S O 0 6.266357104323106e-07
mutations O 0 3.0097208059132186e-10
accounted O 0 1.4441824403021997e-09
for O 0 7.767166250449709e-12
8 O 0 6.318908729596728e-10
( O 0 1.4138363602696907e-13
18 O 0 4.976348499940997e-11
% O 0 6.157998915477803e-13
) O 0 2.950554356707393e-15
and O 0 3.6886647707644327e-13
6 O 0 3.2909555636173593e-10
( O 0 2.035582667052685e-13
14 O 0 6.648150779886564e-11
% O 0 9.53382121512969e-13
) O 0 4.978369655400791e-15
of O 0 3.2958206476474405e-12
44 O 0 1.360183632392875e-10
unrelated O 0 3.804587755951161e-09
alleles O 0 1.935284016374439e-10
, O 0 6.238026067917346e-11
respectively O 0 5.560456983744189e-09
. O 0 2.2392960374872928e-08

The O 0 5.600352537271647e-08
relatively O 0 6.531534069154077e-08
high O 0 1.4876326837054421e-08
residual O 0 1.933122348418692e-06
GALNS O 0 0.007885170169174671
activity O 0 2.5973173478632816e-07
seen O 0 7.339799878991471e-10
when O 0 8.286292658976624e-12
the O 0 4.2679429435033e-11
T312S O 0 9.662739941518339e-09
mutant O 0 6.824580900399724e-10
cDNA O 0 4.978325529592098e-10
is O 0 1.2206632406253082e-11
overexpressed O 0 2.0372073805674518e-08
in O 0 5.759838352797919e-12
mutant O 0 4.3829342932788506e-11
cells O 0 1.4381583597622427e-11
provides O 0 8.279866491056349e-15
an O 0 1.1734064877960805e-17
explanation O 0 3.432421447763234e-13
for O 0 9.487107144800708e-14
the O 0 6.969474997120528e-11
mild O 0 1.598247195033764e-06
phenotype O 0 2.959125595225487e-06
in O 0 2.632887241560411e-10
patients O 0 5.232398403443028e-10
with O 0 5.785950603180712e-14
this O 0 2.8157344511559046e-11
mutation O 0 5.474364961344236e-09
. O 0 1.2629444157141734e-08

The O 0 8.940610474184041e-10
distribution O 0 1.4685899718536177e-10
and O 0 1.606174936975846e-12
relative O 0 6.55272502925186e-11
frequencies O 0 1.6049019752051308e-11
of O 0 7.4102382216501e-12
the O 0 4.363233038762182e-11
I113F O 0 7.289747117056322e-08
and O 0 7.810494473403651e-10
T312S O 0 2.4924239028223383e-07
mutations O 0 8.115667027297491e-10
in O 0 6.001786567733092e-11
Australia O 0 4.82276154775696e-12
corresponded O 0 2.745193482256436e-11
to O 0 5.661440934112694e-12
those O 0 1.8827947881328022e-11
observed O 0 3.1117697307792014e-10
in O 0 2.492534789677592e-10
Northern O 0 5.593186358510138e-09
Ireland O 0 7.909679577977613e-10
and O 0 4.7995472179929166e-11
are O 0 3.8509564460886825e-12
unique O 0 9.155694431772776e-12
to O 0 2.378510062517325e-11
these O 0 5.012713022445325e-10
two O 0 1.5578401416083132e-11
populations O 0 1.305080349345289e-10
, O 0 1.9898711584726003e-12
suggesting O 0 2.0580648296686377e-10
that O 0 1.1652293713249051e-11
both O 0 1.7556818499020466e-10
mutations O 0 5.26806515077638e-11
were O 0 4.4223114059604995e-10
probably O 0 2.37226349675268e-10
introduced O 0 4.0568254311423857e-10
to O 0 1.8440061977376132e-11
Australia O 0 1.941156436979785e-12
by O 0 3.8486415118201e-13
Irish O 0 1.9657717120757923e-10
migrants O 0 4.219110737863074e-12
during O 0 1.984617765266039e-12
the O 0 7.170805182282747e-12
19th O 0 1.8278450752973185e-08
century O 0 1.0775192293976943e-07
. O 0 9.495588670915822e-08

Haplotype O 0 1.6069971309207176e-07
analysis O 0 5.029664462696815e-10
using O 0 4.83186324284901e-10
6 O 0 2.6732353219927063e-08
RFLPs O 0 2.2865995106258197e-06
provides O 0 1.1060318459710228e-11
additional O 0 3.018099008558761e-12
data O 0 7.5204313262911e-12
that O 0 1.2654151814936454e-13
the O 0 1.5801866759534988e-10
I113F O 0 5.733778607464046e-07
mutation O 0 7.516166022902837e-10
originated O 0 1.387203962810446e-10
from O 0 6.317898678179223e-13
a O 0 5.878010751747542e-13
common O 0 1.9734315570563155e-10
ancestor O 0 2.220810557673758e-08
. O 0 1.3139259458228025e-08

The O 0 1.8847092633222928e-06
other O 0 1.7320152423394575e-08
9 O 0 2.2266004862103728e-07
novel O 0 3.389077818383157e-08
mutations O 0 9.633163156053115e-10
identified O 0 5.365182187411222e-10
in O 0 7.915409994119216e-11
these O 0 6.027322391188861e-11
23 O 0 1.4173195950206718e-09
patients O 0 1.5228809324696613e-09
were O 0 1.723434762956888e-11
each O 0 2.272628835337312e-13
limited O 0 1.3333989294650461e-11
to O 0 3.0739885463482164e-12
a O 0 5.0646160876244295e-11
single O 0 2.621895411891728e-08
family O 0 1.923363157629865e-08
. O 0 7.472318230838937e-08

These O 0 4.0427381442498245e-09
data O 0 8.936071327347861e-11
provide O 0 5.320782876794272e-13
further O 0 5.444738626972367e-13
evidence O 0 1.4388414938670824e-11
for O 0 3.7261227089913085e-12
extensive O 0 3.2475582223412403e-09
allelic O 0 4.3933948035146386e-08
heterogeneity O 0 9.845284409948363e-08
in O 0 4.796415709051871e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 8.939549100972499e-11
British O 0 7.53233656003438e-11
- O 0 3.376447732517107e-10
Irish O 0 1.033625629531798e-09
patients O 0 7.665943990708968e-10
and O 0 7.809315802527472e-14
provide O 0 2.1285400945612008e-14
evidence O 0 3.8542538843659713e-13
for O 0 1.6583935830496999e-12
their O 0 6.70065447572199e-10
transmission O 0 7.093251319645333e-09
to O 0 5.901855393286581e-11
Australia O 0 1.8786255103625527e-12
by O 0 1.245601928892559e-13
British O 0 5.7906072298274935e-11
- O 0 8.465445566763208e-10
Irish O 0 6.097710669727974e-10
migrants O 0 4.278644799571296e-11
. O 0 7.491322015842905e-13
. O 0 4.0062651113226266e-11

Identification O 0 4.913485440738441e-08
of O 0 5.622665888438405e-09
constitutional O 0 4.722063385997899e-05
WT1 O 1 0.5284973382949829
mutations O 0 8.77987460512486e-08
, O 0 1.763749736538589e-11
in O 0 1.620796899470811e-11
patients O 0 1.2639607138709152e-09
with O 0 3.635235125074021e-12
isolated O 0 1.2423196494637523e-05
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.9692654451564096e-10
and O 0 4.192683797799718e-13
analysis O 0 1.354076030989082e-12
of O 0 3.645464485835248e-11
genotype O 0 2.1987887066643452e-07
/ O 0 1.7798722495854236e-08
phenotype O 0 1.5231481631516885e-09
correlations O 0 9.111949909879069e-12
by O 0 9.677153216670724e-15
use O 0 5.676196275158918e-13
of O 0 3.977460288212553e-12
a O 0 3.86392237650135e-11
computerized O 0 5.69164853914117e-07
mutation O 0 2.996058157123116e-08
database O 0 7.423844206044805e-09
. O 0 9.554265822941943e-09

Constitutional O 0 4.3094482862215955e-06
mutations O 0 1.326384868605146e-08
of O 0 3.8911722732848375e-09
the O 0 9.087854913047977e-09
WT1 O 0 3.892873792210594e-06
gene O 0 4.198668079880008e-10
, O 0 1.0423952499782896e-11
encoding O 0 3.517975355471492e-10
a O 0 9.354746144385473e-11
zinc O 0 7.672693413951492e-07
- O 0 3.194249131865945e-07
finger O 0 9.261658107106996e-08
transcription O 0 2.2711097358296684e-07
factor O 0 3.6643552192572315e-08
involved O 0 6.453254597360569e-10
in O 0 8.711910304270987e-09
renal O 1 1.0
and O 0 2.166066650488574e-07
gonadal O 0 0.00011895572970388457
development O 0 3.158486379106762e-07
, O 0 4.85551833115383e-12
are O 0 2.390618356485491e-14
found O 0 6.6845781907247555e-15
in O 0 1.4306352597807243e-14
most O 0 2.93248037614921e-13
patients O 0 5.849906496713242e-12
with O 0 9.670797149197163e-13
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.6180123907361121e-09
DDS B-Disease 1 1.0
) O 0 5.08319471584362e-12
, O 0 7.821976573396672e-13
or O 0 5.816434556216166e-10
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 9.370376696793414e-10
DMS B-Disease 0 1.9108560991298873e-06
) O 0 1.4100714682257348e-13
associated O 0 3.665494123505919e-12
with O 0 1.1841881641938556e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.024411514867097e-06
/ O 0 0.00024049858620855957
or O 0 1.6432777272257226e-07
Wilms B-Disease 1 0.9997519850730896
tumor I-Disease 0 0.2796923816204071
( O 0 3.073411247722646e-10
WT B-Disease 1 1.0
) O 0 3.563578945819934e-11
. O 0 4.592446145590401e-10

Most O 0 5.3769689145610755e-08
mutations O 0 1.293908269417443e-08
in O 0 2.081527616937251e-09
DDS B-Disease 1 1.0
patients O 1 0.9898401498794556
lie O 0 1.413667316541023e-08
in O 0 1.5839406175555126e-10
exon O 0 1.1062192051269903e-08
8 O 0 7.873423690796244e-09
or O 0 5.74643499451355e-10
exon O 0 2.8026436282857503e-08
9 O 0 2.7549697634299264e-08
, O 0 2.9332233864032276e-10
encoding O 0 3.4530000903032487e-07
zinc O 0 0.15819112956523895
finger O 0 0.18727615475654602
2 O 0 0.0001421368942828849
or O 0 4.6775832629464276e-07
zinc O 0 0.0001757586287567392
finger O 0 4.275594164937502e-06
3 O 0 8.634148684905085e-08
, O 0 1.5735480626832832e-11
respectively O 0 4.917211637867069e-10
, O 0 3.3365348244690507e-12
with O 0 2.366344425096256e-13
a O 0 1.6715927253496687e-11
hot O 0 1.9360933947609738e-05
spot O 0 9.75754677057239e-09
( O 0 1.9020096370288286e-13
R394W O 0 1.565687912652436e-09
) O 0 2.6784293099407774e-13
in O 0 4.7843840000894033e-11
exon O 0 5.828297844345798e-09
9 O 0 1.3753525429649471e-08
. O 0 7.0448469280393056e-09

We O 0 5.773210798309947e-09
analyzed O 0 3.3173064295510812e-09
a O 0 2.1615302863570163e-12
series O 0 1.4743617568133138e-12
of O 0 1.3413261387013042e-12
24 O 0 3.116039926087666e-10
patients O 0 1.6923772605537124e-08
, O 0 4.872263616867434e-12
10 O 0 4.807289288866201e-11
with O 0 9.379468556003356e-12
isolated B-Disease 0 9.060916636371985e-05
DMS I-Disease 1 1.0
( O 0 5.494858346111187e-09
IDMS B-Disease 1 0.9997933506965637
) O 0 4.284336774240671e-11
, O 0 8.701070246253106e-12
10 O 0 8.747095929517723e-12
with O 0 1.3024132553690615e-12
DDS B-Disease 1 1.0
, O 0 9.943480067109434e-11
and O 0 1.740258111226911e-11
4 O 0 8.040247911900167e-10
with O 0 8.475906608518269e-12
urogenital B-Disease 0 4.389122113934718e-05
abnormalities I-Disease 0 7.568099681520835e-05
and O 0 4.743402826079546e-08
/ O 0 1.5337276408899925e-06
or O 0 2.471120410518779e-07
WT B-Disease 1 1.0
. O 0 3.287840755206162e-08

We O 0 2.6465477276360616e-07
report O 0 6.865674606615357e-08
WT1 O 0 0.0014158880803734064
heterozygous O 0 1.9803532325113338e-07
mutations O 0 4.685677956750567e-10
in O 0 1.5095159497380273e-11
16 O 0 1.4423545691144568e-09
patients O 0 6.620874515306241e-09
, O 0 5.6555480784648005e-12
4 O 0 1.7840383614853295e-09
of O 0 1.6343488784542615e-09
whom O 0 2.675030685850288e-08
presented O 0 5.942142706771847e-07
with O 0 5.468854702428416e-09
IDMS B-Disease 1 0.9999842643737793
. O 0 4.11851033277344e-06

One O 0 8.3438917997114e-09
male O 0 8.816616881013317e-10
and O 0 4.680822136143847e-12
two O 0 4.220654045445499e-13
female O 0 5.142645337352647e-11
IDMS B-Disease 0 0.09077087789773941
patients O 0 2.3195127141661942e-05
with O 0 2.1069849864829848e-08
WT1 O 1 0.9999995231628418
mutations O 0 0.001060905633494258
underwent O 0 0.0002212220279034227
normal O 0 0.04159429296851158
puberty O 0 0.00018107244977727532
. O 0 3.203975040833029e-08

Two O 0 3.57534645445412e-07
mutations O 0 5.317022555573203e-08
associated O 0 1.2063679832863272e-08
with O 0 1.758879292212967e-10
IDMS B-Disease 1 0.9999563694000244
are O 0 8.81550249465235e-11
different O 0 4.824362263844417e-12
from O 0 2.0294428030448453e-12
those O 0 1.1736804019987779e-12
described O 0 1.0878443978956653e-11
in O 0 3.065115661282647e-10
DDS B-Disease 1 1.0
patients O 0 0.05215379595756531
. O 0 2.608984850382967e-08

No O 0 2.6260352115059504e-06
WT1 O 0 0.00024985423078760505
mutations O 0 3.085914102030074e-08
were O 0 2.584406577632592e-10
detected O 0 3.207745846722787e-09
in O 0 2.459621221972963e-11
the O 0 1.672205846015018e-10
six O 0 4.6698027389435737e-11
other O 0 2.8727939471728803e-10
IDMS B-Disease 1 1.0
patients O 0 0.01017676293849945
, O 0 1.5352479704189292e-11
suggesting O 0 2.701475154687216e-10
genetic O 0 1.9423667119156107e-09
heterogeneity O 0 1.8560026404657037e-08
of O 0 1.4639873757715804e-09
this O 0 3.042366802930019e-09
disease O 0 1.0456232303113211e-05
. O 0 1.06106881503365e-07

We O 0 5.1791040789339604e-08
analyzed O 0 8.129742212759083e-08
genotype O 0 7.225605713756522e-07
/ O 0 7.511328448117638e-08
phenotype O 0 1.6686582782199366e-08
correlations O 0 4.926674623817462e-10
, O 0 6.338692456120051e-14
on O 0 2.433403413666657e-13
the O 0 6.188869946036069e-14
basis O 0 2.2735402969986662e-12
of O 0 7.373168915691952e-13
the O 0 4.446225505827517e-12
constitution O 0 2.2995615134302483e-10
of O 0 2.5515036750078934e-09
a O 0 5.803103553247979e-10
WT1 O 0 5.826894721394638e-06
mutation O 0 2.7514865941213884e-09
database O 0 3.142762716734637e-10
of O 0 2.0317263149660647e-10
84 O 0 6.979964606301792e-09
germ O 0 4.0320360312762205e-06
- O 0 1.8609034668770619e-06
line O 0 9.049052459886298e-05
mutations O 0 2.803796972372652e-09
, O 0 1.1473917302384784e-11
to O 0 3.7782589557000534e-12
compare O 0 6.968002841389875e-10
the O 0 3.082091873385373e-11
distribution O 0 1.9351067970241331e-10
and O 0 4.185039901433152e-12
type O 0 2.554001454768695e-09
of O 0 1.7467277624305666e-09
mutations O 0 2.9065675213879594e-11
, O 0 2.086941730539138e-13
according O 0 8.030243137113757e-13
to O 0 1.2260738214628364e-12
the O 0 4.756078864076585e-11
different O 0 1.343924971308752e-09
symptoms O 0 1.2026748663629405e-05
. O 0 7.063862028644508e-08

This O 0 1.1196470417473847e-09
demonstrated O 0 1.1164168256527773e-08
( O 0 2.0773636717069666e-12
1 O 0 2.000696552872938e-10
) O 0 1.8907064228048526e-13
the O 0 3.565496509150279e-11
association O 0 8.11984368631613e-11
between O 0 2.4401092257875234e-10
mutations O 0 7.113150068960294e-10
in O 0 2.228553341865336e-09
exons O 0 5.144691339609153e-09
8 O 0 1.441339714247647e-09
and O 0 2.3192012546524587e-11
9 O 0 8.121660011184417e-10
and O 0 2.3441058122353198e-11
DMS B-Disease 0 8.526254532625899e-06
; O 0 4.481375548426314e-10
( O 0 2.5716585978774464e-12
2 O 0 5.581343720528764e-10
) O 0 3.7253747721226194e-13
among O 0 5.089209002134831e-12
patients O 0 9.335068829052773e-11
with O 0 9.136082732355555e-13
DMS B-Disease 0 1.558254780320567e-06
, O 0 5.348624754902831e-12
a O 0 7.728002265894318e-13
higher O 0 8.812275215097642e-11
frequency O 0 3.9325483841556874e-11
of O 0 7.510014138345511e-11
exon O 0 9.836647052452463e-09
8 O 0 1.019337947383292e-08
mutations O 0 1.1450885795127874e-09
among O 0 1.6959687820783387e-10
46 O 0 1.971273144718566e-09
, O 0 1.0124967531055518e-10
XY O 0 2.2521649043483194e-06
patients O 0 1.2682551009390863e-08
with O 0 1.2782507257530495e-12
female O 0 3.072606752363427e-11
phenotype O 0 1.5186546464818207e-09
than O 0 4.763160005305522e-11
among O 0 5.953047083062657e-11
46 O 0 7.975776150637159e-10
, O 0 5.105526418303086e-11
XY O 0 6.760850283171749e-06
patients O 0 8.533314144187898e-08
with O 0 2.4386642878682085e-12
sexual O 0 2.7414313874540852e-11
ambiguity O 0 4.256417163173154e-10
or O 0 1.278610550770054e-10
male O 0 2.601527153422989e-11
phenotype O 0 6.376402184038454e-11
; O 0 7.461163306111962e-13
and O 0 8.736286975959129e-13
( O 0 7.978042732741455e-14
3 O 0 1.2265561830093752e-11
) O 0 4.247001852302791e-14
statistically O 0 2.5009564731670597e-12
significant O 0 7.135859828380497e-13
evidence O 0 2.013673776335434e-11
that O 0 5.173840956357312e-12
mutations O 0 5.2720583454402e-10
in O 0 2.3944314975210546e-08
exons O 0 1.1209493067099174e-07
8 O 0 1.1435830948869352e-08
and O 0 1.262146082092741e-10
9 O 0 1.9652441896056416e-09
preferentially O 0 1.888904366253996e-09
affect O 0 3.364909462177934e-09
amino O 0 1.0872397426808789e-09
acids O 0 4.906700046269918e-10
with O 0 3.232850402309917e-12
different O 0 4.121628732756122e-11
functions O 0 6.049239581473742e-11
. O 0 1.3064600790091419e-10
. O 0 2.265690968172862e-09

The O 0 1.5327757409977494e-06
185delAG O 0 0.00010414239659439772
BRCA1 O 0 4.429115563198138e-07
mutation O 0 6.193204282745057e-10
originated O 0 1.7203080973637874e-11
before O 0 1.512627913549669e-12
the O 0 1.0476662533386374e-13
dispersion O 0 6.663092300129847e-11
of O 0 4.522624288960664e-11
Jews O 0 2.1800151961404168e-10
in O 0 1.0341293793514339e-11
the O 0 2.023719386512468e-11
diaspora O 0 3.461114381209107e-11
and O 0 1.1768837857376035e-12
is O 0 5.78777138520413e-14
not O 0 2.914819806961594e-13
limited O 0 9.815795398715466e-11
to O 0 5.421968429786261e-10
Ashkenazim O 0 1.5062379134178627e-05
. O 0 1.0871121958189178e-07

The O 0 6.526602192025166e-08
185delAG O 0 5.0725252549455035e-06
mutation O 0 3.483983235241794e-08
in O 0 9.740197981500387e-09
BRCA1 O 0 6.3922755977330326e-09
is O 0 2.3832179719268654e-12
detected O 0 1.6052027762558652e-10
in O 0 5.496589728509749e-12
Ashkenazi O 0 9.36021260500297e-10
Jews O 0 1.1734913041294703e-10
both O 0 4.279148216324025e-12
in O 0 4.771800732328302e-10
familial B-Disease 1 0.9996428489685059
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.5250301849411017e-10
in O 0 4.232579130930558e-12
the O 0 1.6864714486031218e-11
general O 0 2.0063302130779448e-09
population O 0 1.1522692522358824e-11
. O 0 3.7958439169649694e-10

All O 0 2.0282667989590664e-08
tested O 0 1.2598095899818418e-08
Ashkenazi O 0 7.63510286105884e-08
mutation O 0 1.2156203821334088e-09
carriers O 0 2.241648533463092e-10
share O 0 1.8398045240064498e-11
the O 0 1.0366448368118175e-12
same O 0 1.5494806826499286e-11
allelic O 0 9.027923297821872e-09
pattern O 0 4.978745860029221e-09
at O 0 1.549726597049883e-10
the O 0 1.403329119575858e-09
BRCA1 O 0 2.105370100480286e-08
locus O 0 3.400913550777318e-09
. O 0 4.303727152432657e-09

Our O 0 3.0072911272327474e-08
previous O 0 7.610310603922699e-09
study O 0 2.069700140439057e-11
showed O 0 1.5038739567888038e-12
that O 0 2.1859260685179113e-15
this O 0 8.391296338339238e-12
Ashkenazi O 0 6.986907408190746e-08
mutation O 0 4.0665715239640576e-10
also O 0 6.094480931202739e-13
occurs O 0 7.071933099886407e-13
in O 0 6.99003233225158e-14
Iraqi O 0 2.5104111497920023e-11
Jews O 0 1.6447615491799183e-10
with O 0 2.2154402878199475e-13
a O 0 1.1006354248138672e-12
similar O 0 3.60437013569026e-10
allelic O 0 2.867209047963115e-07
pattern O 0 1.8763702769319934e-07
. O 0 2.055454118021771e-08

We O 0 1.2330673371252487e-08
extended O 0 3.845210017061618e-08
our O 0 2.382920527566057e-10
analysis O 0 1.0977323217087331e-11
to O 0 5.07912418720724e-12
other O 0 1.7309953817545853e-11
non O 0 1.3061375980782941e-08
- O 0 2.3177266772478333e-09
Ashkenazi O 0 2.928350228970089e-09
subsets O 0 1.1059949622804766e-09
354 O 0 1.4304717133040157e-10
of O 0 5.359978411632882e-13
Moroccan O 0 9.452388177733084e-11
origin O 0 1.010062086054253e-11
, O 0 1.333408427076077e-12
200 O 0 4.870126871225899e-12
Yemenites O 0 1.1947633993258933e-07
and O 0 2.494720142270923e-12
150 O 0 4.35625407274598e-12
Iranian O 0 4.236670736457171e-10
Jews O 0 4.186978319609125e-09
. O 0 4.398977182518138e-09

Heteroduplex O 0 1.3372285138757434e-05
analysis O 0 2.066617321716535e-09
complemented O 0 7.467741980349274e-09
by O 0 5.816628428911841e-12
direct O 0 6.119565965079232e-11
DNA O 0 1.9292960562466988e-09
sequencing O 0 2.2397831145326563e-08
of O 0 9.484322216479768e-10
abnormally O 0 1.139668004412897e-08
migrating O 0 1.939194360645047e-09
bands O 0 3.685119154273053e-10
were O 0 1.3770066684126725e-11
employed O 0 4.3358830414952365e-10
. O 0 1.1686136502930822e-09

Four O 0 3.2089881862873426e-09
of O 0 6.873687175001919e-10
Moroccan O 0 1.4038946893890625e-08
origin O 0 3.2516034309537645e-10
( O 0 2.0287531420429272e-13
1 O 0 1.2464706350412413e-11
. O 0 1.5833731895065206e-13
1 O 0 8.354310299107937e-12
% O 0 7.374936978384733e-14
) O 0 9.516220344824196e-16
and O 0 1.4585854496863143e-13
none O 0 3.3947528815803096e-11
of O 0 7.787760020194767e-11
the O 0 1.7420331843709391e-09
Yemenites O 0 4.444057140062796e-06
or O 0 1.0176876008571867e-10
Iranians O 0 1.5480397519418432e-10
was O 0 1.1175038325261788e-11
a O 0 8.723428338193451e-14
carrier O 0 3.046804562117922e-12
of O 0 3.113143857286227e-12
the O 0 2.0804905020987974e-10
185delAG O 0 1.5426038544319454e-06
mutation O 0 7.584476691135933e-08
. O 0 4.190096092315798e-08

BRCA1 O 0 4.6550332626793534e-05
allelic O 0 1.8253177813676302e-06
patterns O 0 1.5564614486152095e-08
were O 0 1.2961695605717694e-10
determined O 0 1.6947530878663741e-10
for O 0 5.6709515555697365e-12
four O 0 9.824233440647312e-13
of O 0 2.435336220879547e-12
these O 0 7.616205300979562e-13
individuals O 0 8.730435672359496e-14
and O 0 1.017923375798424e-12
for O 0 2.355330286276519e-13
12 O 0 2.0764288725938496e-12
additional O 0 4.257444223554341e-12
non O 0 2.591436620846821e-09
- O 0 2.290265532778335e-09
Ashkenazi O 0 1.1280497647092602e-09
185delAG O 0 1.7312117295276153e-09
mutation O 0 3.7396453989035905e-11
carriers O 0 9.526124333802954e-11
who O 0 3.716195406955336e-11
had O 0 5.032068770560727e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4489102113657282e-06

Six O 0 1.1668240063045232e-07
non O 0 1.0588222494334332e-06
- O 0 1.717208704121731e-07
Ashkenazi O 0 2.33201529198368e-08
individuals O 0 6.458431879574622e-12
shared O 0 1.40872886272847e-11
the O 0 4.905964957196973e-12
common O 0 2.215752165080076e-10
Ashkenazi O 0 7.2323667055229635e-09
haplotype O 0 4.425275257347039e-09
, O 0 4.703126083027698e-11
four O 0 4.842542165872654e-12
had O 0 4.66350985606212e-11
a O 0 2.4472938866398897e-12
closely O 0 6.65002705679818e-11
related O 0 6.577525191175937e-09
pattern O 0 1.193851684178071e-08
, O 0 1.1643890062210116e-12
and O 0 2.075522262737217e-12
the O 0 4.2361048002703683e-10
rest O 0 2.2647718367352354e-08
( O 0 4.448479616354223e-13
n O 0 3.023862757411955e-11
= O 0 9.379504117834614e-12
6 O 0 3.5460995251312966e-11
) O 0 2.5912325196252202e-14
displayed O 0 1.1900781575480135e-11
a O 0 1.8925664854729796e-11
distinct O 0 1.7430975773891078e-08
BRCA1 O 0 2.2981132019594952e-07
allelic O 0 6.813297090957349e-07
pattern O 0 6.3335750155602e-07
. O 0 3.732318631932685e-08

We O 0 3.77346109914356e-09
conclude O 0 1.0045955178838994e-08
that O 0 3.5543113591218756e-12
the O 0 3.0139488127467473e-10
185delAG O 0 3.4110891533600807e-07
BRCA1 O 0 1.467311872005439e-08
mutation O 0 8.38525221480424e-11
occurs O 0 7.863536211072386e-12
in O 0 1.2793557446072468e-12
some O 0 3.4418041333639238e-12
non O 0 2.0412175061323978e-08
- O 0 6.093565474429852e-08
Ashkenazi O 0 1.1798623233971739e-07
populations O 0 2.048430869372453e-10
at O 0 2.268312274122941e-12
rates O 0 5.344331314299788e-12
comparable O 0 1.2688920227044154e-11
with O 0 2.1676838587460744e-14
that O 0 3.2904673994207934e-13
of O 0 1.0918927983993854e-09
Ashkenazim O 0 1.0701049177441746e-05
. O 0 4.219368676672275e-08

The O 0 2.513433194906156e-08
majority O 0 7.976400095976999e-10
of O 0 4.0937783718497656e-10
Jewish O 0 3.1300114500254494e-08
185delAG O 0 3.0287569074971543e-07
mutation O 0 9.837185510619406e-10
carriers O 0 8.42007852330795e-11
have O 0 8.428698277523905e-13
a O 0 2.529046308312466e-13
common O 0 6.174341593556676e-11
allelic O 0 2.9960562919484346e-09
pattern O 0 9.042273596548966e-10
, O 0 9.447404880971733e-13
supporting O 0 4.00214670431831e-12
the O 0 1.1772531560705346e-10
founder O 0 1.0743742562269176e-09
effect O 0 1.0473392819676519e-08
notion O 0 3.9834127107951645e-08
, O 0 6.453420263452525e-12
but O 0 3.5343279951999262e-12
dating O 0 3.199593090474906e-10
the O 0 7.419770527150593e-12
mutations O 0 6.711439130141494e-13
origin O 0 7.398882721776356e-12
to O 0 1.3173787147963134e-12
an O 0 6.476889523706264e-15
earlier O 0 4.8519452344741865e-12
date O 0 4.823111865448482e-08
than O 0 8.662557476890598e-11
currently O 0 4.35022590866696e-12
estimated O 0 1.624476594908053e-11
. O 0 2.3276458538390443e-09

However O 0 1.8505062371332315e-08
, O 0 6.995214303640029e-12
the O 0 5.647829860039311e-12
different O 0 6.451648243421815e-12
allelic O 0 6.7373351342325805e-09
pattern O 0 5.413610892901488e-09
at O 0 1.801527815814552e-10
the O 0 9.98343074876118e-10
BRCA1 O 0 4.056324609535977e-09
locus O 0 8.253912137101693e-11
even O 0 1.4053239127953532e-10
in O 0 4.428164866038253e-12
some O 0 1.3609165877559448e-12
Jewish O 0 2.8112923100565013e-10
mutation O 0 1.9399063952429962e-11
carriers O 0 3.553303137837638e-11
, O 0 2.967597955566559e-12
might O 0 8.559546127440143e-11
suggest O 0 2.2201518401487874e-10
that O 0 1.5174797182715416e-12
the O 0 1.6762007060133755e-10
mutation O 0 2.293936846031741e-10
arose O 0 1.9463126665897335e-09
independently O 0 1.063975504922432e-10
. O 0 1.550105044323402e-10
. O 0 3.132207826439526e-09

Crystal O 0 3.4967129636243044e-07
structure O 0 6.306476763029423e-08
of O 0 2.3847961827527797e-08
the O 0 5.101129545437288e-07
hemochromatosis B-Disease 1 1.0
protein O 0 8.39326239656657e-05
HFE O 0 0.03279011696577072
and O 0 4.197929504012876e-11
characterization O 0 3.758436051271019e-08
of O 0 2.4571666923378643e-09
its O 0 2.7321880868846904e-10
interaction O 0 3.018965633039272e-10
with O 0 1.474975523663158e-11
transferrin O 0 1.838799192910301e-07
receptor O 0 2.5119236468640338e-08
. O 0 1.5923966145692248e-08

HFE O 1 0.6975380778312683
is O 0 2.918991715006314e-10
an O 0 8.250866895091746e-13
MHC O 0 2.7363691401660617e-07
- O 0 5.494210881806794e-07
related O 0 4.411701013395941e-07
protein O 0 3.653424451854903e-09
that O 0 2.5448727123560978e-14
is O 0 2.2627700833389476e-14
mutated O 0 1.2082359418519317e-11
in O 0 3.3849542635001895e-13
the O 0 1.335840882354944e-10
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 8.10711644589901e-05

HFE O 0 0.00011089950567111373
binds O 0 3.4192615405714832e-09
to O 0 1.8071512342121565e-10
transferrin O 0 1.0944246398025825e-08
receptor O 0 2.759000250485144e-10
( O 0 1.2847524693410106e-12
TfR O 0 1.6648876055569417e-08
) O 0 1.052760241720789e-13
and O 0 1.590504529296044e-13
reduces O 0 1.9637208525935534e-11
its O 0 5.4863565947249615e-12
affinity O 0 1.587215914256035e-10
for O 0 4.4880536786973124e-11
iron O 0 1.3485367844623397e-06
- O 0 1.4891372579484141e-08
loaded O 0 1.1252517806426e-09
transferrin O 0 3.911951296231564e-08
, O 0 1.1963618463950443e-11
implicating O 0 8.737854884088847e-09
HFE O 0 0.3532463610172272
in O 0 6.873824531794526e-08
iron O 1 0.9969854950904846
metabolism O 0 0.2771581709384918
. O 0 4.779429900736432e-07

The O 0 2.458138794736442e-07
2 O 0 4.174150944891153e-07
. O 0 2.392623699165597e-08

6 O 0 2.298254230481689e-06
A O 0 3.13122967554591e-08
crystal O 0 4.2465856608941976e-07
structure O 0 1.4785770190428593e-06
of O 0 6.108418801886728e-06
HFE O 1 0.9999946355819702
reveals O 0 2.463592174706264e-08
the O 0 3.3358048961984466e-11
locations O 0 3.7183808809793106e-10
of O 0 6.876549552004008e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 2.614754350815929e-07
and O 0 4.622112970142922e-10
a O 0 7.159493137232076e-11
patch O 0 0.0023425861727446318
of O 0 0.0009644713718444109
histidines O 1 0.9967167973518372
that O 0 3.205651022408773e-11
could O 0 9.707782321066727e-12
be O 0 5.047387746474896e-13
involved O 0 1.9496461736712156e-12
in O 0 7.66163868459735e-12
pH O 0 3.7470556435437175e-07
- O 0 4.368011161659524e-07
dependent O 0 2.9414170654717964e-08
interactions O 0 1.341645572416894e-09
. O 0 7.931589607323986e-09

We O 0 3.9690863928854014e-08
also O 0 6.831323701161907e-11
demonstrate O 0 8.685140800990254e-11
that O 0 2.0583532708146057e-12
soluble O 0 4.046099547849735e-06
TfR O 0 7.287610060302541e-06
and O 0 5.158097907131953e-11
HFE O 0 1.7266825125261676e-07
bind O 0 2.6463688879152514e-11
tightly O 0 1.6531970237210203e-10
at O 0 8.242596709340244e-12
the O 0 6.433461402499674e-12
basic O 0 7.612067420836865e-09
pH O 0 1.7420083509023243e-07
of O 0 1.2781558922370095e-08
the O 0 9.429811376193697e-10
cell O 0 3.346500021539356e-10
surface O 0 2.1737216471251486e-09
, O 0 1.589983678572382e-12
but O 0 6.8267613784200876e-12
not O 0 1.2605672582155503e-11
at O 0 8.836006232249005e-11
the O 0 2.017450095870288e-10
acidic O 0 1.5200443215235282e-07
pH O 0 4.828519308830437e-07
of O 0 2.936006771037114e-09
intracellular O 0 2.418758082711747e-09
vesicles O 0 1.2926383874400926e-07
. O 0 1.9138559181897108e-08

TfR O 0 0.0010077337501570582
HFE O 0 0.00037050136597827077
stoichiometry O 0 1.2204693575768033e-06
( O 0 1.973100433039221e-10
2 O 0 1.2982286357043904e-09
1 O 0 1.1496092272578196e-10
) O 0 6.891145640230967e-14
differs O 0 1.43761877402504e-10
from O 0 1.2760517469068144e-11
TfR O 0 1.0008224649027397e-07
transferrin O 0 1.1172881286825032e-08
stoichiometry O 0 1.5213197812613544e-08
( O 0 2.186021112390857e-12
2 O 0 3.9120276462689674e-11
2 O 0 8.896034950356402e-12
) O 0 1.8473019473700183e-14
, O 0 8.51290270372472e-14
implying O 0 8.914939966797597e-12
a O 0 1.9914354453670624e-12
different O 0 1.031769027853846e-11
mode O 0 1.1334804206342142e-09
of O 0 7.048371001433518e-12
binding O 0 1.698668705696349e-10
for O 0 2.2341146987958638e-10
HFE O 0 6.0938906244700775e-05
and O 0 1.8372454946291583e-10
transferrin O 0 3.1795568844472655e-08
to O 0 1.8560680770107751e-10
TfR O 0 7.575027325401607e-07
, O 0 1.356979415986781e-12
consistent O 0 4.528390509794811e-11
with O 0 1.0486599246297204e-13
our O 0 2.5910289538910725e-11
demonstration O 0 8.230822690080686e-10
that O 0 1.5138806007397587e-12
HFE O 0 8.759217053011525e-06
, O 0 2.795629179541681e-11
transferrin O 0 4.623863603114842e-08
, O 0 1.758066782431289e-11
and O 0 6.194556586430755e-12
TfR O 0 3.9897923187481865e-08
form O 0 3.0215320263177192e-12
a O 0 2.76366408057116e-12
ternary O 0 3.486430557586573e-07
complex O 0 1.969344111785176e-06
. O 0 9.2074436963685e-08

Identification O 0 1.799902094035133e-07
of O 0 1.3683400190700468e-08
three O 0 2.045994346167035e-10
novel O 0 1.2321333953124736e-09
mutations O 0 3.131272671708096e-11
and O 0 2.6255130881891464e-12
a O 0 1.5267401600772834e-13
high O 0 3.5753844329633466e-11
frequency O 0 2.7556960185970425e-11
of O 0 6.488299481022253e-12
the O 0 9.242004384013569e-11
Arg778Leu O 0 1.300128360526287e-06
mutation O 0 4.959532229342756e-10
in O 0 6.274968392117053e-12
Korean O 0 3.475203058656007e-08
patients O 0 9.590118699165373e-10
with O 0 1.1703071237795237e-12
Wilson B-Disease 0 3.5548680443753256e-08
disease I-Disease 0 1.4141016357882563e-08
. O 0 2.4815651755716317e-08

Four O 0 4.870301051340675e-09
mutations O 0 2.9303587334439385e-11
- O 0 1.7396449558670923e-10
- O 0 5.159192517645295e-10
R778L O 0 9.504409703708916e-09
, O 0 5.328460654478728e-13
A874V O 0 4.961755450949568e-10
, O 0 3.816164235743297e-13
L1083F O 0 6.963525867043074e-10
, O 0 4.928011124172293e-13
and O 0 9.908799448272651e-14
2304delC O 0 5.1230845954375326e-11
- O 0 2.26758663929294e-11
- O 0 3.6725800178771806e-10
in O 0 1.0552687890186263e-10
the O 0 1.3322276615213013e-10
copper O 0 9.255509247907412e-09
- O 0 3.967173117791489e-11
transporting O 0 6.403474972493939e-10
enzyme O 0 1.9412434160148706e-10
, O 0 4.673705519819826e-11
P O 0 2.7778600042438484e-07
- O 0 4.43166925379046e-09
type O 0 6.6229963735509045e-09
ATPase O 0 2.5688240423704656e-09
( O 0 9.880911193416164e-13
ATP7B O 0 2.613632432257873e-06
) O 0 1.1368384261311454e-13
, O 0 3.8441716173134854e-14
were O 0 1.9100548237244858e-13
identified O 0 2.7973600540999455e-13
in O 0 2.468859264161821e-13
Korean O 0 1.4421875249581717e-08
Patients O 0 4.718135659942391e-09
with O 0 1.5767860107873677e-12
Wilson B-Disease 0 4.1662693206490076e-07
disease I-Disease 0 2.637195564147987e-07
. O 0 4.916307148050691e-07

Arg778Leu O 0 0.00017804162052925676
, O 0 1.8062872308988176e-09
the O 0 1.694824947051643e-09
most O 0 1.455780634929127e-10
frequently O 0 1.5074557921379572e-11
reported O 0 6.1485894500834526e-12
mutation O 0 3.4592270020672444e-11
of O 0 4.6259585051444674e-10
this O 0 8.356799974240658e-11
enzyme O 0 1.053714560050878e-09
, O 0 3.7694791732434396e-11
was O 0 1.5584183943317953e-09
found O 0 5.1104561554771166e-11
in O 0 8.16337067388595e-11
six O 0 1.9082105687240336e-11
of O 0 3.691089447976914e-11
eight O 0 1.1937861289779139e-11
unrelated O 0 1.821259809631215e-09
patients O 0 2.620953898357925e-09
studied O 0 5.6210411325530174e-11
, O 0 1.426867115130251e-13
an O 0 1.4144182210824776e-14
allele O 0 1.566212090575725e-11
frequency O 0 1.0340633904704077e-09
of O 0 1.0540139872006193e-09
37 O 0 8.481017488293219e-08
. O 0 4.012404630771016e-08

5 O 0 2.035829140822898e-07
% O 0 8.998504164026144e-10
, O 0 8.095741958757952e-13
which O 0 5.858319742941404e-14
is O 0 6.422371179792483e-14
considerably O 0 3.1563887059604667e-09
higher O 0 2.9150202252026247e-09
than O 0 3.993728091289395e-12
those O 0 4.0982273998013685e-12
in O 0 5.5772309513757445e-12
other O 0 2.6162164448728653e-11
Asian O 0 9.038923776127916e-11
populations O 0 4.5074503157715995e-11
. O 0 1.0974022385257243e-10

The O 0 1.6754087006631835e-09
novel O 0 3.9337952340012805e-10
single O 0 4.754173790755267e-11
nucleotide O 0 1.940230198727022e-09
deletion O 0 5.357492227631155e-10
, O 0 4.811350536731984e-12
2304delC O 0 2.818979005780875e-08
, O 0 6.527859849891904e-12
was O 0 1.196611143505777e-10
found O 0 1.522972373213527e-11
in O 0 3.980072521558853e-11
one O 0 9.332611766721399e-11
patient O 0 5.531675810743764e-07
. O 0 4.721054480683051e-08

Since O 0 3.96162702642755e-09
a O 0 1.3928982967037484e-11
mutation O 0 1.2019196402035526e-11
at O 0 1.7741889554723222e-11
cDNA O 0 7.834052295763172e-10
nucleotide O 0 1.2499150159328565e-08
2302 O 0 1.9735743990167975e-06
( O 0 1.6400892146120616e-12
2302insC O 0 1.1729099913537766e-09
) O 0 4.4754575479616365e-13
had O 0 1.904759683313273e-11
been O 0 9.397161000734844e-12
previously O 0 5.546384879151489e-11
described O 0 4.9125217782552966e-11
, O 0 4.468122649214229e-13
this O 0 8.89694568018129e-13
region O 0 1.445551456313865e-10
of O 0 1.425343315597516e-10
the O 0 2.233152995856358e-09
ATP7B O 1 0.6562425494194031
gene O 0 5.966987459693485e-10
may O 0 1.6285610637822856e-09
be O 0 7.546040181605207e-11
susceptible O 0 1.2356740342056582e-07
to O 0 8.590101963079633e-10
gene O 0 2.855468750340151e-08
rearrangements O 1 0.983170211315155
causing O 1 0.906114399433136
Wilson B-Disease 0 0.485659122467041
disease I-Disease 0 0.00044164134305901825
. O 0 2.8067688617738895e-07

Disruption O 0 5.986326527818164e-07
of O 0 3.83409082260755e-09
splicing O 0 3.1361950814101647e-09
regulated O 0 3.869241316234451e-10
by O 0 3.5662613270467936e-13
a O 0 1.2184086205235811e-12
CUG O 0 7.464279406121932e-06
- O 0 3.6673737380255034e-09
binding O 0 5.910039568846059e-09
protein O 0 2.719713165788562e-07
in O 0 5.412785331060377e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 6.3380257415701635e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.4438554352125266e-08
DM B-Disease 1 1.0
) O 0 1.3848960866980065e-10
is O 0 1.9139251815347702e-12
caused O 0 1.4684324936564686e-11
by O 0 3.733884729184567e-12
a O 0 4.9556428405317376e-11
CTG O 0 1.2753354212691193e-06
expansion O 0 2.605295179591849e-08
in O 0 5.766656596684072e-11
the O 0 1.1374951675025002e-10
3 O 0 4.1871359157674704e-10
untranslated O 0 2.9544571589212865e-07
region O 0 3.6812324022417187e-11
of O 0 1.4118463342871479e-11
the O 0 1.0336517419773372e-08
DM B-Disease 1 1.0
gene O 0 1.6288686310872436e-07
. O 0 2.147513811223689e-07

One O 0 2.4666026166020316e-11
model O 0 1.1789630383063354e-10
of O 0 2.2014305933737432e-09
DM B-Disease 1 1.0
pathogenesis O 0 0.015012674033641815
suggests O 0 1.268193994263811e-09
that O 0 8.287659024764499e-14
RNAs O 0 1.4178751055193839e-11
from O 0 9.38347273146678e-13
the O 0 6.751050239672818e-12
expanded O 0 7.949092495351806e-10
allele O 0 5.314215734131267e-11
create O 0 2.9208822860393724e-12
a O 0 8.734920881221797e-13
gain O 0 1.107377037290469e-10
- O 0 2.7940991534358695e-11
of O 0 1.43195677537733e-10
- O 0 3.475325305313248e-10
function O 0 2.6249885945461848e-11
mutation O 0 2.255783016977264e-12
by O 0 2.9986616352983483e-14
the O 0 9.461433372881523e-13
inappropriate O 0 6.216468312336687e-11
binding O 0 1.1168288516216762e-10
of O 0 2.968048307128157e-10
proteins O 0 6.395411977777599e-12
to O 0 3.713063884136503e-11
the O 0 3.6135892056421426e-09
CUG O 1 0.9878922700881958
repeats O 0 5.226079906606174e-07
. O 0 4.1286849494781563e-08

Data O 0 3.513430657520189e-09
presented O 0 2.6854991563851627e-09
here O 0 5.704910849280154e-11
indicate O 0 5.051514762044462e-11
that O 0 1.4322550578264176e-13
the O 0 7.186609640719155e-11
conserved O 0 9.201892581245374e-09
heterogeneous O 0 1.0945607442636174e-07
nuclear O 0 2.7333280172570085e-07
ribonucleoprotein O 0 4.4984565761296835e-07
, O 0 1.671120880564203e-11
CUG O 0 3.6140568226983305e-07
- O 0 1.2482055666840353e-10
binding O 0 1.2909241731140497e-10
protein O 0 1.0158084096101305e-10
( O 0 1.2235477659262167e-13
CUG O 0 2.172205540773575e-06
- O 0 4.714177492814997e-09
BP O 0 2.918671704321696e-08
) O 0 1.3959341495228816e-13
, O 0 3.988275909614508e-13
may O 0 9.752216395542135e-11
mediate O 0 1.0109607595509829e-10
the O 0 2.9014010638483967e-10
trans O 0 1.4959831151628578e-09
- O 0 4.521751506558758e-08
dominant O 0 2.571198010059561e-08
effect O 0 2.118958697394646e-08
of O 0 2.0498585051598184e-09
the O 0 1.410308314575559e-09
RNA O 0 1.009401007223687e-08
. O 0 4.809852960363514e-09

CUG O 1 0.9999995231628418
- O 1 0.9936843514442444
BP O 0 0.0009467639029026031
was O 0 9.269743861395341e-10
found O 0 7.032923505720379e-13
to O 0 5.987291012369417e-14
bind O 0 6.540244691308206e-13
to O 0 5.134887198603166e-13
the O 0 5.398003224965642e-12
human O 0 2.584583935760776e-10
cardiac O 0 8.166625775629655e-06
troponin O 0 2.159445284632966e-05
T O 0 1.1181513400515541e-05
( O 0 1.3221867177504176e-12
cTNT O 0 2.9955362634837e-09
) O 0 2.0728664824106596e-13
pre O 0 2.5776094592089294e-09
- O 0 4.69307426254062e-10
messenger O 0 2.1213707179779107e-10
RNA O 0 1.125427320780581e-10
and O 0 5.69013640459165e-13
regulate O 0 4.5740832996243874e-12
its O 0 1.1351966458864049e-12
alternative O 0 3.0382263371819818e-09
splicing O 0 1.9969014886100922e-08
. O 0 6.887273418243467e-09

Splicing O 0 5.78830539055275e-09
of O 0 2.4416466626320243e-09
cTNT O 0 6.223464765753306e-07
was O 0 1.153649287211067e-09
disrupted O 0 2.0161446911970415e-07
in O 0 1.738375443594009e-09
DM B-Disease 1 1.0
striated O 0 1.9171483245372656e-07
muscle O 0 4.076593285162744e-08
and O 0 5.172454686785954e-10
in O 0 7.430370763117367e-10
normal O 0 8.140709724102635e-07
cells O 0 5.457582830104002e-08
expressing O 0 1.189191523032207e-10
transcripts O 0 2.105235569205277e-10
that O 0 4.693443442053968e-13
contain O 0 6.1184013411264e-10
CUG O 0 0.0009415536769665778
repeats O 0 5.506422695589208e-08
. O 0 1.1348352479956247e-08

Altered O 0 7.88723752975784e-07
expression O 0 9.608454831777635e-08
of O 0 2.4205315085623624e-08
genes O 0 4.175717549514957e-09
regulated O 0 1.3439743540288873e-08
posttranscriptionally O 0 2.1230492563972803e-07
by O 0 4.3875622579570006e-10
CUG O 1 1.0
- O 0 0.0009679289069026709
BP O 0 2.2464277208200656e-05
therefore O 0 3.4073330268391544e-10
may O 0 1.6875396913196283e-11
contribute O 0 2.1488703177974244e-11
to O 0 3.4418340399966496e-10
DM B-Disease 1 1.0
pathogenesis O 0 0.00029844490927644074
. O 0 2.900379270087683e-09
. O 0 3.134156045803138e-09

Identification O 0 8.222608016694721e-08
of O 0 1.1438900937577046e-09
a O 0 2.0769766115313892e-11
novel O 0 1.251486470010832e-09
nonsense O 0 1.0808472339363107e-08
mutation O 0 7.840521287771907e-11
and O 0 1.0080503055551193e-12
a O 0 1.9530358504483286e-13
missense O 0 1.9257986871856758e-10
substitution O 0 5.996640406458198e-10
in O 0 3.1179468729103377e-11
the O 0 1.3258523445802695e-10
vasopressin O 0 2.7297932803094227e-09
- O 0 1.1693115364863615e-09
neurophysin O 0 6.074916569787092e-08
II O 1 0.9993322491645813
gene O 0 1.9147960994558844e-10
in O 0 2.581281889624254e-11
two O 0 5.653560302201766e-13
Spanish O 0 1.2737082222269436e-10
kindreds O 0 2.2805286548077675e-08
with O 0 1.0175492393127428e-11
familial B-Disease 0 0.0050253416411578655
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999927282333374
. O 0 8.961189450928941e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.0117284787725112e-10
FNDI B-Disease 1 1.0
) O 0 6.086964157540897e-13
is O 0 6.70250665949293e-14
an O 0 2.642684248516103e-13
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.673048574157292e-06
by O 0 7.82723130754448e-09
deficiency O 1 0.9999837875366211
in O 0 5.620317100607508e-09
the O 0 8.607721646569644e-09
antidiuretic O 0 2.360373656529191e-07
hormone O 0 4.557787480763409e-09
arginine O 0 2.4981807733581718e-09
vasopressin O 0 3.1240456888070867e-09
( O 0 2.5228226625817474e-12
AVP O 0 4.407711973186679e-09
) O 0 5.864983520544043e-14
encoded O 0 1.8748338385249363e-13
by O 0 3.4182308676286577e-13
the O 0 2.1235245506456835e-10
AVP O 0 2.025272806349676e-06
- O 0 1.0906428826729098e-07
neurophysin O 0 1.769716982380487e-05
II O 1 1.0
( O 0 7.032871618406489e-09
AVP O 0 1.7569689589436166e-05
- O 0 4.837179403693881e-07
NPII O 0 8.796196198090911e-05
) O 0 1.4019552879718233e-11
gene O 0 1.0128439753565033e-11
on O 0 4.0790629207698714e-10
chromosome O 0 3.4972307272340686e-09
20p13 O 0 2.3148886612034403e-06
. O 0 1.1657962772915198e-07

In O 0 1.2274163907477487e-09
this O 0 1.0127434481310704e-11
study O 0 6.9788229015155245e-12
, O 0 5.097863320716045e-13
we O 0 8.124622394127534e-13
analyzed O 0 1.4707120243873106e-10
two O 0 5.007009889167191e-13
families O 0 6.8142722367547925e-12
with O 0 1.1546601348666474e-12
FNDI B-Disease 1 1.0
using O 0 1.4026593775362528e-10
direct O 0 8.906683723886033e-11
automated O 0 1.0752475576580878e-09
fluorescent O 0 7.283073699682063e-09
, O 0 3.065854048498601e-13
solid O 0 9.147333931980306e-12
phase O 0 1.7101771387917353e-10
, O 0 1.1691820742901898e-13
single O 0 1.0228844680992832e-12
- O 0 6.1796405666225684e-12
stranded O 0 3.516423610627761e-11
DNA O 0 1.0429734333128327e-12
sequencing O 0 7.010735741941332e-12
of O 0 2.6634480211618072e-12
PCR O 0 3.5698022315955313e-08
- O 0 1.0936566923192004e-06
amplified O 0 3.972369540861109e-06
AVP O 0 2.756748472165782e-05
- O 0 2.0064467776137462e-07
NPII O 0 1.8453974917065352e-05
DNA O 0 4.6183195934190735e-08
. O 0 3.1164812952511056e-09

In O 0 2.840935264813993e-09
one O 0 2.974460521637523e-12
of O 0 2.0830574678359914e-12
the O 0 5.317518560893353e-12
families O 0 1.1719160364354053e-11
, O 0 2.795525041923014e-13
affected O 0 8.247319494003591e-11
individuals O 0 8.41432284091892e-13
presented O 0 4.6137188514094873e-10
a O 0 6.082093162440572e-12
novel O 0 7.108701405300621e-10
nonsense O 0 2.676361354758683e-09
mutation O 0 2.2161822724187097e-11
in O 0 1.4275653575923641e-11
exon O 0 1.462836657362132e-10
3 O 0 7.16907228026642e-11
of O 0 3.243376053840841e-11
the O 0 1.2341225263945432e-10
gene O 0 3.3734768450921493e-12
, O 0 2.6917307358736986e-12
consisting O 0 1.5388503188731861e-12
in O 0 2.175987471805807e-12
a O 0 4.1535728849406706e-12
G O 0 1.889914535979642e-08
to O 0 2.401839005461426e-10
T O 0 7.861946471621195e-08
transition O 0 2.2572195224057623e-09
at O 0 6.797529900071098e-11
nucleotide O 0 2.677418287078126e-09
2101 O 0 2.0447887436603196e-06
, O 0 1.5882710728207239e-12
which O 0 4.066842348993127e-14
produces O 0 2.709173387200909e-14
a O 0 6.526269003432348e-15
stop O 0 1.2430037468064148e-12
signal O 0 2.8976182564477426e-10
in O 0 1.92054580572254e-10
codon O 0 4.823967358902337e-08
82 O 0 8.177039489964955e-07
( O 0 7.169550370056399e-11
Glu O 0 7.148777285692631e-07
) O 0 5.002239508028472e-12
of O 0 3.123871439303372e-10
NPII O 0 0.19689016044139862
. O 0 4.279443146515405e-07

The O 0 1.8735809703684936e-07
premature O 0 6.271352503972594e-06
termination O 0 6.572962547579664e-07
eliminates O 0 1.8749709340681875e-08
part O 0 2.1966314878163473e-10
of O 0 9.713125859178717e-10
the O 0 3.598231490542503e-09
C O 0 1.6390112023145775e-07
- O 0 2.011701638604535e-10
terminal O 0 4.1876813128283175e-09
domain O 0 1.1482768902393303e-10
of O 0 2.3228936135710754e-11
NPII O 0 2.3818382032914087e-05
, O 0 3.322366904159879e-12
including O 0 2.855423417245234e-13
a O 0 3.8237853638642405e-13
cysteine O 0 2.1769764810275483e-11
residue O 0 1.7676715646786079e-09
in O 0 3.8211794839426716e-11
position O 0 5.155051385763443e-10
85 O 0 2.4888495708808023e-09
, O 0 1.4858884522100935e-12
which O 0 2.236123477139182e-13
could O 0 2.190131973348053e-12
be O 0 3.837845839738119e-12
involved O 0 9.848176961424482e-12
in O 0 6.7465837604030465e-12
the O 0 8.268204176875571e-11
correct O 0 8.40819502911927e-09
folding O 0 9.18884346390314e-09
of O 0 2.0277581003202982e-10
the O 0 7.968010251602209e-09
prohormone O 0 0.0011059031821787357
. O 0 2.5713063678267645e-07

In O 0 3.451833541223692e-10
the O 0 1.4227602429528474e-10
second O 0 1.0357135149519081e-09
family O 0 1.9848534274502505e-11
, O 0 1.8127720732927927e-13
a O 0 8.349458548596173e-14
G279A O 0 2.2260712717603326e-10
substitution O 0 8.518490912656773e-10
at O 0 1.6643400546634268e-10
position O 0 6.881607089725961e-11
- O 0 7.11307887590884e-11
1 O 0 6.155272957997227e-10
of O 0 6.4590728598989955e-12
the O 0 4.265059659613879e-12
signal O 0 2.099120877119276e-10
peptide O 0 2.3108029378882122e-11
was O 0 3.691061345456603e-11
observed O 0 9.17729225946573e-11
in O 0 1.5667437833211117e-11
all O 0 1.8477205876443747e-11
affected O 0 9.58064849676532e-10
individuals O 0 5.664748878309034e-11
. O 0 1.1395093757471386e-08

This O 0 3.701444484249805e-08
missense O 0 5.1839056141034234e-06
mutation O 0 1.8914830590688325e-08
, O 0 5.602416794370235e-11
which O 0 6.643371963654943e-11
replaces O 0 9.155045859188249e-07
Ala O 0 9.084736234399315e-07
with O 0 2.5065033382176694e-10
Thr O 0 6.6395064095559064e-06
, O 0 6.914987332740097e-11
is O 0 8.357237970234299e-13
frequent O 0 4.487435163041953e-12
among O 0 1.4411623804055917e-11
FNDI B-Disease 1 1.0
patients O 1 1.0
and O 0 1.089795476083566e-09
is O 0 9.768985100022665e-12
thought O 0 2.4129588951926628e-11
to O 0 1.2713429484514926e-12
reduce O 0 3.4687142047573616e-11
the O 0 1.1370520844322662e-11
efficiency O 0 1.1513724196277053e-08
of O 0 4.912849640992256e-11
cleavage O 0 3.323617076000929e-11
by O 0 4.553401058982054e-12
signal O 0 1.0420171392411248e-08
peptidases O 0 6.792082984929948e-08
. O 0 2.337151583375885e-10
. O 0 3.124856151615063e-09

Genetic O 0 8.659679195943681e-08
heterogeneity O 0 7.343167141016238e-08
of O 0 4.53829507307546e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.844793233787058e-11
due O 0 1.5004351894276624e-07
to O 0 1.3516370245270082e-09
TWIST O 1 0.9999759197235107
and O 0 9.687768454114121e-08
FGFR O 1 0.9999995231628418
mutations O 0 8.777344078225724e-07
. O 0 4.744886794583181e-08

Thirty O 0 2.889971483455156e-06
- O 0 2.3609005950220308e-07
two O 0 1.4491117507342555e-11
unrelated O 0 2.3298010631833677e-08
patients O 0 8.19717016486976e-10
with O 0 1.0894021077486986e-14
features O 0 2.2498532984555064e-12
of O 0 2.2097645935303944e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.796204666063231e-12
a O 0 1.1014482511825796e-12
common O 0 7.193490603185637e-08
autosomal B-Disease 1 0.9940383434295654
dominant I-Disease 0 0.0030420145485550165
condition I-Disease 1 0.9496577382087708
of O 0 0.4712141752243042
craniosynostosis B-Disease 1 1.0
and O 0 0.005732930731028318
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999144077301025
, O 0 2.924854525243603e-10
were O 0 1.176422570470237e-10
screened O 0 8.523220462741676e-10
for O 0 2.1193193033841595e-11
mutations O 0 1.0679116618783624e-10
in O 0 9.522999749878025e-11
TWIST O 0 0.000346044369507581
, O 0 5.394961699600742e-10
FGFR2 O 1 0.9999420642852783
, O 0 2.7571170346796237e-10
and O 0 2.4963361933139083e-10
FGFR3 O 1 0.9141363501548767
. O 0 4.533055175670597e-07

Nine O 0 2.984178593123943e-07
novel O 0 6.231957883073846e-08
and O 0 2.3574382446156505e-09
three O 0 1.9143432672397154e-10
recurrent O 0 2.4496438300047885e-07
TWIST O 0 0.000207018296350725
mutations O 0 2.2490713735834333e-09
were O 0 1.4480763810276187e-10
found O 0 2.700962066851109e-12
in O 0 1.3098002717149004e-11
12 O 0 3.04285874275223e-10
families O 0 3.4513331081953424e-10
. O 0 5.225110566442481e-09

Seven O 0 3.261968117840297e-08
families O 0 6.591034940051088e-10
were O 0 8.428224784751137e-11
found O 0 2.1718868023490323e-12
to O 0 1.5279177662669285e-12
have O 0 1.2146873784590895e-11
the O 0 6.159970311614416e-10
FGFR3 O 0 0.04513103887438774
P250R O 0 8.007334599824389e-07
mutation O 0 1.6430622140628515e-10
, O 0 1.2301448922003022e-12
and O 0 3.8858759959792266e-13
one O 0 9.384898728374141e-14
individual O 0 7.652488668782875e-14
was O 0 1.6934662006029555e-11
found O 0 2.0093987238012367e-12
to O 0 8.357019937177412e-12
have O 0 2.1056439578059916e-11
an O 0 2.5857746933227732e-12
FGFR2 O 0 0.00037064074422232807
VV269 O 0 5.711425274057547e-06
- O 0 2.771292599845765e-07
270 O 0 8.758561875765736e-09
deletion O 0 3.0421984931194856e-09
. O 0 2.20601648059926e-09

To O 0 5.45959666364837e-10
date O 0 7.226825573525275e-07
, O 0 2.7835140442578066e-11
our O 0 7.1753202338098454e-12
detection O 0 2.226088202661458e-10
rate O 0 1.220777923194305e-10
for O 0 1.8898555951499946e-13
TWIST O 0 2.8835850685027253e-07
or O 0 2.8507436411473464e-09
FGFR O 0 0.000132062123157084
mutations O 0 8.062146505949386e-10
is O 0 6.906337047390965e-12
68 O 0 1.212262373817552e-10
% O 0 9.34804859388516e-13
in O 0 5.541673348506693e-13
our O 0 4.125114971831323e-10
Saethre B-Disease 1 0.9999648332595825
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0033313275780528784
, O 0 1.620273685186413e-12
including O 0 1.6902382271588579e-12
our O 0 1.6641344968704175e-09
five O 0 5.788089452174461e-11
patients O 0 2.1335126998422993e-09
elsewhere O 0 2.0688763202603155e-10
reported O 0 1.4196096555230131e-11
with O 0 4.147044166402658e-11
TWIST O 0 0.002412330126389861
mutations O 0 2.0775787845650484e-07
. O 0 1.093519443884361e-07

More O 0 6.24010310090739e-09
than O 0 2.4375182428038045e-10
35 O 0 1.9922592464638456e-09
different O 0 2.772065910150445e-10
TWIST O 0 2.6135280677408446e-06
mutations O 0 1.7516020855978809e-09
are O 0 3.825458179396168e-12
now O 0 1.7993659947451723e-12
known O 0 5.12561076481538e-13
in O 0 3.393377159127686e-13
the O 0 1.6349522430347818e-11
literature O 0 1.1500835839228785e-09
. O 0 8.180067734286922e-10

The O 0 1.599642445171412e-07
most O 0 1.27826726981084e-09
common O 0 1.0032828040573705e-10
phenotypic O 0 8.048099686686072e-11
features O 0 1.116355532321256e-11
, O 0 2.9990918602729177e-13
present O 0 1.0394747562703088e-11
in O 0 1.2834207654965901e-11
more O 0 1.5596908259276482e-13
than O 0 1.8750592170515418e-13
a O 0 1.9003125895783457e-13
third O 0 1.072375521715685e-10
of O 0 4.758059501952516e-10
our O 0 1.1407510491778794e-08
patients O 0 8.38254266000149e-09
with O 0 2.474305482724759e-12
TWIST O 0 1.2293026884435676e-05
mutations O 0 1.8437231741330606e-09
, O 0 7.481873627590563e-12
are O 0 1.9447178242759655e-12
coronal B-Disease 0 3.311681950890488e-07
synostosis I-Disease 0 2.028237759077456e-06
, O 0 1.7682001696162075e-10
brachycephaly B-Disease 0 1.6117985069286078e-05
, O 0 1.0525741167555225e-08
low B-Disease 0 0.0009129477548412979
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 4.3078767930637696e-07
facial B-Disease 1 0.9996238946914673
asymmetry I-Disease 1 0.9999806880950928
, O 0 2.9057792616526967e-08
ptosis B-Disease 1 0.9974207878112793
, O 0 1.707482488733092e-09
hypertelorism B-Disease 0 1.9019265891984105e-05
, O 0 2.0294923519514896e-09
broad B-Disease 0 0.0075734807178378105
great I-Disease 1 0.9976797699928284
toes I-Disease 1 0.9982088804244995
, O 0 1.1828106272204764e-09
and O 0 1.5502772399145215e-09
clinodactyly B-Disease 0 0.0006539965397678316
. O 0 1.6875701476237737e-06

Significant O 0 3.756304522539722e-06
intra O 0 9.368905011797324e-05
- O 0 4.358173464424908e-05
and O 0 3.786192692700752e-09
interfamilial O 0 6.6362777033646125e-06
phenotypic O 0 8.769899295657524e-08
variability O 0 1.2292518647427642e-07
is O 0 4.4721298604437354e-13
present O 0 1.3073088618587025e-12
for O 0 7.21252918500781e-13
either O 0 1.2475517285892579e-09
TWIST O 0 0.00041485243127681315
mutations O 0 1.1851049919187062e-07
or O 0 3.8666630786110545e-08
FGFR O 0 0.10804494470357895
mutations O 0 2.803433005738043e-07
. O 0 6.890587656016578e-08

The O 0 5.8959908955102946e-08
overlap O 0 4.929074037818282e-09
in O 0 5.2571145353619286e-11
clinical O 0 1.559969931008709e-10
features O 0 1.4069081837042585e-11
and O 0 2.7704722196930653e-12
the O 0 2.139692763247769e-11
presence O 0 8.74491104529973e-12
, O 0 4.119041045747007e-12
in O 0 4.163725787764694e-12
the O 0 2.9957106240097175e-11
same O 0 6.362588927943946e-11
genes O 0 1.0574361698767465e-11
, O 0 7.974638744495666e-13
of O 0 1.9116931995744046e-11
mutations O 0 8.020706494804575e-13
for O 0 1.722405312994113e-12
more O 0 1.019487554272669e-12
than O 0 8.288284121527045e-12
one O 0 6.425294324374775e-12
craniosynostotic B-Disease 0 2.330436643660505e-08
condition I-Disease 0 3.422872794089926e-07
- O 0 5.139100700546351e-09
such O 0 1.7442930433375636e-10
as O 0 1.0693709806552931e-10
Saethre B-Disease 0 5.397878908297571e-07
- I-Disease 0 8.329596568046327e-09
Chotzen I-Disease 0 6.284712412707449e-07
, I-Disease 0 1.021960554375978e-11
Crouzon I-Disease 0 4.556244221021188e-06
, I-Disease 0 1.3869050352610657e-10
and I-Disease 0 3.7476182157547555e-09
Pfeiffer I-Disease 1 0.999913215637207
syndromes I-Disease 1 1.0
- O 1 0.9996943473815918
support O 0 1.0145473083866818e-07
the O 0 4.479788096034554e-09
hypothesis O 0 1.7352151937544136e-09
that O 0 8.263099812678629e-14
TWIST O 0 3.5726094438359723e-07
and O 0 2.3662611800534528e-11
FGFRs O 0 6.829847620792862e-08
are O 0 1.5725203257599407e-13
components O 0 9.269009171308795e-12
of O 0 4.4353327434409895e-12
the O 0 1.6677575119528054e-12
same O 0 3.745440155938917e-12
molecular O 0 7.014386901177394e-12
pathway O 0 4.5627121872393595e-12
involved O 0 1.6423696102651868e-14
in O 0 6.2357527961501204e-15
the O 0 2.968053930342725e-14
modulation O 0 3.202314455275079e-11
of O 0 5.517169013313783e-11
craniofacial O 1 0.9999998807907104
and O 0 7.595709803354112e-07
limb O 1 1.0
development O 0 0.0003258076903875917
in O 0 2.5109594403716073e-09
humans O 0 3.4976224694283076e-10
. O 0 6.918535883082555e-11
. O 0 6.322211643094988e-10

Mutation O 0 1.4061315445346168e-09
analysis O 0 7.880743800592338e-12
of O 0 9.504925319037127e-11
UBE3A O 1 0.9999998807907104
in O 0 0.0007885381928645074
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9597938656806946
. O 0 3.888896316084356e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.0646590453688987e-07
AS B-Disease 1 1.0
) O 0 6.8542910063029705e-12
is O 0 7.390018230604006e-14
caused O 0 4.131378399108154e-12
by O 0 4.895962541634491e-12
chromosome O 0 7.278681546374344e-10
15q11 O 0 1.2936496318616264e-07
- O 0 7.103188703894148e-09
q13 O 0 3.4464296305714015e-08
deletions O 0 6.665040186426552e-10
of O 0 2.1172385025747253e-11
maternal O 0 8.514544069804231e-10
origin O 0 6.7706638906539496e-12
, O 0 1.501625429903286e-14
by O 0 2.557979327487414e-13
paternal O 0 5.886125109100249e-06
uniparental B-Disease 1 0.9999150037765503
disomy I-Disease 1 0.9998794794082642
( O 0 4.727684022043377e-09
UPD B-Disease 1 1.0
) O 0 3.817711424769499e-11
15 O 0 1.0572491493388014e-10
, O 0 8.879886165573045e-14
by O 0 1.4464628496704823e-12
imprinting O 0 3.777517122216523e-05
defects O 1 0.9999624490737915
, O 0 6.841758826148236e-10
and O 0 9.208796052095902e-12
by O 0 3.34971668458639e-11
mutations O 0 3.754412614132008e-10
in O 0 4.70757988146886e-10
the O 0 3.832023409700014e-08
UBE3A O 0 0.0004629763134289533
gene O 0 2.4034543244511042e-08
. O 0 5.832259830640396e-08

UBE3A O 0 0.0004426849482115358
encodes O 0 1.3617158511891603e-09
a O 0 2.633890675007855e-11
ubiquitin O 0 7.50752970901658e-09
- O 0 4.153691790520497e-08
protein O 0 1.7869875579279437e-09
ligase O 0 4.781351314875337e-09
and O 0 1.827899831496893e-09
shows O 0 1.1058537419117442e-09
brain O 0 1.7381308836661447e-08
- O 0 5.914707834620003e-09
specific O 0 1.4117811808489478e-08
imprinting O 0 8.180110853572842e-06
. O 0 9.466871375707342e-08

Here O 0 6.229117843759013e-08
we O 0 5.260597513156995e-10
describe O 0 8.778162197131678e-09
UBE3A O 0 8.947449532570317e-05
coding O 0 2.3463560410164064e-06
- O 0 6.016040970280301e-06
region O 0 2.209871610148184e-07
mutations O 0 1.0028686325824765e-08
detected O 0 4.400890762923382e-09
by O 0 1.469889661376289e-11
SSCP O 0 0.0074008735828101635
analysis O 0 1.889213230299447e-10
in O 0 4.828875840856561e-11
13 O 0 5.058015672965155e-10
AS B-Disease 1 1.0
individuals O 0 1.9805837525588288e-11
or O 0 1.7740646451880338e-10
families O 0 1.4240741919024913e-10
. O 0 8.1784301553256e-10

Two O 0 7.96009658188268e-09
identical O 0 8.76707275665467e-08
de O 0 2.2695287427154653e-08
novo O 0 2.226702022767313e-08
5 O 0 1.3309494306668057e-07
- O 0 1.9330400391481817e-07
bp O 0 2.9904919074397185e-07
duplications O 0 6.138430563851216e-08
in O 0 4.323019719976173e-09
exon O 0 9.093372455026838e-08
16 O 0 4.580184231883777e-09
were O 0 3.284716110218966e-10
found O 0 1.551619527306869e-10
. O 0 1.4265360448462161e-08

Among O 0 1.7326635770587018e-07
the O 0 2.0408192913379253e-09
other O 0 2.8040308963639404e-10
11 O 0 4.877308001915992e-10
unique O 0 1.240750002740043e-10
mutations O 0 1.4428354344619976e-10
, O 0 1.701112514740366e-11
8 O 0 6.95917046211747e-10
were O 0 1.2910227054074852e-10
small O 0 2.081227724881618e-11
deletions O 0 1.0098165637018042e-09
or O 0 1.2369274493551075e-09
insertions O 0 2.0702087155655136e-08
predicted O 0 2.2171031233142457e-08
to O 0 2.421198519453327e-10
cause O 0 9.81433032620771e-08
frameshifts O 0 6.371602648869157e-05
, O 0 8.933242340303238e-11
1 O 0 5.946219072683334e-10
was O 0 2.1775579603366957e-11
a O 0 5.477988939198153e-13
mutation O 0 1.963554969661163e-12
to O 0 1.147925287811602e-12
a O 0 3.0188878740594616e-12
stop O 0 2.020060646534816e-10
codon O 0 1.0762961633048462e-09
, O 0 1.690200583659429e-11
1 O 0 1.378626240944314e-10
was O 0 1.3903050585795107e-11
a O 0 3.541427134184927e-12
missense O 0 3.374067469863462e-09
mutation O 0 1.838475031934461e-11
, O 0 1.1849834264873738e-12
and O 0 1.7890105629553288e-12
1 O 0 1.6044382489255327e-09
was O 0 9.307729031959866e-10
predicted O 0 8.624384761901638e-09
to O 0 3.435542475505038e-11
cause O 0 6.068159863481526e-10
insertion O 0 1.9828727548798497e-09
of O 0 3.942751458652083e-09
an O 0 2.619870466402663e-12
isoleucine O 0 3.234903234172748e-09
in O 0 9.277592583067928e-11
the O 0 3.8086950260307617e-10
hect O 0 3.1290153401641874e-07
domain O 0 6.456815970778962e-09
of O 0 2.7999920160226566e-09
the O 0 1.4494208500082095e-08
UBE3A O 0 8.042367699090391e-05
protein O 0 1.3000680532115894e-08
, O 0 5.6745437342076155e-12
which O 0 1.5241098856068336e-13
functions O 0 5.069048913258767e-12
in O 0 1.3779446333961332e-11
E2 O 0 4.620134674837573e-08
binding O 0 2.194764592289289e-09
and O 0 1.3239595531011616e-10
ubiquitin O 0 5.062158248136939e-09
transfer O 0 3.786111847148277e-06
. O 0 1.2108151281609025e-07

Eight O 0 2.5677428183712436e-08
of O 0 2.2348564665541915e-10
the O 0 7.951177043163948e-12
cases O 0 1.5720490187387526e-10
were O 0 3.213880828134563e-10
familial O 0 1.3359287898140337e-08
, O 0 1.972754182233416e-10
and O 0 6.604222724249098e-10
five O 0 2.1818329087874844e-10
were O 0 9.492374664077374e-10
sporadic O 0 1.8422974790155422e-07
. O 0 2.4789915897827086e-08

In O 0 1.1198610927465324e-08
two O 0 2.4124161002170297e-11
familial O 0 2.9060605033492948e-09
cases O 0 7.902626109057564e-09
and O 0 4.799357578022523e-10
one O 0 2.092651919805011e-11
sporadic O 0 6.738376079340469e-09
case O 0 1.2160707996144993e-08
, O 0 3.661165537405253e-10
mosaicism O 0 5.245997090241872e-05
for O 0 6.398072116553521e-08
UBE3A O 0 0.00017504581774119288
mutations O 0 3.8408831670722066e-09
was O 0 4.546619192247192e-10
detected O 0 5.151866711017306e-10
in O 0 6.467936863180368e-12
the O 0 2.9634815434942396e-11
mother O 0 5.078790166201941e-10
of O 0 3.531380188270816e-10
three O 0 4.462727062892746e-11
AS B-Disease 1 1.0
sons O 0 9.983363469245887e-08
, O 0 5.862827042422969e-13
in O 0 4.188367588951053e-13
the O 0 1.011384552496164e-11
maternal O 0 2.5590238816874944e-09
grandfather O 0 7.488826270218851e-08
of O 0 7.656262823729776e-08
two O 0 3.1696414937165684e-10
AS B-Disease 1 1.0
first O 0 2.2203139327103827e-09
cousins O 0 3.786638780312046e-10
, O 0 5.648171275303426e-13
and O 0 1.3717022309678306e-13
in O 0 5.07813355168224e-13
the O 0 2.932645792874666e-11
mother O 0 8.534933315651472e-10
of O 0 2.43900177832046e-10
an O 0 6.625235516449779e-12
AS B-Disease 1 1.0
daughter O 0 0.00010944678069790825
. O 0 4.871623104918399e-07

The O 0 3.220597122322033e-08
frequencies O 0 9.23607079705846e-10
with O 0 5.907525445388029e-13
which O 0 1.0252615813624577e-12
we O 0 3.707732905422478e-12
detected O 0 1.7097367965845933e-10
mutations O 0 9.575687465179783e-12
were O 0 1.1220836065861661e-10
5 O 0 7.534937257469565e-11
( O 0 5.1932138873510975e-14
14 O 0 1.7977579494510287e-11
% O 0 3.621986337156574e-13
) O 0 5.793169187363802e-15
of O 0 9.855768111355356e-12
35 O 0 1.8603353579838e-10
in O 0 1.2559018061630844e-11
sporadic O 0 3.5932656849979594e-09
cases O 0 1.4010397286767784e-09
and O 0 4.762054084395118e-10
8 O 0 1.6413778114454658e-09
( O 0 1.8737686098904693e-13
80 O 0 2.381460653677614e-11
% O 0 1.228067127156951e-13
) O 0 9.517963115113172e-16
of O 0 3.475518755170076e-13
10 O 0 2.891194878992809e-12
in O 0 1.2245879657535319e-11
familial O 0 2.941965560054882e-09
cases O 0 3.909524703971101e-09
. O 0 1.0860153665248617e-08
. O 0 6.947611552732269e-08

The O 0 1.3911686664869194e-06
hemochromatosis B-Disease 1 1.0
845 O 0 1.6087743688331102e-06
G O 0 2.0591937044400765e-08
- O 0 8.916360427768666e-10
- O 0 5.328570362728158e-10
> O 0 6.18103734861819e-10
A O 0 4.229918498799279e-11
and O 0 2.9253016025146406e-13
187 O 0 3.4921195709441966e-12
C O 0 1.6048806381063763e-11
- O 0 1.895058112169612e-12
- O 0 6.322559142901696e-11
> O 0 1.3267763554480894e-09
G O 0 7.361998122235036e-09
mutations O 0 1.234484389711632e-11
: O 0 7.824971681898163e-14
prevalence O 0 4.1027185121444987e-11
in O 0 7.491679260458739e-13
non O 0 9.579702364703735e-09
- O 0 6.033875621369589e-08
Caucasian O 0 8.688810559931426e-09
populations O 0 5.538205449795441e-10
. O 0 3.4990838004844704e-10

Hemochromatosis B-Disease 1 0.9999188184738159
, O 0 1.605540367322078e-09
the O 0 2.651652721397113e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 9.186109650727303e-09
leads O 0 7.903892651484057e-09
, O 0 4.08614505079119e-12
if O 0 5.721499385380469e-10
untreated O 1 0.9999963045120239
, O 0 6.715950278540772e-12
to O 0 1.0385755450093015e-10
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 5.869163643978936e-08
premature B-Disease 0 1.459168652218068e-05
death I-Disease 0 1.985481787869503e-07
. O 0 2.058451542552575e-08

The O 0 2.038406364590628e-06
hemochromatosis B-Disease 1 1.0
gene O 0 7.568031890059501e-08
, O 0 1.5263763586403911e-09
HFE O 1 0.9700929522514343
, O 0 4.7330432906278475e-09
recently O 0 2.5314255136521524e-09
has O 0 2.6194808041418716e-12
been O 0 7.420289968411431e-13
identified O 0 3.5169853140892826e-12
, O 0 2.387894298527121e-13
and O 0 7.903605070760933e-13
characterization O 0 4.45880088406625e-09
of O 0 7.775612154148348e-09
this O 0 2.9818039148921116e-09
gene O 0 1.511746838822603e-10
has O 0 1.6135882560663894e-11
shown O 0 1.884144533101373e-12
that O 0 4.443770655268575e-14
it O 0 1.29583626815033e-13
contains O 0 1.000213258571525e-12
two O 0 7.157543600779664e-14
mutations O 0 4.325047806875981e-13
that O 0 4.0995364655044275e-14
result O 0 7.105010330077377e-11
in O 0 9.464313360796339e-11
amino O 0 1.0780830395074048e-10
acid O 0 2.126945702896066e-10
substitutions O 0 1.6193482665904924e-10
- O 0 1.5363385563738063e-10
cDNA O 0 1.5641440920255434e-10
nucleotides O 0 7.872945351206084e-12
845 O 0 1.3120637909480592e-10
G O 0 3.047277014056604e-11
- O 0 6.9972964054920705e-12
- O 0 1.4655924043815993e-11
> O 0 5.2028884672816744e-11
A O 0 6.212853148612751e-11
( O 0 1.8421753651600564e-14
C282Y O 0 1.4880482956947105e-10
) O 0 9.233722151420678e-15
and O 0 1.1930564771788638e-13
187 O 0 1.0658273742747415e-11
C O 0 6.61550328406868e-11
- O 0 2.080711644647515e-11
- O 0 2.604934601357911e-10
> O 0 5.207162256937181e-09
G O 0 7.335047769174707e-08
( O 0 2.503060909583854e-12
H63D O 0 2.5274493964388967e-05
) O 0 2.6370173406009556e-11
. O 0 1.7558736686851262e-09

Although O 0 4.584680937114172e-05
hemochromatosis B-Disease 1 1.0
is O 0 7.114276390218777e-10
common O 0 2.351903949371348e-10
in O 0 1.533074014958835e-11
Caucasians O 0 1.7785750650034515e-09
, O 0 9.826294508977207e-13
affecting O 0 5.198732069833234e-11
> O 0 2.1510242198541363e-10
= O 0 3.834633565541479e-12
1 O 0 2.180450611732887e-11
/ O 0 6.635149894795855e-12
300 O 0 9.019574366900263e-13
individuals O 0 1.2543677881603991e-14
of O 0 6.099914844071019e-12
northern O 0 1.8669531198778344e-11
European O 0 4.835419564752641e-11
origin O 0 2.885281458198108e-10
, O 0 4.3896249482533456e-12
it O 0 1.935908708729575e-13
has O 0 8.478128951921321e-14
not O 0 1.7863399019539539e-13
been O 0 1.4740552528591522e-12
recognized O 0 3.980406629300326e-11
in O 0 2.1517452750141608e-11
other O 0 8.118650196564658e-11
populations O 0 2.3039123386858762e-10
. O 0 1.2382634917429414e-09

The O 0 5.407584602323823e-09
present O 0 1.2396151882754225e-09
study O 0 9.265457324991733e-12
used O 0 1.6159920894921048e-13
PCR O 0 2.207123372954811e-09
and O 0 4.885440576390954e-12
restriction O 0 6.1542393403613e-10
- O 0 8.587165006845865e-11
enzyme O 0 2.8310064362213616e-11
digestion O 0 2.2019095435865665e-09
to O 0 1.1000982026374007e-12
analyze O 0 1.6658183079470978e-12
the O 0 1.4512704731538262e-13
frequency O 0 2.564429137791313e-12
of O 0 8.625666912502605e-13
the O 0 7.933785572955543e-12
845 O 0 2.349236638554686e-10
G O 0 7.148318048599833e-11
- O 0 1.612437613984774e-11
- O 0 3.001143777936477e-11
> O 0 6.714647587946487e-11
A O 0 1.36329445996064e-11
and O 0 2.9096859063869676e-14
187 O 0 1.3094075520039827e-12
C O 0 6.850579565426118e-12
- O 0 8.22048646601653e-13
- O 0 3.2245813658127176e-11
> O 0 1.3322334346810294e-09
G O 0 5.7497926420069234e-09
mutations O 0 2.934229248463538e-11
in O 0 2.2756671547163876e-11
HLA O 0 1.1028694402170913e-08
- O 0 1.0411092432605074e-08
typed O 0 3.676041970823718e-10
samples O 0 1.9548640484146063e-11
from O 0 2.1318619612686884e-12
non O 0 1.1445602243753683e-09
- O 0 1.0378472525829352e-09
Caucasian O 0 4.5802253656468395e-10
populations O 0 4.002087550247779e-11
, O 0 1.7044366948642392e-13
comprising O 0 2.4757911107516073e-13
Australian O 0 8.609070921428152e-12
Aboriginal O 0 2.788595465652577e-10
, O 0 8.076489645255855e-14
Chinese O 0 4.8009391601100404e-11
, O 0 1.2587406160793901e-12
and O 0 5.922601385016657e-12
Pacific O 0 2.649880870286836e-10
Islanders O 0 9.795703448389759e-08
. O 0 3.9504146620572556e-09

Results O 0 4.9289447190403735e-08
showed O 0 2.7302411442775565e-09
that O 0 3.1088106806735627e-13
the O 0 4.3577353531221164e-11
845 O 0 2.416258748638711e-09
G O 0 1.2139335092697934e-09
- O 0 3.697221417908736e-10
- O 0 1.1030919511156867e-09
> O 0 2.697630119286032e-09
A O 0 2.8092450587990925e-10
mutation O 0 5.832670717936805e-12
was O 0 2.811943820152374e-12
present O 0 6.093821194180782e-12
in O 0 6.10359245784009e-12
these O 0 9.896683299259745e-12
populations O 0 1.9620125836505853e-12
( O 0 2.3655070059729532e-15
allele O 0 6.730266978493063e-14
frequency O 0 1.54326822588563e-12
0 O 0 1.6669274467695505e-12
. O 0 9.021617139318497e-14
32 O 0 3.4991003150519617e-12
% O 0 5.81828761060145e-14
) O 0 1.0238313814776119e-15
, O 0 2.7531965693817356e-14
and O 0 1.8901980675112284e-13
, O 0 4.41312025985241e-13
furthermore O 0 2.899542272949418e-10
, O 0 2.895482898584989e-12
it O 0 5.508782991402172e-13
was O 0 2.341869143052122e-09
always O 0 8.181831323561539e-10
seen O 0 8.643973731237153e-11
in O 0 4.724378006859542e-12
conjunction O 0 7.894061099245064e-11
with O 0 4.472063778321322e-12
HLA O 0 5.617270630864368e-07
haplotypes O 0 4.432464173476092e-09
common O 0 1.989440556737776e-10
in O 0 6.3512858167191766e-12
Caucasians O 0 1.9926342520459883e-10
, O 0 2.5314301978392184e-13
suggesting O 0 5.808889827485508e-12
that O 0 5.10692345617042e-13
845 O 0 1.3973781021192622e-09
G O 0 5.6404210191374204e-09
- O 0 4.874576298163902e-09
- O 0 3.9890011294119176e-08
> O 0 1.245059308985219e-07
A O 0 4.5780204516177037e-08
may O 0 3.550915339545213e-09
have O 0 5.7463417704739506e-12
been O 0 3.2452805633770287e-12
introduced O 0 2.4516307386979186e-11
into O 0 4.832005455479571e-12
these O 0 5.809163913794713e-13
populations O 0 7.792859646428216e-14
by O 0 1.2858377557156686e-13
Caucasian O 0 1.7201418067713803e-10
admixture O 0 4.193347891146004e-09
. O 0 9.597480143952453e-09

187 O 0 7.168029725335145e-08
C O 0 3.538940696046211e-09
- O 0 4.872461115135174e-11
- O 0 5.890227194882414e-11
> O 0 3.2979619035700125e-10
G O 0 9.10381103835789e-10
was O 0 1.5592306092104824e-12
present O 0 1.98482224579577e-12
at O 0 5.687641113291675e-13
an O 0 3.830701845276363e-15
allele O 0 7.583908544564477e-13
frequency O 0 4.103438769331724e-11
of O 0 2.44500895224542e-11
2 O 0 4.125761954298923e-09
. O 0 4.481506277187464e-09

68 O 0 6.905190161887731e-07
% O 0 5.190342600158715e-10
in O 0 8.949507801503387e-12
the O 0 1.0652934090416011e-10
two O 0 3.59233519667268e-12
populations O 0 6.893387336642798e-12
analyzed O 0 1.8365553522414757e-10
( O 0 1.4216084906482074e-12
Australian O 0 1.347135514251363e-09
Aboriginal O 0 8.971054121786892e-09
and O 0 4.48147335213589e-12
Chinese O 0 5.957843662862672e-10
) O 0 2.2304423932806294e-12
. O 0 2.9094310294297543e-10

In O 0 3.410072002552056e-09
the O 0 1.701295215816856e-10
Australian O 0 3.4489905376133834e-10
Aboriginal O 0 1.8983917215997792e-10
samples O 0 3.900216521274258e-12
, O 0 5.943734545342527e-14
187 O 0 9.246425673736791e-12
C O 0 5.978079836710393e-11
- O 0 4.584372378241275e-12
- O 0 1.5677939502189986e-10
> O 0 6.554956577531357e-09
G O 0 6.072646385746339e-08
was O 0 1.4937896752886815e-10
found O 0 1.691444402075748e-12
to O 0 1.6790555220063536e-13
be O 0 1.1042901619170986e-12
associated O 0 4.430433520052901e-10
with O 0 7.205757518446987e-11
HLA O 0 5.900963060412323e-06
haplotypes O 0 1.0920558679572423e-08
common O 0 7.083590658485406e-11
in O 0 1.4915618653382756e-12
Caucasians O 0 7.522701905848805e-11
, O 0 1.0648995791076588e-13
suggesting O 0 1.4732654115764965e-12
that O 0 1.1157002784752817e-14
it O 0 7.506651279309134e-14
was O 0 1.1402185619291405e-11
introduced O 0 3.4872757459503134e-11
by O 0 3.0571604275886344e-12
recent O 0 9.87148807141125e-10
admixture O 0 5.2227019153860965e-08
. O 0 8.902294013068968e-09

In O 0 6.290412191134465e-09
the O 0 3.739248077838653e-10
Chinese O 0 1.4611754028948098e-09
samples O 0 1.7629694579190947e-11
analyzed O 0 1.2707229365971351e-11
, O 0 1.5439091791049492e-13
187 O 0 1.0739797939862683e-11
C O 0 2.244637982429243e-11
- O 0 7.51579571148242e-13
- O 0 6.431523282696139e-12
> O 0 6.465313007186779e-11
G O 0 2.3909788038345425e-10
was O 0 2.0625818761277337e-12
present O 0 1.5507371428635786e-11
in O 0 4.2219384238650903e-11
association O 0 1.4534910601493589e-11
with O 0 3.9904519033746866e-13
a O 0 1.3344727232966758e-11
wide O 0 5.705610428563546e-10
variety O 0 3.570547746356567e-10
of O 0 2.992211478591855e-10
HLA O 0 1.6147397730037483e-07
haplotypes O 0 6.116747996998129e-09
, O 0 3.593047951180872e-12
showing O 0 3.4262744551261104e-12
this O 0 1.9152935530966642e-13
mutation O 0 3.6382577723106935e-13
to O 0 2.208954996999954e-13
be O 0 1.3772817521878755e-12
widespread O 0 6.273586650173968e-10
and O 0 6.844623392371352e-12
likely O 0 4.5476428178758965e-10
to O 0 1.1783083189720323e-11
predate O 0 1.5423245258716634e-07
the O 0 1.0178898834922734e-09
more O 0 8.076328668338295e-12
genetically O 0 7.210545494018561e-10
restricted O 0 1.7400439977777182e-09
845 O 0 4.04749123106285e-09
G O 0 3.982917107236972e-09
- O 0 1.1357786933174907e-09
- O 0 3.4150837713298188e-09
> O 0 1.7643108307652255e-08
A O 0 2.8264828255686325e-09
mutation O 0 1.2575953611815294e-09
. O 0 2.8917768180036774e-10

Genotype O 0 3.218834172002971e-05
- O 0 1.3861772458767518e-06
phenotype O 0 2.1380645875979098e-07
correlations O 0 1.5294313371327917e-08
in O 0 2.886184069517128e-10
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 5.455419886857271e-05

Germ O 0 0.000507455668412149
- O 0 1.326220080954954e-05
line O 0 2.5245087726943893e-06
mutations O 0 1.1710083569482777e-08
of O 0 1.3494209916142808e-10
the O 0 3.2667218929915975e-10
tumor B-Disease 0 1.1448935310909292e-06
suppressor O 0 1.5574228200421203e-06
APC O 0 2.8333215773557185e-09
are O 0 1.0889539595569653e-13
implicated O 0 5.7841244814615944e-12
in O 0 2.154272038534799e-10
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.189209619198664e-07
AAPC B-Disease 1 1.0
) O 0 8.154418112971129e-12
, O 0 2.343999357134509e-14
a O 0 1.2486864840732803e-14
variant O 0 8.814452279182206e-09
of O 0 0.009769122116267681
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.273421782054811e-09
FAP B-Disease 0 1.5034016769277514e-06
) O 0 8.238388443659872e-11
. O 0 2.7735640450998744e-09

AAPC B-Disease 1 1.0
is O 0 2.395599496551881e-09
recognized O 0 4.1547237872308074e-11
by O 0 2.6717349036267657e-13
the O 0 1.0195108646193773e-12
occurrence O 0 2.8231554247137858e-11
of O 0 5.384863388524508e-11
< O 0 9.594884176067353e-08
100 O 0 6.202034441571413e-10
colonic B-Disease 0 1.9359081306902226e-06
adenomas I-Disease 0 2.520481530154939e-07
and O 0 7.051043234528043e-13
a O 0 9.665904957944366e-14
later O 0 3.5248845509094906e-11
onset O 0 8.417797289439477e-06
of O 0 0.13946276903152466
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.557719861924327e-13
age O 0 3.8395901041932134e-11
> O 0 9.893612318290224e-11
40 O 0 8.150126407091562e-12
years O 0 2.0545446854230986e-12
) O 0 8.281390438853731e-13
. O 0 1.173169561496934e-09

The O 0 1.846028108154485e-09
aim O 0 7.931675871652999e-10
of O 0 4.577777740211175e-11
this O 0 4.850936492772906e-12
study O 0 3.1030776906360025e-12
was O 0 1.3733993326284222e-12
to O 0 2.2700263977576407e-12
assess O 0 4.810084419659688e-08
genotype O 0 1.0541549272602424e-05
- O 0 3.078306690440513e-06
phenotype O 0 3.443703917582752e-06
correlations O 0 6.436874144810645e-08
in O 0 1.8557611003444663e-09
AAPC B-Disease 1 1.0
families O 0 5.562019111948757e-08
. O 0 1.5120367180543326e-08

By O 0 3.4405145399318826e-10
protein O 0 9.732152861374743e-10
- O 0 1.427496121308991e-09
truncation O 0 2.069576865437739e-08
test O 0 1.087779644137754e-08
( O 0 5.287601953507526e-12
PTT O 0 1.5435031031074686e-09
) O 0 2.0399570924758146e-15
assay O 0 6.238118094997747e-12
, O 0 7.845969289847418e-14
the O 0 4.916960393529235e-13
entire O 0 7.614266855915375e-11
coding O 0 3.93007570931303e-10
region O 0 2.689040767833717e-09
of O 0 2.7895186605064737e-08
the O 0 1.528645952930674e-06
APC B-Disease 0 9.257595934286655e-08
gene O 0 5.6679695659145324e-11
was O 0 5.900256672131121e-11
screened O 0 2.2239748931340841e-10
in O 0 9.983705702432122e-12
affected O 0 6.489865311820608e-10
individuals O 0 4.6537773634725e-12
from O 0 5.1996068561877e-10
11 O 0 3.1862771976420845e-08
AAPC B-Disease 1 1.0
kindreds O 0 0.00014209869550541043
, O 0 3.215885890917036e-10
and O 0 3.768645465140885e-11
their O 0 3.4198535669993646e-10
phenotypic O 0 1.0926413551715086e-08
differences O 0 1.55760994857701e-06
were O 0 5.3237506847381155e-08
examined O 0 5.714709345738811e-07
. O 0 7.354801567771574e-08

Five O 0 1.661163828714507e-08
novel O 0 2.1093534030569572e-08
germ O 0 1.0565027878328692e-05
- O 0 3.3793101010815008e-06
line O 0 1.1309582987450995e-05
APC B-Disease 0 2.2421517087423126e-07
mutations O 0 1.2266370141844618e-09
were O 0 1.0595768012988671e-10
identified O 0 9.677117440709537e-11
in O 0 6.738408442341637e-11
seven O 0 5.130871283398619e-10
kindreds O 0 3.5082073281955672e-06
. O 0 3.192987563238603e-08

Mutations O 0 4.967043665260462e-08
were O 0 3.3203322313823946e-09
located O 0 5.222018928385808e-10
in O 0 2.1123739910033912e-11
three O 0 1.4641918320151825e-12
different O 0 6.443482466339523e-12
regions O 0 1.70180891601035e-09
of O 0 2.4281193944375445e-08
the O 0 1.593158344803669e-06
APC B-Disease 0 7.12371956979041e-08
gene O 0 5.849173229099947e-11
( O 0 1.4308461371032727e-13
1 O 0 6.494046966842859e-11
) O 0 8.591620355425083e-15
at O 0 1.8825282045026315e-12
the O 0 3.0057838162900197e-11
5 O 0 3.1072858175384965e-10
end O 0 2.7276907399453876e-09
spanning O 0 1.4208274556892775e-09
exons O 0 2.067673116057378e-10
4 O 0 1.124819959397172e-10
and O 0 3.37114169045305e-12
5 O 0 1.543787875313285e-10
, O 0 2.1473408988448295e-12
( O 0 7.227591192638522e-14
2 O 0 1.8614844041198175e-11
) O 0 3.647900530907508e-14
within O 0 2.830099522788121e-11
exon O 0 2.4321267222404686e-10
9 O 0 8.629975067897533e-10
, O 0 8.64151371987587e-12
and O 0 2.4212389038158477e-11
( O 0 8.196219310890873e-13
3 O 0 9.225308711391378e-11
) O 0 1.5169689235230294e-14
at O 0 2.5271280294086873e-12
the O 0 1.5142307546733846e-11
3 O 0 4.868757064180329e-10
distal O 0 1.6529083879390782e-08
end O 0 5.8896741705893874e-08
of O 0 2.8309999677844644e-08
the O 0 1.0192702148970056e-07
gene O 0 6.855465084498746e-09
. O 0 1.5904819861134456e-07

Variability O 0 1.587290739735181e-06
in O 0 3.203965426301636e-10
the O 0 8.98615071243114e-11
number O 0 4.4748499350433235e-10
of O 0 3.081303532326274e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.2655226555580157e-07
most O 0 4.419037705205575e-11
apparent O 0 3.9284642205927867e-10
in O 0 9.679825517527885e-12
individuals O 0 8.602090394160822e-13
with O 0 1.8798873048508913e-12
mutations O 0 5.5438566931576005e-11
in O 0 3.5760003291862574e-10
region O 0 3.653412505855158e-08
1 O 0 6.138688490864297e-07
, O 0 5.493396362798997e-11
and O 0 1.7657778572655047e-09
upper O 1 0.9999492168426514
- O 0 0.07235385477542877
gastrointestinal O 1 0.9995249509811401
manifestations O 0 1.2380664884403814e-05
were O 0 9.905214426453313e-09
more O 0 1.7697175322406444e-11
severe O 0 5.733190810985889e-09
in O 0 3.183236729764616e-10
them O 0 2.4697013878416385e-10
. O 0 3.916757584931929e-09

In O 0 6.726626367026256e-09
individuals O 0 4.222566740708089e-11
with O 0 2.6517336503689704e-12
mutations O 0 2.1557835377938872e-11
in O 0 1.4468753972707304e-10
either O 0 5.526492596885646e-10
region O 0 5.898304955564981e-09
2 O 0 5.910828715371963e-09
or O 0 3.537142106990743e-11
region O 0 7.63731022868086e-10
3 O 0 5.216185816614427e-10
, O 0 3.219974742570131e-13
the O 0 4.060839338404509e-12
average O 0 1.7521725736990845e-10
number O 0 2.3686271694023375e-11
of O 0 4.986992485633834e-10
adenomas B-Disease 0 5.572865688918682e-07
tended O 0 1.8217389197161538e-07
to O 0 6.118654888309649e-11
be O 0 5.362008059783818e-11
lower O 0 2.6238662798050427e-08
than O 0 1.587106140954475e-11
those O 0 1.623816879570139e-11
in O 0 9.782615689735152e-12
individuals O 0 1.0641914866688085e-12
with O 0 2.653524535517482e-12
mutations O 0 4.885452112302069e-11
in O 0 3.494020003880216e-11
region O 0 1.9116140614894306e-10
1 O 0 2.5581733953394803e-10
, O 0 5.599085648247404e-14
although O 0 9.082659971348939e-12
age O 0 5.708201133991508e-10
at O 0 4.670007783258434e-11
diagnosis O 0 3.495831890631962e-08
was O 0 1.463937082668565e-09
similar O 0 9.199294659367752e-09
. O 0 1.0645169368217466e-07

In O 0 5.183343532166873e-08
all O 0 3.997242004061263e-08
AAPC B-Disease 1 1.0
kindreds O 0 2.072241159112309e-06
, O 0 1.059834403398241e-12
a O 0 1.1336597486493252e-13
predominance O 0 2.2392523391090435e-09
of O 0 6.943276620319239e-09
right O 1 1.0
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.00011366059334250167
rectal B-Disease 1 1.0
polyp I-Disease 0 0.0007749747601337731
sparing O 0 3.3270534771645544e-08
was O 0 5.026243421468735e-09
observed O 0 1.1754615947268121e-08
. O 0 3.13397805484783e-08

No O 0 0.00023679956211708486
desmoid B-Disease 1 0.9999998807907104
tumors I-Disease 1 1.0
were O 0 3.2511294989490125e-08
found O 0 3.2652142101241566e-10
in O 0 8.04337291215873e-11
these O 0 1.919580050468994e-09
kindreds O 0 1.0155120435229037e-05
. O 0 4.9675080049382814e-08

Our O 0 3.0977267329035385e-07
data O 0 1.0752148060788613e-09
suggest O 0 3.663694347899593e-10
that O 0 5.643573173889915e-13
, O 0 4.2026382374160676e-12
in O 0 4.1324704769252207e-10
AAPC B-Disease 1 1.0
families O 0 2.6582309686773442e-08
, O 0 4.274667913476554e-13
the O 0 3.1484333911681317e-13
location O 0 1.283906314597516e-10
of O 0 3.237827228552703e-10
the O 0 1.8683812186282012e-07
APC B-Disease 0 7.302644462470198e-06
mutation O 0 1.7020896336816804e-07
may O 0 4.286100718786656e-08
partially O 0 3.9898075954170054e-08
predict O 0 4.818686338836642e-09
specific O 0 3.3396150289632942e-09
phenotypic O 0 8.311872790045527e-08
expression O 0 2.652432726790721e-07
. O 0 8.065260459488854e-08

This O 0 4.0161368675128983e-10
should O 0 1.491611695270123e-10
help O 0 3.939753471376983e-12
in O 0 2.6882660052011953e-13
the O 0 3.9232094135865925e-13
design O 0 4.053584967689261e-10
of O 0 1.4309546603197276e-10
tailored O 0 1.0841883835155386e-07
clinical O 0 1.1977404845708861e-08
- O 0 5.578268402750552e-10
management O 0 9.328371408656722e-12
protocols O 0 7.080541708504029e-10
in O 0 8.049180896460562e-13
this O 0 5.900026018960947e-13
subset O 0 6.088030080064755e-10
of O 0 3.7167768862644834e-11
FAP B-Disease 0 2.9730384198956017e-07
patients O 0 4.32258495663973e-08
. O 0 2.0014141732804802e-10
. O 0 3.238113333026149e-09

Wilms B-Disease 1 0.9999982118606567
' I-Disease 0 0.0033074989914894104
tumor I-Disease 0 1.0217563612968661e-05
1 O 0 2.677353272417804e-08
and O 0 4.56385450264829e-11
Dax O 0 1.6110387832668494e-06
- O 0 1.4556960969969168e-08
1 O 0 1.2347642019960858e-08
modulate O 0 4.811816722849471e-09
the O 0 3.461672282156769e-09
orphan O 0 2.387006077242404e-07
nuclear O 0 1.6718216144795406e-08
receptor O 0 1.7320473943982506e-09
SF O 0 2.466504338372033e-05
- O 0 4.398213793166406e-09
1 O 0 4.073744674926161e-10
in O 0 5.111269480578828e-13
sex O 0 5.05383224418815e-13
- O 0 2.4023313720256123e-12
specific O 0 5.363059388946434e-12
gene O 0 1.064344359175129e-11
expression O 0 9.235682774111353e-10
. O 0 3.051450203628292e-09

Products O 0 1.0778953196677321e-07
of O 0 1.2189363296499778e-08
steroidogenic O 0 0.0009369145845994353
factor O 0 4.1578374521122896e-08
1 O 0 4.909033179956168e-09
( O 0 5.861888123341596e-13
SF O 0 7.930507126729935e-05
- O 0 5.83942849630148e-08
1 O 0 6.4194001225814645e-09
) O 0 2.0222985612494693e-12
and O 0 1.9075892254694082e-10
Wilms B-Disease 1 0.9711334705352783
tumor I-Disease 0 0.1751730591058731
1 O 0 4.4307253688202763e-07
( O 0 1.1896741404504585e-11
WT1 O 0 2.3782602909250272e-07
) O 0 2.0802702008909657e-12
genes O 0 2.0361583513012205e-12
are O 0 2.37916426875295e-14
essential O 0 2.9163286369149333e-12
for O 0 4.461684385663467e-13
mammalian O 0 7.067538554395014e-09
gonadogenesis O 0 2.257410756101308e-07
prior O 0 1.3887202499063278e-07
to O 0 1.5081677018358164e-09
sexual O 0 3.789241365126372e-09
differentiation O 0 4.902663519601447e-08
. O 0 2.439041324464597e-08

In O 0 9.271105549935044e-10
males O 0 1.4499640377252376e-10
, O 0 8.09165495024855e-12
SF O 0 0.00044211605563759804
- O 0 1.5609007277817e-06
1 O 0 1.9178617094439687e-07
participates O 0 2.592646930477116e-10
in O 0 4.86838043836646e-12
sexual O 0 1.3293226111890655e-12
development O 0 1.2530513735994897e-12
by O 0 2.435310525288059e-14
regulating O 0 2.606669324833888e-10
expression O 0 7.180553374119825e-11
of O 0 9.363238483162117e-12
the O 0 6.153532544628249e-11
polypeptide O 0 5.861880580937395e-08
hormone O 0 5.230375244025254e-09
Mullerian O 0 3.84952159038221e-07
inhibiting O 0 3.405672899248202e-08
substance O 0 9.862196748144925e-07
( O 0 9.495979558238332e-10
MIS O 0 1.731750126054976e-05
) O 0 1.1029777785553918e-10
. O 0 3.5624410088530567e-09

Here O 0 4.350591353841082e-08
, O 0 1.3349951699659357e-10
we O 0 7.006859068653393e-12
show O 0 6.232385701271381e-12
that O 0 5.857071013089243e-13
WT1 O 0 8.886925570550375e-06
- O 0 1.5816348195585306e-06
KTS O 0 0.0009583625942468643
isoforms O 0 4.1193402466888074e-08
associate O 0 7.099366094998061e-10
and O 0 4.659231334080971e-12
synergize O 0 1.387472625680175e-08
with O 0 6.308124595594267e-12
SF O 1 0.9998873472213745
- O 0 5.0953276513610035e-06
1 O 0 1.733737917675171e-07
to O 0 1.771099517045016e-10
promote O 0 1.9951349017333087e-08
MIS O 0 0.00010390383249614388
expression O 0 2.0076750928410547e-08
. O 0 4.9821657910342765e-09

In O 0 3.947860705011408e-09
contrast O 0 9.341903250970063e-08
, O 0 2.1839992037087086e-09
WT1 O 0 0.000292890181299299
missense O 0 7.785388334013987e-06
mutations O 0 4.6173660450676834e-09
, O 0 9.7210249832419e-13
associated O 0 7.896527182138513e-12
with O 0 1.1521632172634133e-12
male B-Disease 0 1.474721122995959e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.7924337214481056e-07
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.2020545447910536e-08
fail O 0 1.7680947905773792e-07
to O 0 2.1109854142498108e-10
synergize O 0 2.4373453015869018e-06
with O 0 2.773107854459056e-10
SF O 1 1.0
- O 0 0.0005034575005993247
1 O 0 8.389085905946558e-07
. O 0 3.6529159697096247e-09

Additionally O 0 9.469252049143506e-09
, O 0 8.609825526140202e-12
the O 0 1.956374645617487e-11
X O 0 1.9259995553966291e-07
- O 0 8.576697574369518e-09
linked O 0 3.5906918327555104e-08
, O 0 7.2089014445386734e-12
candidate O 0 1.0975006320412817e-10
dosage O 0 2.26668950276121e-09
- O 0 9.457599980944309e-11
sensitive O 0 1.4470811215971935e-08
sex O 0 4.0773495690871187e-11
- O 0 4.621317217790022e-11
reversal O 0 2.227983797453703e-09
gene O 0 1.8270929907915345e-11
, O 0 1.41656946589519e-11
Dax O 0 7.036273927951697e-06
- O 0 1.619822675991145e-08
1 O 0 1.3615347960183044e-08
, O 0 3.872139154453835e-12
antagonizes O 0 9.100200593081809e-10
synergy O 0 4.656034932604136e-11
between O 0 3.074142676529057e-11
SF O 0 9.544117347104475e-06
- O 0 6.29783158956343e-09
1 O 0 1.326778908961046e-09
and O 0 7.402383393750878e-12
WT1 O 0 2.0420476687377231e-07
, O 0 5.814521173569398e-12
most O 0 3.940437386107387e-12
likely O 0 2.080838799878304e-11
through O 0 1.1401608281634557e-13
a O 0 4.778840964982968e-14
direct O 0 9.417179492807182e-13
interaction O 0 1.7109593256070532e-11
with O 0 8.668603161676725e-12
SF O 1 0.9999837875366211
- O 0 1.3945817954663653e-05
1 O 0 7.439225555572193e-07
. O 0 8.130095707770124e-09

We O 0 1.477968680774211e-08
propose O 0 3.0317906407617556e-08
that O 0 7.442707561367001e-11
WT1 O 0 0.00016980079817585647
and O 0 8.166742837545371e-09
Dax O 0 3.1798732379684225e-05
- O 0 1.9402682127633852e-08
1 O 0 2.908017604497104e-09
functionally O 0 4.9373116706163955e-11
oppose O 0 2.1543159617332108e-11
each O 0 5.500139325107303e-14
other O 0 1.4728740145922292e-13
in O 0 2.059020705671988e-12
testis O 0 6.372016247979673e-10
development O 0 3.3157387425986062e-12
by O 0 5.195841586841388e-13
modulating O 0 1.5883136583738633e-08
SF O 0 0.0012878838460892439
- O 0 2.85915376707635e-07
1 O 0 3.4933922421487296e-08
- O 0 1.468036248120086e-09
mediated O 0 6.497275162331562e-09
transactivation O 0 1.7832098819781095e-07
. O 0 3.8281408598628275e-10
. O 0 8.7763507572447e-10

A O 0 4.851822943408024e-09
mouse O 0 3.147837823735955e-10
model O 0 1.7421909401238445e-11
for O 0 2.912973751101333e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999984502792358
centre O 0 4.519760750554269e-06
mutations O 0 7.562043435882515e-08
. O 0 2.141235100339145e-08

Imprinting O 0 3.8072249708420713e-07
in O 0 1.3636930473737152e-10
the O 0 1.7334082780262605e-10
15q11 O 0 9.676836043581716e-08
- O 0 1.2173146046734473e-08
q13 O 0 8.634889780978483e-08
region O 0 1.0718315818225577e-10
involves O 0 1.750701840441682e-11
an O 0 4.756325473992233e-14
imprinting O 0 1.4140557169639578e-08
centre O 0 5.858066476349677e-09
( O 0 8.821801796010664e-13
IC O 0 2.5677083570485593e-08
) O 0 2.0637929299544e-13
, O 0 7.630902203528689e-14
mapping O 0 4.006331724704104e-12
in O 0 7.814535151785817e-13
part O 0 1.809847757772154e-11
to O 0 1.8070401078262854e-11
the O 0 1.5621263171894384e-09
promoter O 0 9.358506503076569e-08
and O 0 1.9127191497325668e-10
first O 0 1.1567008462165518e-09
exon O 0 1.2712509267487349e-08
of O 0 1.3856075176121863e-09
SNRPN O 1 0.9975612163543701
. O 0 5.509227207767253e-07

Deletion O 0 6.43368238684161e-08
of O 0 4.412605281167714e-10
this O 0 1.5699994082574165e-10
IC O 0 8.70362691784976e-06
abolishes O 0 6.405105068552075e-07
local O 0 3.2216891376890544e-09
paternally O 0 8.765230319340844e-09
derived O 0 2.7112038308851893e-11
gene O 0 2.89210902405454e-13
expression O 0 1.5212927217869016e-13
and O 0 1.0511620641910743e-15
results O 0 2.775828883156556e-13
in O 0 1.3079586025366297e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.9285085727460682e-05
PWS B-Disease 1 1.0
) O 0 1.5022192378921773e-09
. O 0 8.467791801081148e-09

We O 0 4.7216488496815145e-08
have O 0 1.0478897610743942e-10
created O 0 1.609844896277579e-10
two O 0 1.1743548841702811e-11
deletion O 0 1.4891989863485833e-09
mutations O 0 6.098176408286804e-10
in O 0 8.8599370895448e-11
mice O 0 1.271163063698566e-09
to O 0 2.4487065153344645e-10
understand O 0 1.051515596373065e-06
PWS B-Disease 1 1.0
and O 0 3.3242864017068996e-09
the O 0 8.248042526748378e-11
mechanism O 0 2.2133614385744238e-10
of O 0 1.6077880346521134e-11
this O 0 5.54755894000003e-11
IC O 0 2.8155189284007065e-05
. O 0 2.570810586632888e-08

Mice O 0 0.00026096031069755554
harbouring O 0 1.1141290087834932e-05
an O 0 9.817593266125968e-11
intragenic O 0 2.009544459724566e-06
deletion O 0 2.1950588902086565e-08
in O 0 7.29580507119465e-10
Snrpn O 0 4.729616557597183e-05
are O 0 7.484378672373282e-10
phenotypically O 0 1.8015000023297034e-05
normal O 0 2.653343472047709e-06
, O 0 2.5621324506452936e-11
suggesting O 0 2.2489889117682793e-10
that O 0 5.4791826457900594e-12
mutations O 0 2.102307439244555e-09
of O 0 6.462372859061816e-09
SNRPN O 1 1.0
are O 0 8.272667967323954e-11
not O 0 5.125310332393385e-12
sufficient O 0 1.15994192029234e-09
to O 0 2.2529214604993797e-10
induce O 0 2.15900627154042e-06
PWS B-Disease 1 1.0
. O 0 1.0682145330065396e-05

Mice O 0 2.8168403787276475e-06
with O 0 9.773197008622336e-12
a O 0 1.791760489977534e-11
larger O 0 1.2094637513726525e-09
deletion O 0 1.5395779096039064e-09
involving O 0 4.686768195760749e-10
both O 0 2.1648290104980816e-10
Snrpn O 0 7.217663096525939e-06
and O 0 7.158837411758157e-11
the O 0 3.5575775658713837e-10
putative O 0 5.06915682763065e-07
PWS O 1 1.0
- O 0 2.8707186174870003e-06
IC O 0 4.2698038669186644e-06
lack O 0 1.3646493712826668e-08
expression O 0 1.4344497811791257e-10
of O 0 8.654230977678257e-12
the O 0 3.462131276110725e-11
imprinted O 0 1.1041660030741696e-08
genes O 0 1.399883098329724e-09
Zfp127 O 0 2.8973699954804033e-06
( O 0 5.450874474011158e-11
mouse O 0 6.12287598400485e-09
homologue O 0 5.101183120359565e-08
of O 0 9.077997020767725e-09
ZNF127 O 1 0.9999998807907104
) O 0 2.1773940428460037e-09
, O 0 1.6783352485560954e-09
Ndn O 0 4.014287924292148e-07
and O 0 3.814918381195298e-10
Ipw O 0 6.128235554569983e-07
, O 0 2.668082699219809e-10
and O 0 2.587596456549157e-11
manifest O 0 6.180180367465482e-09
several O 0 1.0458370280908014e-10
phenotypes O 0 4.7882988241099156e-08
common O 0 1.2909254998305641e-08
to O 0 3.468633735792537e-08
PWS B-Disease 1 1.0
infants O 1 0.9999998807907104
. O 0 3.9249187011591857e-07

These O 0 1.7605114033258928e-09
data O 0 1.4369799794522464e-10
demonstrate O 0 3.0894429375871724e-11
that O 0 1.0010620262422554e-13
both O 0 5.959243515318846e-13
the O 0 3.3017852774791523e-12
position O 0 1.988786912932028e-11
of O 0 2.0882778145603353e-11
the O 0 2.8801993776084167e-11
IC O 0 4.6219062710406433e-07
and O 0 1.646631615781491e-11
its O 0 2.565103945223468e-12
role O 0 9.761660880666656e-13
in O 0 1.0479227078100117e-12
the O 0 4.979526773557508e-12
coordinate O 0 5.525572707720805e-11
expression O 0 8.820905672557444e-10
of O 0 5.991533047478015e-09
genes O 0 5.089185184381506e-10
is O 0 5.4149250187929265e-12
conserved O 0 1.0767699232250294e-10
between O 0 5.302784947258665e-11
mouse O 0 5.402234215523549e-09
and O 0 1.059853160095825e-11
human O 0 1.3488850661436125e-11
, O 0 4.463116508313103e-12
and O 0 2.203393283800592e-12
indicate O 0 2.418529612691067e-11
that O 0 7.306155463612796e-13
the O 0 2.5621432753197837e-10
mouse O 0 9.262568489987189e-10
is O 0 1.0023823134377996e-13
a O 0 2.226491323394867e-14
suitable O 0 5.846473999371327e-11
model O 0 3.681513080500132e-11
system O 0 1.7040142630264654e-09
in O 0 2.905176273160226e-11
which O 0 1.7404165131643112e-12
to O 0 4.7788730438147464e-12
investigate O 0 1.0218226959013421e-10
the O 0 2.3789137326701848e-11
molecular O 0 1.0094289293327563e-10
mechanisms O 0 5.375620504288747e-10
of O 0 6.47120024233061e-10
imprinting O 0 1.0483265810989906e-08
in O 0 2.830758370764297e-11
this O 0 4.8905311224312076e-12
region O 0 2.369640317301247e-10
of O 0 7.635718446419304e-11
the O 0 2.435450174864684e-10
genome O 0 1.666849713810592e-10
. O 0 5.907238587177233e-11
. O 0 1.7057605328218983e-09

Mutations O 0 5.022383575692402e-08
of O 0 2.8323003942176683e-09
the O 0 2.66219735145512e-09
ATM O 0 1.4371765644227708e-07
gene O 0 2.5854407156855608e-11
detected O 0 3.5256531027982874e-10
in O 0 2.449289208950045e-11
Japanese O 1 0.6385287642478943
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
: O 0 1.2149486061305281e-12
possible O 0 4.142456776906611e-12
preponderance O 0 5.949863712828574e-09
of O 0 4.393069935604288e-11
the O 0 1.4887552302056406e-10
two O 0 1.8334533544162035e-11
founder O 0 4.87022688844263e-09
mutations O 0 5.072217090784648e-10
4612del165 O 0 8.192722589228651e-08
and O 0 3.3167227297958846e-10
7883del5 O 0 5.512927145900903e-07
. O 0 3.507091861365552e-08

The O 0 1.0513121040389706e-08
ATM O 0 1.0046569514088333e-06
( O 0 6.339479496908496e-10
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 7.248931316317098e-11
mutated O 0 3.286295124915739e-10
) O 0 9.43332326315549e-13
gene O 0 1.1631726398037001e-12
on O 0 1.1473873934297885e-11
human O 0 3.110426846641978e-11
chromosome O 0 2.0637025421876842e-09
11q22 O 0 1.5958346466504736e-06
. O 0 8.54365538316415e-08

3 O 0 1.2807136045012157e-05
has O 0 1.126279833285615e-10
recently O 0 6.765103754968749e-11
been O 0 4.395850437127757e-12
identified O 0 2.903629160028176e-12
as O 0 1.7551568922205552e-13
the O 0 2.0825477301845974e-13
gene O 0 5.54522062084584e-15
responsible O 0 5.875852308510031e-15
for O 0 5.98175990839967e-16
the O 0 1.4394090303362916e-12
human O 0 1.0021459218023665e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.600507566010492e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.1050067244843262e-10
. O 0 3.30772809142843e-09

In O 0 9.838649894788887e-10
order O 0 5.446627038274698e-10
to O 0 2.536570606337385e-11
define O 0 2.9798241651946e-10
the O 0 2.105110009920086e-11
types O 0 1.6946600789324862e-09
of O 0 1.9843056364710066e-10
disease O 0 1.0341368650301774e-08
- O 0 1.6304632088903759e-09
causing O 0 1.53155566007257e-09
ATM O 0 1.1911887298765578e-07
mutations O 0 1.2615388768344449e-11
in O 0 7.296796630459901e-13
Japanese O 0 1.1078281403342771e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0005112788639962673
as O 0 4.87561987311258e-12
well O 0 1.7896547145710567e-13
as O 0 1.2629436071161931e-13
to O 0 2.1937472997023144e-13
look O 0 4.956642301462422e-12
for O 0 1.8925826346643387e-13
possible O 0 2.2046146852527926e-10
mutational O 0 1.291629132538219e-07
hotspots O 0 2.185100278495611e-08
, O 0 8.136582553552874e-12
reverse O 0 1.0533563604697704e-10
- O 0 4.9860105627574924e-11
transcribed O 0 1.603072362355018e-11
RNA O 0 2.4933737800131306e-12
derived O 0 5.6793289689160975e-12
from O 0 1.925528746865579e-12
ten O 0 7.190997797223986e-11
patients O 0 1.5054625601695903e-10
belonging O 0 3.132119130028199e-12
to O 0 1.6460246794053335e-12
eight O 0 2.292714195578638e-12
unrelated O 0 4.915420848128349e-10
Japanese O 0 3.204311553872685e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 5.430630944935899e-10
was O 0 9.529536014463158e-12
analyzed O 0 4.1172523723709276e-11
for O 0 1.8685337565410576e-12
mutations O 0 1.0093668088850816e-11
by O 0 1.4921023401212596e-12
the O 0 2.2063845542263927e-11
restriction O 0 2.5221817967491234e-09
endonuclease O 0 6.00067062705989e-09
fingerprinting O 0 2.5401507564026815e-09
method O 0 1.1941614808108625e-08
. O 0 7.387330747121723e-09

As O 0 7.750635688807961e-08
has O 0 1.6412791264963644e-11
been O 0 1.4384977584103176e-12
reported O 0 5.027306695937206e-13
by O 0 1.8082526578519498e-12
others O 0 1.1050876880247529e-10
, O 0 3.469076588491493e-12
mutations O 0 5.894382638232942e-12
that O 0 1.9352232490110755e-12
lead O 0 5.086264187603717e-10
to O 0 2.3368451618210884e-09
exon O 0 6.558623226737836e-07
skipping O 0 1.9396929928916506e-06
or O 0 2.9667139855860114e-09
premature O 0 1.8761949149848078e-07
protein O 0 1.3418938182852003e-09
truncation O 0 4.459253588606771e-08
were O 0 9.827358926628449e-10
also O 0 6.047094075478654e-11
predominant O 0 2.0383701837545232e-07
in O 0 6.946452857370389e-10
our O 0 1.753762646217183e-08
mutants O 0 2.0042934067987517e-07
. O 0 8.936591910924108e-09

Six O 0 6.186432699450961e-08
different O 0 4.67825667094246e-10
mutations O 0 5.613789988423434e-10
were O 0 6.50850554007043e-11
identified O 0 3.092272965465881e-11
on O 0 7.407231772393885e-11
12 O 0 4.335211009620643e-11
of O 0 8.491667438659256e-12
the O 0 3.8944372726668064e-10
16 O 0 6.1189648903337e-09
alleles O 0 3.9332326284835517e-10
examined O 0 6.240748007257935e-07
. O 0 8.225651271231982e-08

Four O 0 1.60836322038449e-09
were O 0 3.57804730288791e-10
deletions O 0 1.4575399776006748e-09
involving O 0 7.007757568677775e-11
a O 0 3.734741335637004e-11
loss O 0 4.839613154672406e-09
of O 0 4.323483437929099e-08
a O 0 1.0877437839340587e-09
single O 0 2.695790080053939e-08
exon O 0 7.547216540615409e-08
exon O 0 3.3624470319182365e-08
7 O 0 2.7422251136499654e-08
, O 0 1.5958429022688847e-10
exon O 0 1.561996043619729e-08
16 O 0 2.141439381375676e-08
, O 0 7.902667409354081e-10
exon O 0 2.2183091630267882e-07
33 O 0 5.344464852896635e-07
or O 0 3.2340903288741174e-08
exon O 0 2.518160954423365e-06
35 O 0 5.293910021464399e-07
. O 0 1.2329384446729819e-07

The O 0 1.0687546136978199e-07
others O 0 1.3229479733922744e-09
were O 0 1.5553529297829272e-10
minute O 0 1.0698958385901847e-09
deletions O 0 2.1931452209855706e-09
, O 0 4.3171154151533386e-11
4649delA O 0 5.849683759606705e-08
in O 0 3.2752709433481186e-09
exon O 0 6.243153194418483e-08
33 O 0 1.976077612653171e-08
and O 0 1.030098228937959e-10
7883del5 O 0 2.1982685893817688e-07
in O 0 1.3631717976636537e-08
exon O 0 7.405349151667906e-07
55 O 0 1.5478943282687396e-07
. O 0 2.3937419157959994e-08

The O 0 2.0192901502014138e-06
mutations O 0 9.716357851630164e-08
4612del165 O 0 7.241893626996898e-07
and O 0 1.3651564323424736e-09
7883del5 O 0 2.0565686043028109e-07
were O 0 1.777276326109245e-09
found O 0 8.282342693621825e-12
in O 0 2.5098926843131197e-12
more O 0 1.3523176448006907e-13
than O 0 2.664732041794682e-13
two O 0 4.0281959625548813e-14
unrelated O 0 1.1191809978772227e-10
families O 0 1.0460276308327243e-12
; O 0 4.761029894981283e-13
44 O 0 8.638666171290055e-11
% O 0 1.1112118170064633e-12
( O 0 5.010606882340342e-15
7 O 0 2.8294951451290906e-11
of O 0 5.892283189146141e-11
16 O 0 1.4911166745790183e-10
) O 0 1.8604531164343602e-13
of O 0 5.1853531884971105e-11
the O 0 2.1686186180147615e-10
mutant O 0 9.090346808626748e-10
alleles O 0 1.988608756831045e-11
had O 0 7.794982020969954e-11
one O 0 1.442135039858572e-12
of O 0 1.0594328365975958e-11
the O 0 2.3394930437348194e-10
two O 0 1.1942034860989992e-10
mutations O 0 2.6868209879182814e-09
. O 0 5.0299188814051377e-08

The O 0 5.786949941466446e-07
4612del165 O 0 4.906638878310332e-06
mutations O 0 2.417724909165031e-09
in O 0 6.298919025260474e-11
three O 0 1.5208545685839459e-13
different O 0 4.4563772160291504e-13
families O 0 2.2989583327304164e-12
were O 0 2.0458205442219768e-12
all O 0 1.3195911377494873e-13
ascribed O 0 9.609852497094451e-11
to O 0 7.0846544776570486e-12
the O 0 3.395551340101832e-10
same O 0 5.147996473553462e-10
T O 0 3.395132175398885e-09
- O 0 3.7522204093809464e-11
- O 0 2.894783024398606e-11
> O 0 4.270165818165417e-11
A O 0 1.6245099883349656e-12
substitution O 0 2.796343712141436e-11
at O 0 8.152377427642077e-13
the O 0 1.1427914821046659e-12
splice O 0 3.6572292416714447e-10
donor O 0 5.779796641292023e-10
site O 0 1.1839618174747102e-09
in O 0 3.09274023058137e-10
intron O 0 7.112592470548407e-07
33 O 0 1.8537726020895207e-07
. O 0 5.832126248606073e-08

Microsatellite O 0 1.4482331607723609e-05
genotyping O 0 7.558967354270862e-06
around O 0 1.24900401132777e-09
the O 0 7.25011106705864e-10
ATM O 0 2.285597986428911e-07
locus O 0 6.112231276667046e-10
also O 0 4.527731488346287e-12
indicated O 0 1.8505457582973506e-11
that O 0 7.520434538240035e-15
a O 0 5.1854635358837206e-14
common O 0 2.6792391222274503e-11
haplotype O 0 2.562555279084222e-09
was O 0 5.913350920039306e-10
shared O 0 1.2734526107227584e-11
by O 0 2.6402203990791295e-13
the O 0 2.608403597281761e-11
mutant O 0 1.0809765305097585e-09
alleles O 0 1.7745993563522688e-10
in O 0 1.9644111337591141e-10
both O 0 7.220454789624853e-10
mutations O 0 3.776016832546247e-09
. O 0 1.2610597011075697e-08

This O 0 8.12380118730971e-09
suggests O 0 6.793829943063656e-09
that O 0 3.833046727241829e-12
these O 0 1.9165134756971014e-10
two O 0 1.8524419845289408e-11
founder O 0 1.076503952646135e-08
mutations O 0 6.03877503557726e-10
may O 0 2.8188000822382264e-09
be O 0 4.05790900881442e-10
predominant O 0 1.5212899597827345e-06
among O 0 4.478049528411354e-11
Japanese O 0 2.910026219993256e-09
ATM O 0 3.345967627410573e-07
mutant O 0 6.067713798074692e-08
alleles O 0 4.723069935153035e-09
. O 0 1.0153174301308354e-08

W474C O 0 1.219576404309919e-07
amino O 0 2.5100196920924134e-10
acid O 0 7.326173001587222e-11
substitution O 0 1.9926077454712754e-10
affects O 0 1.912532111847387e-11
early O 0 9.657075139557492e-11
processing O 0 3.4790810232721014e-09
of O 0 3.374085177920705e-10
the O 0 1.9806188633619826e-10
alpha O 0 1.1654922860149242e-10
- O 0 1.700956910044571e-11
subunit O 0 8.621851062956543e-13
of O 0 1.808028553262897e-12
beta O 0 8.440028190226379e-12
- O 0 5.2882601075943114e-11
hexosaminidase O 0 6.4882597072823955e-09
A O 0 1.225930051917956e-10
and O 0 2.0258954561667986e-13
is O 0 4.6454166739446495e-15
associated O 0 2.789193789126676e-12
with O 0 4.286459642094398e-12
subacute O 1 0.9044662714004517
G B-Disease 0 0.08274053782224655
( I-Disease 0 2.3208973631838603e-10
M2 I-Disease 0 4.909129074803786e-06
) I-Disease 0 7.765214860011582e-11
gangliosidosis I-Disease 0 3.103249127889285e-06
. O 0 1.1386538290025783e-07

Mutations O 0 1.1388336496054308e-08
in O 0 3.168976470124818e-10
the O 0 9.57651957733674e-10
HEXA O 0 2.319369968972751e-06
gene O 0 2.237205212751725e-11
, O 0 1.1816071125020366e-12
encoding O 0 4.681804423312119e-12
the O 0 4.019407029431932e-11
alpha O 0 6.367247441102508e-12
- O 0 1.1763182658844351e-12
subunit O 0 2.1205422400666363e-13
of O 0 5.05940721175907e-13
beta O 0 1.5835796216001619e-12
- O 0 2.954586922343516e-11
hexosaminidase O 0 1.8465009077317518e-08
A O 0 6.969880672613726e-09
( O 0 1.1035363161465694e-12
Hex O 0 1.7580753519652603e-09
A O 0 7.451201461394774e-11
) O 0 4.0258303689397895e-14
, O 0 1.7060685207777836e-14
that O 0 5.575615974641587e-15
abolish O 0 5.21461429592307e-10
Hex O 0 6.005285158039442e-09
A O 0 8.03406213084612e-12
enzyme O 0 1.4876821996523404e-10
activity O 0 4.937636521873401e-09
cause O 1 0.9999948740005493
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.604002926793086e-11
TSD B-Disease 0 0.0002815126208588481
) O 0 1.621646393556997e-12
, O 0 3.859057171040625e-13
the O 0 2.47573229278375e-11
fatal O 0 3.2572604613534395e-09
infantile B-Disease 0 2.9430108128281063e-08
form I-Disease 0 2.557558609339594e-10
of I-Disease 0 1.979620662950765e-07
G I-Disease 0 2.939038949989481e-06
( I-Disease 0 2.3042308078952134e-12
M2 I-Disease 0 5.460956487013391e-08
) I-Disease 0 8.496264130609943e-13
gangliosidosis I-Disease 0 2.1735859334626184e-08
, I-Disease 0 3.6115303456152326e-12
Type I-Disease 0 2.755782935182083e-09
1 I-Disease 0 1.6822204074173897e-08
. O 0 3.3816633937533425e-09

Less O 0 1.139463723376366e-08
severe O 0 1.8072466900775908e-07
, O 0 6.691905363176431e-10
subacute O 0 0.001033784938044846
( O 0 5.255116220653777e-12
juvenile O 0 2.7933685942116426e-06
- O 0 2.6966628929869785e-09
onset O 0 0.00010447103704791516
) O 0 6.296660415294753e-11
and O 0 6.036636523987227e-09
chronic O 0 0.06265377998352051
( O 0 3.606704778585934e-12
adult O 0 2.074872273993833e-09
- O 0 3.231485079524532e-10
onset O 0 8.386384564573746e-08
) O 0 3.219491079980985e-12
variants O 0 4.248274232399041e-10
are O 0 3.310083544066922e-12
characterized O 0 1.3886797527867811e-12
by O 0 2.0859309830638384e-13
a O 0 1.0208169379244403e-11
broad O 0 5.317770224166907e-09
spectrum O 0 3.1198908345686505e-08
of O 0 6.212162294988444e-12
clinical O 0 8.421809256919932e-12
manifestations O 0 2.307174243321164e-11
and O 0 1.3074801929070096e-13
are O 0 2.7721804412021885e-15
associated O 0 8.793087650149287e-14
with O 0 2.8383338837893388e-14
residual O 0 1.8065539109102247e-07
levels O 0 8.18264823010395e-07
of O 0 4.6531656749948525e-08
Hex O 0 1.0834440217877273e-05
A O 0 7.744193197822824e-08
enzyme O 0 4.0918305188597515e-08
activity O 0 2.9043172844467335e-07
. O 0 1.307204211542512e-08

We O 0 5.299332084263142e-09
identified O 0 1.7446991074088203e-10
a O 0 2.023374957166313e-12
1422 O 0 2.6630470273403262e-08
G O 0 5.087877674725405e-09
- O 0 1.5445750234377442e-09
- O 0 2.9679139146310263e-09
> O 0 1.0268037087257653e-08
C O 0 4.39417213726756e-09
( O 0 7.013159211623644e-15
amino O 0 2.2571117338446994e-13
acid O 0 6.891608594558618e-13
W474C O 0 9.145048433800707e-12
) O 0 1.1964865805092086e-16
substitution O 0 2.989143492188734e-13
in O 0 2.1141936942456474e-13
the O 0 8.158972629457306e-13
first O 0 2.6747803191090602e-12
position O 0 1.4405750203838608e-10
of O 0 2.003010535212013e-10
exon O 0 9.51220324729718e-10
13 O 0 1.7501251836637977e-10
of O 0 2.264726461920219e-10
HEXA O 0 5.2012939704582095e-05
of O 0 5.069936914736672e-09
a O 0 1.8571374993392453e-10
non O 0 1.0156117014048505e-06
- O 0 3.062080722315841e-08
Jewish O 0 6.490750337206919e-08
proband O 0 0.0011368683772161603
who O 0 1.277033617741452e-10
manifested O 0 1.537526439499004e-09
a O 0 8.019945818560359e-12
subacute O 0 2.2680492861582024e-07
variant O 0 2.0297026281923536e-08
of O 0 6.248363206395879e-06
G B-Disease 0 0.022550752386450768
( I-Disease 0 1.6271163583159165e-10
M2 I-Disease 0 3.8141477034514537e-06
) I-Disease 0 5.788453744104416e-11
gangliosidosis I-Disease 0 1.968521701201098e-06
. O 0 4.53118786936102e-08

On O 0 1.2060183074424913e-08
the O 0 4.891393956540924e-10
second O 0 6.303551902675508e-09
maternally O 0 3.0803749950791826e-07
inherited O 0 3.769176259993401e-07
allele O 0 1.4047751850654322e-09
, O 0 1.4225308214363408e-12
we O 0 6.4538076217837e-14
identified O 0 3.5133495505240697e-13
the O 0 3.064265204424932e-12
common O 0 3.6841322526015574e-07
infantile O 1 0.8593741655349731
disease O 0 1.5170454389590304e-05
- O 0 2.6041028888812434e-08
causing O 0 7.018613690235043e-09
4 O 0 7.76577380179333e-08
- O 0 3.876098109145687e-09
bp O 0 1.2396749404786078e-08
insertion O 0 2.262240839101537e-09
, O 0 3.393755762526318e-11
+ O 0 6.379312633697509e-10
TATC O 0 9.116831279243343e-06
1278 O 0 2.2946539957047207e-06
, O 0 3.540422469083815e-11
in O 0 2.494646433870429e-10
exon O 0 6.54500240671041e-08
11 O 0 4.799900032992355e-09
. O 0 1.0936942018702211e-08

Pulse O 0 2.571120376160252e-06
- O 0 4.4441314628329565e-08
chase O 0 7.399059698265376e-10
analysis O 0 7.602156209228494e-13
using O 0 3.4144013571352216e-12
proband O 0 1.814430845570314e-07
fibroblasts O 0 1.2918860647914698e-08
revealed O 0 7.63538732240221e-10
that O 0 1.413620604037366e-13
the O 0 8.284364513833076e-12
W474C O 0 6.075362990465294e-10
- O 0 7.690481064470678e-12
containing O 0 2.411844161887e-12
alpha O 0 4.562085518383663e-12
- O 0 1.1922199338876283e-12
subunit O 0 3.18025201442515e-13
precursor O 0 3.8248178929611854e-11
was O 0 1.4930967920379068e-11
normally O 0 1.8131187740424992e-12
synthesized O 0 5.256191662472709e-11
, O 0 4.612884510132864e-13
but O 0 4.4305108626990775e-13
not O 0 9.2950831493549e-13
phosphorylated O 0 9.047724791599876e-10
or O 0 1.8012109165299606e-11
secreted O 0 9.469851985910438e-12
, O 0 1.1778448225432947e-12
and O 0 3.735302431945309e-12
the O 0 5.415725645718794e-10
mature O 0 1.430671545676887e-07
lysosomal O 0 4.528751276211551e-07
alpha O 0 5.807148539815898e-09
- O 0 1.8894772413347027e-09
subunit O 0 1.8472176566142195e-10
was O 0 1.3926784725448726e-10
not O 0 2.3198295714954575e-11
detected O 0 3.0572600451250764e-08
. O 0 1.0003106787337401e-08

When O 0 1.4547794080499443e-09
the O 0 2.703000601123051e-10
W474C O 0 6.915864769752034e-09
- O 0 4.006907305953433e-11
containing O 0 2.8299363720452053e-12
alpha O 0 6.682880377556488e-12
- O 0 1.3328668680909206e-12
subunit O 0 1.0137826992814847e-12
was O 0 1.7852483380487172e-11
transiently O 0 1.836009788647175e-09
co O 0 2.2904074470364577e-11
- O 0 4.272210710198898e-11
expressed O 0 5.13901508153447e-12
with O 0 9.565687915976794e-15
the O 0 8.661210854424284e-13
beta O 0 7.846123382081183e-13
- O 0 1.1891494733351493e-12
subunit O 0 1.894543685343822e-13
to O 0 1.9536617061523959e-13
produce O 0 1.832596747963766e-11
Hex O 0 1.0681347362151428e-08
A O 0 8.397804673876408e-10
( O 0 4.3786434439190003e-13
alphabeta O 0 3.665094228111343e-09
) O 0 2.9214711162392493e-13
in O 0 2.252636792376972e-11
COS O 0 4.249283591661879e-08
- O 0 1.6990909790237652e-09
7 O 0 2.7136781710623836e-10
cells O 0 1.9283890456689434e-11
, O 0 2.129946474185504e-13
the O 0 7.63853997415298e-12
mature O 0 2.2429871848750338e-10
alpha O 0 1.0810372562397585e-11
- O 0 7.14764293759107e-13
subunit O 0 6.352635973684573e-14
was O 0 1.2009955746919432e-12
present O 0 1.193917577649306e-12
, O 0 8.304147029302572e-14
but O 0 8.022492988934288e-14
its O 0 1.0365928899752283e-13
level O 0 2.3411333635592335e-12
was O 0 2.8966041804717735e-12
much O 0 3.9912760596561014e-12
lower O 0 8.419842045803705e-10
than O 0 4.1899497109712525e-13
that O 0 5.2947924500780855e-14
from O 0 6.832179787197301e-12
normal O 0 9.582183935208377e-10
alpha O 0 6.25291624034574e-11
- O 0 1.3452443152484062e-11
subunit O 0 2.463610912495362e-12
transfections O 0 6.902446392231809e-10
, O 0 1.0959592608439372e-13
although O 0 1.090430155024913e-12
higher O 0 2.0578320297781616e-11
than O 0 1.2399627223429188e-13
in O 0 2.046171825725862e-12
those O 0 1.1710490216421121e-11
cells O 0 5.3938062349878635e-11
transfected O 0 1.9043875365554186e-09
with O 0 3.724037273217587e-14
an O 0 2.5752783152505065e-14
alpha O 0 2.5225160502073685e-11
- O 0 6.711382144475309e-11
subunit O 0 1.5433602312819872e-11
associated O 0 4.768507255725751e-10
with O 0 2.0824954261033923e-10
infantile O 0 3.350087717990391e-05
TSD B-Disease 0 0.0005374574684537947
. O 0 1.2113834202409635e-07

Furthermore O 0 1.683809536245917e-08
, O 0 1.5278341092272996e-11
the O 0 6.006924992141283e-12
precursor O 0 1.414505401697852e-09
level O 0 4.710815737496432e-09
of O 0 4.2870362815250473e-10
the O 0 4.841180234471665e-10
W474C O 0 8.518998839690539e-09
alpha O 0 6.842746508306519e-11
- O 0 5.6443192134048026e-12
subunit O 0 4.894895795116982e-13
was O 0 2.1047315366257147e-12
found O 0 7.841704987177761e-14
to O 0 8.62730771696539e-14
accumulate O 0 5.252711893916073e-12
in O 0 8.004048270525421e-13
comparison O 0 2.66064281717604e-10
to O 0 6.570092560276297e-12
the O 0 2.3982865693383815e-10
normal O 0 7.98904295606917e-07
alpha O 0 2.452186365076159e-08
- O 0 1.5191269353564962e-09
subunit O 0 3.210149646104554e-10
precursor O 0 1.496646007126401e-08
levels O 0 5.4873826371704126e-08
. O 0 4.761193661551033e-09

We O 0 2.33266361782114e-09
conclude O 0 5.7380153961617e-09
that O 0 1.2789555655853824e-12
the O 0 9.079472416961831e-12
1422 O 0 1.803675075962019e-08
G O 0 1.9655290728337604e-09
- O 0 5.111881473673918e-10
- O 0 1.1969382152088315e-09
> O 0 5.307636996576548e-09
C O 0 1.6282628578778713e-09
mutation O 0 2.920401279745549e-13
is O 0 1.4806798985984192e-16
the O 0 2.7999834506628636e-15
cause O 0 2.2210146916057383e-11
of O 0 1.8732471129823125e-09
Hex B-Disease 1 0.5531216263771057
A I-Disease 1 0.9999805688858032
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.4172731311343796e-09
the O 0 1.9162147424367504e-09
proband O 0 5.303336365614086e-06
. O 0 4.4128366738505065e-08

The O 0 6.408191199902546e-10
resulting O 0 6.154192710994266e-10
W474C O 0 3.9161466958148594e-08
substitution O 0 5.1370165010666824e-08
clearly O 0 2.6753610438134956e-09
interferes O 0 6.534456309381653e-10
with O 0 6.615193419087784e-13
alpha O 0 6.3682678921872515e-12
- O 0 5.729254961076014e-13
subunit O 0 1.8319518807746044e-13
processing O 0 6.359798798705185e-11
, O 0 1.0296409178826155e-13
but O 0 7.570289881075887e-14
because O 0 6.21937668466438e-14
the O 0 9.05019196520071e-14
base O 0 1.474218316865894e-12
substitution O 0 7.569685434027917e-10
falls O 0 5.0293120779087985e-09
at O 0 3.4174700829642246e-12
the O 0 4.447242921146177e-12
first O 0 1.547764347242797e-11
position O 0 2.378993446683353e-09
of O 0 5.32537258735033e-09
exon O 0 1.393429194251894e-08
13 O 0 7.145540825703733e-10
, O 0 1.4922532610636696e-12
aberrant O 0 1.0202588773822185e-10
splicing O 0 2.362248729959049e-10
may O 0 1.8806756152400794e-09
also O 0 1.8480448074620348e-11
contribute O 0 3.1924851651154995e-10
to O 0 7.2412698060020375e-09
Hex B-Disease 1 0.9980849027633667
A I-Disease 0 0.19128349423408508
deficiency I-Disease 1 0.983460009098053
in O 0 1.2465242171799673e-09
this O 0 8.003785967325427e-10
proband O 0 6.018111889716238e-06
. O 0 2.7885864728460774e-09
. O 0 9.696508485035338e-09

Two O 0 5.037354422476881e-10
frequent O 0 2.6213486936654817e-09
missense O 0 2.4449927877867594e-06
mutations O 0 1.3799474629649922e-07
in O 0 3.9792669781490986e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00020681590831372887

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.686258603392446e-10
an O 0 3.894342626153957e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.6949293524248787e-08
by O 0 2.2358985322934455e-12
early O 0 0.41760584712028503
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9999953508377075

A O 0 1.036104757545786e-09
century O 0 4.46490899808083e-10
after O 0 2.139203050810501e-11
its O 0 4.754795190388406e-13
recognition O 0 3.848858037835967e-11
as O 0 7.165719406732052e-12
a O 0 7.37827941105218e-12
syndrome O 0 1.372736257998497e-09
by O 0 1.0499873540070759e-12
Vaughan O 0 2.070509452778424e-07
Pendred O 0 4.2871550931522506e-07
, O 0 1.6910315378884655e-12
the O 0 1.4936978737223328e-11
disease O 0 4.510731788087696e-09
gene O 0 1.4744645782105437e-10
( O 0 4.191688662835702e-11
PDS O 0 0.0002578826970420778
) O 0 4.059592505906151e-12
was O 0 3.301033058011882e-10
mapped O 0 6.346992376116134e-10
to O 0 1.6797244151156576e-10
chromosome O 0 5.9013466113810864e-08
7q22 O 0 1.2095186320948415e-05
- O 0 1.5475549162147217e-06
q31 O 0 6.953318006708287e-06
. O 0 4.727262847836755e-08

1 O 0 9.942078804670018e-07
and O 0 8.078894220275856e-10
, O 0 6.372207622673542e-11
recently O 0 7.035806381949783e-10
, O 0 6.305562842701118e-12
found O 0 1.5030711050800782e-12
to O 0 7.108992214344134e-12
encode O 0 6.776523231444287e-10
a O 0 2.2212277850375273e-10
putative O 0 4.5076893684381503e-07
sulfate O 0 1.1152280876558507e-06
transporter O 0 8.173180390258494e-07
. O 0 8.926102168516081e-08

We O 0 5.829610127960905e-09
performed O 0 2.779345364967156e-10
mutation O 0 7.883841149358695e-12
analysis O 0 1.7291135970959326e-12
of O 0 1.5432778319168783e-11
the O 0 1.6324795959477e-09
PDS B-Disease 0 8.480651013087481e-05
gene O 0 4.73810823908849e-10
in O 0 3.217517918763235e-10
patients O 0 3.952850491373283e-08
from O 0 4.291451916049738e-11
14 O 0 7.058791329228598e-10
Pendred B-Disease 0 2.319409986739629e-06
families O 0 8.441481541554552e-11
originating O 0 1.6244031120216107e-10
from O 0 1.812856982585931e-11
seven O 0 1.841801234095386e-12
countries O 0 3.2537392376762175e-13
and O 0 1.7020440612469656e-11
identified O 0 6.878499991813669e-10
all O 0 1.0053349264182998e-09
mutations O 0 3.187783148561607e-09
. O 0 1.7671196061996852e-08

The O 0 1.4797237213315384e-07
mutations O 0 3.02287395115286e-09
include O 0 1.316945302809458e-10
three O 0 3.613886967457347e-12
single O 0 5.1158299818609976e-11
base O 0 8.75138095324246e-09
deletions O 0 2.9227001618892245e-07
, O 0 3.9941610019411655e-09
one O 0 7.540231217184612e-10
splice O 0 2.8810782737309637e-07
site O 0 1.0928354754469183e-07
mutation O 0 9.098087616621342e-09
and O 0 1.8290742531679172e-10
10 O 0 6.369225147295765e-09
missense O 0 2.741227035585325e-06
mutations O 0 1.4075470744501217e-07
. O 0 3.445246932187729e-07

One O 0 2.8353772663081145e-08
missense O 0 2.444337212637038e-07
mutation O 0 1.6467274210896221e-09
( O 0 1.8456907009689605e-12
L236P O 0 6.615850534075207e-09
) O 0 9.367091520842696e-13
was O 0 3.2300617736069626e-10
found O 0 1.354549285237372e-11
in O 0 7.803547738549632e-12
a O 0 3.4818638857542217e-12
homozygous O 0 1.6855324427855756e-11
state O 0 1.0799181861254059e-11
in O 0 6.695000890483138e-12
two O 0 7.898631835395742e-13
consanguineous O 0 5.262123181637435e-07
families O 0 1.471797961283272e-10
and O 0 8.300370807345914e-12
in O 0 3.091264397236948e-11
a O 0 1.5914892667612257e-11
heterozygous O 0 2.0088517654892613e-11
state O 0 4.966771091630129e-11
in O 0 2.173988940257221e-11
five O 0 3.330684903227188e-12
additional O 0 7.85180531703844e-11
non O 0 8.622322411611094e-07
- O 0 1.115969553211471e-06
consanguineous O 0 0.0007123994873836637
families O 0 1.7512620686943592e-08
. O 0 1.4462202102549782e-08

Another O 0 4.542688358810665e-08
missense O 0 2.66466827270051e-07
mutation O 0 1.0501632896620094e-09
( O 0 1.8170517174231904e-12
T416P O 0 5.0230806181161824e-09
) O 0 2.773166895772561e-13
was O 0 5.223211793636828e-11
found O 0 2.7096411052418556e-12
in O 0 3.9242589212895584e-12
a O 0 9.976620224394495e-13
homozygous O 0 8.112950415639641e-12
state O 0 3.551053895378686e-11
in O 0 1.9732508682590577e-10
one O 0 1.7199342644547144e-11
family O 0 1.4962383762529008e-11
and O 0 9.563878335117071e-12
in O 0 5.0920469230053556e-11
a O 0 1.2786318011326347e-11
heterozygous O 0 1.6995493554161634e-11
state O 0 3.1855858229068446e-11
in O 0 6.150528697457247e-11
four O 0 3.571840045957231e-11
families O 0 7.494306841770992e-10
. O 0 8.296204612179281e-09

Pendred B-Disease 1 0.5411603450775146
patients O 1 0.958489179611206
in O 0 5.388382628979116e-09
three O 0 9.351606988783345e-11
non O 0 2.573622452928248e-07
- O 0 9.274276067117171e-07
consanguineous O 1 0.9922072291374207
families O 0 2.3112374236688993e-09
were O 0 3.699434508730448e-11
shown O 0 2.176556244265493e-12
to O 0 1.694647026873053e-13
be O 0 1.2261064559482282e-12
compound O 0 7.156930048601851e-10
heterozygotes O 0 2.6590714075069855e-09
for O 0 2.0246264734180563e-11
L236P O 0 4.870861047834296e-08
and O 0 1.6412329828519034e-10
T416P O 0 3.2567561447649496e-07
. O 0 1.79550934120698e-08

In O 0 6.363918725327267e-09
total O 0 1.021673079470986e-09
, O 0 9.859345978524559e-11
one O 0 2.1574495662202153e-11
or O 0 8.97506791108782e-11
both O 0 1.5541015696562965e-10
of O 0 2.147090283344255e-09
these O 0 7.771323584648826e-10
mutations O 0 1.9627398664678886e-11
were O 0 1.8715533289803687e-10
found O 0 1.5846528950147487e-11
in O 0 1.0884110453190932e-11
nine O 0 1.7454071174483055e-11
of O 0 1.5458998664508172e-11
the O 0 1.845872205086252e-10
14 O 0 1.2756709022454515e-09
families O 0 5.062715802139905e-10
analyzed O 0 9.202928197282745e-09
. O 0 1.2599345566854936e-08

The O 0 1.0310933218349305e-09
identification O 0 1.8842348126213437e-08
of O 0 3.109658974764784e-09
two O 0 1.90868380128828e-11
frequent O 0 2.932904474839404e-10
PDS B-Disease 0 5.4954707593424246e-06
mutations O 0 1.486530620820048e-10
will O 0 1.4528361153010039e-12
facilitate O 0 9.926250793546032e-12
the O 0 4.5081876599850634e-12
molecular O 0 1.6875405239868968e-10
diagnosis O 0 1.9945202893723035e-06
of O 0 7.235666998894885e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.8910163716063835e-06

Insertional O 0 5.7969304180005565e-05
mutation O 0 1.5253293739192486e-08
by O 0 1.1507910943620026e-11
transposable O 0 7.362969540736231e-07
element O 0 2.174357227602286e-08
, O 0 1.173462299552952e-10
L1 O 0 2.0522419319490837e-08
, O 0 4.1251087289952137e-13
in O 0 1.4061563328657267e-12
the O 0 1.478545952338095e-09
DMD B-Disease 1 1.0
gene O 0 2.1509052872126233e-10
results O 0 1.5708089273758219e-09
in O 0 1.1008555178548818e-09
X B-Disease 1 0.9999998807907104
- I-Disease 1 0.9632446765899658
linked I-Disease 0 7.568973524030298e-05
dilated I-Disease 0 0.017153184860944748
cardiomyopathy I-Disease 1 1.0
. O 0 2.5812964850047138e-06

X B-Disease 1 0.9988808035850525
- I-Disease 1 0.9996311664581299
linked I-Disease 0 0.00022100572823546827
dilated I-Disease 1 0.9999979734420776
cardiomyopathy I-Disease 1 1.0
( O 0 2.5904285383404613e-09
XLDCM B-Disease 1 0.9991483688354492
) O 0 6.677067210768273e-13
is O 0 1.4464973069707766e-14
a O 0 6.321270682460925e-14
clinical O 0 5.08904918206099e-10
phenotype O 0 2.669547143341333e-07
of O 0 6.5198193510696e-09
dystrophinopathy B-Disease 0 0.00022185234411153942
which O 0 1.774882844862713e-11
is O 0 2.3379505254515764e-13
characterized O 0 8.722201563435283e-13
by O 0 2.1309786346537102e-13
preferential O 0 1.1122106791106035e-08
myocardial B-Disease 0 1.2843831598274846e-07
involvement I-Disease 0 7.481049113522431e-11
without O 0 1.2385385252111636e-11
any O 0 7.343349019139911e-12
overt O 0 2.6034099875893446e-10
clinical O 0 2.3784976765917065e-10
signs O 0 1.2464939302958555e-08
of O 0 1.5095506000761816e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.7018629312515259

To O 0 1.143824063243315e-10
date O 0 3.868497060466325e-07
, O 0 1.6000482189193477e-11
several O 0 1.4483180280078223e-12
mutations O 0 2.5120443919446345e-11
in O 0 4.865755715011133e-11
the O 0 6.652408615082095e-07
Duchenne B-Disease 1 0.9806216359138489
muscular I-Disease 1 0.996260404586792
dystrophy I-Disease 1 1.0
gene O 0 6.730666063958779e-05
, O 0 1.4765210210043733e-07
DMD O 1 1.0
, O 0 2.7194710372491215e-10
have O 0 1.0625830727459262e-12
been O 0 8.625139990246777e-13
identified O 0 1.9380525830003936e-12
in O 0 2.8302007005348573e-12
patients O 0 5.402169267476609e-10
with O 0 6.584616207318261e-13
XLDCM B-Disease 1 1.0
, O 0 4.131808228891032e-10
but O 0 2.1608759920299647e-11
a O 0 6.948681539019341e-13
pathogenic O 0 2.193860648702639e-09
correlation O 0 1.4917909962886e-10
of O 0 1.1596178010886415e-11
these O 0 1.0864406596589049e-11
cardiospecific O 0 3.0856138977242153e-08
mutations O 0 2.2365918839195587e-10
in O 0 1.2711333374770817e-10
DMD O 1 1.0
with O 0 4.577155494900342e-12
the O 0 2.305276192160477e-09
XLDCM B-Disease 1 1.0
phenotype O 0 0.3084346652030945
has O 0 1.8172614801859055e-10
remained O 0 2.693655520857874e-09
to O 0 7.772704463566982e-13
be O 0 1.952047204434315e-11
elucidated O 0 2.6588754735712428e-06
. O 0 3.747240739926383e-08

We O 0 3.993993136219842e-09
report O 0 5.700527896945751e-11
here O 0 3.4346366896420566e-12
the O 0 9.960890619276075e-14
identification O 0 9.090684802148807e-12
of O 0 1.6494597571484193e-12
a O 0 1.2149718080570193e-12
unique O 0 1.0002047107215972e-10
de O 0 7.523897060934814e-10
novo O 0 2.5025923555688223e-09
L1 O 0 5.729332563930711e-09
insertion O 0 4.713941459399962e-10
in O 0 5.585358842097321e-10
the O 0 1.1907219654716528e-09
muscle O 0 8.867553802360817e-09
exon O 0 4.68000145303904e-08
1 O 0 2.1679138484387295e-08
in O 0 9.129128564211442e-10
DMD O 1 1.0
in O 0 5.490363719218294e-09
three O 0 7.326005080354747e-11
XLDCM B-Disease 1 0.99994957447052
patients O 0 3.2169557471206645e-06
from O 0 9.58850429610969e-11
two O 0 1.6872395407901974e-12
unrelated O 0 3.32917227119367e-09
Japanese O 0 3.2897727209046934e-08
families O 0 1.155554207876719e-09
. O 0 5.664279267847405e-09

The O 0 4.574360445985803e-09
insertion O 0 1.9595249867165876e-09
was O 0 1.1660798993062826e-09
a O 0 3.123433152743549e-12
5 O 0 1.8084917244309828e-11
- O 0 1.685775867857342e-12
truncated O 0 6.118538314892064e-11
form O 0 2.3898924506049468e-11
of O 0 1.0670014177760478e-10
human O 0 1.9024396641365016e-11
L1 O 0 6.517353878798815e-10
inversely O 0 2.7981981176594672e-09
integrated O 0 5.96424160059783e-11
in O 0 5.857741592132926e-13
the O 0 2.730768302455777e-12
5 O 0 2.1786423359815288e-11
- O 0 4.7733823838047584e-11
untranslated O 0 2.305961714910154e-07
region O 0 2.476237617732302e-11
in O 0 8.422355694814865e-12
the O 0 6.961702048169371e-11
muscle O 0 1.0066333877567502e-10
exon O 0 8.856089195319328e-10
1 O 0 8.382937677353652e-10
, O 0 7.875956289059294e-14
which O 0 2.7697242150617404e-14
affected O 0 1.0014392960722152e-11
the O 0 6.109416358229813e-12
transcription O 0 2.007970525963465e-11
or O 0 5.953396196162197e-12
the O 0 2.926404604752797e-11
stability O 0 3.176898466517031e-10
of O 0 2.725733805331032e-10
the O 0 1.0020607954519534e-10
muscle O 0 1.0690365259691248e-10
form O 0 2.4463222558779307e-09
of O 0 9.857664018397827e-09
dystrophin O 0 1.6417190940032356e-09
transcripts O 0 4.6311052215308735e-10
but O 0 9.237465393302502e-13
not O 0 1.4710688179750409e-13
that O 0 7.189725431764465e-14
of O 0 2.7702423688324984e-10
the O 0 1.7480450864582053e-08
brain O 0 2.189554493270407e-07
or O 0 1.92810767352114e-09
Purkinje O 0 2.90534785563068e-07
cell O 0 8.953024632774031e-08
form O 0 2.386314701396941e-09
, O 0 2.751399975908786e-11
probably O 0 3.567996786912886e-09
due O 0 1.281531467611785e-06
to O 0 4.3676484651200553e-10
its O 0 1.0710755199427879e-10
unique O 0 8.75888667151159e-11
site O 0 4.5769504852799514e-10
of O 0 7.452992389911373e-11
integration O 0 1.4969858241897782e-08
. O 0 6.052491130503768e-08

We O 0 1.5116127016767678e-08
speculate O 0 1.1946170275223267e-08
that O 0 2.4819377239179707e-13
this O 0 9.231037158621835e-13
insertion O 0 2.661886544519376e-10
of O 0 3.636043133248279e-10
an O 0 4.4538812742078715e-12
L1 O 0 1.6836038341239146e-08
sequence O 0 6.13783676661761e-11
in O 0 4.860109537041524e-10
DMD O 1 1.0
is O 0 4.267918310429941e-11
responsible O 0 4.852333378851936e-12
for O 0 8.330389871837041e-13
some O 0 4.713052864646627e-13
of O 0 6.221883360087166e-13
the O 0 4.0947949783536053e-13
population O 0 4.5994121969969e-15
of O 0 1.1752809147983281e-14
Japanese O 0 4.5202119824949705e-10
patients O 0 3.635037548743725e-10
with O 0 1.055571754136897e-12
XLDCM B-Disease 0 0.00038461165968328714
. O 0 6.247796502378833e-09
. O 0 1.817672412585125e-08

Severe O 0 2.8053607366018696e-06
early O 0 0.2070864588022232
- O 1 0.9999516010284424
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.4635489204172245e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.0647627607672803e-08
red O 1 0.9943384528160095
hair O 0 5.6388664233963937e-05
pigmentation O 0 0.39998188614845276
caused O 0 3.8000930402404265e-08
by O 0 1.0744034995013862e-08
POMC O 1 0.9999591112136841
mutations O 0 2.482512684309768e-07
in O 0 7.418051173324614e-10
humans O 0 2.015389632958886e-09
. O 0 2.912330598903168e-09

Sequential O 0 3.351824418018623e-08
cleavage O 0 2.836513068871227e-08
of O 0 1.5771433048428207e-09
the O 0 6.220252091182488e-11
precursor O 0 1.242676073154314e-09
protein O 0 2.8645538718841124e-10
pre O 0 4.403319451284915e-07
- O 0 1.6899716115403862e-07
pro O 0 5.724648417526623e-07
- O 0 8.291207791444322e-07
opiomelanocortin O 0 1.7269770978600718e-05
( O 0 8.283800034813993e-11
POMC O 0 2.679734734556405e-06
) O 0 1.3058160238874073e-12
generates O 0 4.427657893102399e-12
the O 0 1.767975739766503e-12
melanocortin O 0 9.17991300752874e-08
peptides O 0 1.068248267621641e-09
adrenocorticotrophin O 0 9.199491302069873e-08
( O 0 3.3535826025887783e-12
ACTH O 0 1.768707846849793e-08
) O 0 3.793232817694142e-13
, O 0 9.663293385961391e-13
melanocyte O 0 2.9038401905268074e-08
- O 0 8.530543382789801e-09
stimulating O 0 4.809971976271754e-09
hormones O 0 7.270938851000608e-10
( O 0 2.299576761649602e-12
MSH O 0 5.464362402562983e-07
) O 0 8.914713585383982e-13
alpha O 0 2.8591157219537422e-11
, O 0 2.3609253115876305e-13
beta O 0 4.731989539791259e-12
and O 0 1.1850151936110276e-12
gamma O 0 3.831601355641645e-11
as O 0 7.674552833514259e-12
well O 0 2.205424211310092e-12
as O 0 4.55550148385081e-13
the O 0 2.196306504720358e-12
opioid O 0 2.39523290090915e-10
- O 0 1.6408198411088648e-10
receptor O 0 2.140117076609993e-11
ligand O 0 6.191613000083862e-09
beta O 0 7.668290891160723e-08
- O 0 1.1005373323769163e-07
endorphin O 0 1.3989375474920962e-05
. O 0 1.5423296417793608e-08

While O 0 1.8054399086864237e-09
a O 0 2.4952102016528865e-12
few O 0 6.138992092452611e-12
cases O 0 8.410448032458717e-11
of O 0 2.6328700997169108e-08
isolated O 1 0.9999886751174927
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 1.523326353947141e-08
been O 0 2.8947183539074217e-10
reported O 0 9.340126588819331e-11
( O 0 3.909183306921582e-12
OMIM O 0 9.154460940408171e-07
201400 O 0 1.3173763413476536e-08
) O 0 2.2595453611461147e-13
, O 0 4.5462480893591894e-13
an O 0 1.261531027210716e-12
inherited O 1 0.6105164885520935
POMC O 1 1.0
defect O 1 1.0
has O 0 7.817297387191502e-08
not O 0 3.4706287843633277e-10
been O 0 8.086690345132652e-11
described O 0 3.132027137642268e-10
so O 0 5.3579800318726e-11
far O 0 8.502421544598349e-10
. O 0 1.7823548192907879e-09

Recent O 0 2.7563730853330526e-08
studies O 0 9.17601411520863e-11
in O 0 5.96627239800307e-13
animal O 0 1.4306447736547878e-12
models O 0 2.947870029676447e-12
elucidated O 0 2.186449910013266e-09
a O 0 2.792217195304869e-12
central O 0 1.5462926772347174e-10
role O 0 5.618489701264551e-11
of O 0 1.8392589673510429e-09
alpha O 0 4.103356765483568e-09
- O 0 7.62683249888596e-09
MSH O 0 1.971097481145989e-05
in O 0 8.806860622712076e-12
the O 0 8.95807625127254e-13
regulation O 0 5.450812023966023e-11
of O 0 4.2966072865378846e-13
food O 0 8.440286664024299e-12
intake O 0 7.299608508794242e-13
by O 0 3.90242774821691e-15
activation O 0 1.9603985101923627e-10
of O 0 8.14266520876572e-09
the O 0 2.9713601179537363e-07
brain O 0 3.109363433395629e-06
melanocortin O 0 2.3055117708281614e-06
- O 0 6.485639403308596e-08
4 O 0 7.002393775934479e-09
- O 0 3.6809463810349996e-10
receptor O 0 1.6335058306005124e-11
( O 0 6.919676962501009e-13
MC4 O 0 6.858109031782078e-07
- O 0 4.3118943970910095e-09
R O 0 3.0820717089596883e-09
; O 0 1.8107549964660463e-12
refs O 0 1.5771424444199766e-10
3 O 0 5.064249020136913e-11
- O 0 1.2100578351825764e-11
5 O 0 3.384342719264799e-12
) O 0 2.633121983460266e-15
and O 0 2.8850609645443906e-14
the O 0 2.368544596564881e-12
linkage O 0 1.5588226265350613e-09
of O 0 1.2962905748814535e-10
human O 0 3.3817604272456947e-09
obesity B-Disease 1 1.0
to O 0 4.6116516161376353e-10
chromosome O 0 7.319123640492364e-10
2 O 0 9.708458481583193e-10
in O 0 2.6703824915208507e-11
close O 0 1.1837647528878392e-10
proximity O 0 1.5415406728891412e-09
to O 0 1.52137052955581e-10
the O 0 9.779215659477813e-09
POMC O 0 3.143076173728332e-05
locus O 0 8.286996089346133e-10
, O 0 5.217712980426503e-12
led O 0 8.246465142691672e-12
to O 0 2.805492383545216e-13
the O 0 4.205083763836326e-12
proposal O 0 2.809187549246417e-09
of O 0 1.802561572228356e-11
an O 0 7.856736772672915e-14
association O 0 1.3111524886644244e-11
of O 0 3.682863458642771e-10
POMC O 1 0.7634895443916321
with O 0 1.2232440060877536e-10
human O 0 4.3808771010844794e-07
obesity B-Disease 1 1.0
. O 0 1.0386661131178698e-07

The O 0 3.4932823300692917e-10
dual O 0 2.8223601233889895e-10
role O 0 2.9399893630710494e-10
of O 0 1.974773944368735e-08
alpha O 0 1.3141695376361895e-07
- O 0 1.867707908331795e-07
MSH O 0 7.382082549156621e-05
in O 0 1.3807070070592786e-11
regulating O 0 4.385202756473916e-10
food O 0 8.675359874921185e-10
intake O 0 5.787422097114359e-09
and O 0 4.2992675391984037e-11
influencing O 0 2.480666694282263e-07
hair O 0 4.003707545052748e-06
pigmentation O 0 0.00010917056351900101
predicts O 0 1.1551487544281258e-09
that O 0 6.014188035389709e-14
the O 0 5.900974587441654e-12
phenotype O 0 8.950131191731714e-10
associated O 0 8.136442908313057e-12
with O 0 5.228965453988807e-14
a O 0 9.034433357674176e-13
defect O 0 8.091235237372985e-09
in O 0 1.5660195362698914e-09
POMC O 0 3.437519626459107e-05
function O 0 1.835882973422187e-10
would O 0 8.576766900858512e-12
include O 0 3.4372091284318174e-10
obesity B-Disease 1 1.0
, O 0 1.6882341878632356e-12
alteration O 0 8.646539413348364e-07
in O 0 1.204774946472753e-07
pigmentation O 1 1.0
and O 0 0.0001298234419664368
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
. O 0 2.3557549866382033e-06

The O 0 3.058763464736103e-09
observation O 0 3.225318323529791e-08
of O 0 7.315312799960338e-10
these O 0 1.586756503968445e-09
symptoms O 0 5.832306851516478e-05
in O 0 2.0628720953652646e-09
two O 0 2.5674106937656482e-11
probands O 0 3.4614872674865182e-06
prompted O 0 7.940356283597794e-08
us O 0 8.954224167689873e-11
to O 0 6.945707203831475e-11
search O 0 9.177261173221041e-10
for O 0 3.37075159451139e-11
mutations O 0 1.4088027411318649e-09
within O 0 1.0989197107846849e-08
their O 0 1.6156933213551383e-07
POMC O 0 0.006776765920221806
genes O 0 1.2780506040144246e-06
. O 0 1.352625957906639e-07

Patient O 0 0.0053986492566764355
1 O 0 1.3436084600471077e-07
was O 0 2.936012322152237e-09
found O 0 3.170764692472794e-11
to O 0 1.7915203825644155e-12
be O 0 1.2259498971545213e-12
a O 0 8.642101791134227e-13
compound O 0 1.1872001159929368e-09
heterozygote O 0 2.7897050003389268e-08
for O 0 5.346230402825114e-11
two O 0 9.200737394188252e-12
mutations O 0 2.4590489366982382e-11
in O 0 2.7933919066747137e-10
exon O 0 4.934962660740894e-09
3 O 0 1.6333703278803569e-09
( O 0 1.7352191732100675e-12
G7013T O 0 4.2926782128915875e-08
, O 0 2.5841538978110812e-11
C7133delta O 0 1.1751077977351088e-07
) O 0 3.236933290851063e-13
which O 0 4.361670462196647e-14
interfere O 0 9.158171183215602e-13
with O 0 2.733098552774112e-15
appropriate O 0 2.4416536500981856e-11
synthesis O 0 1.5765538874390472e-09
of O 0 2.442983593198278e-09
ACTH O 0 2.1329587980289944e-05
and O 0 1.778535185792407e-08
alpha O 0 6.780562671337975e-07
- O 0 1.014934014165192e-06
MSH O 0 0.00041418379987590015
. O 0 2.2852487902014218e-08

Patient O 0 0.0009031748631969094
2 O 0 3.894262690096184e-08
was O 0 6.941313634989399e-10
homozygous O 0 6.069186819779304e-11
for O 0 9.681777948800097e-13
a O 0 1.3743584178702029e-12
mutation O 0 2.964996997922853e-11
in O 0 1.3465362158626704e-10
exon O 0 1.2808012428422444e-08
2 O 0 5.475869091497998e-09
( O 0 1.2174120218866324e-12
C3804A O 0 7.940822221996768e-09
) O 0 5.27202034198565e-13
which O 0 1.264120318839046e-12
abolishes O 0 3.088040045895468e-07
POMC O 0 0.0002008444134844467
translation O 0 8.066352563673718e-08
. O 0 2.855675873547625e-08

These O 0 3.7278273801177875e-09
findings O 0 1.490978118745545e-09
represent O 0 5.149572174928396e-12
the O 0 3.699804948086721e-13
first O 0 7.945104670741346e-14
examples O 0 2.304775944747539e-12
of O 0 2.140969476358001e-12
a O 0 4.197945463468855e-11
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.26729795733172e-09
the O 0 4.1209941015196705e-10
POMC O 0 6.418117095563503e-07
gene O 0 3.7814022746385234e-12
and O 0 9.493804126094879e-14
define O 0 1.341600008170074e-12
a O 0 1.4171139034371144e-13
new O 0 2.210473759589604e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 2.7227076770941494e-06
resulting O 0 2.4982796387185147e-10
in O 0 5.556981524240667e-12
early O 0 9.962551530406927e-07
- O 0 1.4178295714373235e-05
onset O 1 0.9999997615814209
obesity B-Disease 1 1.0
, O 0 6.494648818744508e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.760424232586047e-08
red O 0 0.0006263723480515182
hair O 0 1.1329436802043347e-06
pigmentation O 0 5.812730705656577e-06
. O 0 1.9720931554445542e-09
. O 0 5.457590379620569e-09

A O 0 3.371526613449305e-09
European O 0 7.703598869923667e-10
multicenter O 0 2.5307375040029e-07
study O 0 6.724336365504513e-11
of O 0 8.852039989903915e-09
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.4449076096999534e-10
classification O 0 1.675058136640928e-08
of O 0 5.086926879727116e-09
105 O 0 8.56700665963217e-08
mutations O 0 7.699232917879328e-11
and O 0 5.011130399523722e-12
a O 0 7.106805920663317e-13
general O 0 3.6325562002836875e-10
system O 0 1.5663771668616988e-10
for O 0 6.057457053315618e-12
genotype O 0 3.190149477916293e-09
- O 0 2.7829155646585946e-10
based O 0 6.527025881580828e-12
prediction O 0 2.963107625930661e-08
of O 0 4.071653084136706e-11
metabolic O 0 3.82924554287456e-05
phenotype O 0 2.2768617782276124e-06
. O 0 9.728427841082521e-09

Phenylketonuria B-Disease 0 0.0006116486038081348
( O 0 1.5073222670025643e-09
PKU B-Disease 0 5.609790969174355e-05
) O 0 1.3317875448282113e-11
and O 0 3.6266681931879097e-12
mild B-Disease 0 6.23634923613281e-06
hyperphenylalaninemia I-Disease 1 1.0
( O 0 6.292322751733082e-08
MHP B-Disease 1 1.0
) O 0 8.254574107580126e-11
are O 0 7.732846307728636e-11
allelic B-Disease 0 2.823676732077729e-05
disorders I-Disease 0 3.1250249321601586e-07
caused O 0 6.947283720526443e-11
by O 0 2.852762730903846e-12
mutations O 0 3.074113186229965e-11
in O 0 3.379414369869549e-12
the O 0 4.6108401818845124e-11
gene O 0 4.933950817354038e-11
encoding O 0 5.1542507151225436e-08
phenylalanine O 0 4.49126964667812e-05
hydroxylase O 0 0.001429861062206328
( O 0 1.23894150494408e-09
PAH O 1 0.9999555349349976
) O 0 7.312913608004123e-10
. O 0 7.015160008450039e-09

Previous O 0 1.4187992292136187e-06
studies O 0 3.2232136959464697e-09
have O 0 1.8791021256375773e-12
suggested O 0 8.52542255541655e-12
that O 0 5.728866681172992e-15
the O 0 1.1761746090965808e-12
highly O 0 2.4884794225243922e-09
variable O 0 2.486193828588057e-08
metabolic O 0 0.003683545393869281
phenotypes O 0 2.2668460587738082e-05
of O 0 5.272112048260169e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 1.4935519175196532e-05
with O 0 1.088070167298838e-08
PAH O 1 1.0
genotypes O 0 0.007183639332652092
. O 0 4.0376744436798617e-07

We O 0 1.0210774448182747e-08
identified O 0 2.793919540167167e-10
both O 0 8.973916228172119e-12
causative O 0 1.267841565066874e-08
mutations O 0 1.2960390538552247e-09
in O 0 2.1168761188405938e-10
686 O 0 2.1287991103235981e-07
patients O 0 1.2177046073702513e-06
from O 0 2.9125513112404633e-10
seven O 0 4.708044371026787e-11
European O 0 3.846557738995671e-09
centers O 0 1.9386442673408055e-08
. O 0 7.88143150742826e-09

On O 0 2.3079126165725938e-08
the O 0 1.2019341077973422e-10
basis O 0 1.5429606203820612e-10
of O 0 7.614321499704868e-12
the O 0 1.2697369197733899e-11
phenotypic O 0 4.5481454713502956e-10
characteristics O 0 4.262986408321012e-08
of O 0 3.2801114713265633e-08
297 O 0 1.18560578243887e-07
functionally O 0 1.717710773618819e-08
hemizygous O 0 3.6892689081469143e-07
patients O 0 5.040723394245106e-08
, O 0 6.2487402405220216e-12
105 O 0 1.6588581619458864e-09
of O 0 1.2361249523973328e-10
the O 0 9.300204495410469e-10
mutations O 0 9.362814690216936e-11
were O 0 3.4189012731999924e-10
assigned O 0 1.2621942380164342e-10
to O 0 4.278342957686476e-11
one O 0 1.3974460477683692e-11
of O 0 3.0273714091144655e-11
four O 0 1.9075181972166844e-12
arbitrary O 0 6.237410588028069e-10
phenotype O 0 8.05499169587165e-08
categories O 0 1.118627235285885e-08
. O 0 4.306362821893117e-09

We O 0 2.7852815165374523e-08
proposed O 0 8.158106368227891e-08
and O 0 1.7168050314708694e-10
tested O 0 1.0328486677035897e-10
a O 0 4.3159749320460794e-13
simple O 0 2.426540522335041e-12
model O 0 1.8449823645846214e-13
for O 0 1.3194099404614107e-13
correlation O 0 7.411142012581085e-12
between O 0 2.5451630386585933e-11
genotype O 0 1.0795347726855198e-08
and O 0 1.9565165459978218e-11
phenotypic O 0 1.4980959806010219e-09
outcome O 0 3.911962267011404e-06
. O 0 2.6710290512710344e-07

The O 0 4.16749195153443e-08
observed O 0 3.5624768912612126e-08
phenotype O 0 5.454875804389303e-07
matched O 0 9.914990783954636e-08
the O 0 1.219531142737651e-09
predicted O 0 3.20565582967447e-08
phenotype O 0 2.794668674255263e-08
in O 0 7.2890006530546e-11
79 O 0 1.4538000803199225e-09
% O 0 5.820043882595605e-13
of O 0 1.6539703363415564e-13
the O 0 9.586831111949023e-13
cases O 0 1.5048166879250147e-10
, O 0 6.589092552827802e-12
and O 0 1.9928156347326365e-11
in O 0 4.804584854967153e-11
only O 0 7.855546074742037e-12
5 O 0 3.4928608616535683e-11
of O 0 2.631383826112721e-12
184 O 0 9.602615230752676e-11
patients O 0 6.29800878115816e-10
was O 0 3.519214780700608e-11
the O 0 2.8816499533790285e-11
observed O 0 4.707400580450383e-10
phenotype O 0 1.7243374506037412e-09
more O 0 2.979479944015262e-12
than O 0 2.9041278930275194e-12
one O 0 4.670002991084832e-13
category O 0 8.89182737856542e-12
away O 0 4.9040003828604295e-12
from O 0 5.464005441678521e-13
that O 0 4.045946791573357e-13
expected O 0 3.700336392853387e-08
. O 0 5.7389488716808046e-08

Among O 0 2.5297890715592075e-07
the O 0 7.496007703444718e-10
seven O 0 3.410042387352874e-11
contributing O 0 1.1076242006913262e-10
centers O 0 4.2333261895954877e-10
, O 0 3.2319240057636367e-13
the O 0 3.788007234273305e-12
proportion O 0 1.6838687388887053e-10
of O 0 8.945211932287478e-11
patients O 0 2.8209083957619896e-09
for O 0 1.8618608391141045e-11
whom O 0 6.510744166021709e-10
the O 0 1.7112734840285526e-10
observed O 0 1.672786492656897e-10
phenotype O 0 2.875997440199285e-09
did O 0 9.904393277748724e-11
not O 0 5.646321951657818e-12
match O 0 6.483502623666482e-11
the O 0 5.349280046695881e-11
predicted O 0 1.3347514205008792e-09
phenotype O 0 9.475895623722863e-10
was O 0 1.288456147330308e-11
4 O 0 8.350247576727199e-12
% O 0 2.091285044442115e-13
- O 0 2.503624477873112e-12
23 O 0 3.279681040635474e-11
% O 0 1.3183162244148616e-12
( O 0 4.774622402092463e-14
P O 0 2.6365369887315637e-09
< O 0 8.289205433165137e-11
. O 0 4.678311774433674e-13
0001 O 0 4.288737143198773e-10
) O 0 8.426989845950611e-14
, O 0 1.694459459897213e-13
suggesting O 0 1.2021076842283485e-11
that O 0 5.45863105150951e-13
differences O 0 3.426689765273494e-10
in O 0 2.275058613721015e-12
methods O 0 2.484886255094132e-11
used O 0 1.852674264002374e-12
for O 0 3.3856337872117948e-12
mutation O 0 1.8117206346257575e-10
detection O 0 2.2430585033816897e-07
or O 0 8.136544771275567e-10
phenotype O 0 7.261645862399746e-08
classification O 0 4.739213022020294e-09
may O 0 2.2879842118128657e-11
account O 0 1.683060293780972e-13
for O 0 5.054126164620847e-15
a O 0 7.946768243449753e-15
considerable O 0 3.68472873740755e-12
proportion O 0 1.2154388606688826e-10
of O 0 2.432780643601973e-10
genotype O 0 1.658951077843085e-05
- O 0 0.00022995837207417935
phenotype O 0 6.362142448779196e-05
inconsistencies O 0 9.841022574619274e-08
. O 0 9.442270965109856e-09

Our O 0 8.114699312500306e-08
data O 0 6.801086915864119e-10
indicate O 0 4.287600552377313e-10
that O 0 1.2117081426774035e-13
the O 0 5.5724379971477944e-11
PAH O 1 0.9999997615814209
- O 0 7.943793207232375e-06
mutation O 0 3.014352767394257e-09
genotype O 0 9.749580032192284e-10
is O 0 8.591124311755347e-16
the O 0 6.663392732043623e-16
main O 0 1.0502558024649833e-12
determinant O 0 3.170306517308319e-10
of O 0 1.7152242126616812e-10
metabolic O 0 0.4984457194805145
phenotype O 0 2.9099149401190516e-07
in O 0 1.4921544902457562e-11
most O 0 3.318904179261395e-11
patients O 0 5.037145367481344e-09
with O 0 6.823981935077938e-10
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.036749258637428284

In O 0 3.2853050835335296e-10
the O 0 1.738433355602531e-11
present O 0 6.974701372008951e-11
study O 0 8.073648520567911e-12
, O 0 3.300333774715683e-14
the O 0 1.1170172859592542e-12
classification O 0 1.2128881010653458e-08
of O 0 3.673268356152448e-09
105 O 0 1.3135496601535124e-06
PAH O 1 0.9999971389770508
mutations O 0 5.895628429897215e-09
may O 0 2.520093578262106e-10
allow O 0 1.8492965839222997e-11
the O 0 3.7091069798877996e-11
prediction O 0 2.4599440706651876e-08
of O 0 2.899452379578893e-11
the O 0 5.155176632798408e-11
biochemical O 0 9.390938693343287e-09
phenotype O 0 1.7541808006171777e-08
in O 0 6.064326818489008e-11
> O 0 5.064379582364609e-09
10 O 0 3.5078356885875905e-11
, O 0 8.283064989109135e-13
000 O 0 4.5345810439911816e-10
genotypes O 0 6.932174834162197e-09
, O 0 3.176773948065925e-12
which O 0 1.9697434059263302e-13
may O 0 1.1075623924938771e-11
be O 0 6.159127027838274e-13
useful O 0 6.2282501205046525e-12
for O 0 3.931104302756089e-13
the O 0 3.3827437379008174e-11
management O 0 2.1501177227545298e-10
of O 0 2.5316415630527445e-10
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.452036286764269e-07
newborns O 0 1.0233654393232428e-05
. O 0 2.8447487920857384e-08

Somatic O 0 1.7774111256585456e-05
instability O 0 4.937676933991497e-08
of O 0 6.407216535109228e-09
the O 0 1.0527592309017564e-07
CTG O 1 0.8186567425727844
repeat O 0 4.202883303605631e-07
in O 0 1.8423136349809965e-09
mice O 0 9.500435993459178e-10
transgenic O 0 2.6625071036789905e-09
for O 0 5.749060082160806e-12
the O 0 5.876243136526682e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 4.149472374592733e-07
is O 0 9.583489384012989e-12
age O 0 1.902505930573284e-10
dependent O 0 9.498433289900632e-12
but O 0 5.971745586095048e-14
not O 0 7.938970119324151e-14
correlated O 0 2.772291944619365e-11
to O 0 4.050649518496513e-13
the O 0 1.2042970787273788e-11
relative O 0 1.1181877646038174e-08
intertissue O 0 2.445857944621821e-06
transcription O 0 1.2536926874417986e-07
levels O 0 1.2546369134724955e-06
and O 0 3.1727096505562713e-09
proliferative O 1 0.9987508058547974
capacities O 0 8.671728210174479e-06
. O 0 5.203417572374747e-07

A O 0 2.342901325391722e-06
( O 0 5.476492592748627e-10
CTG O 0 3.4924478313769214e-06
) O 0 4.724774391173803e-12
nexpansion O 0 3.181995822387762e-08
in O 0 2.8113395292295174e-11
the O 0 4.5216753952193045e-11
3 O 0 7.184064454435202e-10
- O 0 2.6690205601198613e-09
untranslated O 0 6.0995182138867676e-05
region O 0 1.2650243075285061e-09
( O 0 1.242178994213805e-12
UTR O 0 4.743226327263983e-06
) O 0 1.284996956930906e-13
of O 0 7.688002144623507e-12
the O 0 3.1943505618414747e-09
DM O 1 1.0
protein O 0 4.892780225418392e-07
kinase O 0 1.2317555864171936e-08
gene O 0 2.93579244248221e-10
( O 0 1.5486524822944103e-12
DMPK O 0 0.00046710314927622676
) O 0 4.1615639428428663e-13
is O 0 1.391732984689113e-14
responsible O 0 1.624375953841392e-13
for O 0 1.0660768058265435e-12
causing O 0 4.7140946435320075e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.4877064025142772e-08
DM B-Disease 1 1.0
) O 0 2.986128289084178e-10
. O 0 2.4015425204026997e-09

Major O 0 4.324292603996582e-05
instability O 0 4.562930371321272e-07
, O 0 2.4063417924935493e-10
with O 0 3.673501173390159e-12
very O 0 8.39853742107266e-11
large O 0 2.5835084072056702e-11
expansions O 0 4.102016226692484e-10
between O 0 1.4799106384799643e-10
generations O 0 1.4763760214364652e-09
and O 0 8.325105362028129e-12
high O 0 1.8833418158337167e-10
levels O 0 7.002853852355884e-11
of O 0 1.601538172912864e-11
somatic O 0 1.8245714272779878e-07
mosaicism O 0 9.057727652361791e-07
, O 0 1.2987047418380748e-12
is O 0 9.208383160803565e-14
observed O 0 2.902656413839022e-11
in O 0 1.392224391327801e-10
patients O 0 3.8920575207157526e-08
. O 0 1.901833002193598e-08

There O 0 1.3266346909901472e-09
is O 0 2.408589603805633e-12
a O 0 7.489322747036842e-13
good O 0 2.0483399698623117e-11
correlation O 0 9.515329062875777e-13
between O 0 5.193067655583083e-13
repeat O 0 1.8530109738290612e-11
size O 0 1.1831147173069212e-10
( O 0 2.7536284884221995e-13
at O 0 4.677796778401744e-12
least O 0 1.0397061900660476e-12
in O 0 2.556025053071509e-12
leucocytes O 0 1.3946895194294484e-08
) O 0 1.7053632811458996e-13
, O 0 8.618295286406605e-14
clinical O 0 6.3015469578542316e-12
severity O 0 3.6710130491002246e-09
and O 0 2.988645095292064e-11
age O 0 7.759123121786615e-09
of O 0 1.4058580966036516e-09
onset O 0 2.3805165255907923e-05
. O 0 6.719909038110927e-07

The O 0 5.041891881774063e-07
trinucleotide O 0 0.0004036144819110632
repeat O 0 1.495077412982937e-07
instability O 0 6.212385272874599e-09
mechanisms O 0 5.579491868523689e-10
involved O 0 2.5248313856307547e-11
in O 0 9.539947720682562e-10
DM B-Disease 1 1.0
and O 0 1.6117105428037348e-09
other O 0 7.680487495997923e-11
human O 0 2.6794067409241507e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 7.191460534711203e-12
unknown O 0 5.96289129184413e-10
. O 0 4.446865931040378e-10

We O 0 2.9020834624304825e-09
studied O 0 8.67028582263174e-09
somatic O 0 3.934467827093613e-07
instability O 0 1.0146258277998754e-09
by O 0 3.796021223051449e-12
measuring O 0 7.959746639585319e-09
the O 0 2.057806813837715e-09
CTG O 0 1.77524464106682e-06
repeat O 0 4.721896207371401e-10
length O 0 5.103404157602576e-11
at O 0 3.631700842832153e-12
several O 0 2.554649200514625e-13
ages O 0 2.664690412768067e-10
in O 0 3.4570614600160088e-12
various O 0 5.699331631636717e-11
tissues O 0 4.4164323753648205e-08
of O 0 4.30401447815143e-09
transgenic O 0 4.3235908719907457e-07
mice O 0 8.197482692651192e-10
carrying O 0 5.831335848222041e-12
a O 0 5.975408969710605e-12
( O 0 6.083543824947357e-12
CTG O 0 1.3163837593310745e-06
) O 0 5.501446086880746e-12
55expansion O 0 5.3345349471101144e-08
surrounded O 0 5.410232817304461e-10
by O 0 4.0656982988607204e-12
45 O 0 5.233485866895649e-10
kb O 0 1.0895606639138578e-09
of O 0 1.3524201203374275e-10
the O 0 1.739085209173652e-09
human O 0 5.845958739314483e-08
DM B-Disease 1 1.0
region O 0 3.3153540357488964e-07
, O 0 4.720216405240674e-12
using O 0 6.61146311309313e-12
small O 0 5.3995707210985344e-11
- O 0 4.939094133682431e-10
pool O 0 1.7232951732282231e-09
PCR O 0 3.423080841002957e-08
. O 0 1.3693687073157434e-08

These O 0 6.262007445911877e-07
mice O 0 2.1414024331534165e-08
have O 0 9.266817348196899e-12
been O 0 1.8899176928294237e-12
shown O 0 1.1740453444500365e-12
to O 0 1.3291678955390518e-12
reproduce O 0 4.1470382683428397e-10
the O 0 4.885610666027773e-11
intergenerational O 0 1.041410624402772e-09
and O 0 6.762313365521466e-12
somatic O 0 3.711497598146707e-08
instability O 0 1.1466381177882567e-09
of O 0 3.2263855476166725e-10
the O 0 2.3491926182117595e-09
55 O 0 1.481075528886322e-08
CTG O 0 3.0019955374882556e-06
repeat O 0 3.2506257685582796e-09
suggesting O 0 3.3734864901546757e-10
that O 0 4.640453060873739e-13
surrounding O 0 6.959183229682253e-10
sequences O 0 1.1223827423023636e-11
and O 0 3.1249109203046466e-12
the O 0 8.746812302229401e-12
chromatin O 0 9.329438199756623e-08
environment O 0 2.5084483468162944e-07
are O 0 7.066435544350602e-12
involved O 0 1.0753981906364007e-11
in O 0 2.522689175610271e-11
instability O 0 5.422974513891177e-09
mechanisms O 0 2.0621088481220795e-07
. O 0 7.46624948533281e-08

As O 0 6.310433064982135e-09
observed O 0 1.488931977711161e-09
in O 0 1.7475824606871804e-11
some O 0 1.6331996519070024e-12
of O 0 4.928060563791359e-12
the O 0 4.5433379280979125e-12
tissues O 0 6.310574285350867e-10
of O 0 2.4647566210234118e-09
DM B-Disease 1 1.0
patients O 0 0.0005612483946606517
, O 0 7.337772967366818e-13
there O 0 4.4794883405883945e-13
is O 0 8.048870272538144e-14
a O 0 1.6905919752226856e-13
tendency O 0 4.035646469779941e-11
for O 0 2.4091132734549436e-12
repeat O 0 1.0604239708555951e-10
length O 0 1.4815373927667963e-10
and O 0 2.4430558270838176e-11
somatic O 0 1.9745629131762144e-08
mosaicism O 0 4.0603904238878386e-08
to O 0 2.509222430530089e-12
increase O 0 5.271148101337886e-12
with O 0 7.030841702023935e-14
the O 0 2.119889160046018e-11
age O 0 1.993779807918372e-09
of O 0 8.306298010518631e-11
the O 0 1.5795578178767755e-09
mouse O 0 7.105061428092085e-08
. O 0 1.0581176823620808e-08

Furthermore O 0 7.97759184933966e-07
, O 0 1.665267229666867e-10
we O 0 4.129094201971162e-12
observed O 0 8.700274008177633e-12
no O 0 2.934371495788568e-13
correlation O 0 1.3134014275467676e-13
between O 0 8.863608225205891e-14
the O 0 3.617866423111238e-12
somatic O 0 2.49318475198379e-07
mutation O 0 1.5755116322679896e-08
rate O 0 4.5155370997918e-08
and O 0 5.547622777823946e-11
tissue O 0 3.0961075481172884e-08
proliferation O 0 2.5501725531285047e-07
capacity O 0 7.262574541755384e-08
. O 0 2.4908217710617464e-08

The O 0 3.169022591009707e-07
somatic O 0 2.6909181542578153e-05
mutation O 0 5.975990546858156e-08
rates O 0 4.776656847838012e-09
in O 0 4.374989086286529e-12
different O 0 9.069346836032555e-12
tissues O 0 1.194404464222032e-09
were O 0 6.878864144965746e-11
also O 0 2.4463314403713743e-13
not O 0 2.451955739141143e-13
correlated O 0 8.119765276815016e-11
to O 0 4.506631613027112e-12
the O 0 1.3270136378640274e-10
relative O 0 3.627713596188187e-08
inter O 0 7.376461663710643e-09
- O 0 1.6375316658212569e-09
tissue O 0 1.2738011756496803e-09
difference O 0 9.993504634930872e-11
in O 0 1.1743112992429472e-13
transcriptional O 0 1.47087671903412e-11
levels O 0 4.403961362253739e-10
of O 0 1.51863591146828e-11
the O 0 1.346482370045976e-10
three O 0 1.946410914388519e-11
genes O 0 4.133430056563192e-11
( O 0 1.8917714617039394e-12
DMAHP O 0 0.0011719285976141691
, O 0 5.376286638103522e-10
DMPK O 1 0.9443632960319519
and O 0 9.746090157136678e-09
59 O 0 8.18795431456465e-09
) O 0 3.899738333906083e-13
surrounding O 0 2.4287529765132376e-09
the O 0 5.797406443797115e-10
repeat O 0 2.363475859468167e-09
. O 0 1.2251194503321017e-09
. O 0 1.1524556420283716e-08

A O 0 1.1519901477186067e-07
novel O 0 1.1004555489080303e-07
missense O 0 1.3410957535597845e-06
mutation O 0 2.598529391661941e-09
in O 0 4.0582703864089353e-11
patients O 0 2.1748289835699097e-09
from O 0 3.3880110088951865e-12
a O 0 1.169160948610859e-11
retinoblastoma B-Disease 0 1.1637135685305111e-05
pedigree O 0 1.5117893781280145e-06
showing O 0 2.9275908364212455e-09
only O 0 2.1631026830837286e-11
mild O 0 2.540472010537087e-08
expression O 0 2.761886941371472e-09
of O 0 1.1943931399471808e-09
the O 0 5.232071664806881e-09
tumor B-Disease 0 1.9328274447616423e-06
phenotype O 0 1.3233394611233962e-06
. O 0 5.84360337896328e-09

We O 0 1.1996586835039125e-08
have O 0 2.7637904985444717e-12
used O 0 2.236541437076675e-13
single O 0 9.410499723222499e-13
strand O 0 1.3770381536437615e-11
conformation O 0 2.2803545076527376e-12
polymorphism O 0 2.5131693601188054e-12
analysis O 0 1.534681534414925e-13
to O 0 5.264812565942967e-14
study O 0 1.2449730916325175e-12
the O 0 7.816789750203501e-12
27 O 0 5.240571088194201e-09
exons O 0 2.2241242181308962e-09
of O 0 2.5525245805901875e-10
the O 0 2.4366499928873964e-09
RB1 O 0 9.030231353790441e-07
gene O 0 5.197490007824435e-12
in O 0 1.5987112892204558e-12
individuals O 0 3.4363253887358114e-13
from O 0 5.106789990882987e-12
a O 0 5.0271176110783244e-12
family O 0 5.628508076283012e-11
showing O 0 6.87553569633792e-10
mild O 0 1.8879765661949932e-07
expression O 0 3.029305162272067e-08
of O 0 3.5603978432163785e-08
the O 0 7.74329222963388e-08
retinoblastoma B-Disease 0 7.995789201231673e-05
phenotype O 0 1.004253590508597e-05
. O 0 2.913121122105622e-08

In O 0 1.3808637566725679e-09
this O 0 1.1492891360820323e-10
family O 0 5.105275646677399e-10
affected O 0 4.448030388459756e-09
individuals O 0 7.692935177772142e-11
developed O 0 3.8691942449986527e-07
unilateral B-Disease 1 0.96208655834198
tumors I-Disease 1 1.0
and O 0 3.19732684772589e-08
, O 0 3.159907448549437e-12
as O 0 2.865762640212599e-13
a O 0 2.022801753030247e-14
result O 0 2.9740123124594176e-12
of O 0 1.0233297716155665e-11
linkage O 0 1.7179777045406297e-10
analysis O 0 1.0002175303280847e-11
, O 0 1.8020861495757212e-12
unaffected O 0 1.1034648750296583e-08
mutation O 0 6.856151063550087e-11
carriers O 0 8.140048357585528e-11
were O 0 5.396780244915078e-11
also O 0 5.193843185397062e-12
identified O 0 2.316235050980886e-11
within O 0 1.6603259045400165e-10
the O 0 1.7620668257833927e-09
pedigree O 0 5.9608618130369e-07
. O 0 5.6513325574769624e-08

A O 0 1.7453197997951975e-08
single O 0 3.496088418764032e-10
band O 0 1.8863264283908165e-09
shift O 0 5.610043540826837e-10
using O 0 5.371999373116054e-11
SSCP O 0 0.0006247566197998822
was O 0 2.2188575421466794e-09
identified O 0 3.0903579695262806e-10
in O 0 2.270556798134038e-10
exon O 0 4.513201812272882e-09
21 O 0 1.937053017986301e-10
which O 0 7.060432967442853e-14
resulted O 0 3.1132418865098543e-10
in O 0 5.547400386274326e-11
a O 0 1.7921612804894238e-10
missense O 0 2.3098640156149486e-07
mutation O 0 4.428779565301966e-09
converting O 0 1.9397724315695086e-08
a O 0 1.56263224582176e-10
cys O 0 6.144955477793701e-08
- O 0 4.182157731236202e-09
- O 0 3.3016014366893387e-09
> O 0 3.6188794183544815e-09
arg O 0 2.2392554477335125e-10
at O 0 1.4972710571381498e-12
nucleotide O 0 9.780529858227638e-11
position O 0 2.426830125745738e-10
28 O 0 4.1643595238838316e-09
in O 0 9.91747378664698e-11
the O 0 5.0154982389472025e-09
exon O 0 1.4257966540753841e-07
. O 0 3.082261201825531e-08

The O 0 2.213908913972773e-07
mutation O 0 1.5381235130007553e-07
destroyed O 0 5.781577172569996e-08
an O 0 1.4402005629743364e-11
NdeI O 0 1.640155642235186e-05
restriction O 0 5.060094281361671e-06
enzyme O 0 3.9143776575656375e-07
site O 0 9.896645991602782e-08
. O 0 1.659371484663552e-08

Analysis O 0 3.5184449798109085e-10
of O 0 1.7339116809012012e-09
all O 0 7.658636502760885e-10
family O 0 2.5268800940558833e-10
members O 0 7.617163735700039e-13
demonstrated O 0 1.0471659130095734e-11
that O 0 2.0715937645854332e-13
the O 0 3.893642352981175e-10
missense O 0 1.1858976023404466e-07
mutation O 0 1.6055342610954426e-09
co O 0 5.600058194943358e-10
- O 0 2.1293752539008892e-08
segregated O 0 8.253401517777093e-09
with O 0 1.284296779167915e-12
patients O 0 4.795473174112885e-08
with O 0 6.345395320295211e-10
tumors B-Disease 1 1.0
or O 0 0.3931688070297241
who O 0 5.2465740196794286e-08
, O 0 5.52430540548543e-12
as O 0 9.556269621111002e-13
a O 0 1.893191820760004e-14
result O 0 2.0473195621456552e-12
of O 0 6.1074591564680425e-12
linkage O 0 1.7362396242948108e-11
analysis O 0 1.255575396257036e-12
had O 0 6.268580272916768e-12
been O 0 4.777059390420613e-12
predicted O 0 2.8316127220762155e-10
to O 0 8.50332044360913e-12
carry O 0 8.596046791042866e-11
the O 0 6.065602464744302e-10
predisposing O 0 1.8481657662050566e-06
mutation O 0 3.618419270878803e-07
. O 0 1.1908773700497477e-07

These O 0 2.688563816022338e-09
observations O 0 4.196364589148516e-09
point O 0 2.0309048887057202e-10
to O 0 1.2344578484424495e-12
another O 0 8.06963003363581e-12
region O 0 9.474522277841402e-10
of O 0 1.2117404857292513e-09
the O 0 4.89820521920592e-08
RB1 O 0 7.384709533653222e-06
gene O 0 3.4379302182863114e-10
where O 0 4.778704654206933e-10
mutations O 0 1.2682338686176298e-11
only O 0 4.228479979356825e-12
modify O 0 9.81971393088088e-10
the O 0 2.9161870140903545e-10
function O 0 1.3023300493575363e-10
of O 0 1.4616520216392814e-09
the O 0 2.1194870303276048e-09
gene O 0 8.79358807992503e-11
and O 0 9.497355124565843e-10
raise O 0 3.2070364142100516e-09
important O 0 2.698390400013295e-10
questions O 0 1.0707976172419365e-10
for O 0 1.0496189421088653e-12
genetic O 0 1.8470132367998104e-10
counseling O 0 8.736696088806895e-11
in O 0 3.396038333360052e-13
families O 0 8.994200241356498e-13
with O 0 6.483109540747836e-14
these O 0 7.457599815463567e-11
distinctive O 0 9.609972373425535e-09
phenotypes O 0 1.106314542198561e-07
. O 0 4.3545327343963436e-09
. O 0 1.770952806623427e-08

Maternal B-Disease 0 7.535513577749953e-05
disomy I-Disease 0 0.0001487868430558592
and O 0 1.199566895593307e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 2.381711055932101e-05
with O 0 2.3091905124172918e-11
gamete O 0 3.010525233548833e-07
complementation O 0 0.0002234700514236465
in O 0 3.7437705713294633e-11
a O 0 6.832645343610166e-13
case O 0 5.867120678182403e-10
of O 0 5.633894240020254e-09
familial O 0 2.3010255745248287e-07
translocation O 0 1.923845957207959e-06
( O 0 1.9243428465293144e-12
3 O 0 1.20844403928011e-10
; O 0 1.055650250374185e-12
15 O 0 3.13266461382522e-11
) O 0 4.939828724564478e-14
( O 0 6.552690248046167e-14
p25 O 0 1.359717449744835e-09
; O 0 2.8156684882957306e-12
q11 O 0 3.580561180882569e-09
. O 0 3.351314364907765e-11
2 O 0 1.6653466106131276e-10
) O 0 1.897358355498757e-12
. O 0 1.1040791614291834e-09

Maternal B-Disease 1 0.9965301156044006
uniparental I-Disease 1 0.9999997615814209
disomy I-Disease 1 0.9999984502792358
( I-Disease 0 7.600797857776342e-08
UPD I-Disease 1 1.0
) I-Disease 0 2.0230063457749026e-10
for I-Disease 0 1.4232487410836825e-10
chromosome I-Disease 0 1.0564312757921357e-09
15 I-Disease 0 8.52765968950564e-10
is O 0 3.602914407790925e-13
responsible O 0 2.379098654192724e-12
for O 0 6.909732660174972e-13
an O 0 1.8524320871183587e-14
estimated O 0 1.112681669891702e-12
30 O 0 3.4905212401015184e-12
% O 0 9.50211470515357e-15
of O 0 2.640181050163565e-16
cases O 0 4.7637705547854195e-14
of O 0 1.0456022714322444e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.3035356207401492e-05
PWS B-Disease 1 1.0
) O 0 1.0029006514145067e-09
. O 0 6.300690635896444e-09

We O 0 6.1878115964475455e-09
report O 0 9.58848625498554e-11
on O 0 1.7191239751190857e-11
an O 0 2.5657265364625566e-15
unusual O 0 4.108934546775966e-12
case O 0 7.025744569455483e-11
of O 0 4.777829798463529e-10
maternal B-Disease 0 4.3073937376902904e-06
disomy I-Disease 0 0.00019204906129743904
15 I-Disease 0 9.261551525696632e-08
in O 0 7.733797602327286e-09
PWS B-Disease 1 1.0
that O 0 7.489386888437366e-11
is O 0 2.5534860684239824e-12
most O 0 2.805247570694669e-12
consistent O 0 1.4683764620881945e-11
with O 0 1.1153598559337802e-14
adjacent O 0 9.631542091659284e-11
- O 0 1.1496179702641385e-10
1 O 0 5.498073663012804e-10
segregation O 0 7.877666574618303e-11
of O 0 2.4082402738656583e-12
a O 0 2.7939595081960533e-12
paternal O 0 2.0214778828631097e-07
t O 0 4.930926333912566e-09
( O 0 1.7293798500444407e-13
3 O 0 1.8065300991243483e-11
; O 0 2.1060957882193532e-13
15 O 0 3.9375750923720254e-12
) O 0 1.0497199694225502e-14
( O 0 1.8776923036713765e-14
p25 O 0 5.685068527050419e-10
; O 0 5.793384977477445e-13
q11 O 0 6.30215435393211e-10
. O 0 3.584710219634024e-12
2 O 0 6.7372353355910075e-12
) O 0 3.777806331786227e-15
with O 0 1.0583404778366414e-14
simultaneous O 0 4.603228388744274e-12
maternal O 0 3.5832545819403094e-08
meiotic O 0 2.254795390399522e-06
nondisjunction O 0 2.8423241019481793e-05
for O 0 4.5492086542253674e-08
chromosome O 0 4.711123935408068e-08
15 O 0 1.9624245339855406e-08
. O 0 7.652974254312994e-09

The O 0 5.58327677424586e-08
patient O 0 1.2498862815846223e-06
( O 0 2.9140875910244057e-12
J O 0 1.0667279504161797e-08
. O 0 5.191822666228418e-12
B O 0 5.968763261421373e-10
. O 0 1.7470532263702196e-14
) O 0 5.621594617084445e-16
, O 0 7.12819475619025e-15
a O 0 4.37354959106212e-14
17 O 0 5.784974062283954e-12
- O 0 2.2376094033216276e-12
year O 0 1.0717252779679498e-10
- O 0 1.2585120723329624e-09
old O 0 9.822660906877445e-09
white O 0 2.0658135202467065e-09
male O 0 1.1213983734659205e-11
with O 0 7.597659209667568e-14
PWS B-Disease 1 1.0
, O 0 8.137999302215704e-11
was O 0 8.863136335968136e-10
found O 0 4.137073669752134e-11
to O 0 8.543985657860631e-11
have O 0 8.596264255977815e-10
47 O 0 1.239629998650571e-08
chromosomes O 0 7.326941831031775e-11
with O 0 1.8253007070222205e-13
a O 0 4.201868453873603e-12
supernumerary O 0 1.3579941651187255e-06
, O 0 2.8739271379363274e-11
paternal O 0 6.457545254079378e-08
der O 0 9.973899928183982e-09
( O 0 5.860077505713546e-13
15 O 0 1.7991403505890347e-11
) O 0 5.607996350149224e-15
consisting O 0 2.841921305490186e-13
of O 0 7.86079187853339e-12
the O 0 7.329782336640278e-10
short O 0 8.904824433386693e-09
arm O 0 2.3019544048707985e-09
and O 0 4.41657932448436e-10
the O 0 2.9843487681091574e-08
proximal O 0 0.00011488472227938473
long O 0 4.7395502633662545e-07
arm O 0 6.29987395583953e-09
of O 0 2.1785822035269575e-09
chromosome O 0 2.430355083848923e-10
15 O 0 4.76968076146278e-10
, O 0 4.2454997850605025e-12
and O 0 8.295215903064701e-11
distal O 0 6.675059921690263e-06
chromosome O 0 8.574232197133824e-06
arm O 0 0.00014176819240674376
3p O 0 0.0012502952013164759
. O 0 1.39043663693883e-06

The O 0 9.196173209602421e-07
t O 0 1.2684993500045039e-08
( O 0 6.920627807806279e-13
3 O 0 1.3892845207585935e-11
; O 0 9.116164312143737e-14
15 O 0 2.0941119931866536e-12
) O 0 3.856139515231831e-15
was O 0 1.0244097237155358e-11
present O 0 1.3724862392427983e-11
in O 0 9.674731502040679e-12
the O 0 1.131867689851962e-11
balanced O 0 1.2033555575607924e-11
state O 0 1.4143819579079397e-12
in O 0 1.1063286788418059e-12
the O 0 4.099925954292871e-11
patients O 0 8.717931621049502e-08
father O 0 2.00810679196195e-09
and O 0 6.551466036341935e-10
a O 0 5.491170185223382e-09
sister O 0 6.281222795223584e-06
. O 0 1.4132058367977152e-06

Fluorescent O 0 1.9780363800236955e-05
in O 0 2.5841613293664523e-09
situ O 0 2.7239382305310755e-08
hybridization O 0 3.548562138577793e-11
analysis O 0 2.6357475230165406e-13
demonstrated O 0 2.5500547853885003e-12
that O 0 2.4687542659576796e-14
the O 0 8.715259069980164e-11
PWS B-Disease 1 1.0
critical O 0 1.9453880668152124e-05
region O 0 8.199832812749719e-09
resided O 0 1.4497995692863697e-08
on O 0 2.2220753015389505e-10
the O 0 4.057922053934959e-11
derivative O 0 6.273526698130638e-10
chromosome O 0 1.5906002209797876e-11
3 O 0 2.2832541413109197e-11
and O 0 2.60151465257194e-13
that O 0 2.890045245219214e-14
there O 0 1.645390637974864e-12
was O 0 5.7307360246117156e-11
no O 0 6.961075379313675e-12
deletion O 0 5.117791260222937e-11
of O 0 1.6576774675147732e-10
the O 0 1.8185392747227525e-08
PWS B-Disease 1 1.0
region O 0 1.2360158052615589e-07
on O 0 2.4158488542980194e-09
the O 0 4.882946130768673e-11
normal O 0 2.5499078404322972e-09
pair O 0 9.80759917723617e-11
of O 0 9.644754613014062e-12
15s O 0 4.567778599806616e-09
present O 0 9.983355253595505e-10
in O 0 5.712669892687927e-09
J O 0 7.195413490990177e-05
. O 0 1.2121091685912688e-07

B O 0 0.006126876454800367
. O 0 2.429129892789206e-07

Methylation O 0 5.485067511301622e-09
analysis O 0 3.2644859038200025e-10
at O 0 6.205418401350471e-10
exon O 0 1.219285206133236e-08
alpha O 0 1.6505449229597957e-09
of O 0 7.516882671865233e-10
the O 0 1.5749248571950147e-09
small O 0 8.945894025558232e-11
nuclear O 0 2.1532020610948166e-08
ribonucleoprotein O 0 4.5115601920997506e-08
- O 0 1.6165194738348987e-09
associated O 0 3.2871243504928316e-09
polypeptide O 0 3.94829946515074e-08
N O 0 1.5086778049067107e-08
( O 0 7.912006011294437e-13
SNRPN O 0 6.499546429949987e-07
) O 0 2.0396488317753203e-12
gene O 0 4.618160454744613e-12
showed O 0 3.077856372546428e-11
a O 0 4.404055787589345e-13
pattern O 0 3.4861732944868606e-10
characteristic O 0 6.704089366982302e-11
of O 0 2.533780477098624e-11
only O 0 5.700578897815944e-12
the O 0 1.0255871846220899e-10
maternal O 0 3.246915625254587e-08
chromosome O 0 9.272961842832217e-10
15 O 0 7.75337904990181e-10
in O 0 5.382279066878937e-10
J O 0 1.849463842518162e-05
. O 0 7.491055242780931e-08

B O 0 0.008760029450058937
. O 0 2.1316350284905639e-07

Maternal B-Disease 0 0.0012444746680557728
disomy I-Disease 0 0.00018153506971430033
was O 0 3.644516022305311e-09
confirmed O 0 1.3075020233177526e-10
by O 0 3.4927770853517004e-13
polymerase O 0 2.8694945725105114e-12
chain O 0 5.061829861513489e-13
reaction O 0 1.4801181114076911e-12
analysis O 0 4.600226449769096e-12
of O 0 1.6507257366571437e-11
microsatellite O 0 4.124314667564022e-09
repeats O 0 1.132611088250357e-10
at O 0 4.142235599663424e-12
the O 0 4.854981434238015e-12
gamma O 0 4.1155898133915514e-10
- O 0 8.756920188979223e-10
aminobutyric O 0 4.854592816627701e-08
acid O 0 2.396376430624514e-09
receptor O 0 9.753188257022316e-10
beta3 O 0 4.428385125265777e-07
subunit O 0 1.164381924212421e-09
( O 0 1.3811706119082334e-11
GABRB3 O 0 1.06818397398456e-05
) O 0 6.99657901059858e-11
locus O 0 4.6169054690459177e-10
. O 0 2.8434776755403846e-09

A O 0 4.541689122561365e-06
niece O 0 3.670949081424624e-05
( O 0 1.6514510592369191e-10
B O 0 2.829943070992158e-07
. O 0 7.634126837630095e-12
B O 0 5.691458970780161e-10
. O 0 4.3880551996904396e-14
) O 0 2.507821670122358e-15
with O 0 2.4425721387448703e-14
45 O 0 1.8279398827925064e-11
chromosomes O 0 7.134121418617134e-12
and O 0 8.808267158190441e-13
the O 0 9.135808429205916e-12
derivative O 0 7.506677918156512e-11
3 O 0 1.3965560478890193e-11
but O 0 3.8818536059193054e-13
without O 0 7.968377693789996e-12
the O 0 1.0691446339361477e-10
der O 0 2.035586810222867e-09
( O 0 7.054917088890333e-13
15 O 0 4.1857208671336465e-11
) O 0 1.365510352360766e-13
demonstrated O 0 1.0667755567794757e-10
a O 0 2.3531905590790103e-11
phenotype O 0 2.1290182417033066e-07
consistent O 0 1.3511479046712793e-08
with O 0 2.04396287221964e-13
that O 0 3.8685621004362625e-14
reported O 0 9.264851255977313e-13
for O 0 1.1001233561278023e-12
haploinsufficiency O 0 7.777244945827988e-07
of O 0 2.3192276898953423e-07
distal O 0 0.00027414190117269754
3 O 0 2.9671808079001494e-05
p O 0 8.301802267851599e-07
. O 0 1.295750706731269e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.0224479751741455e-07
with O 0 4.261549099715545e-11
unbalanced O 0 1.0590201782179065e-06
segregation O 0 3.2248391335087945e-07
of O 0 2.3258850845309098e-08
non O 0 6.806569672335172e-06
- O 0 1.0060222166430322e-06
Robertsonian O 0 0.0003559482574928552
translocations O 0 1.403940927957592e-06
has O 0 7.506552601732608e-10
been O 0 6.865245177900547e-11
reported O 0 4.255781838047312e-11
previously O 0 2.648561925333581e-10
but O 0 1.9739878134861222e-11
has O 0 3.7429811312016115e-13
not O 0 4.4241777667590465e-13
, O 0 5.127224599749125e-13
to O 0 5.7459028854345284e-12
our O 0 5.592138974108707e-10
knowledge O 0 6.368736094053418e-10
, O 0 7.129778538395026e-13
been O 0 9.485430019565144e-13
observed O 0 1.567655553980085e-11
in O 0 3.142531374011881e-12
a O 0 1.7295653841412073e-12
case O 0 2.254341158192119e-09
of O 0 2.126396125845531e-08
PWS B-Disease 1 1.0
. O 0 1.401284862367902e-05

Furthermore O 0 4.377111963549396e-06
, O 0 1.4644844226197051e-09
our O 0 8.062485123971896e-10
findings O 0 3.8191264040143835e-10
are O 0 9.088807180826497e-13
best O 0 1.2331329533876723e-12
interpreted O 0 2.235729310018364e-11
as O 0 1.2635031909624672e-12
true O 0 3.3954523220858235e-11
gamete O 0 3.208726795378425e-08
complementation O 0 1.34018284825288e-06
resulting O 0 4.1636605274675276e-09
in O 0 9.469156569963388e-10
maternal B-Disease 0 0.00018322045798413455
UPD I-Disease 1 1.0
15 I-Disease 0 8.829095895634964e-05
and O 0 1.1666243153740652e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9994223117828369
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 3.797666181526438e-07
2 I-Disease 0 9.904724151965638e-09
and O 0 6.761114671599566e-12
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.2339524367577237e-11
a O 0 1.9880493464571186e-13
case O 0 7.506258635492369e-12
for O 0 1.2232520768887256e-12
" O 0 1.381972314362656e-10
lumping O 0 2.7594333484870504e-09
" O 0 1.3581362701131638e-09
. O 0 1.1762167906326226e-09

Recent O 0 2.3105675150958405e-09
studies O 0 1.8485560304704052e-11
demonstrated O 0 5.4826954608289125e-12
the O 0 1.7236015132510163e-12
existence O 0 1.0015940334062723e-11
of O 0 1.3047909107333222e-11
a O 0 1.6812620740047635e-11
genetically O 0 3.825280430191924e-07
distinct O 0 1.3368050000295284e-09
, O 0 9.200780870695369e-14
usually O 0 1.2334234585835262e-14
lethal O 0 4.924731954701611e-13
form O 0 6.795666053537389e-14
of O 0 3.0876668409562935e-13
the O 0 3.311821650253677e-11
Schwartz B-Disease 0 0.010957053862512112
- I-Disease 1 0.9999997615814209
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
( O 0 2.6611692016675903e-11
SJS B-Disease 0 7.427376658597495e-06
) O 0 1.1091520930872623e-11
of O 0 2.8831756981873014e-09
myotonia B-Disease 1 0.9999991655349731
and O 0 1.6952870964814792e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 6.411497111002973e-08
which O 0 1.4895731870190332e-10
we O 0 2.0879481477109607e-10
called O 0 8.720784094862211e-10
SJS B-Disease 0 0.00016176237841136754
type I-Disease 0 2.613024435049738e-06
2 I-Disease 0 8.31071602647171e-08
. O 0 1.8933554724043233e-09

This O 0 1.2751656619514051e-08
disorder O 0 8.855909982230514e-05
is O 0 1.4274129621349996e-11
reminiscent O 0 9.554192992311528e-09
of O 0 3.6539646308675344e-11
another O 0 3.6296489360106154e-13
rare O 0 6.416109397250347e-12
condition O 0 7.978712690537293e-10
, O 0 1.0730266230673385e-13
the O 0 9.723830247942988e-12
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.1031917779291689e-07
SWS B-Disease 1 0.8844093680381775
) O 0 2.2898560218115316e-12
, O 0 3.397534803408625e-13
which O 0 2.4183750163032924e-13
comprises O 0 8.138072681018738e-12
campomelia B-Disease 0 7.610299945781662e-08
at O 0 4.504187023357531e-10
birth O 0 1.4956984159653075e-05
with O 0 1.057304133134096e-09
skeletal B-Disease 1 0.99997878074646
dysplasia I-Disease 1 1.0
, O 0 1.4774219181390436e-08
contractures B-Disease 0 0.002694007707759738
, O 0 2.342685767597885e-10
and O 0 1.5637942329949084e-11
early B-Disease 0 2.835707313408875e-08
death I-Disease 0 6.319601197901648e-08
. O 0 4.4684835387442945e-08

To O 0 1.4950959359438798e-09
test O 0 2.981598024032195e-10
for O 0 7.221727989920046e-12
possible O 0 1.7885390946048574e-09
nosologic O 0 1.980359957087785e-05
identity O 0 4.227258820765911e-10
between O 0 3.99178815002621e-11
these O 0 1.3977399793141387e-10
disorders O 0 7.399652557360525e-10
, O 0 8.420118443631941e-13
we O 0 6.884291314096513e-13
reviewed O 0 1.1834357938056428e-09
the O 0 3.791934474750569e-11
literature O 0 2.3473362142922838e-11
and O 0 2.5965857678518674e-14
obtained O 0 3.6965672493491364e-13
a O 0 3.524744989695343e-14
follow O 0 9.821614875560325e-12
- O 0 2.2802816926348335e-11
up O 0 1.5094382341263035e-11
of O 0 1.8443264276912785e-11
the O 0 7.298220187912374e-12
only O 0 1.6378226899704806e-12
two O 0 1.6451606515890255e-13
surviving O 0 2.2550508127494595e-09
patients O 0 8.98828815820707e-08
, O 0 2.200429422005712e-11
one O 0 1.917631331505021e-11
with O 0 1.3202318578653394e-11
SJS B-Disease 0 3.21711513606715e-06
type I-Disease 0 1.2322160500843893e-06
2 I-Disease 0 2.7926969181635286e-08
at O 0 4.063979361368375e-11
age O 0 2.8807503604788565e-10
10 O 0 2.7014621008930595e-12
years O 0 1.5058832002548539e-12
and O 0 6.763690085440088e-13
another O 0 2.0653652399449385e-12
with O 0 9.523394225996462e-12
SWS B-Disease 0 4.438995347300079e-06
at O 0 1.7746365488235938e-10
age O 0 4.446198076379915e-09
7 O 0 2.1870087962838625e-09
years O 0 1.9365653525227344e-10
. O 0 2.5544448778447304e-09

Patients O 0 8.131295908242464e-05
reported O 0 2.4593974079500924e-10
as O 0 5.3914381639708076e-12
having O 0 2.267236572095488e-11
either O 0 5.386471269019921e-09
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 7.967848068801686e-05
SWS B-Disease 0 2.72357228823239e-05
presented O 0 7.10382837623702e-12
a O 0 4.1117346716811314e-15
combination O 0 2.40785798417964e-13
of O 0 4.7567066388184975e-14
a O 0 3.620092439249149e-14
severe O 0 8.619890912164863e-10
, O 0 4.280856918947862e-11
prenatal O 1 0.9898266792297363
- O 1 0.9454206824302673
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 2.9819404723241405e-09
with O 0 2.970009349567704e-09
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9970923662185669
respiratory O 1 1.0
and O 0 0.04857597127556801
feeding O 1 0.9988662004470825
difficulties O 0 1.4309665857581422e-05
, O 0 1.8770515697319468e-10
tendency O 0 1.7358373627374135e-09
to O 0 1.1974309044315845e-10
hyperthermia B-Disease 0 0.047165270894765854
, O 0 9.438871559352968e-12
and O 0 2.2464560593682403e-13
frequent O 0 6.734465551406013e-14
death O 0 3.3296386481307394e-11
in O 0 3.719251642775312e-11
infancy O 0 2.449297653583926e-08
) O 0 1.0227078346247264e-14
with O 0 2.674046803823331e-15
a O 0 3.460840284057881e-13
distinct O 0 8.966978826130401e-10
campomelic B-Disease 0 0.009829484857618809
- I-Disease 1 0.9964340925216675
metaphyseal I-Disease 1 0.9326980710029602
skeletal I-Disease 1 0.9999655485153198
dysplasia I-Disease 1 1.0
. O 0 0.00013183214468881488

The O 0 1.9487680358309944e-09
similarity O 0 7.3689099266971425e-09
of O 0 3.720823649189242e-09
the O 0 1.7289578657653237e-09
clinical O 0 6.369516469817427e-09
and O 0 6.684056780281722e-11
radiographic O 0 8.363692177226767e-05
findings O 0 7.073736924212426e-06
is O 0 2.4589094649307697e-10
so O 0 1.0518981519158643e-11
extensive O 0 9.62647322966248e-11
that O 0 2.7507690136124863e-12
these O 0 3.3488401385284305e-08
disorders O 0 7.474134804397181e-07
appear O 0 3.0401757555864606e-08
to O 0 2.157523465440292e-11
be O 0 7.557890945031343e-12
a O 0 7.041920865868967e-12
single O 0 2.638628482376504e-10
entity O 0 1.0061948607642535e-08
. O 0 5.823256188364212e-08

The O 0 3.35776917381736e-08
follow O 0 5.41031841549966e-09
- O 0 2.2542121502766577e-09
up O 0 1.6645740341658666e-11
observation O 0 1.655674070066837e-10
of O 0 3.7287230594817977e-13
an O 0 1.55262219198721e-15
identical O 0 1.871959358357156e-11
and O 0 1.3360101870293906e-12
unique O 0 6.6672969228909196e-12
pattern O 0 2.8821437680903728e-08
of O 0 2.0109716558636137e-07
progressive O 1 1.0
bone B-Disease 1 0.9999651908874512
dysplasia I-Disease 1 0.853384792804718
in O 0 8.830051356767399e-09
the O 0 3.2973346275610993e-09
two O 0 2.4611934018592407e-11
patients O 0 2.6868978153515855e-09
( O 0 3.819978662274008e-14
one O 0 2.6996371175862233e-13
with O 0 1.06211656765616e-13
SJS B-Disease 0 6.231731930483875e-08
type I-Disease 0 1.1194275728598768e-08
2 I-Disease 0 4.041474266358591e-09
, O 0 8.288690914182162e-13
one O 0 6.531331465248202e-13
with O 0 1.2776656902607764e-12
SWS B-Disease 0 1.9814793006389664e-07
) O 0 4.316798112545539e-13
surviving O 0 2.596151738032404e-09
beyond O 0 1.4254975155836291e-07
infancy O 0 2.8563928822222806e-07
adds O 0 3.788529559511922e-11
to O 0 1.8957990559342885e-12
the O 0 3.958901782785684e-12
evidence O 0 1.7958901726844445e-11
in O 0 7.892687371724438e-12
favor O 0 4.132598263595355e-09
of O 0 2.2010224198787398e-10
identity O 0 3.463600961595148e-09
. O 0 5.951350523503152e-09

The O 0 5.527478563749355e-08
hypothesis O 0 4.962366233485227e-07
that O 0 1.4039816531585814e-10
SWS B-Disease 0 0.00026020430959761143
and O 0 9.344158780066891e-10
SJS B-Disease 0 0.0002876383950933814
type I-Disease 0 2.1856312741874717e-06
2 I-Disease 0 8.544844831703813e-08
are O 0 5.385946679967168e-13
the O 0 6.368085746222274e-12
same O 0 2.995702130803579e-09
disorder O 0 1.2935450968143414e-06
should O 0 1.056166890056609e-10
be O 0 3.2710036068639425e-11
testable O 0 3.24918758565218e-09
by O 0 7.400032192919626e-14
molecular O 0 1.2637538585047459e-12
methods O 0 1.125725693218449e-10
. O 0 6.883799086310205e-11
. O 0 1.8291240744261472e-09

A O 0 1.7384782502460894e-09
mouse O 0 1.2367051827055775e-10
model O 0 1.4888785733815912e-12
of O 0 8.55717493392083e-12
severe O 1 0.9998041987419128
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 4.955521490046522e-06
defects O 0 0.25622594356536865
in O 0 1.9212073709695687e-08
hemostasis O 0 0.15319673717021942
and O 0 6.767691740350301e-09
thrombosis B-Disease 0 0.00016030627011787146
. O 0 1.8741276619493874e-07

von B-Disease 0 0.0004403259954415262
Willebrand I-Disease 0 0.03714485093951225
factor I-Disease 0 1.901487667055335e-05
( I-Disease 0 3.1559810764747454e-08
vWf I-Disease 1 0.9846329689025879
) I-Disease 0 1.0066383993034833e-06
deficiency I-Disease 1 1.0
causes O 1 0.9890483021736145
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.043798141181468964
humans O 0 1.7340224189865694e-07
. O 0 9.67858504452579e-09

We O 0 1.940511751286067e-09
generated O 0 1.9649955274037012e-10
a O 0 1.423258104253644e-12
mouse O 0 3.729615921654883e-11
model O 0 1.8995163515028723e-12
for O 0 4.210089037375714e-13
this O 0 2.845287026820298e-11
disease O 0 1.0793241855822089e-09
by O 0 1.0262735973542991e-11
using O 0 1.416016470745518e-10
gene O 0 2.2203933136566434e-10
targeting O 0 2.9532547518584806e-09
. O 0 3.204665688372188e-08

vWf B-Disease 1 0.9999779462814331
- I-Disease 1 1.0
deficient I-Disease 1 1.0
mice O 0 1.4469120287685655e-05
appeared O 0 3.065924403244935e-09
normal O 0 2.9175679649995345e-09
at O 0 2.074901882254121e-11
birth O 0 1.896724111105641e-09
; O 0 6.6342638847805e-12
they O 0 2.8619513443156608e-12
were O 0 1.9868505451992036e-10
viable O 0 1.2632220602881716e-07
and O 0 3.193910136367606e-10
fertile O 0 2.424097374387202e-06
. O 0 9.943850187710268e-09

Neither O 0 2.0620984287234023e-05
vWf O 0 0.00021215602464508265
nor O 0 1.5299152437364683e-05
vWf O 0 0.0002843845577444881
propolypeptide O 0 0.000538306194357574
( O 0 2.1656600956987404e-09
von B-Disease 0 0.00018901287694461644
Willebrand I-Disease 0 0.00011058185191359371
antigen O 0 1.3874523574486375e-06
II O 1 1.0
) O 0 2.213441652187953e-10
were O 0 1.9216891966600258e-10
detectable O 0 1.0548251161424105e-08
in O 0 3.7062974217461075e-12
plasma O 0 1.1803513721986292e-10
, O 0 6.771048023483661e-13
platelets O 0 9.022616542786466e-10
, O 0 1.6519218718619166e-12
or O 0 1.3733339552374213e-12
endothelial O 0 8.399150264182254e-10
cells O 0 1.8508827803742633e-09
of O 0 9.159087377419439e-11
the O 0 2.147467093038813e-09
homozygous O 0 7.613247277049595e-08
mutant O 0 6.769772085135628e-07
mice O 0 2.0681807200162439e-07
. O 0 8.463479694853504e-09

The O 0 5.290714852890233e-07
mutant O 0 1.8342766452406067e-06
mice O 0 5.292536897627542e-08
exhibited O 0 7.144522751190152e-09
defects O 0 3.8664055068693415e-07
in O 0 1.8108683441653284e-09
hemostasis O 0 4.631270257959841e-06
with O 0 6.3624400886697074e-12
a O 0 8.193633271869061e-11
highly O 0 3.3477724628028227e-06
prolonged O 0 0.03630682826042175
bleeding O 0 0.02066836878657341
time O 0 1.0280151485630995e-07
and O 0 2.8453237987946522e-08
spontaneous O 0 9.500567443865293e-07
bleeding O 0 2.9002974244463076e-08
events O 0 8.509080592911111e-12
in O 0 1.114820909198233e-12
approximately O 0 3.748339529388578e-13
10 O 0 2.3492520862672395e-12
% O 0 1.0330878947445443e-12
of O 0 3.07891754626477e-12
neonates O 0 7.6477689958665e-08
. O 0 3.6798688540784497e-08

As O 0 6.004789443458947e-10
in O 0 1.0229668674643921e-11
the O 0 4.578919274994542e-12
human O 0 2.3113397046997664e-12
disease O 0 1.0272826339585706e-10
, O 0 2.1346154553160412e-13
the O 0 3.71298391338426e-12
factor O 0 1.1350007739219237e-10
VIII O 0 0.06417298316955566
level O 0 2.037131480392418e-06
in O 0 1.6174970252080811e-09
these O 0 2.699213907941811e-10
mice O 0 7.703801485625661e-11
was O 0 1.4523353873696632e-11
reduced O 0 1.1331129368130632e-09
strongly O 0 2.2943349997639473e-10
as O 0 2.6055234358945967e-12
a O 0 2.1666349270255125e-13
result O 0 1.7121280088128188e-11
of O 0 1.100342733595383e-10
the O 0 2.2188607895490264e-10
lack O 0 7.671388857488637e-09
of O 0 2.0773412504060396e-11
protection O 0 1.6604662089747535e-09
provided O 0 2.7334794150402075e-11
by O 0 5.0362568282391607e-11
vWf O 0 3.242440243411693e-06
. O 0 8.955790775644346e-08

Defective O 1 0.9998849630355835
thrombosis B-Disease 1 0.9999997615814209
in O 0 6.736951831953775e-07
mutant O 0 2.4899105710574077e-07
mice O 0 4.635570594047067e-09
was O 0 8.308913279631014e-11
also O 0 1.2859292623790264e-12
evident O 0 1.4060378417113384e-09
in O 0 1.3858248316261923e-12
an O 0 2.1045916355819485e-15
in O 0 1.7750400758617668e-13
vivo O 0 1.3841188611918298e-11
model O 0 2.4515981258965702e-11
of O 0 5.806306546674023e-09
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.002278062282130122

In O 0 5.544649808730817e-11
this O 0 4.385413473334543e-13
model O 0 1.5071598483129556e-11
, O 0 7.105586193219271e-13
the O 0 1.842635072302201e-11
exteriorized O 0 1.4191916761774337e-06
mesentery O 0 5.113035967951873e-06
was O 0 4.4192192127923136e-09
superfused O 0 1.094846425075957e-06
with O 0 6.902403648645361e-11
ferric O 0 2.0643669813580345e-06
chloride O 0 3.636498320247483e-07
and O 0 2.322656511566379e-09
the O 0 3.794115688293687e-09
accumulation O 0 8.016556421353016e-06
of O 0 5.289519222628769e-08
fluorescently O 0 1.5303618056350388e-05
labeled O 0 3.9746392843653666e-08
platelets O 0 4.822311439056648e-08
was O 0 1.495351897862207e-10
observed O 0 3.546789251185345e-11
by O 0 9.248542036377483e-12
intravital O 0 4.278104484001233e-07
microscopy O 0 3.5140899967700534e-07
. O 0 4.9001204871501614e-08

We O 0 6.394275331444987e-09
conclude O 0 1.4989399943488024e-08
that O 0 1.1968404782861097e-12
these O 0 1.5781017118077223e-11
mice O 0 3.248498137153888e-10
very O 0 7.652481946729406e-12
closely O 0 2.594749137774244e-10
mimic O 0 1.1794382004381987e-07
severe O 0 5.070386760053225e-05
human O 1 0.9733449816703796
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 5.248315915196144e-07
will O 0 6.248410122644543e-11
be O 0 8.976500966151324e-12
very O 0 1.3274805516980126e-12
useful O 0 2.097380835631643e-13
for O 0 6.526418081231064e-15
investigating O 0 3.52623963015275e-13
the O 0 1.3187865513172858e-12
role O 0 2.8211786205767364e-12
of O 0 9.197531625204647e-11
vWf O 0 5.240693567998278e-08
in O 0 5.2218201984644e-10
normal O 0 3.6815370094700484e-06
physiology O 0 6.5689015116277e-08
and O 0 4.5831307499133445e-12
in O 0 1.3657409404788101e-11
disease O 0 2.9509222843060456e-10
models O 0 8.426413455886461e-10
. O 0 1.5756550508783107e-09
. O 0 2.0175674464439908e-08

Oral O 0 9.097498150367755e-06
contraceptives O 0 4.472482544315426e-07
and O 0 2.1650994799088386e-12
the O 0 3.5379921214939714e-11
risk O 0 2.5888206778290623e-07
of O 0 0.307433545589447
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.268668933742447e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 1.3041124475421384e-05
Study O 0 1.2141332383919234e-08
Group O 0 1.6813013481442596e-10
. O 0 9.234961129145347e-10

BACKGROUND O 0 0.0004954185569658875
Women O 0 4.733402003687104e-10
with O 0 5.759022815923776e-13
mutations O 0 1.0042568339418967e-11
in O 0 3.700499975889393e-11
either O 0 2.0622861196528675e-09
the O 0 6.058184709445413e-08
BRCA1 O 0 2.1820058648813756e-08
or O 0 1.707987307142389e-09
the O 0 2.1979202458055624e-08
BRCA2 O 0 2.5414981230653666e-09
gene O 0 1.3736011026527217e-12
have O 0 2.0249865898143947e-14
a O 0 2.016468657090216e-14
high O 0 1.1106578157171754e-10
lifetime O 0 1.493368873006773e-09
risk O 0 2.0263688327304408e-07
of O 0 0.01384498830884695
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4244294277432346e-07

Oral O 0 0.002640174701809883
contraceptives O 0 0.38696008920669556
protect O 0 4.800287570105866e-06
against O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.041893373444964e-09
general O 0 4.2374992403892975e-08
, O 0 2.039572156997682e-11
but O 0 6.780744368772851e-12
it O 0 2.577751651456489e-13
is O 0 1.105459108041891e-13
not O 0 4.071151781578214e-13
known O 0 2.2627219542492583e-11
whether O 0 1.3891474082150523e-10
they O 0 2.5378540935427907e-10
also O 0 1.8177806482277958e-11
protect O 0 3.5271310178108806e-11
against O 0 3.4614330846061137e-10
hereditary B-Disease 1 0.9179288744926453
forms I-Disease 1 1.0
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1471905025928208e-07

METHODS O 0 5.266255129754427e-07
We O 0 2.5544351078821137e-09
enrolled O 0 7.168901916543291e-09
207 O 0 2.890227501772813e-10
women O 0 1.912272206902599e-12
with O 0 2.007400148884564e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.742199952694314e-11
161 O 0 1.5709460121637875e-10
of O 0 8.722010613748665e-11
their O 0 5.300555550036279e-09
sisters O 0 1.4050706376167454e-08
as O 0 1.3854500879872944e-11
controls O 0 1.268459365322272e-10
in O 0 1.7780577357684457e-11
a O 0 3.0250034248335833e-12
case O 0 2.6815016873626973e-09
- O 0 2.1676356265487584e-09
control O 0 1.5812940956649868e-09
study O 0 9.855473381836788e-11
. O 0 3.5883396254376976e-10

All O 0 8.32597457645079e-09
the O 0 1.5374972406334564e-09
patients O 0 1.276087013835081e-09
carried O 0 2.2568633160219287e-12
a O 0 1.8786067265599143e-13
pathogenic O 0 2.7335291807872864e-09
mutation O 0 3.494196931796978e-09
in O 0 4.3881814848489853e-10
either O 0 3.6946996573306023e-09
BRCA1 O 0 6.742605584975081e-09
( O 0 3.166627116774068e-13
179 O 0 4.967352085216703e-10
women O 0 2.607626571268784e-12
) O 0 6.02066356839015e-13
or O 0 6.375809324943305e-10
BRCA2 O 0 1.8358811360030813e-08
( O 0 4.232353183197812e-12
28 O 0 4.940710596201825e-08
women O 0 6.771222471613214e-11
) O 0 6.458148685967169e-12
. O 0 1.995255738407309e-09

The O 0 8.104768767225323e-08
control O 0 3.4522255276669966e-08
women O 0 4.251757626527741e-11
were O 0 8.200074647080058e-11
enrolled O 0 1.673303440252738e-10
regardless O 0 1.380549841112355e-10
of O 0 3.744698995333806e-11
whether O 0 4.464685565697124e-11
or O 0 1.3431247780637534e-10
not O 0 6.145520897726797e-11
they O 0 2.03588090830209e-10
had O 0 7.033713056436852e-10
either O 0 4.799570518798646e-09
mutation O 0 1.212668365724312e-08
. O 0 1.0897856839164888e-08

Lifetime O 0 9.535201570542995e-06
histories O 0 1.0196566790909856e-06
of O 0 9.22551102178204e-09
oral O 0 3.8124787238302815e-07
- O 0 3.517245827922011e-09
contraceptive O 0 3.958077421373218e-09
use O 0 2.5079977157560496e-12
were O 0 3.4461264137447545e-12
obtained O 0 6.209982614940879e-12
by O 0 1.7228849640352206e-12
interview O 0 3.565550632522729e-11
or O 0 1.3708137272874787e-12
by O 0 3.74393793961883e-13
written O 0 3.3299482962712013e-12
questionnaire O 0 4.599530934075446e-13
and O 0 1.5131284761401784e-14
were O 0 1.7763407118929347e-13
compared O 0 4.4858947285952855e-12
between O 0 5.8182261092332155e-12
patients O 0 6.405395769348843e-09
and O 0 7.758681717928706e-12
control O 0 3.7224134885605054e-09
women O 0 1.5604869826879586e-11
, O 0 1.2084652939794993e-13
after O 0 2.8726868973871778e-12
adjustment O 0 3.0785565763302714e-10
for O 0 4.349759213841814e-13
year O 0 1.4167153561395196e-11
of O 0 4.234907216571493e-11
birth O 0 1.872815680314943e-08
and O 0 1.3921951091955265e-10
parity O 0 8.108959548280836e-08
. O 0 1.5626635985199755e-08

RESULTS O 0 8.671150197869792e-08
The O 0 7.127287648955871e-10
adjusted O 0 5.2977277675836376e-08
odds O 0 2.6475703407413675e-07
ratio O 0 1.2094526482542278e-06
for O 0 5.4788247325632256e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.6165334343630775e-09
with O 0 1.755311716290786e-12
any O 0 8.986390104270825e-11
past O 0 5.2861326427233735e-11
use O 0 5.4610703979773856e-12
of O 0 3.673180509755625e-11
oral O 0 1.4368719547519504e-08
contraceptives O 0 1.3752318395177099e-08
was O 0 3.288207484075656e-10
0 O 0 1.0722698284837406e-09
. O 0 2.843899560289742e-10

5 O 0 8.64786144916252e-08
( O 0 2.8502188456625e-11
95 O 0 1.019738888885513e-07
percent O 0 4.057423286241146e-09
confidence O 0 1.4202774512028782e-09
interval O 0 1.3462897463512036e-10
, O 0 1.217084701250759e-12
0 O 0 7.296591282568432e-12
. O 0 1.9070734032754222e-13
3 O 0 2.0155710867691967e-12
to O 0 8.038058066373033e-13
0 O 0 4.270239023496103e-11
. O 0 5.3597252504256065e-12
8 O 0 1.6223068721732403e-10
) O 0 2.008142133483326e-12
. O 0 8.909883386643003e-10

The O 0 2.991284375752912e-08
risk O 0 4.5804111614700105e-09
decreased O 0 1.2702274787557144e-09
with O 0 1.773791210484335e-13
increasing O 0 1.3994011678619689e-11
duration O 0 1.074759614638765e-09
of O 0 1.2964952028626797e-11
use O 0 3.81117845615897e-11
( O 0 2.1393936969205107e-12
P O 0 2.894754302928959e-08
for O 0 5.224484907195848e-12
trend O 0 8.330164891212632e-10
, O 0 1.4507779743169746e-13
< O 0 5.650868661888353e-12
0 O 0 1.2579725672604014e-12
. O 0 6.201123463464228e-14
001 O 0 2.3879728489745178e-12
) O 0 3.1832091080879685e-16
; O 0 1.1891249906948419e-15
use O 0 4.8309504318980526e-14
for O 0 5.305642535556598e-13
six O 0 1.0293357312340934e-11
or O 0 5.667707188988791e-12
more O 0 5.606376365756283e-13
years O 0 1.134837232866226e-12
was O 0 2.095022939851976e-12
associated O 0 7.729716172688583e-12
with O 0 2.919733140156755e-13
a O 0 1.1687462629639267e-11
60 O 0 3.995560826641764e-10
percent O 0 1.804735701160798e-11
reduction O 0 1.1891218010262605e-09
in O 0 6.436597921322118e-10
risk O 0 7.06518221704755e-08
. O 0 1.0252913540398367e-07

Oral O 0 0.00010841304901987314
- O 0 2.668152092155651e-06
contraceptive O 0 1.769000050444447e-06
use O 0 1.3326070247288158e-09
protected O 0 6.146674422780052e-05
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 8.3490415969667e-11
for O 0 6.009156930733561e-13
carriers O 0 6.525394807832541e-12
of O 0 2.454737628443393e-11
the O 0 8.263052464485554e-10
BRCA1 O 0 7.410414504249729e-10
mutation O 0 2.507257595985024e-11
( O 0 5.434112090429294e-14
odds O 0 6.371700389529167e-10
ratio O 0 4.6479695092749296e-11
, O 0 1.505511888115832e-13
0 O 0 5.252668959510043e-13
. O 0 3.234253685181765e-14
5 O 0 9.669524295846665e-13
; O 0 2.2128472827991769e-13
95 O 0 2.5624771193832885e-09
percent O 0 6.422090637059341e-10
confidence O 0 5.844124628673342e-10
interval O 0 1.1197084232028587e-10
, O 0 1.8171245758091814e-12
0 O 0 5.9962338913588376e-12
. O 0 2.2777366472971627e-13
3 O 0 4.6411637553978036e-12
to O 0 1.120666493631406e-12
0 O 0 2.4070521617569618e-11
. O 0 1.7393744864563354e-12
9 O 0 3.592062758350778e-11
) O 0 1.5519420668822122e-14
and O 0 1.832444650661999e-13
for O 0 1.7056171199795328e-13
carriers O 0 5.40021950767855e-11
of O 0 7.377358168803028e-10
the O 0 2.0651967247431458e-07
BRCA2 O 0 1.0550367335326882e-07
mutation O 0 7.498238696612702e-10
( O 0 9.141730341472032e-13
odds O 0 3.4943101745454896e-09
ratio O 0 1.26861909865994e-10
, O 0 1.3459564951294467e-13
0 O 0 6.054451102792402e-13
. O 0 5.0661830009986544e-14
4 O 0 2.953582690923273e-12
; O 0 6.942441955516687e-13
95 O 0 7.175290583916194e-09
percent O 0 8.867954703895009e-10
confidence O 0 4.4714201785645e-10
interval O 0 9.789339477928038e-11
, O 0 1.564921261153207e-12
0 O 0 7.646834554453363e-12
. O 0 3.714264139309531e-13
2 O 0 2.7252421239826186e-12
to O 0 3.5210579569198985e-13
1 O 0 9.124875854915615e-11
. O 0 4.750845116613389e-12
1 O 0 6.278434439010994e-10
) O 0 4.579355991629619e-12
. O 0 1.6182284401367042e-09

CONCLUSIONS O 0 0.0002702188503462821
Oral O 0 1.8076058040605858e-05
- O 0 1.4998752462247467e-08
contraceptive O 0 1.680766748002327e-09
use O 0 3.363041724442628e-13
may O 0 1.5662770559699002e-12
reduce O 0 2.0535505587671032e-11
the O 0 3.8533534002516134e-11
risk O 0 1.7688942932636564e-07
of O 0 0.36036378145217896
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.016110972087205e-10
women O 0 3.245551342869607e-13
with O 0 4.6273232031583504e-15
pathogenic O 0 5.539262382114885e-10
mutations O 0 2.8410584995697263e-10
in O 0 8.377051829988602e-11
the O 0 1.75238472621686e-08
BRCA1 O 0 5.566242293753021e-07
or O 0 3.0837671260997013e-07
BRCA2 O 0 2.1389732864918187e-06
gene O 0 6.459972468064734e-08

A O 0 1.0200380984315416e-08
Japanese O 0 3.0547016649506986e-07
family O 0 1.308251174059194e-09
with O 0 3.9147220187718546e-11
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.6379889512282446e-11
a O 0 6.951724612624943e-11
codon O 0 1.7827806786385736e-08
291 O 0 4.543691201064348e-09
deletion O 0 1.6093044952203428e-10
: O 0 2.6062712507905414e-14
a O 0 1.7482131532881896e-14
clinical O 0 7.774176268016131e-12
, O 0 1.0938500132800025e-13
biochemical O 0 2.950214517127847e-09
, O 0 9.96076745390928e-12
pathological O 0 8.230222192651127e-06
, O 0 1.5015538812335194e-10
and O 0 2.248602970489344e-10
genetic O 0 1.135263882900972e-08
report O 0 3.651007274285689e-09
. O 0 5.672520586585961e-08

We O 0 1.2224975198815713e-10
report O 0 1.722595915736036e-12
a O 0 5.888533069356786e-14
Japanese O 0 3.5635264183930815e-10
family O 0 9.707324527541417e-11
with O 0 2.531548581874432e-11
adrenoleukodystrophy B-Disease 1 1.0
( O 0 3.3598318793792714e-08
ALD B-Disease 1 1.0
) O 0 3.76960658868275e-12
with O 0 1.7443270677701406e-13
a O 0 1.8853813909397443e-12
three O 0 2.544530558479252e-12
base O 0 2.3791602021816516e-10
pair O 0 9.370573206268773e-10
deletion O 0 3.504848078428324e-10
( O 0 1.5067824375367134e-12
delGAG O 0 5.704234240511141e-08
291 O 0 2.399059839675033e-10
) O 0 7.556672301789469e-14
in O 0 3.5064629151648763e-12
the O 0 1.1100405039599082e-08
ALD B-Disease 1 1.0
gene O 0 8.436581993009895e-07
. O 0 6.128054792498006e-07

A O 0 1.879314481811889e-07
variety O 0 6.1190585931569785e-09
of O 0 4.272163733887169e-10
phenotypes O 0 2.9539265256062208e-08
were O 0 1.3908044160793054e-10
observed O 0 4.346711532376979e-11
within O 0 3.584883084828405e-11
this O 0 4.669562306269803e-11
family O 0 7.345906105626909e-10
. O 0 8.98009311356418e-09

While O 0 4.330213687619988e-10
the O 0 2.5973290185277165e-10
proband O 0 2.4746846975176595e-05
( O 0 6.618103287614474e-11
patient O 0 1.6452015643153572e-06
1 O 0 4.668560649179199e-09
) O 0 3.453592934635902e-13
was O 0 1.438202890113871e-10
classified O 0 2.125993603385723e-09
as O 0 1.1409109074156376e-10
having O 0 2.2516918884996073e-11
a O 0 1.2539145069490054e-12
rare O 0 2.864596060359048e-11
intermediate O 0 1.2722156661482131e-09
type O 0 1.290722251301446e-10
of O 0 2.0649970622343972e-10
adult O 0 2.6997197810629814e-09
cerebral O 0 4.189632463180715e-08
and O 0 1.3236010898420858e-10
cerebello O 0 1.6692077906554914e-06
- O 0 2.399845584477589e-07
brain O 0 7.585966699252822e-08
stem O 0 2.33845476316219e-09
forms O 0 1.4119871938333972e-10
, O 0 4.3911386029063526e-13
his O 0 3.522512143083745e-11
younger O 0 5.239094136300082e-08
brother O 0 4.3590056009179534e-08
( O 0 3.083019299923717e-12
patient O 0 1.4909334211665737e-08
2 O 0 1.8841348620179943e-11
) O 0 1.3814266266001015e-14
and O 0 5.935934469653015e-12
nephew O 0 1.2667943565247697e-06
( O 0 7.05472277817698e-11
patient O 0 0.0002514295047149062
3 O 0 5.772692990291262e-09
) O 0 7.102076630786935e-13
had O 0 6.607898256349998e-11
a O 0 2.2989168901865753e-10
childhood O 0 1.560452437843196e-05
ALD B-Disease 1 1.0
type O 0 0.02435457706451416
. O 0 1.8929719090010622e-06

Another O 0 1.0688872009723127e-07
nephew O 0 0.0002488231984898448
( O 0 3.058575059888824e-10
patient O 0 3.0900102956366027e-06
4 O 0 9.109109577742913e-10
) O 0 7.535140724270264e-14
of O 0 1.7362537796383748e-10
patient O 0 5.615727059193887e-05
1 O 0 1.2493744350194902e-07
was O 0 1.301111662854737e-09
classified O 0 1.340681787809217e-08
as O 0 4.301033418308009e-10
having O 0 3.6495781396972404e-10
an O 0 4.0849212033788884e-12
adolescent O 0 3.0752951296619813e-09
form O 0 2.832941936592448e-10
. O 0 7.327563888992472e-09

The O 0 6.5068244126109676e-09
tau O 0 7.90103982239998e-10
level O 0 1.3749970606546924e-10
in O 0 3.758607574483319e-12
the O 0 5.327012789213548e-11
cerebrospinal O 0 3.0515723281610008e-09
fluid O 0 4.783196416724422e-08
( O 0 8.90760173954952e-11
CSF O 0 7.625104103681224e-07
) O 0 2.1273816042111093e-12
in O 0 1.4740294540516174e-09
patient O 1 0.9889920949935913
1 O 0 1.6703830851838575e-06
was O 0 4.535692710305739e-08
as O 0 5.005079128928003e-10
high O 0 3.1481877105221656e-09
as O 0 4.821469083899667e-14
that O 0 1.0185219672059851e-15
of O 0 8.777776682594718e-13
patients O 0 3.8302952476421126e-10
with O 0 1.215530974485457e-11
Alzheimers B-Disease 1 0.9999994039535522
disease I-Disease 0 3.119919938399107e-06
( O 0 6.082139999974423e-12
AD B-Disease 0 3.400043624424143e-07
) O 0 2.5675527676183307e-11
. O 0 2.7701276827940546e-09

His O 0 5.665610274263599e-07
brain O 0 6.865569446290465e-08
magnetic O 0 2.241052143858724e-08
resonance O 0 8.781717042438686e-08
image O 0 6.513396044738329e-08
( O 0 1.184146392052554e-10
MRI O 0 1.0297180779161863e-05
) O 0 2.17700163451795e-11
showed O 0 3.2168859243064674e-10
abnormalities B-Disease 0 6.058830326338693e-09
in I-Disease 0 8.406290420703844e-12
the I-Disease 0 1.0276256234842407e-10
bilateral I-Disease 0 0.00016869232058525085
cerebellar I-Disease 1 1.0
hemispheres I-Disease 0 0.006407715380191803
and O 0 4.110354439035291e-07
brain O 0 7.326811868324512e-08
stem O 0 4.6731845060321575e-09
, O 0 1.666478370229707e-13
but O 0 1.7922338960141282e-13
not O 0 3.347950443353259e-13
in O 0 4.340743910147271e-12
the O 0 9.376897175394916e-11
cerebral O 0 9.211428064759275e-09
white O 0 7.940454960220222e-10
matter O 0 7.472211738246415e-10
, O 0 2.272090156264176e-14
where O 0 5.690054784496853e-15
marked O 0 1.41332136423776e-13
reductions O 0 2.507397622864005e-10
of O 0 2.263517290268524e-10
the O 0 1.8780124122486086e-09
cerebral O 0 2.996949888256495e-07
blood O 0 7.72302612972453e-08
flow O 0 6.986694245370018e-08
and O 0 1.2030486329361878e-10
oxygen O 0 7.250335443131917e-09
metabolism O 0 8.10362479342075e-08
were O 0 3.4249059144286775e-10
clearly O 0 2.3535601245683324e-10
demonstrated O 0 2.2146357664398764e-11
by O 0 4.956718195614496e-12
positron O 0 4.5431043815824523e-08
emission O 0 2.1446034281780157e-07
tomography O 0 2.153821924366639e-06
( O 0 2.7121155321552237e-10
PET O 0 5.726462404709309e-06
) O 0 2.3543309662921175e-11
. O 0 6.142020780863788e-10

In O 0 9.26383094679295e-08
patients O 0 9.494100936535688e-07
2 O 0 8.440411036758633e-09
and O 0 5.115917411924187e-11
3 O 0 1.5646490769682941e-09
, O 0 6.898828838926285e-13
the O 0 3.025974609771609e-11
autopsy O 0 1.0846661524510637e-07
findings O 0 1.6637828892385187e-08
showed O 0 1.631726309625492e-09
massive O 0 1.7287741016502878e-08
demyelination B-Disease 1 1.0
of I-Disease 0 7.303759048227221e-06
the I-Disease 0 7.512202415682623e-08
cerebral I-Disease 0 3.5334733183844946e-07
white I-Disease 0 3.4746376886829466e-09
matter I-Disease 0 1.921986042541235e-10
with O 0 3.9878760084194505e-15
sparing O 0 1.8125216605380245e-11
of O 0 3.65929481160876e-10
the O 0 1.3253909969535016e-08
U O 0 0.00018053766689263284
- O 0 2.223581986982026e-06
fibers O 0 4.053365216805105e-07
, O 0 9.64845842110762e-11
compatible O 0 1.1217289319631618e-09
with O 0 7.500583135275005e-14
the O 0 2.5714330838255695e-12
findings O 0 1.608660010754548e-10
of O 0 2.677641719461832e-10
childhood O 0 2.007477633014787e-06
ALD B-Disease 1 1.0
. O 0 1.3045810192124918e-06

Oleic O 0 0.004704901482909918
and O 0 3.23837468840793e-07
erucic O 0 0.016468871384859085
acids O 0 1.8926778011518763e-06
( O 0 1.5727237567819685e-10
Lorenzos O 0 9.180608685710467e-06
Oil O 0 3.008168789619958e-07
) O 0 5.926892548795137e-13
were O 0 7.315557014331286e-12
administered O 0 3.864097410100076e-12
to O 0 8.121402855776338e-12
patients O 0 5.901726662926876e-09
1 O 0 1.0914430470521097e-09
and O 0 3.126486569637876e-11
4 O 0 1.209124689260932e-09
, O 0 1.3174616562625086e-12
but O 0 2.0276863955254187e-12
sufficient O 0 1.5241238826568804e-10
effectiveness O 0 6.177807709839556e-10
was O 0 1.1697415258637989e-10
not O 0 1.2979501154419815e-11
obtained O 0 2.2689561340882847e-09
. O 0 9.052804728071351e-09

The O 0 2.364009077382434e-08
findings O 0 1.3143544919103078e-08
in O 0 1.4621337474096663e-10
this O 0 4.358400446102806e-11
family O 0 4.5139291610096777e-11
suggest O 0 2.404294645319549e-11
that O 0 4.6868477659002886e-14
delGAG291 O 0 7.898828258134927e-09
is O 0 3.979385451800127e-13
part O 0 1.792029632324832e-12
of O 0 1.567066615359991e-11
the O 0 4.347059864850955e-11
cause O 0 7.667142476464051e-10
of O 0 3.875615661730336e-10
Japanese O 0 5.1153383537894115e-06
ALD B-Disease 1 1.0
with O 0 1.6616312492612195e-10
phenotypic O 0 2.677649213467248e-08
variations O 0 1.0397001233286574e-06
. O 0 3.5634279527130275e-08

Moreover O 0 4.437114569100231e-07
, O 0 1.7061329779521905e-11
although O 0 5.2470137609783585e-12
the O 0 2.093600900282544e-12
scale O 0 6.077321978992245e-10
of O 0 1.0042879722282905e-10
the O 0 3.4118315811459965e-11
study O 0 2.801077512298855e-12
is O 0 1.0934073030397905e-14
limited O 0 1.0559825583400517e-12
, O 0 1.348695867443503e-13
there O 0 1.27460379490546e-12
is O 0 5.027115334253762e-13
a O 0 2.0518855711748607e-12
possibility O 0 4.388895025186912e-09
that O 0 1.8486487340929614e-10
PET O 1 0.9999909400939941
can O 0 1.393923554360299e-08
detect O 0 6.365523290696729e-07
an O 0 3.954926316995788e-11
insidious B-Disease 0 4.689998604590073e-05
lesion I-Disease 0 0.0032156971283257008
which O 0 1.637708857415987e-10
is O 0 5.043453935732467e-12
undetectable O 0 7.943359858764154e-11
by O 0 3.5591824626424184e-12
computed O 0 1.890181167141236e-08
tomogram O 0 1.741013147693593e-05
( O 0 3.765469533401067e-11
CT O 0 2.3235267576637852e-07
) O 0 1.0828011664382187e-12
or O 0 2.4227898333395448e-12
MRI O 0 1.6915696621211396e-09
analysis O 0 1.3408223099517502e-12
, O 0 4.045397168834543e-14
and O 0 1.6522604139902752e-14
that O 0 4.7165017964605985e-15
the O 0 2.0198274476579403e-12
higher O 0 6.687184139764213e-10
level O 0 9.299099684723089e-11
of O 0 2.8429908167232343e-12
tau O 0 1.2761027477770082e-11
reflects O 0 9.963960212466816e-12
the O 0 3.139941377652139e-13
process O 0 2.848589975013027e-10
of O 0 1.0527583249597683e-09
neuronal B-Disease 0 0.0003567180538084358
degeneration I-Disease 1 0.9999995231628418
in O 0 2.4225141714850906e-06
ALD B-Disease 1 1.0
. O 0 7.266755346790887e-06

Lorenzos O 0 6.573006248800084e-05
Oil O 0 1.3453289682274772e-07
should O 0 6.798408190566985e-12
be O 0 2.250513143897681e-13
given O 0 1.920734404858848e-12
in O 0 4.12632845643926e-13
the O 0 1.9531188732296867e-12
early O 0 1.5213248438783467e-09
stage O 0 5.302331906875679e-10
. O 0 5.722205695390947e-11
. O 0 1.4597937303406638e-09

Nonsense O 0 2.888128392442013e-06
mutation O 0 2.0584595361583524e-08
in O 0 8.683240237949974e-10
exon O 0 6.821333897732984e-08
4 O 0 2.4358324246520624e-09
of O 0 4.1051922278212416e-11
human O 0 1.1346652090127307e-10
complement O 0 1.0556748009094008e-07
C9 O 1 0.999994158744812
gene O 0 1.3451045832724162e-09
is O 0 4.978906826755281e-13
the O 0 8.537476823590462e-13
major O 0 4.251238944208424e-11
cause O 0 2.427936740545533e-10
of O 0 5.894025545405412e-11
Japanese O 0 1.212042093357013e-07
complement B-Disease 0 9.733877959661186e-06
C9 I-Disease 1 1.0
deficiency I-Disease 0 0.03161723166704178
. O 0 5.762332762060396e-07

Deficiency B-Disease 1 0.894042432308197
of I-Disease 0 3.246863684580603e-07
the I-Disease 0 1.1581136050153873e-07
ninth I-Disease 0 8.157729098456912e-06
component I-Disease 0 5.654900974150223e-07
of I-Disease 0 6.210824210484134e-08
human I-Disease 0 3.840312068348339e-09
complement I-Disease 0 4.6309423851198517e-07
( O 0 3.528234648886297e-11
C9 O 0 0.0006772380438633263
) O 0 2.7550731878170365e-13
is O 0 1.3325604488400537e-14
the O 0 9.39869181288723e-14
most O 0 1.355962651189424e-12
common O 0 2.1741788813756102e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.7823513775994115e-09
Japan O 0 1.699013152389739e-09
but O 0 1.476830810420715e-11
is O 0 2.357842653760711e-13
rare O 0 8.935214547423076e-12
in O 0 2.2494027040326214e-12
other O 0 1.0869048716610763e-11
countries O 0 2.724651233798614e-11
. O 0 1.1639783359385092e-08

We O 0 1.2277692751361258e-10
studied O 0 8.138585291805889e-12
the O 0 6.076706520787012e-14
molecular O 0 1.296405582711102e-12
basis O 0 6.178511868792924e-11
of O 0 1.2628426082628152e-09
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999762773513794
in O 0 1.7924015605075283e-09
four O 0 4.920697096316706e-12
Japanese O 0 1.5082692428336486e-08
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9123039841651917
deficient I-Disease 0 0.1920996904373169
patients O 0 0.00030173995764926076
who O 0 1.8813312019361206e-10
had O 0 2.416506439395505e-10
suffered O 0 2.5680268578298637e-08
from O 0 1.090285650207079e-06
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.0542202605611237e-07

Direct O 0 6.559384146953562e-09
sequencing O 0 7.633730980671771e-09
of O 0 6.087368387142078e-10
amplified O 0 2.276908084297702e-08
C9 O 0 8.564458767068572e-06
cDNA O 0 2.3051265340967575e-09
and O 0 1.0693032397035562e-11
DNA O 0 1.4586797048021793e-10
revealed O 0 6.63429242098168e-11
a O 0 6.570163792359029e-13
nonsense O 0 2.5141883019941247e-10
substitution O 0 1.348194555994553e-09
( O 0 6.638412692813733e-13
CGA O 0 2.5379620627319355e-09
- O 0 1.602415977686178e-10
- O 0 1.6582181461277656e-10
> O 0 1.3502654550023863e-10
TGA O 0 2.0545829482188083e-09
) O 0 5.664513183598757e-14
at O 0 1.9176121194425244e-12
codon O 0 3.2836743740771723e-11
95 O 0 7.050542927267145e-10
in O 0 6.83546830249071e-11
exon O 0 1.6348414844102876e-09
4 O 0 3.5541727894106145e-10
in O 0 1.756977202616028e-11
the O 0 3.8952915892842555e-10
four O 0 2.6141377951205413e-10
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9684635996818542
deficient I-Disease 0 0.00016419812163803726
individuals O 0 1.6143748560182303e-09
. O 0 1.6251082257667804e-08

An O 0 8.697988163053338e-11
allele O 0 8.880412516454328e-10
- O 0 2.6255958518461853e-10
specific O 0 8.002759566139162e-11
polymerase O 0 1.9545220997230217e-10
chain O 0 3.173057303018645e-11
reaction O 0 3.703524154019533e-10
system O 0 1.1140657285579891e-09
designed O 0 5.244727985243003e-10
to O 0 9.100473152834354e-11
detect O 0 4.687805144065749e-10
exclusively O 0 5.0756017444530954e-11
only O 0 1.490822222616206e-12
one O 0 1.6752583749477662e-13
of O 0 3.655635689991943e-12
the O 0 6.483193148998367e-11
normal O 0 1.3040365232086515e-08
and O 0 1.711812080973374e-10
mutant O 0 4.5956530247970306e-10
alleles O 0 1.595854351443826e-11
indicated O 0 9.284815277732505e-11
that O 0 6.979565037902591e-13
all O 0 2.845936810866312e-12
the O 0 1.3258820256989434e-11
four O 0 1.6249222020009446e-12
patients O 0 5.845548350924545e-11
were O 0 1.4170694132009665e-11
homozygous O 0 6.7200372870501734e-12
for O 0 7.076983530446279e-12
the O 0 1.4071672715942896e-09
mutation O 0 9.946899970358913e-10
in O 0 5.09100361867354e-09
exon O 0 1.5630332583782547e-08
4 O 0 6.236509531021284e-09
and O 0 5.3847889688873884e-12
that O 0 2.43750061367648e-13
the O 0 1.7941176322366914e-10
parents O 0 2.9071953178139154e-10
of O 0 5.849042361560919e-10
patient O 0 8.958983812590304e-07
2 O 0 1.969718255168118e-08
were O 0 1.0733113287031415e-09
heterozygous O 0 1.6195160768006645e-09
. O 0 5.261513003063101e-09

The O 0 6.1900657932767444e-09
common O 0 3.6752518806082435e-09
mutation O 0 7.30503713075592e-10
at O 0 9.564977282439102e-11
codon O 0 6.794072526794537e-10
95 O 0 1.5671766107061558e-08
in O 0 6.55695442386417e-10
exon O 0 9.252473454068877e-09
4 O 0 5.234544464549629e-10
might O 0 9.351850890904068e-12
be O 0 1.4245611526346458e-13
responsible O 0 1.5909453658993766e-12
for O 0 7.911794591870802e-13
most O 0 5.871428343517948e-11
Japanese O 0 1.1603251550695859e-06
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.00018046109471470118
. O 0 5.778608702655674e-09
. O 0 8.336590084923046e-09

BRCA1 O 0 1.5745353465490552e-08
required O 0 2.0398833663892724e-11
for O 0 6.534287867732136e-12
transcription O 0 1.204614079597377e-07
- O 0 8.003448215276876e-07
coupled O 0 1.4785939583816798e-06
repair O 0 9.765007234818768e-06
of O 0 9.305603398956919e-09
oxidative O 0 8.632462413515896e-05
DNA O 0 9.901968587655574e-05
damage O 1 0.8060373663902283
. O 0 1.0676316151148058e-06

The O 0 7.911142347438727e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 0.0001465659443056211
gene O 0 1.4808496651141922e-08
BRCA1 O 0 2.5773060130518388e-08
encodes O 0 3.351422958597361e-11
a O 0 1.1428225553389293e-11
zinc O 0 9.258020128299904e-08
finger O 0 1.490313650265307e-08
protein O 0 1.2282318273548753e-08
of O 0 9.255262334306735e-09
unknown O 0 8.751151625574494e-08
function O 0 2.135352783483313e-09
. O 0 1.852694775372754e-09

Association O 0 4.842016565476115e-08
of O 0 8.455412370267368e-09
the O 0 1.2222749923296305e-08
BRCA1 O 0 6.499155658090672e-10
protein O 0 5.0365833031973395e-11
with O 0 9.985696487356185e-14
the O 0 1.5346069900945558e-11
DNA O 0 1.5460577262871311e-09
repair O 0 6.405239787454775e-07
protein O 0 1.5264442154716562e-08
Rad51 O 0 8.476521884404065e-08
and O 0 3.1051142559967992e-12
changes O 0 1.5086322815993647e-11
in O 0 3.036669223369093e-12
the O 0 1.1207221132028544e-12
phosphorylation O 0 1.552666849258255e-11
and O 0 4.396764202718728e-12
cellular O 0 1.6630951824025964e-11
localization O 0 2.503251161911635e-09
of O 0 1.4024131855805422e-10
the O 0 7.388084588555444e-11
protein O 0 5.931229812849992e-11
after O 0 2.2748308792230887e-10
exposure O 0 1.0780527581744082e-09
to O 0 3.0227095132451254e-11
DNA O 0 1.907070057427518e-09
- O 0 8.405994234017555e-10
damaging O 0 2.146844702011208e-09
agents O 0 1.416767397843799e-10
are O 0 1.5217288150057295e-12
consistent O 0 1.3410991935025596e-11
with O 0 6.739911041520616e-15
a O 0 2.355999781118029e-13
role O 0 2.19918753346926e-11
for O 0 5.202007713478451e-10
BRCA1 O 0 1.4852907348483768e-08
in O 0 1.4142221838042701e-09
DNA O 0 6.532380893986556e-07
repair O 0 0.0693243220448494
. O 0 1.1719936310328194e-06

Here O 0 4.585081114782952e-08
, O 0 1.326061569578707e-11
it O 0 2.446420073898975e-13
is O 0 1.2804072580842318e-13
shown O 0 1.461727874157992e-12
that O 0 5.366607223715458e-13
mouse O 0 8.790125960445039e-09
embryonic O 0 1.1937387398575083e-06
stem O 0 2.1822269502536074e-07
cells O 0 1.1360896223777672e-07
deficient B-Disease 0 2.0189808935811016e-07
in I-Disease 0 2.748726246615263e-10
BRCA1 I-Disease 0 1.1011384859482831e-10
are O 0 1.379381499430274e-13
defective O 0 7.896309162092052e-10
in O 0 5.0433799497762166e-11
the O 0 1.000712290810668e-10
ability O 0 7.958824571607792e-12
to O 0 3.882862781301455e-12
carry O 0 3.0479861690135834e-11
out O 0 4.580159602279865e-12
transcription O 0 3.5603622272617486e-09
- O 0 6.324750501107701e-08
coupled O 0 7.479104624508182e-07
repair O 0 5.309332664182875e-06
of O 0 1.9063099987448595e-09
oxidative O 0 2.3630764189874753e-07
DNA O 0 1.2059593927915557e-06
damage O 0 0.056041643023490906
, O 0 3.693619576861096e-10
and O 0 1.8695196779550116e-10
are O 0 4.3341941147190255e-11
hypersensitive O 0 9.536033189760929e-07
to O 0 9.786431665048667e-10
ionizing O 0 0.00023395461903419346
radiation O 0 0.00023774111468810588
and O 0 3.794017877645217e-11
hydrogen O 0 5.255796242664701e-09
peroxide O 0 4.871298528996704e-07
. O 0 1.5458018864933365e-08

These O 0 9.952312751693171e-09
results O 0 1.2806326665781853e-08
suggest O 0 1.267394189596871e-08
that O 0 1.2992486253526891e-10
BRCA1 O 0 4.793495822497107e-09
participates O 0 1.801049413774347e-11
, O 0 8.67921525122585e-14
directly O 0 2.227477913490511e-13
or O 0 1.2866457031746048e-12
indirectly O 0 9.11999989416934e-12
, O 0 4.450737196327881e-13
in O 0 1.152414275118474e-11
transcription O 0 3.741356806585827e-07
- O 0 6.346227564790752e-06
coupled O 0 2.7954978577326983e-05
repair O 0 4.476683898246847e-05
of O 0 7.360552167767764e-09
oxidative O 0 7.798896035637881e-07
DNA O 0 1.1634143675109954e-06
damage O 0 8.528710168320686e-06
. O 0 4.7447303863634716e-09
. O 0 8.76145200834344e-09

Truncation O 0 7.688568985031452e-06
mutations O 0 2.144762589750826e-08
in O 0 7.949892133485292e-11
the O 0 2.4193752556911363e-10
transactivation O 0 4.096845032108831e-07
region O 0 5.636344724280207e-09
of O 0 3.306908080702442e-09
PAX6 O 0 7.935491885291412e-05
result O 0 1.1187492532371834e-07
in O 0 2.649287011990964e-08
dominant O 0 9.380169103678782e-06
- O 0 2.871176434382505e-07
negative O 0 4.106843221052259e-08
mutants O 0 1.0228420421753981e-07
. O 0 1.2622429768072152e-09

PAX6 O 0 0.008293977938592434
is O 0 9.99537785872917e-10
a O 0 2.4564612496891236e-11
transcription O 0 7.151516268066871e-09
factor O 0 6.112036654570829e-09
with O 0 3.0247265195987305e-12
two O 0 9.734031072503035e-13
DNA O 0 5.01441249634027e-11
- O 0 1.404986127440111e-10
binding O 0 9.249680466005827e-10
domains O 0 9.277632551096815e-10
( O 0 3.271611768388555e-13
paired O 0 6.560675613886957e-12
box O 0 1.1163411861581096e-10
and O 0 1.2068119940866762e-12
homeobox O 0 1.6000978320107606e-10
) O 0 3.4926753058727583e-14
and O 0 7.229662831939598e-13
a O 0 2.5958753376020827e-12
proline O 0 2.9865170336762503e-09
- O 0 6.557482556956984e-09
serine O 0 7.76943380742523e-08
- O 0 1.9653917604500748e-07
threonine O 0 5.182780071777415e-08
( O 0 4.1063801664575905e-12
PST O 0 8.415175898335292e-07
) O 0 9.98812577784891e-12
- O 0 5.1722799376818784e-09
rich O 0 8.305688581344839e-09
transactivation O 0 2.5126385025942e-06
domain O 0 5.2345697554301296e-08
. O 0 8.384013483464514e-09

PAX6 O 1 0.9999957084655762
regulates O 0 0.0028736605308949947
eye O 1 0.9999984502792358
development O 0 7.371260153377079e-07
in O 0 2.7268726165985413e-10
animals O 0 1.2932234449980484e-10
ranging O 0 7.186942707626542e-10
from O 0 3.1223152535675425e-11
jellyfish O 0 5.591690444006758e-10
to O 0 1.622477013851764e-10
Drosophila O 0 7.485253306072082e-09
to O 0 1.289624795841604e-10
humans O 0 3.4160412276662555e-09
. O 0 7.342841890078944e-09

Heterozygous O 0 7.559418122582429e-07
mutations O 0 1.4626371225290313e-08
in O 0 1.059487844679019e-10
the O 0 4.3620868028781956e-10
human O 0 6.155357556991703e-09
PAX6 O 0 0.011393213644623756
gene O 0 6.698906762636625e-09
result O 0 4.729848956941396e-09
in O 0 1.0130415950548866e-10
various O 0 8.227396541826693e-11
phenotypes O 0 6.128753504697215e-09
, O 0 1.4779394071420815e-13
including O 0 5.270502458944171e-13
aniridia B-Disease 1 1.0
, O 0 6.885339520756872e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.2193706044882902e-09
autosomal B-Disease 0 1.5186059499683324e-05
dominant I-Disease 0 3.8119495002320036e-05
keratitis I-Disease 1 0.9988792538642883
, O 0 3.173181495341737e-09
and O 0 1.836192886628396e-08
familial B-Disease 1 0.9999994039535522
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999990463256836

It O 0 6.736393665107698e-10
is O 0 3.0696059843265955e-12
believed O 0 1.7458558470434538e-12
that O 0 2.085675314639039e-14
the O 0 3.222089912588433e-12
mutated O 0 8.270180096303648e-10
allele O 0 2.3610879917868033e-09
of O 0 1.867360932550355e-09
PAX6 O 0 0.00013031408889219165
produces O 0 1.0782742754233965e-10
an O 0 3.062666832924672e-14
inactive O 0 2.0419048396558281e-10
protein O 0 7.52430895367695e-11
and O 0 2.568517620815669e-11
aniridia B-Disease 1 1.0
is O 0 4.5549344851458784e-10
caused O 0 1.786854664231896e-09
due O 0 1.7596952375242836e-06
to O 0 3.649385238446712e-09
genetic O 0 4.192570486338809e-07
haploinsufficiency O 0 0.000167539095855318
. O 0 1.991922573552074e-07

However O 0 1.2360952723611263e-06
, O 0 9.331210248930688e-10
several O 0 9.54824483367922e-11
truncation O 0 3.023336603291682e-08
mutations O 0 9.26497156772399e-10
have O 0 2.2954631251348445e-11
been O 0 5.107179436303344e-12
found O 0 2.929891843462401e-13
to O 0 4.994074069759359e-14
occur O 0 2.9188548279768245e-12
in O 0 4.1449070738164284e-12
the O 0 9.90129506162063e-11
C O 0 3.2565846908028107e-08
- O 0 2.3531379622632187e-10
terminal O 0 2.5307029360988054e-08
half O 0 5.907598715770845e-11
of O 0 2.0242790083058182e-11
PAX6 O 0 1.5027264907985227e-06
in O 0 8.492967440432153e-11
patients O 0 1.510972236218322e-09
with O 0 3.6333843919655884e-12
Aniridia B-Disease 1 1.0
resulting O 0 1.5998025446606334e-06
in O 0 7.509764365920546e-09
mutant O 0 1.1728563675816872e-09
proteins O 0 8.292268781351364e-12
that O 0 1.0732646325492534e-12
retain O 0 8.709277049545605e-11
the O 0 1.0774472460062245e-11
DNA O 0 5.0366794068779086e-11
- O 0 5.8014187204191714e-11
binding O 0 3.365857592640964e-10
domains O 0 2.8583865829823196e-10
but O 0 1.1562348994909044e-10
have O 0 2.4002714746340637e-11
lost O 0 3.7748990044939035e-10
most O 0 1.8092290903284902e-12
of O 0 4.375757135105518e-12
the O 0 2.400702969751478e-10
transactivation O 0 7.833407948965032e-07
domain O 0 9.48847329595992e-08
. O 0 3.587255292814007e-08

It O 0 1.417078260290694e-10
is O 0 9.413085545403876e-13
not O 0 1.3188739380123882e-13
clear O 0 6.790321777083719e-12
whether O 0 1.431217991343381e-12
such O 0 2.482015808158433e-11
mutants O 0 2.4135846388162463e-07
really O 0 1.7504598881501465e-09
behave O 0 7.517610145502118e-11
as O 0 4.215040642907564e-12
loss O 0 2.1286165538536572e-11
- O 0 5.624848156693396e-11
of O 0 2.1810714345704696e-10
- O 0 5.838667771485007e-09
function O 0 6.419041409522208e-10
mutants O 0 1.0293588204035586e-08
as O 0 3.7223015468546006e-12
predicted O 0 1.7209260405604e-10
by O 0 1.4015301072478614e-11
haploinsufficiency O 0 3.476625352050178e-05
. O 0 2.1136189332082722e-07

Contrary O 0 9.892512053966129e-08
to O 0 6.0020695011320235e-12
this O 0 3.577442812471854e-12
theory O 0 1.5804528796792283e-09
, O 0 1.5456984650552563e-12
our O 0 1.1689068116216283e-11
data O 0 1.459054578545338e-11
showed O 0 1.6525876153639096e-11
that O 0 3.373878596207164e-14
these O 0 8.254743243119034e-12
mutants O 0 8.353048031040089e-09
are O 0 2.657588385468479e-11
dominant O 0 3.244561508353172e-09
- O 0 8.97139307287631e-10
negative O 0 9.885431362377517e-10
in O 0 6.200032848235892e-11
transient O 0 3.035874440726616e-09
transfection O 0 2.893792538927187e-09
assays O 0 3.825235961318896e-10
when O 0 4.8008291786416635e-11
they O 0 2.2268643526390797e-11
are O 0 3.5911707635394308e-12
coexpressed O 0 1.0477952372411892e-07
with O 0 5.0844840490671395e-12
wild O 0 2.0445301629479218e-07
- O 0 3.4600898146663894e-08
type O 0 4.6708788659088896e-07
PAX6 O 0 0.41761448979377747
. O 0 3.349607595737325e-07

We O 0 4.1478373513648137e-10
found O 0 1.2534793081969697e-12
that O 0 5.7941640275603525e-15
the O 0 7.0138252844520466e-12
dominant O 0 9.654874233433475e-09
- O 0 3.083547195359415e-09
negative O 0 1.42590683704924e-09
effects O 0 4.433580169660445e-09
result O 0 1.5043266632375207e-09
from O 0 5.896522159432038e-11
the O 0 9.374424847496954e-12
enhanced O 0 1.465377819087621e-10
DNA O 0 1.276598271537921e-09
binding O 0 2.8387741046742576e-09
ability O 0 1.6502237354387717e-09
of O 0 8.484552505017007e-10
these O 0 3.754835331548634e-10
mutants O 0 4.941794173873859e-08
. O 0 2.1652926118775895e-09

Kinetic O 0 1.094759056741168e-07
studies O 0 2.521026165602791e-10
of O 0 5.737777006992184e-12
binding O 0 5.31106714163343e-10
and O 0 4.2078557305202935e-10
dissociation O 0 1.331248533631424e-08
revealed O 0 8.770409398728418e-10
that O 0 2.20502354439725e-13
various O 0 1.60139766031131e-11
truncation O 0 4.685760224276692e-09
mutants O 0 1.9019155139687882e-09
have O 0 7.341566590768345e-13
3 O 0 2.5992493747628576e-12
- O 0 9.521283501207067e-13
5 O 0 5.0150027360029714e-12
- O 0 5.0636183614172214e-12
fold O 0 1.746270489322299e-10
higher O 0 1.3346241889422572e-09
affinity O 0 2.2628213539044317e-11
to O 0 3.6483286010302596e-12
various O 0 6.788029773691084e-12
DNA O 0 7.91250832216095e-12
- O 0 1.0711643161007145e-12
binding O 0 3.3313521212441355e-12
sites O 0 5.146293113877931e-12
when O 0 9.055791598371055e-13
compared O 0 2.9365919418378184e-11
with O 0 2.8781081793001484e-14
the O 0 3.00476345194145e-11
wild O 0 2.4431946243907987e-08
- O 0 5.2628079671990236e-09
type O 0 1.226181893798639e-07
PAX6 O 0 0.0024637780152261257
. O 0 2.438549131511536e-07

These O 0 2.5067378728316214e-10
results O 0 5.755821513853121e-11
provide O 0 2.0815521615397126e-12
a O 0 1.740302644831146e-13
new O 0 4.093432537377595e-11
insight O 0 2.200290991072329e-11
into O 0 1.261124451396034e-12
the O 0 1.336038267865658e-12
role O 0 3.4538454995319823e-12
of O 0 3.19206917842596e-11
mutant O 0 2.1449507059401185e-08
PAX6 O 0 0.00028887263033539057
in O 0 9.65225455118457e-10
causing O 0 1.1577653502570229e-08
aniridia B-Disease 1 1.0
. O 0 4.190711777596334e-08
. O 0 3.841999074438718e-08

Reversal O 0 3.399028685180383e-07
of O 0 2.665377918376066e-09
severe O 0 5.036398306401679e-06
hypertrophic B-Disease 1 0.9972858428955078
cardiomyopathy I-Disease 1 1.0
and O 0 4.3856925913132727e-07
excellent O 0 2.538881771485535e-09
neuropsychologic O 0 2.5641602618975412e-08
outcome O 0 4.7891853682813235e-06
in O 0 3.0131457329218847e-09
very B-Disease 0 1.5613987880414015e-10
- I-Disease 0 8.586759636663999e-10
long I-Disease 0 1.9786478011596387e-10
- I-Disease 0 3.7756911486219735e-10
chain I-Disease 0 1.0955199941653504e-10
acyl I-Disease 0 1.3233277229574014e-07
- I-Disease 0 2.455065271078638e-07
coenzyme I-Disease 0 7.045534999861047e-08
A I-Disease 0 9.255547439579459e-08
dehydrogenase I-Disease 0 6.992845101194689e-06
deficiency I-Disease 0 0.25342994928359985
. O 0 6.341250724517522e-08

Very B-Disease 0 1.11935287705478e-08
- I-Disease 0 2.0318320359535846e-09
long I-Disease 0 4.663305158691955e-11
- I-Disease 0 3.5205442727725966e-11
chain I-Disease 0 3.2348180124125436e-12
acyl I-Disease 0 5.922547868797423e-11
- I-Disease 0 1.2943431916545567e-11
coenzyme I-Disease 0 3.4336149375147063e-12
A I-Disease 0 1.75595464817907e-12
dehydrogenase I-Disease 0 8.759350883513761e-12
( I-Disease 0 3.461936141403721e-13
VLCAD I-Disease 0 0.00038439431227743626
) I-Disease 0 1.0154655588623385e-10
deficiency I-Disease 0 6.305490387603641e-07
is O 0 1.2752457510117887e-12
a O 0 4.641570981733789e-12
disorder O 0 5.0693375669652596e-05
of O 0 0.0002725097874645144
fatty O 0 0.010970456525683403
acid O 0 1.5391256056318525e-06
beta O 0 8.470181889208561e-09
oxidation O 0 4.471654690973992e-08
that O 0 2.007939994830288e-11
reportedly O 0 4.681142140583461e-09
has O 0 1.1082591008099163e-12
high O 0 7.196691853561532e-11
rates O 0 2.107142585416888e-11
of O 0 3.992096095969261e-13
morbidity O 0 2.453992387074777e-08
and O 0 9.818248297710497e-11
mortality O 0 3.623211597414411e-08
. O 0 4.534142394874152e-09

We O 0 1.5745689474488955e-11
describe O 0 3.546571022972067e-12
the O 0 1.2446430604912129e-12
outcome O 0 1.0093679225775531e-09
of O 0 7.541507696107175e-11
a O 0 1.48758338546634e-13
5 O 0 8.177169336619217e-13
- O 0 1.0438127277670808e-13
year O 0 3.2548456117831304e-12
- O 0 3.615172883275619e-10
old O 0 1.8048140759674425e-08
girl O 0 7.64445484691123e-09
with O 0 3.938357973076734e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.896978396587201e-08
was O 0 2.1319820908693998e-10
first O 0 4.822669607412733e-12
seen O 0 5.793722446245653e-11
at O 0 1.8543040367080543e-12
5 O 0 1.0238837772416631e-12
months O 0 7.911745125146682e-14
of O 0 1.8280216478993444e-13
age O 0 1.002377608000371e-11
with O 0 2.954193760820213e-14
severe O 0 4.907020567657128e-09
hypertrophic B-Disease 0 0.0007020590710453689
cardiomyopathy I-Disease 1 1.0
, O 0 0.00018335766799282283
hepatomegaly B-Disease 1 1.0
, O 0 1.0744284736574627e-05
encephalopathy B-Disease 1 0.8950238823890686
, O 0 1.8055510864201096e-08
and O 0 6.318263956472947e-08
hypotonia B-Disease 1 1.0
. O 1 0.9836370348930359

Biochemical O 0 2.190063952411947e-07
studies O 0 4.355878768791399e-09
indicated O 0 0.00022086731041781604
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.5674194742132386e-07
by O 0 9.547984798630171e-12
a O 0 2.724225185712914e-11
stable O 0 8.709370149517781e-07
yet O 0 3.410873716802598e-08
inactive O 0 8.730809213375323e-07
enzyme O 0 1.995131810872408e-07
. O 0 6.511221783966903e-08

Molecular O 0 1.494882106989337e-09
genetic O 0 1.1841554126146292e-10
analysis O 0 1.1459679559455704e-11
of O 0 9.820351198897015e-10
her O 0 5.655621304612168e-09
VLCAD O 1 1.0
gene O 0 1.4229327049974927e-08
revealed O 0 1.1860214144121528e-08
a O 0 1.8183770461588367e-11
T1372C O 0 6.702756394361131e-08
( O 0 2.208345485643637e-12
F458L O 0 9.340100248778072e-09
) O 0 1.8285465155920555e-11
missense O 0 1.8895468301138862e-08
mutation O 0 5.9573895816456e-10
and O 0 1.5061625557866165e-11
a O 0 1.454839720915757e-10
1668 O 0 0.00010718918201746419
ACAG O 1 0.9999240636825562
1669 O 0 0.0015351759502664208
splice O 0 2.9135742806829512e-05
site O 0 1.0805873671415611e-06
mutation O 0 2.921329098626302e-07
. O 0 1.5785044382710112e-08

After O 0 6.1508749205074764e-09
initial O 0 2.0167325587294727e-08
treatment O 0 1.7038436794791778e-07
with O 0 1.9221978175831822e-11
intravenous O 0 8.622867420093883e-10
glucose O 0 3.4807121074287295e-10
and O 0 3.81106040822643e-12
carnitine O 0 4.237363238068781e-11
, O 0 4.381391896426251e-13
the O 0 1.798448334699998e-10
patient O 0 1.7422055407223525e-06
has O 0 4.73866388836508e-12
thrived O 0 1.534554983084746e-10
on O 0 4.978377519254673e-12
a O 0 2.9611903207271695e-13
low O 0 1.5819003884587346e-09
- O 0 1.545549799253365e-10
fat O 0 2.8411699659613987e-08
diet O 0 1.1413953338035299e-08
supplemented O 0 8.453533706376248e-11
with O 0 2.207514634413807e-13
medium O 0 1.407015037813153e-08
- O 0 1.214354949929941e-09
chain O 0 9.306699300104526e-10
triglyceride O 0 2.214330152128241e-06
oil O 0 8.041743626563402e-08
and O 0 3.3217332964102786e-12
carnitine O 0 5.732805341551739e-10
and O 0 1.1511725817384133e-12
avoidance O 0 5.078153453297318e-09
of O 0 1.919121528359824e-10
fasting O 0 1.073776942916993e-07
. O 0 1.7769789195654084e-08

Her O 0 1.4603675708713126e-06
ventricular O 0 0.00012786350271198899
hypertrophy O 1 0.7062029242515564
resolved O 0 0.0018043399322777987
significantly O 0 1.0510794936635648e-06
over O 0 6.67748148441838e-11
1 O 0 6.028322979689804e-11
year O 0 1.6272762217578451e-12
, O 0 8.197783272524684e-13
and O 0 3.134069045951371e-11
cognitively O 0 6.594196975129307e-07
, O 0 1.290975139289774e-11
she O 0 2.1210208069055714e-12
is O 0 5.797571895217041e-14
in O 0 5.115511963679764e-13
the O 0 2.2693043624788523e-11
superior O 0 6.184710343859479e-08
range O 0 2.6626459259659896e-08
for O 0 5.388914314785609e-10
age O 0 7.687737593187194e-07
. O 0 1.7157960030544928e-07

Clinical O 0 1.660236392808656e-07
recognition O 0 1.406416117788467e-06
of O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 4.16007459591583e-08
important O 0 1.2732279675020663e-09
because O 0 1.2626896056522341e-11
it O 0 1.3965040332897943e-13
is O 0 9.201447655031447e-14
one O 0 2.1218683548488576e-14
of O 0 9.624995028420513e-13
the O 0 2.102196888786878e-11
few O 0 2.039487606575463e-10
directly O 0 9.09228914380833e-10
treatable O 0 0.0002094564842991531
causes O 0 1.714106412364913e-09
of O 0 5.902702771010127e-10
cardiomyopathy B-Disease 1 1.0
in O 0 4.1714047256391495e-05
children O 0 1.387641335170997e-09
. O 0 6.666638768804134e-11
. O 0 1.2842178431782258e-09

Cloning O 0 2.9564978376583895e-07
of O 0 2.8041324817706936e-10
a O 0 3.928302995392929e-12
novel O 0 1.2426309980995143e-09
member O 0 1.0815590610613324e-11
of O 0 3.2218887280333064e-11
the O 0 5.661486557340112e-11
low O 0 9.811631507261609e-09
- O 0 3.49429485346775e-10
density O 0 4.465260161623519e-09
lipoprotein O 0 2.01143689082528e-06
receptor O 0 4.667298867389036e-07
family O 0 2.3339421062473775e-08
. O 0 1.8988933092600746e-08

A O 0 6.3933240923574886e-09
gene O 0 3.3283688305463244e-11
encoding O 0 1.1574665670366358e-09
a O 0 5.868450170254391e-11
novel O 0 6.859322887464714e-09
transmembrane O 0 1.3084507921590216e-09
protein O 0 6.769909077775083e-10
was O 0 2.975915000535956e-11
identified O 0 9.089357413429033e-14
by O 0 4.9713672340258395e-15
DNA O 0 2.89135875615118e-13
sequence O 0 6.197126823205903e-14
analysis O 0 2.7527711894356245e-14
within O 0 2.6694477791439075e-13
the O 0 1.1559564069840711e-11
insulin B-Disease 1 0.9466564655303955
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.2996574649815074e-10
IDDM B-Disease 0 1.3650128494191449e-05
) O 0 3.392912903757428e-12
locus O 0 1.2595439968787758e-10
IDDM4 O 0 1.173541591015237e-06
on O 0 2.184253222736743e-09
chromosome O 0 2.240734930936128e-09
11q13 O 0 3.2637734648233163e-07
. O 0 1.0249879167645304e-08

Based O 0 1.52181822699049e-09
on O 0 4.1977793463487956e-10
its O 0 8.445004244517218e-12
chromosomal O 0 1.6732147889442217e-09
position O 0 2.1399122474008436e-08
, O 0 1.0582169689132837e-11
this O 0 6.125284741226311e-12
gene O 0 1.8236974430596575e-12
is O 0 1.0685375517347981e-13
a O 0 2.5238418668339924e-13
candidate O 0 1.0099623914960887e-10
for O 0 1.1419003763391e-12
conferring O 0 3.799114267621917e-08
susceptibility O 0 5.636558853439055e-06
to O 0 3.025678552148747e-08
diabetes B-Disease 1 0.9999750852584839
. O 0 8.305742994707543e-06

The O 0 7.041411009822696e-08
gene O 0 1.4071727116871102e-09
, O 0 2.6617276091545072e-11
termed O 0 1.453107190130254e-09
low O 0 1.7777551875042263e-08
- O 0 2.0069799988586823e-10
density O 0 6.296398957772453e-10
lipoprotein O 0 1.053188647404113e-08
receptor O 0 9.120525862327256e-11
related O 0 6.753517189928004e-10
protein O 0 3.995040409598971e-11
5 O 0 1.163604212983671e-10
( O 0 2.5086120789170885e-14
LRP5 O 0 3.2828876328494516e-07
) O 0 2.259062755654087e-13
, O 0 1.1025848203199962e-13
encodes O 0 1.9279117012679578e-14
a O 0 1.131754263331182e-13
protein O 0 3.2785177350724837e-11
of O 0 2.393748532725226e-10
1615 O 0 2.241973106720252e-06
amino O 0 3.6369904421462707e-08
acids O 0 3.588835895129705e-08
that O 0 3.9064872864313926e-11
contains O 0 4.9737765989155136e-11
conserved O 0 7.80916442622015e-11
modules O 0 7.856775126324766e-12
which O 0 2.261066191862251e-14
are O 0 1.541598608750111e-14
characteristic O 0 2.0602226522004052e-12
of O 0 4.015839581445607e-13
the O 0 5.265360196460289e-12
low O 0 2.4737756287862567e-09
- O 0 8.070481088973125e-11
density O 0 6.509278671629204e-10
lipoprotein O 0 1.595391836417548e-07
( O 0 1.202491300977826e-10
LDL O 0 7.309322427317966e-07
) O 0 1.1161836038775519e-10
receptor O 0 2.027298773299435e-09
family O 0 1.6415875325748175e-09
. O 0 3.890845867715598e-09

These O 0 2.5808317705156014e-09
modules O 0 1.601759724856322e-09
include O 0 1.2878001616478674e-11
a O 0 1.2642915143620814e-12
putative O 0 5.220575083342283e-10
signal O 0 2.4805785203696473e-10
peptide O 0 2.560837826515172e-11
for O 0 1.4142039319112176e-12
protein O 0 3.9029796755629675e-11
export O 0 8.190047751099883e-09
, O 0 5.4243523735231225e-12
four O 0 5.416895230980767e-13
epidermal O 0 3.288684047308976e-10
growth O 0 3.3683622557845183e-10
factor O 0 3.9517689121026933e-10
( O 0 2.14192509215283e-12
EGF O 0 3.811589266433657e-09
) O 0 5.770975060673256e-13
repeats O 0 6.9756817509813995e-12
with O 0 3.3568108823199896e-14
associated O 0 1.3605469528776837e-10
spacer O 0 4.576230594466324e-08
domains O 0 1.945508110168248e-08
, O 0 7.305786531297542e-11
three O 0 1.1008060782358164e-11
LDL O 0 8.520530769828838e-08
- O 0 2.0633738984088268e-07
receptor O 0 1.4656300617588158e-09
( O 0 5.183471273734197e-12
LDLR O 0 0.00027076504193246365
) O 0 5.295090754753318e-12
repeats O 0 3.5006574028439985e-11
, O 0 2.1568466142870418e-13
a O 0 4.932571820610854e-13
single O 0 5.81984981040673e-11
transmembrane O 0 2.956521971686499e-10
spanning O 0 2.3371795609961055e-09
domain O 0 2.2251809284057344e-09
, O 0 2.2636458679725635e-11
and O 0 1.4738507289613345e-11
a O 0 3.242454915675097e-11
cytoplasmic O 0 1.3154780376112285e-08
domain O 0 1.0838840047711074e-08
. O 0 7.691813408428061e-09

The O 0 8.121605077349159e-08
encoded O 0 5.065645236612681e-09
protein O 0 3.403502590870744e-09
has O 0 1.2764795730840772e-12
a O 0 2.858676565863777e-13
unique O 0 7.930639651931859e-12
organization O 0 3.8411138852945115e-11
of O 0 3.6445416129460284e-10
EGF O 0 9.452469953430409e-07
and O 0 4.4210910488118316e-09
LDLR O 0 0.003065094817429781
repeats O 0 6.359656135046521e-10
; O 0 2.905734680647143e-12
therefore O 0 9.236453962779834e-11
, O 0 6.238105951933415e-12
LRP5 O 0 0.00024066604964900762
likely O 0 1.5101122130545264e-07
represents O 0 8.802766848781118e-11
a O 0 3.685092324606093e-13
new O 0 1.1168943374328943e-11
category O 0 6.07266112395699e-11
of O 0 2.1874403330346404e-11
the O 0 9.379407250875715e-10
LDLR O 1 0.9999994039535522
family O 0 1.213066553873432e-07
. O 0 8.206657753362379e-08

Both O 0 3.8289112325173846e-08
human O 0 3.356320332770224e-09
and O 0 8.368420623128259e-09
mouse O 0 4.447922776762425e-07
LRP5 O 1 0.7927212715148926
cDNAs O 0 0.00020401358779054135
have O 0 7.605333252058699e-09
been O 0 1.9268173723219206e-09
isolated O 0 9.50489997819659e-09
and O 0 1.4669018777446752e-10
the O 0 1.7204707658535767e-09
encoded O 0 4.1547276730113936e-09
mature O 0 3.7669764196834876e-08
proteins O 0 5.10516325394339e-12
are O 0 1.0648163665909205e-13
95 O 0 2.0634879221992364e-11
% O 0 1.871004300926446e-13
identical O 0 9.21026709760353e-13
, O 0 1.5677070440965092e-14
indicating O 0 1.5206900409042712e-12
a O 0 6.539542941452064e-14
high O 0 3.184668501132748e-11
degree O 0 2.0090366870118004e-10
of O 0 2.546823689442146e-11
evolutionary O 0 2.3410298144455055e-09
conservation O 0 4.84019491153731e-09
. O 0 7.460700807149223e-11
. O 0 2.4995057135157595e-09

The O 0 2.6040984835162817e-07
APC B-Disease 0 2.686730624645861e-07
variants O 0 7.795257772613695e-09
I1307K O 0 1.2168810314960865e-07
and O 0 4.397932365507451e-11
E1317Q O 0 2.0337404649239943e-08
are O 0 8.874139270642623e-12
associated O 0 3.517728552893118e-09
with O 0 1.2002454923276673e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.4759085326973036e-10
but O 0 7.612142687019041e-12
not O 0 2.753929246104847e-12
always O 0 9.73013770250164e-12
with O 0 1.4283667361413878e-14
a O 0 1.5634264716180013e-12
family O 0 5.363931174229286e-11
history O 0 7.750391994854056e-10
. O 0 4.48815251630208e-09

Classical O 0 0.00018887000624090433
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.1477103711854397e-09
FAP B-Disease 0 9.883535057042536e-08
) O 0 2.897055967517048e-13
is O 0 2.2969925861002737e-14
a O 0 4.2171452961647926e-13
high O 0 0.00018448193441145122
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999992847442627
that O 0 2.9860655614832865e-10
predisposes O 0 8.650088290096392e-08
to O 0 9.998804562094676e-11
hundreds O 0 1.5916054585396466e-10
or O 0 2.1522504264903652e-11
thousands O 0 1.1150600581766312e-10
of O 0 4.786075464835449e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.18070712685585022
carcinoma I-Disease 1 1.0
and O 0 2.3720629627188572e-11
that O 0 5.251724551655172e-14
results O 0 2.0597051841875214e-11
from O 0 4.136450557079563e-11
truncating O 0 6.849047551327203e-09
mutations O 0 5.998547492058748e-11
in O 0 4.04264156872447e-11
the O 0 2.7033888461147626e-09
APC B-Disease 0 9.273501433426645e-08
gene O 0 1.9397197181802994e-09
. O 0 1.5355697158270232e-08

A O 0 1.475593425226407e-09
variant O 0 3.643626289573376e-09
of O 0 1.0059026944730931e-09
FAP B-Disease 0 4.938943220622605e-06
is O 0 1.486902712066751e-09
attenuated B-Disease 1 0.9996516704559326
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
, O 0 2.3223720169163187e-10
which O 0 9.702484041890225e-13
results O 0 2.7818155765024777e-11
from O 0 1.4636118705890766e-11
germ O 0 6.319643262031605e-07
- O 0 3.9071188950856595e-08
line O 0 4.8193049906331e-07
mutations O 0 4.8118117129680726e-11
in O 0 1.0413062773162451e-11
the O 0 3.428511988201599e-11
5 O 0 5.7437801043169756e-11
and O 0 6.928816786815062e-13
3 O 0 2.6311189338379393e-11
regions O 0 3.210582841250975e-11
of O 0 1.8266860246640704e-10
the O 0 2.2935934040901884e-08
APC B-Disease 0 1.5589192514653405e-07
gene O 0 4.017326471483784e-09
. O 0 7.846965388580429e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 9.408508638841795e-09
" O 0 8.794988737292897e-09
multiple O 0 7.1911969712346036e-09
" O 0 0.00037155611789785326
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.2654228713374644e-12
typically O 0 3.1662606564397677e-12
fewer O 0 2.1548041129193507e-12
than O 0 2.0388621075739105e-13
100 O 0 1.7119181506403125e-12
) O 0 1.7332119456824318e-15
without O 0 6.613742214479912e-13
the O 0 1.906784452554433e-11
florid O 0 1.0853614895722785e-07
phenotype O 0 9.27257737259879e-09
of O 0 7.826626152729332e-11
classical O 0 6.132611751752393e-09
FAP B-Disease 0 2.6465505698070046e-07
. O 0 3.8625405096581744e-09

Another O 0 7.461277817810696e-09
group O 0 6.091337850788747e-11
of O 0 1.1425115020724519e-10
patients O 0 1.7549036002151297e-08
with O 0 1.9898494310610637e-11
multiple O 0 2.122715301311473e-07
adenomas B-Disease 1 0.9999994039535522
has O 0 7.148583947014231e-09
no O 0 7.79617592705506e-10
mutations O 0 1.224018802981064e-10
in O 0 9.271896445062211e-11
the O 0 1.7103736205115183e-09
APC B-Disease 0 1.197755894466468e-09
gene O 0 1.421094231873754e-11
, O 0 4.707979232160264e-12
and O 0 4.2922518837806845e-12
their O 0 4.945615098006506e-11
phenotype O 0 2.269795906784111e-09
probably O 0 1.7722620593296767e-10
results O 0 1.729648889392532e-11
from O 0 2.480717671213273e-12
variation O 0 9.419367508201049e-10
at O 0 1.254757235613635e-11
a O 0 2.208320332153235e-12
locus O 0 3.676853613243658e-11
, O 0 2.2278019273097582e-12
or O 0 1.324054841461697e-11
loci O 0 2.742954752221749e-10
, O 0 5.088529857893986e-12
elsewhere O 0 6.116079309670397e-10
in O 0 2.459705703006243e-11
the O 0 9.011110746470763e-10
genome O 0 2.1058310650801104e-09
. O 0 1.1597943938568278e-08

Recently O 0 1.1890095663602551e-07
, O 0 2.1365157906738652e-11
however O 0 3.016304914171819e-11
, O 0 2.522624307794291e-13
a O 0 2.1370841836627907e-13
missense O 0 5.058614083175428e-10
variant O 0 2.2564490276266724e-09
of O 0 1.3636954463436268e-06
APC B-Disease 0 1.2346320090728113e-06
( O 0 2.2601986254811024e-11
I1307K O 0 4.8316010747839755e-08
) O 0 5.986014635361858e-13
was O 0 1.829181424384263e-11
described O 0 2.478050750709393e-12
that O 0 2.3851207738446317e-14
confers O 0 1.8782145977391806e-11
an O 0 8.379958680367495e-15
increased O 0 7.062386786493846e-10
risk O 0 2.4369100515286846e-07
of O 0 0.3431917428970337
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.8608908009839524e-09
including O 0 5.6187575425692415e-11
multiple O 0 1.963640361424268e-09
adenomas B-Disease 0 1.6736546967877075e-05
, O 0 1.5963788624340225e-10
in O 0 5.636710209699913e-09
Ashkenazim O 0 6.335781654343009e-05
. O 0 1.2956559203303186e-07

We O 0 2.2725522796918085e-08
have O 0 3.499809470008941e-11
studied O 0 1.4276560489356882e-10
a O 0 1.6591963263382081e-13
set O 0 3.4196738323000186e-12
of O 0 2.8107854585512904e-12
164 O 0 1.0978821185503307e-09
patients O 0 5.502448496841339e-10
with O 0 3.1246726126671343e-12
multiple O 0 1.0724997082434129e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 3.126946694465005e-06
/ I-Disease 0 0.00020556943491101265
or I-Disease 0 5.099451527712517e-07
carcinoma I-Disease 1 1.0
and O 0 2.338725602069047e-10
analyzed O 0 5.262022484409101e-10
codons O 0 1.1435519198244037e-09
1263 O 0 2.9308161231256236e-08
- O 0 4.407743059431368e-10
1377 O 0 1.194767946799402e-07
( O 0 7.170559285230027e-12
exon O 0 1.4047591978538776e-09
15G O 0 6.1349401114796365e-09
) O 0 1.3245992031094694e-13
of O 0 9.770158640454163e-12
the O 0 8.013348318236524e-10
APC B-Disease 0 8.655530514545262e-09
gene O 0 4.6920335672329117e-11
for O 0 4.323905816727702e-11
germ O 0 6.831086648162454e-05
- O 0 7.762795917187759e-07
line O 0 1.6458322988910368e-06
variants O 0 2.75329412602332e-08
. O 0 2.730669557138299e-08

Three O 0 2.324439485335006e-08
patients O 0 1.685702066822614e-08
with O 0 1.1911495010827333e-12
the O 0 3.182077379371151e-10
I1307K O 0 1.3763279582690302e-07
allele O 0 4.0082009933328777e-10
were O 0 1.0021252924707902e-11
detected O 0 7.60770543783984e-11
, O 0 1.0908414877766268e-13
each O 0 4.14479174181033e-14
of O 0 2.2652955899982175e-11
Ashkenazi O 0 2.1188905918734235e-07
descent O 0 1.7675738206435199e-07
. O 0 3.536918313784554e-08

Four O 0 2.0152944202322942e-08
patients O 0 4.805806952390412e-07
had O 0 2.3538787585764e-10
a O 0 6.2888431441587844e-12
germ O 0 9.990122862291173e-07
- O 0 1.841703749505541e-07
line O 0 5.861226782144513e-06
E1317Q O 0 2.669506329766591e-06
missense O 0 2.94193345240501e-08
variant O 0 4.385305452103694e-09
of O 0 1.0067497058230401e-08
APC O 0 4.602723480129356e-10
that O 0 2.124890568404661e-13
was O 0 4.085157212507795e-11
not O 0 1.8689294903340148e-12
present O 0 1.238050356677789e-10
in O 0 2.6034632782945266e-11
controls O 0 2.4754630637002784e-11
; O 0 4.151117383860425e-12
one O 0 1.976013536825194e-12
of O 0 2.5874583725604694e-11
these O 0 4.167565251234073e-11
individuals O 0 6.666914850045336e-12
had O 0 8.568763476546337e-10
an O 0 4.34137128373438e-13
unusually O 0 2.540305965581524e-09
large O 0 4.1481516138697216e-11
number O 0 6.588564763210236e-12
of O 0 1.60827642869954e-10
metaplastic B-Disease 0 8.386381523450837e-05
polyps I-Disease 0 3.0406913538172375e-06
of I-Disease 0 6.626967063994016e-08
the I-Disease 0 7.54632480948203e-08
colorectum I-Disease 0 0.00010713695519370958
. O 0 4.904833872387826e-07

There O 0 2.686282973840548e-09
is O 0 1.2597685481591236e-12
increasing O 0 1.3348895556639095e-12
evidence O 0 5.127305264390758e-12
that O 0 1.0120531257658272e-13
there O 0 5.84698392133709e-12
exist O 0 2.150108389942229e-11
germ O 0 1.1225085749799746e-08
- O 0 3.4123603942504133e-10
line O 0 2.8486999426036164e-09
variants O 0 2.003491816893188e-10
of O 0 3.46686429564258e-10
the O 0 5.411718850822922e-10
APC B-Disease 0 8.494592251828692e-10
gene O 0 1.5633430964709372e-12
that O 0 1.421933317619084e-13
predispose O 0 8.625005709639311e-10
to O 0 1.4752006907703397e-11
the O 0 5.288310414575115e-11
development O 0 2.4308615120816057e-09
of O 0 8.876928525580752e-09
multiple O 1 0.6110551357269287
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.14772433042526245
carcinoma I-Disease 1 1.0
, O 0 6.346780739852065e-12
but O 0 2.396770499082934e-12
without O 0 2.7950801395615343e-11
the O 0 1.5711977552346212e-10
florid O 0 1.5976421252617e-07
phenotype O 0 6.210086667124415e-09
of O 0 6.940330254945337e-11
classical O 0 1.4776267986960079e-09
FAP B-Disease 0 8.475984358824462e-09
, O 0 9.077165017898348e-13
and O 0 1.4346884140772898e-13
possibly O 0 2.8483749647117973e-12
with O 0 2.5382556909721472e-14
importance O 0 2.5820134919030124e-09
for O 0 3.5173391097487183e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 8.691529274074128e-09
in O 0 1.1488534190813582e-13
the O 0 2.8965144085318917e-13
general O 0 4.320434981996968e-11
population O 0 1.35379121107837e-13
. O 0 4.101730673861104e-12
. O 0 4.543194986883492e-10

Genomic O 0 1.3626770822838807e-09
structure O 0 9.976668102762432e-11
of O 0 5.516408510541915e-12
the O 0 6.924675416408732e-11
human O 0 3.1057304283876874e-08
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 9.435684944492095e-08
CLD B-Disease 1 0.9999908208847046
) O 0 1.7177066435891675e-09
gene O 0 2.7919391243358405e-09
. O 0 5.054770468859715e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 8.907869641916477e-08
CLD B-Disease 1 1.0
) O 0 3.152570912656749e-11
is O 0 6.465651039740117e-13
caused O 0 1.1307866101817332e-11
by O 0 3.571157041956652e-12
mutations O 0 6.238716487860785e-11
in O 0 4.36488102606436e-11
a O 0 8.266496862030515e-12
gene O 0 9.17814435563713e-12
which O 0 2.8548528558519637e-12
encodes O 0 3.237786991641678e-12
an O 0 2.641787071218371e-13
intestinal O 0 8.322007261085673e-07
anion O 0 3.234825101117167e-07
transporter O 0 7.43488556054217e-07
. O 0 4.184800772577546e-08

We O 0 1.2668932569681601e-09
report O 0 2.3595727802194766e-11
here O 0 2.0769755273292168e-12
the O 0 1.1400652828470054e-13
complete O 0 5.363631847693506e-12
genomic O 0 1.6407948610908107e-10
organization O 0 4.044068205311113e-11
of O 0 4.069207124035579e-11
the O 0 5.306480255207191e-10
human O 0 1.1105996122751094e-08
CLD B-Disease 1 0.9960575103759766
gene O 0 2.356193240515836e-09
which O 0 3.0319018129443265e-11
spans O 0 1.3206832849554928e-10
approximately O 0 8.723349733535946e-13
39kb O 0 8.673614360077408e-08
, O 0 4.550243168366386e-11
and O 0 1.4185005947631169e-10
comprises O 0 1.847809683042101e-10
21 O 0 7.342435548451931e-09
exons O 0 2.993909831161545e-08
. O 0 1.5457606750146624e-08

All O 0 8.656162009401669e-08
exon O 0 2.0831099334372993e-07
/ O 0 2.267373844233589e-08
intron O 0 1.230264778939727e-08
boundaries O 0 5.549244397329289e-10
conform O 0 2.320482472839558e-09
to O 0 2.149973081511103e-11
the O 0 5.802716085412385e-10
GT O 0 1.8002780279857689e-06
/ O 0 2.427763376999792e-07
AG O 0 1.7659474451647839e-06
rule O 0 2.898357536196272e-07
. O 0 1.2542811589355551e-07

An O 0 2.4213023079588947e-12
analysis O 0 9.262382527630564e-12
of O 0 2.3183389236125507e-11
the O 0 3.689247241034366e-10
putative O 0 1.973547085754035e-07
promoter O 0 9.886024088245904e-08
region O 0 2.070539295573326e-09
sequence O 0 1.964920726127417e-10
shows O 0 1.0000673900112389e-10
a O 0 1.995976821322909e-11
putative O 0 2.2555825580639066e-06
TATA O 0 0.0001533616305096075
box O 0 3.170110858263797e-07
and O 0 1.2735819343578925e-10
predicts O 0 1.1846801317716427e-09
multiple O 0 1.645808836436835e-11
transcription O 0 2.5330340047702293e-09
factor O 0 1.7900100290901833e-09
binding O 0 4.919277873938199e-09
sites O 0 2.2884458772409744e-08
. O 0 1.0000188233050267e-08

The O 0 9.250797461390903e-09
genomic O 0 1.1673934707800981e-08
structure O 0 9.08473563043799e-09
was O 0 1.113768299809692e-09
determined O 0 2.3017161787652896e-10
using O 0 1.3345591125257794e-11
DNA O 0 1.9628390024450937e-09
from O 0 2.486024060222025e-11
several O 0 2.308977878687224e-12
sources O 0 1.1114928422095716e-10
including O 0 1.8106581772120434e-12
multiple O 0 1.899807047789359e-11
large O 0 2.6811641795632113e-09
- O 0 1.9046899168984055e-08
insert O 0 4.522355112612786e-08
libaries O 0 1.1872698451043107e-05
and O 0 5.88941007073629e-10
genomic O 0 5.151021831295566e-10
DNA O 0 5.888545207000107e-10
from O 0 1.988938701236176e-11
Finnish O 0 5.53904192202026e-06
CLD B-Disease 1 1.0
patients O 0 0.07946789264678955
and O 0 1.3553389521803183e-09
controls O 0 5.07952186978855e-08
. O 0 6.488645709623597e-08

Exon O 0 4.4121472342339985e-07
- O 0 9.502868714150736e-09
specific O 0 1.1481985362493674e-09
primers O 0 3.731308240162434e-08
developed O 0 1.0083518464654162e-09
in O 0 1.4440018625272444e-11
this O 0 5.173910345296351e-12
study O 0 1.1316187787172027e-12
will O 0 6.435222363668225e-14
facilitate O 0 2.692362175218954e-12
mutation O 0 9.931282142147668e-13
screening O 0 4.730457692225798e-11
studies O 0 7.56043936223777e-13
of O 0 8.104965266639286e-13
patients O 0 2.1078953860165228e-10
with O 0 1.7088863961053913e-13
the O 0 1.4631499345441057e-09
disease O 0 4.791117476088402e-07
. O 0 1.3442311797007278e-07

Genomic O 0 1.957874395941417e-08
sequencing O 0 1.0938381755920545e-08
of O 0 1.354220069416101e-09
a O 0 6.89737933434742e-10
BAC O 0 7.863647624617442e-06
clone O 0 4.466276664061297e-07
H O 1 1.0
_ O 0 1.2759044931698327e-09
RG364P16 O 0 4.769610484345321e-09
revealed O 0 7.74759492672139e-11
the O 0 6.090192369509473e-13
presence O 0 1.7202909019173318e-12
of O 0 2.9863087697146184e-11
another O 0 2.393875202233442e-11
, O 0 4.9374311063277165e-12
highly O 0 2.3249825675808466e-10
homologous O 0 2.921318395521233e-11
gene O 0 1.1743102150407747e-11
3 O 0 3.9424938313992186e-10
of O 0 5.079788256701079e-10
the O 0 2.6472413594547106e-08
CLD B-Disease 1 0.9573567509651184
gene O 0 3.420298710921088e-09
, O 0 2.489706357744481e-11
with O 0 5.63804035467845e-14
a O 0 2.719446304429163e-13
similar O 0 1.8562583761760898e-11
genomic O 0 1.044454078780177e-09
structure O 0 1.2262585613598276e-08
, O 0 3.842313620050497e-12
recently O 0 1.0344568951436983e-11
identified O 0 1.1048062421512017e-12
as O 0 3.713569978868597e-13
the O 0 1.98315275312666e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.249759217283099e-08
( O 0 3.1614828810422324e-11
PDS B-Disease 0 2.6294933377357665e-06
) O 0 5.784444537942912e-12
. O 0 1.3419390598734537e-10
. O 0 5.614221088023896e-09

The O 0 3.881167742747493e-08
APCI1307K O 0 0.0777290016412735
allele O 0 1.6431586402632092e-07
and O 0 4.817601872986188e-09
cancer B-Disease 0 6.0146121541038156e-06
risk O 0 2.288536249395179e-09
in O 0 3.390404623715426e-11
a O 0 1.2600720813993327e-11
community O 0 3.0445465593054166e-11
- O 0 2.114598947333679e-11
based O 0 1.8061983115755242e-12
study O 0 8.668978620889056e-13
of O 0 4.0369975157911187e-13
Ashkenazi O 0 1.5769598959991526e-09
Jews O 0 1.962165319113751e-09
. O 0 4.132172826132319e-09

Mutations O 0 1.8346531760471407e-07
in O 0 6.361475790583881e-10
APC O 0 8.815007390694518e-09
are O 0 2.714911357792199e-13
classically O 0 6.783813788491244e-11
associated O 0 5.012222581424197e-11
with O 0 3.335952902805417e-10
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 7.617000918891392e-10
FAP B-Disease 0 4.215580062805202e-08
) O 0 6.841836803052684e-14
, O 0 2.818339925179285e-15
a O 0 1.1115928463074562e-13
highly O 0 0.0001922971714520827
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.5143541693687439
by O 0 2.764671158672627e-08
multiple O 0 2.601636197141488e-06
intestinal O 1 1.0
polyps B-Disease 0 4.165556219959399e-06
and O 0 3.8865917428854146e-11
, O 0 4.548277986876625e-13
without O 0 9.370617996828923e-12
surgical O 0 5.820840556225448e-07
intervention O 0 3.852040075802421e-10
, O 0 1.3642894051892757e-13
the O 0 5.428896047987575e-12
development O 0 2.8907376048437072e-08
of O 1 0.9986312985420227
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.231238610013065e-10
CRC B-Disease 0 6.550974376295926e-06
) O 0 1.8032322163241687e-11
. O 0 1.5596641755877272e-09

APC B-Disease 0 2.72496004072309e-06
is O 0 6.699705373813813e-11
a O 0 3.955280894474278e-11
tumour O 1 1.0
- O 0 4.6979246803857677e-07
suppressor O 0 2.6743376224658277e-07
gene O 0 1.0838042963090544e-10
, O 0 1.1017885822445228e-12
and O 0 4.855398201553118e-12
somatic O 0 5.420512934506405e-06
loss O 0 3.3962388101826946e-07
occurs O 0 8.006982739061641e-07
in O 0 2.1971285946165153e-07
tumours B-Disease 1 1.0
. O 0 2.8348745217954274e-06

The O 0 2.9950584234939015e-07
germline O 0 2.672027790140419e-07
T O 0 6.682103048660792e-08
- O 0 2.9259034084461177e-10
to O 0 6.644724701021509e-12
- O 0 7.32998869934498e-11
A O 0 5.0611299873271065e-11
transversion O 0 7.0072170288426605e-09
responsible O 0 3.7253767778966385e-12
for O 0 1.1225704610665077e-12
the O 0 2.6148908038869934e-10
APC O 0 3.667149917063739e-09
I1307K O 0 2.358878958830246e-08
allele O 0 8.393285372276793e-11
converts O 0 1.1426553453430799e-10
the O 0 3.4735059880469654e-12
wild O 0 7.091671434117375e-12
- O 0 9.059207106264927e-14
type O 0 3.3141184566619353e-13
sequence O 0 1.058938771088605e-13
to O 0 3.942966829775796e-14
a O 0 2.770382230912749e-12
homopolymer O 1 0.9951677322387695
tract O 1 0.992070734500885
( O 0 7.2468957917903865e-12
A8 O 0 7.37744665357809e-09
) O 0 1.8095169934391302e-14
that O 0 7.037734178522333e-15
is O 0 1.7794613439009455e-12
genetically O 0 4.730112834749889e-07
unstable O 0 0.0005170358344912529
and O 0 9.240198828308621e-09
prone O 0 9.625730399420718e-07
to O 0 6.76695588452958e-09
somatic O 0 0.0005611438537016511
mutation O 0 2.6772695491672494e-06
. O 0 5.466500496709159e-08

The O 0 3.162247352861414e-08
I1307K O 0 1.409402216268063e-06
allele O 0 7.493653697565605e-09
was O 0 6.487204662342094e-10
found O 0 3.14503353915363e-11
in O 0 2.8849056823987418e-11
6 O 0 1.706467500639519e-08
. O 0 7.533148327354411e-09

1 O 0 2.314260711955285e-07
% O 0 1.1857268500392593e-09
of O 0 2.1303155073315594e-10
unselected O 0 0.00045232728007249534
Ashkenazi O 0 1.7505983862520225e-07
Jews O 0 3.937768777717565e-09
and O 0 9.117147141413096e-12
higher O 0 2.0064672145991835e-10
proportions O 0 2.839417034827818e-10
of O 0 4.649080287411067e-10
Ashkenazim O 0 1.4024260508449515e-07
with O 0 9.265328304933207e-13
family O 0 1.56489821101502e-11
or O 0 3.3659247264394843e-12
personal O 0 1.1812957279033753e-09
histories O 0 4.2605478256518836e-08
of O 0 4.6222410787777335e-08
CRC B-Disease 1 0.9999996423721313
( O 0 1.2093732959517212e-10
ref O 0 4.4579533664546034e-07
. O 0 3.683214844230065e-10
2 O 0 6.302418587011971e-10
) O 0 1.3481795974740196e-12
. O 0 4.362977201743945e-10

To O 0 1.9669501583052806e-09
evaluate O 0 1.4013317617411758e-08
the O 0 1.069862670677324e-10
role O 0 1.63069557856943e-10
of O 0 6.092862880890948e-10
I1307K O 0 4.7130831148933794e-07
in O 0 1.1962330015435896e-09
cancer B-Disease 0 5.5723933911622225e-08
, O 0 3.244104637700751e-12
we O 0 2.7839494598502768e-11
genotyped O 0 9.094341066884226e-07
5 O 0 1.4689164551384692e-08
, O 0 6.886399089855999e-11
081 O 0 6.190824706209241e-07
Ashkenazi O 0 1.9547476526327046e-08
volunteers O 0 8.108070326251493e-10
in O 0 1.4930511688104886e-11
a O 0 2.7889879641862514e-11
community O 0 8.373748916490342e-10
survey O 0 7.987330796765946e-10
. O 0 2.0063570804751407e-09

Risk O 0 7.050212298054248e-05
of O 0 1.4645070223195944e-06
developing O 1 0.9998952150344849
colorectal B-Disease 1 1.0
, I-Disease 1 0.9998652935028076
breast I-Disease 1 1.0
and I-Disease 0 2.8037345600750996e-06
other I-Disease 0 7.529214371970738e-07
cancers I-Disease 0 0.2603209912776947
were O 0 1.3613192351158432e-08
compared O 0 1.5622969584683233e-08
between O 0 1.287185247278444e-09
genotyped O 0 1.8100528222930734e-06
I1307K O 0 6.770961391566743e-08
carriers O 0 1.3280719579622513e-10
and O 0 3.716285525839913e-12
non O 0 6.478149960909008e-11
- O 0 5.910097931882685e-12
carriers O 0 7.510064076697576e-13
and O 0 9.477593948363505e-14
their O 0 2.4632136540430997e-14
first O 0 3.7901230548129106e-13
- O 0 1.3378443318445843e-11
degree O 0 1.1121586984685905e-10
relatives O 0 2.874756266368905e-10
. O 0 1.4550784188660515e-10

Sperm O 0 3.2117788983931916e-10
DNA O 0 1.5938892566902396e-11
analysis O 0 4.666325377315761e-13
in O 0 1.5982204708969716e-12
a O 0 1.0510404352404024e-10
Friedreich B-Disease 1 0.9999996423721313
ataxia I-Disease 1 1.0
premutation O 1 1.0
carrier O 0 1.8326876670471393e-05
suggests O 0 2.546730968333577e-07
both O 0 1.3699080758655668e-10
meiotic O 0 9.533007983009156e-08
and O 0 4.816310891775366e-11
mitotic O 0 2.3017918682199934e-09
expansion O 0 5.095863286896929e-08
in O 0 3.42307737710712e-10
the O 0 3.6478957632368747e-09
FRDA B-Disease 0 0.0005933952634222806
gene O 0 1.0574539466290389e-08
. O 0 1.169191765626465e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.9912496540541724e-08
usually O 0 5.227320798439905e-10
caused O 0 2.4536235890271207e-11
by O 0 1.0447668256788681e-13
an O 0 4.227102676679535e-15
expansion O 0 8.530278705620731e-10
of O 0 8.93001006474492e-10
a O 0 1.3892408334825745e-09
GAA O 0 2.2199303373326984e-07
trinucleotide O 0 8.899630756786792e-07
repeat O 0 4.130423558734719e-09
in O 0 2.093123868673885e-10
intron O 0 2.910964358449064e-09
1 O 0 3.465455977735843e-10
of O 0 3.031300557787553e-11
the O 0 3.996126984873172e-09
FRDA B-Disease 1 0.9866804480552673
gene O 0 1.5767658112508798e-07
. O 0 3.346497408074356e-07

Occasionally O 0 4.939306208484595e-08
, O 0 6.4950260447727e-11
a O 0 1.7957874770546667e-11
fully O 0 4.904737060940079e-09
expanded O 0 8.142420426793251e-08
allele O 0 6.695163978776009e-09
has O 0 6.804077266886477e-12
been O 0 1.2351668082430378e-12
found O 0 3.109783210022282e-13
to O 0 6.008308542533591e-13
arise O 0 3.084022204280501e-10
from O 0 2.3316370535708675e-12
a O 0 3.0042675703938204e-13
premutation O 0 1.1682108613797482e-08
of O 0 1.8743574747848157e-10
100 O 0 1.2625843426317118e-10
or O 0 2.3073676649887354e-11
less O 0 8.500398607225179e-09
triplet O 0 2.386599362580455e-06
repeats O 0 5.738598574112075e-08
. O 0 2.3060776399574934e-08

We O 0 2.996046788439344e-08
have O 0 3.244069249341841e-11
examined O 0 3.2520439119387845e-10
the O 0 4.614586057022363e-12
sperm O 0 6.013792328701806e-12
DNA O 0 2.1877576139583965e-11
of O 0 6.1877078981475986e-12
a O 0 1.154394288493954e-11
premutation O 0 3.103756171185523e-05
carrier O 0 1.4425290828512516e-07
. O 0 1.7249904260552285e-07

This O 0 1.365039903333809e-08
mans O 0 1.0335570550523698e-06
leucocyte O 0 1.065906076291867e-06
DNA O 0 1.5968188549209117e-08
showed O 0 6.656172835128871e-10
one O 0 1.6738187441980856e-12
normal O 0 3.2768940338989694e-10
allele O 0 9.862825139927978e-11
and O 0 2.2450693647896314e-12
one O 0 3.1749852313217586e-13
allele O 0 6.733624942356631e-12
of O 0 3.801781806034299e-12
approximately O 0 1.833012040763915e-12
100 O 0 4.9307991717428834e-11
repeats O 0 2.2973740965159806e-10
. O 0 7.18732628968155e-10

His O 0 7.575657434699679e-08
sperm O 0 2.762266193556684e-09
showed O 0 1.2457319897851704e-10
an O 0 2.252019202359217e-14
expanded O 0 3.03870595352862e-10
allele O 0 3.685653449103654e-10
in O 0 9.903863840143856e-11
a O 0 5.1514709165090267e-11
tight O 0 3.9373128402075963e-07
range O 0 1.4221864574892606e-08
centering O 0 1.4575317619502925e-09
on O 0 1.1862233417758716e-11
a O 0 1.0656900980166722e-13
size O 0 2.3745980876066497e-11
of O 0 5.206382547306987e-11
approximately O 0 9.78394448791775e-11
320 O 0 2.415438515868118e-09
trinucleotide O 0 2.5294104943895945e-06
repeats O 0 3.027346906492312e-08
. O 0 1.2960225781455392e-08

His O 0 5.2675081860797945e-06
affected O 0 0.0035482884850353003
son O 0 0.001236469717696309
has O 0 1.728225201835798e-10
repeat O 0 1.950938993688922e-10
sizes O 0 1.342436495299637e-09
of O 0 1.9671256290543226e-10
1040 O 0 1.1464702964758544e-08
and O 0 5.8086379456367965e-11
540 O 0 3.565955752904415e-09
. O 0 1.7135344254626261e-09

These O 0 3.959179650792066e-09
data O 0 2.3954521699565134e-10
suggest O 0 2.8312928390672454e-11
that O 0 1.1041037198010126e-14
expansion O 0 6.551287984324361e-11
occurs O 0 3.3865380118236477e-12
in O 0 3.063755304143212e-13
two O 0 6.2124373672439986e-15
stages O 0 2.9245390831267315e-12
, O 0 1.2681036979495484e-14
the O 0 1.5652248648665573e-13
first O 0 6.165038640183751e-13
during O 0 1.0023201886533162e-11
meiosis O 0 5.5276602739517955e-11
followed O 0 2.8841684249214516e-11
by O 0 1.4854349304413428e-12
a O 0 4.23051307527067e-12
second O 0 8.23229401314407e-11
mitotic O 0 8.59902371530552e-09
expansion O 0 1.297624976359657e-06
. O 0 1.7026708576395322e-07

We O 0 6.98592117487351e-08
also O 0 4.894866179050439e-10
show O 0 7.596406143006718e-12
that O 0 2.232184909459721e-14
in O 0 1.938884599747559e-12
all O 0 5.648494367550827e-13
informative O 0 1.5945399514660785e-11
carrier O 0 2.216531862567206e-12
father O 0 3.335200518539416e-11
to O 0 1.3349894974201693e-11
affected O 0 1.380920338078795e-07
child O 0 3.549271809788479e-08
transmissions O 0 1.3817121891079864e-09
, O 0 2.4259145582107566e-13
with O 0 9.095700673764431e-15
the O 0 6.7999906920579445e-12
notable O 0 5.6187575425692415e-11
exception O 0 2.0539706047095763e-10
of O 0 1.0263875860339056e-10
the O 0 1.3133356902006454e-10
premutation O 0 6.644293648605526e-08
carrier O 0 2.0051547922061985e-10
, O 0 1.3446741550099395e-12
the O 0 4.506846285057264e-12
expansion O 0 2.09278572249616e-09
size O 0 8.504253967700492e-10
decreases O 0 2.783757224733563e-08
. O 0 7.032747162405428e-10
. O 0 1.0513141468493359e-08

The O 0 1.1230054219879548e-08
R496H O 0 4.8226331728074e-07
mutation O 0 2.47880138637413e-09
of O 0 1.077041025809855e-10
arylsulfatase O 0 2.65552425844362e-05
A O 0 2.2488889328542427e-07
does O 0 4.5990555808117506e-10
not O 0 2.6815361042764607e-10
cause O 0 1.9954066374339163e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 5.395552875597787e-07

Deficiency B-Disease 1 0.8876156806945801
of I-Disease 0 2.4085443328658585e-07
arylsulfatase I-Disease 1 0.9999986886978149
A I-Disease 0 0.42420241236686707
( O 0 1.0646322934348973e-08
ARSA O 0 0.004827027674764395
) O 0 2.2440856464744918e-11
enzyme O 0 3.430117745395478e-09
activity O 0 3.2208799183308656e-08
causes O 0 8.568384259888262e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.32748339992861e-09
MLD B-Disease 1 1.0
) O 0 5.000317937486898e-10
. O 0 3.753763078151451e-09

A O 0 4.77717883029527e-08
number O 0 1.5609290526796826e-09
of O 0 3.2008764527802214e-09
ARSA O 0 0.0003304531564936042
gene O 0 4.930503116895579e-09
mutations O 0 3.6455172214289178e-09
responsible O 0 2.444786317834513e-10
for O 0 2.0810988488051407e-09
MLD B-Disease 1 1.0
have O 0 1.3682283395155537e-07
been O 0 5.102423483727136e-10
identified O 0 9.069288098295658e-10
. O 0 2.5784945290041605e-09

Recently O 0 7.253022005215826e-08
, O 0 3.2478582323580696e-11
the O 0 6.043116007603544e-11
R496H O 0 1.2596082399340958e-07
mutation O 0 1.870319676910981e-09
of O 0 2.638796070542071e-09
ARSA O 0 0.0002642086474224925
was O 0 1.0995964139226544e-09
proposed O 0 1.0433350849936573e-09
to O 0 3.3355928696215953e-12
be O 0 1.0445741494002903e-12
a O 0 3.3491192132951986e-13
cause O 0 1.2004219840378028e-10
of O 0 6.606771130179823e-09
MLD B-Disease 1 1.0
( O 0 4.340781623035639e-10
Draghia O 0 1.051403273777396e-06
et O 0 2.308105040427222e-09
al O 0 1.0585122361961297e-10
. O 0 1.48425683636072e-12
, O 0 8.469712561506859e-13
1997 O 0 1.98601315948288e-10
) O 0 3.9494834486175634e-11
. O 0 1.3234180862298217e-08

We O 0 2.2449155423487355e-08
have O 0 4.37716182744019e-11
investigated O 0 5.441383454929394e-10
the O 0 1.881751143795185e-10
R496H O 0 1.9973738218936887e-08
mutation O 0 3.189501093792124e-11
and O 0 4.2018661770490406e-13
found O 0 4.716332982794211e-14
this O 0 5.074299270699245e-13
mutation O 0 6.093612160001927e-12
at O 0 1.474323094163843e-11
a O 0 1.3715565141958486e-12
relatively O 0 1.0604764982824477e-10
high O 0 8.491165236212961e-12
frequency O 0 1.4491441900632562e-12
in O 0 1.774434142372619e-13
an O 0 4.140775619794219e-15
African O 0 1.1017144770260334e-13
American O 0 1.5633540740179336e-13
population O 0 6.027896840124546e-15
( O 0 3.9154902668129925e-15
f O 0 1.9399471612446817e-11
= O 0 1.109407487751013e-12
0 O 0 2.8903899672999556e-12
. O 0 1.5412551877119762e-13
09 O 0 1.835381326087404e-11
, O 0 1.2718230331734692e-12
n O 0 5.47516372517709e-11
= O 0 3.843050322416275e-10
61 O 0 1.9268651119119795e-09
subjects O 0 7.970712423421844e-10
) O 0 1.0703029608427617e-11
. O 0 3.996591946275885e-09

The O 0 2.760430106718559e-06
ARSA O 0 0.00011457140499260277
enzyme O 0 1.422748052704037e-08
activity O 0 2.9129321177379097e-08
in O 0 5.308907480294778e-11
subjects O 0 1.2801380788740602e-10
with O 0 3.453696882519189e-14
and O 0 8.513735506518461e-13
without O 0 1.322265474196227e-11
the O 0 2.2955694289894524e-10
R496H O 0 3.597759246076748e-08
mutation O 0 6.051605744294974e-11
was O 0 2.7265538785070653e-11
determined O 0 7.579967903348361e-11
and O 0 8.116510068212346e-12
found O 0 1.7659703994282738e-12
to O 0 2.1987333828632494e-12
be O 0 9.49713363507243e-11
normal O 0 1.3551427855418297e-06
. O 0 6.674600427913902e-08

It O 0 7.484792230449955e-10
is O 0 1.1671288935310997e-11
therefore O 0 4.961658167657035e-11
concluded O 0 6.282612624586292e-11
that O 0 1.145320004201228e-13
the O 0 2.9991523153860555e-11
R496H O 0 6.02616978540027e-08
mutation O 0 1.363342772009446e-09
of O 0 1.5704794131821131e-09
ARSA O 0 5.840592166350689e-06
does O 0 1.4007905946300525e-10
not O 0 1.986493435024439e-11
negatively O 0 2.1029931129845636e-09
influence O 0 1.857999420984413e-09
the O 0 5.123651503069482e-11
activity O 0 1.5016864418626596e-09
of O 0 5.442628570051511e-10
ARSA O 0 0.00031562670483253896
and O 0 2.8221487646806764e-11
is O 0 3.7487829680771245e-13
not O 0 6.531007830899715e-13
a O 0 2.369990705422542e-12
cause O 0 8.704502896250688e-09
of O 0 9.452022453615427e-08
MLD B-Disease 1 1.0

Down O 0 1.6758130527705362e-07
- O 0 3.6449190332632497e-09
regulation O 0 2.0701642622356076e-09
of O 0 8.527541867087152e-11
transmembrane O 0 1.6176019412839082e-09
carbonic O 0 3.9949827623786405e-07
anhydrases O 0 4.154288944846485e-06
in O 0 5.041320036980323e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.19538377225399017
lines O 0 2.346407512732185e-09
by O 0 1.2738024177116891e-11
wild O 0 1.3953534107713494e-05
- O 0 2.6112306272807473e-07
type O 0 1.0285079042660072e-05
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999141693115234
Lindau I-Disease 0 0.025116009637713432
transgenes O 0 0.00034029397647827864
. O 0 1.0444969689160644e-07

To O 0 5.20615905941213e-09
discover O 0 4.66192917603081e-10
genes O 0 2.6627380855792637e-11
involved O 0 4.514124751081594e-12
in O 0 5.6249768731753136e-11
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 8.906828163901537e-09
VHL B-Disease 1 0.9999994039535522
) O 0 5.687682547161899e-10
- O 0 1.206534108177948e-07
mediated O 0 2.242099839122602e-08
carcinogenesis O 0 0.00016638364468235523
, O 0 1.8156321932027986e-11
we O 0 5.707585445935415e-12
used O 0 3.7984365652832253e-10
renal B-Disease 1 1.0
cell I-Disease 1 0.9992228746414185
carcinoma I-Disease 1 1.0
cell O 0 6.304610724328086e-05
lines O 0 1.346690936543382e-07
stably O 0 6.302262249846535e-07
transfected O 0 5.047111528710957e-08
with O 0 1.6385476959632217e-12
wild O 0 8.4756930363028e-09
- O 0 2.5162718575444387e-09
type O 0 1.0357441482256036e-07
VHL O 1 0.9998514652252197
- O 0 2.627001413202379e-05
expressing O 0 2.0953314106009202e-07
transgenes O 0 3.68813234672416e-05
. O 0 2.5778222223493685e-08

Large O 0 3.1829241464720326e-08
- O 0 3.3955984690692276e-09
scale O 0 1.729344845102787e-08
RNA O 0 6.075722702725272e-10
differential O 0 2.536566789945738e-10
display O 0 4.4357746642464946e-11
technology O 0 2.2122557952197752e-10
applied O 0 9.136510298324296e-11
to O 0 2.2897599614990494e-12
these O 0 2.3665756854196474e-12
cell O 0 9.800381339797326e-11
lines O 0 9.334440338737426e-12
identified O 0 9.259339172132397e-13
several O 0 1.6158595457765185e-13
differentially O 0 4.731428138171623e-09
expressed O 0 3.5188946201358817e-10
genes O 0 2.7480973052718127e-10
, O 0 1.7949510150785941e-12
including O 0 6.349731396064484e-13
an O 0 1.1951638680465781e-12
alpha O 0 1.2741396382409675e-08
carbonic O 0 2.798936748149572e-06
anhydrase O 0 8.08291406428907e-06
gene O 0 4.617833226916446e-09
, O 0 4.0293801628621395e-10
termed O 0 1.158114173449576e-06
CA12 O 1 0.9999856948852539
. O 0 3.8772864172642585e-06

The O 0 9.86277903791688e-09
deduced O 0 3.4501634882389e-09
protein O 0 7.090241588292301e-11
sequence O 0 2.108308493065092e-11
was O 0 2.8844655830528865e-11
classified O 0 9.983140702995996e-11
as O 0 3.997767394903207e-12
a O 0 2.0262791011055326e-12
one O 0 9.346466309234636e-12
- O 0 4.0191679318013485e-08
pass O 0 3.927748821297428e-06
transmembrane O 0 1.2103821234177303e-07
CA O 0 5.144123861100525e-06
possessing O 0 2.1035948538639104e-09
an O 0 2.777159578692956e-12
apparently O 0 8.447187394011735e-10
intact O 0 1.1629968099668986e-09
catalytic O 0 1.479665945325337e-09
domain O 0 1.620953860026475e-08
in O 0 4.508811379810851e-10
the O 0 1.8412878999285454e-09
extracellular O 0 7.248167435136565e-07
CA O 0 0.00047518685460090637
module O 0 7.952297664814978e-07
. O 0 1.6005756720005593e-08

Reintroduced O 0 3.490173639875138e-06
wild O 0 5.306395109982986e-07
- O 0 4.1597093769496496e-08
type O 0 9.212239149292145e-08
VHL B-Disease 0 0.32625335454940796
strongly O 0 7.68737251632956e-08
inhibited O 0 4.631958105960621e-08
the O 0 2.7719654349667167e-10
overexpression O 0 5.697956773076385e-09
of O 0 1.3581686990338238e-11
the O 0 5.303209260620889e-11
CA12 O 0 5.886119652132038e-06
gene O 0 1.5425950447567338e-11
in O 0 3.803747247732581e-12
the O 0 4.0482456276080825e-10
parental O 0 0.007846241816878319
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999985694885254
lines O 0 4.056976194988238e-06
. O 0 5.839628443027323e-07

Similar O 0 8.915952420807116e-10
results O 0 1.1303321473254968e-10
were O 0 7.354773040590956e-12
obtained O 0 2.174900450707673e-12
with O 0 3.471000884717329e-13
CA9 O 0 7.670640115975402e-06
, O 0 1.0011342449489646e-10
encoding O 0 7.130119605847085e-09
another O 0 9.11429332006719e-09
transmembrane O 0 3.4580843077947065e-08
CA O 0 2.3508355297963135e-06
with O 0 2.5645659641054808e-12
an O 0 7.923423202271795e-13
intact O 0 6.319321954606494e-09
catalytic O 0 2.6436991262812626e-08
domain O 0 2.8945979124728183e-07
. O 0 4.842940271032603e-08

Although O 0 8.507295490289835e-08
both O 0 2.5831942140897013e-10
domains O 0 4.340880987996343e-10
of O 0 3.0771771242221746e-10
the O 0 1.055806775340784e-09
VHL B-Disease 0 8.590704237576574e-05
protein O 0 1.9186110478131013e-08
contribute O 0 9.176158166646076e-10
to O 0 1.4037774415109894e-11
regulation O 0 5.725151552837815e-08
of O 0 9.122832267394188e-09
CA12 O 1 0.9992642998695374
expression O 0 2.855489178443804e-09
, O 0 5.847795121402544e-13
the O 0 8.944895605461634e-13
elongin O 0 1.7917690664503994e-09
binding O 0 8.970246212491872e-10
domain O 0 5.9820326470116925e-09
alone O 0 3.7563108179483606e-10
could O 0 1.782737152344893e-11
effectively O 0 4.295138966714518e-10
regulate O 0 4.858233282334368e-08
CA9 O 0 0.000986811239272356
expression O 0 8.44057410631649e-07
. O 0 1.9269475615146803e-07

We O 0 2.629934670039802e-07
mapped O 0 1.4126209180176375e-06
CA12 O 0 0.00808384083211422
and O 0 5.290164750704207e-08
CA9 O 0 0.00022773019736632705
loci O 0 3.145740024024235e-08
to O 0 5.668090996557851e-10
chromosome O 0 2.6051745205535326e-09
bands O 0 1.2617284994576039e-08
15q22 O 0 1.5260954455698084e-07
and O 0 2.5193630515119025e-10
17q21 O 0 5.281237918097759e-07
. O 0 3.1474208128656755e-08

2 O 0 4.27866773122787e-08
respectively O 0 4.49848824857213e-09
, O 0 7.490401354726117e-11
regions O 0 1.1620174156234953e-08
prone O 0 1.1521461829033797e-07
to O 0 2.539640997500925e-10
amplification O 0 4.075967081007548e-05
in O 0 1.963607765276265e-08
some O 0 2.0620185559039328e-09
human O 0 1.0998846988741207e-07
cancers B-Disease 0 0.00026242766762152314
. O 0 1.692374809181274e-07

Additional O 0 1.8551778779851702e-08
experiments O 0 6.826510912105732e-09
are O 0 1.0262730335691694e-12
needed O 0 9.769711949159099e-12
to O 0 9.201382060800012e-13
define O 0 9.996077576790441e-11
the O 0 3.869866926908827e-11
role O 0 1.2382464498195134e-10
of O 0 1.6832506943842418e-08
CA O 0 0.00010270499478792772
IX O 1 0.9999998807907104
and O 0 8.697768549836837e-08
CA O 0 3.0356964089151006e-06
XII O 0 3.322680277051404e-05
enzymes O 0 3.096512213307534e-10
in O 0 5.037957204190313e-11
the O 0 4.571353712234938e-12
regulation O 0 2.8567895271613963e-10
of O 0 1.4927637251305192e-11
pH O 0 1.7599541823898335e-09
in O 0 6.100450439944227e-12
the O 0 7.10021104410874e-12
extracellular O 0 1.0465774080703483e-10
microenvironment O 0 5.95282870108349e-07
and O 0 1.1451900192027686e-11
its O 0 4.12551199799327e-12
potential O 0 7.399864054846716e-10
impact O 0 1.3517774277715944e-07
on O 0 4.058048034494277e-06
cancer B-Disease 0 3.4031259019684512e-06
cell O 0 9.53126289005013e-08
growth O 0 8.316515476280983e-09
. O 0 4.77562744904958e-09

A O 0 5.786417567321678e-09
gene O 0 7.896922699091036e-11
encoding O 0 2.527599463064689e-09
a O 0 1.0207805434259143e-10
transmembrane O 0 1.0534010330687238e-09
protein O 0 8.745436597124012e-10
is O 0 3.1360748416545126e-13
mutated O 0 2.972148568924915e-11
in O 0 4.457890491211397e-13
patients O 0 3.0050745225551623e-10
with O 0 9.362774444632294e-12
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999955892562866
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9580222964286804
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 6.870865681962712e-11
. O 0 4.848184631534025e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.509529792860121e-07
WFS B-Disease 0 5.4470710892928764e-05
; O 0 9.162848813026869e-10
OMIM O 0 7.629478204762563e-06
222300 O 0 3.132171855213528e-09
) O 0 1.7288415097844838e-14
is O 0 4.707729499742359e-15
an O 0 3.817875377822022e-13
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
defined O 0 5.122032242788066e-10
by O 0 3.360901617774359e-12
young O 0 4.283246202163582e-09
- O 0 1.305311570831691e-06
onset O 1 1.0
non O 1 1.0
- O 1 1.0
immune O 1 0.6936255693435669
insulin B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
dependent I-Disease 0 0.00021794115309603512
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.2708490260138205e-07
progressive O 1 0.9999963045120239
optic B-Disease 1 0.9999880790710449
atrophy I-Disease 0 0.0006915777339600027
. O 0 1.0200817087024916e-05

Linkage O 0 5.426592224466731e-07
to O 0 1.4580121832086235e-10
markers O 0 1.2025635598433837e-08
on O 0 4.26483026672031e-09
chromosome O 0 5.336872721528607e-09
4p O 0 1.844442158471793e-05
was O 0 1.1262094590236416e-09
confirmed O 0 2.301050017194939e-09
in O 0 2.031776691335807e-10
five O 0 7.682128544406197e-11
families O 0 1.3694848033374285e-10
. O 0 2.40605868562227e-09

On O 0 3.5551848132087116e-09
the O 0 2.3834829943059077e-11
basis O 0 1.5145809606487148e-10
of O 0 1.2777985614054188e-10
meiotic O 0 0.00017784599913284183
recombinants O 1 0.9999750852584839
and O 0 4.001605091730198e-08
disease O 0 1.9331923795107286e-06
- O 0 1.4452330887593234e-08
associated O 0 1.2343450705998293e-08
haplotypes O 0 6.254619222545443e-08
, O 0 1.2048278173748539e-11
the O 0 2.6995847224320357e-10
WFS B-Disease 0 1.8812111193255987e-06
gene O 0 1.419951656256302e-10
was O 0 3.4169977958242725e-10
localized O 0 1.395887139210572e-08
to O 0 4.670482334212522e-10
a O 0 3.5273768350663204e-09
BAC O 0 2.7675796445691958e-05
/ O 0 6.573953470478955e-08
P1 O 0 1.5016763654784882e-07
contig O 0 2.799054357183195e-07
of O 0 2.708878954482685e-10
less O 0 7.359214904134603e-10
than O 0 2.26660096941389e-11
250 O 0 1.5664400332404682e-10
kb O 0 1.1805506794360099e-08
. O 0 1.5898049099405398e-08

Mutations O 0 2.993641956550164e-08
in O 0 7.778081650977597e-11
a O 0 8.50100111832175e-12
novel O 0 1.132343774301603e-09
gene O 0 4.822892779587917e-11
( O 0 1.1540728442338555e-11
WFS1 O 0 0.001609129598364234
) O 0 1.0585970988685744e-10
encoding O 0 1.1789080822666165e-08
a O 0 2.2932904464312287e-09
putative O 0 4.238901851749688e-07
transmembrane O 0 6.504041749622047e-10
protein O 0 9.164994457799835e-11
were O 0 3.8254965167849875e-11
found O 0 1.9353672310595815e-12
in O 0 1.6137966614079846e-12
all O 0 3.3481370887572526e-12
affected O 0 4.5910797386028435e-10
individuals O 0 2.6078217710279183e-11
in O 0 1.4870759068585926e-09
six O 0 3.1460025695650984e-09
WFS B-Disease 0 0.0006647738046012819
families O 0 1.569461116623927e-09
, O 0 4.580273226667542e-12
and O 0 3.1036813744056424e-12
these O 0 1.231018585678978e-11
mutations O 0 1.406830381356361e-11
were O 0 1.0645453268898208e-11
associated O 0 8.544657759124163e-10
with O 0 4.8998700930003025e-11
the O 0 1.9062352407672734e-07
disease O 0 4.3562879000091925e-05
phenotype O 0 1.9916478777304292e-05
. O 0 9.161634295651311e-08

WFS1 O 0 0.04420819878578186
appears O 0 2.7161405569131603e-08
to O 0 1.5801377567514763e-11
function O 0 9.598934147536653e-11
in O 0 1.9981186150097585e-10
survival O 0 1.6336286989826476e-06
of O 0 1.9770645121042207e-09
islet O 0 3.0534201300724817e-07
beta O 0 6.42601705180823e-08
- O 0 1.948985186572827e-07
cells O 0 4.970076616928054e-08
and O 0 1.3692889877514602e-10
neurons O 0 1.4293297656564619e-09
. O 0 9.546533008553126e-11
. O 0 1.651407677272232e-09

Stable O 0 6.806959390814882e-06
interaction O 0 1.1880993966428832e-09
between O 0 2.04842601214672e-11
the O 0 1.2396234212730395e-11
products O 0 1.7670918062151486e-09
of O 0 5.741003672454781e-09
the O 0 1.7502495097687643e-07
BRCA1 O 0 1.547515040556391e-07
and O 0 1.4378698232064835e-08
BRCA2 O 0 4.187451807524667e-08
tumor B-Disease 0 2.7706107630365295e-07
suppressor O 0 1.7469659496782697e-07
genes O 0 1.5344205073208883e-10
in O 0 1.056811149008352e-11
mitotic O 0 5.91328976895511e-08
and O 0 3.013749250158071e-09
meiotic O 0 6.516994744742988e-06
cells O 0 8.462589903501794e-06
. O 0 1.1057154836180416e-07

BRCA1 O 0 0.0003096914733760059
and O 0 3.464905091732362e-07
BRCA2 O 0 8.12141891515239e-08
account O 0 9.74683701804313e-12
for O 0 1.8238808087520791e-13
most O 0 1.84911480116505e-13
cases O 0 1.9485496115939638e-12
of O 0 4.142535706824768e-12
familial O 0 4.1238956693945283e-10
, O 0 1.1992010032560452e-12
early O 0 5.215551546200459e-09
onset O 0 0.43272772431373596
breast B-Disease 1 1.0
and I-Disease 1 0.9999963045120239
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.731404960686916e-10
encode O 0 2.194318685089236e-11
products O 0 2.5675150894244325e-10
that O 0 1.4207248658776317e-12
each O 0 1.1778133806802926e-12
interact O 0 2.0545327591992013e-12
with O 0 1.9967365163641587e-13
hRAD51 O 0 3.2784850390044085e-08
. O 0 4.427842092979972e-09

Results O 0 2.8116224015661828e-08
presented O 0 7.896466769352628e-08
here O 0 1.4918144497499952e-09
show O 0 8.98371724233904e-11
that O 0 3.2779219876627463e-12
BRCA1 O 0 5.464777519392783e-09
and O 0 2.2563371171457902e-09
BRCA2 O 0 2.2548498179730814e-08
coexist O 0 1.1475854710951694e-09
in O 0 2.1639517434890454e-12
a O 0 1.9267878579535408e-13
biochemical O 0 1.4227093947383196e-09
complex O 0 1.1271065858409202e-07
and O 0 1.1941238275969823e-10
colocalize O 0 2.6440277451911243e-06
in O 0 4.15358911709518e-08
subnuclear O 0 0.00021225051023066044
foci O 0 6.780084618185356e-07
in O 0 2.9240401766550406e-10
somatic O 0 4.03082154321055e-08
cells O 0 2.2301183122408474e-09
and O 0 1.4939363765162361e-12
on O 0 3.0695884202514012e-12
the O 0 1.5964594013082034e-12
axial O 0 1.905360175191717e-10
elements O 0 8.281213492722372e-10
of O 0 9.107910536876318e-10
developing O 0 1.1875476246814287e-07
synaptonemal O 0 3.4900789614766836e-05
complexes O 0 3.5543465060072776e-07
. O 0 4.5141163695916475e-08

Like O 0 4.829343652090756e-06
BRCA1 O 0 5.562799742619973e-06
and O 0 2.30284715740936e-08
RAD51 O 0 0.040460363030433655
, O 0 1.7161167420454149e-07
BRCA2 O 0 7.768327350277104e-07
relocates O 0 1.0790205351440818e-07
to O 0 9.839775660935857e-10
PCNA O 0 2.568593345131376e-06
+ O 0 4.364891781349911e-10
replication O 0 1.7181275499544846e-11
sites O 0 3.668166031339792e-12
following O 0 7.95603166681147e-12
exposure O 0 3.3832942003542144e-10
of O 0 1.759060536121737e-10
S O 0 6.397962124538026e-07
phase O 0 2.7890487785953155e-07
cells O 0 1.9539683648872597e-08
to O 0 5.126469804217493e-10
hydroxyurea O 0 6.837159389760927e-07
or O 0 3.2020670559518294e-09
UV O 0 0.002592732198536396
irradiation O 0 2.5737188479979523e-05
. O 0 5.9349392955709845e-08

Thus O 0 1.2248792700120248e-06
, O 0 1.3518207886420441e-08
BRCA1 O 0 1.6359090082573857e-08
and O 0 1.269350735633168e-09
BRCA2 O 0 1.5531126384971117e-09
participate O 0 3.9868344736682104e-11
, O 0 2.9014467152650714e-13
together O 0 2.0869644987847602e-14
, O 0 1.1693865819249749e-14
in O 0 7.711507214042124e-14
a O 0 2.3891517019966613e-13
pathway O 0 2.0192862659751398e-10
( O 0 1.5126125991939826e-13
s O 0 3.2294687757339346e-11
) O 0 6.3996003083681505e-15
associated O 0 2.9083517278510884e-12
with O 0 9.136217308950215e-14
the O 0 3.2105383889619032e-12
activation O 0 1.271142913150669e-10
of O 0 1.0866151728405882e-10
double O 0 2.269434293267203e-11
- O 0 3.4930840442370936e-09
strand O 0 2.3808182092466268e-09
break O 0 4.0669281831107185e-10
repair O 0 8.449564603552062e-08
and O 0 2.7608426655945095e-10
/ O 0 5.583103757089702e-09
or O 0 3.3997182846690066e-10
homologous O 0 5.381324275077759e-10
recombination O 0 4.785100760074101e-09
. O 0 3.864146780330202e-09

Dysfunction O 0 0.0002365860709687695
of O 0 6.704661359435704e-07
this O 0 4.1052880539460546e-10
pathway O 0 4.286229149386145e-09
may O 0 4.8762452409256696e-11
be O 0 1.3609400065228705e-12
a O 0 8.698344778831912e-13
general O 0 5.982748185751063e-10
phenomenon O 0 5.092331001321782e-10
in O 0 2.4003527030608263e-12
the O 0 1.7263914907014732e-12
majority O 0 1.137276579334101e-13
of O 0 3.730293119752828e-14
cases O 0 8.432380770202752e-13
of O 0 9.344452295279027e-12
hereditary B-Disease 0 0.0021521029993891716
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9990106821060181
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.457771929367027e-09
. O 0 3.3537861376942146e-09

A O 0 5.637702926719612e-08
novel O 0 2.1911100489546698e-08
Arg362Ser O 0 1.2580466091094422e-06
mutation O 0 2.072711446921005e-10
in O 0 1.0280166475029606e-12
the O 0 3.3909331505904694e-12
sterol O 0 4.85367621649857e-08
27 O 0 3.2612589961900085e-08
- O 0 4.2617891438112565e-09
hydroxylase O 0 3.165618238654133e-07
gene O 0 1.7744775093753162e-10
( O 0 2.0420934908338406e-12
CYP27 O 1 0.8887457251548767
) O 0 4.686664684810937e-12
: O 0 5.14929461917224e-13
its O 0 7.905505135068214e-13
effects O 0 1.1370852176506574e-10
on O 0 3.682701921192688e-10
pre O 0 1.651594416784974e-08
- O 0 1.9632211412101697e-09
mRNA O 0 1.0550680329401985e-09
splicing O 0 1.1289709167527917e-09
and O 0 4.123639797681822e-12
enzyme O 0 6.617206782522089e-11
activity O 0 1.1407810251995443e-09
. O 0 5.495284782774945e-10

A O 0 2.8962398701537495e-08
novel O 0 2.0440420911427282e-08
C O 0 9.65371711458829e-08
to O 0 2.5391635408850144e-12
A O 0 5.7377578382977745e-11
mutation O 0 9.149514479389609e-12
in O 0 7.571998041598638e-13
the O 0 3.62062073031022e-12
sterol O 0 3.519656743833366e-08
27 O 0 2.1101945080204132e-08
- O 0 4.266612396719438e-09
hydroxylase O 0 3.020680026111222e-07
gene O 0 4.976407619317058e-10
( O 0 6.276787683362484e-12
CYP27 O 1 0.5548105835914612
) O 0 7.100428318224106e-12
was O 0 6.79492434541018e-11
identified O 0 3.1860399735128553e-12
by O 0 1.9184278731571025e-12
sequencing O 0 5.2040247666695905e-09
amplified O 0 1.1131938038033695e-07
CYP27 O 0 7.753167301416397e-05
gene O 0 6.711113609281227e-11
products O 0 2.734565351936169e-10
from O 0 3.556162742751612e-12
a O 0 6.844750460865967e-13
patient O 0 1.1656173803942238e-09
with O 0 1.1194915437370834e-12
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.229096047161704e-09
CTX B-Disease 0 1.3993379070598166e-05
) O 0 5.993538304549517e-11
. O 0 2.569652046702231e-09

The O 0 3.4381042013365004e-08
mutation O 0 8.761201542029085e-09
changed O 0 3.067954112978555e-09
the O 0 4.3989138720501586e-11
adrenodoxin O 0 1.927660342460058e-08
cofactor O 0 4.124477703815188e-10
binding O 0 3.196689302153999e-10
residue O 0 2.5865691810622593e-08
362Arg O 0 2.872271132048354e-08
to O 0 4.8606261376926696e-11
362Ser O 0 2.5972283879127644e-07
( O 0 2.727568171323469e-11
CGT O 0 1.1471942116259015e-06
362Arg O 0 3.2808253536131815e-07
to O 0 1.03325692446532e-09
AGT O 0 2.9505590646294877e-06
362Ser O 0 9.134305756219874e-09
) O 0 2.164388053548308e-13
, O 0 7.152535264369139e-14
and O 0 3.409699280733369e-14
was O 0 1.483363258614201e-11
responsible O 0 1.8395668321957714e-10
for O 0 9.627363795061683e-09
deficiency O 0 0.44846946001052856
in O 0 3.125036229789657e-08
the O 0 1.4869177888954255e-08
sterol O 0 1.5536577393504558e-06
27 O 0 1.2605215715666418e-07
- O 0 2.7759243792502275e-09
hydroxylase O 0 4.7607878173039353e-07
activity O 0 8.16713594531393e-08
, O 0 9.361501374441361e-13
as O 0 6.804099384610796e-13
confirmed O 0 1.3660848494079225e-11
by O 0 3.950770266492043e-12
expression O 0 2.4548935106949443e-10
of O 0 1.058163071054885e-10
mutant O 0 3.116688018778291e-10
cDNA O 0 1.1977147051922543e-09
into O 0 8.037794874127258e-10
COS O 0 1.834644081100123e-06
- O 0 6.73876385803851e-08
1 O 0 6.0856994998914615e-09
cells O 0 1.3451122438112861e-09
. O 0 5.807145320169127e-10

Quantitative O 0 1.3041361768273418e-08
analysis O 0 1.0181011589338596e-10
showed O 0 1.1230363861081116e-10
that O 0 5.727351508636944e-14
the O 0 1.0820398396726993e-11
expression O 0 8.833074549574604e-11
of O 0 3.80275727573931e-10
CYP27 O 0 3.3138412618427537e-06
gene O 0 4.200730475273362e-12
mRNA O 0 3.0996247235570706e-11
in O 0 2.232745021854554e-12
the O 0 1.884461857393216e-11
patient O 0 6.112549133518996e-09
represented O 0 5.648093659438302e-10
52 O 0 3.3051438919073917e-08
. O 0 2.6392454444135183e-08

5 O 0 1.5644648243551273e-08
% O 0 7.11330924718645e-11
of O 0 6.536606325657779e-12
the O 0 1.0709202274972185e-10
normal O 0 6.768545404156612e-07
level O 0 8.468778673886845e-07
. O 0 7.044943828304895e-08

As O 0 7.588448758255595e-10
the O 0 5.805724651031241e-11
mutation O 0 1.272855171957632e-11
occurred O 0 9.521419763736105e-11
at O 0 1.0922515062544713e-12
the O 0 7.07957238839374e-13
penultimate O 0 6.865265689270927e-09
nucleotide O 0 1.0465679434190633e-09
of O 0 1.1954695011695549e-08
exon O 0 3.801555514826305e-09
6 O 0 2.7696627213913416e-09
( O 0 1.950214214294435e-13
- O 0 8.323283035016615e-11
2 O 0 1.7742575464385624e-10
position O 0 9.65254473572763e-11
of O 0 5.896558796791851e-10
exon O 0 9.632887820743008e-10
6 O 0 6.0290190617706685e-09
- O 0 1.2179580011206781e-08
intron O 0 2.7752378173317993e-08
6 O 0 3.74843311945483e-09
splice O 0 1.1471740224422433e-09
site O 0 1.2694251205758178e-10
) O 0 3.5738518942190003e-14
of O 0 1.2690008766025329e-11
the O 0 6.538533048328077e-10
gene O 0 5.926118623600374e-11
, O 0 5.891665627588694e-11
we O 0 2.5394119099186874e-11
hypothesized O 0 5.879597503311018e-11
that O 0 2.9467777501977765e-13
the O 0 3.9044909666552385e-11
mutation O 0 4.869572106658282e-11
may O 0 1.3029860523872117e-10
partially O 0 4.25227908440462e-10
affect O 0 4.908085049493138e-10
the O 0 5.1015549423771844e-11
normal O 0 3.7327779756068935e-10
splicing O 0 3.493861866488146e-10
efficiency O 0 7.674114499423013e-08
in O 0 8.000047291290002e-10
exon O 0 1.217709488798846e-08
6 O 0 5.466651020746838e-10
and O 0 2.7865177613245473e-13
cause O 0 1.7121205711859155e-12
alternative O 0 7.738929497236313e-10
splicing O 0 3.15811515827491e-10
elsewhere O 0 3.107191171025647e-10
, O 0 1.7777564766422935e-14
which O 0 2.49671071543675e-15
resulted O 0 8.146800942188115e-12
in O 0 5.416216086739922e-12
decreased O 0 5.813864500936461e-09
transcript O 0 1.1276065636778299e-09
in O 0 1.8197370693640025e-11
the O 0 4.981687840022175e-10
patient O 0 1.0067343509945204e-06
. O 0 2.527099773885766e-08

Transfection O 0 2.795697810142883e-06
of O 0 1.287676898442669e-08
constructed O 0 4.451877444466845e-08
minigenes O 0 3.272109097451903e-06
, O 0 1.962327869642344e-11
with O 0 1.1547410434537692e-13
or O 0 1.8512084226651737e-12
without O 0 3.7685663617503806e-11
the O 0 7.737094992465998e-11
mutation O 0 1.4375385430642762e-11
, O 0 2.144709106491338e-12
into O 0 3.2614098921524004e-11
COS O 0 1.7867506585389492e-07
- O 0 9.672476153355092e-09
1 O 0 1.308291031065778e-09
cells O 0 1.6676375558244416e-11
confirmed O 0 4.526419170036711e-12
that O 0 1.2980001493393626e-14
the O 0 2.604147366497278e-12
mutant O 0 2.5210358800542565e-10
minigene O 0 2.1302932751154913e-08
was O 0 9.212085955168092e-11
responsible O 0 5.232223074941311e-12
for O 0 1.9744611761546293e-12
a O 0 5.352380431228321e-12
mRNA O 0 6.196477220221652e-10
species O 0 3.2592316432517032e-12
alternatively O 0 7.403799795469013e-11
spliced O 0 6.70621613796385e-10
at O 0 1.151215373029757e-10
an O 0 2.5120671601902567e-12
activated O 0 1.1202134373888839e-05
cryptic O 0 1.4327677490655333e-05
5 O 0 1.2422952444524071e-08
splice O 0 6.741657188058525e-08
site O 0 1.348450240357124e-07
88 O 0 1.6214369225053815e-07
bp O 0 2.447961833240697e-08
upstream O 0 2.1186059573352622e-09
from O 0 1.9788242225371455e-11
the O 0 6.201404667560695e-11
3 O 0 1.0668148586745474e-09
end O 0 2.1051562715257433e-09
of O 0 4.8039758837603586e-09
exon O 0 7.899178200432289e-08
6 O 0 6.283399756057406e-08
. O 0 1.0257701354987603e-08

Our O 0 4.090839311743366e-08
data O 0 6.438153482557496e-11
suggest O 0 7.2727765650093534e-12
that O 0 2.8213103850220113e-14
the O 0 2.4090271444343614e-11
C O 0 3.491233968588858e-08
to O 0 1.6449513192545728e-12
A O 0 1.1376123654205372e-10
mutation O 0 5.119175049139724e-12
at O 0 8.082149858222587e-13
the O 0 1.3474443999808572e-12
penultimate O 0 3.2214495515603403e-09
nucleotide O 0 7.171743199307912e-10
of O 0 1.1966483359771019e-09
exon O 0 8.278939200856428e-10
6 O 0 1.7862573920002234e-10
of O 0 5.193129780367567e-12
the O 0 5.256953553023358e-11
CYP27 O 0 6.346402642520843e-06
gene O 0 6.347979000093096e-12
not O 0 3.378331685580105e-12
only O 0 3.1777254438924984e-12
causes O 0 6.804602992183106e-10
the O 0 1.3187130276648418e-09
deficiency B-Disease 0 6.708921773679322e-08
in I-Disease 0 8.657585759408448e-11
the I-Disease 0 3.124669689658077e-10
sterol I-Disease 0 2.1152442286620499e-07
27 I-Disease 0 2.7062121432663844e-08
- I-Disease 0 3.908099122096331e-10
hydroxylase I-Disease 0 2.958081779524946e-08
activity I-Disease 0 1.2714109764999648e-08
, O 0 2.1951212549053967e-12
but O 0 1.789475685687325e-11
also O 0 1.8189250453048977e-11
partially O 0 1.44760214926265e-09
leads O 0 4.6565858807801064e-11
to O 0 6.806344767310013e-13
alternative O 0 9.064895500898729e-10
pre O 0 1.3418144373389396e-09
- O 0 3.4777639101868374e-11
mRNA O 0 2.6221613422250378e-11
splicing O 0 1.112328354424541e-10
of O 0 2.3379796362799077e-11
the O 0 6.830189885898008e-11
gene O 0 8.561113623573036e-11
. O 0 1.8879173779851044e-09

To O 0 6.077148229088891e-10
our O 0 9.810573881052775e-11
knowledge O 0 1.4269446735326596e-11
, O 0 2.0427380286965925e-14
this O 0 1.1567067528144622e-14
is O 0 8.50647067433645e-15
the O 0 7.136632729004208e-14
first O 0 3.1596348259131657e-13
report O 0 1.640267349029001e-12
regarding O 0 5.089534349522751e-10
effects O 0 2.860551795436095e-10
on O 0 1.5371329209479256e-10
pre O 0 2.6054663981867066e-10
- O 0 4.9646662649005524e-12
mRNA O 0 4.089715979066488e-12
splicing O 0 1.042224292979732e-11
of O 0 3.706396300984238e-12
a O 0 1.0980390994239433e-13
mutation O 0 4.708892780910801e-13
at O 0 2.4247962578799465e-12
the O 0 2.1000930161552134e-11
- O 0 1.5030647837477318e-09
2 O 0 4.8605293123671345e-09
position O 0 6.399762386699592e-10
of O 0 2.1431859065224046e-10
a O 0 1.549673445122579e-10
5 O 0 1.0531343797026693e-08
splice O 0 3.747777199691882e-08
site O 0 4.5377696267223655e-08
. O 0 1.5062912694929764e-08

ATM O 0 1.1894752788066398e-05
germline O 0 1.4233554566089879e-06
mutations O 0 1.331433296947182e-09
in O 0 6.691812381998119e-11
classical O 1 0.838415265083313
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 1.3526807451924583e-10
the O 0 4.5680959015470535e-11
Dutch O 0 1.857461739973587e-08
population O 0 6.624944950267553e-12
. O 0 3.2190830556722005e-10

Germline O 0 0.00029921240638941526
mutations O 0 6.656534168314465e-08
in O 0 6.225130133596934e-11
the O 0 3.714792015663271e-11
ATM O 0 1.1272152100616495e-09
gene O 0 3.538148777865874e-14
are O 0 2.272359772145243e-17
responsible O 0 9.396777714302805e-17
for O 0 1.7393584402641826e-15
the O 0 8.90095464001206e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.284987310474662e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.795018354071146e-10
. O 0 8.362867731648294e-09

In O 0 1.5889742854824362e-08
our O 0 1.3912614393873923e-09
study O 0 2.1647909159705492e-11
, O 0 6.834405545837197e-13
we O 0 6.971395032431826e-13
have O 0 2.3505326916632707e-13
determined O 0 3.122076902561943e-11
the O 0 5.4338297750256004e-11
ATM O 0 7.348853081623474e-09
mutation O 0 5.609034764431087e-11
spectrum O 0 8.109682703150156e-09
in O 0 8.018247524277378e-12
19 O 0 2.0147199186748566e-10
classical O 0 3.4915736080165516e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999971389770508
T I-Disease 1 1.0
patients O 0 6.211373147380073e-06
, O 0 3.0679302956589105e-13
including O 0 8.88846084950469e-14
some O 0 3.2945995649506787e-13
immigrant O 0 8.119026562170006e-10
populations O 0 2.118232152181765e-11
, O 0 5.631863248325986e-13
as O 0 2.3461678780312134e-11
well O 0 1.5823492516275905e-10
as O 0 3.5984677043687796e-11
12 O 0 4.0438447729274074e-11
of O 0 9.976510936815508e-12
Dutch O 0 2.0759014507376605e-09
ethnic O 0 1.8601287177233417e-11
origin O 0 8.648760596585703e-10
. O 0 4.80811923608826e-09

Both O 0 4.968156996909556e-10
the O 0 5.961728333225835e-11
protein O 0 2.4895923864121094e-11
truncation O 0 2.863178805156963e-09
test O 0 1.7741713875807363e-08
( O 0 4.20592796701591e-11
PTT O 0 9.037970016834151e-08
) O 0 2.4288681959791503e-13
and O 0 2.998073794432954e-13
the O 0 2.0284561790678834e-12
restriction O 0 1.2991352438262993e-09
endonuclease O 0 2.6725469837174387e-08
fingerprinting O 0 8.456738953555032e-08
( O 0 8.3639241366118e-12
REF O 0 4.811295895024159e-08
) O 0 8.234810267493051e-14
method O 0 1.949238166709666e-11
were O 0 3.128089367393505e-12
used O 0 8.466886046443189e-13
and O 0 5.826355457122512e-12
compared O 0 5.352518428480835e-10
for O 0 1.0163815969410628e-11
their O 0 1.0790864729548488e-11
detection O 0 9.687594060281413e-10
efficiency O 0 2.5011907212046935e-08
, O 0 4.16265372865654e-12
identifying O 0 1.0550393197972241e-10
76 O 0 3.6437652894960593e-09
% O 0 2.2926790674282493e-12
and O 0 1.6020377299058586e-13
60 O 0 3.120872700893007e-12
% O 0 3.006721119910155e-13
of O 0 1.0380476860027965e-12
the O 0 4.475046166962926e-10
mutations O 0 1.9457671029954327e-09
, O 0 9.288008140373449e-10
respectively O 0 1.8642307964000793e-07
. O 0 8.593614211349632e-07

Most O 0 1.5651758644708025e-07
patients O 0 1.4546587578934123e-07
were O 0 3.5515299035004944e-10
found O 0 5.6689401436993414e-12
to O 0 1.3310173276048776e-12
be O 0 2.0852567936269217e-11
compound O 0 1.7922936024206138e-07
heterozygote O 0 6.9406578404596075e-06
. O 0 3.456521469047402e-08

Seventeen O 0 4.173444722255226e-06
mutations O 0 5.034177519291916e-09
were O 0 1.4246726021127643e-09
distinct O 0 8.089991870852131e-11
, O 0 2.1902490671826813e-12
of O 0 6.684703138248871e-12
which O 0 5.001121045067336e-13
10 O 0 6.814519434850119e-12
were O 0 1.3859391065351723e-11
not O 0 2.5736326264569342e-11
reported O 0 4.1020395413760014e-10
previously O 0 1.4671972081714557e-08
. O 0 2.8309191435482717e-08

Mutations O 0 9.237529638994602e-07
are O 0 8.517560962095772e-11
small O 0 9.177169441043631e-11
deletions O 0 6.521214857002633e-08
or O 0 3.4510085811234603e-07
point O 0 1.0058523912448436e-05
mutations O 0 1.5764862837386318e-07
frequently O 0 2.871119342273687e-09
affecting O 0 2.993955661168002e-08
splice O 0 1.8242996020489954e-06
sites O 0 2.3711626795375196e-07
. O 0 7.284966585530128e-08

Moreover O 0 3.4695881367952097e-06
, O 0 5.493943633361198e-10
a O 0 1.4141245119336787e-10
16 O 0 1.4087738975376851e-08
. O 0 1.8078322838732674e-08

7 O 0 3.328183879602875e-07
- O 0 1.892349210663724e-08
kb O 0 2.920486963375879e-08
genomic O 0 1.956529604996149e-09
deletion O 0 3.325508757257012e-10
of O 0 6.098292426592877e-10
the O 0 1.5926107654884447e-10
3 O 0 2.4234669826483923e-10
end O 0 2.4241561535909284e-10
of O 0 2.5308161122339357e-10
the O 0 1.36774369607906e-10
gene O 0 3.6027307439429057e-12
, O 0 4.7762488408764625e-12
most O 0 9.65633215749273e-12
likely O 0 1.1581993003551005e-10
a O 0 9.026440619258613e-13
result O 0 1.1848309833251136e-10
of O 0 2.886574868021796e-10
recombination O 0 2.597461482012342e-11
between O 0 3.562152309233291e-11
two O 0 3.6261080943456037e-12
LINE O 0 1.5540784943368635e-06
elements O 0 1.5298974309629898e-09
, O 0 1.2570856681992648e-11
was O 0 3.8762365539568577e-10
identified O 0 1.00080255194257e-09
. O 0 1.4107179424627247e-08

The O 0 2.3404757598655124e-07
most O 0 3.411496640737255e-09
frequently O 0 4.4803820375971526e-11
found O 0 2.4550923360261434e-12
mutation O 0 3.2882104157583303e-12
, O 0 3.0977537158680124e-13
identified O 0 6.525880964086683e-12
in O 0 8.278682600559861e-11
three O 0 4.815849108386061e-12
unrelated O 0 6.412189113014222e-10
Turkish O 0 9.028043201908531e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
T I-Disease 1 1.0
individuals O 0 1.4674050169416475e-11
, O 0 3.680695071645035e-13
was O 0 1.969542411106584e-11
previously O 0 1.6850149747726917e-11
described O 0 2.3652399483431452e-12
to O 0 1.0420840351656885e-13
be O 0 7.285263971951172e-14
a O 0 1.2915502814372232e-13
Turkish O 0 1.6931942070641526e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 1.7558295439812355e-06
mutation O 0 4.7277680437218805e-08
. O 0 2.870068183113972e-09

The O 0 2.047116609560362e-08
presence O 0 1.6559402737925666e-09
of O 0 3.028612027833333e-08
a O 0 1.6109636957750695e-09
founder O 0 1.8404746526812232e-07
mutation O 0 4.426997435302837e-09
among O 0 2.5786553448092775e-10
relatively O 0 2.3941731930321453e-10
small O 0 1.789036990383283e-13
ethnic O 0 1.7420463129750458e-13
population O 0 1.2689892708959028e-14
groups O 0 1.980327624703359e-14
in O 0 1.7416275398859232e-13
Western O 0 4.0826897418355657e-10
Europe O 0 3.2970293162293274e-11
could O 0 2.141730195970304e-11
indicate O 0 7.608749741372378e-11
a O 0 7.560914242789318e-13
high O 0 2.6154830037872223e-11
carrier O 0 3.43082414691262e-13
frequency O 0 1.511195509007468e-11
in O 0 1.6934814011174137e-12
such O 0 4.0655999400396325e-11
communities O 0 1.9064225753595565e-09
. O 0 1.4171498641246671e-08

In O 0 4.8802256458202464e-08
patients O 0 1.0047146759006864e-07
of O 0 3.228873002303345e-10
Dutch O 0 1.903988966489578e-08
ethnic O 0 1.28346482747288e-11
origin O 0 1.4691720062742775e-11
, O 0 3.8480614636578203e-13
however O 0 3.209346330357299e-11
, O 0 7.017594513304692e-13
no O 0 4.040173143954329e-12
significant O 0 5.423043680785611e-10
founder O 0 2.769155571513693e-09
effect O 0 1.1425060897352068e-08
could O 0 6.589136458678979e-10
be O 0 3.4459590736446444e-10
identified O 0 2.3052542097445894e-09
. O 0 6.729822032980337e-09

The O 0 5.9366573879060525e-09
observed O 0 2.3283297512222134e-09
genetic O 0 1.1641569652720563e-10
heterogeneity O 0 4.1513514847935085e-10
including O 0 6.447929755230841e-13
the O 0 2.623481987207299e-11
relative O 0 1.4414277416108234e-07
high O 0 5.496818175743101e-06
percentage O 0 1.3937220444404375e-07
of O 0 1.061523313694579e-09
splice O 0 4.3371863966967794e-07
- O 0 9.25609128898941e-07
site O 0 2.271326309255528e-07
mutations O 0 9.628350339241365e-10
had O 0 8.277687563174041e-11
no O 0 1.0705623020024202e-11
reflection O 0 1.9100031278806995e-10
on O 0 1.7035356458805495e-10
the O 0 2.689542200062789e-10
phenotype O 0 3.975822835400322e-07
. O 0 8.51644799126916e-09

All O 0 4.999325953214395e-10
patients O 0 5.590120033538426e-11
manifested O 0 2.069415992733692e-11
classical O 0 4.770092321138009e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 2.307575797111383e-10
increased O 0 2.3382362712709437e-09
cellular O 0 1.0956981988385905e-09
radioresistant O 0 1.1825383339214568e-08
DNA O 0 1.2009745420371587e-09
synthesis O 0 4.646121709583895e-09
. O 0 3.3376408303809058e-09

Determination O 0 7.599072660013917e-08
of O 0 9.150920021738784e-10
the O 0 3.5260547953663846e-11
genomic O 0 1.0098968883376358e-10
structure O 0 9.69285623986238e-11
of O 0 2.9883887031623146e-11
the O 0 7.166733873020803e-11
COL4A4 O 0 0.0005781071959063411
gene O 0 1.4045702101395108e-11
and O 0 9.691842462042008e-14
of O 0 2.593331582464997e-12
novel O 0 4.109436346766415e-08
mutations O 0 3.953997804728715e-07
causing O 0 0.00021765728888567537
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.051181531394832e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 6.093975324361622e-11
a O 0 2.7091773269205532e-11
progressive O 1 0.9998828172683716
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0005228676018305123
by O 0 2.8442061150713016e-08
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999985694885254
membrane I-Disease 0 2.5389203983650077e-06
abnormalities I-Disease 0 4.192660708213225e-05
and O 0 3.8031341964561705e-10
associated O 0 1.1524115883787545e-08
with O 0 4.021586952340783e-10
mutations O 0 1.2762062517879258e-09
in O 0 2.0574142389762073e-09
either O 0 7.72017672012737e-10
the O 0 4.180196189196295e-09
COL4A3 O 1 0.9999996423721313
or O 0 3.745988852443816e-09
the O 0 5.31669508418986e-09
COL4A4 O 0 0.0033274844754487276
gene O 0 6.941296842866151e-11
, O 0 1.2907948364684896e-12
which O 0 1.9222947886254893e-13
encode O 0 1.1943372506262318e-11
the O 0 9.52425291411707e-11
alpha3 O 0 2.356901404709788e-06
and O 0 4.447061052736956e-10
alpha4 O 0 1.4592149000236532e-06
type O 0 1.1640214552244288e-06
IV O 1 0.9999995231628418
collagen O 0 3.1306764867622405e-05
chains O 0 2.8534027478599455e-06
, O 0 1.133895644045424e-09
respectively O 0 2.8953508035556297e-08
. O 0 3.0909507842125095e-08

To O 0 6.927026313663376e-11
date O 0 2.5661758940032087e-08
, O 0 2.1463419149631013e-12
mutation O 0 1.3521525750199298e-13
screening O 0 1.433722168764362e-10
in O 0 2.7648409603453494e-11
the O 0 8.630781644924923e-10
two O 0 2.547543842545963e-10
genes O 0 6.565454846452212e-09
has O 0 2.0444522810803e-11
been O 0 2.084986350237017e-11
hampered O 0 1.6012879200388852e-07
by O 0 8.124501939266171e-12
the O 0 3.356215860783607e-10
lack O 0 5.350796250525036e-09
of O 0 7.3494335617319e-11
genomic O 0 2.8203797630688143e-10
structure O 0 9.899827624337831e-10
information O 0 2.4536062070978915e-10
. O 0 4.22905133135032e-09

We O 0 2.7105859778941976e-09
report O 0 6.37225619493087e-11
here O 0 4.466915119044623e-12
the O 0 2.8493678770613595e-13
complete O 0 2.730413985185809e-12
characterization O 0 2.9702795778518976e-10
of O 0 1.0444078241134136e-10
the O 0 6.540815666866706e-10
48 O 0 8.42463343531108e-09
exons O 0 9.736423889350476e-10
of O 0 2.667752130314227e-10
the O 0 2.9693689729271e-09
COL4A4 O 0 0.08827582001686096
gene O 0 9.314121696135658e-10
, O 0 8.899377762494609e-12
a O 0 1.9213500148523854e-12
comprehensive O 0 2.069449722696959e-09
gene O 0 8.44887094314517e-12
screen O 0 8.228691505962615e-09
, O 0 5.713295808673635e-11
and O 0 5.733608900160281e-12
the O 0 3.4858307646629116e-12
subsequent O 0 2.8873828675224367e-11
detection O 0 2.315071245817535e-09
of O 0 3.22399121288619e-11
10 O 0 7.541302651792314e-12
novel O 0 4.7407005404620506e-11
mutations O 0 5.202111744845306e-12
in O 0 9.932533311454717e-13
eight O 0 3.459128122829114e-11
patients O 0 5.271239444937237e-08
diagnosed O 0 8.023211194085889e-06
with O 0 8.024595672395662e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.992305523250252e-05

Furthermore O 0 1.7861611922853626e-07
, O 0 2.748611060976458e-10
we O 0 2.9799475387282115e-11
identified O 0 8.003003815204579e-11
a O 0 1.5348490707556284e-12
glycine O 0 3.615005864099352e-11
to O 0 9.010551853261273e-12
alanine O 0 8.444835386534066e-10
substitution O 0 4.3423679585430364e-07
in O 0 3.150730165657478e-08
the O 0 1.0767606362094284e-08
collagenous O 0 1.0285344842486666e-06
domain O 0 3.0679175866410446e-10
that O 0 1.3151235471724892e-13
is O 0 7.750879338309577e-14
apparently O 0 5.1452917447514235e-12
silent O 0 4.3422369866430444e-11
in O 0 9.666979673347842e-13
the O 0 2.2129804932990993e-11
heterozygous O 0 4.602956037158545e-12
carriers O 0 5.5248774305516335e-11
, O 0 3.839866792587632e-12
in O 0 7.765926096636733e-11
11 O 0 2.5844719697687424e-09
. O 0 1.4054728048051857e-08

5 O 0 2.4486389804678765e-08
% O 0 1.1401059957227844e-10
of O 0 1.3705764821680955e-11
all O 0 6.294576405246888e-13
control O 0 1.7251549147556666e-11
individuals O 0 3.6221128093399946e-12
, O 0 2.1026581517591403e-11
and O 0 1.0990381521525094e-10
in O 0 2.9513499977262825e-10
one O 0 6.4351059203549e-12
control O 0 7.088591519321952e-11
individual O 0 4.176173296066565e-12
homozygous O 0 4.7845551305603085e-12
for O 0 1.1691731296222668e-13
this O 0 1.592575680706143e-12
glycine O 0 1.0414775986067326e-10
substitution O 0 8.383473470985336e-08
. O 0 5.565574312527133e-08

There O 0 7.596224760320069e-10
has O 0 6.820783629742089e-13
been O 0 1.405249343538334e-13
no O 0 3.34118854545401e-13
previous O 0 1.6745485553748551e-10
finding O 0 3.157711592205459e-10
of O 0 4.767431935337463e-11
a O 0 7.961599044967183e-13
glycine O 0 5.7944378462071455e-12
substitution O 0 1.7832423315766732e-09
that O 0 2.514276764217782e-12
is O 0 3.19468518479582e-13
not O 0 2.0924020437303181e-13
associated O 0 1.2444134264710804e-11
with O 0 2.3927726662022197e-13
any O 0 5.809402611745007e-11
obvious O 0 2.0139985235090307e-09
phenotype O 0 6.692061571555996e-09
in O 0 1.3980965690718605e-11
homozygous O 0 2.3088304879070876e-10
individuals O 0 2.9045172517117024e-11
. O 0 2.1417732032347203e-09

Founder O 0 0.0016333067324012518
BRCA1 O 0 3.840809586108662e-05
and O 0 1.617452340951786e-07
BRCA2 O 0 7.680733205006618e-08
mutations O 0 4.951391380236814e-11
in O 0 2.355807606282956e-12
French O 0 2.368886864445585e-09
Canadian O 0 3.057971071029897e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.8942485502957425e-07
. O 0 2.950356581266078e-08

We O 0 1.0358622404282869e-08
have O 0 3.821361629907649e-11
identified O 0 3.321811228862437e-11
four O 0 1.7885524875374537e-13
mutations O 0 2.3617585209571856e-13
in O 0 1.2599144817715402e-13
each O 0 5.781493854625439e-14
of O 0 8.032288723036629e-11
the O 0 7.114423169696238e-06
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999754428863525
- O 1 0.9999986886978149
susceptibility O 1 0.9997031092643738
genes O 0 3.2047532840806525e-06
, O 0 7.790605494051306e-09
BRCA1 O 0 5.626841925732151e-08
and O 0 2.0967771963142923e-09
BRCA2 O 0 1.7142536279379783e-09
, O 0 3.8415620782095844e-14
in O 0 3.061709008067917e-14
French O 0 1.7473557323288702e-11
Canadian O 0 3.7751810566533095e-09
breast B-Disease 0 1.262710384253296e-06
cancer I-Disease 0 1.6959306776698213e-06
and O 0 5.100560883875005e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4719363505832916e-09
from O 0 4.652448912234597e-11
Quebec O 0 7.072598151580678e-08
. O 0 5.7415734389110185e-09

To O 0 2.2462266713318968e-07
identify O 0 1.5091086424945388e-06
founder O 0 3.3041783353837673e-06
effects O 0 3.7562683701253263e-06
, O 0 2.372938956440862e-09
we O 0 2.339403948337093e-10
examined O 0 2.905040874523479e-09
independently O 0 1.1167032576420155e-10
ascertained O 0 1.640946578618241e-08
French O 0 7.318258221644669e-10
Canadian O 0 4.702521039234853e-09
cancer B-Disease 0 1.1857245141300155e-07
families O 0 9.230777600621742e-12
for O 0 1.895324446433283e-13
the O 0 7.311581895486086e-12
distribution O 0 1.2575642749368399e-09
of O 0 2.5899100641879613e-09
these O 0 2.4040780033374176e-08
eight O 0 8.25547985527919e-09
mutations O 0 8.957205643866928e-09
. O 0 4.2077235917759026e-08

Mutations O 0 5.0179988875243e-07
were O 0 2.4031416856473697e-09
found O 0 2.695544308595199e-11
in O 0 2.15734669711809e-11
41 O 0 1.814830841162518e-09
of O 0 4.332788988703484e-11
97 O 0 1.332211780891157e-07
families O 0 9.71284830342256e-10
. O 0 1.1145296241465985e-08

Six O 0 3.8195672402707714e-08
of O 0 2.5335702424911233e-09
eight O 0 4.800977948526963e-10
mutations O 0 7.566981763407199e-11
were O 0 1.1459750509645872e-10
observed O 0 3.776425561152763e-10
at O 0 6.382270267835111e-10
least O 0 8.242444227146706e-11
twice O 0 1.3101689733119315e-09
. O 0 1.1529789567532589e-08

The O 0 5.768475148215657e-06
BRCA1 O 0 2.259815346405958e-06
C4446T O 0 1.2946779861522373e-06
mutation O 0 3.808987791842355e-09
was O 0 8.141089191671114e-11
the O 0 1.9172838663927827e-11
most O 0 9.69353503715853e-12
common O 0 8.058513578657056e-11
mutation O 0 3.6949353299231547e-11
found O 0 1.434393619506591e-12
, O 0 1.3860778030980875e-13
followed O 0 8.715553452554037e-12
by O 0 7.656233286246206e-12
the O 0 2.6627677840451724e-08
BRCA2 O 0 6.80053460655472e-07
8765delAG O 0 3.4271749882464064e-06
mutation O 0 1.0570651198804626e-07
. O 0 6.53356257984683e-09

Together O 0 1.3507103346910299e-07
, O 0 6.769482752133626e-10
these O 0 8.96023880092578e-11
mutations O 0 4.865718938873442e-11
were O 0 3.182537219870163e-11
found O 0 2.998144050733731e-12
in O 0 2.721242719008754e-12
28 O 0 2.7651338996292907e-09
of O 0 9.410263679399122e-10
41 O 0 1.6278910663913848e-08
families O 0 2.4032675155494232e-11
identified O 0 4.5826262923265304e-11
to O 0 6.904628951920344e-11
have O 0 1.4429840655694193e-10
a O 0 6.864267487749487e-10
mutation O 0 6.589331746909011e-08
. O 0 1.4361491196268616e-07

The O 0 3.7167676936178395e-08
odds O 0 1.2439649310636014e-07
of O 0 1.6467006577758347e-11
detection O 0 1.4661222236256322e-09
of O 0 6.49793760465478e-11
any O 0 7.324259254648524e-11
of O 0 1.2001890592472364e-09
the O 0 1.4523182656489553e-08
four O 0 9.266278855335486e-10
BRCA1 O 0 4.269885334196033e-09
mutations O 0 1.9742522894272696e-10
was O 0 1.3124399345088023e-09
18 O 0 5.0299164833234045e-09
. O 0 2.3489610256888227e-08

7x O 0 4.766650454257615e-05
greater O 0 2.6207903403019372e-08
if O 0 3.0635278758239792e-09
one O 0 3.118910338328895e-11
or O 0 4.839061443218107e-12
more O 0 2.645730314519701e-13
cases O 0 3.202786369449484e-10
of O 0 1.2119004168198444e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.4252325975536735e-10
also O 0 1.6906662430715008e-13
present O 0 7.843478470881404e-12
in O 0 7.004243018915446e-11
the O 0 1.7144302644211962e-09
family O 0 2.26066210196052e-09
. O 0 3.4225047240710182e-09

The O 0 3.83961058503246e-08
odds O 0 1.8424100289848866e-07
of O 0 2.2866753629502412e-11
detection O 0 1.1581711145680629e-09
of O 0 5.575095940457686e-11
any O 0 2.626918127468514e-10
of O 0 6.804853569519764e-09
the O 0 1.803183202753189e-08
four O 0 3.3958704737102607e-09
BRCA2 O 0 2.686366151749553e-08
mutations O 0 4.1777306614143583e-10
was O 0 3.926593716840898e-09
5 O 0 1.0546761686214268e-08
. O 0 5.117249735064888e-09

3x O 0 1.6934177438088227e-07
greater O 0 1.147007822055457e-09
if O 0 3.555893079987271e-11
there O 0 4.7264327868168365e-12
were O 0 2.8338685564843757e-12
at O 0 4.1814235450868265e-13
least O 0 7.384692087431671e-14
five O 0 2.258655281984481e-15
cases O 0 1.5119153758819115e-12
of O 0 1.3113989894009137e-09
breast B-Disease 0 0.002999081276357174
cancer I-Disease 0 2.679872750377399e-06
in O 0 2.905472973324663e-09
the O 0 3.822767666861182e-07
family O 0 7.291207992921045e-08
. O 0 1.2695335271928343e-07

Interestingly O 0 2.5774443201953545e-07
, O 0 5.0499153469996116e-11
the O 0 1.1227509373601396e-11
presence O 0 7.852134914498876e-11
of O 0 3.6065934683193746e-09
a O 0 1.0551147511250747e-08
breast B-Disease 0 9.978500747820362e-05
cancer I-Disease 0 2.827973446528631e-07
case O 0 7.744101360174227e-09
< O 0 2.460253512026611e-08
36 O 0 1.1850259662438134e-09
years O 0 4.589603870563952e-12
of O 0 7.148286736841092e-12
age O 0 2.2933724364015973e-10
was O 0 4.482424501017768e-11
strongly O 0 5.558635149394142e-12
predictive O 0 1.4060015304795392e-11
of O 0 2.570978326066342e-11
the O 0 3.730773936311271e-12
presence O 0 7.57330222839192e-12
of O 0 1.0091108504362012e-11
any O 0 3.7311601724931975e-11
of O 0 4.4081216454827654e-10
the O 0 6.44777953251463e-10
eight O 0 2.110429747625986e-10
mutations O 0 1.9556406494203316e-10
screened O 0 6.752492964778867e-08
. O 0 3.05980343284773e-08

Carriers O 0 3.7596048940713445e-08
of O 0 1.9544035279039917e-09
the O 0 2.798976050932822e-10
same O 0 1.7128801155230633e-10
mutation O 0 9.257419483765794e-12
, O 0 6.582026725954551e-14
from O 0 1.9431149939942716e-13
different O 0 2.9186991365448556e-12
families O 0 7.277133756700138e-12
, O 0 3.526306850687444e-13
shared O 0 2.932190948379265e-12
similar O 0 6.229441268379432e-11
haplotypes O 0 2.0175203729877467e-09
, O 0 6.8169632265469016e-12
indicating O 0 1.9982940302476493e-10
that O 0 2.856398386048842e-13
the O 0 2.1121764059994774e-11
mutant O 0 3.085787181333899e-10
alleles O 0 3.982485348441589e-12
were O 0 3.7212455339386e-11
likely O 0 6.844992628263213e-11
to O 0 5.754761901385907e-13
be O 0 4.973335653891964e-13
identical O 0 1.2191437963327001e-11
by O 0 4.000145212897793e-13
descent O 0 6.178418193725221e-11
for O 0 4.608285866618267e-13
a O 0 1.7558675867446194e-12
mutation O 0 5.148926771059159e-11
in O 0 2.7767373469989032e-11
the O 0 9.029623715406387e-10
founder O 0 6.122306217548612e-08
population O 0 8.413576779719989e-11
. O 0 3.5148783883443002e-09

The O 0 4.989105240049696e-10
identification O 0 4.9516231115376286e-09
of O 0 5.3517963394256185e-09
common O 0 1.6029416656238027e-05
BRCA1 O 0 1.572409200889524e-05
and O 0 3.7260954286466585e-06
BRCA2 O 0 3.7680047171306796e-07
mutations O 0 6.780350725321682e-10
will O 0 1.7873188823055997e-12
facilitate O 0 3.334411566302542e-11
carrier O 0 1.1534099413415544e-12
detection O 0 4.6033708095416515e-11
in O 0 7.534541024943608e-13
French O 0 1.72881861604246e-10
Canadian O 0 2.984906899428097e-08
breast B-Disease 0 5.081723429611884e-05
cancer I-Disease 0 4.252962753525935e-06
and O 0 0.0002875008212868124
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1710441505385916e-08
. O 0 1.6649663869827691e-09

Are O 0 9.381195820168386e-10
Dp71 O 0 1.8476813465895248e-06
and O 0 3.210106902518106e-10
Dp140 O 0 3.3548440114827827e-07
brain O 0 2.4779517104889237e-08
dystrophin O 0 9.897816255488578e-08
isoforms O 0 1.226586121561013e-08
related O 0 1.899828028228967e-08
to O 0 2.6757679405520207e-10
cognitive B-Disease 0 9.420465175935533e-06
impairment I-Disease 1 0.9999922513961792
in O 0 0.0001687907933956012
Duchenne B-Disease 1 1.0
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
? O 1 0.9999945163726807

Molecular O 0 1.4830888517280982e-07
study O 0 8.251099248290927e-10
and O 0 1.3283620080642433e-12
neuropsychological O 0 2.8893071268853987e-10
analysis O 0 6.585047177681824e-12
were O 0 3.1728803612240952e-12
performed O 0 4.7708586213557336e-12
concurrently O 0 6.61483064504087e-12
on O 0 5.161886890148182e-11
49 O 0 7.054282158414082e-10
patients O 0 3.3694674828055327e-10
with O 0 6.61067242613278e-11
Duchenne B-Disease 1 0.9999810457229614
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.027644327057715e-08
DMD B-Disease 1 1.0
) O 0 4.992162824617175e-13
in O 0 2.0698007652426853e-13
order O 0 2.662670648204135e-12
to O 0 7.888393714280961e-13
find O 0 1.281077132396502e-12
a O 0 6.5200979448951264e-15
molecular O 0 4.430519265265914e-13
explanation O 0 9.139729771623362e-12
for O 0 3.061821629568584e-13
the O 0 6.091712134725924e-10
cognitive B-Disease 0 1.7775320770851977e-07
impairment I-Disease 0 1.7787395734103484e-07
observed O 0 2.8996156586913457e-09
in O 0 1.624446410719571e-10
most O 0 2.0686365953537234e-09
DMD B-Disease 1 1.0
patients O 0 3.116366860922426e-05
. O 0 1.220239109755994e-08

Complete O 0 1.6729659879644032e-09
analysis O 0 9.648274540419166e-11
of O 0 2.1123912341547424e-10
the O 0 1.2594966181112e-09
dystrophin O 0 7.114797995200206e-08
gene O 0 8.035678789042322e-10
was O 0 1.571580021675345e-08
performed O 0 2.2595372239919698e-09
to O 0 1.3353027017437569e-11
define O 0 1.050832421078951e-09
the O 0 1.6017222270736653e-10
localization O 0 5.732121621804254e-07
of O 0 6.275872599381671e-10
deletions O 0 1.8292880543668844e-09
and O 0 2.0800898503647858e-10
duplications O 0 7.556947290154881e-10
in O 0 1.5986632156961278e-11
relation O 0 1.0834157876393746e-10
to O 0 7.428153578348251e-12
the O 0 2.737174376044038e-10
different O 0 4.3065867316727235e-08
DMD B-Disease 1 1.0
promoters O 0 0.0001554027694510296
. O 0 1.139020895379872e-07

Qualitative O 0 1.16603153799133e-08
analysis O 0 2.0360985120149167e-10
of O 0 7.08194614063018e-10
the O 0 7.3019905677540464e-09
Dp71 O 0 3.265564373577945e-05
transcript O 0 3.6442330042518734e-08
and O 0 7.128802756439789e-12
testing O 0 1.2588252489009744e-11
for O 0 5.517142190152036e-13
the O 0 1.1953194510583298e-11
specific O 0 1.8005556767786146e-10
first O 0 4.650401452810371e-10
exon O 0 1.2139844685066237e-09
of O 0 2.4619317695595555e-10
Dp140 O 0 1.992158189523252e-07
were O 0 2.8355491288323265e-09
also O 0 7.941507694508854e-12
carried O 0 6.736711882782132e-11
out O 0 3.3263631432634e-11
. O 0 8.818921148900927e-10

Neuropsychological O 0 1.6257009747278062e-06
analysis O 0 9.83009562638415e-10
assessed O 0 2.806580745584597e-08
verbal O 0 6.451682299513095e-09
and O 0 1.1011321715548306e-10
visuospatial O 0 1.1537030530917036e-07
intelligence O 0 1.9410917317941312e-10
, O 0 2.3821649514088605e-11
verbal O 0 8.370783177724661e-09
memory O 0 0.1606707125902176
, O 0 3.4745317734063974e-09
and O 0 3.1285298796035477e-09
reading O 0 3.4496533771744e-05
skills O 0 1.180985123028222e-06
. O 0 2.8062059342914836e-08

Comparison O 0 8.423719464190071e-07
of O 0 5.285603510429837e-09
molecular O 0 8.145849328400345e-09
and O 0 1.7718970735103312e-10
psychometric O 0 1.0176380556004005e-06
findings O 0 5.640369948878288e-08
demonstrated O 0 2.953057576249307e-09
that O 0 9.696419882299079e-12
deletions O 0 3.312298879620812e-09
and O 0 9.061242728369834e-11
duplications O 0 1.8059555240146352e-10
that O 0 3.8934954977969116e-13
were O 0 2.390922876349677e-11
localized O 0 9.98868765478278e-10
in O 0 2.3296109832871004e-11
the O 0 1.5256711172195736e-10
distal O 0 7.681788360969222e-08
part O 0 7.743452101749426e-09
of O 0 8.542922813603582e-08
the O 0 2.8594263312697876e-07
gene O 0 9.008189194581462e-10
seemed O 0 5.766225541492531e-08
to O 0 1.2084173722434755e-12
be O 0 1.4021871771324745e-12
preferentially O 0 8.854805777502861e-10
associated O 0 2.4918371810400686e-09
with O 0 1.822572370802078e-10
cognitive B-Disease 0 0.00014772899157833308
impairment I-Disease 0 0.40918007493019104
. O 0 1.5382938727270812e-05

Two O 0 1.451113718076158e-08
altered O 0 1.29307761653763e-06
Dp71 O 0 0.0005055989604443312
transcripts O 0 1.7911451095642406e-06
and O 0 1.8888322017573955e-09
two O 0 2.4912360369055975e-11
deleted O 0 8.157025055410827e-10
Dp140 O 0 9.97686822046262e-09
DNA O 0 1.503307756056671e-10
sequences O 0 1.497068311331895e-12
were O 0 2.0488419175210965e-13
found O 0 2.354147828282152e-14
in O 0 5.3735793890735337e-14
four O 0 1.152454867647812e-13
patients O 0 1.4755195676396937e-10
with O 0 2.518620511801628e-12
severe O 1 0.9999995231628418
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.2363785356283188

These O 0 4.4890708039702076e-08
findings O 0 1.2763043955033027e-08
suggest O 0 4.542337339596969e-10
that O 0 5.359569125312769e-13
some O 0 8.177730953344564e-13
sequences O 0 8.355230027810856e-13
located O 0 4.54906078084516e-12
in O 0 2.6932559914899512e-12
the O 0 1.256805909344294e-10
distal O 0 5.0584450406176984e-08
part O 0 4.2883002038252016e-08
of O 0 4.5853568053644267e-07
the O 0 4.1477147050272833e-08
gene O 0 8.597600929804994e-12
and O 0 1.350504343772263e-11
, O 0 3.2566261970110033e-13
in O 0 2.3769837010148565e-13
particular O 0 6.6945277446550655e-12
, O 0 1.667419593240696e-13
some O 0 2.2767213461727387e-12
DMD B-Disease 1 0.9999973773956299
isoforms O 0 5.960256732606695e-09
expressed O 0 7.950764491226892e-09
in O 0 2.5862423314038097e-09
the O 0 1.0385883264518725e-08
brain O 0 3.956825977979861e-08
may O 0 3.3273529764787924e-11
be O 0 9.899019538101017e-13
related O 0 7.678455649084981e-10
to O 0 1.2365110671486157e-11
the O 0 3.1137659117774774e-09
cognitive B-Disease 0 4.969037490809569e-06
impairment I-Disease 0 5.971705832052976e-06
associated O 0 4.2435735281287634e-07
with O 0 4.6044466017747254e-09
DMD B-Disease 1 1.0
. O 0 3.400525727670356e-08
. O 0 6.142070407832989e-09

I1307K O 0 4.2454805225133896e-05
APC O 0 1.2176976724731503e-06
and O 0 2.9212208207951562e-09
hMLH1 O 0 8.529471529072907e-07
mutations O 0 8.448896027246633e-10
in O 0 4.408966681329618e-12
a O 0 1.208954594419942e-12
non O 0 5.303741001938533e-09
- O 0 4.6327927605283037e-10
Jewish O 0 6.278518815960865e-10
family O 0 3.967504276503053e-12
with O 0 1.2470399875490895e-13
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.47786021848151e-06

We O 0 7.210229080456543e-10
describe O 0 4.926972718699574e-11
a O 0 2.5898405056797025e-13
French O 0 1.1109650699392404e-10
Canadian O 0 1.5116704332740483e-08
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.5726564939200216e-08
HNPCC B-Disease 1 0.9999748468399048
) O 0 2.5220892041488696e-10
kindred O 0 7.312027605621552e-08
which O 0 8.437867375296615e-13
carries O 0 8.618813995830976e-12
a O 0 2.5143954843556693e-13
novel O 0 2.2232282681500237e-10
truncating O 0 1.1030823543478618e-07
mutation O 0 4.5391348457712866e-09
in O 0 3.2284169781959804e-10
hMLH1 O 0 2.1421803921839455e-06
. O 0 1.2717146091745235e-07

Interestingly O 0 5.204633524158453e-08
, O 0 3.417895133583926e-11
the O 0 6.002988384157248e-11
I1307K O 0 1.0427711316651767e-07
APC O 0 4.0804186696163924e-09
polymorphism O 0 2.347956273851537e-09
, O 0 2.17475516761656e-12
associated O 0 1.9859705893687796e-11
with O 0 8.70722019334115e-14
an O 0 1.5875850438960837e-14
increased O 0 9.19597453741261e-10
risk O 0 9.516458021607832e-08
of O 1 0.6460967659950256
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.0087726487473248e-10
is O 0 4.187886406474377e-14
also O 0 3.91134022888792e-15
present O 0 2.1065216086225969e-13
in O 0 1.2398450321970955e-12
this O 0 2.3189625567021643e-11
family O 0 5.046423279253531e-10
. O 0 3.319027941373065e-09

The O 0 1.0217363666242818e-07
I1307K O 0 1.4535758054989856e-06
polymorphism O 0 1.7618737047087052e-07
has O 0 4.3175272385065355e-11
previously O 0 1.421029179743405e-11
only O 0 1.2507560904952836e-13
been O 0 2.670960512225068e-13
identified O 0 9.40560129780721e-13
in O 0 5.543914936498306e-13
individuals O 0 2.9315967513786345e-13
of O 0 6.860873674741086e-11
self O 0 1.4484977661766152e-08
- O 0 2.8780236860370678e-08
reported O 0 2.746546046150655e-10
Ashkenazi O 0 1.274757099878343e-08
Jewish O 0 1.1717344428063825e-08
origins O 0 4.434166100963921e-08
. O 0 1.8493830911125997e-09

In O 0 8.607388690684559e-10
addition O 0 1.0043473691601079e-10
, O 0 2.1297119883606497e-12
in O 0 2.4811769392535377e-12
this O 0 1.2314835783067135e-11
family O 0 2.5700514633131277e-11
, O 0 8.144280063716869e-13
there O 0 1.7482249372105518e-12
appears O 0 2.1658976695482224e-11
to O 0 6.012607946248583e-13
be O 0 1.2368600935119822e-11
no O 0 7.55432036370074e-11
relationship O 0 2.3878876306837604e-11
between O 0 2.1393132057512254e-11
the O 0 3.16638902597699e-11
I1307K O 0 4.265747477472104e-10
polymorphism O 0 9.829716207665484e-11
and O 0 2.0035385297437897e-13
the O 0 4.5019383728729656e-13
presence O 0 1.0306282736960437e-11
or O 0 6.300399091330178e-10
absence O 0 4.686513648266555e-07
of O 0 1.3871768089757097e-07
cancer B-Disease 0 2.043966105702566e-06
. O 0 1.456067377780812e-09
. O 0 9.983626370058118e-09

Identification O 0 1.599797272433534e-08
of O 0 1.30992341973446e-10
a O 0 9.89082839068789e-13
novel O 0 6.14065881476833e-11
mutation O 0 3.2680413930563645e-11
of O 0 1.3271553300775452e-10
the O 0 2.12993569448372e-08
CPO O 0 5.2254363254178315e-05
gene O 0 4.157228727930118e-11
in O 0 4.9529946116733115e-12
a O 0 1.857057693385733e-12
Japanese O 0 8.171529231049135e-08
hereditary B-Disease 1 0.9966722726821899
coproporphyria I-Disease 1 0.9990859031677246
family O 0 4.868938390245603e-07
. O 0 3.68756261082126e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.9714726679230807e-08
HCP B-Disease 1 0.9999992847442627
) O 0 2.4615394358246112e-12
is O 0 6.860355924835637e-13
an O 0 5.64196172420095e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 1.7676109465014633e-09
by O 0 8.169343565338216e-13
a O 0 5.268353895498956e-12
deficiency B-Disease 0 1.645116753934417e-06
of I-Disease 0 5.008980963339127e-08
coproporphyrinogen I-Disease 0 0.05277646705508232
oxidase I-Disease 0 5.564289153880964e-07
( O 0 1.8720164307595155e-11
CPO O 0 2.235451113108411e-08
) O 0 6.891851388082619e-15
caused O 0 1.1255028213672663e-13
by O 0 2.584499962947264e-14
a O 0 4.529949549150758e-13
mutation O 0 3.275529847357461e-11
in O 0 7.279011421390535e-11
the O 0 3.224100453280698e-08
CPO O 0 0.00028804675093851984
gene O 0 4.566793609939168e-09
. O 0 1.4803158698839525e-08

Only O 0 1.0147404694293982e-08
11 O 0 2.88618551280706e-09
mutations O 0 6.079211578580157e-10
of O 0 5.829162708081981e-10
the O 0 1.603408072980983e-08
gene O 0 7.251313993705821e-10
have O 0 1.560841213221753e-11
been O 0 8.081382785185554e-12
reported O 0 3.2853473413974044e-11
in O 0 1.6058526730589051e-09
HCP B-Disease 1 1.0
patients O 0 0.0016333683161064982
. O 0 1.3905729190355487e-07

We O 0 4.373660988932215e-09
report O 0 1.1109776987261455e-10
another O 0 7.72287876010802e-12
mutation O 0 2.2873210270279998e-11
in O 0 9.906461501812958e-13
a O 0 9.330751232425327e-13
Japanese O 0 4.399222675033343e-08
family O 0 2.4824919897525888e-09
. O 0 1.913709901657512e-08

Polymerase O 0 1.294708162902225e-08
chain O 0 4.0991382510568997e-10
reaction O 0 2.521690078971517e-10
- O 0 6.179410316775602e-10
single O 0 6.305466131867332e-12
strand O 0 7.514194128033225e-12
conformational O 0 6.815347440049246e-13
polymorphism O 0 5.413344685706312e-12
and O 0 1.0433683234609744e-14
direct O 0 2.6590290367234544e-14
sequence O 0 4.109714074585456e-14
analyses O 0 1.1031869862065946e-12
demonstrated O 0 7.788097423910845e-12
a O 0 3.466457156042768e-12
C O 0 6.6927001718397605e-09
to O 0 7.855710873472255e-12
T O 0 3.478097254649981e-10
substitution O 0 1.6519771661727134e-10
in O 0 6.563745380550046e-11
exon O 0 2.131551046780089e-10
1 O 0 7.131485679767735e-11
of O 0 9.008042575753272e-12
the O 0 3.823018568382963e-10
CPO O 0 1.2181838826563762e-07
gene O 0 2.3001954074092223e-12
at O 0 3.5951200350048396e-11
nucleotide O 0 1.8003265545019076e-09
position O 0 9.955863689015132e-09
85 O 0 1.615302913648975e-08
, O 0 3.497171953067979e-12
which O 0 1.1313490292166883e-12
lies O 0 2.8507899166307915e-11
in O 0 2.343416259653619e-12
the O 0 1.4275607085334485e-10
putative O 0 2.8321018419319444e-08
presequence O 0 2.1580089537565073e-07
for O 0 4.465434966238746e-11
targeting O 0 5.144070724938388e-10
to O 0 1.673006594371529e-10
mitochondria O 0 6.600148481084034e-07
. O 0 1.0325959465262713e-07

This O 0 4.4784706498823823e-10
mutation O 0 6.182968720347404e-11
changes O 0 1.1242472924832825e-10
the O 0 8.059897887990886e-11
codon O 0 4.047859547551269e-10
for O 0 5.8506094934018815e-12
glutamine O 0 2.220511829964522e-10
to O 0 6.141870866060994e-13
a O 0 7.122452042214455e-13
termination O 0 7.917245525845829e-09
codon O 0 1.2734125975910615e-09
at O 0 3.3120572950906535e-10
amino O 0 3.015317440180354e-10
acid O 0 3.850389340698257e-09
position O 0 1.163490015443358e-08
29 O 0 1.1510369546385846e-07
. O 0 3.651510382951528e-08

MaeI O 0 1.703413545328658e-05
restriction O 0 1.9566283526728512e-07
analysis O 0 1.9147092800153587e-09
showed O 0 1.779681291225188e-09
two O 0 5.72443785082366e-13
other O 0 3.3677081305930057e-13
carriers O 0 6.864325947930627e-12
in O 0 2.475746517516253e-11
the O 0 2.1508448355689325e-09
family O 0 3.1775422293378597e-09
. O 0 1.4027357053691958e-08

The O 0 1.662349973230448e-07
C O 0 6.791967734898208e-06
- O 0 1.5716479992988752e-06
T O 0 6.309875857368752e-07
mutation O 0 4.3244688385790653e-10
is O 0 4.081406978877211e-13
located O 0 1.0647763053206472e-12
within O 0 1.976729760780338e-12
a O 0 6.284043923242277e-13
recently O 0 1.1208082205393932e-11
proposed O 0 1.0991770826862535e-09
putative O 0 4.045777490802038e-09
alternative O 0 2.106525842648921e-09
translation O 0 1.7299656498992455e-11
initiation O 0 1.371233404601213e-10
codon O 0 8.640050480623884e-11
( O 0 7.314224367230976e-14
TIC O 0 5.910830852551285e-12
- O 0 9.075923172729983e-12
1 O 0 1.8825713557490964e-12
) O 0 1.5340769350026691e-15
, O 0 2.2442021046955966e-14
supporting O 0 3.0147260556001587e-13
that O 0 4.846371852548943e-14
TIC O 0 2.1726925814036235e-10
- O 0 1.9775547865918952e-09
1 O 0 4.526806041127429e-09
is O 0 5.323564397467784e-13
the O 0 1.9908553972047827e-11
real O 0 1.0964151808678935e-09
TIC O 0 2.378752972376219e-09
rather O 0 1.110781244761938e-09
than O 0 3.1296742974973313e-10
TIC O 0 1.150733552890415e-08
- O 0 1.1748944928058336e-08
2 O 0 1.3487552186219887e-09
. O 0 1.828156029337613e-11
. O 0 2.5993907026844454e-10

Human B-Disease 0 8.164616205341702e-11
complement I-Disease 0 3.945022974960466e-09
factor I-Disease 0 3.547610958776204e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999949932098389
associated O 0 3.3842381981230574e-06
with O 0 3.915108209184837e-06
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.23814445734024048

This O 0 2.8511992766766525e-10
study O 0 3.519698074661015e-11
reports O 0 3.9237350347998134e-12
on O 0 1.4941243771729451e-12
six O 0 5.462335567044986e-14
cases O 0 2.5164851105707875e-11
of O 0 4.489693505860259e-09
deficiency B-Disease 0 0.33500537276268005
in I-Disease 0 2.788235198281086e-09
the I-Disease 0 3.257594194394642e-10
human I-Disease 0 2.127342052515857e-11
complement I-Disease 0 1.0056124682966683e-10
regulatory I-Disease 0 3.653605640252522e-09
protein I-Disease 0 2.7244342892807083e-10
Factor I-Disease 0 2.585586189596256e-09
H I-Disease 1 0.9998462200164795
( O 0 2.189696584860637e-13
FH O 0 4.3671818938939566e-10
) O 0 4.2544887341719245e-16
in O 0 2.1742738862487871e-16
the O 0 7.308234679623586e-16
context O 0 1.9356613751089768e-13
of O 0 6.84101416465431e-14
an O 0 3.336641130492063e-13
acute B-Disease 1 0.9999990463256836
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.4500617453450104e-06

Five O 0 3.560384342904399e-08
of O 0 1.3110806884597537e-10
the O 0 9.876261267138808e-12
cases O 0 6.2334915874873165e-12
were O 0 5.297027465094029e-13
observed O 0 2.2218101924237343e-12
in O 0 6.376781833692183e-14
children O 0 1.519302838105894e-14
presenting O 0 3.3956904128829013e-12
with O 0 1.709602077959449e-11
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.247373688784137e-06
HUS B-Disease 1 1.0
) O 0 3.2962403917480287e-09
. O 0 6.618364523092168e-08

Two O 0 8.57452997493624e-11
of O 0 3.255368891119659e-11
the O 0 8.787367361540177e-11
children O 0 4.576526657640301e-12
exhibited O 0 3.2458782883715287e-10
a O 0 3.6762101696119487e-10
homozygous O 0 4.112573606107617e-07
deficiency O 0 4.022073426313e-06
characterized O 0 4.047921442484892e-10
by O 0 7.247023814382914e-11
the O 0 2.468644311193202e-08
absence O 0 3.1874280921329046e-06
of O 0 1.8451771666150307e-08
the O 0 2.829523559899627e-10
150 O 0 6.753961105665507e-12
- O 0 4.740289107421636e-13
kD O 0 1.8491413261711998e-11
form O 0 7.05626366798856e-13
of O 0 1.4876162801602533e-11
Factor O 0 3.026899564329e-10
H O 1 0.9999964237213135
and O 0 8.419416205884822e-12
the O 0 2.9020568500376376e-12
presence O 0 9.616150107097376e-13
, O 0 6.248745688637938e-14
upon O 0 5.852283935237068e-12
immunoblotting O 0 1.9012963647924153e-08
, O 0 2.568452612053407e-12
of O 0 1.0613521346514165e-11
the O 0 3.482835547741203e-11
42 O 0 7.253066897083826e-11
- O 0 5.1510462562021075e-12
kD O 0 1.025066975746114e-10
Factor O 0 2.1035698183347051e-10
H O 1 0.982435941696167
- O 0 6.519222495171562e-09
like O 0 1.5907821934724176e-11
protein O 0 1.3670342635663246e-10
1 O 0 7.249806865949893e-10
( O 0 9.758267463392048e-14
FHL O 0 1.731429790652328e-07
- O 0 2.749304339744185e-09
1 O 0 1.0745095924136194e-09
) O 0 6.572893677904076e-14
and O 0 3.8512042947053127e-13
other O 0 4.2379515695356584e-12
FH O 0 1.0904432201641612e-07
- O 0 5.628868038343171e-09
related O 0 3.225625988534375e-08
protein O 0 2.3724546771575206e-09
( O 0 2.242843714569953e-12
FHR O 0 6.05113427809556e-06
) O 0 5.924668741719152e-12
bands O 0 5.24324050843461e-09
. O 0 1.6579407846606387e-09

Southern O 0 2.3356794542905845e-07
blot O 0 3.663823733290883e-08
and O 0 2.975913135708219e-12
PCR O 0 9.321830807262899e-11
analysis O 0 2.701549487588162e-12
of O 0 5.902929512378863e-13
DNA O 0 2.2977057756445873e-11
of O 0 3.7288196835794096e-11
one O 0 4.6101256492847575e-12
patient O 0 1.705741858870624e-08
with O 0 1.5698130295671575e-11
homozygous O 0 7.939947721524732e-08
deficiency O 0 2.0200557628413662e-05
ruled O 0 4.1853758148135967e-07
out O 0 1.3121689845796425e-10
the O 0 1.041447310334842e-11
presence O 0 1.2984205724486664e-11
of O 0 1.8812692723080282e-11
a O 0 3.484373163262222e-13
large O 0 6.117543104033896e-12
deletion O 0 4.170465622149733e-12
of O 0 1.1342406180947506e-11
the O 0 1.900634372109522e-10
FH O 0 7.666097445735431e-08
gene O 0 6.689792816927387e-12
as O 0 1.1323378215979951e-12
the O 0 2.8067905638584634e-11
underlying O 0 5.589617302348415e-08
defect O 0 1.8426307590857505e-08
for O 0 2.0333662531513141e-10
the O 0 4.2352368723186373e-07
deficiency O 1 0.9997648596763611
. O 0 5.822606453875778e-06

The O 0 3.0531460026850255e-08
other O 0 9.420279140082144e-11
four O 0 1.1279318408094485e-12
children O 0 1.5668648561777132e-13
presented O 0 7.691203923743117e-11
with O 0 5.871338137897197e-11
heterozygous O 0 6.357357307251732e-08
deficiency O 0 0.0002588367206044495
and O 0 2.2806394273100494e-10
exhibited O 0 4.115654483882736e-09
a O 0 2.1880162612286647e-11
normal O 0 4.0783672261568427e-07
immunoblotting O 0 1.082668973140244e-06
pattern O 0 1.801409332813364e-08
of O 0 8.521639643932488e-11
proteins O 0 3.4395273088017042e-12
of O 0 3.361256065148588e-11
the O 0 1.192051346521339e-09
FH O 0 1.127366067521507e-05
family O 0 5.636613398252166e-09
. O 0 6.256835938245331e-09

Factor B-Disease 1 0.9998931884765625
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
is O 0 1.1723295945120782e-11
the O 0 1.34534440879297e-11
only O 0 3.7264963337335644e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.0611594234433142e-06
with O 0 1.990303033494456e-09
HUS B-Disease 1 1.0
. O 0 8.890019671525806e-06

These O 0 9.915630094781136e-09
observations O 0 1.0380516890506897e-08
suggest O 0 3.1911884246227373e-10
a O 0 8.184097388501399e-13
role O 0 7.99654526623117e-12
for O 0 2.5222948729641814e-11
FH O 0 1.1666381396935321e-05
and O 0 2.768110185513706e-09
/ O 0 3.5503482820331556e-08
or O 0 3.9160233389345933e-10
FH O 0 5.022929983056201e-08
receptors O 0 3.084162092381604e-11
in O 0 6.921247971448941e-13
the O 0 4.827915411204087e-12
pathogenesis O 0 4.856417490373133e-08
of O 0 2.120881109624051e-10
idiopathic O 0 2.189239785366226e-05
HUS B-Disease 1 0.9999992847442627
. O 0 2.137615595643183e-08
. O 0 1.5220397386883633e-08

Further O 0 2.4522786024050447e-09
evidence O 0 9.53655904245565e-11
for O 0 5.790601288399588e-13
a O 0 4.983933188026923e-13
major O 0 1.1660347687403316e-10
ancient O 0 9.064816453019375e-08
mutation O 0 4.263527557668567e-07
underlying O 0 1.1404818906157743e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.655482944646792e-09
linkage O 0 5.946970027537191e-09
disequilibrium O 0 9.500875641776929e-09
studies O 0 9.627767333375559e-13
in O 0 9.436804229755527e-15
the O 0 1.3191002652158945e-13
Japanese O 0 4.380354134969622e-10
population O 0 1.019479748017027e-12
. O 0 2.2902948981773363e-10

The O 0 3.3786420772230485e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.3555821737630822e-09
DM B-Disease 1 1.0
) O 0 1.9272602611031253e-11
mutation O 0 6.328507162756125e-11
is O 0 4.0063070048945715e-13
an O 0 1.1757589801937585e-13
unstable O 0 3.362031009146449e-07
( O 0 4.0697504394282547e-11
CTG O 0 4.688257035923016e-07
) O 0 1.0073603192925495e-12
n O 0 1.0522433618875837e-11
repeat O 0 2.0967590511067336e-11
, O 0 1.7377653406969867e-13
present O 0 3.755648136233303e-12
at O 0 2.5033428021487003e-12
a O 0 6.967802799583839e-14
copy O 0 3.800913403462225e-11
number O 0 2.3184481678234503e-12
of O 0 8.39789262435664e-12
5 O 0 7.761068870903998e-11
- O 0 3.2824301610112627e-10
37 O 0 4.5149300964553163e-10
repeats O 0 7.2117346816558126e-12
on O 0 1.7431847632032316e-11
normal O 0 4.4771553131539576e-10
chromosomes O 0 6.908843636077577e-11
but O 0 2.642787724771445e-11
amplified O 0 1.976853347684937e-09
to O 0 6.360648119319023e-11
50 O 0 5.020472926275943e-10
- O 0 8.843577259387558e-11
3000 O 0 5.086746995841551e-11
copies O 0 5.6915645807453785e-11
on O 0 1.247190017927835e-09
DM B-Disease 1 0.9999998807907104
chromosomes O 0 1.6082297804587142e-07
. O 0 8.131692652568745e-09

Previous O 0 2.595841692709655e-07
findings O 0 4.9845705341056146e-09
in O 0 9.556844204894333e-11
Caucasian O 0 1.1205613104081635e-09
populations O 0 4.528068458381496e-12
of O 0 1.868683593281295e-12
a O 0 2.8701966151012392e-11
DM B-Disease 1 1.0
founder O 0 1.0544837095949333e-05
chromosome O 0 8.269742224342735e-09
raise O 0 6.772298277724076e-10
a O 0 2.8643144171607016e-13
question O 0 5.601356184437023e-12
about O 0 1.908273242385867e-14
the O 0 2.1120494133990142e-13
molecular O 0 1.320694638720643e-12
events O 0 5.023070718049305e-13
involved O 0 9.622865655353752e-13
in O 0 1.9637048064014007e-12
the O 0 4.007533888072956e-11
expansion O 0 1.461578023054244e-07
mutation O 0 7.614579189407777e-09
. O 0 9.96597115943132e-09

To O 0 2.3730386544684734e-09
investigate O 0 6.194175838913907e-09
whether O 0 1.0001975914164518e-09
a O 0 1.2289172457435882e-10
founder O 0 3.9964773712597434e-09
chromosome O 0 1.6281873072010455e-10
for O 0 7.380700217662906e-12
the O 0 9.626079489066797e-09
DM B-Disease 1 1.0
mutation O 0 3.272536019949257e-09
exists O 0 1.3176400075198824e-12
in O 0 9.79361431768756e-15
the O 0 8.741011556332324e-15
Japanese O 0 2.0877641629390986e-11
population O 0 1.7046959885900527e-14
, O 0 3.3131941065472556e-14
we O 0 8.268448317520771e-13
genotyped O 0 1.518675674105907e-08
families O 0 3.741912595750518e-12
using O 0 8.319434008884075e-13
polymorphic O 0 1.7212453684578577e-09
markers O 0 2.315376113060097e-09
near O 0 3.085624200593884e-09
the O 0 1.274027217057494e-09
( O 0 1.93108706109113e-11
CTG O 0 8.001181299732707e-07
) O 0 6.201129020000362e-12
n O 0 5.844949524380638e-10
repeat O 0 9.619852692210884e-10
region O 0 1.880161720757556e-10
and O 0 8.431967797595252e-12
constructed O 0 1.3881900073897668e-08
haplotypes O 0 1.025889915240441e-07
. O 0 2.9441393323281773e-08

Six O 0 3.7047783507659915e-08
different O 0 5.944019165760039e-10
haplotypes O 0 1.670638916095868e-08
were O 0 2.228899877165791e-11
found O 0 1.8997409981930113e-12
and O 0 2.2231425034213714e-11
DM B-Disease 1 1.0
alleles O 0 7.791924327982258e-10
were O 0 4.775944084656203e-10
always O 0 3.17880777256363e-10
haplotype O 0 2.7083379983139366e-09
A O 0 3.563745964996201e-09
. O 0 4.850286838831153e-09

To O 0 7.564417425776071e-10
find O 0 1.6669124414114833e-11
an O 0 2.091243031607931e-15
origin O 0 2.4164671999504783e-12
of O 0 2.5324565361417584e-11
the O 0 9.491103042380544e-11
( O 0 3.0301369052798677e-12
CTG O 0 9.43593718716329e-08
) O 0 7.899776752889887e-13
n O 0 1.768647901745357e-11
repeat O 0 1.4055463737339124e-10
mutation O 0 1.6255150003807728e-11
and O 0 3.4173200293835526e-12
to O 0 1.9937500001648845e-12
investigate O 0 8.722825239892984e-11
the O 0 3.9526413392332316e-11
mechanism O 0 3.711734253286636e-10
of O 0 9.722170846160338e-10
the O 0 8.722542826911095e-11
expansion O 0 6.314984091204678e-09
mutation O 0 2.292352418997723e-11
in O 0 7.853879222322058e-13
the O 0 1.0821054339041347e-12
Japanese O 0 4.501258532574326e-10
population O 0 3.1083542315589463e-13
we O 0 8.861934488102116e-14
have O 0 3.52467790468592e-14
studied O 0 1.7737414184995637e-12
90 O 0 2.196042609911575e-12
Japanese O 0 6.15466178022217e-10
DM B-Disease 1 1.0
families O 0 3.017883443146019e-10
comprising O 0 3.5797296116940602e-12
190 O 0 1.40657555047774e-11
affected O 0 6.988523648665534e-11
and O 0 3.0140681617218945e-11
130 O 0 1.7691962339583256e-09
unaffected O 0 8.014263244149333e-07
members O 0 3.759378641721156e-10
. O 0 1.0769804603683042e-08

The O 0 4.780469353704575e-08
results O 0 1.8959763536940955e-08
suggest O 0 9.42765865374895e-09
that O 0 4.9627155683518165e-12
a O 0 1.3675082767561353e-11
few O 0 3.196762576873624e-10
common O 0 1.5787625651242365e-09
ancestral O 0 3.1668713518229197e-07
mutations O 0 2.8559139497730257e-09
in O 0 3.06581732223421e-10
both O 0 1.7355156201048771e-10
Caucasian O 0 6.524555340448046e-10
and O 0 1.4663222025479428e-11
Japanese O 0 2.3403567084301358e-08
populations O 0 6.18010365105448e-11
have O 0 1.6450980389135644e-13
originated O 0 1.3196672487419958e-12
by O 0 2.9918345497434787e-14
expansion O 0 4.01520233728192e-10
of O 0 2.2509660801972586e-11
an O 0 5.920551592389356e-14
ancestral O 0 1.949477107521247e-10
n O 0 2.7545925609939736e-11
= O 0 2.9513694006083613e-12
5 O 0 5.5089431280630485e-12
repeat O 0 2.0634555262383225e-12
to O 0 5.388539007361581e-12
n O 0 2.2856691539452356e-10
= O 0 2.79364781308189e-10
19 O 0 3.114199564890896e-09
- O 0 2.693871570258466e-09
37 O 0 1.6455532492187785e-09
copies O 0 8.715678734283472e-10
. O 0 4.3815595596186085e-09

These O 0 4.776717910104367e-10
data O 0 2.0752897664233494e-11
support O 0 1.16267637878531e-11
multistep O 0 6.818953579568188e-08
models O 0 6.063916924148316e-09
of O 0 2.0411130208231043e-07
triplet O 0 1.5554247511317953e-05
repeat O 0 6.0787157529773594e-09
expansion O 0 2.5932083147495177e-08
that O 0 1.4045935638543061e-12
have O 0 8.891020921884471e-14
been O 0 1.3347888231176903e-14
proposed O 0 1.1587217730452126e-12
for O 0 3.140732032086424e-13
both O 0 3.4476144161743605e-11
DM B-Disease 1 1.0
and O 0 6.211839931324903e-09
Friedreichs B-Disease 0 0.00029111848562024534
ataxia I-Disease 0 0.0004910668358206749
. O 0 1.1090674689739899e-07
. O 0 1.1459439264172033e-07

The O 0 1.184370101992016e-10
molecular O 0 2.583810110312612e-10
basis O 0 2.9705586879202883e-09
of O 0 1.0763756108644884e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.166782333203116e-10
the O 0 1.3571309354087902e-10
western O 0 1.5615185811057586e-09
Cape O 0 7.277269009620113e-09
, O 0 1.2322395707975442e-12
South O 0 1.6514501571807116e-11
Africa O 0 1.57120289001611e-11
. O 0 1.2098831658757803e-10

Deficiency B-Disease 1 0.9083520174026489
of I-Disease 0 2.150982936655055e-06
the I-Disease 0 3.328374305056059e-07
sixth I-Disease 0 7.135561645554844e-06
component I-Disease 0 6.809841011090612e-07
of I-Disease 0 1.2999940679492283e-07
human I-Disease 0 1.1895943785589225e-08
complement I-Disease 0 8.701649107933918e-07
( O 0 6.792475609751492e-11
C6 O 0 2.717110191952088e-06
) O 0 1.916855129485695e-12
has O 0 1.4549075919717547e-12
been O 0 1.5362754471337503e-12
reported O 0 7.624053840506184e-13
in O 0 1.888407101047554e-13
a O 0 3.94211708632311e-14
number O 0 1.6468182611854842e-13
of O 0 4.594910064416313e-13
families O 0 2.4171761597510666e-13
from O 0 1.8002370698756015e-13
the O 0 6.002103761920674e-12
western O 0 3.465271125602243e-10
Cape O 0 6.964844256884817e-09
, O 0 3.310045596990885e-12
South O 0 4.379031859347293e-11
Africa O 0 1.4245516224975496e-11
. O 0 3.733190701016298e-10

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 7.208358909771562e-10
endemic O 0 3.8541843327966063e-11
in O 0 1.195081793942121e-12
the O 0 1.9440142204341093e-11
Cape O 0 2.0838921699350976e-08
and O 0 7.241337520932922e-13
almost O 0 1.3029543264632404e-13
all O 0 8.248278091354394e-15
pedigrees O 0 1.286768955277573e-11
of O 0 4.354991194055469e-12
total O 0 1.1262920907029184e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.0837195724144877e-10
C6Q0 O 0 9.987067460315302e-05
) O 0 2.065180058213878e-12
have O 0 1.0923905416305654e-13
been O 0 1.1367300736765326e-13
ascertained O 0 1.3055788672389212e-09
because O 0 1.0969229691237814e-10
of O 0 7.798555690108344e-10
recurrent O 0 1.720674663374666e-05
disease O 0 7.941649187159783e-07
. O 0 1.4268141512729926e-07

We O 0 3.1935036837182906e-09
have O 0 1.5029227862228822e-11
sequenced O 0 2.7582217065891257e-10
the O 0 2.6302559089086408e-11
expressed O 0 3.649640867298132e-10
exons O 0 1.0315660325943554e-08
of O 0 1.210405331519837e-09
the O 0 1.147404482537695e-08
C6 O 0 5.663574938807869e-06
gene O 0 4.861943139755631e-11
from O 0 3.063103937162026e-11
selected O 0 8.087847752635824e-11
cases O 0 8.001019291548062e-11
and O 0 5.388251043264569e-12
have O 0 3.8500363379150027e-13
found O 0 8.817007454003933e-13
three O 0 2.3698222746150466e-13
molecular O 0 9.004461620776283e-10
defects O 0 0.00013004944776184857
leading O 0 3.80230460450548e-07
to O 0 1.2604656873804743e-08
total O 0 8.753955626161769e-06
deficiency O 1 0.9701817035675049
879delG O 0 0.00045015374780632555
, O 0 1.4884428412020867e-10
which O 0 4.721441120014713e-12
is O 0 1.0404918029602306e-12
the O 0 3.864327260960643e-11
common O 0 3.4274298954528604e-09
defect O 0 5.308469752662859e-08
in O 0 1.309714225961045e-09
the O 0 4.2606105310483144e-09
Cape O 0 6.53325287203188e-08
and O 0 2.781428212750292e-11
hitherto O 0 1.8480078578519965e-09
unreported O 0 8.248015048728519e-10
, O 0 7.203098252410445e-13
and O 0 1.4880069832551301e-12
1195delC O 0 5.0582107391505815e-09
and O 0 3.1131926897520756e-11
1936delG O 0 3.2668186378259634e-08
, O 0 7.442576069327522e-12
which O 0 1.3069323184441983e-12
have O 0 6.286828262841437e-12
been O 0 2.1641344966072396e-11
previously O 0 2.7421480017220112e-11
reported O 0 1.286842681025302e-11
in O 0 4.750747711890213e-11
African O 0 8.276250518246542e-11
- O 0 7.824748626816813e-10
Americans O 0 1.5390867746933878e-10
. O 0 7.705538984659199e-10

We O 0 7.323501449718606e-08
also O 0 1.1414987011182376e-10
show O 0 3.2888878252756992e-12
that O 0 8.291876571215467e-15
the O 0 1.7703074249586503e-12
879delG O 0 1.1704836211379188e-08
and O 0 3.7733347696411457e-11
1195delC O 0 1.0603642977002892e-06
defects O 0 6.257654149521841e-06
are O 0 6.055885827527252e-12
associated O 0 1.3483866800889643e-10
with O 0 3.0720676003070935e-11
characteristic O 0 0.0005291732377372682
C6 O 1 1.0
/ O 0 0.00045115925604477525
C7 O 0 4.1685889300424606e-05
region O 0 7.559675552215595e-09
DNA O 0 7.600910123528593e-09
marker O 0 1.0204311173822589e-08
haplotypes O 0 7.446293359691936e-09
, O 0 2.4429100235756618e-12
although O 0 1.5393384483752826e-11
small O 0 4.1775909988273074e-12
variations O 0 5.945992032074798e-10
were O 0 2.356933537228656e-10
observed O 0 6.639971239508213e-09
. O 0 4.97113816777528e-08

The O 0 4.768612527072946e-08
1936delG O 0 4.884481313638389e-06
defect O 0 6.227181188478426e-07
was O 0 1.8768099963040186e-08
observed O 0 1.0441473241584731e-09
only O 0 3.025801137424011e-11
once O 0 3.564177425419146e-11
in O 0 3.171549394637152e-12
the O 0 5.400683025791331e-11
Cape O 0 2.566518553237529e-08
, O 0 7.465091912683963e-13
but O 0 1.4053680094661125e-12
its O 0 2.0582275033625974e-12
associated O 0 9.013981228100931e-10
haplotype O 0 2.2668549704008e-08
could O 0 1.2699221674239425e-09
be O 0 6.261106633154156e-10
deduced O 0 1.8115052569100953e-07
. O 0 1.756387035811713e-08

The O 0 1.5592933166885814e-08
data O 0 5.036989159101779e-10
from O 0 3.540510246091699e-11
the O 0 1.0563381419581575e-10
haplotypes O 0 1.9607211410033187e-09
indicate O 0 1.9579210475129116e-10
that O 0 4.030980464784367e-13
these O 0 1.5730739627572987e-11
three O 0 1.974559188031022e-12
molecular O 0 6.111053885149431e-10
defects O 0 2.8254126505089516e-07
account O 0 1.4343073950762175e-10
for O 0 1.3569445567185312e-10
the O 0 4.1943982864722784e-07
defects O 1 0.9999994039535522
in O 0 7.499384537368314e-06
all O 0 1.958501982812777e-08
the O 0 4.252994845188596e-09
38 O 0 3.989516272895344e-09
unrelated O 0 7.929743972567849e-09
C6Q0 O 0 7.563590042991564e-05
individuals O 0 7.005579449881338e-11
we O 0 3.892586253329e-11
have O 0 3.987319589088267e-12
studied O 0 9.754485413848712e-11
from O 0 3.227767228844436e-12
the O 0 7.846984173554006e-11
Cape O 0 4.527369412699045e-08
. O 0 3.78009534784951e-09

We O 0 5.077281706178383e-09
have O 0 7.609500703165128e-12
also O 0 1.4515335277059255e-13
observed O 0 1.8313380326095974e-12
the O 0 7.852894549909006e-12
879delG O 0 7.630371356981414e-08
defect O 0 6.841295174808693e-08
in O 0 7.378821997860996e-10
two O 0 4.4475506610908155e-11
Dutch O 0 0.0001448873954359442
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 1.668510890340258e-06
, O 0 1.7508513085531807e-12
but O 0 1.0821549819434173e-12
the O 0 4.161496841570411e-11
879delG O 0 1.0892998858480496e-07
defect O 0 3.124297904832929e-07
in O 0 2.2218984430111277e-09
the O 0 3.493737077420178e-09
Cape O 0 1.1289009194115351e-07
probably O 0 4.5886808242023847e-10
did O 0 1.3147437132043915e-11
not O 0 2.232191428225283e-12
come O 0 1.5809365969121636e-11
from O 0 1.9206795442289204e-12
The O 0 1.885058602268952e-11
Netherlands O 0 5.780918105324773e-11
. O 0 2.594570044922584e-11
. O 0 1.0361284052962105e-09

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.8612463509603003e-09
seven O 0 5.3660596799343097e-11
further O 0 1.5147226528622326e-10
molecular O 0 9.661288657980549e-08
defects O 0 0.004710144363343716
and O 0 1.7658855488988934e-09
their O 0 5.15160136771442e-10
associated O 0 2.2099595042845976e-08
marker O 0 7.356989044637885e-07
haplotypes O 0 4.150738845964952e-07
. O 0 3.3448568359517594e-08

Seven O 0 1.3390429876025678e-09
further O 0 1.3376503897599701e-11
molecular O 0 6.298188637288149e-10
bases O 0 8.208846047352836e-09
of O 0 0.3836067020893097
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.497884979557057e-09
described O 0 3.100230960839667e-09
. O 0 3.192273778651611e-09

All O 0 4.0719831950752905e-09
these O 0 6.273774555420886e-11
new O 0 4.1407940964965917e-10
molecular O 0 1.948221584058274e-09
defects O 0 3.8833739779420284e-08
involve O 0 2.1792459503622297e-10
single O 0 4.411306736562537e-11
- O 0 6.522949957954438e-10
nucleotide O 0 8.630506087570211e-09
events O 0 2.1306811870402953e-10
, O 0 1.294669059459519e-11
deletions O 0 2.4436359602475477e-09
and O 0 8.354047453806857e-10
substitutions O 0 7.975126337100846e-09
, O 0 3.418625799112007e-11
some O 0 1.495359565339971e-11
of O 0 2.47556836141527e-10
which O 0 4.095619329791411e-11
alter O 0 2.482512684309768e-07
splice O 0 4.363947425645165e-07
sites O 0 4.278104270838412e-08
, O 0 3.7682284376172603e-11
and O 0 2.1130267674474013e-11
others O 0 1.5959099319839964e-10
codons O 0 7.69257937349721e-08
. O 0 1.233126454280864e-07

They O 0 2.745505156553918e-09
are O 0 5.543452415851524e-12
distributed O 0 1.4246820737029431e-11
along O 0 7.986230426970664e-11
the O 0 6.394357265904205e-10
C7 O 0 1.3475982996169478e-06
gene O 0 3.3408539823476247e-11
, O 0 1.8853740183649714e-12
but O 0 1.721909290500201e-12
predominantly O 0 1.1149824553219334e-12
towards O 0 1.3190362864456961e-11
the O 0 6.085461995430919e-11
3 O 0 1.1411160905083761e-09
end O 0 5.4008739702737785e-09
. O 0 9.399002465215744e-09

All O 0 1.099997604114833e-08
were O 0 2.9846874971539705e-10
found O 0 2.8564488014498624e-12
in O 0 2.5593667810075438e-12
compound O 0 6.925144457881061e-09
heterozygous O 0 1.4002116133227105e-09
individuals O 0 3.0111146215316964e-11
. O 0 6.651823536429902e-09

The O 0 1.01569994512829e-05
C6 O 1 0.8890559077262878
/ O 0 0.0001292971574002877
C7 O 0 4.4455435272539034e-05
marker O 0 4.975957068609205e-08
haplotypes O 0 1.9074420265496883e-08
associated O 0 1.1674641253733853e-09
with O 0 2.928006795355209e-11
most O 0 3.5017244215396204e-08
C7 B-Disease 1 0.9999997615814209
defects I-Disease 1 0.9997976422309875
are O 0 9.196172712222506e-09
tabulated O 0 1.143034040751445e-07
. O 0 9.481139207068168e-10
. O 0 2.9736595408280664e-09

A O 0 2.1384082629083423e-06
genome O 0 6.571082877826484e-08
- O 0 7.452772621263648e-09
wide O 0 4.5555775818328925e-10
search O 0 6.967650414968496e-12
for O 0 2.2301221470639315e-13
chromosomal O 0 3.6161488026209554e-08
loci O 0 1.0256120930307588e-07
linked O 0 1.4244010344555136e-06
to O 0 2.4829465150588703e-09
mental O 1 1.0
health O 1 0.6413363814353943
wellness O 0 1.8619792854224215e-06
in O 0 2.652998480623392e-12
relatives O 0 1.3257530490085045e-11
at O 0 1.1958153651320247e-13
high O 0 1.6509902819872302e-11
risk O 0 6.542871106018922e-11
for O 0 2.3286036987535397e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9650623798370361
the O 0 3.649059721055892e-08
Old O 0 9.248118715277087e-08
Order O 0 3.729408248887012e-08
Amish O 0 2.568394847912714e-07
. O 0 2.5690789495769195e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 7.389680263258924e-07
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 6.365340965430732e-08
is O 0 6.543832836714003e-11
characterized O 0 1.335178495542877e-10
by O 0 5.699513343920826e-12
episodes O 0 1.557318940470509e-09
of O 0 8.44844416647561e-10
mania B-Disease 0 2.645773236054083e-07
and O 0 1.7233961480123128e-10
/ O 0 2.0431883740457124e-08
or O 0 2.1078110090666513e-10
hypomania B-Disease 0 6.99497419986983e-08
interspersed O 0 3.7600436653129066e-11
with O 0 2.3815966085642855e-15
periods O 0 1.4148616722664542e-09
of O 0 3.217045518866257e-10
depression B-Disease 0 5.140202006259642e-07
. O 0 1.0446084530713051e-07

Compelling O 0 9.66182298611784e-08
evidence O 0 5.799607460943434e-10
supports O 0 4.160457048318911e-11
a O 0 3.304770194480222e-13
significant O 0 8.176023746919725e-11
genetic O 0 2.4328608017043507e-09
component O 0 9.042953763582773e-08
in O 0 5.926155677293821e-10
the O 0 6.548421360719203e-09
susceptibility O 0 1.049689672072418e-05
to O 0 6.914166306160041e-08
develop O 1 0.5126380324363708
BPAD B-Disease 1 1.0
. O 0 0.009804843924939632

To O 0 9.930534172752914e-11
date O 0 2.5147264182123763e-07
, O 0 2.0403892117548672e-11
however O 0 2.4904248108192917e-10
, O 0 5.956315302091397e-12
linkage O 0 1.6896541943367538e-09
studies O 0 1.87344514901433e-11
have O 0 3.374826459956459e-13
attempted O 0 6.040615230240576e-11
only O 0 4.615025809423523e-12
to O 0 1.2158834702957755e-11
identify O 0 4.631008077016219e-10
chromosomal O 0 1.9665129968871042e-07
loci O 0 9.938526090991218e-08
that O 0 6.591169970926458e-11
cause O 0 9.698450043060802e-09
or O 0 1.087960537632382e-11
increase O 0 1.1575626741866518e-11
the O 0 9.011896784372198e-11
risk O 0 1.8986716643354384e-09
of O 0 1.288516515707272e-09
developing O 0 8.276969310827553e-06
BPAD B-Disease 1 1.0
. O 0 0.00046835350804030895

To O 0 6.66642963054187e-09
determine O 0 8.611925395030084e-09
whether O 0 2.499501050579056e-09
there O 0 2.332747051081441e-10
could O 0 3.5134738868292104e-11
be O 0 1.5817208653956527e-11
protective O 0 9.009860946207482e-07
alleles O 0 4.2490033713704634e-10
that O 0 1.0591898452066983e-12
prevent O 0 2.259478715238572e-11
or O 0 1.8370274051937585e-11
reduce O 0 3.297269957069915e-10
the O 0 1.6709082728549873e-10
risk O 0 1.6530024016248035e-09
of O 0 1.1763670038078544e-09
developing O 0 7.078359658407862e-07
BPAD B-Disease 1 1.0
, O 0 1.3023804257272786e-09
similar O 0 1.7302832777676969e-10
to O 0 3.787046631148483e-12
what O 0 4.07897890811193e-13
is O 0 9.192426754143189e-15
observed O 0 1.0675275767535464e-12
in O 0 2.9612709853688024e-12
other O 0 4.966899336267261e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.044290076443691e-12
we O 0 3.470656379477022e-13
used O 0 3.050789482150762e-11
mental O 0 0.37715944647789
health O 0 0.0010031959973275661
wellness O 0 4.357120815257076e-06
( O 0 1.1032810814026392e-13
absence O 0 1.5683164836244323e-11
of O 0 2.6601631054196107e-12
any O 0 1.7920324113518404e-09
psychiatric B-Disease 1 0.9999998807907104
disorder I-Disease 0 7.396645855806128e-07
) O 0 6.654639404628238e-13
as O 0 4.638490980202192e-12
the O 0 3.971443313099954e-11
phenotype O 0 6.903568827709705e-09
in O 0 2.0593252103573434e-10
our O 0 1.5370046346774302e-09
genome O 0 2.6596583269089535e-10
- O 0 1.1465550731060148e-09
wide O 0 2.7186997098027632e-09
linkage O 0 4.804516784417956e-09
scan O 0 1.1549250444886638e-07
of O 0 4.170606970888002e-09
several O 0 1.51840484630128e-10
large O 0 4.39508374139308e-10
multigeneration O 0 8.850860240272596e-07
Old O 0 2.734907411650056e-08
Order O 0 4.4836628632083375e-08
Amish O 0 2.3076205479810596e-07
pedigrees O 0 6.815845665641973e-08
exhibiting O 0 4.240260087495784e-10
an O 0 4.286316039516652e-14
extremely O 0 2.4667731746141897e-10
high O 0 9.26610232987457e-10
incidence O 0 8.817042207454051e-09
of O 0 2.1450366816111455e-08
BPAD B-Disease 1 1.0
. O 0 0.0012135376455262303

We O 0 9.011290558191831e-08
have O 0 2.71870859158696e-10
found O 0 1.2004533651854832e-11
strong O 0 2.0738482545828996e-12
evidence O 0 5.061658123889368e-12
for O 0 2.0865118443777475e-13
a O 0 5.169182681723228e-13
locus O 0 9.684368758311468e-12
on O 0 2.858343006728603e-10
chromosome O 0 1.3646955787649517e-09
4p O 0 3.601169282774208e-06
at O 0 1.1210915529247245e-09
D4S2949 O 0 6.164935939523275e-08
( O 0 8.823971826658894e-13
maximum O 0 3.1809913036973114e-10
GENEHUNTER O 0 5.25328596268082e-06
- O 0 1.0212176881907453e-08
PLUS O 0 8.306622945042363e-09
nonparametric O 0 2.1098081504078436e-08
linkage O 0 1.3177626767557626e-09
score O 0 5.7416116999720046e-11
= O 0 1.0885764945706145e-12
4 O 0 2.2240659834638077e-12
. O 0 8.397210878030581e-14
05 O 0 2.670923759939825e-10
, O 0 7.330726303766966e-12
P O 0 8.841646526036584e-09
= O 0 2.3881641022377442e-12
5 O 0 3.4623276468082054e-12
. O 0 1.0633733612619781e-13
22 O 0 1.0725836885328022e-11
x O 0 2.8198848811555877e-10
10 O 0 1.4830189853931586e-10
( O 0 3.8410363756812005e-13
- O 0 2.1769652747138935e-10
4 O 0 9.386166843761146e-11
) O 0 2.4025671114592285e-14
; O 0 1.1198267790488159e-12
SIBPAL O 0 3.1109236715565203e-06
Pempirical O 0 1.2084895217867597e-07
value O 0 6.14858386427386e-10
< O 0 1.7387957740311322e-10
3 O 0 1.3606136183008655e-11
x O 0 3.1889900442561014e-11
10 O 0 6.676790630794072e-12
( O 0 4.127624755661738e-14
- O 0 5.829159377412907e-11
5 O 0 8.491995995285606e-11
) O 0 6.692542841527788e-14
) O 0 1.8084760577095904e-13
and O 0 3.370544078215576e-12
suggestive O 0 6.774387995012177e-11
evidence O 0 3.5154899824529906e-12
for O 0 2.5900530093055096e-13
a O 0 5.081817779084563e-12
locus O 0 1.0997342619889494e-10
on O 0 9.32203558789979e-09
chromosome O 0 2.1239682013174388e-08
4q O 0 2.958542779651907e-07
at O 0 8.722081390466485e-10
D4S397 O 0 7.289052206260749e-08
( O 0 1.802003641790395e-12
maximum O 0 4.681416365670543e-10
GENEHUNTER O 0 3.353063220856711e-05
- O 0 2.877881044582864e-08
PLUS O 0 1.8244280752810482e-08
nonparametric O 0 1.5872144487616424e-08
linkage O 0 1.3370217155639352e-09
score O 0 4.5322613717591054e-11
= O 0 5.118489182845409e-13
3 O 0 1.330436086820208e-12
. O 0 1.0366166068977514e-13
29 O 0 2.0685173018897274e-10
, O 0 5.325882096451906e-12
P O 0 8.396304096436324e-09
= O 0 2.3865250053933806e-12
2 O 0 5.526508070619052e-12
. O 0 3.50747073529431e-13
57 O 0 4.4765722378992123e-11
x O 0 3.032204209940659e-10
10 O 0 7.052556455500181e-11
( O 0 3.567656153141696e-13
- O 0 2.2132687349518676e-10
3 O 0 5.439066211310184e-11
) O 0 2.1507243956695593e-14
; O 0 1.2477424692416972e-12
SIBPAL O 0 3.7463662465597736e-06
Pempirical O 0 3.1797273436495743e-07
value O 0 1.1677224742712156e-09
< O 0 2.389679287784219e-10
1 O 0 4.663127523008015e-11
x O 0 1.71856764930034e-10
10 O 0 2.6892535073819168e-11
( O 0 2.344505882836967e-13
- O 0 1.4062784270407747e-10
3 O 0 4.3195533955264764e-11
) O 0 5.9904401961640135e-15
) O 0 1.7069269251423548e-15
that O 0 2.0914264142410117e-15
are O 0 1.8321754974726795e-13
linked O 0 1.3461286529903305e-09
to O 0 5.825897098077348e-09
mental O 1 1.0
health O 1 0.999947190284729
wellness O 0 0.000711878587026149
. O 0 4.6450165314126934e-07

These O 0 9.856910843097921e-09
findings O 0 4.412927356867158e-09
are O 0 3.195369533207093e-12
consistent O 0 7.652208033892549e-11
with O 0 4.413362172462146e-14
the O 0 4.735627688601252e-12
hypothesis O 0 1.7385437534045423e-10
that O 0 9.841482690635742e-14
certain O 0 6.193405233112514e-10
alleles O 0 2.487618999680308e-10
could O 0 5.1273860157685647e-11
prevent O 0 2.097304996340199e-09
or O 0 7.100936505466393e-10
modify O 0 2.637619900269783e-08
the O 0 1.5910106565542037e-10
clinical O 0 3.230622158678642e-10
manifestations O 0 2.7588491491314926e-09
of O 0 6.476967295832026e-10
BPAD B-Disease 1 1.0
and O 0 4.5107358820350996e-11
perhaps O 0 5.665418481570761e-11
other O 0 5.7855369800519085e-12
related O 0 1.011915628623683e-05
affective B-Disease 1 0.9999992847442627
disorders I-Disease 1 0.9999995231628418
. O 0 1.733002318360377e-05

Segregation O 0 1.4159918464429211e-05
distortion O 0 8.534029802831355e-06
in O 0 1.6873788410975976e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 5.214007251197472e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.828015960825269e-08
DM B-Disease 1 1.0
) O 0 9.322257549237989e-11
is O 0 8.737524592739021e-12
an O 0 8.970835359278784e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999929666519165
disease I-Disease 1 0.9854961037635803
which O 0 6.750831230833976e-12
, O 0 2.284018514684544e-13
in O 0 2.108571834930767e-13
the O 0 2.3323576143347013e-12
typical O 0 3.2473890243522874e-10
pedigree O 0 7.93182741709586e-10
, O 0 3.272335744389232e-13
shows O 0 1.930809895647756e-12
a O 0 3.843645508209287e-13
three O 0 2.70278135809654e-12
generation O 0 5.231914101955226e-08
anticipation O 0 1.2526354566944065e-06
cascade O 0 8.834011282488063e-07
. O 0 1.761812384870609e-08

This O 0 4.951710048939351e-12
results O 0 1.1340204469911797e-10
in O 0 3.538277726367056e-10
infertility B-Disease 0 0.0002304977097082883
and O 0 8.971688281178558e-09
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.35186150741174e-10
CDM B-Disease 0 2.8572620180966624e-07
) O 0 2.969628056371902e-14
with O 0 2.209197239952539e-15
the O 0 6.400570720134502e-13
disappearance O 0 4.4403543342230734e-11
of O 0 1.3257164255264797e-09
DM B-Disease 1 1.0
in O 0 7.649764377504198e-09
that O 0 1.0220858187581783e-10
pedigree O 0 1.0616275858410518e-07
. O 0 4.345986237552779e-09

The O 0 2.92572632787369e-09
concept O 0 6.757411519231482e-09
of O 0 3.0211044776962126e-09
segregation O 0 6.9782473133273015e-09
distortion O 0 2.5068536135819386e-09
, O 0 5.265287446494515e-13
where O 0 3.4096485942818056e-13
there O 0 1.753084778581028e-14
is O 0 2.583917204279553e-15
preferential O 0 2.349432454140654e-11
transmission O 0 6.963983209540281e-12
of O 0 2.172727709554012e-12
the O 0 7.905176513389733e-12
larger O 0 8.962562636494198e-11
allele O 0 4.359911737195077e-12
at O 0 5.904813530493991e-12
the O 0 6.706186994609453e-11
DM B-Disease 1 1.0
locus O 0 3.915223978356863e-10
, O 0 4.081797833760392e-12
has O 0 4.3896982403202056e-13
been O 0 1.1448051707996232e-12
put O 0 1.6113830755837277e-11
forward O 0 1.8410419855285909e-09
to O 0 1.3113382602014667e-10
explain O 0 1.4041725560076657e-09
partially O 0 6.693947618430229e-10
the O 0 5.084348306955144e-12
maintenance O 0 6.819746545261296e-08
of O 0 2.0380818810394885e-08
DM B-Disease 1 1.0
in O 0 4.154173005588291e-09
the O 0 8.622291769455614e-10
population O 0 1.6247928349977236e-11
. O 0 1.7791644546516494e-10

In O 0 7.684682334918591e-10
a O 0 7.021119796668529e-12
survey O 0 1.4243778032052568e-11
of O 0 2.7638762806203587e-11
DM B-Disease 1 1.0
in O 0 4.0221589614475306e-08
Northern O 0 4.7172832751130045e-08
Ireland O 0 4.094920402764046e-09
, O 0 3.0249244081792526e-11
59 O 0 2.3314004060637217e-09
pedigrees O 0 8.46452952174559e-09
were O 0 5.171682873617023e-11
ascertained O 0 1.1967246393851383e-07
. O 0 2.9191948414108992e-08

Sibships O 0 1.2965640053153038e-05
where O 0 1.0026367514015533e-09
the O 0 6.057252616153974e-11
status O 0 6.485661341315563e-09
of O 0 4.25834389972124e-09
all O 0 1.4933652925375185e-10
the O 0 5.474320441400948e-10
members O 0 7.706574961519053e-12
had O 0 5.4598648518977555e-11
been O 0 6.5824854247886755e-12
identified O 0 6.935152972731284e-12
were O 0 1.4610066628728546e-11
examined O 0 3.092374412094756e-10
to O 0 9.352899314404861e-13
determine O 0 2.336544152603537e-11
the O 0 2.0576436388086705e-11
transmission O 0 7.575390315039954e-10
of O 0 4.475891601796178e-10
the O 0 1.6568794336535575e-08
DM B-Disease 1 1.0
expansion O 0 0.00012266254634596407
from O 0 1.823457473904e-08
affected O 0 3.477206007573841e-07
parents O 0 8.296849318689681e-10
to O 0 4.7273369246925157e-11
their O 0 1.3775964813333985e-09
offspring O 0 1.8191417439084034e-07
. O 0 1.1137348820966508e-08

Where O 0 7.568313753480993e-10
the O 0 2.512299535073481e-10
transmitting O 0 4.764525840528222e-07
parent O 0 3.752338884055462e-09
was O 0 1.4488817257074516e-08
male O 0 5.927933699467758e-09
, O 0 1.3778743424008866e-10
58 O 0 2.524685882576705e-08
. O 0 1.3609220417265533e-08

3 O 0 8.705286802523915e-08
% O 0 3.9063699497354776e-10
of O 0 3.3221977252528845e-11
the O 0 8.48623116223024e-11
offspring O 0 6.8560006560858255e-09
were O 0 6.837062582754072e-10
affected O 0 1.988402109631693e-09
, O 0 8.203606197132451e-12
and O 0 4.150840261785138e-12
in O 0 3.555375828814822e-12
the O 0 5.0704995757655524e-12
case O 0 3.1552177537363946e-11
of O 0 2.2154795359385915e-12
a O 0 7.533679084216482e-13
female O 0 1.0774062197960177e-11
transmitting O 0 6.961497600599387e-09
parent O 0 4.942609654889907e-10
, O 0 7.610839736216235e-11
68 O 0 7.940553814478335e-08
. O 0 1.0857259269414499e-07

7 O 0 8.455454576505872e-07
% O 0 2.8270596974522277e-09
were O 0 1.613789102350438e-10
affected O 0 1.1002914135360697e-08
. O 0 4.9499824683607585e-08

Studies O 0 2.2778637642772992e-08
on O 0 6.613210534744951e-10
meiotic O 0 2.3393486969780497e-07
drive O 0 2.7726715146059178e-08
in O 0 2.4519525965160938e-08
DM B-Disease 1 1.0
have O 0 9.178556803490778e-10
shown O 0 1.648132693689297e-12
increased O 0 3.276628100790102e-12
transmission O 0 4.032735517051078e-12
of O 0 1.1083346832538657e-13
the O 0 2.2741769405143497e-13
larger O 0 3.063143272016844e-12
allele O 0 2.423349064820113e-12
at O 0 1.8428448871066205e-12
the O 0 3.112504004532113e-11
DM B-Disease 1 0.9999903440475464
locus O 0 2.8972702015295226e-10
in O 0 1.554254988600512e-11
non O 0 3.959634398142953e-08
- O 0 2.400774974375963e-07
DM O 1 1.0
heterozygotes O 0 3.8176818861757056e-07
for O 0 2.8563265641601276e-10
CTGn O 0 1.8274049580213614e-05
. O 0 3.5332028858192643e-08

This O 0 2.5217488097695195e-09
study O 0 1.955431788713824e-10
provides O 0 1.23704770927692e-13
further O 0 1.0830132770407383e-13
evidence O 0 4.909369894119664e-13
that O 0 1.0978318135210913e-13
the O 0 2.8663043050158876e-09
DM B-Disease 1 1.0
expansion O 0 0.07492007315158844
tends O 0 6.777214025532885e-07
to O 0 2.1419671591971223e-11
be O 0 3.976741505540282e-11
transmitted O 0 3.3839797630719204e-09
preferentially O 0 4.5679374949259e-08
. O 0 3.4183424979516985e-09

Diagnosis O 1 0.9882709383964539
of O 0 2.5900188120431267e-05
hemochromatosis B-Disease 1 1.0
. O 1 0.5775754451751709

If O 0 5.12358155901893e-07
untreated O 1 0.9999377727508545
, O 0 1.0703163910719127e-09
hemochromatosis B-Disease 1 1.0
can O 0 2.4297362344327667e-08
cause O 0 0.00017438546638004482
serious O 0 3.3656767755019246e-06
illness O 0 2.8771029974450357e-05
and O 0 2.416836045529558e-12
early B-Disease 0 2.1821701390312143e-10
death I-Disease 0 1.388493209297792e-10
, O 0 8.02449740770067e-14
but O 0 2.46779539078007e-13
the O 0 3.8663681631301294e-12
disease O 0 3.566661410658867e-10
is O 0 1.7594672734825428e-13
still O 0 1.0322370128795777e-12
substantially O 0 1.8186806505227082e-09
under O 0 4.170292129401787e-07
- O 0 0.008057836443185806
diagnosed O 0 0.007239908911287785
. O 0 7.421361942760996e-07

The O 0 2.3618186517637696e-08
cornerstone O 0 7.885380910011008e-06
of O 0 1.2464932419575803e-09
screening O 0 1.7710245003854652e-07
and O 0 5.641800828598553e-12
case O 0 2.551024148866876e-11
detection O 0 1.414308559155586e-09
is O 0 8.29441157142001e-14
the O 0 4.4865855280094846e-13
measurement O 0 1.6141062098018466e-10
of O 0 1.6217461401568656e-11
serum O 0 2.0018492419282552e-10
transferrin O 0 6.48960885030192e-09
saturation O 0 5.9446452205236255e-09
and O 0 5.3283206839782604e-12
the O 0 5.322815539027248e-12
serum O 0 4.544434550890486e-10
ferritin O 0 4.706094713924358e-08
level O 0 8.3320434995926e-09
. O 0 2.104028284932724e-09

Once O 0 1.9986236665658907e-08
the O 0 1.1755904583132804e-10
diagnosis O 0 3.522555971358088e-06
is O 0 5.740918591207178e-12
suspected O 0 4.2726200355502897e-10
, O 0 1.630455319368007e-11
physicians O 0 3.6337552411502827e-10
must O 0 6.691149023740905e-11
use O 0 3.5276104259907015e-10
serum O 0 3.849752658879879e-07
ferritin O 0 6.33367380942218e-05
levels O 0 2.410286288068164e-05
and O 0 5.230135879941145e-09
hepatic O 0 3.9202215702971444e-05
iron O 0 4.574099511955865e-05
stores O 0 5.6873627585218856e-08
on O 0 2.2041364289293597e-09
liver O 0 4.70815697539706e-09
biopsy O 0 1.0096875557863427e-09
specimens O 0 6.338895380819665e-11
to O 0 5.495633245353182e-13
assess O 0 3.6096765576587586e-09
patients O 0 1.0192795940611177e-08
for O 0 4.379948660704347e-12
the O 0 2.061734533098658e-10
presence O 0 1.898063262117944e-09
of O 0 1.2751465305882448e-07
iron B-Disease 1 0.9999496936798096
overload I-Disease 0 0.02962031215429306
. O 0 2.329753897356568e-06

Liver O 1 0.9992095232009888
biopsy O 0 0.11608560383319855
is O 0 8.227243886160807e-10
also O 0 1.4006262512647472e-12
used O 0 1.1354650943443123e-12
to O 0 4.021828009515005e-12
establish O 0 2.0291895941326743e-10
the O 0 2.0668924904931885e-10
presence O 0 1.0360335922499075e-09
or O 0 4.996440594595697e-09
absence O 0 7.533969892392633e-07
of O 0 5.8375132283572384e-08
cirrhosis B-Disease 1 0.9999977350234985
, O 0 8.091403523764751e-13
which O 0 1.1608353608059691e-14
can O 0 2.543995558917239e-13
affect O 0 5.108602252335004e-08
prognosis O 1 1.0
and O 0 8.772673254497931e-09
management O 0 2.155531930725374e-08
. O 0 1.4054887920167403e-08

A O 0 2.0455670934893533e-08
DNA O 0 4.310307222255005e-09
- O 0 4.2428002777761264e-10
based O 0 9.294147916560913e-12
test O 0 3.179485147386529e-11
for O 0 4.507259149244547e-12
the O 0 1.054052289894969e-09
HFE O 0 2.6924250050797127e-05
gene O 0 2.0107579490336036e-10
is O 0 7.398145681139501e-13
commercially O 0 3.8422716397423784e-11
available O 0 2.6208299853253125e-12
, O 0 8.83046687529844e-14
but O 0 1.4500641627116645e-13
its O 0 2.16294674228526e-14
place O 0 6.007197235306794e-13
in O 0 3.581979683567674e-14
the O 0 4.864257325924715e-13
diagnosis O 0 5.3361020491138333e-08
of O 0 1.968974494559461e-08
hemochromatosis B-Disease 1 1.0
is O 0 7.956999503733186e-09
still O 0 1.2064219068186333e-10
being O 0 2.1201481542609812e-11
evaluated O 0 1.533795668251514e-08
. O 0 1.5735505343172917e-08

Currently O 0 2.7455837603440614e-09
, O 0 6.471095360949253e-12
the O 0 2.970856199935312e-11
most O 0 1.293950710468117e-11
useful O 0 1.600689199243721e-11
role O 0 4.3713027989000786e-12
for O 0 3.0164991598330415e-12
this O 0 6.379305937664892e-12
test O 0 2.347068650543349e-10
is O 0 3.785997123445517e-13
in O 0 1.0322797982078094e-13
the O 0 1.2038480835026982e-13
detection O 0 3.3182159797640054e-10
of O 0 5.726947804873816e-10
hemochromatosis B-Disease 1 1.0
in O 0 7.416558389650163e-08
the O 0 2.6973587807788135e-08
family O 0 1.855707115749894e-10
members O 0 3.6686395566386254e-13
of O 0 5.7908167844233915e-11
patients O 0 4.467756831161296e-09
with O 0 7.763781344162154e-14
a O 0 3.3867316503316536e-12
proven O 0 3.971348583320378e-09
case O 0 1.4526276848059183e-09
of O 0 7.239636667932814e-10
the O 0 1.3258410369587637e-08
disease O 0 2.523045168345561e-07
. O 0 2.295457868228823e-08

It O 0 6.78302119333507e-12
is O 0 3.0990065114783194e-13
crucial O 0 1.416607942061887e-10
to O 0 1.3172694879326485e-10
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 6.811153525632108e-07
because O 0 4.879317505590564e-10
phlebotomy O 0 1.3888096873415634e-05
therapy O 0 2.2301149371628526e-08
can O 0 2.3257708259283305e-11
avert O 0 1.412479377904674e-07
serious O 0 0.00015092807007022202
chronic O 1 0.9881138205528259
disease O 0 4.178647543540137e-07
and O 0 1.0748794215809099e-11
can O 0 1.3376421281394157e-12
even O 0 2.5171715406502315e-11
lead O 0 7.47874852324859e-12
to O 0 3.68097739789075e-12
normal O 0 7.847579297504126e-08
life O 0 6.984795519748843e-10
expectancy O 0 1.0407592565542245e-09
. O 0 2.4041844903788245e-11
. O 0 1.0696999952486408e-09

Prevalence O 0 2.881289219658356e-06
of O 0 4.2427861224325625e-09
the O 0 2.107173990850697e-08
I1307K O 0 1.910182982101105e-05
APC B-Disease 0 2.405973305030784e-07
gene O 0 1.328289839230834e-10
variant O 0 7.563291659629101e-10
in O 0 7.780125502176993e-12
Israeli O 0 9.358529923231274e-11
Jews O 0 6.957016907005453e-11
of O 0 2.3230163452570007e-12
differing O 0 8.169429716042842e-11
ethnic O 0 1.9211878182073816e-13
origin O 0 2.425092245073035e-12
and O 0 2.6031342879873076e-12
risk O 0 3.803845294303443e-10
for O 0 1.5290112287402735e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.049189323675819e-06

BACKGROUND O 1 0.5306242108345032
& O 0 6.977783755246492e-07
AIMS O 0 1.9481074531313425e-08
Israeli O 0 1.5976092671010633e-10
Jews O 0 1.1094510032894078e-10
of O 0 3.597594444570973e-12
European O 0 1.778064501190002e-11
birth O 0 8.102233550744131e-08
, O 0 8.515087072946681e-12
i O 0 1.3683797150942922e-11
. O 0 3.8111692621245474e-12
e O 0 3.8589344393547e-12
. O 0 1.3961400395154366e-12
, O 0 1.7351066330245635e-12
Ashkenazim O 0 2.66919002456234e-08
, O 0 6.724624112761091e-13
have O 0 4.050634068615555e-13
the O 0 3.58291646351816e-10
highest O 1 0.5080108046531677
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 2.8179522715277017e-08
of O 0 3.2806301078491806e-12
any O 0 1.0582009227211309e-11
Israeli O 0 2.82070011792257e-08
ethnic O 0 7.038628346833775e-09
group O 0 4.5363371392603824e-10
. O 0 9.212213769593802e-10

The O 0 1.6303154382057983e-07
I1307K O 0 1.366850938211428e-05
APC B-Disease 0 1.2062521648203983e-07
gene O 0 8.782792548789331e-11
variant O 0 2.10978678971685e-09
was O 0 3.0103768366984696e-09
found O 0 7.8130529823639e-11
in O 0 2.6061372504493363e-10
6 O 0 6.223488213663586e-08
. O 0 1.195154908373297e-08

1 O 0 5.4884818467826335e-08
% O 0 7.672551483040024e-11
of O 0 1.3259268899848409e-12
American O 0 3.7656236093717987e-13
Jews O 0 1.4971832801302654e-11
, O 0 2.6436521700055893e-13
28 O 0 1.6133705482701544e-10
% O 0 5.338147892469669e-12
of O 0 8.610351147353423e-12
their O 0 5.729258845121876e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.0392125204816693e-06
, O 0 1.6147081501743932e-12
but O 0 1.3535234131417662e-12
not O 0 2.1726904129992786e-12
in O 0 2.181415638402573e-11
non O 0 7.047602057497215e-09
- O 0 7.111156108408068e-10
Jews O 0 1.9757564473366074e-09
. O 0 1.2225238599228305e-09

We O 0 2.5689136151640923e-08
assessed O 0 1.5585386847760674e-07
the O 0 2.0383996712780572e-09
I1307K O 0 2.7945361580350436e-07
prevalence O 0 2.7788804590755944e-09
in O 0 9.590592886911734e-14
Israeli O 0 2.477077137158501e-12
Jews O 0 1.5338110989637777e-11
of O 0 1.323885012033399e-12
differing O 0 1.5059622993085497e-10
ethnic O 0 8.072258139701916e-13
origin O 0 7.9518449117022e-12
and O 0 6.402112347203559e-12
risk O 0 7.860634920753284e-10
for O 0 3.252463187664034e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.1851230889733415e-06

METHODS O 0 1.7209595171152614e-06
DNA O 0 3.31396243780091e-08
samples O 0 2.3882087418769515e-09
from O 0 1.3636793950999593e-11
500 O 0 6.740255489162683e-12
unrelated O 0 2.8863531356670968e-11
Jews O 0 7.088010040012804e-11
of O 0 6.256781898139607e-11
European O 0 2.4735388737262554e-10
or O 0 1.599887167191838e-10
non O 0 9.45345579594914e-10
- O 0 8.447533471345192e-12
European O 0 3.5125140643299524e-12
origin O 0 4.3150552575532686e-12
, O 0 2.0058239940420712e-14
with O 0 2.9611406274217364e-16
or O 0 3.77026426572058e-14
without O 0 2.86263937901432e-12
a O 0 5.957493613012455e-13
personal O 0 2.8470364954458205e-10
and O 0 8.470157214501839e-11
/ O 0 1.231544288771147e-08
or O 0 3.376351143113965e-10
family O 0 2.8334484064584942e-11
history O 0 4.541910597621879e-11
of O 0 3.8616453784667826e-11
neoplasia B-Disease 0 7.017384717755704e-08
, O 0 1.0900107205724652e-11
were O 0 1.6554490417375334e-11
examined O 0 4.184780855176484e-10
for O 0 2.9858858441311753e-12
the O 0 6.045929035192188e-11
I1307K O 0 2.1415362816412653e-09
variant O 0 6.358367304892809e-11
by O 0 4.7510446098131265e-12
the O 0 4.340944964598137e-11
allele O 0 2.2940888771971757e-11
- O 0 2.9183110789032796e-11
specific O 0 9.392397970486854e-11
oligonucleotide O 0 1.8645893717916806e-08
( O 0 1.8254278297269444e-11
ASO O 0 4.387124590721214e-06
) O 0 1.935116129836434e-12
method O 0 2.1124928473170712e-09
. O 0 2.228425666217504e-09

RESULTS O 0 1.3464010635289014e-06
In O 0 1.893907253247562e-10
persons O 0 2.4497563699821256e-11
at O 0 1.8571145055795713e-12
average O 0 3.360819955666727e-11
risk O 0 2.46735659681363e-10
for O 0 1.91726474696452e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.7436254662328565e-09
I1307K O 0 3.235657786149204e-08
was O 0 2.23101065399689e-10
found O 0 1.260079280501758e-11
in O 0 4.0211629165343155e-11
5 O 0 2.936415555154781e-09
. O 0 1.7493017034908576e-09

0 O 0 8.664933659474627e-08
% O 0 7.035252241882617e-11
of O 0 3.5471734056991e-12
120 O 0 5.868740909908965e-11
European O 0 1.409154043452432e-10
and O 0 5.468309693945628e-10
1 O 0 7.100536691950765e-08
. O 0 8.969207598852336e-09

6 O 0 4.0023041947279125e-07
% O 0 8.958482844434457e-10
of O 0 1.0092499058700355e-10
188 O 0 1.91639371038832e-09
non O 0 5.213204090637191e-09
- O 0 2.473019844462243e-10
European O 0 2.518133201956374e-10
Jews O 0 7.1464438811119635e-09
( O 0 3.0858549222856357e-12
P O 0 1.2091923018431316e-08
= O 0 7.895547930736324e-12
0 O 0 1.1483747980323145e-11
. O 0 2.8622885854014124e-13
08 O 0 1.9146792484825426e-10
) O 0 1.686773008595377e-12
. O 0 5.986914297650969e-10

It O 0 1.7321490075605794e-10
occurred O 0 2.6180174472756335e-08
in O 0 3.636057011036087e-10
15 O 0 2.978654878305065e-09
. O 0 5.807004654911907e-09

4 O 0 5.009907866337926e-08
% O 0 7.680546476596106e-11
of O 0 6.970202626882527e-12
52 O 0 2.929248232863557e-10
Ashkenazi O 0 1.3249858987762764e-09
Israelis O 0 4.552982435512831e-09
with O 0 7.791534084589102e-11
familial O 0 5.92047545069363e-05
cancer B-Disease 1 0.9717838168144226
( O 0 2.3077902436274833e-11
P O 0 1.0708154718486185e-07
= O 0 6.223713818614973e-12
0 O 0 5.3610033079465325e-12
. O 0 1.2047598975297585e-13
02 O 0 7.26091192379541e-12
) O 0 7.882640226046077e-15
and O 0 2.4574241838486166e-13
was O 0 1.054212012824296e-11
not O 0 4.57397878253496e-12
detected O 0 7.796908008117498e-09
in O 0 6.978430611148667e-10
51 O 0 5.464047880820999e-09
non O 0 4.682820797796694e-09
- O 0 6.616878572840434e-11
European O 0 7.078913410313303e-12
Jews O 0 1.71064037934876e-10
at O 0 4.369129363857027e-11
increased O 0 1.4790091817928896e-08
cancer B-Disease 0 1.1161846487084404e-06
risk O 0 3.6262932656683233e-09
. O 0 7.93791521402909e-09

Colorectal B-Disease 1 0.9999263286590576
neoplasia I-Disease 0 0.0037818229757249355
occurred O 0 4.2601048335200176e-05
personally O 0 1.855744358181255e-08
or O 0 2.388407006892468e-11
in O 0 4.151022407750116e-12
the O 0 1.1687283953121241e-11
families O 0 7.065802370281871e-12
of O 0 7.707225135877849e-11
13 O 0 1.8880570717971779e-10
of O 0 3.2711050534928177e-10
20 O 0 6.809653951833639e-10
Ashkenazi O 0 1.2352016076633276e-09
I1307K O 0 1.850335662467728e-09
carriers O 0 8.511762822349667e-11
, O 0 1.2496907805456536e-12
8 O 0 2.4797067177395604e-11
of O 0 2.4367499337762943e-11
whom O 0 1.4931068603729614e-09
also O 0 4.898281780185698e-11
had O 0 4.787746310519481e-10
a O 0 3.008680457550206e-11
personal O 0 4.4554962386200714e-08
or O 0 1.14759857172686e-09
family O 0 6.422749138090822e-11
history O 0 1.029616947256784e-10
of O 0 1.9369385262368866e-10
noncolonic O 0 2.2526595785166137e-05
neoplasia B-Disease 0 0.0008360256906598806
. O 0 1.230597717949422e-06

CONCLUSIONS O 0 4.295911367080407e-06
The O 0 1.990729359135912e-08
I1307K O 0 1.6055618061727728e-06
APC O 0 3.1093048136199286e-08
variant O 0 9.467192363388222e-09
may O 0 1.3326229897359099e-08
represent O 0 1.234631619162485e-09
a O 0 1.9961417241365353e-10
susceptibility O 0 8.058279377110011e-08
gene O 0 5.323734786344403e-10
for O 0 2.955480526978249e-09
colorectal B-Disease 1 1.0
, I-Disease 0 2.6457644707988948e-05
or I-Disease 0 3.485563411231851e-06
other I-Disease 0 1.6714972161935293e-07
, I-Disease 0 1.2507276325735006e-09
cancers I-Disease 0 3.0102808068477316e-06
in O 0 5.88470550066944e-10
Ashkenazi O 0 9.770023901012337e-09
Jews O 0 2.4896518180383964e-09
, O 0 3.211689811669083e-12
and O 0 1.995503805599097e-12
partially O 0 3.333275322425777e-10
explains O 0 1.674228464199068e-11
the O 0 1.1016814630698812e-12
higher O 0 8.339671730972498e-10
incidence O 0 1.5849758838726302e-08
of O 0 9.448110915855068e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.848127537788628e-10
European O 0 1.7542056696129293e-10
Israelis O 0 2.81526468803861e-09
. O 0 1.746757849474534e-09

Systematic O 0 3.9986923494605975e-11
analysis O 0 2.3593106635022565e-12
of O 0 1.3069354626304985e-11
coproporphyrinogen O 0 1.7367841564919217e-06
oxidase O 0 2.541662979638204e-06
gene O 0 1.4760958322312945e-07
defects O 0 0.0004417354066390544
in O 0 3.248290525448283e-08
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 8.26329539904691e-07
mutation O 0 6.563166010664645e-08
update O 0 7.05147670032602e-07
. O 0 2.2956687928399333e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.2246982922524694e-08
HC B-Disease 1 0.9999992847442627
) O 0 2.1942685515807803e-11
is O 0 5.87702412777058e-13
an O 0 2.545451642434887e-13
acute O 0 0.05424068868160248
hepatic B-Disease 1 1.0
porphyria I-Disease 1 0.9999997615814209
with O 0 1.4685858751306569e-08
autosomal O 1 1.0
dominant O 1 0.9999998807907104
inheritance O 0 0.0036319689825177193
caused O 0 2.8726367951037446e-09
by O 0 5.954827343029878e-12
deficient B-Disease 0 4.0092068331887276e-08
activity I-Disease 0 2.4246230023727833e-10
of I-Disease 0 3.312175533842776e-11
coproporphyrinogen I-Disease 0 3.943065166822635e-06
III I-Disease 1 1.0
oxidase I-Disease 0 1.6622880139038898e-05
( O 0 1.53889367915383e-09
CPO O 0 2.1184146135055926e-06
) O 0 5.518502755458288e-12
. O 0 3.9775552296283934e-10

Clinical O 0 1.3780592098555644e-06
manifestations O 0 9.60014403972309e-07
of O 0 3.7550882403536434e-09
the O 0 1.2271893501392128e-09
disease O 0 3.492739253374566e-08
are O 0 1.6872476180963825e-14
characterized O 0 1.9608058869613997e-14
by O 0 2.6169497951565764e-15
acute O 0 8.093886116888882e-10
attacks O 0 4.417771270331938e-12
of O 0 8.939493767456952e-08
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 6.389472062551249e-09
precipitated O 0 4.429755173784855e-11
by O 0 2.3438785702362304e-14
drugs O 0 2.46536883789783e-12
, O 0 4.474618917581219e-14
fasting O 0 7.742177454694854e-10
, O 0 1.235794279408342e-11
cyclical O 0 1.637951640987012e-07
hormonal O 0 3.929262604174255e-08
changes O 0 4.193668079466306e-09
, O 0 2.2717523695536812e-10
or O 0 2.0829868674354657e-07
infectious B-Disease 0 0.0001897132460726425
diseases I-Disease 0 5.202068109610991e-07
. O 0 1.7448405387199273e-08

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 6.906728231115267e-05
also O 0 3.128892422932239e-10
be O 0 1.9288267164019324e-11
present O 0 2.4848509916353123e-09
. O 0 1.5547140463922915e-08

The O 0 2.408670809472824e-07
seven O 0 3.252387026364545e-09
exons O 0 2.9106201893114303e-09
, O 0 1.023556326501529e-11
the O 0 2.3197510579109348e-10
exon O 0 9.238224407681628e-09
/ O 0 4.751377957745717e-09
intron O 0 1.1870172400563206e-08
boundaries O 0 1.4521678304291186e-09
and O 0 2.625304140746465e-11
part O 0 1.1194926236024472e-10
of O 0 2.1601362920620204e-09
3 O 0 2.1543717920735617e-09
noncoding O 0 7.789843770034111e-10
sequence O 0 4.415901238424835e-12
of O 0 4.3196546339885344e-10
the O 0 1.0181604004344535e-08
CPO O 0 1.3599783414974809e-06
gene O 0 1.496055883343228e-11
were O 0 3.991628208521725e-11
systematically O 0 4.6067589846987556e-12
analyzed O 0 1.4493108102531238e-11
by O 0 2.769033646040503e-13
an O 0 1.3889041826364856e-13
exon O 0 8.201450629741203e-11
- O 0 3.347851856849715e-11
by O 0 3.290539368761003e-11
- O 0 6.801728602567891e-08
exon O 0 3.326279340853944e-08
denaturing O 0 1.872097982413834e-06
gradient O 0 4.7085723764439535e-08
gel O 0 1.2927685588692839e-08
electrophoresis O 0 4.468657943679233e-10
( O 0 3.080644463485105e-12
DGGE O 0 4.436540621099994e-06
) O 0 6.642629697163616e-13
strategy O 0 5.5376637303483633e-11
followed O 0 2.4692325007596994e-12
by O 0 8.345318929176351e-14
direct O 0 7.306437573018076e-12
sequencing O 0 2.2355566287046713e-09
in O 0 3.1699012859043307e-10
seven O 0 2.639937435322537e-10
unrelated O 0 4.5192937392357635e-08
heterozygous O 0 2.6098694316800675e-09
HC B-Disease 0 0.00011561377323232591
patients O 0 1.7286904494540067e-06
from O 0 2.7851193573624755e-10
France O 0 2.7218580167520656e-10
, O 0 9.701599766598346e-12
Holland O 0 1.280044159557292e-08
, O 0 2.2977673583279845e-11
and O 0 5.487866758246973e-11
Czech O 0 4.890662097523091e-08
Republic O 0 1.0022456109481936e-07
. O 0 4.168315967945091e-07

Seven O 0 4.583712893690972e-07
novel O 0 1.0470161271314282e-07
mutations O 0 3.8911278643638525e-09
and O 0 5.7955903964845845e-11
two O 0 2.009927597620975e-12
new O 0 4.3259537618745014e-10
polymorphisms O 0 1.8671522639124305e-07
were O 0 2.6572462008545017e-09
detected O 0 1.7533955087856157e-07
. O 0 2.1887627710270863e-08

Among O 0 1.4627048017246125e-07
these O 0 6.920348183392377e-10
mutations O 0 7.628570691808889e-11
two O 0 4.522854746974447e-12
are O 0 4.231546103100614e-12
missense O 0 7.927733136625648e-09
( O 0 8.858288993822405e-13
G197W O 0 3.198363529577364e-08
, O 0 2.0573260109402192e-11
W427R O 0 1.0161078201065266e-08
) O 0 7.328723131833081e-13
, O 0 1.1941089393327498e-12
two O 0 3.71162248071627e-13
are O 0 1.7394672941623002e-12
nonsense O 0 1.8239227905780808e-09
( O 0 5.691342037407454e-13
Q306X O 0 8.340788504312968e-09
, O 0 1.1116788045661963e-11
Q385X O 0 1.2148699823910647e-08
) O 0 1.5372250998166304e-12
, O 0 2.2386209639485566e-12
two O 0 3.1022829704435706e-13
are O 0 8.740470370041664e-13
small O 0 3.062325349897921e-12
deletions O 0 2.616003247357668e-10
( O 0 2.2379038726316747e-12
662de14bp O 0 3.4960052630594873e-08
; O 0 7.938815577146485e-11
1168del3bp O 0 1.301956871202492e-07
removing O 0 3.266799808443466e-08
a O 0 1.1958012358093129e-10
glycine O 0 8.798067135940002e-11
at O 0 3.246596325112705e-10
position O 0 1.9000580275818635e-10
390 O 0 9.1150996472944e-11
) O 0 2.922628908634192e-14
, O 0 2.1195756738298654e-13
and O 0 4.262106076055594e-13
one O 0 1.066690613333969e-13
is O 0 1.2326143727123089e-14
a O 0 6.89774639858233e-14
splicing O 0 2.4875052018202837e-10
mutation O 0 2.1323438847975495e-10
( O 0 5.451784314790264e-13
IVS1 O 0 2.6723844825937704e-07
- O 0 1.9940600559653632e-10
15c O 0 4.734442615728085e-09
- O 0 8.561424486019931e-11
- O 0 1.4133424985907084e-10
> O 0 6.99043323226789e-10
g O 0 6.463216767338409e-11
) O 0 1.3372554677633895e-14
which O 0 2.927594554584176e-14
creates O 0 2.730705852410642e-12
a O 0 1.6009013505038222e-13
new O 0 9.482291341011972e-11
acceptor O 0 1.0041032005858597e-08
splice O 0 1.029587011203148e-07
site O 0 2.1044385789537046e-08
. O 0 3.9852876554391514e-09

The O 0 6.0513465349743e-09
pathological O 0 8.360096614978829e-08
significance O 0 2.2723094517118625e-08
of O 0 3.437669704453583e-09
the O 0 1.2694161277693183e-09
point O 0 8.408351237498835e-10
mutations O 0 7.645172689363378e-12
G197W O 0 5.617980747274487e-09
, O 0 5.9008058855836154e-12
W427R O 0 2.386889441652329e-08
, O 0 1.749119772631591e-11
and O 0 1.0123205225476273e-11
the O 0 1.3037790291825502e-10
in O 0 6.473049180000245e-11
- O 0 2.527439368904538e-10
frame O 0 2.6602229308281267e-09
deletion O 0 1.0088694324394964e-09
390delGly O 0 2.814142474605319e-09
were O 0 7.590135117641061e-12
assessed O 0 3.738625728444411e-11
by O 0 7.87318235780099e-13
their O 0 2.2249750653013933e-11
respective O 0 1.0195863042739006e-09
expression O 0 4.682083887264099e-11
in O 0 1.960273306525484e-12
a O 0 4.700350351993787e-13
prokaryotic O 0 1.7144923258882727e-09
system O 0 5.514815271112639e-10
using O 0 1.792133108580174e-11
site O 0 2.842436730432496e-09
- O 0 8.473975410261403e-10
directed O 0 1.5971340916465238e-10
mutagenesis O 0 4.138109034101944e-06
. O 0 1.366120727652742e-08

These O 0 1.1875556094054218e-09
mutations O 0 1.944733610259597e-11
resulted O 0 5.506193764825973e-11
in O 0 3.20139661308394e-12
the O 0 3.3693180190308425e-11
absence O 0 5.71393377057916e-09
or O 0 8.946657650832357e-12
a O 0 8.983450376816304e-13
dramatic O 0 2.8233509974384674e-10
decrease O 0 7.277216695911193e-08
of O 0 6.587458187823358e-07
CPO O 0 0.002804926596581936
activity O 0 1.069041672963067e-06
. O 0 3.598843889562886e-08

The O 0 5.136242364756072e-08
two O 0 2.1315103848618122e-10
polymorphisms O 0 1.5450590140630993e-08
were O 0 3.400249803942046e-10
localized O 0 5.0559152420248665e-09
in O 0 3.3924635323145935e-10
noncoding O 0 3.543914317560848e-08
part O 0 2.6656002405367474e-10
of O 0 2.8725544165553174e-09
the O 0 6.355536097402137e-09
gene O 0 3.522873399247617e-12
1 O 0 2.7892232967730024e-10
) O 0 2.4525857622473106e-14
a O 0 3.844424778520761e-12
C O 0 3.5189768876620064e-09
/ O 0 6.275904795849385e-11
G O 0 1.6856684104116226e-10
polymorphism O 0 4.562488234438611e-11
in O 0 1.908479017181941e-12
the O 0 3.890381766735729e-11
promotor O 0 6.152472309395307e-08
region O 0 8.239948723343105e-10
, O 0 1.7446617067706782e-11
142 O 0 8.937234285966156e-10
bp O 0 1.7777271876795453e-09
upstream O 0 3.775784684911798e-10
from O 0 4.158400186693445e-12
the O 0 2.0161593748679874e-12
transcriptional O 0 1.0521275517483275e-10
initiation O 0 3.4916836089138314e-10
site O 0 3.4177083385600326e-10
( O 0 5.6188882621146727e-14
- O 0 1.8692263015207544e-11
142C O 0 9.971194980806786e-10
/ O 0 5.962001725645649e-11
G O 0 3.695747874399302e-10
) O 0 2.3988581235897914e-14
, O 0 1.9749272475635266e-13
and O 0 1.1368044092879837e-12
2 O 0 5.409631770314505e-11
) O 0 7.37534490945213e-14
a O 0 1.0563133701069205e-11
6 O 0 1.152158368711298e-09
bp O 0 1.7599306456617114e-09
deletion O 0 4.039065262806396e-11
polymorphism O 0 1.840500390981603e-10
in O 0 6.979142090635104e-12
the O 0 1.1173717333334832e-11
3 O 0 6.991723172644626e-11
noncoding O 0 5.466244679119825e-10
part O 0 2.874782356609984e-11
of O 0 6.882331926583163e-10
the O 0 1.345511151384926e-07
CPO O 0 5.9105474065290764e-05
gene O 0 6.193688339983794e-10
, O 0 1.2131134985438052e-10
574 O 0 3.590259822772168e-08
bp O 0 7.917789091038685e-09
downstream O 0 2.092254813845784e-09
of O 0 2.415302680081055e-11
the O 0 4.021720890340363e-12
last O 0 6.813206682859674e-12
base O 0 3.2282555101348365e-11
of O 0 8.583410891771504e-12
the O 0 1.9815248400445462e-11
normal O 0 8.411980445544032e-09
termination O 0 9.130285860692311e-08
codon O 0 7.670539758919404e-09
( O 0 3.5696744171698214e-11
+ O 0 2.4813697763192977e-09
574 O 0 1.4816690097063656e-08
delATTCTT O 0 1.5659657037758734e-07
) O 0 2.0785538221157474e-11
. O 0 1.5574198597434474e-09

Five O 0 6.612585679022231e-08
intragenic O 0 8.586597687099129e-06
dimorphisms O 0 1.6435313227702864e-05
are O 0 9.987164428792994e-10
now O 0 4.986134422013677e-11
well O 0 2.911776288833101e-12
characterized O 0 1.1995607632209193e-11
and O 0 8.010707982369913e-13
the O 0 9.444165068039911e-12
high O 0 4.2892117635418003e-10
degree O 0 2.4654514541033734e-10
of O 0 9.205428780356684e-11
allelic O 0 4.0014351831985095e-09
heterogeneity O 0 7.218818875998068e-09
in O 0 9.639922887716423e-11
HC B-Disease 0 1.6434969438705593e-05
is O 0 9.285806845671374e-11
demonstrated O 0 4.819759036323035e-10
with O 0 6.143815382657347e-13
seven O 0 1.895849796595961e-12
new O 0 4.143523631844337e-12
different O 0 6.699200113917392e-13
mutations O 0 6.006464314638194e-13
making O 0 7.181875536985127e-13
a O 0 1.1985304784224715e-13
total O 0 1.8122477260171244e-12
of O 0 1.1133429594911703e-10
nineteen O 0 7.782453508298204e-07
CPO O 0 0.025272168219089508
gene B-Disease 0 1.3170854629152018e-07
defects I-Disease 0 0.0003331234329380095
reported O 0 4.6335375536443735e-09
so O 0 3.8799866097782854e-10
far O 0 6.713228861698894e-10
. O 0 5.850479128932662e-11
. O 0 1.348047895533e-09

Coincidence O 0 1.0289405736330082e-06
of O 0 3.955979099856677e-09
two O 0 1.0274173005420106e-11
novel O 0 2.4702995204961553e-10
arylsulfatase O 0 1.3054255987299257e-07
A O 0 8.13855116632567e-09
alleles O 0 2.3041672736479057e-10
and O 0 4.997121466621124e-11
mutation O 0 1.125715007321837e-10
459 O 0 4.81811368580054e-10
+ O 0 6.493811738339517e-11
1G O 0 2.0036854664340353e-07
> O 0 2.564344736555313e-09
A O 0 2.2946325395345468e-10
within O 0 3.596697245589198e-11
a O 0 5.261244565013534e-12
family O 0 2.638879045835374e-11
with O 0 1.2386354962534707e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 5.884522730204012e-11
molecular O 0 1.6540635180972707e-11
basis O 0 1.6149491466332933e-11
of O 0 3.732061968492184e-12
phenotypic O 0 7.883130592745147e-09
heterogeneity O 0 3.4315314678678988e-06
. O 0 3.9329933088083635e-07

In O 0 4.58734428221419e-09
a O 0 7.948512681377196e-11
family O 0 9.428260949739808e-11
with O 0 1.904784273018545e-12
three O 0 9.530812944413825e-11
siblings O 0 1.4581560492388235e-07
, O 0 9.98672932545075e-13
one O 0 9.11527797686773e-14
developed O 0 8.599797957087318e-12
classical O 0 1.6039464867390052e-08
late O 0 0.00011006322893081233
infantile O 1 0.9306780695915222
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.6370274019971163e-11
MLD B-Disease 1 1.0
) O 0 4.435601191898897e-13
, O 0 4.940384039364698e-14
fatal O 0 3.0317499812720916e-12
at O 0 2.3713845123674027e-11
age O 0 1.1086012108307841e-09
5 O 0 1.1907780317343963e-10
years O 0 3.5801663283291374e-12
, O 0 3.064059151802051e-13
with O 0 1.2914596692406577e-12
deficient O 0 2.8137337722000666e-05
arylsulfatase O 0 0.0002686106017790735
A O 0 1.6120122381835245e-05
( O 0 1.1282987738558958e-10
ARSA O 0 1.6657443211443024e-06
) O 0 2.323688930074702e-13
activity O 0 2.2922518050361163e-11
and O 0 8.089918844414803e-14
increased O 0 9.601022060712339e-11
galactosylsulfatide O 0 4.323089797253488e-06
( O 0 7.163826754030822e-10
GS O 1 0.9999995231628418
) O 0 8.550424951403457e-11
excretion O 0 3.2355032431041764e-08
. O 0 7.301902416045891e-10

The O 0 2.1070177069759666e-07
two O 0 6.079742265185928e-11
other O 0 1.4225377820142882e-10
siblings O 0 1.0763602453778276e-08
, O 0 4.901213983277142e-12
apparently O 0 7.693441439471371e-09
healthy O 0 1.348518452459757e-07
at O 0 4.564120636985081e-09
12 O 0 1.2117543635170591e-09
( O 0 4.576865145558551e-13
1 O 0 1.3642219576226466e-09
/ O 0 3.8998467649653534e-11
2 O 0 3.4827422196181956e-11
) O 0 4.3106391835201225e-15
and O 0 2.0647024400518438e-13
15 O 0 5.023485100119629e-12
years O 0 4.763148642866755e-12
, O 0 2.3278587716300814e-13
respectively O 0 7.617240171953199e-12
, O 0 4.913041544776786e-13
and O 0 1.696377955641426e-12
their O 0 5.712500264487552e-11
father O 0 1.5635690520099388e-09
, O 0 4.253193630621155e-11
apparently O 0 9.524575261821155e-08
healthy O 0 4.6445823187468704e-08
as O 0 4.6610736104124584e-11
well O 0 7.2033663756077e-11
, O 0 5.198640129489007e-12
presented O 0 2.5168681361265044e-08
ARSA O 0 0.00012982296175323427
and O 0 4.753907045795813e-09
GS O 1 1.0
values O 0 8.242672322467115e-09
within O 0 2.8800566098663438e-11
the O 0 1.6754413611694274e-12
range O 0 1.4259660119364526e-10
of O 0 1.4370951650910513e-10
MLD B-Disease 1 1.0
patients O 0 0.0007577090873382986
. O 0 2.7153586046324563e-08

Mutation O 0 2.1245221137888848e-09
screening O 0 5.428003380103519e-09
and O 0 6.55342186767216e-12
sequence O 0 2.787369944232121e-12
analysis O 0 3.835787210863112e-13
disclosed O 0 3.478475563145622e-10
the O 0 2.8213199138038547e-11
involvement O 0 5.414940162928872e-10
of O 0 1.3597303283319206e-09
three O 0 5.4425530054968974e-11
different O 0 8.408997054232259e-09
ARSA O 0 0.00018178363097831607
mutations O 0 6.587465573026918e-10
being O 0 9.412946984366233e-12
the O 0 1.374511181956306e-11
molecular O 0 9.439524856214021e-11
basis O 0 1.4211355703341866e-10
of O 0 3.774716997306804e-11
intrafamilial O 0 7.971606805767806e-07
phenotypic O 0 8.333284995387658e-07
heterogeneity O 0 1.2382129170873668e-05
. O 0 8.316065418512153e-07

The O 0 5.470002228946669e-09
late O 0 9.57436623139074e-06
infantile O 0 1.4512249435938429e-05
patient O 0 6.3949451032385696e-06
inherited O 0 5.241311100689927e-06
from O 0 8.49602628250068e-08
his O 0 1.0515126405152841e-06
mother O 0 1.4481199173133064e-07
the O 0 1.1143079792219623e-09
frequent O 0 1.5059162250530278e-10
0 O 0 2.2815226097261387e-10
- O 0 9.865553513010994e-11
type O 0 8.02419242162955e-10
mutation O 0 5.42343725484784e-10
459 O 0 5.615513609669165e-10
+ O 0 2.9416410713550833e-12
1G O 0 2.19319118421879e-09
> O 0 9.803610180603162e-12
A O 0 8.254427523446406e-12
, O 0 3.5199680626860075e-14
and O 0 8.940933524147557e-14
from O 0 2.2689222462651815e-12
his O 0 7.811920554878782e-11
father O 0 3.9140221619327065e-10
a O 0 7.438115878430351e-13
novel O 0 1.0187538312944611e-10
, O 0 3.3580676759258077e-13
single O 0 8.284206653996762e-12
basepair O 0 3.388767666478998e-08
microdeletion O 0 7.476695174091219e-08
of O 0 5.872248243221634e-10
guanine O 0 3.264161996252568e-10
at O 0 7.758464010132471e-11
nucleotide O 0 5.138098835288929e-10
7 O 0 1.428310358875251e-09
in O 0 9.77687444891906e-11
exon O 0 6.31178087573403e-09
1 O 0 5.589038121200929e-09
( O 0 6.698627763590537e-12
7delG O 0 1.51457740571459e-07
) O 0 5.4291578177600996e-11
. O 0 6.396080554083028e-09

The O 0 7.285549941116187e-08
two O 0 1.7722359135774468e-09
clinically O 0 0.0021767127327620983
unaffected O 0 0.00011298101890133694
siblings O 0 7.872225182836701e-08
carried O 0 9.08957908940522e-11
the O 0 1.6287590720587275e-10
maternal O 0 3.0230549441512267e-07
mutation O 0 1.1107288422351758e-08
459 O 0 9.300137548962084e-09
+ O 0 4.577299650421196e-10
1G O 0 3.6455682561609137e-07
> O 0 2.4287436506398308e-09
A O 0 3.9943875984604915e-10
and O 0 1.7493590126829717e-12
, O 0 1.4518990393633247e-13
on O 0 1.4545615580063842e-11
their O 0 1.2909579655273618e-11
paternal O 0 7.472856999868327e-09
allele O 0 1.0344416295771097e-10
, O 0 1.6184082069284345e-12
a O 0 5.38154156654036e-13
novel O 0 7.291461184832926e-11
cytosine O 0 2.029691692495561e-11
to O 0 1.3744842937424284e-12
thymidine O 0 2.7006468172885434e-09
transition O 0 3.6115219703702905e-09
at O 0 2.259634979129288e-10
nucleotide O 0 1.438484353855074e-08
2435 O 0 1.8898730331784463e-06
in O 0 6.583671940951774e-10
exon O 0 1.644926506116917e-08
8 O 0 9.537509670920485e-10
, O 0 1.7468108394220333e-13
resulting O 0 2.3985769967427295e-12
in O 0 1.1051498258196624e-12
substitution O 0 1.5173314826810724e-09
of O 0 1.890666095905047e-10
alanine O 0 3.0281945839760738e-09
464 O 0 7.769459742235085e-09
by O 0 4.1924902438594813e-10
valine O 0 1.2167085969849722e-06
( O 0 7.617695363393295e-11
A464V O 0 2.3698424911344773e-07
) O 0 4.4596128873086727e-11
. O 0 1.2496284007568192e-09

The O 0 1.0962213359277939e-08
fathers O 0 2.9171689064355633e-08
genotype O 0 4.527064945136772e-09
thus O 0 9.143901608110738e-11
was O 0 2.843368041016703e-10
7delG O 0 6.534100975841284e-07
/ O 0 2.2542140243331232e-07
A464V O 0 1.3129811122780666e-06
. O 0 3.129014913838546e-08

Mutation O 0 6.943914740986656e-07
A464V O 0 9.897171366901603e-07
was O 0 1.4783710922117166e-09
not O 0 4.565541521228678e-12
found O 0 1.4371787180472717e-12
in O 0 1.063978440941915e-12
18 O 0 1.3521185560083637e-10
unrelated O 0 4.842750627176429e-07
MLD B-Disease 1 1.0
patients O 1 0.9999880790710449
and O 0 5.984018169868932e-09
50 O 0 6.983933431570222e-09
controls O 0 3.355195232757069e-08
. O 0 1.5433219857641234e-07

A464V O 0 3.839189957943745e-06
, O 0 2.326286524523269e-10
although O 0 8.619792102315671e-10
clearly O 0 9.2089855741051e-09
modifying O 0 6.513956122944364e-06
ARSA O 1 0.999962568283081
and O 0 9.633647550799651e-07
GS O 1 1.0
levels O 0 2.231057806056924e-05
, O 0 2.3212636673930476e-11
apparently O 0 3.003779724952693e-10
bears O 0 6.1111471438835e-10
little O 0 1.832099576215551e-12
significance O 0 1.2589140667429444e-11
for O 0 3.558698474792621e-13
clinical O 0 3.54104384703291e-11
manifestation O 0 6.6366032669407105e-09
of O 0 4.8769939198223256e-09
MLD B-Disease 1 1.0
, O 0 7.225786080589103e-10
mimicking O 0 1.0633821823091694e-08
the O 0 4.420354915435354e-10
frequent O 0 4.827361177461853e-09
ARSA O 0 0.00011956744128838181
pseudodeficiency O 0 1.6263154975604266e-05
allele O 0 1.3452768143906724e-06
. O 0 1.337377426580133e-07

Our O 0 1.3682826427441341e-08
results O 0 3.6914574175206383e-10
demonstrate O 0 4.062909730873088e-11
that O 0 8.25192880335706e-15
in O 0 1.6765145586898622e-13
certain O 0 8.83394572770424e-12
genetic O 0 1.3313537772230433e-10
conditions O 0 9.491203627476352e-07
MLD B-Disease 1 1.0
- O 0 0.10920129716396332
like O 0 3.885596910890854e-08
ARSA O 0 0.002504361094906926
and O 0 2.1857493592847277e-09
GS O 1 1.0
values O 0 7.129993262466883e-10
need O 0 2.3693037549260554e-12
not O 0 2.269075904818077e-14
be O 0 1.0407249030391832e-14
paralleled O 0 1.2961367222563691e-11
by O 0 7.326091637635188e-14
clinical O 0 9.372038700661278e-10
disease O 0 5.740847242030611e-10
, O 0 5.287881677668027e-13
a O 0 9.349082922757712e-13
finding O 0 1.6975935934748776e-10
with O 0 8.18999978512841e-13
serious O 0 9.404059753137517e-09
diagnostic O 0 1.2168118246336235e-06
and O 0 4.177517887171689e-09
prognostic O 1 0.9994365572929382
implications O 0 4.3610012653516605e-05
. O 0 1.9366491699202015e-07

Moreover O 0 2.790487769743777e-06
, O 0 8.716659616325728e-10
further O 0 3.441798313019717e-08
ARSA O 0 0.0003200125938747078
alleles O 0 1.4879277365764665e-08
functionally O 0 3.453112906726119e-09
similar O 0 2.975165946939029e-11
to O 0 6.607366129923742e-12
A464V O 0 2.892248751606985e-08
might O 0 8.553605740369008e-11
exist O 0 1.2346256829387503e-11
which O 0 4.697473421529097e-13
, O 0 2.284907560465982e-13
together O 0 8.187840596501905e-14
with O 0 4.885901186131407e-14
0 O 0 2.1582202691661223e-10
- O 0 2.7499061361346833e-10
type O 0 3.3820892753055887e-09
mutations O 0 1.2786282033161456e-09
, O 0 7.84329892700164e-12
may O 0 3.1818969681296494e-09
cause O 0 7.265559247571218e-07
pathological O 0 0.002167991129681468
ARSA O 0 0.016280263662338257
and O 0 4.839465272965526e-09
GS O 1 1.0
levels O 0 5.2242661752188724e-08
, O 0 1.0774646013725006e-13
but O 0 8.44446023930091e-15
not O 0 5.9531034073655176e-15
clinical O 0 7.105613298273583e-13
outbreak O 0 5.598368643666696e-11
of O 0 1.4938971934497225e-11
the O 0 3.963430972309112e-10
disease O 0 2.066590809590707e-08
. O 0 1.436276542143844e-09
. O 0 1.1793646059743423e-08

Human O 0 0.00043666138662956655
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 1.8210879716207273e-05
to O 0 1.5364573613396715e-08
hematological B-Disease 1 0.9999997615814209
malignancy I-Disease 1 0.9999988079071045
and O 0 4.860149172003503e-09
neurofibromatosis B-Disease 0 6.848383782198653e-05
type I-Disease 0 4.4995645112066995e-06
1 I-Disease 0 9.966285688278731e-06
. O 0 5.707325101411698e-08

Heterozygous O 0 5.35475983554079e-08
germ O 0 1.0206412071056548e-06
- O 0 4.424813582204479e-08
line O 0 2.5423817717751263e-08
mutations O 0 4.606304226939528e-11
in O 0 4.750117942216303e-13
the O 0 2.2229208491292285e-12
DNA O 0 3.835129547269389e-09
mismatch O 0 0.00018396636005491018
repair O 0 0.3257465660572052
genes O 0 1.6815988601592835e-07
lead O 0 1.6564465354917957e-08
to O 0 7.857925865550897e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.546124505897751e-06

The O 0 1.5747634307672342e-08
disease O 0 2.185191938508524e-08
susceptibility O 0 4.604756398407517e-08
of O 0 2.181427305458783e-08
individuals O 0 1.800275040153565e-09
who O 0 1.706998098427448e-08
constitutionally O 0 5.9247795434203e-05
lack O 0 3.470193041721359e-05
both O 0 1.2812079175361646e-10
wild O 0 1.1900022078847883e-09
- O 0 6.033360616664041e-11
type O 0 3.3668015597676515e-10
alleles O 0 3.196309536490638e-11
is O 0 7.224396861987836e-13
unknown O 0 4.950667098491124e-10
. O 0 3.893567968038525e-10

We O 0 4.684562959766936e-09
have O 0 2.2552248263307817e-11
identified O 0 3.52074550069581e-11
three O 0 8.255458897868037e-14
offspring O 0 3.962892514142169e-11
in O 0 3.889517017924976e-13
a O 0 1.765584033142087e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999977350234985
who O 0 1.7822697762071016e-09
developed O 0 1.0481185697130968e-08
hematological B-Disease 1 0.999998927116394
malignancy I-Disease 1 0.9998539686203003
at O 0 1.903240010037166e-09
a O 0 1.7775142252193787e-12
very O 0 2.1344779242704615e-12
early O 0 7.153122538738899e-10
age O 0 1.4224190714173801e-09
, O 0 1.873615845804366e-12
and O 0 4.642075786265298e-12
at O 0 1.8008500940469574e-11
least O 0 4.132387140809435e-12
two O 0 2.1874673296687352e-13
of O 0 8.640272199968158e-13
them O 0 9.04137536865933e-14
displayed O 0 4.923794878763932e-12
signs O 0 3.333109621639352e-10
of O 0 3.5596409153626496e-10
neurofibromatosis B-Disease 0 1.250192667612282e-06
type I-Disease 0 2.1894855706250382e-07
1 I-Disease 0 3.053833665944694e-07
( O 0 4.4245367786244216e-11
NF1 B-Disease 0 1.5793131751706824e-05
) O 0 2.640707930101627e-10
. O 0 1.2363171819629315e-08

DNA O 0 1.13736564610889e-09
sequence O 0 5.428440683075131e-12
analysis O 0 4.767517760781437e-13
and O 0 1.125489946466468e-13
allele O 0 2.5513721994482874e-13
- O 0 3.281542518187436e-13
specific O 0 3.826193376889331e-13
amplification O 0 3.06076330947036e-10
in O 0 1.4558939123721082e-11
two O 0 5.970533095700503e-12
siblings O 0 1.8887313935067596e-09
revealed O 0 2.549444544364121e-10
a O 0 2.832162282473405e-11
homozygous O 0 9.524934618809766e-09
MLH1 O 0 0.00029529587482102215
mutation O 0 8.982012467129152e-09
( O 0 1.204379152831836e-12
C676T O 0 3.770201928432471e-09
- O 0 3.552737659617833e-09
- O 0 4.062076897071165e-09
> O 0 1.8028186943297442e-08
Arg226Stop O 0 2.292544394322249e-07
) O 0 3.639550466560948e-12
. O 0 3.5743774606800116e-10

Thus O 0 8.717649535583405e-08
, O 0 6.788020145975793e-11
a O 0 6.723934777019824e-12
homozygous O 0 1.5487846560802154e-09
germ O 0 5.2097557272645645e-06
- O 0 4.126091823764e-07
line O 0 8.647974141240411e-07
MLH1 O 1 0.6479541063308716
mutation O 0 5.732100305522181e-08
and O 0 4.99109868018488e-12
consequent O 0 3.144728179904632e-05
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 0.9999990463256836
results O 0 5.273653300719161e-07
in O 0 7.954188419034836e-10
a O 0 1.0368159802931487e-10
mutator O 0 0.0003322581760585308
phenotype O 0 1.400755138547538e-07
characterized O 0 2.1023252583241003e-11
by O 0 3.857629547830005e-13
leukemia B-Disease 1 0.9546582698822021
and O 0 7.467741980349274e-09
/ O 1 0.9999992847442627
or O 0 0.1336648017168045
lymphoma B-Disease 1 1.0
associated O 0 0.00020789775589946657
with O 0 1.1037527558599436e-09
neurofibromatosis B-Disease 1 0.9998939037322998
type I-Disease 0 6.589724944205955e-05
1 I-Disease 0 2.8073707198927877e-06
. O 0 6.161121612890952e-10
. O 0 2.4284749766678715e-09

Missense O 0 0.0004746262275148183
mutations O 0 6.683682727270934e-07
in O 0 1.5420493770790245e-09
the O 0 1.2966424600691084e-09
most O 0 8.767327835945693e-11
ancient O 0 3.26649929327516e-09
residues O 0 8.272881935056375e-09
of O 0 1.922547121502305e-10
the O 0 1.4635238576587994e-09
PAX6 O 0 6.2335173424799e-05
paired O 0 3.69008645861868e-09
domain O 0 8.062699952127161e-10
underlie O 0 4.680577037063927e-10
a O 0 5.535588263813618e-13
spectrum O 0 1.781461733685319e-08
of O 0 6.783335004811875e-11
human O 0 4.3598458887572633e-07
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.0001348984515061602

Mutations O 0 1.710497770091024e-07
of O 0 4.910238882160911e-10
the O 0 9.61715013181319e-11
human O 0 2.9715829796828075e-10
PAX6 O 0 0.00018427941540721804
gene O 0 1.4170121076517717e-08
underlie O 0 0.002551708370447159
aniridia B-Disease 1 1.0
( O 0 6.266706805035938e-06
congenital B-Disease 1 1.0
absence I-Disease 0 0.35354140400886536
of I-Disease 0 5.529014288185863e-06
the I-Disease 0 1.1233058216930658e-07
iris I-Disease 0 1.0620725561238942e-06
) O 0 7.220429766238712e-13
, O 0 1.4207458451896693e-13
a O 0 3.594067318063443e-13
rare O 0 4.5224329170423516e-08
dominant O 1 0.9982377290725708
malformation B-Disease 1 1.0
of I-Disease 1 0.9999998807907104
the I-Disease 1 0.9999843835830688
eye I-Disease 1 0.9999998807907104
. O 0 8.606244819020503e-07

The O 0 4.4985252856122315e-08
spectrum O 0 6.758052677469095e-06
of O 0 5.489685861448379e-08
PAX6 O 0 0.015522195026278496
mutations O 0 3.816123808064731e-07
in O 0 2.1402879468723768e-08
aniridia B-Disease 1 1.0
patients O 1 0.9999828338623047
is O 0 3.243796897756113e-11
highly O 0 2.7024954496468467e-10
biased O 0 1.91424834317111e-10
, O 0 5.039941445954266e-13
with O 0 3.061825898614638e-14
92 O 0 1.5043696288685737e-09
% O 0 3.5976768439360818e-12
of O 0 1.8013369658745337e-12
all O 0 3.247398443900762e-12
reported O 0 2.344740894499875e-11
mutations O 0 6.407674391084583e-11
leading O 0 7.936665907815055e-11
to O 0 1.380351562219051e-11
premature O 0 5.1291642932937975e-08
truncation O 0 3.762165334819656e-08
of O 0 1.9945565199464e-08
the O 0 5.390109691916223e-09
protein O 0 1.7483977599042078e-09
( O 0 2.8279507641865154e-12
nonsense O 0 7.463907825133731e-10
, O 0 4.4327592269542693e-13
splicing O 0 3.9316182254278687e-11
, O 0 2.639788778194263e-12
insertions O 0 6.930026691387425e-11
and O 0 3.0655688491171285e-12
deletions O 0 4.292606201050653e-11
) O 0 1.5489766045338749e-13
and O 0 4.498258536489441e-12
just O 0 1.9884227944744204e-11
2 O 0 2.2126861454196955e-10
% O 0 1.4213808081919854e-12
leading O 0 2.8352564436853744e-13
to O 0 3.673756719842214e-14
substitution O 0 8.163391074234028e-10
of O 0 1.9640449266944415e-09
one O 0 1.4421797957242521e-11
amino O 0 2.3052827008429588e-11
acid O 0 5.008123082905769e-11
by O 0 8.269760744250565e-12
another O 0 1.58618077006345e-10
( O 0 3.4070777449324297e-11
missense O 0 6.916527439670972e-08
) O 0 3.304521239977376e-11
. O 0 6.791549989060286e-09

The O 0 1.6668760816074268e-09
extraordinary O 0 1.296343254963972e-09
conservation O 0 5.961643623209056e-09
of O 0 8.510346073686836e-12
the O 0 6.189269236012152e-11
PAX6 O 0 2.5974761683755787e-06
protein O 0 5.529096624989904e-10
at O 0 1.2358320096439446e-11
the O 0 2.2003706148798763e-11
amino O 0 2.07575490129841e-09
acid O 0 2.2028815749308706e-07
level O 0 3.157491846650373e-06
amongst O 0 2.499636480024492e-07
vertebrates O 0 1.1328647815389559e-06
predicts O 0 9.903307507386216e-09
that O 0 3.4810158228149035e-11
pathological O 0 2.2277221432887018e-05
missense O 0 5.039228199166246e-06
mutations O 0 4.538321274338841e-09
should O 0 2.514485564208968e-10
in O 0 1.0994449101131565e-10
fact O 0 6.06541414316375e-11
be O 0 1.886842765363994e-11
common O 0 4.315808543875477e-10
even O 0 2.615617618328958e-11
though O 0 3.5564225175921393e-11
they O 0 2.156354088345136e-12
are O 0 1.0394186596499044e-12
hardly O 0 1.1633296548296812e-09
ever O 0 6.560466059291059e-11
seen O 0 3.5772759754415517e-10
in O 0 6.844134148309422e-10
aniridia B-Disease 1 1.0
patients O 0 0.007529592607170343
. O 0 1.9172911436271534e-07

This O 0 7.377889271742433e-11
indicates O 0 1.2099800328346788e-10
that O 0 3.1687949790179526e-14
there O 0 1.4406414971558645e-13
is O 0 7.981097641769023e-15
a O 0 2.6415135812203616e-14
heavy O 0 5.669553715392794e-09
ascertainment O 0 6.315625000752334e-07
bias O 0 2.4805086873413984e-09
in O 0 3.447318472349359e-11
the O 0 1.942187036196863e-11
selection O 0 1.9785884042278212e-09
of O 0 1.22828455739743e-10
patients O 0 7.256032441560478e-10
for O 0 2.3932498344203523e-11
PAX6 O 0 3.617094989749603e-06
mutation O 0 1.0102499947706178e-09
analysis O 0 4.668217548631226e-11
and O 0 1.4913341828820537e-12
that O 0 1.254045424361333e-13
the O 0 9.775854570293063e-10
missing O 0 3.467833948889165e-07
PAX6 O 1 0.9941079616546631
missense O 0 0.0005971768405288458
mutations O 0 1.8859539352433785e-07
frequently O 0 3.445689844561173e-10
may O 0 8.83665141060419e-10
underlie O 0 7.295519708350184e-07
phenotypes O 0 7.315954348996456e-07
distinct O 0 1.8277465096971923e-09
from O 0 1.0622498713974693e-10
textbook O 0 3.001131290147896e-07
aniridia B-Disease 1 1.0
. O 0 1.199221401293471e-06

Here O 0 5.361423305316748e-08
we O 0 2.415119493281992e-10
present O 0 5.869112973400092e-10
four O 0 1.4179481373777225e-11
novel O 0 1.1323163739973552e-08
PAX6 O 0 0.0013173656770959496
missense O 0 1.347113629890373e-05
mutations O 0 2.911793473003854e-08
, O 0 3.403115983457994e-11
two O 0 7.674212827712967e-13
in O 0 8.517815792974393e-12
association O 0 1.1087439126533649e-11
with O 0 1.1507883404884844e-12
atypical O 0 3.2824184017954394e-05
phenotypes O 0 0.0004344652115833014
ectopia B-Disease 0 0.0003490252420306206
pupillae I-Disease 0 0.00023956508084665984
( O 0 1.5587080237633444e-11
displaced B-Disease 0 4.560776478701456e-10
pupils I-Disease 0 1.2150849215686321e-09
) O 0 5.219803755895924e-12
and O 0 2.089136419414217e-09
congenital B-Disease 1 1.0
nystagmus I-Disease 0 0.0005926046287640929
( O 0 1.3080758698436057e-10
searching B-Disease 0 8.939523787887538e-09
gaze I-Disease 0 1.2709738816951699e-09
) O 0 1.0019349445163778e-13
, O 0 7.047923442776716e-13
and O 0 3.4431370515147774e-12
two O 0 6.426712460816386e-13
in O 0 5.1225960973066975e-11
association O 0 5.901517469153461e-11
with O 0 1.5265166517994255e-12
more O 0 8.077595536892801e-11
recognizable O 0 1.473329461987305e-06
aniridia B-Disease 1 1.0
phenotypes O 0 3.9888022001832724e-05
. O 0 1.1034379809871098e-07

Strikingly O 0 0.0001383647322654724
, O 0 3.1569846736800855e-09
all O 0 4.564997546641081e-10
four O 0 3.669497344871431e-11
mutations O 0 1.3792961564562667e-11
are O 0 1.9875915149847323e-12
located O 0 2.510439772729356e-11
within O 0 9.97474672304044e-11
the O 0 1.0509151771032066e-08
PAX6 O 0 0.0011997763067483902
paired O 0 2.6556566723456854e-08
domain O 0 3.711141616236091e-09
and O 0 3.768587872321483e-11
affect O 0 4.542755505099194e-09
amino O 0 1.3973995294236374e-09
acids O 0 1.0712906117760213e-09
which O 0 1.7201408700207033e-11
are O 0 1.4314118466918213e-12
highly O 0 3.2096231228351257e-10
conserved O 0 2.3562682360811493e-10
in O 0 1.751132572280767e-11
all O 0 4.8366741167704674e-11
known O 0 1.7707482702356003e-10
paired O 0 6.205667091307987e-10
domain O 0 1.220122114453659e-09
proteins O 0 1.5956237719993993e-10
. O 0 1.1649017306325504e-09

Our O 0 4.5121968383909916e-08
results O 0 4.272361575630157e-09
support O 0 1.1242585751247702e-09
the O 0 7.229779969142314e-11
hypothesis O 0 4.1348570400945306e-11
that O 0 1.4606805772110184e-15
the O 0 3.2945099149835413e-14
under O 0 5.430467273775941e-13
- O 0 1.4674721507401678e-11
representation O 0 5.010428183460647e-10
of O 0 1.1232276220241033e-09
missense O 0 2.4800303322081163e-07
mutations O 0 8.051051492152794e-10
is O 0 1.4731951552757194e-12
caused O 0 3.7173934069878456e-11
by O 0 2.3563031734119555e-11
ascertainment O 0 1.5239010281220544e-05
bias O 0 9.27309500298179e-08
and O 0 5.0582833061030286e-11
suggest O 0 3.1474638867434734e-11
that O 0 7.265431034304392e-15
a O 0 3.081664087865692e-14
substantial O 0 8.450470878607064e-11
burden O 0 2.8330319423730543e-07
of O 0 2.766241209428699e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
related I-Disease 1 1.0
disease I-Disease 1 1.0
remains O 0 9.344611129336045e-08
to O 0 1.6275834846535275e-12
be O 0 7.560140014017946e-12
uncovered O 0 4.364211214635816e-09
. O 0 1.7953054320951622e-10
. O 0 2.6240352113404697e-09

The O 0 2.373101937180877e-09
chromosomal O 0 1.0251525139892692e-07
order O 0 5.861455676381411e-08
of O 0 2.8043014026479796e-06
genes O 0 1.1599916405202748e-07
controlling O 0 5.22119805168586e-08
the O 0 5.780573530955735e-08
major O 0 1.5046027328935452e-05
histocompatibility O 1 0.9925744533538818
complex O 0 7.47086014598608e-05
, O 0 2.227939187304795e-11
properdin O 0 1.642907143661887e-08
factor O 0 5.755783405447801e-09
B O 0 3.6982226447435096e-05
, O 0 7.670349273271315e-13
and O 0 4.106239653856036e-12
deficiency B-Disease 0 1.7818210551467928e-07
of I-Disease 0 5.183551365917083e-08
the I-Disease 0 1.385438253009852e-07
second I-Disease 0 2.6410941700305557e-07
component I-Disease 0 3.220332018827321e-06
of I-Disease 0 2.9930768619124137e-07
complement I-Disease 0 5.360932391340612e-07
. O 0 3.822877090442489e-07

The O 0 6.171192445947327e-09
relationship O 0 1.0288537799496567e-09
of O 0 2.343124805292973e-09
the O 0 4.935854502896575e-10
genes O 0 2.9083142144559204e-11
coding O 0 1.8663987022549122e-10
for O 0 1.0167693076379436e-11
HLA O 0 4.6136932496665395e-07
to O 0 1.5811062181736446e-10
those O 0 4.777171366820987e-11
coding O 0 2.8422602812994135e-11
for O 0 4.2505533598066747e-13
properdin O 0 9.966521830051533e-09
Factor O 0 1.7077658176489763e-09
B O 0 8.075696911191699e-08
allotypes O 0 2.6759632287820523e-09
and O 0 5.74026991304738e-13
for O 0 9.741795044260204e-13
deficiency B-Disease 0 5.105923506221188e-08
of I-Disease 0 1.3294825684795342e-08
the I-Disease 0 6.117798267979424e-09
second I-Disease 0 3.0609651702206975e-08
component I-Disease 0 1.346609110441932e-06
of I-Disease 0 3.177630787831731e-06
complement I-Disease 0 6.3911323877619e-07
( O 0 1.2234166457680828e-10
C2 O 0 2.1633936864162706e-09
) O 0 3.4818053744122912e-15
was O 0 3.735875744501592e-14
studied O 0 1.1675775906001828e-13
in O 0 2.318718811790757e-15
families O 0 1.9928887844979613e-14
of O 0 4.5343495126172473e-13
patients O 0 8.798877737525856e-10
with O 0 2.268816523542938e-10
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 4.265916686563287e-06

Patients O 0 0.001203151186928153
were O 0 2.1024607832487163e-08
selected O 0 2.992749603691891e-09
because O 0 1.2401957065477642e-11
they O 0 2.471065236112069e-12
were O 0 3.111186308579761e-11
heterozygous O 0 3.53351445325778e-11
or O 0 2.4517617103203548e-11
homozygous O 0 6.561336363120063e-09
for O 0 1.7952837083612394e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.4380474314966705e-06

12 O 0 3.185129457961011e-07
families O 0 1.9474823975684785e-09
with O 0 3.2329985043266785e-12
15 O 0 1.4119150293367966e-09
matings O 0 4.78861920782947e-06
informative O 0 1.615717792446958e-06
for O 0 2.719179121868365e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 2.0178907433887616e-08
found O 0 5.86193038554228e-10
. O 0 4.896362426620726e-09

Of O 0 2.826114950948977e-06
57 O 0 1.8570420934338472e-06
informative O 0 4.3822556250461275e-08
meioses O 0 3.9772638160684437e-07
, O 0 4.3473252775427795e-11
two O 0 5.764572304743643e-13
crossovers O 0 5.47154092866986e-11
were O 0 2.4432282585973297e-11
noted O 0 2.542281142547953e-11
between O 0 1.7143117481133174e-10
the O 0 1.7249312804779038e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 6.873985408661909e-11
and O 0 6.441135385476526e-12
the O 0 6.04181357721778e-11
HLA O 0 9.63217757998791e-07
- O 1 0.9523999094963074
B O 0 0.0016486054519191384
gene O 0 9.858814285779172e-12
, O 0 4.249335258665887e-14
with O 0 5.346838834214423e-16
a O 0 1.540419877700712e-14
recombinant O 0 7.955185815644583e-11
fraction O 0 2.2168440416692192e-09
of O 0 8.404647533488685e-10
0 O 0 6.358737536515946e-09
. O 0 7.453792583156371e-10

035 O 0 0.01242119912058115
. O 0 4.181297299510334e-06

A O 0 1.876273003631468e-08
lod O 0 2.1935620679869317e-06
score O 0 2.2223729523318525e-09
of O 0 1.3053609408675282e-11
13 O 0 3.932898711561661e-12
was O 0 3.2396882485713485e-13
calculated O 0 3.069559146792744e-12
for O 0 2.1170840688172765e-12
linkage O 0 2.3538638060927042e-07
between O 0 1.7750193364918232e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.831310351782747e-10
HLA O 0 3.821709881890456e-08
- O 0 6.520176043522952e-07
B O 0 9.333903108199593e-07
at O 0 2.092489999631561e-13
a O 0 5.44302736630903e-16
maximum O 0 5.4362476298959114e-14
likelihood O 0 3.318200098370583e-12
value O 0 3.147445845619323e-11
of O 0 5.4762574683286935e-12
the O 0 5.17620018028464e-12
recombinant O 0 1.5415368981308575e-10
fraction O 0 1.4732114417270736e-09
of O 0 1.6798845647869598e-10
0 O 0 1.2674756799668785e-09
. O 0 2.6886803894399236e-10

04 O 0 0.0007103598909452558
. O 0 5.56369604964857e-06

18 O 0 5.814543442284048e-07
families O 0 1.9114545501963676e-09
with O 0 7.255858240629021e-12
21 O 0 4.071462722521346e-09
informative O 0 6.024257204195749e-10
matings O 0 5.863924457116809e-09
for O 0 9.496367234240743e-12
both O 0 6.358257670369127e-11
properdin O 0 1.3551970141634229e-06
Factor O 0 1.3070167597106774e-06
B O 0 1.6544167010579258e-05
allotype O 0 1.999295449195415e-07
and O 0 2.374545005068285e-10
HLA O 0 1.4169006590236677e-06
- O 0 7.548386929556727e-05
B O 0 0.00012341199908405542
were O 0 4.4877712657154234e-11
found O 0 1.3239463345082747e-11
. O 0 4.4694761780483816e-10

Of O 0 3.927572834072635e-06
72 O 0 2.9556113076978363e-06
informative O 0 1.0064216837690765e-07
meioses O 0 5.009142569178948e-06
, O 0 3.3389127573890676e-10
three O 0 3.1388190657732906e-11
recombinants O 0 2.488519839971559e-06
were O 0 7.142778368773861e-09
found O 0 8.336391299490487e-11
, O 0 7.089855503898679e-13
giving O 0 6.741254689884846e-13
a O 0 1.9315198583353538e-13
recombinant O 0 3.094841050099717e-10
fraction O 0 1.954941453163883e-08
of O 0 4.651903307006933e-09
0 O 0 1.829742579673166e-08
. O 0 1.5101165873332434e-09

042 O 0 0.0024699417408555746
. O 0 4.265070856490638e-06

A O 0 1.410080407993064e-08
lod O 0 1.5939333479764173e-06
score O 0 5.310796691304631e-09
of O 0 3.0182290000624334e-10
16 O 0 3.4905581203226177e-10
between O 0 3.3983291874983834e-11
HLA O 0 5.652787535836978e-07
- O 0 4.9072485126089305e-05
B O 0 1.0153086805075873e-05
and O 0 2.1441843526398552e-13
Factor O 0 3.2975767949583457e-11
B O 0 7.332107365698448e-09
allotypes O 0 5.150746495985459e-10
was O 0 3.728405171404825e-12
calculated O 0 3.527285755144938e-11
at O 0 1.3048947773014463e-12
a O 0 4.175882255545889e-14
maximum O 0 3.832272173209805e-12
likelihood O 0 1.0786938703377658e-10
value O 0 2.872969362410771e-10
of O 0 1.463338304696915e-11
the O 0 1.1211074603389992e-11
recombinant O 0 5.163071636893335e-10
fraction O 0 4.58873561370865e-09
of O 0 2.544251753722193e-10
0 O 0 3.9042191701810225e-09
. O 0 4.697095490335812e-10

04 O 0 0.0004975565243512392
. O 0 3.133505288133165e-06

A O 0 2.3518481384599e-08
crossover O 0 5.026607574620812e-09
was O 0 2.423004852314392e-10
shown O 0 9.289238649123899e-12
to O 0 1.2659155407962475e-12
have O 0 6.257049457551733e-13
occurred O 0 1.7219144166080724e-10
between O 0 1.548448652285983e-12
genes O 0 2.948509492117779e-13
for O 0 2.4726764689605996e-13
Factor O 0 2.8634994375664746e-10
B O 0 5.377902567715864e-08
and O 0 8.648076178785491e-12
HLA O 0 4.700924538525442e-09
- O 0 3.0982053544903465e-07
D O 0 3.740214538083819e-08
, O 0 8.324783462403118e-13
in O 0 1.0472053996526953e-12
which O 0 1.2164070748929556e-12
HLA O 0 6.173902988848567e-08
- O 0 2.000600579776801e-05
D O 0 3.0424268970818957e-07
segregared O 0 3.214589696654002e-07
with O 0 9.83458713771368e-12
HLA O 0 1.5598427580698626e-06
- O 0 2.5673809886939125e-06
A O 0 5.388044996834651e-07
and O 0 2.8158768650143884e-09
B O 0 2.1623982320306823e-06
. O 0 2.653193220680805e-10

These O 0 1.7667581841962487e-09
studies O 0 3.698354816839e-11
suggest O 0 4.8431150583005955e-12
that O 0 1.6462773120640498e-14
the O 0 1.1976306448294172e-12
genes O 0 1.1243898607321556e-12
for O 0 1.8356919716938647e-12
Factor O 0 1.3033425148023525e-06
B O 1 1.0
and O 0 1.6686573189872433e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.4992751831699458e-11
located O 0 1.2249564427038728e-12
outside O 0 2.2848081933368736e-12
those O 0 9.079139350054444e-13
for O 0 1.1261218737027012e-12
HLA O 0 8.041064702979384e-09
, O 0 2.3156639366445075e-12
that O 0 8.550032731780791e-15
the O 0 9.072838509129044e-13
order O 0 3.73053393731837e-11
of O 0 1.339382077469864e-10
genese O 0 3.985594076993948e-08
is O 0 2.3427503426792784e-12
HLA O 0 1.8684323532802694e-10
- O 0 1.8535278867304328e-10
A O 0 5.198962371721905e-10
, O 0 4.2639513881531643e-13
- O 0 1.4481731092086392e-10
B O 0 1.7931649054503396e-08
, O 0 6.568569744114933e-14
- O 0 1.2774665873738211e-11
D O 0 5.734935096257665e-11
, O 0 1.158617337270948e-13
Factor O 0 2.3043265073852126e-09
B O 0 0.00019399161101318896
allotype O 0 0.002296401420608163
, O 0 8.998698035611596e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 5.872623134312027e-12
that O 0 4.327710878462149e-14
the O 0 1.5255017735138487e-11
genes O 0 1.327790793981265e-10
coding O 0 2.0657159538473024e-08
for O 0 4.755406024514741e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.1266192839753941e-10
Factor O 0 1.6807379932259892e-09
B O 0 2.940867460665686e-08
allotypes O 0 1.024658913273413e-09
are O 0 4.049032973057337e-14
approximately O 0 6.213504205241065e-15
3 O 0 7.610378256403538e-14
- O 0 2.330879900983712e-13
- O 0 1.497134707872938e-11
5 O 0 2.851072503085028e-11
centimorgans O 0 2.304330948277311e-09
from O 0 1.751342994238403e-11
the O 0 8.479791868687414e-11
HLA O 0 2.4234095619135587e-08
- O 0 2.188787640022838e-08
A O 0 1.524084680681881e-08
and O 0 1.1746909868437516e-11
HLA O 0 9.523844823888794e-09
- O 0 1.3561573553033668e-07
B O 0 8.980919119494502e-08
loci O 0 2.2784285309135344e-12
, O 0 8.455548747613416e-15
and O 0 4.1867242455070083e-16
that O 0 2.005457374359698e-17
the O 0 1.7073968378456678e-14
apparent O 0 1.556453056716922e-11
lack O 0 4.668024300436002e-10
of O 0 2.5449834947788297e-11
recombinants O 0 1.8490726727549145e-09
between O 0 3.03176147381512e-12
the O 0 2.872726882763299e-11
Factor O 0 8.932194539568172e-09
B O 0 3.5991663025924936e-05
gene O 0 2.7180478312516243e-08
and O 0 4.687971795647172e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.110332849753377e-09
suggests O 0 2.151575140274531e-09
that O 0 1.332127225368851e-12
these O 0 4.8841479471928295e-11
two O 0 2.34479341325311e-12
genes O 0 2.3218349118336867e-11
lie O 0 1.694054896361763e-10
in O 0 4.9025601286945e-12
close O 0 5.414235379475052e-11
proximity O 0 8.516367167032968e-09
to O 0 1.3802055054412676e-09
one O 0 5.001185576780642e-10
another O 0 1.2001615257162257e-09
. O 0 7.890640318919395e-08

Distribution O 0 1.8330014839307296e-08
of O 0 6.056160906098285e-09
emerin O 0 1.3682738426723517e-05
and O 0 1.2706684593410955e-09
lamins O 0 7.832003575458657e-06
in O 0 3.0351088309288343e-10
the O 0 6.942624808381481e-10
heart O 0 3.935608106075961e-08
and O 0 3.1454356480553614e-11
implications O 0 1.0269325390055428e-09
for O 0 3.250752445005389e-11
Emery B-Disease 0 5.937166133662686e-05
- I-Disease 1 0.9999815225601196
Dreifuss I-Disease 1 0.8883925676345825
muscular I-Disease 1 0.8538395166397095
dystrophy I-Disease 1 0.9999957084655762
. O 0 0.00018248401465825737

Emerin O 0 0.008138976991176605
is O 0 9.379692578193044e-10
a O 0 1.1730968627055027e-11
nuclear O 0 1.78903469816305e-08
membrane O 0 3.1887745777225973e-09
protein O 0 2.0265709943512178e-10
which O 0 5.091537001039592e-13
is O 0 7.393645157921513e-13
missing O 0 6.740426272688893e-11
or O 0 9.515841239982059e-12
defective O 0 4.665189123898017e-08
in O 0 4.111214035873445e-09
Emery B-Disease 1 0.9414097666740417
- I-Disease 1 1.0
Dreifuss I-Disease 1 0.9999833106994629
muscular I-Disease 1 0.9999995231628418
dystrophy I-Disease 1 1.0
( O 0 5.5198299264702655e-08
EDMD B-Disease 1 1.0
) O 0 2.1386952209212495e-09
. O 0 1.3400912379779584e-08

It O 0 2.999752876653439e-11
is O 0 1.5136293910963938e-12
one O 0 2.0571551732039006e-13
member O 0 7.521016144942938e-13
of O 0 1.5615826340353856e-11
a O 0 1.1499069058062972e-11
family O 0 4.284158861000975e-10
of O 0 4.4712349378528415e-09
lamina O 1 0.9999994039535522
- O 0 1.671810787229333e-05
associated O 0 5.455328846437624e-07
proteins O 0 8.541105600556875e-10
which O 0 2.8339928060533426e-12
includes O 0 3.882944313304826e-12
LAP1 O 0 0.00023358863836620003
, O 0 1.319713921477117e-10
LAP2 O 1 0.8788315653800964
and O 0 3.0134689410488136e-08
lamin O 0 3.9933283915161155e-06
B O 0 8.276858352473937e-06
receptor O 0 4.2519974208232725e-09
( O 0 6.259264634378425e-11
LBR O 0 1.490548811489134e-06
) O 0 4.91414339776064e-11
. O 0 3.9073855262472534e-09

A O 0 5.832382043990947e-07
panel O 0 1.3253024455650575e-08
of O 0 4.2438927372323576e-10
16 O 0 7.952080105511072e-10
monoclonal O 0 1.2665695159341794e-09
antibodies O 0 1.8526664646856261e-09
( O 0 4.972655100188295e-12
mAbs O 0 1.63304090250449e-08
) O 0 1.2105743924656354e-12
has O 0 6.516871460873763e-13
been O 0 1.1220418040872038e-12
mapped O 0 1.9844985377215352e-10
to O 0 2.2780732161775674e-11
six O 0 3.804184744993222e-11
specific O 0 1.162761664730283e-09
sites O 0 1.6076187492330973e-08
throughout O 0 4.2051380155783136e-09
the O 0 1.7767983750971439e-09
emerin O 0 4.1933026295737363e-07
molecule O 0 1.0267797723173544e-09
using O 0 1.9759249791917455e-10
phage O 0 1.076023159463091e-09
- O 0 3.897258904483891e-11
displayed O 0 5.826680804510431e-11
peptide O 0 6.194382506929941e-11
libraries O 0 1.7602956592366326e-10
and O 0 2.348539548599482e-12
has O 0 1.747613962181302e-13
been O 0 1.1959134854286346e-13
used O 0 3.78940748137907e-13
to O 0 3.056987302185732e-11
localize O 0 3.860105550756998e-07
emerin O 0 5.929688541073119e-06
in O 0 4.973940703756341e-10
human O 0 6.291704934824338e-10
and O 0 3.660148184536638e-09
rabbit O 0 3.7281924392118526e-07
heart O 0 1.4536587400471035e-07
. O 0 8.218579239382962e-08

Several O 0 3.381885278486152e-07
mAbs O 0 6.8878798629157245e-06
against O 0 8.044271027074501e-09
different O 0 7.211085506497739e-09
emerin O 0 7.5687121352530085e-06
epitopes O 0 1.1086312952102162e-06
did O 0 3.7853045142810515e-09
not O 0 2.4233007267504547e-10
recognize O 0 3.850262608739996e-10
intercalated O 0 2.8856035783064726e-08
discs O 0 1.1491719575928983e-08
in O 0 7.449069833187494e-11
the O 0 7.416664504766857e-10
heart O 0 2.883765759520429e-08
, O 0 8.064306167288038e-12
though O 0 5.887115794855902e-11
they O 0 4.067839381310945e-12
recognized O 0 7.85832232619299e-11
cardiomyocyte O 0 9.836574577093415e-08
nuclei O 0 2.2155435885906627e-07
strongly O 0 7.667936507971262e-09
, O 0 1.9964871769695414e-11
both O 0 1.7801683738216667e-11
at O 0 2.0395654609650649e-10
the O 0 1.402141180939509e-09
rim O 0 1.0926870963601232e-08
and O 0 1.7640264249330073e-10
in O 0 8.015962338348004e-10
intranuclear O 0 3.670256046461873e-05
spots O 0 1.3122925111019867e-06
or O 0 3.5327902825343926e-09
channels O 0 5.377458478506014e-09
. O 0 2.577722479912836e-09

A O 0 1.9295920594686322e-07
polyclonal O 0 4.833093953493517e-06
rabbit O 0 2.3240498592258518e-07
antiserum O 0 3.095236991157435e-07
against O 0 1.796577220325446e-09
emerin O 0 1.9324852473801002e-05
did O 0 1.5295952948690683e-07
recognize O 0 2.398055620744799e-08
both O 0 8.833310471967337e-11
nuclear O 0 6.91528434515476e-09
membrane O 0 5.215131104741033e-10
and O 0 7.931814927086833e-13
intercalated O 0 1.9085756586267877e-10
discs O 0 4.679173368216105e-11
but O 0 1.1279453066004308e-11
, O 0 4.13190423716181e-13
after O 0 2.2213780294377816e-12
affinity O 0 1.823197495753881e-11
purification O 0 4.515758877943199e-09
against O 0 2.3265738294253602e-11
a O 0 2.117730253312078e-12
pure O 0 3.1027197477939694e-10
- O 0 6.072568836668069e-11
emerin O 0 9.95690729865828e-09
band O 0 1.9805319884103056e-10
on O 0 6.14299800263951e-12
a O 0 3.5882042237651846e-13
western O 0 1.5096261740676908e-10
blot O 0 8.538002305158443e-08
, O 0 9.958165368695315e-12
it O 0 2.8811924634303265e-12
stained O 0 6.909472176630516e-07
only O 0 6.398782892436117e-11
the O 0 1.8683432578825432e-10
nuclear O 0 6.944816277609789e-08
membrane O 0 1.0962928342905798e-07
. O 0 7.495897236253768e-09

These O 0 4.414585585976738e-09
results O 0 5.359536703331003e-10
would O 0 2.980072785763177e-11
not O 0 3.950943738839641e-12
be O 0 5.260361590764262e-12
expected O 0 1.0685850426739307e-08
if O 0 5.666891400579743e-10
immunostaining O 0 4.242076556693064e-07
at O 0 5.98734603562967e-11
intercalated O 0 1.9246320093202485e-09
discs O 0 1.0080229984055222e-09
were O 0 4.7594182067678403e-11
due O 0 3.374183377147233e-09
to O 0 1.2897446131920898e-11
a O 0 3.925052557279818e-12
product O 0 1.2867825693874124e-09
of O 0 3.860346264872305e-09
the O 0 4.01029076613213e-09
emerin O 0 6.000730650157493e-07
gene O 0 1.6244681988464293e-10
and O 0 5.473952194301468e-11
, O 0 1.1434434128709814e-12
therefore O 0 1.077367708934851e-10
, O 0 4.108809213004827e-12
cast O 0 5.965292149134882e-10
some O 0 3.5071117017448916e-12
doubt O 0 9.026398378741973e-11
upon O 0 1.41303982403862e-11
the O 0 8.888707478393876e-12
hypothesis O 0 5.414548254201179e-10
that O 0 8.762487805659414e-13
cardiac B-Disease 0 1.5891910152276978e-05
defects I-Disease 0 0.0003253306495025754
in O 0 2.773349478957243e-07
EDMD B-Disease 1 1.0
are O 0 4.870867709172444e-09
caused O 0 1.3603217441371385e-09
by O 0 1.9809162990491735e-11
absence O 0 8.45538181692973e-07
of O 0 9.446976179106059e-08
emerin O 0 0.00020300806500017643
from O 0 8.852850896801101e-09
intercalated O 0 3.964610641560284e-06
discs O 0 8.55164955737564e-07
. O 0 4.987949253631996e-08

Although O 0 9.759970964751119e-08
emerin O 0 2.1707517589675263e-05
was O 0 9.5487635576319e-09
abundant O 0 8.371389803585316e-09
in O 0 1.1979191076594287e-11
the O 0 1.4778395521219956e-11
membranes O 0 7.286261871630728e-11
of O 0 1.6466386587588033e-10
cardiomyocyte O 0 1.7562461707143484e-08
nuclei O 0 2.423663758577277e-08
, O 0 4.699545873981803e-12
it O 0 1.2342266152241127e-13
was O 0 1.5191552182880486e-10
absent O 0 1.493950740893979e-08
from O 0 8.049358402040241e-11
many O 0 1.1322995492613064e-11
non O 0 2.0106285525400835e-09
- O 0 6.036828814615092e-10
myocyte O 0 1.0812991746433909e-07
cells O 0 1.2995416964756146e-09
in O 0 5.507440857532853e-12
the O 0 1.290741957760133e-10
heart O 0 3.4190353659369066e-08
. O 0 2.8744086222332044e-08

This O 0 1.2967234230831792e-10
distribution O 0 9.508430709459503e-10
of O 0 4.711343537522339e-10
emerin O 0 2.1738176201324677e-06
was O 0 1.9754813340711053e-09
similar O 0 5.646992248808935e-11
to O 0 2.38182759106087e-12
that O 0 2.7211897015225195e-13
of O 0 4.3216652478861306e-10
lamin O 0 2.1220529333731974e-08
A O 0 2.242286800679949e-09
, O 0 2.0624008143649286e-12
a O 0 2.1916782624864517e-12
candidate O 0 1.1564229573934881e-09
gene O 0 2.434718442481665e-12
for O 0 1.4145708259263867e-12
an O 0 6.949290860640278e-13
autosomal O 0 3.884507648876934e-08
form O 0 8.848584087672862e-08
of O 0 0.0006088344380259514
EDMD B-Disease 1 1.0
. O 1 0.5516176819801331

In O 0 7.727900097620477e-09
contrast O 0 1.2286541561934428e-07
, O 0 1.9891532865301542e-09
lamin O 0 2.4892198780435137e-05
B1 O 0 2.064384716504719e-05
was O 0 2.732085224721459e-09
absent O 0 6.79201903608373e-08
from O 0 1.2222364786929063e-10
cardiomyocyte O 0 1.3390100548349437e-06
nuclei O 0 9.584578947396949e-06
, O 0 3.000996395829958e-10
showing O 0 3.0592768318626895e-09
that O 0 4.1446265863775977e-10
lamin O 0 0.00013348503853194416
B1 O 0 4.005571099696681e-06
is O 0 7.093020290040164e-13
not O 0 1.617450612464641e-13
essential O 0 2.3947201860385903e-11
for O 0 6.622982869596006e-13
localization O 0 1.397003615011272e-07
of O 0 3.777860690945545e-09
emerin O 0 5.693419552699197e-06
to O 0 8.058241851571779e-10
the O 0 1.9248742599842217e-09
nuclear O 0 2.249484350613784e-05
lamina O 1 0.9999456405639648
. O 0 3.8202384189389704e-07

Lamin O 1 0.9572632312774658
B1 O 0 0.002812489867210388
is O 0 9.677670470553679e-11
also O 0 2.3207191376939384e-11
almost O 0 7.743044400099208e-11
completely O 0 7.211223174152792e-09
absent O 0 1.2198533738683182e-07
from O 0 9.504894649126072e-10
skeletal O 0 1.6649756844344665e-06
muscle O 0 9.266618690162431e-06
nuclei O 1 0.9969353675842285
. O 0 4.761690888699377e-06

In O 0 5.772905353751412e-08
EDMD B-Disease 1 1.0
, O 0 1.0768109320880015e-10
the O 0 7.740870444639114e-12
additional O 0 1.4462070430099061e-11
absence O 0 1.3205259996595942e-08
of O 0 1.19300764822583e-07
lamin O 0 0.0006257086060941219
B1 O 0 0.0005698339664377272
from O 0 2.0382218579584332e-08
heart O 1 0.999737560749054
and O 0 7.730371862635366e-07
skeletal O 1 0.999984860420227
muscle O 1 0.9966799020767212
nuclei O 1 1.0
which O 0 3.400046466595086e-07
already O 0 8.251421945715265e-08
lack O 0 7.990886956577015e-07
emerin O 0 2.8632516659854446e-06
may O 0 1.7241763572428681e-09
offer O 0 4.718328852626463e-11
an O 0 2.1666658098467694e-15
alternative O 0 6.025184517977067e-11
explanation O 0 1.42673595160403e-10
of O 0 1.8025546333344522e-11
why O 0 4.5945289239845977e-11
these O 0 4.77342557841931e-12
tissues O 0 1.6872067076789676e-09
are O 0 5.9966107600339935e-12
particularly O 0 2.1002020955673828e-10
affected O 0 9.522423960461879e-10
. O 0 9.977967341257e-10
. O 0 2.220387074203245e-08

Genetic O 0 2.414647681803217e-08
mapping O 0 1.898077695017264e-09
of O 0 5.329139352028278e-10
the O 0 1.7649941952413428e-08
copper B-Disease 0 0.18285250663757324
toxicosis I-Disease 1 0.9118286967277527
locus O 0 3.856543173696991e-08
in O 0 2.2251300801912066e-09
Bedlington O 0 2.6464849156582204e-07
terriers O 0 5.474921138670652e-08
to O 0 3.1999333738319535e-11
dog O 0 2.266041132514829e-09
chromosome O 0 1.2827948425719882e-10
10 O 0 2.7843423747175855e-11
, O 0 2.7631510361031397e-13
in O 0 1.852381095734934e-12
a O 0 3.939798574187359e-12
region O 0 3.8855803019544055e-09
syntenic O 0 2.7882267659151694e-06
to O 0 5.210488152052051e-10
human O 0 2.8308313471114843e-09
chromosome O 0 7.557368952859633e-09
region O 0 2.394640041814e-09
2p13 O 0 1.9111973870167276e-07
- O 0 2.539115406818837e-08
p16 O 0 3.3730266579823365e-08
. O 0 3.922155045188447e-09

Abnormal O 1 0.9604945778846741
hepatic B-Disease 1 0.9994602799415588
copper I-Disease 0 2.509362388991576e-07
accumulation I-Disease 0 3.90589711685152e-08
is O 0 5.332242893757444e-13
recognized O 0 2.6498174314493195e-12
as O 0 2.7754281078234966e-12
an O 0 1.4059719534442738e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.060997333377599716
man O 0 1.4983161236159503e-06
, O 0 4.519004892511447e-10
mouse O 0 2.790541202557506e-07
, O 0 2.1530602301034207e-10
rat O 0 1.887025428004563e-05
and O 0 1.6383344680903633e-09
dog O 0 5.451305696624331e-06
. O 0 1.7631646187510341e-07

The O 0 1.1638473296216034e-08
major O 0 5.3015490664165554e-08
cause O 0 4.4751789118890883e-07
of O 0 1.1181438821949996e-05
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 1 0.9501729011535645
accumulation I-Disease 0 0.012589250691235065
in O 0 6.080560055465867e-09
man O 0 8.935325812586825e-10
is O 0 1.4492603081159294e-12
a O 0 3.6329617699587535e-12
dysfunctional O 0 7.138176556509279e-07
ATP7B O 1 0.9998857975006104
gene O 0 1.0509372039280152e-08
, O 0 2.1927498011775626e-11
causing O 0 5.668313463047525e-08
Wilson B-Disease 0 0.0007928224513307214
disease I-Disease 0 4.769328734255396e-05
( O 0 1.1283225048730472e-10
WD B-Disease 0 4.250632628099993e-05
) O 0 2.902458273723596e-10
. O 0 2.4703821210891874e-08

Mutations O 0 2.6321527002437506e-07
in O 0 1.8008793345458685e-09
the O 0 1.502323243585124e-08
ATP7B O 1 0.999997615814209
genes O 0 9.747858342734617e-08
have O 0 5.448982931532953e-11
also O 0 2.1793103346240406e-12
been O 0 6.031793120531148e-12
demonstrated O 0 6.114609929497306e-10
in O 0 1.4050191010639423e-09
mouse O 0 3.6119067203799204e-07
and O 0 2.0174972803488345e-09
rat O 0 4.9840159590530675e-06
. O 0 2.3782414260153928e-08

The O 0 1.0889793884416576e-06
ATP7B O 1 0.9999196529388428
gene O 0 2.1676532568903895e-08
has O 0 4.134863024890523e-12
been O 0 6.170826111380479e-13
excluded O 0 1.2976264507358337e-10
in O 0 1.5189615515907862e-13
the O 0 1.9879241211061965e-13
much O 0 2.233801468451424e-12
rarer O 0 3.058485162910074e-07
human O 0 6.500934546238568e-08
copper B-Disease 1 0.9999525547027588
overload I-Disease 1 0.9999959468841553
disease O 0 0.18334349989891052
non B-Disease 0 1.819481667553191e-06
- I-Disease 0 1.978121488832585e-08
Indian I-Disease 0 4.704456268989077e-10
childhood I-Disease 0 4.088312266503635e-08
cirrhosis I-Disease 0 0.006808827631175518
, O 0 1.731001973703794e-11
indicating O 0 1.46423306812693e-09
genetic O 0 9.277867363266523e-09
heterogeneity O 0 5.556398718908895e-07
. O 0 7.817536129550717e-08

By O 0 6.165100981808669e-12
investigating O 0 1.0598213279200408e-10
the O 0 1.8796167400303432e-10
common O 0 2.0157794722308608e-07
autosomal O 1 0.9877741932868958
recessive O 1 0.9998069405555725
copper B-Disease 1 0.999994158744812
toxicosis I-Disease 1 0.9999858140945435
( O 0 3.690915351128865e-10
CT B-Disease 0 6.025542461429723e-06
) O 0 1.6729069518550688e-11
in O 0 4.997486313662591e-10
Bedlington O 0 1.2947274399266462e-06
terriers O 0 6.801546419410442e-07
, O 0 1.123175077250016e-11
we O 0 7.467673181216217e-12
have O 0 3.3687167096639603e-13
identified O 0 1.4675768738280082e-13
a O 0 3.3001055840396927e-15
new O 0 1.8711578510591242e-13
locus O 0 4.3320409108885127e-13
involved O 0 4.942498233601045e-13
in O 0 6.568595667388877e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.3266906029894017e-06

We O 0 2.444503266474385e-09
examined O 0 4.695995592385316e-09
whether O 0 1.6665731294995823e-10
the O 0 2.659330089471723e-09
WD B-Disease 0 0.00027153751580044627
gene O 0 6.531720941893582e-08
ATP7B O 1 1.0
was O 0 1.4493163291717792e-07
also O 0 4.382792392898516e-11
causative O 0 2.385422748218957e-09
for O 0 5.0090494252419404e-11
CT B-Disease 0 7.584432637486316e-08
by O 0 3.2523387195199094e-12
investigating O 0 3.371389556416915e-10
the O 0 5.219171761439156e-10
chromosomal O 0 9.946433721097492e-08
co O 0 2.5326682973059178e-08
- O 0 4.768293848655958e-08
localization O 0 2.9023927709204145e-05
of O 0 1.1679618694415694e-07
ATP7B O 1 0.9999966621398926
and O 0 1.052009590551961e-09
C04107 O 0 1.4509724977074256e-08
, O 0 3.4787751563951363e-13
using O 0 1.2181338023779104e-13
fluorescence O 0 2.5561883165714505e-10
in O 0 7.928556422509558e-11
situ O 0 7.902945498017289e-08
hybridization O 0 2.9800413248182167e-09
( O 0 1.3652513147777157e-11
FISH O 0 1.4823535821051337e-07
) O 0 2.8671639715205366e-12
. O 0 4.833983213714532e-10

C04107 O 0 6.482842582045123e-05
is O 0 1.733732185593695e-10
an O 0 8.935857696151794e-13
anonymous O 0 2.1587800991262895e-10
microsatellite O 0 6.424963316931098e-08
marker O 0 1.2982744124201417e-07
closely O 0 5.878941777837099e-09
linked O 0 5.1063910433413184e-08
to O 0 8.836554599156443e-09
CT B-Disease 1 0.9882558584213257
. O 0 7.251568945321196e-07

However O 0 2.194465560023673e-05
, O 0 1.4071551390770765e-07
BAC O 0 7.621984696015716e-05
clones O 0 6.543754125232226e-07
containing O 0 4.449685064855657e-09
ATP7B O 0 0.04473494738340378
and O 0 2.3944850546797625e-09
C04107 O 0 1.6754199805291137e-07
mapped O 0 4.310290790954241e-09
to O 0 7.697058962419234e-11
the O 0 1.5648640161458616e-09
canine O 0 4.121218566410789e-08
chromosome O 0 6.346935421674971e-09
regions O 0 4.341727866119527e-09
CFA22q11 O 0 1.7447229083700222e-06
and O 0 2.741626370372785e-10
CFA10q26 O 0 2.4148794182110578e-06
, O 0 2.051006239844888e-11
respectively O 0 1.329232696134497e-10
, O 0 1.6697850784355706e-12
demonstrating O 0 2.8592793063775268e-11
that O 0 4.520009366792976e-12
WD B-Disease 0 4.892630727226788e-07
cannot O 0 2.1764638979959727e-09
be O 0 6.342656955204973e-11
homologous O 0 2.9272487211962073e-10
to O 0 1.3765379947017209e-09
CT B-Disease 0 2.2225402062758803e-05
. O 0 2.3470040133588554e-08

The O 0 9.258077966478595e-07
copper O 0 2.4581848265370354e-05
transport O 0 2.6658376555133145e-06
genes O 0 1.1738466554334082e-07
CTR1 O 1 0.8547223806381226
and O 0 5.8635327704337215e-09
CTR2 O 1 0.9999854564666748
were O 0 3.9485254177407114e-08
also O 0 2.1792667670439414e-10
excluded O 0 2.714121016822446e-08
as O 0 1.1788939824342037e-09
candidate O 0 1.8019386871515053e-08
genes O 0 5.407774922305819e-11
for O 0 6.821581060439952e-12
CT B-Disease 0 7.411905471599312e-07
since O 0 2.694102718692193e-09
they O 0 2.613933236528254e-10
both O 0 8.263238010508545e-11
mapped O 0 3.2078011358294134e-09
to O 0 9.923307731085629e-10
canine O 0 7.985203751559311e-07
chromosome O 0 3.1191356697490846e-07
region O 0 1.0921500148697305e-07
CFA11q22 O 0 0.0003510548558551818
. O 0 5.486471650328895e-07

2 O 0 4.228281795803923e-06
- O 0 1.0983749234583229e-06
22 O 0 1.1879396311087476e-07
. O 0 1.076865441262953e-08

5 O 0 6.915854100952856e-06
. O 0 1.8504307774946938e-07

A O 0 7.344736019376796e-08
transcribed O 0 5.627082688697271e-10
sequence O 0 1.7254279602307854e-11
identified O 0 7.207361877453744e-12
from O 0 2.201385341377149e-12
the O 0 2.7053099344032105e-11
C04107 O 0 2.079913308250525e-08
- O 0 1.4552122840072457e-09
containing O 0 3.151466310136186e-10
BAC O 0 1.6697508442575781e-07
was O 0 2.7382029976763533e-10
found O 0 2.691130304710576e-12
to O 0 6.464233445399592e-13
be O 0 2.1110799740264863e-12
homologous O 0 7.100766589301921e-12
to O 0 3.021014688409096e-11
a O 0 2.3940077351070066e-11
gene O 0 4.608888271029343e-11
expressed O 0 3.2548427841838645e-10
from O 0 1.1864682847306796e-10
human O 0 9.295003655651612e-11
chromosome O 0 1.5705924061304444e-10
2p13 O 0 1.3343881555272219e-08
- O 0 6.98173185931239e-10
p16 O 0 5.574577466305186e-10
, O 0 9.55307989831955e-13
a O 0 3.320806628813455e-13
region O 0 5.455544696553183e-11
devoid O 0 1.8381998145855505e-09
of O 0 2.3343202371073346e-12
any O 0 4.698571393069173e-11
positional O 0 1.4388086810868117e-07
candidate O 0 6.384354492183775e-06
genes O 0 6.482349590442027e-08
. O 0 2.977389890190807e-08

Molecular O 0 8.793340500190538e-10
analysis O 0 4.2851045628511386e-11
of O 0 1.0137412437272175e-10
the O 0 1.537532434703337e-09
APC B-Disease 0 5.788084234126245e-09
gene O 0 5.31279404150653e-12
in O 0 9.836556916220651e-12
205 O 0 7.149531661143627e-11
families O 0 3.673648191204748e-12
: O 0 1.357571553003284e-13
extended O 0 1.1960846757474997e-09
genotype O 0 4.541925946455194e-08
- O 0 7.413292024693874e-08
phenotype O 0 8.298709275322835e-08
correlations O 0 3.587301344865068e-09
in O 0 6.3880120811099506e-12
FAP B-Disease 0 2.637376983471995e-09
and O 0 8.165725582688632e-14
evidence O 0 1.3551835977183846e-13
for O 0 1.4989611724709924e-14
the O 0 2.729553508131616e-13
role O 0 2.192255058042214e-12
of O 0 6.048593570451288e-11
APC B-Disease 0 1.0219304291680942e-09
amino O 0 7.700819149025762e-11
acid O 0 9.343623652569022e-10
changes O 0 1.0988153320568017e-07
in O 0 0.08939383924007416
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999171495437622
. O 0 1.532458554720506e-06

BACKGROUND O 0 0.023029929026961327
/ O 0 2.8189683689561207e-06
AIMS O 0 8.511548088563359e-08
The O 0 2.477949234691579e-10
development O 0 1.4668894543490296e-08
of O 0 2.91526657747454e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.1369089697454982e-11
a O 0 3.643499008900396e-14
variable O 0 1.0738604016430342e-12
range O 0 6.358457597249734e-13
of O 0 1.7662120951975752e-13
extracolonic O 0 1.6322967866244653e-08
manifestations O 0 3.2833074214977387e-07
in O 0 3.942874400308938e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 1.0
( O 0 4.351489307774514e-11
FAP B-Disease 0 7.700326598580887e-09
) O 0 8.959079680383175e-14
is O 0 3.958895199645618e-15
the O 0 8.077579776658971e-15
result O 0 1.0116656861194895e-12
of O 0 9.165758430018656e-12
the O 0 1.5277504261668184e-10
dominant O 0 4.0379399024459417e-07
inheritance O 0 4.227345925755799e-06
of O 0 7.10603671905119e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.999998927116394
coli I-Disease 1 1.0
( O 0 1.7535007890145948e-09
APC B-Disease 0 6.944895858396194e-08
) O 0 9.222621000226638e-10
gene O 0 2.314206160036747e-09
mutations O 0 4.5253923275367924e-08
. O 0 9.589340521642953e-08

In O 0 4.044957702120655e-10
this O 0 5.018533765638322e-12
study O 0 2.482535444575662e-12
, O 0 5.878609824269817e-15
direct O 0 9.235207000177215e-14
mutation O 0 1.2917596679817844e-13
analysis O 0 5.911041513033399e-13
of O 0 3.161700068421425e-11
the O 0 7.566426596383735e-09
APC B-Disease 0 3.5552883304035277e-08
gene O 0 2.5530114133864856e-10
was O 0 7.003128743576781e-09
performed O 0 6.544110253692281e-10
to O 0 1.9983462801187457e-11
determine O 0 2.06365546873144e-09
genotype O 0 2.7930386181651556e-07
- O 0 2.481807257481705e-07
phenotype O 0 1.2648615665966645e-07
correlations O 0 3.738408693720885e-09
for O 0 3.4160623548634694e-12
nine O 0 1.6997115520611672e-11
extracolonic O 0 1.1380947029238087e-07
manifestations O 0 7.658512402031192e-08
and O 0 1.70371685509485e-11
to O 0 6.446724664516124e-13
investigate O 0 4.576125069155612e-12
the O 0 1.377791435629161e-12
incidence O 0 2.422191613948854e-10
of O 0 1.2183354325401297e-10
APC B-Disease 0 7.035863447413249e-09
mutations O 0 5.828050819722819e-10
in O 0 4.4599919313270675e-09
non O 1 1.0
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.615198119812703e-07

METHODS O 0 1.6679921372997342e-06
The O 0 1.6773223876498378e-07
APC B-Disease 0 1.1882228534432215e-07
gene O 0 8.952227154024328e-11
was O 0 8.177458710179053e-11
analysed O 0 3.018608696336855e-10
in O 0 3.909049299533063e-12
190 O 0 3.7392387797208215e-11
unrelated O 0 3.0530727945787817e-10
FAP B-Disease 0 3.093409972620975e-08
and O 0 9.705171562235382e-12
15 O 0 1.6273997704985277e-09
non O 1 0.8401771187782288
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.1025374508099048e-07
using O 0 1.1332631014160377e-11
denaturing O 0 1.493743440050821e-07
gradient O 0 2.376640928503093e-08
gel O 0 5.078637954625265e-09
electrophoresis O 0 2.055648151699785e-10
, O 0 5.592367714746249e-12
the O 0 2.5895667554731716e-11
protein O 0 6.300528848646181e-11
truncation O 0 3.964423900271186e-09
test O 0 7.312913608004123e-10
, O 0 3.412773535993452e-12
and O 0 7.51694279738091e-13
direct O 0 2.5127872005370477e-11
sequencing O 0 3.966291739487815e-09
. O 0 5.576962447406686e-09

RESULTS O 0 0.00019443550263531506
Chain O 0 6.478542502463824e-08
terminating O 0 7.492412379406233e-08
signals O 0 4.702395361988465e-09
were O 0 3.764988321108831e-11
only O 0 5.155908794525488e-13
identified O 0 3.832878459064659e-12
in O 0 4.1125098118599546e-12
patients O 0 2.2549249967251939e-10
belonging O 0 7.366829585589429e-13
to O 0 1.2970708491641392e-12
the O 0 2.114903807637347e-09
FAP B-Disease 0 0.0003908390935976058
group O 0 6.506510330517301e-10
( O 0 1.934175259191151e-12
105 O 0 2.716487834675263e-08
patients O 0 6.346499326070898e-09
) O 0 2.518836918555256e-12
. O 0 1.5758503391083423e-09

Amino O 0 1.1236979702289318e-07
acid O 0 3.0553930496779458e-09
changes O 0 1.6514203338147126e-09
were O 0 9.962145552933066e-10
identified O 0 5.302096955928093e-11
in O 0 1.6932625440668758e-11
four O 0 2.042023451373498e-12
patients O 0 2.9067465101562107e-10
, O 0 4.0064522879856845e-13
three O 0 6.135664892825687e-13
of O 0 1.0494789037807095e-08
whom O 0 3.7143590247978864e-07
belonged O 0 4.946433662667005e-08
to O 0 1.8729173767439988e-10
the O 0 3.247875568490599e-08
non O 1 0.6365019679069519
- O 0 0.00017476598441135138
FAP O 0 2.1886720787733793e-05
group O 0 2.4475205195884087e-10
of O 0 2.4686913846494463e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 8.290867117466405e-05
. O 0 1.5490424942754544e-08

Genotype O 0 0.00029624957824125886
- O 0 5.8921566960634664e-05
phenotype O 0 1.295054630645609e-06
correlations O 0 3.147996707753009e-08
identified O 0 4.005541454077388e-10
significant O 0 6.887782011411048e-10
differences O 0 7.19615300681653e-08
in O 0 4.625234917288168e-10
the O 0 2.395456888404368e-10
nature O 0 1.78409204076857e-10
of O 0 9.638189552019227e-12
certain O 0 3.747687438160341e-10
extracolonic O 0 4.669435895721108e-07
manifestations O 0 4.0959534430839994e-08
in O 0 2.486622852071463e-10
FAP B-Disease 0 1.351460241494351e-07
patients O 0 1.5228519556487186e-09
belonging O 0 1.7120421833688448e-12
to O 0 4.309281664144349e-12
three O 0 2.8163358797850258e-11
mutation O 0 5.369538769173232e-08
subgroups O 0 4.737873666726955e-07
. O 0 1.421589868044748e-08

CONCLUSIONS O 0 2.243665949208662e-05
Extended O 0 3.6309024835645687e-06
genotype O 0 1.103466956919874e-06
- O 0 2.729696575443086e-07
phenotype O 0 3.587487995559968e-08
correlations O 0 4.5205739152009983e-10
made O 0 4.166625378054789e-12
in O 0 8.293055370027502e-13
this O 0 3.254825337202505e-13
study O 0 6.89026797857234e-13
may O 0 1.6569211280792473e-11
have O 0 1.1187514456501013e-11
the O 0 3.336301027112576e-11
potential O 0 3.389118152785642e-11
to O 0 7.125159837140238e-12
determine O 0 4.3771891666821716e-10
the O 0 1.8678658619819544e-10
most O 0 1.4439111364894508e-11
appropriate O 0 3.3488881112653246e-10
surveillance O 0 1.8869670270760253e-09
and O 0 1.491514203810773e-11
prophylactic O 0 1.9795122625509975e-06
treatment O 0 6.817573989792436e-07
regimens O 0 1.4893650757130672e-07
for O 0 6.468506980050748e-11
those O 0 1.4037252471510442e-09
patients O 0 1.5053397417474912e-09
with O 0 4.0519009588541044e-13
mutations O 0 8.080889256356638e-12
associated O 0 7.745338259645962e-10
with O 0 5.6617027038852186e-11
life O 0 5.1731213090988604e-08
threatening O 0 4.036006373553391e-08
conditions O 1 0.9927621483802795
. O 0 1.0383168955740985e-06

This O 0 3.1974227709952174e-09
study O 0 9.260938543809161e-11
also O 0 9.494039940067395e-14
provided O 0 8.630385495882534e-14
evidence O 0 3.439033183661594e-13
for O 0 1.888525821185441e-13
the O 0 4.141376824806642e-11
pathological O 0 3.3090964279836044e-07
nature O 0 6.30726471051446e-10
of O 0 3.925758329526019e-11
amino O 0 9.204125309136835e-12
acid O 0 3.216645005910124e-11
changes O 0 9.811177426044537e-10
in O 0 1.9197559097960948e-09
APC O 0 5.888806331455498e-09
associated O 0 8.84984141524825e-10
with O 0 3.0989017775484573e-12
both O 0 8.232890758019806e-11
FAP B-Disease 0 3.617042807491089e-07
and O 0 9.164474734646433e-10
non O 1 0.9910545945167542
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 9.534892342344392e-06
. O 0 1.4180137619668187e-10
. O 0 1.3284122690748745e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.00025163841200992465
cancer B-Disease 1 0.9999397993087769
risk O 0 3.0746399204417685e-08
of O 0 2.67204613990657e-09
the O 0 6.714438427479763e-08
APC O 0 6.766273941138934e-07
I1307K O 0 2.2187796275829896e-06
polymorphism O 0 5.617393981083296e-07
. O 0 3.4374551205473836e-08

Germ O 0 0.00014967804600019008
- O 0 1.7446762967665563e-06
line O 0 2.2865921778247866e-07
and O 0 3.395834655139929e-11
somatic O 0 1.0437720021627683e-07
truncating O 0 1.875137769502544e-07
mutations O 0 1.0123910598736074e-09
of O 0 1.5748820303418398e-10
the O 0 1.2966102636013943e-09
APC B-Disease 0 2.2718241510233383e-08
gene O 0 7.338116225774627e-11
are O 0 4.883093061847088e-12
thought O 0 2.7663336898964275e-11
to O 0 7.601233011078623e-12
initiate O 0 2.1851668918770883e-08
colorectal B-Disease 1 1.0
tumor I-Disease 0 1.440633582205919e-06
formation O 0 1.3235826656909921e-07
in O 0 3.29347756178322e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 4.70599206892075e-06
sporadic O 1 0.7510415315628052
colorectal O 1 1.0
carcinogenesis O 1 0.9999617338180542
, O 0 8.347170954436933e-09
respectively O 0 7.287592751481498e-08
. O 0 1.3439132828807487e-07

Recently O 0 4.731303988592117e-07
, O 0 5.097722244329361e-11
an O 0 4.754079074853479e-13
isoleucine O 0 2.839169344071024e-09
- O 0 6.3379470560676054e-09
- O 0 1.5949712661722515e-08
> O 0 1.4378972679196522e-08
lysine O 0 2.7824234027917782e-09
polymorphism O 0 1.3003072230066692e-10
at O 0 1.9955799165916055e-12
codon O 0 6.963442322760471e-11
1307 O 0 9.757918917330244e-09
( O 0 2.3085979200358764e-13
I1307K O 0 1.3569607659746907e-09
) O 0 3.8447234762192806e-13
of O 0 7.135893959064887e-11
the O 0 2.2901216478743436e-09
APC B-Disease 0 1.5992146273902108e-08
gene O 0 1.8144215296889143e-10
has O 0 6.258031853140222e-12
been O 0 4.9652625760954194e-12
identified O 0 7.122713877039111e-12
in O 0 3.2428057634981133e-12
6 O 0 1.335637017652047e-10
% O 0 1.1776830595791599e-12
- O 0 6.024871140181132e-12
7 O 0 3.236967638375887e-11
% O 0 2.6711337135221225e-13
of O 0 1.7860809131600014e-13
the O 0 1.4610123874603254e-11
Ashkenazi O 0 1.157540108209787e-08
Jewish O 0 9.478991813693938e-09
population O 0 2.3983448907416438e-11
. O 0 7.344183039492691e-10

To O 0 1.1611727135374394e-09
assess O 0 2.0526803368170476e-08
the O 0 2.6492694149560236e-10
risk O 0 1.3445422553104436e-10
of O 0 4.062117395925435e-12
this O 0 2.9042937759599097e-12
common O 0 2.8757558556691265e-09
APC B-Disease 0 2.208910210299564e-08
allelic O 0 4.174819423496956e-08
variant O 0 9.699915892724675e-08
in O 0 2.2584873704545316e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9993070363998413
, O 0 4.450813939627096e-09
we O 0 1.8416768110540715e-10
have O 0 2.6737449060343366e-12
analyzed O 0 1.827423976030751e-11
a O 0 1.6270270992036623e-13
large O 0 6.815780145136285e-12
cohort O 0 2.527599463064689e-09
of O 0 1.8338486978963786e-11
unselected O 0 0.0005560978897847235
Ashkenazi O 0 6.444109885705984e-07
Jewish O 0 1.6506503186519694e-07
subjects O 0 9.776403686601043e-08
with O 0 6.111645217687922e-11
adenomatous B-Disease 0 2.7670932922774227e-06
polyps I-Disease 0 1.8495451570288424e-07
and O 0 2.0383170151738739e-10
. O 0 1.0792692073380294e-08
or O 1 0.9999982118606567
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 7.197556439741959e-11
for O 0 5.636487370591636e-12
the O 0 3.417488292356552e-09
APC O 0 8.774769355568424e-08
I1307K O 0 4.711187102657277e-07
polymorphism O 0 2.1119586790518952e-07
. O 0 1.220849021876802e-08

The O 0 2.2295840551578294e-07
APC O 0 3.920426081549522e-07
I1307K O 0 5.686022745976516e-07
allele O 0 9.290524460858762e-10
was O 0 1.7346385439154233e-10
identified O 0 3.333476897293686e-11
in O 0 2.8844215210765967e-11
48 O 0 2.3945259108870687e-09
( O 0 4.3257986168804274e-13
10 O 0 2.8582529138648782e-12
. O 0 3.688312947159461e-13
1 O 0 7.38259106625172e-11
% O 0 4.0376442423870063e-13
) O 0 3.3619095547943395e-15
of O 0 2.368015939585577e-12
476 O 0 7.213068897726771e-08
patients O 0 2.829122536240902e-07
. O 0 2.0066796224682548e-08

Compared O 0 5.960756777056986e-09
with O 0 2.0602138430577538e-13
the O 0 3.217262827676093e-12
frequency O 0 6.013505665647401e-12
in O 0 1.61952905513435e-12
two O 0 3.318715406110638e-14
separate O 0 1.2580103517061125e-13
population O 0 4.5271657923102657e-14
control O 0 4.14696315481633e-12
groups O 0 9.66532084402394e-13
, O 0 4.126910944056428e-13
the O 0 2.2676915900632366e-10
APC O 0 1.109208724869859e-08
I1307K O 0 1.205885382660199e-07
allele O 0 2.921576036651885e-10
is O 0 1.7021722031017317e-13
associated O 0 2.80189852439397e-13
with O 0 3.584759476293973e-15
an O 0 6.055319425912785e-16
estimated O 0 1.3882157142569573e-13
relative O 0 2.3500207335658274e-10
risk O 0 1.8592960504548728e-10
of O 0 5.643786549214269e-10
1 O 0 2.3464943410544947e-07
. O 0 3.099203738088363e-08

5 O 0 1.6625352827759343e-06
- O 0 5.095013193567866e-07
1 O 0 1.1793584064889728e-07
. O 0 8.21617707202904e-09

7 O 0 7.31106467810605e-07
for O 0 5.1789528221490855e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9995287656784058
( O 0 5.429501848119855e-10
both O 0 1.794724369119649e-09
P O 0 2.9672983146156184e-06
= O 0 2.0130221101144485e-10
. O 0 1.1197056302980624e-11
01 O 0 1.0702061459255674e-09
) O 0 1.781930505928564e-12
. O 0 7.671063229075514e-10

Furthermore O 0 4.508721218599021e-08
, O 0 2.7016075140884332e-11
compared O 0 3.9328201806299035e-10
with O 0 5.280949722658024e-12
noncarriers O 0 3.879121140926145e-05
, O 0 2.8349000924521306e-09
APC O 0 7.540511148818041e-08
I1307K O 0 2.2624281825756043e-07
carriers O 0 3.7939187902402693e-10
had O 0 7.302230001227095e-12
increased O 0 7.800660291323869e-12
numbers O 0 5.733359967341478e-11
of O 0 1.307182972976051e-10
adenomas B-Disease 0 0.00047451426507905126
and O 0 6.163543275761185e-07
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.8389820456504822
per O 0 1.8373461330156715e-07
patient O 0 1.142449036706239e-05
( O 0 2.489762085736147e-12
P O 0 8.008814056381652e-09
= O 0 1.509279138299513e-12
. O 0 3.107862003772638e-13
03 O 0 1.3378749497139353e-11
) O 0 1.8287392203309404e-14
, O 0 1.5995217032393344e-13
as O 0 1.0705801479701793e-12
well O 0 1.4662598392389814e-12
as O 0 7.877598313249523e-13
a O 0 3.698204936730676e-12
younger O 0 4.081305959857673e-09
age O 0 4.5066554932304825e-09
at O 0 3.9766143156150235e-10
diagnosis O 0 8.035408427531365e-07
. O 0 6.658171969320392e-08

We O 0 4.4460626291709104e-09
conclude O 0 1.1478269001941044e-08
that O 0 1.6691738052507232e-12
the O 0 1.5684789578251923e-10
APC O 0 5.746879594425991e-08
I1307K O 0 5.732231329602655e-07
variant O 0 7.693605539316195e-07
leads O 0 3.4097745071903773e-08
to O 0 7.622229930559499e-11
increased O 0 7.85912845913117e-08
adenoma B-Disease 1 1.0
formation O 0 2.8676458896370605e-06
and O 0 8.942110940601822e-10
directly O 0 6.639837984989683e-11
contributes O 0 1.2545108181438724e-11
to O 0 7.0931016052031e-13
3 O 0 5.6622210392598404e-11
% O 0 5.172999615471463e-13
- O 0 2.162284891069066e-12
4 O 0 6.4911587389915315e-12
% O 0 7.022947354955525e-14
of O 0 2.828540997072953e-14
all O 0 1.8897160312253414e-12
Ashkenazi O 0 4.899031864624703e-07
Jewish O 0 0.10371579974889755
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.899449498272588e-07

The O 0 6.644772287955902e-09
estimated O 0 2.8242017058310864e-10
relative O 0 1.2309078201155899e-08
risk O 0 6.215416514798733e-10
for O 0 6.8353738467974434e-12
carriers O 0 5.08162956158742e-10
may O 0 6.932858731545366e-10
justify O 0 9.996521388444535e-10
specific O 0 6.668902929884979e-11
clinical O 0 2.8238234667243844e-11
screening O 0 1.8749976571363902e-10
for O 0 1.5390791939517978e-12
the O 0 5.427925470202766e-11
360 O 0 8.79175968138135e-11
, O 0 1.5243017893913635e-13
000 O 0 4.47006841264308e-12
Americans O 0 1.0875211863860257e-14
expected O 0 1.1040311460180918e-12
to O 0 2.6825091627158404e-13
harbor O 0 2.25493046457359e-09
this O 0 1.9012055384876048e-12
allele O 0 1.2933560472605521e-11
, O 0 8.044193024366042e-13
and O 0 1.488437601252987e-13
genetic O 0 1.2306370928815563e-13
testing O 0 3.844019286908251e-13
in O 0 3.434556241840858e-13
the O 0 5.935289152519951e-12
setting O 0 1.0243580428337395e-09
of O 0 1.1286474532745672e-10
long O 0 1.3170125580386216e-11
- O 0 1.3381301275372515e-11
term O 0 2.5850044327313526e-09
- O 0 1.2286641148939736e-10
outcome O 0 3.0548221729986835e-09
studies O 0 8.449978455664364e-13
may O 0 4.952387241616285e-13
impact O 0 6.255111012487546e-11
significantly O 0 1.5058710687299026e-06
on O 1 0.9935989379882812
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 3.414252773836779e-07
in O 0 6.880877703556443e-13
this O 0 8.120950201369326e-13
population O 0 2.072978290759697e-12
. O 0 1.8513762745087092e-10

Localization O 0 7.098856826814881e-07
of O 0 5.316167950297768e-09
human O 0 4.5117104496839033e-10
BRCA1 O 0 1.819988826312624e-09
and O 0 6.252651174598611e-12
its O 0 3.3024026221961655e-12
loss O 0 9.150775970301339e-11
in O 0 6.071745883851065e-11
high O 0 2.0396885247464525e-07
- O 0 9.61143875599646e-09
grade O 0 2.3209312871586008e-07
, O 0 1.7633124127502953e-11
non B-Disease 0 0.00046555843437090516
- I-Disease 1 0.9998699426651001
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 9.370789484819397e-06

Although O 0 4.186930802063671e-09
the O 0 1.9020704455918747e-10
link O 0 3.1082697526940706e-10
between O 0 1.907945884616069e-10
the O 0 4.86033480129322e-09
BRCA1 O 0 2.568085655241248e-08
tumour B-Disease 1 1.0
- O 0 3.914885553513159e-07
suppressor O 0 7.537764901144328e-08
gene O 0 1.1052942588962722e-10
and O 0 4.9939771068485683e-11
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.1234149895067436e-11
established O 0 1.1914703598736587e-11
, O 0 7.38325484192677e-14
the O 0 2.0387894931334083e-12
role O 0 1.9739793567091768e-12
, O 0 2.3660150986863637e-13
if O 0 1.2900901321614283e-13
any O 0 1.3659096640208923e-12
, O 0 1.8583854073661588e-13
of O 0 8.053592515100405e-12
BRCA1 O 0 1.5195320002270307e-10
in O 0 1.1463642535236573e-10
non B-Disease 1 0.9214771389961243
- I-Disease 1 0.9999902248382568
familial I-Disease 1 0.9988849759101868
cancers I-Disease 1 0.9999978542327881
is O 0 5.686597304155327e-10
unclear O 0 3.3268764809690765e-07
. O 0 1.940760618879267e-08

BRCA1 O 0 4.089887170266593e-06
mutations O 0 7.264648882454594e-09
are O 0 4.8296562062122295e-12
rare O 0 7.721232681001666e-11
in O 0 1.360188767174364e-10
sporadic B-Disease 0 1.3793426205666037e-06
cancers I-Disease 0 2.335988756385632e-05
, O 0 1.3651946240145207e-10
but O 0 3.5446559021323765e-09
loss O 0 2.04698972083861e-06
of O 0 0.00014627582277171314
BRCA1 O 0 2.4969434520016875e-08
resulting O 0 1.1852384629307267e-09
from O 0 2.6253339779902518e-11
reduced O 0 3.927243252821455e-10
expression O 0 2.7367190111315942e-11
or O 0 4.0066071120559155e-12
incorrect O 0 2.922662667437237e-10
subcellular O 0 9.839483539053617e-08
localization O 0 6.013127062942658e-08
is O 0 8.132467138946553e-13
postulated O 0 2.3923460434893684e-11
to O 0 2.0525996944882954e-14
be O 0 1.1303428523311721e-14
important O 0 1.11263288079394e-12
in O 0 4.9574745350500216e-12
non B-Disease 0 8.619958680355921e-05
- I-Disease 1 0.9999706745147705
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 7.46418081689626e-05

Epigenetic O 0 0.00016781699378043413
loss O 0 5.293902177072596e-06
, O 0 3.250499869267287e-10
however O 0 4.415231791288221e-10
, O 0 1.046436700312403e-12
has O 0 6.386041004948504e-15
not O 0 6.396671268436545e-15
received O 0 5.139051077046597e-13
general O 0 1.4593726227474235e-10
acceptance O 0 1.882338196423916e-08
due O 0 5.8018592596909e-08
to O 0 3.3669154270166146e-11
controversy O 0 2.0204855566419155e-09
regarding O 0 5.162500427147165e-10
the O 0 2.0724742755273695e-10
subcellular O 0 5.988638804410584e-06
localization O 0 7.982768875081092e-05
of O 0 5.176734134693106e-07
BRCA1 O 0 6.270646668582458e-09
proteins O 0 1.8171150348300635e-11
, O 0 2.224591821517463e-12
reports O 0 5.536362167324338e-12
of O 0 8.155958547417796e-12
which O 0 2.0814331161411737e-12
have O 0 4.9514927748239845e-12
ranged O 0 3.960072803010917e-08
from O 0 2.939113188937803e-11
exclusively O 0 4.059493713404194e-11
nuclear O 0 5.525230939440462e-09
, O 0 1.5727559879441522e-11
to O 0 1.0975523441481005e-11
conditionally O 0 5.8780900147326065e-09
nuclear O 0 1.6377073919215945e-08
, O 0 3.3524123147637974e-12
to O 0 3.3667209645149576e-12
the O 0 1.5083690962924834e-09
ER O 0 6.549680256284773e-05
/ O 0 1.3337494664256155e-08
golgi O 0 3.2931197324614914e-07
, O 0 1.9649346386096944e-11
to O 0 2.9465221929037e-11
cytoplasmic O 0 1.774936286835782e-08
invaginations O 0 1.3363132893573493e-06
into O 0 4.569457590086756e-10
the O 0 4.063950564958674e-10
nucleus O 0 1.900397172960311e-08
. O 0 1.44242955357754e-08

In O 0 1.957978001954075e-09
an O 0 3.2407017065520793e-13
attempt O 0 7.774921678693758e-11
to O 0 8.90126167218952e-12
resolve O 0 6.003186281411388e-10
this O 0 4.288258550338986e-12
issue O 0 1.3069292315037728e-09
, O 0 1.3535027048802717e-12
we O 0 4.809928063481683e-12
have O 0 7.537506209465139e-12
comprehensively O 0 2.2390874221400736e-07
characterized O 0 4.1235928449623316e-08
19 O 0 3.153947147893632e-08
anti O 0 1.3189297760618501e-06
- O 0 2.0359961126814596e-05
BRCA1 O 0 4.356728311449842e-08
antibodies O 0 6.099016847116445e-09
. O 0 1.2313868147373341e-08

These O 0 6.417000708580645e-09
reagents O 0 9.545016155243502e-08
detect O 0 4.036043055322125e-09
a O 0 2.1552202730812375e-11
220 O 0 2.359042960975444e-10
- O 0 5.126762903095994e-10
kD O 0 1.8719763517083265e-08
protein O 0 4.3354692058628075e-10
localized O 0 1.0301523190037187e-08
in O 0 2.8702637488997595e-10
discrete O 0 5.606345609976415e-09
nuclear O 0 1.2220026235354453e-07
foci O 0 4.7434801331291965e-07
in O 0 1.110587871666624e-10
all O 0 5.525570018899417e-12
epithelial O 0 3.098285850100524e-09
cell O 0 7.924870759623559e-10
lines O 0 3.8384552480952294e-11
, O 0 3.3075305054487344e-14
including O 0 8.655938108208944e-14
those O 0 5.651795437905394e-12
derived O 0 1.301434293665693e-09
from O 0 2.8937108709214954e-08
breast B-Disease 0 1.3621157449961174e-05
malignancies I-Disease 0 4.951898517902009e-06
. O 0 2.9027381387436435e-08

Immunohistochemical O 0 6.342044071061537e-05
staining O 0 2.8573254894581623e-05
of O 0 1.4520030333642353e-07
human O 0 3.438101714436925e-07
breast O 0 0.030142556875944138
specimens O 0 1.196053176499845e-06
also O 0 5.750162568318729e-10
revealed O 0 1.1738634242419721e-07
BRCA1 O 0 1.1307704284035935e-07
nuclear O 0 4.314907542379842e-08
foci O 0 2.139924930588677e-07
in O 0 4.823714205848262e-10
benign O 1 0.9999868869781494
breast O 1 0.9995930790901184
, O 0 1.902123258901156e-08
invasive B-Disease 1 0.9999502897262573
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 1.7156436342702364e-06
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.1025288586097304e-05

Conversely O 0 7.586293577332981e-06
, O 0 8.016318275849699e-09
BRCA1 O 0 3.8990921602533035e-09
expression O 0 9.406238982156978e-11
was O 0 1.3011532129514336e-10
reduced O 0 5.435117911289922e-10
or O 0 3.709423393449818e-12
undetectable O 0 1.4772259804285426e-10
in O 0 1.606291380289171e-12
the O 0 2.3612192930067e-12
majority O 0 8.284218580220659e-13
of O 0 2.245019101176915e-11
high O 0 1.74471153968625e-07
- O 0 3.779312294227566e-07
grade O 0 0.00015852900105528533
, O 0 6.217174330913622e-09
ductal B-Disease 1 0.9999979734420776
carcinomas I-Disease 1 1.0
, O 0 2.33721403342102e-10
suggesting O 0 2.0953698776082774e-09
that O 0 2.315241227901499e-11
absence O 0 2.092574504786171e-06
of O 0 4.2815329948098224e-07
BRCA1 O 0 2.8385249706275317e-09
may O 0 8.296481557312774e-11
contribute O 0 7.764899834228345e-12
to O 0 1.479229065626253e-12
the O 0 1.95170095362851e-11
pathogenesis O 0 1.2628601275821438e-08
of O 0 2.01526360703308e-12
a O 0 2.2553558684263592e-13
significant O 0 5.487615570287652e-11
percentage O 0 4.645601592301318e-08
of O 0 5.057130270103016e-09
sporadic B-Disease 1 0.9992324113845825
breast I-Disease 1 0.9999988079071045
cancers I-Disease 1 0.98331218957901
. O 0 3.965303392305941e-07
. O 0 5.247130161478708e-07

